data_2ejy_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ejy _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.85 0.357 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.74 129.64 49.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.76 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.52 99.42 9.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.003 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.0 mt -89.34 146.45 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.465 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -138.59 123.16 18.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.957 0.408 . . . . 0.0 111.681 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.452 ' CE2' HD22 ' A' ' 146' ' ' LEU . 20.8 p90 -138.57 131.86 30.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.096 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -80.33 138.11 36.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.047 0.451 . . . . 0.0 111.612 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.13 111.27 12.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.19 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.86 -28.28 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.3 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.46 148.52 22.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.256 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -87.5 90.28 8.31 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.298 0.571 . . . . 0.0 110.463 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.65 153.9 11.61 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.964 -178.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -49.88 140.42 30.93 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.463 2.109 . . . . 0.0 112.247 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.438 ' HG2' ' CZ ' ' A' ' 74' ' ' PHE . 0.3 OUTLIER -55.14 -56.56 18.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 138.42 39.12 0.11 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.53 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.406 ' CA ' HD23 ' A' ' 100' ' ' LEU . 15.3 pt -160.02 158.46 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.771 0.32 . . . . 0.0 110.889 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.495 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -124.61 124.12 41.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.935 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.411 ' HA ' ' O ' ' A' ' 95' ' ' THR . 0.4 OUTLIER -128.21 158.52 37.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.15 -179.26 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.9 pttt -138.45 166.75 23.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.025 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.504 ' HA ' ' O ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -107.29 103.37 12.71 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.802 179.797 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -64.9 176.43 1.21 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.797 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -50.82 -30.1 13.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.984 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -75.95 -18.09 59.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.091 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 76.27 87.71 0.08 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.634 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 3.6 m -165.06 143.71 6.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.355 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -87.93 111.42 21.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.035 0.445 . . . . 0.0 111.463 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 7.4 m -130.43 131.03 45.02 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.395 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.509 HG13 ' HA ' ' A' ' 113' ' ' VAL . 2.4 p -59.01 106.15 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.295 0.569 . . . . 0.0 110.724 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -73.16 -22.55 60.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.994 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -173.57 136.15 0.57 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.854 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.422 ' CD1' HG21 ' A' ' 96' ' ' VAL . 12.3 mm -86.02 131.8 33.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.462 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.406 HD23 ' CA ' ' A' ' 84' ' ' ILE . 2.0 mm? -89.46 147.64 23.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.831 0.348 . . . . 0.0 111.01 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 17.0 m170 -83.16 136.54 34.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.78 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.37 -28.46 15.28 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.346 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.63 166.23 7.44 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.467 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -72.34 -25.89 61.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.666 0.269 . . . . 0.0 111.069 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 29.6 mm -76.71 -36.53 27.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.105 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -80.02 -31.19 39.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.783 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -83.46 -51.23 7.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.826 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -73.76 -43.01 60.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.836 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.99 69.54 1.22 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.471 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.59 -27.96 9.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.745 0.307 . . . . 0.0 111.045 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.82 172.61 12.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.968 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -139.88 141.84 36.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.84 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.509 ' HA ' HG13 ' A' ' 96' ' ' VAL . 7.6 p -44.97 120.57 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.499 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 110.26 -27.95 10.96 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.711 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -48.11 135.82 12.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.779 0.323 . . . . 0.0 110.92 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -94.72 120.41 34.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.336 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 148' ' ' VAL . 4.2 mp -99.19 99.03 7.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.633 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -63.92 -28.33 69.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.448 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -147.08 139.05 24.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.868 0.366 . . . . 0.0 111.198 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.418 ' CD1' ' N ' ' A' ' 120' ' ' ILE . 2.7 mp -118.51 98.74 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.953 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 64.64 28.26 13.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.651 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 92.05 7.51 64.08 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.786 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.58 128.18 34.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.717 0.294 . . . . 0.0 110.948 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -91.78 110.88 22.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.678 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 6.0 t -63.38 133.63 28.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.237 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 24.5 p -117.07 -177.42 3.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.837 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -59.68 -20.58 57.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.038 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -58.18 -165.2 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.588 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.09 134.08 46.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.917 0.389 . . . . 0.0 110.954 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.463 HG23 ' CZ ' ' B' ' 126' ' ' TYR . 0.6 OUTLIER -89.34 -18.75 7.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.16 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -44.81 -26.53 0.41 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.474 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.49 -42.14 87.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.877 0.37 . . . . 0.0 110.634 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -81.61 -39.74 24.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.229 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -56.89 -44.7 82.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.644 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.6 -48.89 52.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.78 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.7 -40.35 79.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.072 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 24.5 mmt -69.07 -33.15 73.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.018 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.71 -26.5 37.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.887 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.02 -14.07 23.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.447 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 12.6 t -59.31 156.76 12.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.838 0.351 . . . . 0.0 110.981 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -152.08 104.43 2.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.872 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 141.48 -149.3 20.98 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.646 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 7.8 mtp -87.82 114.37 24.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.869 0.366 . . . . 0.0 110.975 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.408 HG21 HD12 ' A' ' 144' ' ' ILE . 32.8 mt -85.33 130.53 36.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.97 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.4 m -113.57 114.98 27.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.448 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.452 HD22 ' CE2' ' A' ' 74' ' ' PHE . 0.4 OUTLIER -120.55 138.66 53.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.074 -179.52 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 7.1 mmtt -95.94 105.42 17.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.872 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 117' ' ' ILE . 4.2 t -122.79 158.28 27.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.057 0.456 . . . . 0.0 111.926 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 26.2 mt -134.07 133.81 22.36 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.619 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo . . . . . 0 C--N 1.346 0.398 0 C-N-CA 122.407 2.071 . . . . 0.0 112.44 -179.844 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.896 0.379 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -152.3 135.15 15.53 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 121.195 0.522 . . . . 0.0 110.017 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 126' ' ' TYR . . . . . 0.463 ' CZ ' HG23 ' A' ' 130' ' ' VAL . 39.3 m-85 -117.49 134.26 55.05 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.565 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 1.7 m -106.05 115.98 31.15 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . 0.455 ' N ' ' CD1' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.488 -177.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.951 0.405 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.08 148.25 37.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.756 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.2 tt -115.08 99.35 7.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.071 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.9 mm -89.61 110.36 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.41 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -113.05 126.66 55.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.014 0.435 . . . . 0.0 111.772 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.456 ' CZ ' HD21 ' A' ' 146' ' ' LEU . 4.5 p90 -143.17 145.42 32.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.234 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.27 139.68 36.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.014 0.435 . . . . 0.0 111.4 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -129.35 111.28 12.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.364 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.69 12.95 4.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.636 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.68 147.78 46.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.859 0.361 . . . . 0.0 111.228 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -87.76 84.57 7.03 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.249 0.547 . . . . 0.0 110.462 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -174.08 156.92 2.56 Favored Pre-proline 0 N--CA 1.447 -0.587 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.045 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -51.56 132.15 39.66 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.594 2.196 . . . . 0.0 112.4 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.449 ' HG2' ' CE1' ' A' ' 74' ' ' PHE . 0.7 OUTLIER -46.82 -34.98 5.79 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.144 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 123.56 36.41 0.64 Allowed Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.533 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.9 pt -157.02 165.39 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.787 0.327 . . . . 0.0 110.897 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.501 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -130.04 123.14 29.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.062 179.716 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.449 ' N ' ' CD1' ' A' ' 86' ' ' LEU . 4.5 mp -121.3 156.11 33.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.812 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.8 pttt -140.05 159.7 41.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.257 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.516 ' HA ' ' O ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -105.95 103.09 12.5 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.621 179.586 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -65.52 176.34 1.49 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.764 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -51.87 -26.96 11.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.876 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.0 -13.24 59.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.252 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 71.93 88.81 0.1 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.812 0.339 . . . . 0.0 110.601 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.516 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 2.6 m -166.29 141.67 4.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.483 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 11.5 p -87.79 111.44 21.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.099 0.476 . . . . 0.0 111.359 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 15.6 m -132.63 133.95 44.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.323 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.494 HG13 ' HA ' ' A' ' 113' ' ' VAL . 2.5 p -58.84 106.01 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.196 0.522 . . . . 0.0 110.729 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -71.32 -23.98 62.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.866 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.4 ' HA ' ' CG2' ' A' ' 113' ' ' VAL . 16.4 ttm180 -173.55 141.25 0.86 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.784 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.401 ' CD1' HG21 ' A' ' 96' ' ' VAL . 17.2 mm -86.06 138.84 18.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.485 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.2 mt -96.37 126.54 41.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.821 0.343 . . . . 0.0 111.005 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.423 ' HA ' ' CD2' ' A' ' 106' ' ' HIS . 0.3 OUTLIER -68.5 132.48 47.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.902 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 101.84 -27.9 18.36 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.545 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.8 166.26 17.85 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.537 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 8.8 ttp -67.88 -25.67 65.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.81 0.338 . . . . 0.0 111.068 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 19.9 mm -79.46 -32.31 14.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.969 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . 0.423 ' CD2' ' HA ' ' A' ' 101' ' ' HIS . 6.0 t-80 -81.67 -47.75 12.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.548 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.22 -42.17 98.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.558 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -87.4 -43.93 11.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.643 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.37 42.35 5.23 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.597 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.2 p -74.46 -26.14 59.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.812 0.339 . . . . 0.0 111.019 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.1 mt -140.54 172.7 12.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.033 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -140.87 140.91 34.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.82 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.494 ' HA ' HG13 ' A' ' 96' ' ' VAL . 6.0 p -44.96 120.3 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.595 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 111.23 -27.15 11.07 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.748 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.42 ' HB3' HG13 ' A' ' 148' ' ' VAL . 0.2 OUTLIER -46.99 133.38 11.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.762 0.315 . . . . 0.0 110.991 179.871 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.53 114.64 26.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.174 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 148' ' ' VAL . 4.9 mp -94.02 101.58 12.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.84 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.34 -42.43 95.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.96 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -142.72 153.02 42.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.969 0.414 . . . . 0.0 111.218 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 39.4 mt -124.01 98.77 5.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.723 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 59.05 27.72 16.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.703 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 93.87 13.46 54.82 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.617 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 74.4 m -133.64 127.97 34.08 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.894 0.378 . . . . 0.0 111.098 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -110.72 87.57 2.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.674 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.2 p -51.11 158.32 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.328 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 37.9 p -131.9 -176.44 4.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.965 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -62.13 -18.55 61.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.277 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -59.47 -109.11 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.684 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.19 133.97 52.34 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.89 0.376 . . . . 0.0 111.071 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.461 HG21 ' CE1' ' B' ' 126' ' ' TYR . 0.8 OUTLIER -89.27 -23.95 6.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.18 179.551 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.3 -26.44 0.51 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.54 -179.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -56.77 -57.5 12.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.826 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.49 -38.68 59.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.867 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -58.97 -57.7 11.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.906 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.07 -44.91 87.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.896 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.25 -34.09 75.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.083 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.01 -31.37 71.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.984 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -87.92 -24.96 23.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.129 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -90.36 -28.67 18.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.119 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 12.2 t -59.5 156.79 12.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.949 0.404 . . . . 0.0 111.033 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.4 100.12 1.95 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.797 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 149.6 -152.14 24.14 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.511 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 22.9 mtp -80.82 118.82 22.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.827 0.346 . . . . 0.0 111.052 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.42 HG23 HD12 ' A' ' 144' ' ' ILE . 46.1 mt -93.23 145.58 7.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.191 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.9 m -125.39 113.6 17.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.268 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.46 HD23 ' N ' ' A' ' 146' ' ' LEU . 1.9 mm? -115.6 134.36 55.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.13 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 7.5 mmtm -98.72 107.19 19.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.878 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 117' ' ' ILE . 10.1 t -125.49 158.29 34.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.056 0.455 . . . . 0.0 111.939 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 23.8 mt -138.21 126.57 14.17 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.768 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo . . . . . 0 C--N 1.346 0.416 0 C-N-CA 122.513 2.142 . . . . 0.0 112.299 -179.828 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.837 0.351 . . . . 0.0 110.918 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -159.87 133.25 6.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.794 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 126' ' ' TYR . . . . . 0.461 ' CE1' HG21 ' A' ' 130' ' ' VAL . 33.4 m-85 -124.47 134.91 52.91 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.426 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 127' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 85' ' ' CYS . 1.8 m -106.01 116.1 31.36 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . 0.411 HD11 ' N ' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.372 -177.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 120.932 0.396 . . . . 0.0 111.258 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.54 146.07 24.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.747 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.82 99.26 6.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.066 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.0 mp -91.43 140.96 15.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.224 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' A' ' 144' ' ' ILE . 32.4 mt-30 -135.41 132.33 37.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.113 0.482 . . . . 0.0 111.911 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.471 ' CZ ' ' CD2' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -144.98 125.97 14.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.298 179.054 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 0.0 OUTLIER -80.26 137.86 36.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.538 -179.216 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -129.07 123.9 33.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.49 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -104.03 -37.31 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.02 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.56 156.53 18.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.258 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -88.63 90.88 8.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.544 0.688 . . . . 0.0 110.565 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -147.18 141.36 15.79 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.947 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.74 144.87 41.54 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.43 2.087 . . . . 0.0 112.082 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.55 -47.01 83.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.97 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 120.74 28.75 1.67 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.755 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.8 pt -146.96 166.3 6.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.844 0.354 . . . . 0.0 110.983 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.481 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -131.18 126.47 35.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.124 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.434 ' HA ' ' O ' ' A' ' 95' ' ' THR . 0.4 OUTLIER -131.72 156.99 44.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.036 -179.467 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.3 pttt -136.16 166.78 22.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.327 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.485 ' HA ' ' O ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -111.11 103.23 11.66 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.419 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -66.94 176.67 1.98 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.819 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -47.73 -37.49 13.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.349 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -70.2 -18.17 63.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.183 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 76.56 88.51 0.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.546 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 1.7 t -162.69 139.55 7.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.46 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.65 111.47 21.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.986 0.422 . . . . 0.0 111.405 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 19.0 m -130.0 133.5 46.81 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.424 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.552 HG12 ' HA ' ' A' ' 113' ' ' VAL . 3.2 p -61.03 105.91 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.214 0.53 . . . . 0.0 110.458 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -72.98 -25.25 60.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.858 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.406 ' HA ' ' CG2' ' A' ' 113' ' ' VAL . 47.5 ttt180 -173.61 128.84 0.42 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.387 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 21.1 mt -85.84 125.51 40.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.897 0.379 . . . . 0.0 110.693 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.0 mp -83.13 135.73 34.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.146 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.419 ' HA ' ' CG ' ' A' ' 106' ' ' HIS . 32.8 t-80 -79.26 136.98 37.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.869 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 114.57 -41.44 2.18 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.388 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.3 -173.06 0.24 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.702 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 64.7 ttp -84.61 -29.69 25.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.716 0.293 . . . . 0.0 111.157 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 33.4 mm -71.56 -42.15 72.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.257 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . 0.419 ' CG ' ' HA ' ' A' ' 101' ' ' HIS . 5.5 t60 -71.49 -35.97 70.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.843 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.62 -51.0 10.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.746 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -73.15 -46.32 51.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.804 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.42 77.48 1.35 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.471 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.0 m -112.4 -30.86 7.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.804 0.335 . . . . 0.0 111.038 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.5 mp -135.53 158.29 44.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.954 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -121.19 135.31 55.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.714 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.552 ' HA ' HG12 ' A' ' 96' ' ' VAL . 7.6 p -45.28 115.01 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.473 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 112.39 -25.62 12.11 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.707 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -55.06 137.78 45.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.696 0.284 . . . . 0.0 110.808 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -91.62 123.2 34.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.908 0.385 . . . . 0.0 111.492 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.406 ' N ' ' CD1' ' A' ' 117' ' ' ILE . 3.3 mp -97.78 94.25 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.354 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -59.05 -26.14 64.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.512 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.16 138.97 25.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.901 0.381 . . . . 0.0 111.481 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.437 ' HA ' HD13 ' A' ' 146' ' ' LEU . 2.5 mp -119.88 98.67 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.56 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 61.99 26.91 16.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.619 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 92.03 13.37 57.77 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.796 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.3 m -133.58 133.69 42.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.839 0.352 . . . . 0.0 111.161 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.29 84.35 2.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.579 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.2 p -55.79 125.69 11.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.217 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 26.3 p -103.6 -168.55 1.52 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.696 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.01 -22.27 60.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.937 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -54.57 -176.1 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.685 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.6 p -59.2 134.07 56.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.926 0.393 . . . . 0.0 110.914 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.454 HG21 ' CZ ' ' B' ' 126' ' ' TYR . 0.7 OUTLIER -89.25 -20.0 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.208 179.777 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -45.6 -25.6 0.48 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.417 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -68.9 -47.77 65.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.738 0.304 . . . . 0.0 110.815 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.2 mp -81.43 -46.53 14.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.722 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -54.54 -39.55 67.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.955 0.407 . . . . 0.0 110.756 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.36 -50.08 29.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.964 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -58.25 -43.51 87.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.306 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 77.2 mmm -65.06 -37.6 88.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.964 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -74.53 -27.64 60.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.864 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -106.92 10.1 30.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.462 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 12.8 t -69.3 156.9 38.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.857 0.361 . . . . 0.0 110.846 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -144.55 113.81 6.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.815 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 130.2 -145.39 16.6 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.636 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.455 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 2.4 mtp -97.41 119.97 36.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.858 0.361 . . . . 0.0 111.188 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 73' ' ' GLN . 41.0 mt -90.23 131.75 36.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.122 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.1 m -112.87 114.26 26.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.107 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.471 ' CD2' ' CZ ' ' A' ' 74' ' ' PHE . 1.0 OUTLIER -116.96 131.2 57.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.384 -179.251 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.29 110.3 22.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.314 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.8 t -121.79 158.25 25.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.575 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 29.2 mt -140.89 130.5 13.04 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.897 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 C--N 1.347 0.467 0 C-N-CA 122.428 2.085 . . . . 0.0 112.304 -179.924 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . 0.435 ' CD ' ' CE1' ' B' ' 126' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.848 0.356 . . . . 0.0 110.988 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -155.33 135.84 13.34 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.124 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 126' ' ' TYR . . . . . 0.454 ' CZ ' HG21 ' A' ' 130' ' ' VAL . 33.1 m-85 -115.53 133.21 56.25 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.42 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 1.8 m -105.94 116.05 31.28 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . 0.46 ' N ' ' CD1' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.47 -177.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.9 p . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.777 0.322 . . . . 0.0 111.077 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 -116.06 137.83 51.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.858 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.8 tp -108.93 99.38 8.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.921 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.1 mm -90.41 118.9 36.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.601 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -113.3 127.32 56.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.0 0.428 . . . . 0.0 111.566 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -145.54 131.52 19.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.378 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.33 141.7 35.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.006 0.432 . . . . 0.0 111.299 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.8 ttpt -129.12 111.21 12.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.358 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -105.69 -22.53 4.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.277 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.54 146.09 24.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.185 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -88.36 89.82 8.14 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.259 0.552 . . . . 0.0 110.54 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -167.86 158.72 9.44 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.899 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -50.88 145.18 24.96 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.559 2.172 . . . . 0.0 112.486 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 19.2 ttm -54.27 -65.68 0.53 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.083 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 144.62 38.41 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.704 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.9 pp -163.5 164.83 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.777 0.322 . . . . 0.0 110.907 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -129.29 128.07 42.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.27 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.78 157.43 41.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.824 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -138.86 166.21 25.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.399 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.513 ' HA ' ' O ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -106.54 102.98 12.33 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.485 179.38 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.404 ' O ' ' N ' ' A' ' 92' ' ' GLN . 68.6 m-80 -67.86 176.73 2.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.613 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -49.46 -25.5 2.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.904 0.383 . . . . 0.0 111.021 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 91' ' ' LYS . 12.8 tptt -88.05 12.31 13.8 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.261 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.404 ' N ' ' O ' ' A' ' 89' ' ' ASN . 5.1 pt20 44.02 87.15 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.849 0.357 . . . . 0.0 111.258 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.513 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 1.6 m -160.33 145.05 14.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.428 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -87.83 111.63 21.6 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.932 0.396 . . . . 0.0 111.468 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.6 m -132.17 129.3 39.61 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.616 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.495 HG12 ' HA ' ' A' ' 113' ' ' VAL . 4.1 p -58.79 106.36 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.261 0.553 . . . . 0.0 110.601 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -74.44 -21.5 59.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.384 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -173.53 134.43 0.5 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.06 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 22.6 mm -86.13 103.71 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.639 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.8 mp -57.12 141.87 44.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.216 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.42 ' HA ' ' CD2' ' A' ' 106' ' ' HIS . 78.5 m-70 -78.08 136.36 37.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.819 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.23 -25.03 26.21 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.525 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.51 155.75 18.03 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.459 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 2.9 tmm? -61.26 -37.39 82.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.776 0.322 . . . . 0.0 110.983 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 35.3 mm -68.51 -32.02 53.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.185 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . 0.42 ' CD2' ' HA ' ' A' ' 101' ' ' HIS . 17.4 t60 -74.44 -54.3 7.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.774 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -42.84 94.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.743 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -77.23 -49.57 14.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.755 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.41 76.37 1.33 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.521 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -113.71 -28.77 7.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.734 0.302 . . . . 0.0 111.149 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.83 172.59 12.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.059 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.406 ' O ' HG12 ' A' ' 96' ' ' VAL . 27.2 m-70 -139.59 132.92 30.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.789 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.495 ' HA ' HG12 ' A' ' 96' ' ' VAL . 7.1 p -42.38 108.32 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.768 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 96' ' ' VAL . . . 119.03 -27.45 7.06 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.946 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -50.49 139.9 14.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.765 0.317 . . . . 0.0 110.835 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -90.77 116.78 28.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.46 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 148' ' ' VAL . 4.6 mp -96.7 101.95 12.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.503 179.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.0 mp -68.56 -27.31 65.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.481 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -148.45 141.12 24.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.93 0.395 . . . . 0.0 111.286 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.414 ' HA ' ' CD1' ' A' ' 146' ' ' LEU . 3.5 mp -119.65 99.14 7.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.818 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 62.46 25.39 15.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.716 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 99.94 1.44 56.12 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.984 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.8 m -133.62 130.59 38.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.844 0.354 . . . . 0.0 111.142 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -101.42 98.04 8.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.643 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.6 p -58.85 138.33 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.012 0.434 . . . . 0.0 111.189 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.2 p -123.14 -171.19 2.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.515 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 44.4 p-10 -50.21 -24.88 3.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.244 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.26 -166.04 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.652 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.81 133.88 45.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.883 0.373 . . . . 0.0 110.934 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.456 HG21 ' CZ ' ' B' ' 126' ' ' TYR . 0.7 OUTLIER -89.26 -20.48 7.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.282 179.738 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.0 -26.35 0.42 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.429 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.67 -50.65 73.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.766 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.5 mp -72.16 -41.73 66.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.718 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -55.38 -52.41 63.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.559 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -62.5 -34.9 77.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.529 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.78 -30.34 62.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.986 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 3.8 mmt -69.84 -32.73 71.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.823 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -85.39 -25.96 26.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.023 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -88.92 -32.64 17.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.159 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 11.9 t -59.38 150.63 25.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.012 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.94 124.33 8.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.734 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 124.08 -146.61 16.35 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.547 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 1.6 ttm -78.07 121.1 23.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.894 0.378 . . . . 0.0 111.095 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.402 HG22 HD23 ' A' ' 146' ' ' LEU . 42.8 mt -96.73 136.35 27.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.035 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 87.2 p -107.82 127.67 53.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.632 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.414 ' CD1' ' HA ' ' A' ' 120' ' ' ILE . 3.3 mm? -130.17 121.16 25.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.186 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt -95.87 105.35 17.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.837 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 117' ' ' ILE . 2.7 t -127.64 157.93 39.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.002 0.429 . . . . 0.0 111.773 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 46.1 mt -134.36 135.97 24.94 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.845 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo . . . . . 0 C--N 1.346 0.437 0 C-N-CA 122.436 2.091 . . . . 0.0 112.281 -179.985 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . 0.41 ' HD2' ' CE1' ' B' ' 126' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.048 0 CA-C-O 120.772 0.32 . . . . 0.0 110.875 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -141.21 133.07 27.47 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.231 0.538 . . . . 0.0 109.814 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 126' ' ' TYR . . . . . 0.456 ' CZ ' HG21 ' A' ' 130' ' ' VAL . 42.2 m-85 -109.9 132.34 54.24 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.575 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 1.8 m -105.98 115.95 31.1 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . 0.469 ' N ' ' CD1' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.583 -177.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.2 p . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.887 0.375 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.1 mtt85 -101.92 126.04 48.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.922 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.6 99.47 10.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.5 mp -89.37 145.27 7.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.957 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -136.7 123.11 20.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.172 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.469 ' CZ ' ' CD2' ' A' ' 146' ' ' LEU . 10.8 p90 -148.33 129.36 14.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.779 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 1.3 pt-20 -80.33 129.72 34.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.219 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.36 111.57 12.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.225 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -125.65 15.52 4.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.568 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.15 154.94 21.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.54 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -80.9 79.54 7.55 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.267 0.556 . . . . 0.0 110.001 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.14 137.87 1.66 Allowed Pre-proline 0 N--CA 1.447 -0.601 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.132 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.32 156.4 10.74 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.336 2.024 . . . . 0.0 112.258 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.429 ' HG2' ' CE1' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -59.13 -39.89 83.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.857 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 119.86 35.01 0.93 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.488 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.6 pt -152.45 154.31 8.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.77 0.319 . . . . 0.0 110.977 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.5 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -125.61 122.81 37.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.095 179.618 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.404 ' CD1' HD12 ' B' ' 128' ' ' ILE . 0.3 OUTLIER -125.17 159.23 32.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.87 -179.663 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.421 ' HB3' ' HA ' ' B' ' 125' ' ' GLU . 7.0 pttt -142.79 161.44 38.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.2 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.563 ' HA ' ' O ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -101.65 102.9 13.66 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.557 179.389 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -65.25 176.76 1.24 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.448 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -49.67 -27.64 4.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.815 0.34 . . . . 0.0 110.879 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.66 -9.18 59.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.713 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 67.79 76.43 0.27 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.902 0.382 . . . . 0.0 110.946 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.563 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 1.3 p -153.87 145.02 22.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.522 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -87.74 112.63 22.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.105 0.479 . . . . 0.0 111.292 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.5 m -132.85 130.82 40.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.378 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.468 HG13 ' HA ' ' A' ' 113' ' ' VAL . 2.6 p -58.59 106.08 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.312 0.577 . . . . 0.0 110.615 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -71.77 -23.22 61.55 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.038 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.1 mtt180 -173.45 145.92 1.3 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.591 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.4 HG13 ' HB ' ' A' ' 113' ' ' VAL . 54.0 mt -86.01 135.67 24.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.634 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -85.6 123.35 30.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.028 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -70.14 131.99 45.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.911 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.15 -24.52 28.45 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.543 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.61 -178.05 0.62 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.633 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 29.1 ttp -84.42 -27.18 27.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.707 0.289 . . . . 0.0 111.069 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 25.5 mm -78.45 -34.64 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.116 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -72.67 -45.7 57.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.914 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 29.7 ttp180 -71.96 -46.55 57.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.906 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.61 -46.89 29.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.837 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.23 75.55 1.3 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.446 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -111.28 -29.82 7.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.785 0.326 . . . . 0.0 111.104 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 mp -136.95 172.61 12.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.934 0.397 . . . . 0.0 111.034 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -139.48 134.9 32.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.741 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.468 ' HA ' HG13 ' A' ' 96' ' ' VAL . 7.1 p -42.21 113.03 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.705 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 111.75 -24.17 15.67 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.979 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.428 ' HB3' ' CG2' ' A' ' 148' ' ' VAL . 11.4 m-20 -48.95 142.79 6.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.725 0.298 . . . . 0.0 110.848 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.3 mp0 -91.69 114.77 27.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.691 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.42 HG13 ' HB ' ' A' ' 148' ' ' VAL . 4.6 mp -92.79 107.81 19.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.538 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.436 ' N ' ' O ' ' A' ' 147' ' ' LYS . 4.3 mm? -70.11 -27.97 65.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.584 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -155.05 161.0 41.44 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.046 0.45 . . . . 0.0 111.355 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.449 HG21 HD11 ' A' ' 120' ' ' ILE . 30.2 mt -142.02 98.81 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.861 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 62.83 28.33 16.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.041 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.63 -25.09 22.28 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.64 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.8 m -120.27 137.13 54.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.805 0.336 . . . . 0.0 110.979 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -93.92 21.39 6.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.205 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.1 t 58.65 156.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.266 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.5 p -137.8 172.9 12.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.777 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -59.7 -25.65 64.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.811 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -59.23 -163.06 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.48 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.3 m -67.41 134.15 50.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.936 0.398 . . . . 0.0 110.722 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.477 ' CG2' ' CZ ' ' B' ' 126' ' ' TYR . 0.4 OUTLIER -89.13 -16.34 8.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.231 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -44.24 -25.95 0.28 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.432 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -62.03 -58.93 5.99 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.516 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.426 ' N ' ' CD2' ' A' ' 133' ' ' LEU . 2.7 mm? -74.68 -39.08 62.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.336 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.407 ' HG2' ' CG2' ' B' ' 128' ' ' ILE . 7.5 tm0? -57.76 -51.28 70.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.791 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -64.29 -37.31 87.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.844 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.64 -40.35 84.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.089 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -67.08 -29.03 68.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.913 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -84.32 -30.65 25.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.996 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -104.98 10.08 34.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.378 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.36 138.76 55.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.881 0.372 . . . . 0.0 110.916 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.5 76.5 1.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.762 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 167.21 -161.37 35.2 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.383 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.52 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 4.3 ptm -85.01 120.64 26.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.923 0.392 . . . . 0.0 111.002 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.4 HG23 HD22 ' A' ' 146' ' ' LEU . 48.8 mt -95.71 134.36 33.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.354 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.1 m -111.06 113.64 26.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.032 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.469 ' CD2' ' CZ ' ' A' ' 74' ' ' PHE . 2.5 mm? -113.65 142.01 46.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.108 0.48 . . . . 0.0 111.381 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.436 ' O ' ' N ' ' A' ' 118' ' ' LEU . 10.9 mttt -110.61 105.53 14.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.63 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.428 ' CG2' ' HB3' ' A' ' 115' ' ' ASP . 5.2 p -141.62 149.66 19.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.007 0.432 . . . . 0.0 111.676 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.1 mt -125.15 121.45 25.25 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.947 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo . . . . . 0 C--N 1.346 0.433 0 C-N-CA 122.439 2.093 . . . . 0.0 112.241 -179.931 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.526 0.048 0 CA-C-O 120.935 0.398 . . . . 0.0 110.918 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . 0.421 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 3.9 mp0 -163.62 135.53 4.96 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.866 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 126' ' ' TYR . . . . . 0.477 ' CZ ' ' CG2' ' A' ' 130' ' ' VAL . 36.4 m-85 -128.54 131.66 48.25 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.572 -179.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 1.7 m -106.01 115.92 31.05 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . 0.471 ' N ' ' CD1' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.508 -177.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.788 0.327 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -107.37 161.26 14.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.904 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.4 tp -118.89 101.95 8.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.943 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 27.6 mm -89.28 126.79 42.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.915 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -122.57 123.65 41.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.276 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.459 ' CZ ' ' HG3' ' A' ' 82' ' ' MET . 10.4 p90 -149.15 130.96 15.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.539 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -82.41 137.58 34.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.079 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -129.2 111.21 12.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.366 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -125.47 11.9 4.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.706 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.7 158.59 18.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.836 0.351 . . . . 0.0 111.404 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.08 78.93 8.82 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.375 0.607 . . . . 0.0 110.297 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -167.53 149.68 5.41 Favored Pre-proline 0 N--CA 1.445 -0.702 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.152 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -64.77 160.68 39.47 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.507 2.138 . . . . 0.0 112.26 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.459 ' HG3' ' CZ ' ' A' ' 74' ' ' PHE . 15.0 ttm -51.52 -47.45 63.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.037 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 122.71 -6.51 9.68 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.603 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 32.6 pt -113.34 167.84 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.768 0.318 . . . . 0.0 110.779 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.48 ' O ' ' N ' ' A' ' 97' ' ' ALA . 18.7 m -134.27 126.26 29.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.513 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.443 ' HA ' ' O ' ' A' ' 95' ' ' THR . 0.3 OUTLIER -124.15 159.32 30.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.964 -179.463 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -136.42 164.83 27.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.102 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.537 ' HA ' ' O ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -106.51 103.21 12.61 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.951 179.71 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -64.85 176.5 1.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.665 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -52.24 -26.26 11.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.013 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.0 tptp -81.58 -8.41 59.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.325 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 67.67 89.2 0.1 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.849 0.357 . . . . 0.0 110.704 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.537 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 0.3 OUTLIER -166.31 146.28 6.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.416 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -87.88 114.98 25.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.964 0.411 . . . . 0.0 111.348 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 3.1 m -133.66 128.02 34.17 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.486 HG13 ' HA ' ' A' ' 113' ' ' VAL . 2.8 p -58.54 106.2 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.405 0.621 . . . . 0.0 110.404 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -72.67 -24.09 60.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.311 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.6 ttt85 -172.38 126.92 0.53 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.859 0.361 . . . . 0.0 111.175 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.404 ' CD1' ' CG2' ' A' ' 96' ' ' VAL . 17.7 mm -86.17 103.69 13.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.511 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.4 mp -63.87 144.32 57.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.091 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -82.96 128.03 34.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.808 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.36 -35.08 3.88 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.484 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.41 179.33 0.55 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.611 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 12.4 ptm -84.47 -30.31 25.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.772 0.32 . . . . 0.0 110.967 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 39.5 mm -68.4 -36.54 75.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.865 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 18.5 t60 -74.43 -45.24 47.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.631 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.09 -49.8 53.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.604 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -73.79 -48.04 34.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.698 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.34 74.55 1.23 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.598 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -109.63 -30.28 7.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.824 0.345 . . . . 0.0 110.814 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -147.81 164.5 33.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.92 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -130.29 143.58 50.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.792 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.486 ' HA ' HG13 ' A' ' 96' ' ' VAL . 8.6 p -43.36 113.07 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.637 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 116.15 -24.18 10.15 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.708 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.23 134.59 14.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.717 0.294 . . . . 0.0 110.844 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 148' ' ' VAL . 10.7 mt-10 -93.6 107.84 19.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.485 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.466 HG13 ' HB ' ' A' ' 148' ' ' VAL . 2.6 mp -87.14 98.41 7.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.626 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.03 -29.49 70.86 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.018 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -156.61 147.64 22.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.821 0.343 . . . . 0.0 111.162 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 18.6 mt -122.04 107.92 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.826 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 63.05 24.43 14.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.731 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.9 0.43 58.85 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.943 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.2 m -133.6 127.47 33.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.881 0.372 . . . . 0.0 111.181 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -93.02 142.03 27.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.72 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.0 t -91.69 137.32 22.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.178 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 62.7 p -116.07 -177.0 3.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.779 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -56.88 -22.27 35.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.169 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.36 -167.34 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.713 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 42.4 m -68.25 134.07 49.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.964 0.411 . . . . 0.0 110.775 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.457 HG22 ' CZ ' ' B' ' 126' ' ' TYR . 0.6 OUTLIER -89.27 -20.14 7.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.219 179.714 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -44.76 -26.43 0.39 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.426 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.06 -57.6 10.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.831 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.7 mp -77.62 -34.68 53.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.035 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -59.76 -50.54 73.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.645 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -65.79 -44.97 84.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.69 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -65.67 -32.68 74.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.036 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 4.1 mmt -73.55 -26.37 60.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.049 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.35 -19.62 27.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.291 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.59 -23.52 13.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.432 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.4 t -59.32 147.19 36.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.821 0.343 . . . . 0.0 110.99 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -140.68 124.08 16.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.805 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 134.33 -160.02 24.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.493 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 27.8 mtp -77.31 110.17 11.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.774 0.321 . . . . 0.0 110.974 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.415 HD13 ' CE1' ' A' ' 74' ' ' PHE . 53.8 mt -85.39 128.86 38.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.234 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 71.6 m -109.28 120.95 44.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.335 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.48 ' CD2' ' N ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -123.98 132.28 53.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.993 0.425 . . . . 0.0 111.379 -179.396 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.2 105.22 17.33 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.466 ' HB ' HG13 ' A' ' 117' ' ' ILE . 6.1 p -136.04 141.9 40.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.037 0.446 . . . . 0.0 112.052 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 4.3 mt -105.45 131.58 21.63 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.643 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo . . . . . 0 C--N 1.346 0.446 0 C-N-CA 122.524 2.149 . . . . 0.0 112.322 -179.822 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . 0.423 ' HE2' ' CE1' ' B' ' 126' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.038 0 CA-C-O 121.02 0.438 . . . . 0.0 110.94 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -156.48 135.75 12.13 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.848 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 126' ' ' TYR . . . . . 0.457 ' CZ ' HG22 ' A' ' 130' ' ' VAL . 38.2 m-85 -121.54 132.04 54.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.433 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 72.3 m -105.91 116.1 31.35 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . 0.4 HD11 HD13 ' A' ' 86' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.576 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.5 p . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.857 0.361 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 9.8 ttt-85 -109.53 129.9 55.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.831 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.59 99.34 10.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.966 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.5 mm -98.47 110.4 25.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.428 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -122.27 144.22 49.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.054 0.454 . . . . 0.0 111.737 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.456 ' CZ ' ' CD2' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -153.29 145.04 23.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.271 179.132 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.22 139.07 36.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.016 0.436 . . . . 0.0 111.415 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -129.22 111.24 12.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.369 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -111.63 -28.63 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.263 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.48 150.45 21.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.306 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -89.34 91.32 8.7 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.323 0.582 . . . . 0.0 110.485 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -159.53 159.58 28.11 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.917 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.83 145.18 61.74 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.461 2.107 . . . . 0.0 112.159 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.3 mtm -54.95 -39.58 69.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.874 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.2 18.76 9.49 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.682 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 22.5 pt -127.75 165.85 25.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.731 0.3 . . . . 0.0 110.697 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -133.67 125.18 28.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.247 179.752 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.41 ' HA ' ' O ' ' A' ' 95' ' ' THR . 0.2 OUTLIER -134.1 155.8 49.41 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.364 -179.118 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.405 ' HB3' ' HA ' ' B' ' 125' ' ' GLU . 0.6 OUTLIER -131.61 166.69 20.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.054 179.766 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.546 ' HA ' ' O ' ' A' ' 93' ' ' SER . 0.1 OUTLIER -98.59 103.19 15.11 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.643 179.594 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -64.29 176.45 1.05 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.594 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.71 -30.91 24.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.07 0.462 . . . . 0.0 110.833 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.98 -1.26 43.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.211 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 62.34 86.84 0.11 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.923 0.392 . . . . 0.0 110.462 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.546 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 0.3 OUTLIER -165.57 150.11 8.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.284 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.86 114.95 24.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.036 0.446 . . . . 0.0 111.508 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 2.2 m -126.9 124.77 40.32 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.521 HG13 ' HA ' ' A' ' 113' ' ' VAL . 2.2 p -58.46 105.86 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.433 0.635 . . . . 0.0 110.504 -178.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -71.78 -24.34 61.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.761 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.402 ' HA ' ' CG2' ' A' ' 113' ' ' VAL . 11.3 tpp180 -173.52 130.0 0.44 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.736 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.413 HG21 ' CD2' ' A' ' 106' ' ' HIS . 44.4 mt -86.04 130.34 36.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.564 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.28 122.03 35.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.833 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -56.37 141.74 40.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.06 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.0 -36.9 4.05 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.429 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.25 160.09 17.81 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.634 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.5 ttp -66.28 -22.06 66.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.775 0.322 . . . . 0.0 111.044 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.428 ' CD1' ' N ' ' A' ' 105' ' ' ILE . 2.4 mp -83.11 -31.28 8.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.536 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . 0.413 ' CD2' HG21 ' A' ' 99' ' ' ILE . 1.9 t-80 -88.02 -39.6 14.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.551 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.84 -47.5 68.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.6 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -83.26 -37.4 23.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.653 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.15 46.93 4.58 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.489 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.24 -29.13 48.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.731 0.3 . . . . 0.0 111.044 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.4 mp -136.28 166.79 22.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.984 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -126.67 139.39 53.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.722 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.521 ' HA ' HG13 ' A' ' 96' ' ' VAL . 7.2 p -49.68 114.95 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.357 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 113.41 -21.49 17.02 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.837 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.413 ' HB3' ' CG1' ' A' ' 148' ' ' VAL . 6.0 m-20 -54.7 138.67 41.27 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.714 0.292 . . . . 0.0 110.821 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.408 ' HA ' HG22 ' A' ' 95' ' ' THR . 0.1 OUTLIER -93.6 120.01 33.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.911 0.386 . . . . 0.0 111.585 -179.286 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.439 ' HA ' ' HA ' ' A' ' 148' ' ' VAL . 4.4 mp -101.95 94.29 3.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.52 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.3 mp -61.73 -31.12 71.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.578 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -137.55 141.51 41.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.921 0.391 . . . . 0.0 111.353 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.42 ' HA ' HD12 ' A' ' 146' ' ' LEU . 19.8 mt -122.01 98.79 6.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.839 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 63.76 30.04 14.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.617 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 90.78 1.35 73.78 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.817 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 38.9 m -133.64 121.68 22.36 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.874 0.369 . . . . 0.0 111.136 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -88.63 120.59 30.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.647 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.7 t -63.3 136.22 26.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.21 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 73.7 p -103.96 -176.51 3.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.789 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -77.51 -16.56 58.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.23 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -61.25 -112.59 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.488 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 66.0 m -109.15 133.97 52.32 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.912 0.386 . . . . 0.0 110.944 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.464 ' CG2' ' CZ ' ' B' ' 126' ' ' TYR . 0.7 OUTLIER -89.37 -23.75 6.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.08 179.478 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -45.58 -26.66 0.63 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.404 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -57.97 -56.92 15.83 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.728 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.9 mp -73.73 -33.46 64.36 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.757 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -59.78 -56.48 21.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.586 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.7 tptp -60.51 -38.55 84.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.564 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.4 -32.62 73.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.863 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 3.4 mmt -70.38 -30.27 67.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.805 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -83.84 -28.73 27.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.901 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -98.0 -5.02 34.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.577 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.44 154.07 17.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.799 0.333 . . . . 0.0 110.856 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.05 99.14 2.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 145.92 -149.73 21.89 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.611 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 2.8 mmm -93.42 122.45 35.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.879 0.371 . . . . 0.0 111.001 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.412 HD11 HG22 ' A' ' 144' ' ' ILE . 57.2 mt -87.78 152.85 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.09 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 67.5 p -139.26 113.7 9.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.236 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.476 HD22 ' N ' ' A' ' 146' ' ' LEU . 0.5 OUTLIER -116.4 133.12 56.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.116 -179.418 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.68 105.54 17.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.947 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 117' ' ' ILE . 2.7 t -117.92 158.2 18.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.809 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 31.4 mt -136.63 133.08 18.87 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.8 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo . . . . . 0 C--N 1.346 0.415 0 C-N-CA 122.447 2.098 . . . . 0.0 112.325 -179.901 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.041 0 CA-C-O 120.99 0.424 . . . . 0.0 110.961 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . 0.405 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 0.6 OUTLIER -174.99 139.13 0.48 Allowed 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.788 179.634 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 126' ' ' TYR . . . . . 0.464 ' CZ ' ' CG2' ' A' ' 130' ' ' VAL . 29.9 m-85 -129.41 133.22 47.24 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.131 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 1.3 m -105.72 116.14 31.44 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . 0.47 ' N ' ' CD1' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.283 -0.865 . . . . 0.0 111.356 -177.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 13.6 p . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 120.834 0.35 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -101.87 145.15 29.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.821 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.7 tp -106.94 113.81 27.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.042 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.1 mm -89.31 130.11 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.861 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -119.12 123.43 44.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.962 0.411 . . . . 0.0 111.252 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.455 ' CZ ' HD22 ' A' ' 146' ' ' LEU . 19.7 p90 -150.22 132.91 15.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.624 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.492 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 22.7 tt0 -83.38 138.04 33.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.349 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -129.38 113.59 15.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.31 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.97 13.9 6.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.613 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.07 148.57 31.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.756 0.312 . . . . 0.0 110.615 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -83.61 80.29 9.17 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.202 0.525 . . . . 0.0 110.011 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.81 163.25 5.57 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.175 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.5 148.66 92.97 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.507 2.138 . . . . 0.0 112.243 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.446 ' HG2' ' CE1' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -50.38 -41.58 52.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.224 -179.88 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 127.55 6.05 5.26 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.094 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.12 165.1 26.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.814 0.34 . . . . 0.0 110.914 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.497 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -127.09 127.85 45.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.106 179.855 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 mp -130.63 158.43 40.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.816 0.341 . . . . 0.0 110.917 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.411 ' HB3' ' HA ' ' B' ' 125' ' ' GLU . 0.0 OUTLIER -138.69 162.89 33.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.179 -179.768 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.518 ' HA ' ' O ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -104.66 103.14 12.74 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.474 179.425 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -64.39 176.34 1.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.781 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -52.88 -26.43 14.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.861 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 43.8 tptt -82.54 -8.17 59.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.188 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 68.56 89.84 0.1 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.8 0.333 . . . . 0.0 110.634 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 0.2 OUTLIER -166.64 146.19 5.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.52 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.8 111.95 21.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.931 0.396 . . . . 0.0 111.428 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.6 m -129.12 126.13 38.64 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.499 HG13 ' HA ' ' A' ' 113' ' ' VAL . 3.4 p -58.8 105.99 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 121.312 0.577 . . . . 0.0 110.549 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -74.9 -22.02 58.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.443 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.3 ptt180 -171.22 131.63 0.78 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.075 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 27.3 mm -86.22 103.72 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.73 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.6 mt -60.49 131.38 50.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.042 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.422 ' HA ' ' CG ' ' A' ' 106' ' ' HIS . 2.9 p80 -75.52 146.23 40.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.909 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.21 -33.51 5.57 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.525 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.67 -179.93 1.88 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.49 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 48.9 ttp -79.72 -33.21 41.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.772 0.32 . . . . 0.0 110.87 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 23.1 mm -70.7 -33.93 54.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.997 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . 0.422 ' CG ' ' HA ' ' A' ' 101' ' ' HIS . 46.1 t-80 -78.58 -51.9 9.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.787 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.4 tpm_? -61.09 -43.35 99.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.717 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -83.05 -46.68 12.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.769 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.02 51.35 2.1 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.553 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.64 -29.36 30.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.752 0.31 . . . . 0.0 110.865 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 46.5 mt -134.41 172.21 13.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.953 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -138.04 131.72 31.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.727 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.499 ' HA ' HG13 ' A' ' 96' ' ' VAL . 8.3 p -43.72 112.78 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.595 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 116.14 -25.49 9.32 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.603 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -47.16 142.35 3.83 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.714 0.292 . . . . 0.0 110.902 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.27 111.18 23.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.428 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.4 mp -95.69 95.82 5.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.67 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -65.49 -26.04 67.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.572 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.36 145.54 30.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.926 0.393 . . . . 0.0 111.375 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.455 ' HA ' HD12 ' A' ' 146' ' ' LEU . 2.8 mp -126.14 98.79 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.639 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 60.63 28.37 18.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.524 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.51 16.48 52.5 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.578 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 58.9 m -133.65 128.61 35.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.894 0.378 . . . . 0.0 111.228 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -104.56 87.88 2.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.48 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.442 HG11 ' HB3' ' A' ' 133' ' ' LEU . 10.8 m -53.36 156.53 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.709 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 55.9 p -138.08 -172.08 3.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.743 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -55.02 -23.32 19.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.151 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -56.76 -167.69 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.806 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 m -67.55 134.03 50.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.068 0.461 . . . . 0.0 111.001 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.462 HG21 ' CZ ' ' B' ' 126' ' ' TYR . 0.4 OUTLIER -89.47 -16.23 8.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.344 179.746 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -43.6 -26.71 0.24 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.467 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.67 -43.37 69.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.979 0.419 . . . . 0.0 110.426 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.442 ' HB3' HG11 ' A' ' 125' ' ' VAL . 0.2 OUTLIER -78.58 -30.5 46.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.546 179.678 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -75.09 -54.14 7.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.999 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.6 tptt -60.7 -47.79 84.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.002 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.06 -42.47 98.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.223 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 27.4 mmt -69.3 -27.58 65.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.195 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -90.56 -25.94 19.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.271 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -93.46 -26.58 17.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.26 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 6.4 t -59.41 153.34 19.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.89 0.376 . . . . 0.0 111.006 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 24.1 mttp -143.82 114.26 7.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.764 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 142.66 -155.41 25.78 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.429 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.492 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 8.6 ptm -86.85 114.29 23.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.932 0.396 . . . . 0.0 110.995 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.462 HD11 HG21 ' A' ' 144' ' ' ILE . 45.1 mt -87.38 141.22 14.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.327 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 54.0 p -124.64 113.59 18.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.31 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.455 HD22 ' CZ ' ' A' ' 74' ' ' PHE . 0.3 OUTLIER -115.63 143.43 45.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.994 -179.566 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -97.39 105.23 17.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.837 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.4 t -122.59 158.34 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.081 0.467 . . . . 0.0 111.891 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.3 mp -133.04 134.89 24.92 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.62 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo . . . . . 0 C--N 1.346 0.397 0 C-N-CA 122.383 2.056 . . . . 0.0 112.443 -179.842 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.854 0.359 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . 0.411 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 13.2 pt-20 -153.08 134.75 14.5 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.148 0.499 . . . . 0.0 110.225 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 126' ' ' TYR . . . . . 0.462 ' CZ ' HG21 ' A' ' 130' ' ' VAL . 31.3 m-85 -116.55 134.89 54.31 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.306 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 2.0 m -106.02 115.87 30.97 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . 0.451 HG21 HD12 ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.337 -177.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.1 p . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 120.951 0.405 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -109.39 144.61 37.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.835 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 tp -117.86 99.51 6.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.99 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.2 mm -89.33 120.51 38.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.356 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -120.72 125.44 47.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.075 0.464 . . . . 0.0 111.889 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.468 ' CE2' HD22 ' A' ' 146' ' ' LEU . 10.8 p90 -141.58 132.63 26.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.065 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 1.5 pt-20 -80.24 134.26 36.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.089 0.471 . . . . 0.0 111.519 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.18 123.79 32.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.271 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -140.14 15.67 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.581 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -117.75 173.02 6.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.863 0.363 . . . . 0.0 110.831 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -97.9 81.01 2.81 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.317 0.58 . . . . 0.0 110.021 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -162.04 147.77 10.47 Favored Pre-proline 0 N--CA 1.446 -0.627 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.366 -178.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.87 160.83 48.12 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.562 2.174 . . . . 0.0 112.342 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.7 -49.0 78.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.969 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 115.86 16.48 6.83 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.748 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.6 pp -128.82 162.02 36.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.73 0.3 . . . . 0.0 110.851 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.504 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -125.31 127.39 46.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.251 179.783 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.46 157.87 37.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.803 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.0 pttt -138.96 158.15 44.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.754 0.311 . . . . 0.0 111.407 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.505 ' HA ' ' O ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -106.35 106.1 16.46 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.592 179.586 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -64.22 176.21 1.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.905 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -53.09 -29.69 31.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.914 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.2 tptm -82.52 -4.8 58.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.174 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 69.11 87.09 0.12 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.818 0.342 . . . . 0.0 110.526 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 1.4 t -157.47 136.74 11.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.353 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.79 115.21 25.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.067 0.46 . . . . 0.0 111.598 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.3 m -133.55 130.49 38.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.159 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.506 HG11 ' HA ' ' A' ' 113' ' ' VAL . 3.7 p -59.9 105.97 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.271 0.558 . . . . 0.0 110.638 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -72.62 -24.32 61.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.192 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 11.2 ptt85 -172.2 131.82 0.63 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.09 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 29.3 mm -86.15 107.2 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.675 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.2 mt -61.29 135.79 57.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.958 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -81.28 130.31 34.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.989 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.3 -27.3 9.58 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.634 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.97 179.81 10.39 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.643 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 6.3 ptm -80.95 -30.36 35.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.868 0.366 . . . . 0.0 110.965 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.6 mm -69.47 -34.99 64.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.959 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -80.42 -41.11 25.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.74 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -73.17 -50.48 22.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.714 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -73.37 -44.33 58.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.86 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.24 75.87 1.31 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.502 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.1 m -111.76 -30.63 7.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.84 0.352 . . . . 0.0 111.082 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.1 mt -143.36 170.14 16.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.988 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.404 ' O ' HG11 ' A' ' 96' ' ' VAL . 23.2 m80 -137.19 138.83 40.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.792 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.506 ' HA ' HG11 ' A' ' 96' ' ' VAL . 7.6 p -44.99 114.23 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.633 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 119.19 -29.22 6.27 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.022 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.43 ' HB3' ' CG2' ' A' ' 148' ' ' VAL . 4.8 m-20 -50.65 134.93 24.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.713 0.292 . . . . 0.0 110.68 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -92.25 108.8 20.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.942 0.401 . . . . 0.0 111.568 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.456 ' HA ' ' HA ' ' A' ' 148' ' ' VAL . 2.7 mp -86.9 99.31 8.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.718 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.422 ' N ' ' O ' ' A' ' 147' ' ' LYS . 4.0 mm? -52.06 -38.32 56.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.098 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -164.26 152.55 12.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.808 0.337 . . . . 0.0 111.374 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 26.8 mt -111.94 114.25 46.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.903 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 62.9 31.06 16.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.92 0.39 . . . . 0.0 110.659 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 83.38 19.57 62.05 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.596 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 19.3 m -133.63 111.61 10.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.832 0.348 . . . . 0.0 111.06 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -73.98 104.84 4.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.772 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.1 t -63.25 128.24 24.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.991 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 24.6 p -119.51 -170.48 1.95 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.863 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.01 -21.56 45.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.264 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 43.5 m80 -52.37 179.14 0.01 OUTLIER 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.802 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 45.6 m -63.97 133.89 54.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.009 0.433 . . . . 0.0 110.925 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.484 HG23 ' CZ ' ' B' ' 126' ' ' TYR . 0.3 OUTLIER -89.56 -24.91 5.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.165 179.765 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.453 ' HA ' ' HG2' ' A' ' 134' ' ' GLN . 7.3 t70 -46.31 -26.01 0.74 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.599 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -70.24 -41.73 73.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.252 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.1 mt -74.02 -54.03 8.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.25 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.453 ' HG2' ' HA ' ' A' ' 131' ' ' ASP . 3.8 pt20 -55.85 -43.03 76.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.817 0.341 . . . . 0.0 111.061 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm -63.91 -40.76 97.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.645 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.13 -27.17 56.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.089 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 4.6 mmt -76.34 -27.94 56.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.6 mttm -82.06 -39.15 23.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.01 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -82.58 -16.11 49.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.403 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.29 131.39 50.84 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.879 0.371 . . . . 0.0 111.045 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -119.09 87.49 2.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.689 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 167.17 -150.32 16.9 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.541 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.466 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 1.0 OUTLIER -96.61 126.22 41.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.918 0.389 . . . . 0.0 111.183 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 59.2 mt -92.64 130.63 41.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.095 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.4 m -116.93 116.79 28.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.409 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.468 HD22 ' CE2' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -117.76 142.98 46.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.261 -179.457 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 118' ' ' LEU . 7.5 mttp -104.78 108.64 20.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.505 179.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' ' 117' ' ' ILE . 2.5 p -138.19 149.7 24.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.176 0.513 . . . . 0.0 111.863 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 6.3 mm -107.63 120.0 48.72 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.528 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo . . . . . 0 C--N 1.346 0.425 0 C-N-CA 122.398 2.065 . . . . 0.0 112.359 -179.866 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 2.0 tptt . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.819 0.343 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -161.43 133.62 5.84 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.005 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 126' ' ' TYR . . . . . 0.484 ' CZ ' HG23 ' A' ' 130' ' ' VAL . 38.0 m-85 -129.02 135.87 49.54 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.555 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 1.7 m -106.05 116.04 31.25 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . 0.426 ' N ' ' CD1' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.276 -0.868 . . . . 0.0 111.485 -177.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.9 p . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.798 0.332 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.56 138.07 39.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 tp -112.1 99.33 7.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.982 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 23.0 mt -94.44 149.27 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.424 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 144' ' ' ILE . 10.4 mt-30 -145.92 135.39 23.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.036 0.446 . . . . 0.0 111.846 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.463 ' CZ ' HD21 ' A' ' 146' ' ' LEU . 2.4 p90 -145.52 130.89 18.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.204 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 3.7 tt0 -80.32 136.8 36.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.059 0.457 . . . . 0.0 111.617 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.13 116.41 19.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.29 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -96.28 -30.52 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.035 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.44 150.25 21.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.252 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -91.79 92.5 8.42 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.231 0.539 . . . . 0.0 110.61 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -163.54 159.77 17.72 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.027 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.52 136.47 40.83 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.573 2.182 . . . . 0.0 112.292 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.0 mpp? -58.34 -35.33 71.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.963 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 117.18 32.78 1.45 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.508 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.408 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 14.2 pt -151.27 158.71 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.778 0.323 . . . . 0.0 110.875 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.492 ' O ' ' N ' ' A' ' 97' ' ' ALA . 25.9 m -129.39 122.36 29.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.204 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.503 ' HA ' ' O ' ' A' ' 95' ' ' THR . 4.2 mp -116.38 159.62 21.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.955 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.62 148.25 48.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.335 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.538 ' HA ' ' O ' ' A' ' 93' ' ' SER . 0.3 OUTLIER -81.73 107.23 14.3 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.407 179.285 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -64.2 176.11 1.11 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.898 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.31 -23.27 14.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.08 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.84 17.97 20.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.958 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 56.57 82.18 0.12 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.782 0.325 . . . . 0.0 110.471 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.538 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 1.2 m -151.04 142.42 23.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.484 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -87.67 111.2 21.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.01 0.433 . . . . 0.0 111.495 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 7.0 m -128.82 130.03 46.4 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.523 HG11 ' HA ' ' A' ' 113' ' ' VAL . 3.7 p -58.7 105.7 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-O 121.355 0.598 . . . . 0.0 110.657 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -70.41 -26.65 63.78 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.955 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.2 ttt-85 -173.4 133.94 0.51 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.045 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 25.0 mm -86.07 143.04 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.577 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.408 ' CD2' ' HA ' ' A' ' 84' ' ' ILE . 0.5 OUTLIER -101.54 142.11 33.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.877 0.37 . . . . 0.0 110.956 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.425 ' HA ' ' CD2' ' A' ' 106' ' ' HIS . 43.7 m-70 -77.25 137.25 38.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.95 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.19 -24.95 26.53 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.539 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.16 161.31 11.23 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.49 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 11.8 tmm? -67.47 -22.71 65.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.705 0.288 . . . . 0.0 111.158 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 28.2 mm -84.93 -38.36 13.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.017 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . 0.425 ' CD2' ' HA ' ' A' ' 101' ' ' HIS . 75.1 t60 -76.13 -39.88 54.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.538 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 7.8 tpp85 -71.28 -45.92 62.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.563 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -79.21 -42.74 25.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.663 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.82 72.0 1.21 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.531 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.3 m -113.48 -29.4 7.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.758 0.313 . . . . 0.0 111.155 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -132.78 169.22 17.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.981 0.42 . . . . 0.0 111.113 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -143.02 132.28 23.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.572 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.523 ' HA ' HG11 ' A' ' 96' ' ' VAL . 8.3 p -41.67 110.94 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.773 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 119.09 -31.45 5.47 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.915 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -52.0 133.62 32.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.668 0.271 . . . . 0.0 110.548 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -92.75 114.47 27.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.931 0.396 . . . . 0.0 111.735 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.409 ' N ' ' CD1' ' A' ' 117' ' ' ILE . 3.2 mp -89.39 98.58 8.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.552 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -69.91 -24.38 63.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.579 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -142.79 139.04 30.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.99 0.424 . . . . 0.0 111.346 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 4.1 mp -124.28 98.66 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.727 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 62.79 28.68 16.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.714 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 96.78 -1.9 61.78 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.985 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 25.8 m -133.53 134.89 43.98 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.848 0.356 . . . . 0.0 111.158 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -103.72 105.63 15.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.679 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.7 p -56.4 137.38 18.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.213 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.1 p -117.62 -173.3 2.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.691 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -52.35 -24.31 7.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.29 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 13.8 m170 -57.31 -166.82 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.813 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.9 m -69.45 134.29 48.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.903 0.382 . . . . 0.0 110.939 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.457 HG22 ' CZ ' ' B' ' 126' ' ' TYR . 0.5 OUTLIER -89.11 -21.03 6.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.263 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -46.09 -26.43 0.75 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.278 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.47 -48.94 79.71 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.622 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.6 mp -79.47 -35.38 40.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.818 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -58.42 -49.4 77.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.71 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.9 tptm -68.96 -44.91 72.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.723 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.19 -30.96 71.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.01 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 21.7 mmt -74.35 -31.85 62.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.896 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.6 mttp -83.8 -30.49 26.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.749 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -86.64 -17.03 34.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.229 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.28 145.03 44.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.844 0.354 . . . . 0.0 111.021 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -141.92 93.59 2.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.669 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 151.53 -149.41 21.17 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.626 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.435 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 72.9 mtp -87.83 119.85 28.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.85 0.357 . . . . 0.0 111.333 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.428 HD11 HG22 ' A' ' 144' ' ' ILE . 46.2 mt -97.43 130.99 45.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.995 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.6 m -108.99 114.32 27.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.506 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.463 HD21 ' CZ ' ' A' ' 74' ' ' PHE . 0.7 OUTLIER -116.57 130.58 56.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.929 -179.577 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.47 119.09 34.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.241 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.8 t -132.01 154.99 41.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.07 0.462 . . . . 0.0 111.843 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.2 mm -119.92 122.4 29.06 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.655 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo . . . . . 0 C--N 1.346 0.44 0 C-N-CA 122.403 2.068 . . . . 0.0 112.439 -179.881 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.88 0.372 . . . . 0.0 111.005 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -144.32 131.64 20.81 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.298 0.57 . . . . 0.0 109.925 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 126' ' ' TYR . . . . . 0.457 ' CZ ' HG22 ' A' ' 130' ' ' VAL . 18.6 m-85 -100.92 140.95 34.49 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.666 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 95.6 m -106.39 116.02 31.21 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . 0.456 HG23 HD12 ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.453 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.2 p . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.867 0.365 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.4 ttt-85 -112.5 156.18 23.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.836 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.9 tp -121.26 100.4 7.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.004 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.3 mp -89.17 143.22 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.511 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -133.0 131.77 41.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.072 0.463 . . . . 0.0 111.838 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.446 ' CZ ' ' CD2' ' A' ' 146' ' ' LEU . 6.9 p90 -146.69 137.42 23.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.096 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -80.35 139.72 36.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.964 0.411 . . . . 0.0 111.396 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.13 111.14 12.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.292 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -116.12 -22.9 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.573 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.48 151.47 21.36 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.954 0.407 . . . . 0.0 111.501 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -87.22 88.25 7.64 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.37 0.605 . . . . 0.0 110.462 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -167.38 152.95 7.2 Favored Pre-proline 0 N--CA 1.446 -0.641 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.985 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -56.47 142.51 89.33 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.522 2.148 . . . . 0.0 112.119 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -55.01 -37.06 66.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.987 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 117.57 29.47 2.07 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.527 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.8 pp -145.4 164.59 11.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.684 0.278 . . . . 0.0 110.909 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.481 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -131.98 123.6 27.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.35 -0.386 . . . . 0.0 109.989 179.617 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.444 ' HA ' ' O ' ' A' ' 95' ' ' THR . 0.1 OUTLIER -126.58 158.01 37.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.944 -179.373 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.9 pttp -141.54 163.41 33.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.006 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.518 ' HA ' ' O ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -103.75 103.09 12.94 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.68 179.706 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -68.07 176.75 2.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.626 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.57 -27.3 6.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.941 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -77.04 -15.18 59.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.255 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 71.11 88.57 0.1 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.896 0.379 . . . . 0.0 110.637 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 10.1 t -171.04 148.67 2.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.386 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -87.78 111.43 21.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.962 0.411 . . . . 0.0 111.39 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 9.4 m -129.93 132.22 46.27 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.331 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.471 HG12 ' HA ' ' A' ' 113' ' ' VAL . 2.2 p -58.67 106.09 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.326 0.584 . . . . 0.0 110.86 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -71.26 -24.56 62.19 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.981 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.6 ttt180 -171.44 138.72 1.2 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.031 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.409 ' CD1' HG23 ' A' ' 96' ' ' VAL . 19.8 mm -86.11 109.13 18.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.657 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 21.4 mt -62.78 146.57 52.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.105 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -80.93 129.59 34.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.17 4.35 81.44 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.806 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -76.17 160.3 51.1 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.494 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 40.5 ttp -59.72 -31.86 70.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.867 0.365 . . . . 0.0 110.819 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 29.5 mm -80.77 -31.85 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.828 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -77.93 -53.85 6.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.622 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -60.63 -46.13 91.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.605 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -77.88 -42.68 32.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.685 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.32 67.69 1.43 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.523 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -112.06 -20.47 11.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.631 0.253 . . . . 0.0 111.226 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.4 171.06 14.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.876 0.37 . . . . 0.0 111.026 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -139.46 142.0 37.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.795 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.471 ' HA ' HG12 ' A' ' 96' ' ' VAL . 7.1 p -45.86 121.67 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.509 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 110.35 -21.75 23.66 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.583 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.407 ' HB3' ' CG2' ' A' ' 148' ' ' VAL . 0.4 OUTLIER -52.63 121.41 7.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.656 0.265 . . . . 0.0 110.544 179.762 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.423 ' O ' HG23 ' A' ' 148' ' ' VAL . 62.3 mt-10 -85.25 107.58 17.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.809 0.338 . . . . 0.0 111.447 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.8 mp -84.86 96.88 4.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.767 179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -57.85 -29.84 65.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.171 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -154.28 145.32 22.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.902 0.382 . . . . 0.0 111.241 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 17.0 mt -116.77 102.6 13.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.664 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 56.87 25.43 10.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.737 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 95.73 24.78 14.68 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.541 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.4 m -133.57 123.05 24.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.849 0.357 . . . . 0.0 111.225 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.81 82.69 1.91 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.609 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.6 p -56.5 158.33 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.347 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.4 p -136.88 -173.5 3.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.75 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -61.02 -15.37 31.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.493 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -58.87 -116.9 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.833 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 m -109.01 134.15 52.04 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.88 0.372 . . . . 0.0 111.143 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.452 HG21 ' CZ ' ' B' ' 126' ' ' TYR . 0.6 OUTLIER -89.26 -20.68 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.984 179.53 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -45.55 -26.4 0.58 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.345 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -59.42 -40.31 86.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.55 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.41 -51.54 9.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.546 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -49.74 -46.78 50.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.909 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -53.36 42.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.912 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.76 -64.26 1.01 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.537 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -46.0 -35.83 5.11 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.502 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -80.52 -26.14 38.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.253 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -99.28 3.22 46.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.597 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.93 149.29 41.51 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.893 0.377 . . . . 0.0 110.83 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.91 89.45 1.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.821 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 161.35 -130.75 2.41 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.43 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 38.6 mmm -109.26 122.6 47.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.814 0.34 . . . . 0.0 110.901 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.43 HG22 HD11 ' A' ' 144' ' ' ILE . 46.9 mt -96.69 143.72 11.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.298 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 28.4 p -125.61 113.68 17.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.918 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.446 ' CD2' ' CZ ' ' A' ' 74' ' ' PHE . 2.7 mm? -110.36 123.17 49.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.975 0.417 . . . . 0.0 111.587 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -98.06 105.25 17.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.484 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.45 HG23 ' N ' ' A' ' 149' ' ' ILE . 2.9 p -135.16 143.22 37.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.033 0.444 . . . . 0.0 111.99 -178.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.45 ' N ' HG23 ' A' ' 148' ' ' VAL . 4.6 mt -112.86 130.71 23.24 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.666 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo . . . . . 0 C--N 1.346 0.396 0 C-N-CA 122.435 2.09 . . . . 0.0 112.075 179.979 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.906 0.384 . . . . 0.0 110.935 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -164.09 136.18 4.83 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.712 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 126' ' ' TYR . . . . . 0.452 ' CZ ' HG21 ' A' ' 130' ' ' VAL . 34.4 m-85 -113.91 131.19 56.38 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.267 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 1.8 m -105.83 116.07 31.31 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . 0.466 HG23 HD12 ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.458 -177.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.89 0.376 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -108.97 147.83 31.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.716 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.44 99.24 7.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.002 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.5 mm -91.16 110.37 22.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.307 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.419 ' HA ' ' O ' ' A' ' 144' ' ' ILE . 26.0 mt-30 -113.84 130.71 56.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.98 0.419 . . . . 0.0 111.889 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.466 ' CZ ' ' CD2' ' A' ' 146' ' ' LEU . 4.5 p90 -142.4 146.33 34.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.067 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -80.25 143.49 33.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.992 0.425 . . . . 0.0 111.245 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -128.93 111.28 12.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.593 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -105.9 -30.14 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.162 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.59 146.66 23.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.151 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -99.29 96.3 7.64 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.637 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.401 ' CB ' ' CD ' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -174.65 178.09 0.57 Allowed Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.921 -179.135 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.401 ' CD ' ' CB ' ' A' ' 80' ' ' GLU . 51.9 Cg_exo -54.53 125.32 18.58 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.444 2.096 . . . . 0.0 112.327 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 26.4 ttm -47.13 -48.15 23.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.06 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 135.65 -7.88 4.25 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.495 -0.86 . . . . 0.0 113.031 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.8 pt -117.81 166.93 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.888 0.375 . . . . 0.0 111.254 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.495 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -129.31 124.28 33.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.711 179.594 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.404 ' HA ' ' O ' ' A' ' 95' ' ' THR . 0.3 OUTLIER -121.43 157.39 30.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.711 0.291 . . . . 0.0 111.158 -179.294 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.502 ' HB3' ' HA ' ' B' ' 125' ' ' GLU . 0.0 OUTLIER -140.37 160.54 39.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.328 179.923 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.551 ' HA ' ' O ' ' A' ' 93' ' ' SER . 0.4 OUTLIER -90.43 103.12 15.84 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.47 179.454 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -64.3 176.51 1.04 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.784 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -51.31 -23.77 3.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.046 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.28 15.48 20.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.273 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.0 mp0 50.17 81.59 0.06 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.776 0.322 . . . . 0.0 110.798 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.551 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 0.3 OUTLIER -153.6 155.37 35.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.774 -179.737 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.85 111.49 21.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.946 0.403 . . . . 0.0 111.088 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 1.9 m -133.22 127.87 34.67 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.506 HG13 ' HA ' ' A' ' 113' ' ' VAL . 3.9 p -58.68 106.02 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.411 0.624 . . . . 0.0 110.56 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -73.24 -23.54 60.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.493 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -172.16 134.02 0.71 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.124 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 29.1 mm -86.21 109.13 18.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.5 mt -65.74 143.57 57.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.035 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -78.39 133.24 37.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.933 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.43 45.7 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.676 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.95 164.1 6.18 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.679 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 6.6 tmm? -60.44 -43.36 96.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.82 0.343 . . . . 0.0 110.981 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 32.2 mm -67.94 -38.39 79.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.05 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -71.53 -44.7 64.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.661 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -69.56 -52.02 30.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.712 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -71.54 -52.16 19.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.624 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.98 105.82 1.86 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.579 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.06 -45.58 0.13 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.874 0.368 . . . . 0.0 110.958 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.5 mp -117.41 172.6 7.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.974 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -141.73 143.45 33.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.506 ' HA ' HG13 ' A' ' 96' ' ' VAL . 7.1 p -44.31 112.01 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.631 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 115.84 -23.18 11.05 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.847 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.425 ' HB3' ' CG2' ' A' ' 148' ' ' VAL . 1.0 OUTLIER -47.87 140.73 6.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.633 0.254 . . . . 0.0 110.825 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -93.18 111.62 23.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.759 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 148' ' ' VAL . 3.7 mp -99.25 109.03 23.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.513 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -71.22 -26.96 63.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.698 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -154.05 156.85 38.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.059 0.456 . . . . 0.0 111.625 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.413 ' N ' ' CD1' ' A' ' 120' ' ' ILE . 3.2 mp -129.54 100.84 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.387 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 67.02 24.25 9.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.612 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 95.89 8.5 58.03 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.832 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.2 m -133.75 127.33 32.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.805 0.336 . . . . 0.0 111.212 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -87.8 121.0 29.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.453 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.412 ' CG1' HD13 ' A' ' 88' ' ' LEU . 14.9 t -77.1 119.08 24.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.117 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.7 p -108.52 -167.06 1.18 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.906 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -67.58 -16.74 64.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.171 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -166.93 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.599 0.238 . . . . 0.0 110.441 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 21.4 t -68.7 133.53 48.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.942 0.401 . . . . 0.0 110.621 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.461 ' CG2' ' CZ ' ' B' ' 126' ' ' TYR . 0.6 OUTLIER -89.6 -26.2 5.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.095 179.746 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -45.49 -27.76 0.79 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.309 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -51.49 68.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.593 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.0 mp -80.78 -29.68 36.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.752 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -63.32 -43.06 98.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.728 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.93 -41.41 51.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.823 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.6 -45.42 87.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.142 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 70.1 mmm -70.43 -30.32 67.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.999 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -76.5 -28.52 56.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.027 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.12 -0.27 26.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.424 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 12.3 t -60.97 153.69 24.45 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.818 0.342 . . . . 0.0 110.886 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.02 118.18 6.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.849 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 129.98 -153.12 19.91 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.585 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 18.3 mmm -85.34 113.52 21.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.77 0.319 . . . . 0.0 110.975 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.435 HG21 HD12 ' A' ' 144' ' ' ILE . 49.6 mt -85.26 148.19 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.11 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.404 ' N ' HG23 ' A' ' 144' ' ' ILE . 48.8 p -128.3 115.24 17.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.399 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.466 ' CD2' ' CZ ' ' A' ' 74' ' ' PHE . 2.3 mm? -117.71 131.86 56.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.25 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.95 105.42 17.44 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 117' ' ' ILE . 5.3 p -139.05 157.86 28.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.101 0.477 . . . . 0.0 112.045 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.9 mp -137.68 127.32 15.22 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.679 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo . . . . . 0 C--N 1.348 0.503 0 C-N-CA 122.378 2.052 . . . . 0.0 112.241 179.957 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 4.2 mmtp . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.867 0.365 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . 0.502 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 13.5 mt-10 -168.01 135.73 2.25 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.196 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 126' ' ' TYR . . . . . 0.461 ' CZ ' ' CG2' ' A' ' 130' ' ' VAL . 37.9 m-85 -129.12 132.64 47.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.175 -179.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 1.8 m -105.81 115.95 31.1 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . 0.478 HG22 HD11 ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.289 -0.862 . . . . 0.0 111.24 -177.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.3 p . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.789 0.328 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -96.68 132.88 41.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.962 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.0 tp -110.25 102.84 11.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.921 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 23.9 mm -89.26 120.5 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.774 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -119.37 123.23 43.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.426 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.443 ' CE2' HD22 ' A' ' 146' ' ' LEU . 18.4 p90 -152.18 135.56 15.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.556 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -80.33 139.9 36.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.253 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -129.21 111.21 12.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.25 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.42 12.95 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.47 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.67 163.11 16.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.012 0.434 . . . . 0.0 111.327 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.95 79.52 6.58 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.285 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.36 126.89 0.95 Allowed Pre-proline 0 N--CA 1.445 -0.684 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.275 -178.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.44 166.76 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.574 2.182 . . . . 0.0 112.411 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 21.9 ttm -58.83 -51.27 70.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 121.79 21.55 2.91 Favored Glycine 0 CA--C 1.517 0.163 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.808 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.7 pt -137.48 166.4 24.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.657 0.265 . . . . 0.0 110.639 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.485 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -130.67 124.94 32.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.582 179.798 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' A' ' 95' ' ' THR . 0.4 OUTLIER -129.22 155.99 44.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.025 -179.564 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.407 ' O ' ' O ' ' A' ' 93' ' ' SER . 0.1 OUTLIER -134.63 166.83 22.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.119 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.512 ' HA ' ' O ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -102.12 106.36 17.21 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.224 179.598 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.411 ' HB2' ' HD2' ' A' ' 91' ' ' LYS . 1.4 m120 -64.22 176.36 1.05 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.809 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -51.19 -23.19 3.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.322 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.411 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -97.1 15.69 21.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.367 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.438 ' HB3' ' HA ' ' A' ' 126' ' ' THR . 1.0 OUTLIER 54.37 75.56 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.723 0.296 . . . . 0.0 110.68 179.925 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 78.8 p -143.93 133.05 22.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.712 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 10.9 p -87.63 112.18 22.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.058 0.456 . . . . 0.0 111.459 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 23.9 m -133.57 134.61 43.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.419 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.462 HG13 ' HA ' ' A' ' 113' ' ' VAL . 2.1 p -58.93 106.21 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.71 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -71.47 -25.33 62.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.862 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.403 ' HA ' ' CG2' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -173.52 131.03 0.45 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.563 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.421 HG22 HD12 ' A' ' 99' ' ' ILE . 39.3 mt -85.92 138.26 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.453 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.404 ' CD2' ' N ' ' A' ' 100' ' ' LEU . 0.9 OUTLIER -97.8 142.24 29.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.85 0.357 . . . . 0.0 111.069 -179.715 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.437 ' HA ' ' CD2' ' A' ' 106' ' ' HIS . 0.5 OUTLIER -75.05 143.54 43.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.87 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.54 -29.01 11.0 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.359 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.5 160.76 27.9 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.424 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 2.3 ppp? -65.47 -31.3 72.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.773 0.321 . . . . 0.0 110.826 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.2 mm -71.9 -36.07 56.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.948 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . 0.437 ' CD2' ' HA ' ' A' ' 101' ' ' HIS . 86.2 t60 -80.48 -47.16 14.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.622 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -64.35 -46.72 82.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.664 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -79.76 -41.79 25.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.682 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 85.17 70.67 1.33 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.418 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.3 m -109.12 -26.79 9.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.774 0.321 . . . . 0.0 111.027 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.2 mt -134.39 168.2 19.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.066 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -133.07 136.73 46.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.65 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.462 ' HA ' HG13 ' A' ' 96' ' ' VAL . 7.5 p -46.02 115.75 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.292 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 112.22 -18.83 23.13 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.725 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.424 ' HB3' ' CG1' ' A' ' 148' ' ' VAL . 0.2 OUTLIER -55.51 132.38 48.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.694 0.247 . . . . 0.0 110.539 179.79 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -89.78 113.13 24.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.86 0.362 . . . . 0.0 111.483 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 148' ' ' VAL . 3.4 mp -87.21 99.79 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.734 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -57.21 -29.44 63.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.125 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -160.55 143.16 13.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.18 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.492 HD12 HG22 ' A' ' 120' ' ' ILE . 17.6 mt -112.56 104.62 17.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.888 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 58.99 30.56 20.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.893 0.378 . . . . 0.0 110.556 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 87.65 13.14 65.6 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.581 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.6 m -133.62 117.14 16.69 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.764 0.316 . . . . 0.0 111.137 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -94.98 84.44 4.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.539 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.2 p -47.11 142.87 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.254 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.438 ' HA ' ' HB3' ' A' ' 92' ' ' GLN . 10.1 p -119.0 -173.42 2.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.868 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 27.9 p30 -51.75 -25.77 8.18 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.202 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.09 -171.61 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.765 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 10.0 m -65.4 134.44 53.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.91 0.386 . . . . 0.0 111.127 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.466 HG22 ' CE1' ' B' ' 126' ' ' TYR . 0.8 OUTLIER -88.82 -16.36 8.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.15 179.612 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -45.18 -25.92 0.42 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.348 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.23 -52.34 62.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.508 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.2 mp -76.87 -33.35 57.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.624 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 11.1 tp60 -64.0 -51.07 65.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.566 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.85 -40.64 97.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.749 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.77 -40.71 79.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.058 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 12.4 mmt -65.8 -33.28 75.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.832 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.15 -37.01 58.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -99.65 10.13 41.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.276 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.9 t -61.32 156.93 17.66 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.778 0.323 . . . . 0.0 110.996 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -154.1 110.29 3.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.016 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 129.21 -158.78 22.17 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.67 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 17.4 mtp -85.24 116.18 23.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.916 0.389 . . . . 0.0 110.937 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.413 HG23 HD12 ' A' ' 144' ' ' ILE . 32.1 mt -87.1 130.13 37.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.257 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.1 m -112.44 113.66 25.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.254 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.443 HD22 ' CE2' ' A' ' 74' ' ' PHE . 0.5 OUTLIER -116.53 129.85 56.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.405 -179.412 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -95.82 107.41 19.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.014 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 117' ' ' ILE . 2.3 t -124.92 157.88 33.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.013 0.435 . . . . 0.0 111.805 -178.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 31.1 mt -137.21 118.82 11.04 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.745 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo . . . . . 0 C--N 1.349 0.564 0 C-N-CA 122.489 2.126 . . . . 0.0 112.523 -179.818 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.916 0.389 . . . . 0.0 110.962 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -158.69 136.55 10.43 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.009 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 126' ' ' TYR . . . . . 0.466 ' CE1' HG22 ' A' ' 130' ' ' VAL . 34.4 m-85 -117.35 132.52 56.58 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.165 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 2.0 m -105.74 116.12 31.4 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . 0.472 ' N ' ' CD1' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.43 -177.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.3 p . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.843 0.354 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -123.95 119.82 30.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.821 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.7 tp -87.44 99.3 11.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.026 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 37.1 mt -109.11 133.51 54.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.342 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.428 ' HA ' ' O ' ' A' ' 144' ' ' ILE . 0.0 OUTLIER -132.36 126.51 33.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.946 0.403 . . . . 0.0 111.689 -179.436 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.43 ' CE2' HD23 ' A' ' 146' ' ' LEU . 4.5 p90 -117.74 144.06 45.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.324 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -80.27 137.32 36.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.884 0.373 . . . . 0.0 111.333 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -129.2 111.24 12.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.368 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.71 10.85 4.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.562 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.6 152.7 38.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.879 0.371 . . . . 0.0 111.291 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -93.59 87.47 5.52 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.435 0.636 . . . . 0.0 110.374 179.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.41 ' HG2' ' HD2' ' A' ' 81' ' ' PRO . 0.3 OUTLIER -171.22 164.07 4.99 Favored Pre-proline 0 N--CA 1.448 -0.573 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.666 -178.829 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.41 ' HD2' ' HG2' ' A' ' 80' ' ' GLU . 25.0 Cg_endo -61.85 141.82 91.25 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.411 2.074 . . . . 0.0 112.071 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -54.11 -40.67 67.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.96 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.432 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 117.22 15.05 6.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.89 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.9 pt -128.74 163.98 32.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.789 0.328 . . . . 0.0 110.743 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.491 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -129.98 124.96 34.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.062 179.634 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.416 ' HA ' ' O ' ' A' ' 95' ' ' THR . 0.2 OUTLIER -135.9 159.35 41.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.137 -179.293 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.492 ' HB3' ' HA ' ' B' ' 125' ' ' GLU . 0.0 OUTLIER -140.51 166.95 23.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.281 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.518 ' HA ' ' O ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -100.34 102.96 14.33 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.064 179.635 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -64.16 176.39 1.03 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.877 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -51.73 -26.26 9.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.883 0.373 . . . . 0.0 110.766 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.99 4.33 38.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.454 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 59.48 77.04 0.33 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.803 0.335 . . . . 0.0 110.363 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 67.1 m -155.91 138.71 15.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.664 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 8.8 p -87.91 114.98 25.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.149 0.5 . . . . 0.0 111.676 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 28.1 m -130.51 135.16 47.66 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.253 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.498 HG13 ' HA ' ' A' ' 113' ' ' VAL . 4.0 p -60.69 106.13 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.244 0.545 . . . . 0.0 110.955 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -74.29 -24.39 59.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.22 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.7 132.61 1.19 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.997 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 24.3 mm -86.24 110.26 19.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.9 mp -70.21 133.23 46.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.918 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 51.7 m80 -69.77 142.17 53.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.842 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.75 -24.28 28.85 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.591 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.432 ' HA3' ' HA3' ' A' ' 83' ' ' GLY . . . -63.39 162.02 33.66 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.641 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.1 ptm -64.97 -37.27 87.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.784 0.326 . . . . 0.0 110.64 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 35.9 mm -67.56 -29.85 46.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.825 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -85.83 -43.06 13.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.627 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.28 -46.94 68.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.607 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -80.98 -45.34 16.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.725 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.38 73.58 1.26 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.643 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.9 t -111.34 -29.42 7.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.811 0.339 . . . . 0.0 110.967 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.1 tp -136.37 169.01 18.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.865 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.4 ' O ' HG13 ' A' ' 96' ' ' VAL . 0.5 OUTLIER -137.56 139.88 40.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.498 ' HA ' HG13 ' A' ' 96' ' ' VAL . 7.6 p -44.08 111.38 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.638 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 119.06 -24.96 8.06 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.607 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.443 ' HB3' ' CG1' ' A' ' 148' ' ' VAL . 1.0 OUTLIER -54.71 131.55 43.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.719 0.295 . . . . 0.0 110.68 179.835 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -90.16 121.47 32.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.668 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 148' ' ' VAL . 4.4 mp -98.18 95.39 4.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.465 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 8.9 mp -56.94 -27.76 61.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.493 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -156.53 153.44 28.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.051 0.453 . . . . 0.0 111.453 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.402 HD11 HG22 ' A' ' 120' ' ' ILE . 36.2 mt -124.96 101.28 8.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.651 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 65.25 16.47 10.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.969 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.54 10.81 26.45 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.063 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.9 t -129.64 124.3 33.35 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.952 0.406 . . . . 0.0 111.371 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -96.76 75.76 2.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.242 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.406 ' HB ' ' CD1' ' A' ' 133' ' ' LEU . 10.7 p -44.71 143.49 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.723 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 39.3 p -120.04 -171.1 2.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.824 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -48.68 -26.31 2.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.422 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -52.24 -179.02 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.926 0.393 . . . . 0.0 111.07 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.85 134.77 57.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.216 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.446 HG21 ' CZ ' ' B' ' 126' ' ' TYR . 0.4 OUTLIER -88.74 -16.42 8.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.071 179.584 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -48.05 -25.18 1.31 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.031 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -58.73 -45.72 88.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.615 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.406 ' CD1' ' HB ' ' A' ' 125' ' ' VAL . 8.4 mt -73.0 -35.26 66.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.285 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.7 -45.91 87.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.752 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.416 ' HG3' ' N ' ' A' ' 136' ' ' ALA . 0.0 OUTLIER -70.36 -30.18 67.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.992 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.416 ' N ' ' HG3' ' A' ' 135' ' ' LYS . . . -79.59 -35.56 39.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.22 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.65 -30.51 67.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.951 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -85.08 -30.04 24.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.09 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -86.81 -34.69 19.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.105 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 9.1 t -59.65 146.57 40.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.966 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.03 106.91 4.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.73 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 150.23 -146.77 16.23 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.55 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 4.0 mtp -94.27 118.31 31.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.851 0.358 . . . . 0.0 111.021 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.428 ' O ' ' HA ' ' A' ' 73' ' ' GLN . 29.1 mt -89.9 139.03 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.056 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 84.4 p -116.5 113.61 23.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.289 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.43 HD23 ' CE2' ' A' ' 74' ' ' PHE . 6.9 mp -112.19 134.05 53.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.947 0.403 . . . . 0.0 111.417 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -95.85 105.4 17.41 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.54 179.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 117' ' ' ILE . 2.6 t -124.72 158.32 32.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.199 0.523 . . . . 0.0 112.094 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 24.1 mt -133.33 135.62 25.73 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.701 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo . . . . . 0 C--N 1.346 0.397 0 C-N-CA 122.403 2.068 . . . . 0.0 112.352 -179.926 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . 0.416 ' HD3' ' CE1' ' B' ' 126' ' ' TYR . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.741 0.305 . . . . 0.0 110.926 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . 0.492 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 3.6 pt-20 -156.01 135.75 12.59 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.171 0.51 . . . . 0.0 110.345 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 126' ' ' TYR . . . . . 0.446 ' CZ ' HG21 ' A' ' 130' ' ' VAL . 32.1 m-85 -115.31 133.14 56.31 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.037 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 1.4 m -105.83 116.08 31.33 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . 0.441 HG21 HD12 ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.409 -177.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.9 0.381 . . . . 0.0 111.264 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.2 ptp85 -120.21 144.85 47.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.783 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.7 tp -92.9 99.08 11.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.959 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 37.2 mt -91.63 145.94 6.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.223 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -143.56 126.36 16.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.014 0.435 . . . . 0.0 111.618 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.433 ' CE2' HD23 ' A' ' 146' ' ' LEU . 3.9 p90 -117.72 133.33 56.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.96 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 10.8 pm0 -80.14 134.14 36.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.941 0.4 . . . . 0.0 111.392 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.09 111.31 12.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.586 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -96.99 -34.11 4.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.065 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.52 155.51 18.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.177 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.15 93.14 7.16 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.266 0.555 . . . . 0.0 110.59 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -167.36 164.75 9.28 Favored Pre-proline 0 N--CA 1.449 -0.52 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.028 -179.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -52.01 141.16 47.89 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.584 2.19 . . . . 0.0 112.288 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.96 -56.14 24.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.866 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 147.64 -17.29 1.44 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.982 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.0 pt -115.98 170.59 5.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.77 0.319 . . . . 0.0 111.188 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.481 ' O ' ' N ' ' A' ' 97' ' ' ALA . 5.0 m -131.79 133.61 44.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.362 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.453 ' HA ' ' O ' ' A' ' 95' ' ' THR . 0.5 OUTLIER -127.96 159.48 34.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.327 -179.228 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.436 ' HB3' ' HA ' ' B' ' 125' ' ' GLU . 7.5 pttm -133.02 160.85 35.95 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.954 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.501 ' HA ' ' O ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -99.66 104.71 16.49 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.389 179.559 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -64.3 176.19 1.12 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.942 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -53.68 -22.75 9.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.227 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.407 ' CD ' ' N ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -95.61 16.3 17.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.945 179.818 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 51.9 85.98 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.737 0.303 . . . . 0.0 110.7 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.501 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 1.1 m -159.3 134.13 8.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.437 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 28.0 p -87.72 115.51 25.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.136 0.493 . . . . 0.0 111.438 -179.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 5.8 m -130.04 130.91 45.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.487 -0.779 . . . . 0.0 108.922 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.508 HG13 ' HA ' ' A' ' 113' ' ' VAL . 2.0 p -58.51 105.92 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.629 -178.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -70.57 -25.37 63.05 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.799 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.44 131.29 0.46 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.974 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.3 mt -85.97 128.44 39.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.167 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.9 mt -89.55 146.34 24.65 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.905 0.383 . . . . 0.0 111.228 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.429 ' HA ' ' CD2' ' A' ' 106' ' ' HIS . 8.4 m-70 -79.72 146.67 32.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.809 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.97 -33.64 5.44 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.387 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.61 171.87 4.15 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.549 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 1.8 tmm? -73.53 -28.55 61.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.758 0.313 . . . . 0.0 111.034 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.6 mm -74.59 -37.15 43.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.124 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . 0.429 ' CD2' ' HA ' ' A' ' 101' ' ' HIS . 78.8 t60 -78.45 -49.69 13.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.621 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.91 -44.19 97.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.592 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -82.26 -47.08 12.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.557 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.83 69.92 1.35 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.476 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.3 p -108.77 -29.22 8.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.833 0.349 . . . . 0.0 110.918 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -123.94 172.56 8.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.948 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -135.09 137.89 43.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.79 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.508 ' HA ' HG13 ' A' ' 96' ' ' VAL . 7.5 p -49.75 118.99 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.117 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.77 -20.13 32.15 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.826 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.419 ' HB3' ' CG1' ' A' ' 148' ' ' VAL . 26.9 m-20 -50.32 138.14 17.27 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.675 0.274 . . . . 0.0 110.684 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -90.01 110.48 21.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.717 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.495 ' HA ' ' HA ' ' A' ' 148' ' ' VAL . 5.3 mp -94.72 94.39 4.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.314 179.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.402 ' CD2' ' CD1' ' A' ' 149' ' ' ILE . 3.4 mm? -54.36 -40.32 68.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.887 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -142.12 164.17 30.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.095 0.474 . . . . 0.0 111.66 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.1 mp -131.48 99.12 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.352 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 69.14 17.61 8.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.917 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.58 -0.32 34.55 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.747 -0.739 . . . . 0.0 113.107 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.5 t -132.58 134.56 45.09 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 117.0 0.4 . . . . 0.0 111.449 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -96.05 122.69 39.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.514 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.7 t -58.48 155.03 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.375 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 74.1 p -119.11 171.04 8.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.696 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.35 -21.12 62.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.196 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -59.4 -107.22 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.762 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.3 t -109.07 134.32 51.84 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.884 0.374 . . . . 0.0 111.242 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.458 ' CG2' ' CZ ' ' B' ' 126' ' ' TYR . 0.5 OUTLIER -89.16 -19.26 7.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.059 179.533 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -46.1 -25.29 0.56 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.444 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -54.24 -55.92 23.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.987 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -70.7 -41.88 71.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.796 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -50.3 -53.29 29.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.18 -32.6 73.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.709 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.19 -27.79 61.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.21 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -78.22 -32.25 49.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.912 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -87.57 -29.29 21.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.976 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -81.73 -30.58 32.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.958 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 12.5 t -71.56 149.06 46.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.992 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 11.6 mttp -140.48 125.35 18.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.711 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 127.95 -136.7 9.33 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.336 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.409 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -100.04 137.06 39.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.86 0.362 . . . . 0.0 111.058 -179.867 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 35.7 mt -109.18 142.96 20.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.177 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 28.0 p -121.08 113.7 20.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.456 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.433 HD23 ' CE2' ' A' ' 74' ' ' PHE . 5.8 mp -112.74 142.68 45.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.339 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.71 108.52 20.83 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.471 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.495 ' HA ' ' HA ' ' A' ' 117' ' ' ILE . 2.7 t -125.05 158.33 33.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.267 0.556 . . . . 0.0 112.274 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.402 ' CD1' ' CD2' ' A' ' 118' ' ' LEU . 12.6 mt -132.32 115.98 15.17 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.426 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 C--N 1.347 0.46 0 C-N-CA 122.428 2.085 . . . . 0.0 112.391 -179.646 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.074 0 CA-C-O 120.851 0.358 . . . . 0.0 110.933 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . 0.436 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 8.6 pt-20 -158.07 135.96 10.63 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.202 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 126' ' ' TYR . . . . . 0.458 ' CZ ' ' CG2' ' A' ' 130' ' ' VAL . 16.8 m-85 -115.7 138.19 51.34 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.352 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 98.9 m -106.4 116.11 31.36 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . 0.431 ' N ' ' CD1' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.45 -177.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.916 0.389 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -95.52 152.61 18.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.864 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.43 99.77 4.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.999 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.0 mp -89.32 159.18 2.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.648 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -146.21 124.69 12.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.011 0.434 . . . . 0.0 111.634 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.464 ' CZ ' ' CD2' ' A' ' 146' ' ' LEU . 0.9 OUTLIER -142.47 130.49 21.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.331 179.078 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 10.5 tt0 -80.21 140.85 36.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.646 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 15.8 tttm -129.2 115.86 18.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.305 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -105.73 -26.54 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.329 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.53 149.09 22.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.282 -179.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -87.62 90.43 8.37 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.434 0.635 . . . . 0.0 110.56 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -161.97 157.14 19.98 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.836 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.07 142.61 99.54 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.441 2.094 . . . . 0.0 112.155 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -53.08 -42.42 65.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.045 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 127.58 -8.29 6.95 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.78 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.2 pt -113.5 168.84 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.854 0.359 . . . . 0.0 111.052 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.47 ' O ' ' N ' ' A' ' 97' ' ' ALA . 17.2 m -135.88 132.54 36.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.225 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.8 159.65 39.96 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.272 -179.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.99 162.4 32.99 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.982 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.512 ' HA ' ' O ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -105.89 103.26 12.71 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.511 179.694 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.2 m-20 -64.13 176.42 1.01 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.709 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -51.42 -24.34 4.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.108 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.11 9.32 25.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.516 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 54.36 79.55 0.14 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.768 0.318 . . . . 0.0 110.649 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 11.2 m -152.44 131.89 12.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.561 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 18.3 p -87.68 111.49 21.35 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.08 0.467 . . . . 0.0 111.255 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.6 m -127.58 132.31 49.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.454 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.544 HG12 ' HA ' ' A' ' 113' ' ' VAL . 3.9 p -58.72 106.22 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.195 0.521 . . . . 0.0 110.561 -179.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -73.77 -27.11 60.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.354 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.9 ttp85 -165.77 129.34 2.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.852 0.358 . . . . 0.0 111.47 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.404 ' CD1' ' CG2' ' A' ' 96' ' ' VAL . 32.6 mm -87.65 103.76 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.439 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.5 mt -65.66 135.4 54.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.93 0.395 . . . . 0.0 111.05 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 22.7 m170 -73.07 140.25 47.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.808 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 103.97 -36.52 4.31 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.44 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -55.59 174.59 1.0 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.51 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.53 -29.42 52.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.793 0.33 . . . . 0.0 111.002 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 28.6 mm -69.03 -35.24 67.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.065 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -80.62 -50.63 9.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.707 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -60.22 -41.72 93.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.628 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.74 -43.82 12.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.672 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.73 51.43 2.67 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.517 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 m -87.64 -22.95 24.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.618 0.247 . . . . 0.0 111.051 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.403 HD22 HG11 ' A' ' 96' ' ' VAL . 0.0 OUTLIER -145.84 165.2 29.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.805 0.336 . . . . 0.0 110.901 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.411 ' O ' HG12 ' A' ' 96' ' ' VAL . 12.1 m-70 -133.5 137.93 45.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.894 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.544 ' HA ' HG12 ' A' ' 96' ' ' VAL . 7.5 p -46.74 111.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.714 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 117.41 -26.0 8.37 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.434 -0.888 . . . . 0.0 113.223 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.404 ' HB3' ' CG2' ' A' ' 148' ' ' VAL . 4.6 m-20 -54.13 138.61 37.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.905 0.352 . . . . 0.0 110.67 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.52 118.84 30.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.62 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.493 HG13 ' HB ' ' A' ' 148' ' ' VAL . 4.5 mp -93.43 99.18 9.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.629 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -56.96 -31.58 65.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.241 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -161.23 141.7 11.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.878 0.371 . . . . 0.0 111.349 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 28.2 mt -107.72 103.28 15.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.675 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 65.19 27.28 12.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.696 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 92.51 5.94 64.64 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.875 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.2 m -133.71 127.0 31.93 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.867 0.365 . . . . 0.0 111.221 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -94.89 120.82 35.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.598 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 17.9 t -54.53 149.48 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.357 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 58.6 p -119.16 161.5 20.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.771 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -61.59 -18.85 61.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.165 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -60.22 -111.98 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.723 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.09 134.29 51.88 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.921 0.391 . . . . 0.0 110.973 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.454 ' CG2' ' CZ ' ' B' ' 126' ' ' TYR . 0.6 OUTLIER -89.06 -26.11 5.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.042 179.652 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -46.05 -27.44 0.94 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.452 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -62.24 -48.71 78.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.673 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.8 mp -81.53 -35.89 29.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.801 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -63.87 -46.09 86.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.529 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -68.05 -45.7 73.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.602 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -65.59 -38.16 88.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.911 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 2.0 mmt -65.55 -32.05 73.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -85.29 -28.17 25.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.958 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -91.45 -15.39 28.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.335 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 9.8 t -60.78 156.93 15.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.931 0.396 . . . . 0.0 111.056 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -146.26 117.25 7.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.639 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 134.81 -152.58 20.77 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.625 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.489 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 9.9 ptm -90.47 115.31 27.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.851 0.358 . . . . 0.0 111.29 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 47.0 mt -87.83 130.14 38.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.063 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 14.6 m -111.9 113.68 26.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.255 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.464 ' CD2' ' CZ ' ' A' ' 74' ' ' PHE . 0.9 OUTLIER -112.53 133.93 54.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.063 0.459 . . . . 0.0 111.197 -179.489 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.37 105.3 17.43 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.493 ' HB ' HG13 ' A' ' 117' ' ' ILE . 2.8 p -133.35 156.45 41.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.149 0.5 . . . . 0.0 112.045 -178.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 26.0 mt -122.71 119.05 28.24 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.62 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo . . . . . 0 C--N 1.347 0.496 0 C-N-CA 122.543 2.162 . . . . 0.0 112.534 -179.634 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 120.92 0.391 . . . . 0.0 110.956 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -164.73 139.98 5.54 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.481 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 126' ' ' TYR . . . . . 0.454 ' CZ ' ' CG2' ' A' ' 130' ' ' VAL . 31.6 m-85 -117.81 132.33 56.46 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.324 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 91.4 m -106.01 116.01 31.2 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . 0.463 HD13 HG23 ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.28 -0.867 . . . . 0.0 111.476 -177.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.9 p . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.85 0.357 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -95.42 114.6 26.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.636 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.7 tp -92.17 102.5 15.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.118 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mt -89.22 152.13 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.638 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -140.8 123.2 15.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.005 0.431 . . . . 0.0 111.52 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.452 ' CE2' HD23 ' A' ' 146' ' ' LEU . 25.9 p90 -146.97 134.55 20.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.133 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.27 143.47 33.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.071 0.462 . . . . 0.0 111.571 -179.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.11 111.23 12.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.159 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -109.72 -25.84 3.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.465 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.57 146.23 24.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.313 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.96 90.54 8.38 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.385 0.612 . . . . 0.0 110.421 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -168.43 174.47 2.18 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.673 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -74.93 142.75 28.46 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.347 2.031 . . . . 0.0 112.415 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -52.55 -58.06 7.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.033 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 143.26 39.0 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.657 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.0 pt -157.88 170.08 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.719 0.295 . . . . 0.0 110.879 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.475 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -135.48 113.56 11.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.48 179.704 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.431 ' N ' ' CD2' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -122.12 159.1 27.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.079 -179.159 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.447 ' HB3' ' HA ' ' B' ' 125' ' ' GLU . 0.0 OUTLIER -136.09 166.79 22.56 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.325 -179.69 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.569 ' HA ' ' O ' ' A' ' 93' ' ' SER . 0.1 OUTLIER -89.65 103.11 15.78 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.201 179.339 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.408 ' O ' ' N ' ' A' ' 92' ' ' GLN . 4.9 t30 -64.07 176.38 1.01 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.71 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.86 -27.41 3.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.946 0.403 . . . . 0.0 110.803 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.401 ' HD2' ' HB2' ' A' ' 93' ' ' SER . 0.1 OUTLIER -93.56 21.11 6.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.418 179.887 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 89' ' ' ASN . 45.5 mm-40 45.57 74.11 0.15 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.889 0.376 . . . . 0.0 110.666 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.569 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 5.5 m -148.28 147.8 29.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.654 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 1.4 m -87.8 114.18 24.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.119 0.485 . . . . 0.0 111.548 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 2.7 m -130.1 126.63 38.03 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.319 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' A' ' 113' ' ' VAL . 3.6 p -58.78 105.83 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.408 0.623 . . . . 0.0 110.597 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -74.4 -22.69 59.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.149 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 24.2 ttt180 -171.59 139.04 1.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.679 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 31.8 mm -86.11 121.0 36.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.9 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.428 ' CD2' ' HB2' ' A' ' 85' ' ' CYS . 4.6 mm? -74.23 143.33 45.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.038 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 16.0 p-80 -85.54 131.33 34.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.945 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.57 -27.9 16.25 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.48 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.28 176.05 8.23 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.516 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -80.48 -30.03 37.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.757 0.313 . . . . 0.0 110.941 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 42.9 mm -65.18 -36.73 78.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.989 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -81.46 -46.02 15.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.757 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -45.66 85.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.715 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -81.97 -43.84 17.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.755 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.39 63.13 1.31 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.503 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -101.1 -27.34 13.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.878 0.371 . . . . 0.0 111.106 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.3 mt -142.3 157.79 44.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.043 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 50.4 m170 -129.52 142.56 50.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.773 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.484 ' HA ' HG12 ' A' ' 96' ' ' VAL . 8.2 p -43.83 113.75 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.654 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 119.07 -28.78 6.47 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.564 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -47.06 126.12 8.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.667 0.27 . . . . 0.0 110.754 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -89.0 111.36 22.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.868 0.366 . . . . 0.0 111.675 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.513 ' HA ' ' HA ' ' A' ' 148' ' ' VAL . 4.4 mp -91.2 98.1 8.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.663 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -60.97 -32.81 72.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.551 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -141.07 146.8 37.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.934 0.397 . . . . 0.0 111.687 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.428 ' CD1' ' CG2' ' A' ' 117' ' ' ILE . 14.9 mm -118.0 99.75 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.772 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 62.19 27.87 16.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.743 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 94.98 2.58 62.46 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.866 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 21.9 m -133.55 131.52 39.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.813 0.339 . . . . 0.0 111.052 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -93.34 116.24 28.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.727 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 25.5 t -56.16 158.76 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.319 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 10.9 p -137.5 -178.94 5.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.908 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -59.64 -25.41 64.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.954 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -54.96 -175.03 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.76 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.7 m -64.32 134.23 54.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.907 0.384 . . . . 0.0 110.885 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.48 ' CG2' ' CZ ' ' B' ' 126' ' ' TYR . 0.3 OUTLIER -88.95 -17.18 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.198 179.663 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.23 -25.94 0.7 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.285 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -65.21 -52.82 52.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.489 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.23 -29.87 60.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.338 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -67.65 -45.58 74.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.507 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.1 pttp -68.98 -38.03 79.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.63 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.04 -38.46 66.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.016 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 5.9 mmt -67.47 -28.87 68.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.992 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -86.85 -34.88 19.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.07 10.05 42.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.324 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.37 129.96 41.56 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.813 0.34 . . . . 0.0 110.901 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.17 93.34 3.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.814 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 151.25 -157.15 27.05 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.594 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 11.5 mmm -90.15 123.13 33.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.848 0.356 . . . . 0.0 110.985 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 29.3 mt -92.79 131.48 39.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.215 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 59.5 m -112.79 113.53 25.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.056 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.452 HD23 ' CE2' ' A' ' 74' ' ' PHE . 1.1 mm? -117.02 136.06 53.23 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.949 0.404 . . . . 0.0 111.456 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 7.3 mttm -100.32 105.96 17.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.649 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 117' ' ' ILE . 4.8 t -123.94 153.58 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.168 0.509 . . . . 0.0 112.16 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.435 HD13 HG21 ' A' ' 149' ' ' ILE . 17.7 mm -117.28 122.43 31.1 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.442 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo . . . . . 0 C--N 1.347 0.45 0 C-N-CA 122.526 2.151 . . . . 0.0 112.507 -179.87 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.845 0.355 . . . . 0.0 111.025 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . 0.447 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 2.8 pt-20 -152.53 134.3 14.69 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.303 0.573 . . . . 0.0 110.25 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 126' ' ' TYR . . . . . 0.48 ' CZ ' ' CG2' ' A' ' 130' ' ' VAL . 22.0 m-85 -113.02 136.94 52.14 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.174 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 1.7 m -105.86 116.16 31.47 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . 0.401 HD13 ' N ' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.399 -177.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.8 p . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.805 0.335 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.38 122.19 45.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.912 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 tt -90.96 99.31 12.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.977 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.2 mt -96.08 154.9 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.724 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -145.9 128.08 15.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.938 0.399 . . . . 0.0 111.458 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.425 ' CE2' HD21 ' A' ' 146' ' ' LEU . 8.1 p90 -141.05 135.71 31.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.459 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -80.35 138.1 36.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.909 0.385 . . . . 0.0 111.034 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.8 tttm -129.18 111.28 12.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.405 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -130.53 14.25 2.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.67 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.42 154.94 20.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.904 0.383 . . . . 0.0 111.33 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.79 79.08 6.77 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.338 0.589 . . . . 0.0 110.48 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.65 153.24 2.71 Favored Pre-proline 0 N--CA 1.446 -0.655 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.014 -178.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.52 158.49 31.75 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.504 2.136 . . . . 0.0 112.285 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 23.7 ttm -56.07 -54.21 47.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.956 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 132.24 -9.09 5.37 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.939 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.8 pt -114.92 168.07 6.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.802 0.334 . . . . 0.0 111.139 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.471 ' O ' ' N ' ' A' ' 97' ' ' ALA . 19.3 m -135.02 127.68 30.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.275 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.441 ' HA ' ' O ' ' A' ' 95' ' ' THR . 0.1 OUTLIER -125.9 159.56 32.25 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.238 -179.177 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.425 ' HB3' ' HA ' ' B' ' 125' ' ' GLU . 22.4 pttp -137.06 162.3 33.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.178 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.584 ' HA ' ' O ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -103.26 102.96 12.95 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.597 179.504 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -64.37 176.67 1.01 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.638 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -50.29 -27.57 6.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.937 0.399 . . . . 0.0 110.838 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.04 -16.9 57.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.347 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 74.78 78.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.821 0.343 . . . . 0.0 110.248 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.584 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 49.1 p -154.94 150.62 27.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.667 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -87.85 113.58 23.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.062 0.458 . . . . 0.0 111.219 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 2.9 m -131.96 126.76 34.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.322 179.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.558 HG11 ' HA ' ' A' ' 113' ' ' VAL . 2.6 p -58.72 105.91 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.279 0.561 . . . . 0.0 110.02 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -72.04 -25.03 61.64 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.266 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.21 123.03 0.39 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.854 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.0 mt -85.97 120.75 36.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.361 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.421 ' N ' ' CD1' ' A' ' 100' ' ' LEU . 5.9 mp -83.96 135.8 34.32 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.148 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.433 ' HA ' ' CG ' ' A' ' 106' ' ' HIS . 11.7 p80 -73.6 138.63 45.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.826 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.69 -36.53 4.3 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.382 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.16 -171.02 0.12 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.51 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.4 ttp -84.42 -40.6 17.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.865 0.364 . . . . 0.0 110.906 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.6 mm -65.54 -36.88 78.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.105 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . 0.433 ' CG ' ' HA ' ' A' ' 101' ' ' HIS . 63.7 t-80 -75.11 -54.98 6.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.748 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.6 ttt-85 -60.05 -47.17 86.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.693 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -75.99 -47.06 26.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.638 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.72 73.39 1.28 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.565 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.6 m -111.91 -29.26 7.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.776 0.322 . . . . 0.0 110.986 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -134.26 172.53 12.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.09 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -134.46 137.42 43.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.711 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.558 ' HA ' HG11 ' A' ' 96' ' ' VAL . 7.5 p -47.02 115.99 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.901 0.381 . . . . 0.0 111.359 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 112.23 -24.95 13.23 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.853 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -50.29 143.35 8.76 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.74 0.27 . . . . 0.0 110.7 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.401 ' O ' HG21 ' A' ' 148' ' ' VAL . 1.6 mt-10 -95.32 107.71 19.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.819 0.342 . . . . 0.0 111.725 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.471 HG13 ' HB ' ' A' ' 148' ' ' VAL . 3.9 mp -86.67 99.83 8.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.66 179.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.411 ' N ' ' O ' ' A' ' 147' ' ' LYS . 4.3 mm? -51.46 -35.12 38.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.311 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -169.72 145.64 3.1 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.959 0.409 . . . . 0.0 111.271 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 45.1 mt -104.56 125.29 59.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.828 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 60.87 27.74 17.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.777 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 83.32 18.13 65.17 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.743 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 27.4 m -133.58 128.11 34.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.828 0.347 . . . . 0.0 111.023 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -92.56 114.96 27.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.792 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.7 p -82.07 127.04 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.246 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.8 p -98.0 -167.09 1.46 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.714 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -67.05 -15.51 63.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.294 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.9 -166.91 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.678 0.275 . . . . 0.0 110.572 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 28.6 t -67.67 134.03 50.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.941 0.401 . . . . 0.0 110.682 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.448 HG23 ' CZ ' ' B' ' 126' ' ' TYR . 0.6 OUTLIER -89.42 -16.32 8.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.335 179.755 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -45.02 -26.01 0.39 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.328 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 51.1 mm-40 -63.78 -54.07 40.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.884 0.373 . . . . 0.0 110.633 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.8 mp -77.18 -37.64 53.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.789 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -60.29 -49.57 77.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.712 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.29 -44.06 92.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.73 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.17 -35.52 80.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.979 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -68.54 -28.36 66.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.894 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.7 mttp -84.94 -29.38 25.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.898 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.77 10.05 32.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.442 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.55 147.9 52.65 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.771 0.32 . . . . 0.0 110.789 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -150.91 94.97 2.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.783 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 149.2 -154.72 25.95 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.453 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 8.1 mmm -88.03 121.06 29.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.87 0.367 . . . . 0.0 110.833 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.453 HG22 HD22 ' A' ' 146' ' ' LEU . 49.8 mt -95.8 144.02 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.215 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.9 p -116.24 113.57 23.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.178 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.453 HD22 HG22 ' A' ' 144' ' ' ILE . 3.2 mm? -109.49 125.16 52.18 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.987 0.422 . . . . 0.0 111.46 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 118' ' ' LEU . 10.0 ttpt -105.53 112.02 24.95 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.471 ' HB ' HG13 ' A' ' 117' ' ' ILE . 3.4 p -147.03 144.03 20.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.157 0.503 . . . . 0.0 112.131 -178.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.416 ' N ' HG21 ' A' ' 148' ' ' VAL . 14.6 mt -105.4 136.12 19.26 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.381 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--N 1.347 0.472 0 C-N-CA 122.456 2.104 . . . . 0.0 112.47 -179.679 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 2.6 mttp . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.863 0.363 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . 0.425 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 1.4 pt-20 -161.45 136.76 7.6 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.348 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 126' ' ' TYR . . . . . 0.448 ' CZ ' HG23 ' A' ' 130' ' ' VAL . 32.1 m-85 -122.41 133.28 54.63 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.327 -179.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 89.0 m -106.01 115.98 31.16 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . 0.458 ' N ' ' CD1' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.512 -177.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.819 0.342 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.3 ttt-85 -95.47 119.95 34.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.762 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.91 99.36 10.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.047 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mp -98.48 148.24 6.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.447 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -135.03 123.14 22.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.959 0.409 . . . . 0.0 111.533 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.441 ' CZ ' HG23 ' A' ' 144' ' ' ILE . 8.1 p90 -126.64 133.23 51.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.285 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -80.43 135.36 36.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.98 0.419 . . . . 0.0 111.324 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.09 113.59 15.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.47 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -110.66 -27.84 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.257 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.55 157.18 17.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.37 -179.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -92.52 89.91 6.94 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.52 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -160.04 152.74 17.75 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.966 -178.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.13 147.56 92.83 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.509 2.139 . . . . 0.0 112.207 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 13.6 ttm -55.39 -41.86 73.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.045 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.422 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 117.14 1.79 18.63 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.581 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.403 ' CG2' HD11 ' A' ' 99' ' ' ILE . 2.0 pp -122.17 165.14 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.67 0.271 . . . . 0.0 110.856 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.472 ' O ' ' N ' ' A' ' 97' ' ' ALA . 6.8 m -135.03 130.13 35.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.368 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.45 ' N ' ' CD1' ' A' ' 86' ' ' LEU . 4.4 mp -121.7 159.5 26.45 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.209 -178.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.425 ' HB3' ' HA ' ' B' ' 125' ' ' GLU . 0.0 OUTLIER -137.39 152.82 50.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.249 179.835 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.537 ' HA ' ' O ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -102.21 103.38 13.89 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.819 179.803 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -64.3 176.45 1.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.759 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -52.45 -29.17 23.27 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.969 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -81.05 -2.36 47.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.234 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 63.99 86.97 0.12 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.826 0.346 . . . . 0.0 110.53 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.537 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 3.3 m -160.66 137.94 9.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.289 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.404 ' O ' ' HB ' ' A' ' 117' ' ' ILE . 12.9 p -87.61 115.22 24.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.234 0.54 . . . . 0.0 111.489 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 9.1 m -132.1 131.53 42.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.53 -0.759 . . . . 0.0 108.97 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.534 HG12 ' HA ' ' A' ' 113' ' ' VAL . 4.4 p -58.8 106.15 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.209 0.528 . . . . 0.0 110.667 -179.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -72.59 -23.34 60.94 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.333 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -172.71 131.53 0.55 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.818 0.342 . . . . 0.0 111.515 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.418 ' CD1' ' CG2' ' A' ' 96' ' ' VAL . 25.1 mm -90.09 103.63 14.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.497 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.6 mp -65.92 147.77 52.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.946 0.403 . . . . 0.0 111.303 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.425 ' HA ' ' CD2' ' A' ' 106' ' ' HIS . 56.3 t-80 -85.57 142.44 29.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.735 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.3 -39.4 2.86 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.457 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.422 ' HA3' ' HA3' ' A' ' 83' ' ' GLY . . . -54.0 -178.85 0.13 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.646 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 18.6 ptm -84.44 -29.46 26.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.759 0.314 . . . . 0.0 111.166 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 32.5 mm -70.02 -37.91 73.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.975 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . 0.425 ' CD2' ' HA ' ' A' ' 101' ' ' HIS . 46.9 t60 -77.87 -44.06 28.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.514 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.9 mtt85 -64.3 -49.98 69.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.512 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -79.07 -44.3 22.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.681 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.13 77.53 1.35 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.625 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.2 m -115.2 -28.19 7.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.666 0.27 . . . . 0.0 111.156 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.44 172.22 12.75 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.846 0.355 . . . . 0.0 111.111 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -142.4 132.3 24.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.771 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.534 ' HA ' HG12 ' A' ' 96' ' ' VAL . 7.4 p -44.07 111.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.732 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 117.35 -28.99 6.92 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.9 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -48.99 137.6 12.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.63 0.252 . . . . 0.0 110.77 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -89.52 111.32 22.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.827 0.346 . . . . 0.0 111.601 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.48 ' HA ' ' HA ' ' A' ' 148' ' ' VAL . 4.6 mp -89.25 110.43 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.687 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.84 -30.11 69.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.095 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -162.48 148.14 12.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.893 0.378 . . . . 0.0 111.582 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 49.6 mt -119.47 106.63 19.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.726 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 66.99 29.2 8.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.827 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 87.35 8.96 73.64 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.891 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.6 124.37 26.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.839 0.352 . . . . 0.0 111.06 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 -88.13 107.75 18.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.732 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.8 t -59.34 126.45 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.114 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 14.2 p -113.38 -171.77 1.94 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.834 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -60.32 -23.69 64.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.041 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -55.29 -176.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.738 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 m -64.28 134.08 54.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.926 0.393 . . . . 0.0 110.878 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.473 ' CG2' ' CZ ' ' B' ' 126' ' ' TYR . 0.4 OUTLIER -89.24 -21.94 6.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.127 179.702 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.402 ' HA ' ' HG2' ' A' ' 134' ' ' GLN . 4.7 t0 -46.87 -25.61 0.8 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.489 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.12 -41.99 48.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.188 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -73.61 -44.7 56.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.318 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.402 ' HG2' ' HA ' ' A' ' 131' ' ' ASP . 17.0 pt20 -68.34 -47.47 67.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.463 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.14 -35.59 80.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.443 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -82.74 -44.97 14.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.773 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.77 -25.24 65.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.509 -179.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -85.18 -47.63 9.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.809 0.338 . . . . 0.0 111.191 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -71.5 -13.62 61.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.492 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 14.0 t -59.48 150.83 25.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.901 0.381 . . . . 0.0 110.964 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.07 113.64 14.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.702 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 145.75 -131.99 4.38 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.473 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 29.1 mtp -109.17 119.68 40.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.769 0.319 . . . . 0.0 111.126 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.441 HG23 ' CZ ' ' A' ' 74' ' ' PHE . 33.6 mt -88.09 130.76 37.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.969 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.5 m -108.78 123.35 48.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.603 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.409 ' CD1' HG23 ' A' ' 144' ' ' ILE . 3.2 mp -122.43 130.25 52.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.287 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -103.26 108.17 19.28 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 117' ' ' ILE . 6.1 t -133.0 158.36 43.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.168 0.509 . . . . 0.0 112.271 -178.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 53.1 mt -125.39 124.25 25.13 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.457 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo . . . . . 0 C--N 1.346 0.439 0 C-N-CA 122.502 2.135 . . . . 0.0 112.515 -179.709 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.84 0.353 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . 0.425 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 6.7 pt-20 -164.72 137.56 4.74 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.35 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 126' ' ' TYR . . . . . 0.473 ' CZ ' ' CG2' ' A' ' 130' ' ' VAL . 26.0 m-85 -121.27 134.73 55.18 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.146 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 96.0 m -106.16 115.9 31.02 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . 0.439 HD11 HG21 ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.234 -0.888 . . . . 0.0 111.523 -177.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.854 0.359 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.5 mtt85 -118.6 125.4 49.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.89 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.99 99.45 10.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.849 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 32.6 mt -93.95 143.26 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.831 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -132.25 123.19 26.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.909 0.385 . . . . 0.0 111.194 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.418 ' CZ ' HD21 ' A' ' 146' ' ' LEU . 42.0 p90 -143.53 130.55 20.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.52 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -80.32 141.09 35.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.369 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -129.08 111.12 12.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.442 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -112.01 -25.29 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.419 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.45 154.22 19.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.282 -179.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -90.89 88.93 7.24 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.251 0.548 . . . . 0.0 110.607 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -166.2 146.15 5.23 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.978 -179.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -51.55 151.43 14.16 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.497 2.131 . . . . 0.0 112.275 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -56.89 -41.5 78.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 120.11 28.22 1.88 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.619 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.2 pt -147.8 168.36 4.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.876 0.369 . . . . 0.0 111.004 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.492 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -131.49 126.77 35.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.746 179.519 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.47 ' HA ' ' O ' ' A' ' 95' ' ' THR . 0.6 OUTLIER -127.9 159.5 34.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.809 -179.337 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' B' ' 124' ' ' LYS . 1.8 pttp -136.22 152.37 50.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.527 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.555 ' HA ' ' O ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -95.46 102.95 14.79 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.304 179.148 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -65.8 176.52 1.56 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.639 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -52.1 -24.6 7.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.873 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.45 2.04 46.2 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.574 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 59.98 80.59 0.2 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.744 0.307 . . . . 0.0 110.529 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.555 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 2.7 m -158.06 139.06 13.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.659 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -87.55 111.42 21.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.062 0.458 . . . . 0.0 111.394 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 6.3 m -126.18 129.41 48.96 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.363 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.498 HG12 ' HA ' ' A' ' 113' ' ' VAL . 4.0 p -58.84 106.08 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.233 0.539 . . . . 0.0 110.801 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -75.71 -21.82 57.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.311 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.8 mtp85 -171.67 133.83 0.79 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.765 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 26.9 mm -86.13 103.88 13.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.86 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.0 mp -58.76 138.65 57.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.011 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -79.76 137.25 36.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.935 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.88 -23.85 32.45 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.638 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.13 176.27 1.98 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.625 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 31.3 ttp -78.33 -33.56 49.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.822 0.344 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 40.1 mm -72.36 -35.86 53.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -77.45 -41.86 38.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.657 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.7 ttt85 -72.15 -41.59 66.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.705 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.49 -44.77 14.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.755 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.52 79.87 1.4 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.559 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.6 t -117.6 -32.41 4.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.713 0.292 . . . . 0.0 111.192 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.68 172.59 12.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.84 0.352 . . . . 0.0 111.029 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.406 ' O ' HG12 ' A' ' 96' ' ' VAL . 10.9 m-70 -137.75 140.58 40.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.849 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.498 ' HA ' HG12 ' A' ' 96' ' ' VAL . 9.2 p -43.59 113.56 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.702 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 96' ' ' VAL . . . 119.0 -28.36 6.67 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.504 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.401 ' HB3' HG11 ' A' ' 148' ' ' VAL . 0.7 OUTLIER -50.02 131.91 23.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.735 0.302 . . . . 0.0 110.785 179.851 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -95.11 109.6 21.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.648 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.6 mp -89.27 94.31 4.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.438 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.69 -26.86 67.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.465 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -135.49 130.07 34.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.867 0.365 . . . . 0.0 111.31 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.1 mt -112.48 98.8 7.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.719 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.9 t30 61.76 27.69 16.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.664 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 96.13 -2.18 63.41 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.814 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 27.9 m -133.63 127.54 33.2 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.854 0.359 . . . . 0.0 111.275 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -85.04 121.39 27.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.59 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.0 p -50.6 141.59 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.259 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 40.8 p -108.99 151.79 25.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.913 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -59.69 -25.36 64.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.006 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -59.26 -105.7 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.398 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 28.8 t -109.15 133.7 52.68 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.963 0.411 . . . . 0.0 110.848 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.481 ' CG2' ' CZ ' ' B' ' 126' ' ' TYR . 0.9 OUTLIER -89.62 -20.47 7.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.185 179.508 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -43.68 -27.68 0.34 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.248 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -62.83 -43.85 97.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.432 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.401 ' N ' ' CD2' ' A' ' 133' ' ' LEU . 3.2 mm? -83.85 -43.14 15.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.62 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -59.35 -49.21 78.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.448 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -68.71 -46.45 68.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.796 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.36 -28.9 69.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.275 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 8.7 mmt -72.3 -36.92 69.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.168 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.3 pttt -90.61 -21.56 21.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.428 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -90.97 -16.99 27.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.554 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 9.7 t -76.5 156.94 32.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.963 0.411 . . . . 0.0 111.082 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -143.81 120.88 11.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.716 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 134.71 -160.28 24.2 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.603 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 60.1 mmm -77.28 111.55 13.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.786 0.327 . . . . 0.0 111.129 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.425 HG22 HD23 ' A' ' 146' ' ' LEU . 22.9 mt -85.93 140.28 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.998 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.4 m -108.47 117.33 33.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.486 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.425 HD23 HG22 ' A' ' 144' ' ' ILE . 3.3 mm? -120.18 119.08 32.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.208 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -95.64 105.29 17.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.774 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.401 HG11 ' HB3' ' A' ' 115' ' ' ASP . 2.7 t -118.62 154.46 20.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.808 -178.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 8.3 mt -130.76 134.19 25.71 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.596 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo . . . . . 0 C--N 1.345 0.382 0 C-N-CA 122.453 2.102 . . . . 0.0 112.332 -179.886 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 0.1 OUTLIER . . . . . 0 CA--C 1.527 0.063 0 CA-C-O 120.617 0.246 . . . . 0.0 110.734 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.67 130.95 25.02 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 121.243 0.544 . . . . 0.0 110.058 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 126' ' ' TYR . . . . . 0.481 ' CZ ' ' CG2' ' A' ' 130' ' ' VAL . 5.2 m-85 -115.69 151.0 35.89 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.3 -0.863 . . . . 0.0 112.098 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 1.2 m -110.31 116.12 30.9 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 176.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.236 -0.888 . . . . 0.0 111.512 -177.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.85 0.357 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.74 129.64 49.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.76 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.52 99.42 9.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.003 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.0 mt -89.34 146.45 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.465 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -138.59 123.16 18.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.957 0.408 . . . . 0.0 111.681 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.452 ' CE2' HD22 ' A' ' 146' ' ' LEU . 20.8 p90 -138.57 131.86 30.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.096 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -80.33 138.11 36.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.047 0.451 . . . . 0.0 111.612 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.13 111.27 12.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.19 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.86 -28.28 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.3 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.46 148.52 22.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.256 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -87.5 90.28 8.31 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.298 0.571 . . . . 0.0 110.463 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.65 153.9 11.61 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.964 -178.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -49.88 140.42 30.93 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.463 2.109 . . . . 0.0 112.247 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.438 ' HG2' ' CZ ' ' A' ' 74' ' ' PHE . 0.3 OUTLIER -55.14 -56.56 18.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 138.42 39.12 0.11 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.53 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.406 ' CA ' HD23 ' A' ' 100' ' ' LEU . 15.3 pt -160.02 158.46 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.771 0.32 . . . . 0.0 110.889 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.495 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -124.61 124.12 41.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.935 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.411 ' HA ' ' O ' ' A' ' 95' ' ' THR . 0.4 OUTLIER -128.21 158.52 37.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.15 -179.26 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.9 pttt -138.45 166.75 23.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.025 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.504 ' HA ' ' O ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -107.29 103.37 12.71 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.802 179.797 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -64.9 176.43 1.21 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.797 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -50.82 -30.1 13.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.984 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -75.95 -18.09 59.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.091 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 76.27 87.71 0.08 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.634 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 3.6 m -165.06 143.71 6.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.355 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -87.93 111.42 21.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.035 0.445 . . . . 0.0 111.463 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 7.4 m -130.43 131.03 45.02 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.395 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.509 HG13 ' HA ' ' A' ' 113' ' ' VAL . 2.4 p -59.01 106.15 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.295 0.569 . . . . 0.0 110.724 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -73.16 -22.55 60.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.994 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -173.57 136.15 0.57 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.854 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.422 ' CD1' HG21 ' A' ' 96' ' ' VAL . 12.3 mm -86.02 131.8 33.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.462 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.406 HD23 ' CA ' ' A' ' 84' ' ' ILE . 2.0 mm? -89.46 147.64 23.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.831 0.348 . . . . 0.0 111.01 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 17.0 m170 -83.16 136.54 34.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.78 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.37 -28.46 15.28 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.346 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.63 166.23 7.44 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.467 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -72.34 -25.89 61.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.666 0.269 . . . . 0.0 111.069 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 29.6 mm -76.71 -36.53 27.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.105 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -80.02 -31.19 39.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.783 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -83.46 -51.23 7.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.826 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -73.76 -43.01 60.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.836 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.99 69.54 1.22 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.471 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.59 -27.96 9.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.745 0.307 . . . . 0.0 111.045 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.82 172.61 12.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.968 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -139.88 141.84 36.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.84 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.509 ' HA ' HG13 ' A' ' 96' ' ' VAL . 7.6 p -44.97 120.57 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.499 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 110.26 -27.95 10.96 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.711 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -48.11 135.82 12.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.779 0.323 . . . . 0.0 110.92 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -94.72 120.41 34.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.336 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 148' ' ' VAL . 4.2 mp -99.19 99.03 7.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.633 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -63.92 -28.33 69.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.448 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -147.08 139.05 24.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.868 0.366 . . . . 0.0 111.198 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.418 ' CD1' ' N ' ' A' ' 120' ' ' ILE . 2.7 mp -118.51 98.74 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.953 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 64.64 28.26 13.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.651 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 92.05 7.51 64.08 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.786 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.58 128.18 34.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.717 0.294 . . . . 0.0 110.948 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -91.78 110.88 22.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.678 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 6.0 t -63.38 133.63 28.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.237 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 24.5 p -117.07 -177.42 3.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.837 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -59.68 -20.58 57.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.038 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -58.18 -165.2 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.588 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.09 134.08 46.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.917 0.389 . . . . 0.0 110.954 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.463 HG23 ' CZ ' ' B' ' 126' ' ' TYR . 0.6 OUTLIER -89.34 -18.75 7.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.16 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -44.81 -26.53 0.41 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.474 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.49 -42.14 87.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.877 0.37 . . . . 0.0 110.634 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -81.61 -39.74 24.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.229 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -56.89 -44.7 82.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.644 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.6 -48.89 52.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.78 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.7 -40.35 79.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.072 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 24.5 mmt -69.07 -33.15 73.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.018 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.71 -26.5 37.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.887 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.02 -14.07 23.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.447 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 12.6 t -59.31 156.76 12.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.838 0.351 . . . . 0.0 110.981 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -152.08 104.43 2.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.872 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 141.48 -149.3 20.98 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.646 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 7.8 mtp -87.82 114.37 24.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.869 0.366 . . . . 0.0 110.975 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.408 HG21 HD12 ' A' ' 144' ' ' ILE . 32.8 mt -85.33 130.53 36.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.97 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.4 m -113.57 114.98 27.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.448 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.452 HD22 ' CE2' ' A' ' 74' ' ' PHE . 0.4 OUTLIER -120.55 138.66 53.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.074 -179.52 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 7.1 mmtt -95.94 105.42 17.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.872 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 117' ' ' ILE . 4.2 t -122.79 158.28 27.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.057 0.456 . . . . 0.0 111.926 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 26.2 mt -134.07 133.81 22.36 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.619 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.88 122.17 8.82 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.407 2.071 . . . . 0.0 112.44 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -96.54 41.09 1.11 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.907 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.1 109.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.914 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.884 -179.989 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.808 0.337 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.87 167.86 15.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.973 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -152.3 135.15 15.53 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 121.195 0.522 . . . . 0.0 110.017 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' TYR . . . . . 0.463 ' CZ ' HG23 ' A' ' 130' ' ' VAL . 39.3 m-85 -117.49 134.26 55.05 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.565 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 1.7 m -106.05 115.98 31.15 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . 0.455 ' N ' ' CD1' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.488 -177.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.951 0.405 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.08 148.25 37.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.756 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.2 tt -115.08 99.35 7.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.071 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.9 mm -89.61 110.36 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.41 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -113.05 126.66 55.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.014 0.435 . . . . 0.0 111.772 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.456 ' CZ ' HD21 ' A' ' 146' ' ' LEU . 4.5 p90 -143.17 145.42 32.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.234 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.27 139.68 36.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.014 0.435 . . . . 0.0 111.4 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -129.35 111.28 12.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.364 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.69 12.95 4.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.636 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.68 147.78 46.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.859 0.361 . . . . 0.0 111.228 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -87.76 84.57 7.03 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.249 0.547 . . . . 0.0 110.462 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -174.08 156.92 2.56 Favored Pre-proline 0 N--CA 1.447 -0.587 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.045 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -51.56 132.15 39.66 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.594 2.196 . . . . 0.0 112.4 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.449 ' HG2' ' CE1' ' A' ' 74' ' ' PHE . 0.7 OUTLIER -46.82 -34.98 5.79 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.144 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 123.56 36.41 0.64 Allowed Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.533 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.9 pt -157.02 165.39 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.787 0.327 . . . . 0.0 110.897 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.501 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -130.04 123.14 29.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.062 179.716 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.449 ' N ' ' CD1' ' A' ' 86' ' ' LEU . 4.5 mp -121.3 156.11 33.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.812 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.8 pttt -140.05 159.7 41.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.257 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.516 ' HA ' ' O ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -105.95 103.09 12.5 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.621 179.586 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -65.52 176.34 1.49 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.764 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -51.87 -26.96 11.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.876 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.0 -13.24 59.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.252 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 71.93 88.81 0.1 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.812 0.339 . . . . 0.0 110.601 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.516 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 2.6 m -166.29 141.67 4.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.483 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 11.5 p -87.79 111.44 21.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.099 0.476 . . . . 0.0 111.359 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 15.6 m -132.63 133.95 44.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.323 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.494 HG13 ' HA ' ' A' ' 113' ' ' VAL . 2.5 p -58.84 106.01 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.196 0.522 . . . . 0.0 110.729 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -71.32 -23.98 62.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.866 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.4 ' HA ' ' CG2' ' A' ' 113' ' ' VAL . 16.4 ttm180 -173.55 141.25 0.86 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.784 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.401 ' CD1' HG21 ' A' ' 96' ' ' VAL . 17.2 mm -86.06 138.84 18.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.485 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.2 mt -96.37 126.54 41.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.821 0.343 . . . . 0.0 111.005 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.423 ' HA ' ' CD2' ' A' ' 106' ' ' HIS . 0.3 OUTLIER -68.5 132.48 47.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.902 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 101.84 -27.9 18.36 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.545 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.8 166.26 17.85 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.537 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 8.8 ttp -67.88 -25.67 65.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.81 0.338 . . . . 0.0 111.068 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 19.9 mm -79.46 -32.31 14.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.969 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.423 ' CD2' ' HA ' ' A' ' 101' ' ' HIS . 6.0 t-80 -81.67 -47.75 12.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.548 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.22 -42.17 98.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.558 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -87.4 -43.93 11.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.643 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.37 42.35 5.23 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.597 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.2 p -74.46 -26.14 59.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.812 0.339 . . . . 0.0 111.019 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.1 mt -140.54 172.7 12.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.033 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -140.87 140.91 34.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.82 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.494 ' HA ' HG13 ' A' ' 96' ' ' VAL . 6.0 p -44.96 120.3 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.595 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 111.23 -27.15 11.07 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.748 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.42 ' HB3' HG13 ' A' ' 148' ' ' VAL . 0.2 OUTLIER -46.99 133.38 11.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.762 0.315 . . . . 0.0 110.991 179.871 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.53 114.64 26.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.174 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 148' ' ' VAL . 4.9 mp -94.02 101.58 12.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.84 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.34 -42.43 95.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.96 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -142.72 153.02 42.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.969 0.414 . . . . 0.0 111.218 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 39.4 mt -124.01 98.77 5.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.723 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 59.05 27.72 16.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.703 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 93.87 13.46 54.82 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.617 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 74.4 m -133.64 127.97 34.08 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.894 0.378 . . . . 0.0 111.098 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -110.72 87.57 2.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.674 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.2 p -51.11 158.32 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.328 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 37.9 p -131.9 -176.44 4.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.965 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -62.13 -18.55 61.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.277 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -59.47 -109.11 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.684 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.19 133.97 52.34 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.89 0.376 . . . . 0.0 111.071 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.461 HG21 ' CE1' ' B' ' 126' ' ' TYR . 0.8 OUTLIER -89.27 -23.95 6.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.18 179.551 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.3 -26.44 0.51 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.54 -179.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -56.77 -57.5 12.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.826 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.49 -38.68 59.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.867 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -58.97 -57.7 11.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.906 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.07 -44.91 87.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.896 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.25 -34.09 75.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.083 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.01 -31.37 71.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.984 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -87.92 -24.96 23.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.129 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -90.36 -28.67 18.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.119 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 12.2 t -59.5 156.79 12.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.949 0.404 . . . . 0.0 111.033 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.4 100.12 1.95 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.797 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 149.6 -152.14 24.14 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.511 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 22.9 mtp -80.82 118.82 22.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.827 0.346 . . . . 0.0 111.052 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.42 HG23 HD12 ' A' ' 144' ' ' ILE . 46.1 mt -93.23 145.58 7.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.191 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.9 m -125.39 113.6 17.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.268 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.46 HD23 ' N ' ' A' ' 146' ' ' LEU . 1.9 mm? -115.6 134.36 55.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.13 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 7.5 mmtm -98.72 107.19 19.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.878 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 117' ' ' ILE . 10.1 t -125.49 158.29 34.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.056 0.455 . . . . 0.0 111.939 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 23.8 mt -138.21 126.57 14.17 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.768 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.12 124.62 16.75 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.513 2.142 . . . . 0.0 112.299 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -124.85 -171.76 2.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.912 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 63.11 77.69 0.32 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.951 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.98 179.927 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.809 0.337 . . . . 0.0 111.177 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.87 167.76 16.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.918 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -159.87 133.25 6.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.794 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' TYR . . . . . 0.461 ' CE1' HG21 ' A' ' 130' ' ' VAL . 33.4 m-85 -124.47 134.91 52.91 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.426 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 85' ' ' CYS . 1.8 m -106.01 116.1 31.36 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . 0.411 HD11 ' N ' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.372 -177.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 120.932 0.396 . . . . 0.0 111.258 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.54 146.07 24.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.747 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.82 99.26 6.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.066 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.0 mp -91.43 140.96 15.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.224 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' A' ' 144' ' ' ILE . 32.4 mt-30 -135.41 132.33 37.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.113 0.482 . . . . 0.0 111.911 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.471 ' CZ ' ' CD2' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -144.98 125.97 14.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.298 179.054 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 0.0 OUTLIER -80.26 137.86 36.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.538 -179.216 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -129.07 123.9 33.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.49 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -104.03 -37.31 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.02 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.56 156.53 18.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.258 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -88.63 90.88 8.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.544 0.688 . . . . 0.0 110.565 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -147.18 141.36 15.79 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.947 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.74 144.87 41.54 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.43 2.087 . . . . 0.0 112.082 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.55 -47.01 83.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.97 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 120.74 28.75 1.67 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.755 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.8 pt -146.96 166.3 6.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.844 0.354 . . . . 0.0 110.983 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.481 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -131.18 126.47 35.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.124 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.434 ' HA ' ' O ' ' A' ' 95' ' ' THR . 0.4 OUTLIER -131.72 156.99 44.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.036 -179.467 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.3 pttt -136.16 166.78 22.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.327 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.485 ' HA ' ' O ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -111.11 103.23 11.66 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.419 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -66.94 176.67 1.98 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.819 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -47.73 -37.49 13.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.349 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -70.2 -18.17 63.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.183 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 76.56 88.51 0.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.546 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 1.7 t -162.69 139.55 7.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.46 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.65 111.47 21.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.986 0.422 . . . . 0.0 111.405 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 19.0 m -130.0 133.5 46.81 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.424 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.552 HG12 ' HA ' ' A' ' 113' ' ' VAL . 3.2 p -61.03 105.91 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.214 0.53 . . . . 0.0 110.458 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -72.98 -25.25 60.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.858 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.406 ' HA ' ' CG2' ' A' ' 113' ' ' VAL . 47.5 ttt180 -173.61 128.84 0.42 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.387 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 21.1 mt -85.84 125.51 40.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.897 0.379 . . . . 0.0 110.693 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.0 mp -83.13 135.73 34.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.146 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.419 ' HA ' ' CG ' ' A' ' 106' ' ' HIS . 32.8 t-80 -79.26 136.98 37.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.869 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 114.57 -41.44 2.18 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.388 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.3 -173.06 0.24 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.702 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 64.7 ttp -84.61 -29.69 25.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.716 0.293 . . . . 0.0 111.157 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 33.4 mm -71.56 -42.15 72.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.257 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.419 ' CG ' ' HA ' ' A' ' 101' ' ' HIS . 5.5 t60 -71.49 -35.97 70.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.843 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.62 -51.0 10.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.746 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -73.15 -46.32 51.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.804 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.42 77.48 1.35 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.471 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.0 m -112.4 -30.86 7.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.804 0.335 . . . . 0.0 111.038 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.5 mp -135.53 158.29 44.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.954 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -121.19 135.31 55.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.714 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.552 ' HA ' HG12 ' A' ' 96' ' ' VAL . 7.6 p -45.28 115.01 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.473 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 112.39 -25.62 12.11 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.707 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -55.06 137.78 45.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.696 0.284 . . . . 0.0 110.808 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -91.62 123.2 34.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.908 0.385 . . . . 0.0 111.492 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.406 ' N ' ' CD1' ' A' ' 117' ' ' ILE . 3.3 mp -97.78 94.25 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.354 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -59.05 -26.14 64.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.512 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.16 138.97 25.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.901 0.381 . . . . 0.0 111.481 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.437 ' HA ' HD13 ' A' ' 146' ' ' LEU . 2.5 mp -119.88 98.67 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.56 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 61.99 26.91 16.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.619 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 92.03 13.37 57.77 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.796 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.3 m -133.58 133.69 42.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.839 0.352 . . . . 0.0 111.161 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.29 84.35 2.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.579 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.2 p -55.79 125.69 11.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.217 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 26.3 p -103.6 -168.55 1.52 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.696 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.01 -22.27 60.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.937 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -54.57 -176.1 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.685 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.6 p -59.2 134.07 56.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.926 0.393 . . . . 0.0 110.914 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.454 HG21 ' CZ ' ' B' ' 126' ' ' TYR . 0.7 OUTLIER -89.25 -20.0 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.208 179.777 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -45.6 -25.6 0.48 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.417 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -68.9 -47.77 65.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.738 0.304 . . . . 0.0 110.815 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.2 mp -81.43 -46.53 14.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.722 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -54.54 -39.55 67.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.955 0.407 . . . . 0.0 110.756 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.36 -50.08 29.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.964 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -58.25 -43.51 87.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.306 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 77.2 mmm -65.06 -37.6 88.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.964 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -74.53 -27.64 60.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.864 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -106.92 10.1 30.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.462 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 12.8 t -69.3 156.9 38.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.857 0.361 . . . . 0.0 110.846 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -144.55 113.81 6.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.815 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 130.2 -145.39 16.6 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.636 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.455 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 2.4 mtp -97.41 119.97 36.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.858 0.361 . . . . 0.0 111.188 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 73' ' ' GLN . 41.0 mt -90.23 131.75 36.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.122 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.1 m -112.87 114.26 26.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.107 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.471 ' CD2' ' CZ ' ' A' ' 74' ' ' PHE . 1.0 OUTLIER -116.96 131.2 57.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.384 -179.251 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.29 110.3 22.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.314 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.8 t -121.79 158.25 25.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.575 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 29.2 mt -140.89 130.5 13.04 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.897 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.08 126.06 20.83 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.428 2.085 . . . . 0.0 112.304 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -59.93 120.22 9.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.857 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 61.5 105.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.856 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.167 -0.921 . . . . 0.0 110.958 179.977 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.844 0.354 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . 0.435 ' CD ' ' CE1' ' B' ' 126' ' ' TYR . 0.0 OUTLIER -127.79 167.81 16.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.988 -179.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -155.33 135.84 13.34 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.124 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' TYR . . . . . 0.454 ' CZ ' HG21 ' A' ' 130' ' ' VAL . 33.1 m-85 -115.53 133.21 56.25 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.42 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 1.8 m -105.94 116.05 31.28 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . 0.46 ' N ' ' CD1' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.47 -177.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.9 p . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.777 0.322 . . . . 0.0 111.077 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 -116.06 137.83 51.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.858 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.8 tp -108.93 99.38 8.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.921 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.1 mm -90.41 118.9 36.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.601 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -113.3 127.32 56.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.0 0.428 . . . . 0.0 111.566 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -145.54 131.52 19.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.378 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.33 141.7 35.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.006 0.432 . . . . 0.0 111.299 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.8 ttpt -129.12 111.21 12.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.358 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -105.69 -22.53 4.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.277 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.54 146.09 24.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.185 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -88.36 89.82 8.14 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.259 0.552 . . . . 0.0 110.54 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -167.86 158.72 9.44 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.899 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -50.88 145.18 24.96 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.559 2.172 . . . . 0.0 112.486 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 19.2 ttm -54.27 -65.68 0.53 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.083 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 144.62 38.41 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.704 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.9 pp -163.5 164.83 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.777 0.322 . . . . 0.0 110.907 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -129.29 128.07 42.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.27 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.78 157.43 41.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.824 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -138.86 166.21 25.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.399 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.513 ' HA ' ' O ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -106.54 102.98 12.33 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.485 179.38 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.404 ' O ' ' N ' ' A' ' 92' ' ' GLN . 68.6 m-80 -67.86 176.73 2.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.613 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -49.46 -25.5 2.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.904 0.383 . . . . 0.0 111.021 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 91' ' ' LYS . 12.8 tptt -88.05 12.31 13.8 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.261 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.404 ' N ' ' O ' ' A' ' 89' ' ' ASN . 5.1 pt20 44.02 87.15 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.849 0.357 . . . . 0.0 111.258 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.513 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 1.6 m -160.33 145.05 14.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.428 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -87.83 111.63 21.6 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.932 0.396 . . . . 0.0 111.468 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.6 m -132.17 129.3 39.61 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.616 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.495 HG12 ' HA ' ' A' ' 113' ' ' VAL . 4.1 p -58.79 106.36 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.261 0.553 . . . . 0.0 110.601 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -74.44 -21.5 59.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.384 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -173.53 134.43 0.5 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.06 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 22.6 mm -86.13 103.71 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.639 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.8 mp -57.12 141.87 44.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.216 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.42 ' HA ' ' CD2' ' A' ' 106' ' ' HIS . 78.5 m-70 -78.08 136.36 37.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.819 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.23 -25.03 26.21 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.525 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.51 155.75 18.03 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.459 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 2.9 tmm? -61.26 -37.39 82.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.776 0.322 . . . . 0.0 110.983 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 35.3 mm -68.51 -32.02 53.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.185 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.42 ' CD2' ' HA ' ' A' ' 101' ' ' HIS . 17.4 t60 -74.44 -54.3 7.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.774 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -42.84 94.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.743 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -77.23 -49.57 14.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.755 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.41 76.37 1.33 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.521 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -113.71 -28.77 7.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.734 0.302 . . . . 0.0 111.149 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.83 172.59 12.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.059 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.406 ' O ' HG12 ' A' ' 96' ' ' VAL . 27.2 m-70 -139.59 132.92 30.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.789 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.495 ' HA ' HG12 ' A' ' 96' ' ' VAL . 7.1 p -42.38 108.32 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.768 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 96' ' ' VAL . . . 119.03 -27.45 7.06 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.946 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -50.49 139.9 14.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.765 0.317 . . . . 0.0 110.835 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -90.77 116.78 28.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.46 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 148' ' ' VAL . 4.6 mp -96.7 101.95 12.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.503 179.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.0 mp -68.56 -27.31 65.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.481 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -148.45 141.12 24.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.93 0.395 . . . . 0.0 111.286 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.414 ' HA ' ' CD1' ' A' ' 146' ' ' LEU . 3.5 mp -119.65 99.14 7.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.818 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 62.46 25.39 15.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.716 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 99.94 1.44 56.12 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.984 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.8 m -133.62 130.59 38.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.844 0.354 . . . . 0.0 111.142 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -101.42 98.04 8.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.643 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.6 p -58.85 138.33 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.012 0.434 . . . . 0.0 111.189 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.2 p -123.14 -171.19 2.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.515 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 44.4 p-10 -50.21 -24.88 3.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.244 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.26 -166.04 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.652 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.81 133.88 45.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.883 0.373 . . . . 0.0 110.934 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.456 HG21 ' CZ ' ' B' ' 126' ' ' TYR . 0.7 OUTLIER -89.26 -20.48 7.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.282 179.738 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.0 -26.35 0.42 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.429 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.67 -50.65 73.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.766 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.5 mp -72.16 -41.73 66.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.718 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -55.38 -52.41 63.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.559 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -62.5 -34.9 77.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.529 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.78 -30.34 62.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.986 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 3.8 mmt -69.84 -32.73 71.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.823 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -85.39 -25.96 26.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.023 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -88.92 -32.64 17.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.159 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 11.9 t -59.38 150.63 25.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.012 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.94 124.33 8.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.734 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 124.08 -146.61 16.35 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.547 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 1.6 ttm -78.07 121.1 23.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.894 0.378 . . . . 0.0 111.095 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.402 HG22 HD23 ' A' ' 146' ' ' LEU . 42.8 mt -96.73 136.35 27.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.035 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 87.2 p -107.82 127.67 53.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.632 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.414 ' CD1' ' HA ' ' A' ' 120' ' ' ILE . 3.3 mm? -130.17 121.16 25.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.186 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt -95.87 105.35 17.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.837 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 117' ' ' ILE . 2.7 t -127.64 157.93 39.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.002 0.429 . . . . 0.0 111.773 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 46.1 mt -134.36 135.97 24.94 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.845 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.92 117.7 4.88 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.436 2.091 . . . . 0.0 112.281 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -70.68 65.27 0.31 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.005 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 52.79 29.9 8.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.052 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.154 -0.927 . . . . 0.0 111.001 179.98 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.786 0.327 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . 0.41 ' HD2' ' CE1' ' B' ' 126' ' ' TYR . 0.0 OUTLIER -77.8 167.94 20.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.875 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -141.21 133.07 27.47 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.231 0.538 . . . . 0.0 109.814 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' TYR . . . . . 0.456 ' CZ ' HG21 ' A' ' 130' ' ' VAL . 42.2 m-85 -109.9 132.34 54.24 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.575 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 1.8 m -105.98 115.95 31.1 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . 0.469 ' N ' ' CD1' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.583 -177.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.2 p . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.887 0.375 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.1 mtt85 -101.92 126.04 48.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.922 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.6 99.47 10.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.5 mp -89.37 145.27 7.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.957 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -136.7 123.11 20.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.172 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.469 ' CZ ' ' CD2' ' A' ' 146' ' ' LEU . 10.8 p90 -148.33 129.36 14.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.779 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 1.3 pt-20 -80.33 129.72 34.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.219 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.36 111.57 12.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.225 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -125.65 15.52 4.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.568 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.15 154.94 21.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.54 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -80.9 79.54 7.55 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.267 0.556 . . . . 0.0 110.001 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.14 137.87 1.66 Allowed Pre-proline 0 N--CA 1.447 -0.601 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.132 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.32 156.4 10.74 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.336 2.024 . . . . 0.0 112.258 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.429 ' HG2' ' CE1' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -59.13 -39.89 83.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.857 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 119.86 35.01 0.93 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.488 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.6 pt -152.45 154.31 8.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.77 0.319 . . . . 0.0 110.977 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.5 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -125.61 122.81 37.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.095 179.618 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.404 ' CD1' HD12 ' B' ' 128' ' ' ILE . 0.3 OUTLIER -125.17 159.23 32.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.87 -179.663 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.421 ' HB3' ' HA ' ' B' ' 125' ' ' GLU . 7.0 pttt -142.79 161.44 38.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.2 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.563 ' HA ' ' O ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -101.65 102.9 13.66 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.557 179.389 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -65.25 176.76 1.24 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.448 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -49.67 -27.64 4.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.815 0.34 . . . . 0.0 110.879 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.66 -9.18 59.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.713 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 67.79 76.43 0.27 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.902 0.382 . . . . 0.0 110.946 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.563 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 1.3 p -153.87 145.02 22.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.522 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -87.74 112.63 22.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.105 0.479 . . . . 0.0 111.292 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.5 m -132.85 130.82 40.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.378 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.468 HG13 ' HA ' ' A' ' 113' ' ' VAL . 2.6 p -58.59 106.08 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.312 0.577 . . . . 0.0 110.615 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -71.77 -23.22 61.55 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.038 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.1 mtt180 -173.45 145.92 1.3 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.591 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.4 HG13 ' HB ' ' A' ' 113' ' ' VAL . 54.0 mt -86.01 135.67 24.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.634 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -85.6 123.35 30.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.028 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -70.14 131.99 45.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.911 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.15 -24.52 28.45 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.543 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.61 -178.05 0.62 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.633 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 29.1 ttp -84.42 -27.18 27.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.707 0.289 . . . . 0.0 111.069 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 25.5 mm -78.45 -34.64 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.116 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -72.67 -45.7 57.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.914 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 29.7 ttp180 -71.96 -46.55 57.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.906 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.61 -46.89 29.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.837 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.23 75.55 1.3 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.446 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -111.28 -29.82 7.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.785 0.326 . . . . 0.0 111.104 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 mp -136.95 172.61 12.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.934 0.397 . . . . 0.0 111.034 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -139.48 134.9 32.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.741 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.468 ' HA ' HG13 ' A' ' 96' ' ' VAL . 7.1 p -42.21 113.03 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.705 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 111.75 -24.17 15.67 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.979 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.428 ' HB3' ' CG2' ' A' ' 148' ' ' VAL . 11.4 m-20 -48.95 142.79 6.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.725 0.298 . . . . 0.0 110.848 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.3 mp0 -91.69 114.77 27.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.691 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.42 HG13 ' HB ' ' A' ' 148' ' ' VAL . 4.6 mp -92.79 107.81 19.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.538 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.436 ' N ' ' O ' ' A' ' 147' ' ' LYS . 4.3 mm? -70.11 -27.97 65.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.584 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -155.05 161.0 41.44 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.046 0.45 . . . . 0.0 111.355 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.449 HG21 HD11 ' A' ' 120' ' ' ILE . 30.2 mt -142.02 98.81 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.861 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 62.83 28.33 16.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.041 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.63 -25.09 22.28 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.64 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.8 m -120.27 137.13 54.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.805 0.336 . . . . 0.0 110.979 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -93.92 21.39 6.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.205 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.1 t 58.65 156.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.266 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.5 p -137.8 172.9 12.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.777 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -59.7 -25.65 64.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.811 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -59.23 -163.06 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.48 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.3 m -67.41 134.15 50.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.936 0.398 . . . . 0.0 110.722 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.477 ' CG2' ' CZ ' ' B' ' 126' ' ' TYR . 0.4 OUTLIER -89.13 -16.34 8.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.231 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -44.24 -25.95 0.28 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.432 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -62.03 -58.93 5.99 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.516 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.426 ' N ' ' CD2' ' A' ' 133' ' ' LEU . 2.7 mm? -74.68 -39.08 62.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.336 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.407 ' HG2' ' CG2' ' B' ' 128' ' ' ILE . 7.5 tm0? -57.76 -51.28 70.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.791 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -64.29 -37.31 87.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.844 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.64 -40.35 84.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.089 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -67.08 -29.03 68.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.913 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -84.32 -30.65 25.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.996 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -104.98 10.08 34.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.378 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.36 138.76 55.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.881 0.372 . . . . 0.0 110.916 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.5 76.5 1.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.762 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 167.21 -161.37 35.2 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.383 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.52 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 4.3 ptm -85.01 120.64 26.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.923 0.392 . . . . 0.0 111.002 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.4 HG23 HD22 ' A' ' 146' ' ' LEU . 48.8 mt -95.71 134.36 33.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.354 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.1 m -111.06 113.64 26.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.032 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.469 ' CD2' ' CZ ' ' A' ' 74' ' ' PHE . 2.5 mm? -113.65 142.01 46.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.108 0.48 . . . . 0.0 111.381 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.436 ' O ' ' N ' ' A' ' 118' ' ' LEU . 10.9 mttt -110.61 105.53 14.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.63 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.428 ' CG2' ' HB3' ' A' ' 115' ' ' ASP . 5.2 p -141.62 149.66 19.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.007 0.432 . . . . 0.0 111.676 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.1 mt -125.15 121.45 25.25 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.947 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -59.25 117.45 4.19 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.439 2.093 . . . . 0.0 112.241 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 13.0 p30 43.67 38.36 1.93 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.473 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 61.41 40.3 14.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.91 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.866 -179.981 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.834 0.349 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.63 167.8 13.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.918 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . 0.421 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 3.9 mp0 -163.62 135.53 4.96 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.866 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' TYR . . . . . 0.477 ' CZ ' ' CG2' ' A' ' 130' ' ' VAL . 36.4 m-85 -128.54 131.66 48.25 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.572 -179.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 1.7 m -106.01 115.92 31.05 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . 0.471 ' N ' ' CD1' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.508 -177.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.788 0.327 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -107.37 161.26 14.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.904 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.4 tp -118.89 101.95 8.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.943 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 27.6 mm -89.28 126.79 42.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.915 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -122.57 123.65 41.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.276 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.459 ' CZ ' ' HG3' ' A' ' 82' ' ' MET . 10.4 p90 -149.15 130.96 15.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.539 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -82.41 137.58 34.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.079 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -129.2 111.21 12.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.366 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -125.47 11.9 4.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.706 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.7 158.59 18.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.836 0.351 . . . . 0.0 111.404 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.08 78.93 8.82 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.375 0.607 . . . . 0.0 110.297 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -167.53 149.68 5.41 Favored Pre-proline 0 N--CA 1.445 -0.702 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.152 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -64.77 160.68 39.47 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.507 2.138 . . . . 0.0 112.26 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.459 ' HG3' ' CZ ' ' A' ' 74' ' ' PHE . 15.0 ttm -51.52 -47.45 63.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.037 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 122.71 -6.51 9.68 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.603 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 32.6 pt -113.34 167.84 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.768 0.318 . . . . 0.0 110.779 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.48 ' O ' ' N ' ' A' ' 97' ' ' ALA . 18.7 m -134.27 126.26 29.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.513 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.443 ' HA ' ' O ' ' A' ' 95' ' ' THR . 0.3 OUTLIER -124.15 159.32 30.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.964 -179.463 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -136.42 164.83 27.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.102 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.537 ' HA ' ' O ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -106.51 103.21 12.61 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.951 179.71 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -64.85 176.5 1.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.665 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -52.24 -26.26 11.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.013 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.0 tptp -81.58 -8.41 59.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.325 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 67.67 89.2 0.1 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.849 0.357 . . . . 0.0 110.704 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.537 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 0.3 OUTLIER -166.31 146.28 6.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.416 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -87.88 114.98 25.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.964 0.411 . . . . 0.0 111.348 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 3.1 m -133.66 128.02 34.17 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.486 HG13 ' HA ' ' A' ' 113' ' ' VAL . 2.8 p -58.54 106.2 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.405 0.621 . . . . 0.0 110.404 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -72.67 -24.09 60.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.311 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.6 ttt85 -172.38 126.92 0.53 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.859 0.361 . . . . 0.0 111.175 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.404 ' CD1' ' CG2' ' A' ' 96' ' ' VAL . 17.7 mm -86.17 103.69 13.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.511 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.4 mp -63.87 144.32 57.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.091 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -82.96 128.03 34.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.808 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.36 -35.08 3.88 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.484 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.41 179.33 0.55 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.611 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 12.4 ptm -84.47 -30.31 25.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.772 0.32 . . . . 0.0 110.967 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 39.5 mm -68.4 -36.54 75.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.865 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 18.5 t60 -74.43 -45.24 47.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.631 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.09 -49.8 53.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.604 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -73.79 -48.04 34.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.698 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.34 74.55 1.23 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.598 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -109.63 -30.28 7.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.824 0.345 . . . . 0.0 110.814 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -147.81 164.5 33.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.92 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -130.29 143.58 50.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.792 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.486 ' HA ' HG13 ' A' ' 96' ' ' VAL . 8.6 p -43.36 113.07 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.637 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 116.15 -24.18 10.15 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.708 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.23 134.59 14.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.717 0.294 . . . . 0.0 110.844 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 148' ' ' VAL . 10.7 mt-10 -93.6 107.84 19.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.485 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.466 HG13 ' HB ' ' A' ' 148' ' ' VAL . 2.6 mp -87.14 98.41 7.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.626 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.03 -29.49 70.86 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.018 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -156.61 147.64 22.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.821 0.343 . . . . 0.0 111.162 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 18.6 mt -122.04 107.92 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.826 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 63.05 24.43 14.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.731 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.9 0.43 58.85 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.943 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.2 m -133.6 127.47 33.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.881 0.372 . . . . 0.0 111.181 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -93.02 142.03 27.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.72 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.0 t -91.69 137.32 22.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.178 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 62.7 p -116.07 -177.0 3.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.779 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -56.88 -22.27 35.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.169 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.36 -167.34 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.713 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 42.4 m -68.25 134.07 49.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.964 0.411 . . . . 0.0 110.775 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.457 HG22 ' CZ ' ' B' ' 126' ' ' TYR . 0.6 OUTLIER -89.27 -20.14 7.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.219 179.714 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -44.76 -26.43 0.39 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.426 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.06 -57.6 10.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.831 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.7 mp -77.62 -34.68 53.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.035 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -59.76 -50.54 73.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.645 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -65.79 -44.97 84.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.69 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -65.67 -32.68 74.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.036 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 4.1 mmt -73.55 -26.37 60.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.049 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.35 -19.62 27.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.291 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.59 -23.52 13.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.432 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.4 t -59.32 147.19 36.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.821 0.343 . . . . 0.0 110.99 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -140.68 124.08 16.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.805 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 134.33 -160.02 24.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.493 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 27.8 mtp -77.31 110.17 11.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.774 0.321 . . . . 0.0 110.974 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.415 HD13 ' CE1' ' A' ' 74' ' ' PHE . 53.8 mt -85.39 128.86 38.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.234 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 71.6 m -109.28 120.95 44.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.335 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.48 ' CD2' ' N ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -123.98 132.28 53.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.993 0.425 . . . . 0.0 111.379 -179.396 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.2 105.22 17.33 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.466 ' HB ' HG13 ' A' ' 117' ' ' ILE . 6.1 p -136.04 141.9 40.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.037 0.446 . . . . 0.0 112.052 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 4.3 mt -105.45 131.58 21.63 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.643 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -56.86 140.82 92.6 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.524 2.149 . . . . 0.0 112.322 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.92 98.12 4.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.802 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -144.87 37.94 1.19 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.904 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.003 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.771 0.32 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . 0.423 ' HE2' ' CE1' ' B' ' 126' ' ' TYR . 0.1 OUTLIER -127.79 167.69 16.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.94 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -156.48 135.75 12.13 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.848 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' TYR . . . . . 0.457 ' CZ ' HG22 ' A' ' 130' ' ' VAL . 38.2 m-85 -121.54 132.04 54.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.433 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 72.3 m -105.91 116.1 31.35 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . 0.4 HD11 HD13 ' A' ' 86' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.576 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.5 p . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.857 0.361 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 9.8 ttt-85 -109.53 129.9 55.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.831 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.59 99.34 10.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.966 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.5 mm -98.47 110.4 25.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.428 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -122.27 144.22 49.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.054 0.454 . . . . 0.0 111.737 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.456 ' CZ ' ' CD2' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -153.29 145.04 23.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.271 179.132 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.22 139.07 36.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.016 0.436 . . . . 0.0 111.415 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -129.22 111.24 12.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.369 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -111.63 -28.63 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.263 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.48 150.45 21.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.306 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -89.34 91.32 8.7 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.323 0.582 . . . . 0.0 110.485 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -159.53 159.58 28.11 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.917 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.83 145.18 61.74 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.461 2.107 . . . . 0.0 112.159 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.3 mtm -54.95 -39.58 69.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.874 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.2 18.76 9.49 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.682 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 22.5 pt -127.75 165.85 25.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.731 0.3 . . . . 0.0 110.697 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -133.67 125.18 28.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.247 179.752 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.41 ' HA ' ' O ' ' A' ' 95' ' ' THR . 0.2 OUTLIER -134.1 155.8 49.41 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.364 -179.118 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.405 ' HB3' ' HA ' ' B' ' 125' ' ' GLU . 0.6 OUTLIER -131.61 166.69 20.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.054 179.766 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.546 ' HA ' ' O ' ' A' ' 93' ' ' SER . 0.1 OUTLIER -98.59 103.19 15.11 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.643 179.594 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -64.29 176.45 1.05 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.594 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.71 -30.91 24.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.07 0.462 . . . . 0.0 110.833 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.98 -1.26 43.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.211 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 62.34 86.84 0.11 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.923 0.392 . . . . 0.0 110.462 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.546 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 0.3 OUTLIER -165.57 150.11 8.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.284 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.86 114.95 24.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.036 0.446 . . . . 0.0 111.508 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 2.2 m -126.9 124.77 40.32 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.521 HG13 ' HA ' ' A' ' 113' ' ' VAL . 2.2 p -58.46 105.86 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.433 0.635 . . . . 0.0 110.504 -178.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -71.78 -24.34 61.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.761 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.402 ' HA ' ' CG2' ' A' ' 113' ' ' VAL . 11.3 tpp180 -173.52 130.0 0.44 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.736 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.413 HG21 ' CD2' ' A' ' 106' ' ' HIS . 44.4 mt -86.04 130.34 36.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.564 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.28 122.03 35.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.833 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -56.37 141.74 40.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.06 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.0 -36.9 4.05 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.429 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.25 160.09 17.81 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.634 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.5 ttp -66.28 -22.06 66.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.775 0.322 . . . . 0.0 111.044 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.428 ' CD1' ' N ' ' A' ' 105' ' ' ILE . 2.4 mp -83.11 -31.28 8.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.536 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.413 ' CD2' HG21 ' A' ' 99' ' ' ILE . 1.9 t-80 -88.02 -39.6 14.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.551 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.84 -47.5 68.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.6 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -83.26 -37.4 23.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.653 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.15 46.93 4.58 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.489 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.24 -29.13 48.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.731 0.3 . . . . 0.0 111.044 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.4 mp -136.28 166.79 22.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.984 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -126.67 139.39 53.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.722 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.521 ' HA ' HG13 ' A' ' 96' ' ' VAL . 7.2 p -49.68 114.95 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.357 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 113.41 -21.49 17.02 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.837 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.413 ' HB3' ' CG1' ' A' ' 148' ' ' VAL . 6.0 m-20 -54.7 138.67 41.27 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.714 0.292 . . . . 0.0 110.821 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.408 ' HA ' HG22 ' A' ' 95' ' ' THR . 0.1 OUTLIER -93.6 120.01 33.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.911 0.386 . . . . 0.0 111.585 -179.286 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.439 ' HA ' ' HA ' ' A' ' 148' ' ' VAL . 4.4 mp -101.95 94.29 3.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.52 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.3 mp -61.73 -31.12 71.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.578 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -137.55 141.51 41.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.921 0.391 . . . . 0.0 111.353 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.42 ' HA ' HD12 ' A' ' 146' ' ' LEU . 19.8 mt -122.01 98.79 6.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.839 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 63.76 30.04 14.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.617 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 90.78 1.35 73.78 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.817 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 38.9 m -133.64 121.68 22.36 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.874 0.369 . . . . 0.0 111.136 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -88.63 120.59 30.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.647 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.7 t -63.3 136.22 26.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.21 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 73.7 p -103.96 -176.51 3.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.789 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -77.51 -16.56 58.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.23 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -61.25 -112.59 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.488 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 66.0 m -109.15 133.97 52.32 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.912 0.386 . . . . 0.0 110.944 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.464 ' CG2' ' CZ ' ' B' ' 126' ' ' TYR . 0.7 OUTLIER -89.37 -23.75 6.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.08 179.478 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -45.58 -26.66 0.63 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.404 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -57.97 -56.92 15.83 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.728 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.9 mp -73.73 -33.46 64.36 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.757 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -59.78 -56.48 21.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.586 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.7 tptp -60.51 -38.55 84.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.564 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.4 -32.62 73.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.863 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 3.4 mmt -70.38 -30.27 67.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.805 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -83.84 -28.73 27.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.901 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -98.0 -5.02 34.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.577 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.44 154.07 17.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.799 0.333 . . . . 0.0 110.856 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.05 99.14 2.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 145.92 -149.73 21.89 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.611 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 2.8 mmm -93.42 122.45 35.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.879 0.371 . . . . 0.0 111.001 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.412 HD11 HG22 ' A' ' 144' ' ' ILE . 57.2 mt -87.78 152.85 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.09 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 67.5 p -139.26 113.7 9.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.236 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.476 HD22 ' N ' ' A' ' 146' ' ' LEU . 0.5 OUTLIER -116.4 133.12 56.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.116 -179.418 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.68 105.54 17.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.947 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 117' ' ' ILE . 2.7 t -117.92 158.2 18.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.809 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 31.4 mt -136.63 133.08 18.87 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.8 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.03 117.06 3.36 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.447 2.098 . . . . 0.0 112.325 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -65.72 143.5 57.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.956 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -144.83 77.58 1.54 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.902 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.879 -179.992 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.877 0.37 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.88 167.74 13.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.961 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . 0.405 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 0.6 OUTLIER -174.99 139.13 0.48 Allowed 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.788 179.634 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' TYR . . . . . 0.464 ' CZ ' ' CG2' ' A' ' 130' ' ' VAL . 29.9 m-85 -129.41 133.22 47.24 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.131 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 1.3 m -105.72 116.14 31.44 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . 0.47 ' N ' ' CD1' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.283 -0.865 . . . . 0.0 111.356 -177.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 13.6 p . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 120.834 0.35 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -101.87 145.15 29.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.821 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.7 tp -106.94 113.81 27.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.042 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.1 mm -89.31 130.11 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.861 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -119.12 123.43 44.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.962 0.411 . . . . 0.0 111.252 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.455 ' CZ ' HD22 ' A' ' 146' ' ' LEU . 19.7 p90 -150.22 132.91 15.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.624 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.492 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 22.7 tt0 -83.38 138.04 33.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.349 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -129.38 113.59 15.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.31 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.97 13.9 6.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.613 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.07 148.57 31.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.756 0.312 . . . . 0.0 110.615 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -83.61 80.29 9.17 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.202 0.525 . . . . 0.0 110.011 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.81 163.25 5.57 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.175 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.5 148.66 92.97 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.507 2.138 . . . . 0.0 112.243 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.446 ' HG2' ' CE1' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -50.38 -41.58 52.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.224 -179.88 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 127.55 6.05 5.26 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.094 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.12 165.1 26.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.814 0.34 . . . . 0.0 110.914 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.497 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -127.09 127.85 45.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.106 179.855 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 mp -130.63 158.43 40.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.816 0.341 . . . . 0.0 110.917 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.411 ' HB3' ' HA ' ' B' ' 125' ' ' GLU . 0.0 OUTLIER -138.69 162.89 33.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.179 -179.768 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.518 ' HA ' ' O ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -104.66 103.14 12.74 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.474 179.425 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -64.39 176.34 1.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.781 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -52.88 -26.43 14.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.861 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 43.8 tptt -82.54 -8.17 59.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.188 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 68.56 89.84 0.1 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.8 0.333 . . . . 0.0 110.634 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 0.2 OUTLIER -166.64 146.19 5.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.52 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.8 111.95 21.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.931 0.396 . . . . 0.0 111.428 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.6 m -129.12 126.13 38.64 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.499 HG13 ' HA ' ' A' ' 113' ' ' VAL . 3.4 p -58.8 105.99 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 121.312 0.577 . . . . 0.0 110.549 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -74.9 -22.02 58.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.443 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.3 ptt180 -171.22 131.63 0.78 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.075 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 27.3 mm -86.22 103.72 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.73 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.6 mt -60.49 131.38 50.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.042 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.422 ' HA ' ' CG ' ' A' ' 106' ' ' HIS . 2.9 p80 -75.52 146.23 40.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.909 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.21 -33.51 5.57 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.525 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.67 -179.93 1.88 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.49 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 48.9 ttp -79.72 -33.21 41.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.772 0.32 . . . . 0.0 110.87 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 23.1 mm -70.7 -33.93 54.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.997 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.422 ' CG ' ' HA ' ' A' ' 101' ' ' HIS . 46.1 t-80 -78.58 -51.9 9.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.787 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.4 tpm_? -61.09 -43.35 99.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.717 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -83.05 -46.68 12.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.769 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.02 51.35 2.1 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.553 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.64 -29.36 30.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.752 0.31 . . . . 0.0 110.865 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 46.5 mt -134.41 172.21 13.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.953 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -138.04 131.72 31.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.727 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.499 ' HA ' HG13 ' A' ' 96' ' ' VAL . 8.3 p -43.72 112.78 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.595 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 116.14 -25.49 9.32 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.603 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -47.16 142.35 3.83 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.714 0.292 . . . . 0.0 110.902 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.27 111.18 23.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.428 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.4 mp -95.69 95.82 5.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.67 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -65.49 -26.04 67.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.572 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.36 145.54 30.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.926 0.393 . . . . 0.0 111.375 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.455 ' HA ' HD12 ' A' ' 146' ' ' LEU . 2.8 mp -126.14 98.79 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.639 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 60.63 28.37 18.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.524 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.51 16.48 52.5 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.578 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 58.9 m -133.65 128.61 35.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.894 0.378 . . . . 0.0 111.228 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -104.56 87.88 2.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.48 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.442 HG11 ' HB3' ' A' ' 133' ' ' LEU . 10.8 m -53.36 156.53 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.709 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 55.9 p -138.08 -172.08 3.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.743 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -55.02 -23.32 19.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.151 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -56.76 -167.69 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.806 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 m -67.55 134.03 50.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.068 0.461 . . . . 0.0 111.001 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.462 HG21 ' CZ ' ' B' ' 126' ' ' TYR . 0.4 OUTLIER -89.47 -16.23 8.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.344 179.746 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -43.6 -26.71 0.24 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.467 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.67 -43.37 69.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.979 0.419 . . . . 0.0 110.426 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.442 ' HB3' HG11 ' A' ' 125' ' ' VAL . 0.2 OUTLIER -78.58 -30.5 46.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.546 179.678 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -75.09 -54.14 7.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.999 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.6 tptt -60.7 -47.79 84.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.002 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.06 -42.47 98.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.223 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 27.4 mmt -69.3 -27.58 65.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.195 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -90.56 -25.94 19.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.271 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -93.46 -26.58 17.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.26 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 6.4 t -59.41 153.34 19.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.89 0.376 . . . . 0.0 111.006 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 24.1 mttp -143.82 114.26 7.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.764 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 142.66 -155.41 25.78 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.429 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.492 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 8.6 ptm -86.85 114.29 23.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.932 0.396 . . . . 0.0 110.995 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.462 HD11 HG21 ' A' ' 144' ' ' ILE . 45.1 mt -87.38 141.22 14.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.327 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 54.0 p -124.64 113.59 18.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.31 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.455 HD22 ' CZ ' ' A' ' 74' ' ' PHE . 0.3 OUTLIER -115.63 143.43 45.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.994 -179.566 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -97.39 105.23 17.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.837 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.4 t -122.59 158.34 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.081 0.467 . . . . 0.0 111.891 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.3 mp -133.04 134.89 24.92 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.62 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -51.9 128.75 27.8 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.383 2.056 . . . . 0.0 112.443 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -129.09 117.49 20.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.927 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 -72.98 65.91 0.77 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.854 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.24 -0.885 . . . . 0.0 110.91 179.979 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 120.832 0.349 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.57 167.71 9.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.934 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . 0.411 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 13.2 pt-20 -153.08 134.75 14.5 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.148 0.499 . . . . 0.0 110.225 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' TYR . . . . . 0.462 ' CZ ' HG21 ' A' ' 130' ' ' VAL . 31.3 m-85 -116.55 134.89 54.31 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.306 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 2.0 m -106.02 115.87 30.97 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . 0.451 HG21 HD12 ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.337 -177.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.1 p . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 120.951 0.405 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -109.39 144.61 37.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.835 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 tp -117.86 99.51 6.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.99 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.2 mm -89.33 120.51 38.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.356 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -120.72 125.44 47.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.075 0.464 . . . . 0.0 111.889 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.468 ' CE2' HD22 ' A' ' 146' ' ' LEU . 10.8 p90 -141.58 132.63 26.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.065 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 1.5 pt-20 -80.24 134.26 36.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.089 0.471 . . . . 0.0 111.519 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.18 123.79 32.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.271 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -140.14 15.67 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.581 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -117.75 173.02 6.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.863 0.363 . . . . 0.0 110.831 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -97.9 81.01 2.81 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.317 0.58 . . . . 0.0 110.021 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -162.04 147.77 10.47 Favored Pre-proline 0 N--CA 1.446 -0.627 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.366 -178.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.87 160.83 48.12 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.562 2.174 . . . . 0.0 112.342 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.7 -49.0 78.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.969 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 115.86 16.48 6.83 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.748 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.6 pp -128.82 162.02 36.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.73 0.3 . . . . 0.0 110.851 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.504 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -125.31 127.39 46.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.251 179.783 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.46 157.87 37.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.803 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.0 pttt -138.96 158.15 44.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.754 0.311 . . . . 0.0 111.407 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.505 ' HA ' ' O ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -106.35 106.1 16.46 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.592 179.586 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -64.22 176.21 1.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.905 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -53.09 -29.69 31.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.914 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.2 tptm -82.52 -4.8 58.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.174 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 69.11 87.09 0.12 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.818 0.342 . . . . 0.0 110.526 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 1.4 t -157.47 136.74 11.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.353 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.79 115.21 25.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.067 0.46 . . . . 0.0 111.598 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.3 m -133.55 130.49 38.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.159 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.506 HG11 ' HA ' ' A' ' 113' ' ' VAL . 3.7 p -59.9 105.97 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.271 0.558 . . . . 0.0 110.638 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -72.62 -24.32 61.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.192 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 11.2 ptt85 -172.2 131.82 0.63 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.09 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 29.3 mm -86.15 107.2 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.675 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.2 mt -61.29 135.79 57.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.958 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -81.28 130.31 34.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.989 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.3 -27.3 9.58 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.634 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.97 179.81 10.39 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.643 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 6.3 ptm -80.95 -30.36 35.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.868 0.366 . . . . 0.0 110.965 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.6 mm -69.47 -34.99 64.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.959 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -80.42 -41.11 25.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.74 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -73.17 -50.48 22.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.714 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -73.37 -44.33 58.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.86 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.24 75.87 1.31 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.502 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.1 m -111.76 -30.63 7.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.84 0.352 . . . . 0.0 111.082 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.1 mt -143.36 170.14 16.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.988 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.404 ' O ' HG11 ' A' ' 96' ' ' VAL . 23.2 m80 -137.19 138.83 40.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.792 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.506 ' HA ' HG11 ' A' ' 96' ' ' VAL . 7.6 p -44.99 114.23 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.633 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 119.19 -29.22 6.27 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.022 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.43 ' HB3' ' CG2' ' A' ' 148' ' ' VAL . 4.8 m-20 -50.65 134.93 24.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.713 0.292 . . . . 0.0 110.68 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -92.25 108.8 20.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.942 0.401 . . . . 0.0 111.568 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.456 ' HA ' ' HA ' ' A' ' 148' ' ' VAL . 2.7 mp -86.9 99.31 8.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.718 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.422 ' N ' ' O ' ' A' ' 147' ' ' LYS . 4.0 mm? -52.06 -38.32 56.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.098 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -164.26 152.55 12.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.808 0.337 . . . . 0.0 111.374 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 26.8 mt -111.94 114.25 46.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.903 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 62.9 31.06 16.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.92 0.39 . . . . 0.0 110.659 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 83.38 19.57 62.05 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.596 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 19.3 m -133.63 111.61 10.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.832 0.348 . . . . 0.0 111.06 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -73.98 104.84 4.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.772 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.1 t -63.25 128.24 24.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.991 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 24.6 p -119.51 -170.48 1.95 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.863 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.01 -21.56 45.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.264 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 43.5 m80 -52.37 179.14 0.01 OUTLIER 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.802 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 45.6 m -63.97 133.89 54.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.009 0.433 . . . . 0.0 110.925 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.484 HG23 ' CZ ' ' B' ' 126' ' ' TYR . 0.3 OUTLIER -89.56 -24.91 5.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.165 179.765 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.453 ' HA ' ' HG2' ' A' ' 134' ' ' GLN . 7.3 t70 -46.31 -26.01 0.74 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.599 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -70.24 -41.73 73.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.252 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.1 mt -74.02 -54.03 8.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.25 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.453 ' HG2' ' HA ' ' A' ' 131' ' ' ASP . 3.8 pt20 -55.85 -43.03 76.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.817 0.341 . . . . 0.0 111.061 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm -63.91 -40.76 97.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.645 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.13 -27.17 56.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.089 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 4.6 mmt -76.34 -27.94 56.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.6 mttm -82.06 -39.15 23.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.01 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -82.58 -16.11 49.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.403 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.29 131.39 50.84 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.879 0.371 . . . . 0.0 111.045 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -119.09 87.49 2.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.689 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 167.17 -150.32 16.9 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.541 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.466 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 1.0 OUTLIER -96.61 126.22 41.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.918 0.389 . . . . 0.0 111.183 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 59.2 mt -92.64 130.63 41.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.095 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.4 m -116.93 116.79 28.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.409 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.468 HD22 ' CE2' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -117.76 142.98 46.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.261 -179.457 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 118' ' ' LEU . 7.5 mttp -104.78 108.64 20.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.505 179.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' ' 117' ' ' ILE . 2.5 p -138.19 149.7 24.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.176 0.513 . . . . 0.0 111.863 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 6.3 mm -107.63 120.0 48.72 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.528 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.51 145.13 59.53 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.398 2.065 . . . . 0.0 112.359 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.52 122.36 21.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.835 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -130.19 104.85 7.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.002 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.902 179.947 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.752 0.31 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 2.0 tptt -121.67 167.8 12.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.915 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -161.43 133.62 5.84 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.005 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' TYR . . . . . 0.484 ' CZ ' HG23 ' A' ' 130' ' ' VAL . 38.0 m-85 -129.02 135.87 49.54 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.555 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 1.7 m -106.05 116.04 31.25 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . 0.426 ' N ' ' CD1' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.276 -0.868 . . . . 0.0 111.485 -177.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.9 p . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.798 0.332 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.56 138.07 39.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 tp -112.1 99.33 7.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.982 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 23.0 mt -94.44 149.27 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.424 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 144' ' ' ILE . 10.4 mt-30 -145.92 135.39 23.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.036 0.446 . . . . 0.0 111.846 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.463 ' CZ ' HD21 ' A' ' 146' ' ' LEU . 2.4 p90 -145.52 130.89 18.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.204 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 3.7 tt0 -80.32 136.8 36.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.059 0.457 . . . . 0.0 111.617 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.13 116.41 19.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.29 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -96.28 -30.52 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.035 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.44 150.25 21.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.252 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -91.79 92.5 8.42 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.231 0.539 . . . . 0.0 110.61 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -163.54 159.77 17.72 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.027 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.52 136.47 40.83 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.573 2.182 . . . . 0.0 112.292 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.0 mpp? -58.34 -35.33 71.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.963 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 117.18 32.78 1.45 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.508 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.408 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 14.2 pt -151.27 158.71 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.778 0.323 . . . . 0.0 110.875 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.492 ' O ' ' N ' ' A' ' 97' ' ' ALA . 25.9 m -129.39 122.36 29.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.204 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.503 ' HA ' ' O ' ' A' ' 95' ' ' THR . 4.2 mp -116.38 159.62 21.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.955 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.62 148.25 48.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.335 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.538 ' HA ' ' O ' ' A' ' 93' ' ' SER . 0.3 OUTLIER -81.73 107.23 14.3 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.407 179.285 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -64.2 176.11 1.11 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.898 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.31 -23.27 14.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.08 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.84 17.97 20.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.958 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 56.57 82.18 0.12 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.782 0.325 . . . . 0.0 110.471 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.538 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 1.2 m -151.04 142.42 23.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.484 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -87.67 111.2 21.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.01 0.433 . . . . 0.0 111.495 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 7.0 m -128.82 130.03 46.4 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.523 HG11 ' HA ' ' A' ' 113' ' ' VAL . 3.7 p -58.7 105.7 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-O 121.355 0.598 . . . . 0.0 110.657 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -70.41 -26.65 63.78 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.955 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.2 ttt-85 -173.4 133.94 0.51 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.045 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 25.0 mm -86.07 143.04 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.577 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.408 ' CD2' ' HA ' ' A' ' 84' ' ' ILE . 0.5 OUTLIER -101.54 142.11 33.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.877 0.37 . . . . 0.0 110.956 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.425 ' HA ' ' CD2' ' A' ' 106' ' ' HIS . 43.7 m-70 -77.25 137.25 38.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.95 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.19 -24.95 26.53 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.539 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.16 161.31 11.23 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.49 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 11.8 tmm? -67.47 -22.71 65.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.705 0.288 . . . . 0.0 111.158 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 28.2 mm -84.93 -38.36 13.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.017 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.425 ' CD2' ' HA ' ' A' ' 101' ' ' HIS . 75.1 t60 -76.13 -39.88 54.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.538 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 7.8 tpp85 -71.28 -45.92 62.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.563 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -79.21 -42.74 25.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.663 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.82 72.0 1.21 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.531 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.3 m -113.48 -29.4 7.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.758 0.313 . . . . 0.0 111.155 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -132.78 169.22 17.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.981 0.42 . . . . 0.0 111.113 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -143.02 132.28 23.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.572 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.523 ' HA ' HG11 ' A' ' 96' ' ' VAL . 8.3 p -41.67 110.94 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.773 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 119.09 -31.45 5.47 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.915 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -52.0 133.62 32.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.668 0.271 . . . . 0.0 110.548 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -92.75 114.47 27.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.931 0.396 . . . . 0.0 111.735 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.409 ' N ' ' CD1' ' A' ' 117' ' ' ILE . 3.2 mp -89.39 98.58 8.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.552 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -69.91 -24.38 63.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.579 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -142.79 139.04 30.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.99 0.424 . . . . 0.0 111.346 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 4.1 mp -124.28 98.66 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.727 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 62.79 28.68 16.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.714 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 96.78 -1.9 61.78 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.985 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 25.8 m -133.53 134.89 43.98 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.848 0.356 . . . . 0.0 111.158 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -103.72 105.63 15.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.679 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.7 p -56.4 137.38 18.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.213 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.1 p -117.62 -173.3 2.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.691 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -52.35 -24.31 7.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.29 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 13.8 m170 -57.31 -166.82 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.813 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.9 m -69.45 134.29 48.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.903 0.382 . . . . 0.0 110.939 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.457 HG22 ' CZ ' ' B' ' 126' ' ' TYR . 0.5 OUTLIER -89.11 -21.03 6.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.263 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -46.09 -26.43 0.75 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.278 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.47 -48.94 79.71 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.622 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.6 mp -79.47 -35.38 40.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.818 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -58.42 -49.4 77.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.71 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.9 tptm -68.96 -44.91 72.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.723 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.19 -30.96 71.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.01 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 21.7 mmt -74.35 -31.85 62.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.896 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.6 mttp -83.8 -30.49 26.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.749 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -86.64 -17.03 34.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.229 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.28 145.03 44.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.844 0.354 . . . . 0.0 111.021 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -141.92 93.59 2.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.669 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 151.53 -149.41 21.17 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.626 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.435 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 72.9 mtp -87.83 119.85 28.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.85 0.357 . . . . 0.0 111.333 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.428 HD11 HG22 ' A' ' 144' ' ' ILE . 46.2 mt -97.43 130.99 45.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.995 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.6 m -108.99 114.32 27.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.506 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.463 HD21 ' CZ ' ' A' ' 74' ' ' PHE . 0.7 OUTLIER -116.57 130.58 56.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.929 -179.577 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.47 119.09 34.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.241 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.8 t -132.01 154.99 41.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.07 0.462 . . . . 0.0 111.843 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.2 mm -119.92 122.4 29.06 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.655 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.44 118.5 5.69 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.403 2.068 . . . . 0.0 112.439 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -107.95 138.2 44.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.855 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 11.6 mp0 -128.48 100.36 5.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.954 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.917 179.967 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.957 0.408 . . . . 0.0 111.067 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.55 162.06 14.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.005 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -144.32 131.64 20.81 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.298 0.57 . . . . 0.0 109.925 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' TYR . . . . . 0.457 ' CZ ' HG22 ' A' ' 130' ' ' VAL . 18.6 m-85 -100.92 140.95 34.49 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.666 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 95.6 m -106.39 116.02 31.21 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . 0.456 HG23 HD12 ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.453 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.2 p . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.867 0.365 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.4 ttt-85 -112.5 156.18 23.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.836 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.9 tp -121.26 100.4 7.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.004 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.3 mp -89.17 143.22 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.511 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -133.0 131.77 41.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.072 0.463 . . . . 0.0 111.838 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.446 ' CZ ' ' CD2' ' A' ' 146' ' ' LEU . 6.9 p90 -146.69 137.42 23.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.096 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -80.35 139.72 36.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.964 0.411 . . . . 0.0 111.396 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.13 111.14 12.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.292 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -116.12 -22.9 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.573 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.48 151.47 21.36 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.954 0.407 . . . . 0.0 111.501 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -87.22 88.25 7.64 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.37 0.605 . . . . 0.0 110.462 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -167.38 152.95 7.2 Favored Pre-proline 0 N--CA 1.446 -0.641 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.985 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -56.47 142.51 89.33 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.522 2.148 . . . . 0.0 112.119 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -55.01 -37.06 66.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.987 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 117.57 29.47 2.07 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.527 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.8 pp -145.4 164.59 11.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.684 0.278 . . . . 0.0 110.909 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.481 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -131.98 123.6 27.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.35 -0.386 . . . . 0.0 109.989 179.617 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.444 ' HA ' ' O ' ' A' ' 95' ' ' THR . 0.1 OUTLIER -126.58 158.01 37.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.944 -179.373 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.9 pttp -141.54 163.41 33.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.006 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.518 ' HA ' ' O ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -103.75 103.09 12.94 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.68 179.706 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -68.07 176.75 2.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.626 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.57 -27.3 6.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.941 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -77.04 -15.18 59.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.255 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 71.11 88.57 0.1 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.896 0.379 . . . . 0.0 110.637 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 10.1 t -171.04 148.67 2.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.386 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -87.78 111.43 21.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.962 0.411 . . . . 0.0 111.39 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 9.4 m -129.93 132.22 46.27 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.331 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.471 HG12 ' HA ' ' A' ' 113' ' ' VAL . 2.2 p -58.67 106.09 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.326 0.584 . . . . 0.0 110.86 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -71.26 -24.56 62.19 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.981 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.6 ttt180 -171.44 138.72 1.2 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.031 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.409 ' CD1' HG23 ' A' ' 96' ' ' VAL . 19.8 mm -86.11 109.13 18.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.657 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 21.4 mt -62.78 146.57 52.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.105 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -80.93 129.59 34.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.17 4.35 81.44 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.806 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -76.17 160.3 51.1 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.494 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 40.5 ttp -59.72 -31.86 70.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.867 0.365 . . . . 0.0 110.819 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 29.5 mm -80.77 -31.85 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.828 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -77.93 -53.85 6.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.622 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -60.63 -46.13 91.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.605 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -77.88 -42.68 32.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.685 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.32 67.69 1.43 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.523 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -112.06 -20.47 11.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.631 0.253 . . . . 0.0 111.226 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.4 171.06 14.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.876 0.37 . . . . 0.0 111.026 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -139.46 142.0 37.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.795 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.471 ' HA ' HG12 ' A' ' 96' ' ' VAL . 7.1 p -45.86 121.67 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.509 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 110.35 -21.75 23.66 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.583 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.407 ' HB3' ' CG2' ' A' ' 148' ' ' VAL . 0.4 OUTLIER -52.63 121.41 7.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.656 0.265 . . . . 0.0 110.544 179.762 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.423 ' O ' HG23 ' A' ' 148' ' ' VAL . 62.3 mt-10 -85.25 107.58 17.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.809 0.338 . . . . 0.0 111.447 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.8 mp -84.86 96.88 4.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.767 179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -57.85 -29.84 65.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.171 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -154.28 145.32 22.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.902 0.382 . . . . 0.0 111.241 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 17.0 mt -116.77 102.6 13.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.664 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 56.87 25.43 10.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.737 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 95.73 24.78 14.68 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.541 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.4 m -133.57 123.05 24.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.849 0.357 . . . . 0.0 111.225 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.81 82.69 1.91 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.609 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.6 p -56.5 158.33 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.347 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.4 p -136.88 -173.5 3.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.75 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -61.02 -15.37 31.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.493 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -58.87 -116.9 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.833 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 m -109.01 134.15 52.04 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.88 0.372 . . . . 0.0 111.143 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.452 HG21 ' CZ ' ' B' ' 126' ' ' TYR . 0.6 OUTLIER -89.26 -20.68 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.984 179.53 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -45.55 -26.4 0.58 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.345 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -59.42 -40.31 86.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.55 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.41 -51.54 9.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.546 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -49.74 -46.78 50.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.909 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -53.36 42.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.912 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.76 -64.26 1.01 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.537 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -46.0 -35.83 5.11 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.502 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -80.52 -26.14 38.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.253 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -99.28 3.22 46.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.597 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.93 149.29 41.51 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.893 0.377 . . . . 0.0 110.83 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.91 89.45 1.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.821 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 161.35 -130.75 2.41 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.43 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 38.6 mmm -109.26 122.6 47.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.814 0.34 . . . . 0.0 110.901 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.43 HG22 HD11 ' A' ' 144' ' ' ILE . 46.9 mt -96.69 143.72 11.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.298 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 28.4 p -125.61 113.68 17.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.918 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.446 ' CD2' ' CZ ' ' A' ' 74' ' ' PHE . 2.7 mm? -110.36 123.17 49.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.975 0.417 . . . . 0.0 111.587 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -98.06 105.25 17.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.484 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.45 HG23 ' N ' ' A' ' 149' ' ' ILE . 2.9 p -135.16 143.22 37.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.033 0.444 . . . . 0.0 111.99 -178.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.45 ' N ' HG23 ' A' ' 148' ' ' VAL . 4.6 mt -112.86 130.71 23.24 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.666 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.21 137.54 79.59 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.435 2.09 . . . . 0.0 112.075 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -134.83 23.86 3.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.159 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 173.35 132.96 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.84 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.854 179.891 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.965 0.412 . . . . 0.0 111.061 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.78 167.84 9.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.935 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -164.09 136.18 4.83 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.712 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 126' ' ' TYR . . . . . 0.452 ' CZ ' HG21 ' A' ' 130' ' ' VAL . 34.4 m-85 -113.91 131.19 56.38 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.267 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 1.8 m -105.83 116.07 31.31 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . 0.466 HG23 HD12 ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.458 -177.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.89 0.376 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -108.97 147.83 31.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.716 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.44 99.24 7.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.002 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.5 mm -91.16 110.37 22.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.307 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.419 ' HA ' ' O ' ' A' ' 144' ' ' ILE . 26.0 mt-30 -113.84 130.71 56.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.98 0.419 . . . . 0.0 111.889 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.466 ' CZ ' ' CD2' ' A' ' 146' ' ' LEU . 4.5 p90 -142.4 146.33 34.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.067 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -80.25 143.49 33.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.992 0.425 . . . . 0.0 111.245 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -128.93 111.28 12.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.593 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -105.9 -30.14 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.162 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.59 146.66 23.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.151 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -99.29 96.3 7.64 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.637 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.401 ' CB ' ' CD ' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -174.65 178.09 0.57 Allowed Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.921 -179.135 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.401 ' CD ' ' CB ' ' A' ' 80' ' ' GLU . 51.9 Cg_exo -54.53 125.32 18.58 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.444 2.096 . . . . 0.0 112.327 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 26.4 ttm -47.13 -48.15 23.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.06 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 135.65 -7.88 4.25 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.495 -0.86 . . . . 0.0 113.031 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.8 pt -117.81 166.93 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.888 0.375 . . . . 0.0 111.254 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.495 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -129.31 124.28 33.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.711 179.594 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.404 ' HA ' ' O ' ' A' ' 95' ' ' THR . 0.3 OUTLIER -121.43 157.39 30.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.711 0.291 . . . . 0.0 111.158 -179.294 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.502 ' HB3' ' HA ' ' B' ' 125' ' ' GLU . 0.0 OUTLIER -140.37 160.54 39.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.328 179.923 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.551 ' HA ' ' O ' ' A' ' 93' ' ' SER . 0.4 OUTLIER -90.43 103.12 15.84 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.47 179.454 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -64.3 176.51 1.04 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.784 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -51.31 -23.77 3.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.046 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.28 15.48 20.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.273 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.0 mp0 50.17 81.59 0.06 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.776 0.322 . . . . 0.0 110.798 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.551 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 0.3 OUTLIER -153.6 155.37 35.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.774 -179.737 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.85 111.49 21.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.946 0.403 . . . . 0.0 111.088 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 1.9 m -133.22 127.87 34.67 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.506 HG13 ' HA ' ' A' ' 113' ' ' VAL . 3.9 p -58.68 106.02 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.411 0.624 . . . . 0.0 110.56 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -73.24 -23.54 60.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.493 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -172.16 134.02 0.71 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.124 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 29.1 mm -86.21 109.13 18.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.5 mt -65.74 143.57 57.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.035 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -78.39 133.24 37.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.933 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.43 45.7 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.676 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.95 164.1 6.18 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.679 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 6.6 tmm? -60.44 -43.36 96.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.82 0.343 . . . . 0.0 110.981 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 32.2 mm -67.94 -38.39 79.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.05 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -71.53 -44.7 64.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.661 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -69.56 -52.02 30.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.712 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -71.54 -52.16 19.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.624 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.98 105.82 1.86 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.579 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.06 -45.58 0.13 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.874 0.368 . . . . 0.0 110.958 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.5 mp -117.41 172.6 7.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.974 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -141.73 143.45 33.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.506 ' HA ' HG13 ' A' ' 96' ' ' VAL . 7.1 p -44.31 112.01 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.631 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 115.84 -23.18 11.05 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.847 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.425 ' HB3' ' CG2' ' A' ' 148' ' ' VAL . 1.0 OUTLIER -47.87 140.73 6.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.633 0.254 . . . . 0.0 110.825 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -93.18 111.62 23.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.759 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 148' ' ' VAL . 3.7 mp -99.25 109.03 23.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.513 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -71.22 -26.96 63.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.698 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -154.05 156.85 38.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.059 0.456 . . . . 0.0 111.625 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.413 ' N ' ' CD1' ' A' ' 120' ' ' ILE . 3.2 mp -129.54 100.84 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.387 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 67.02 24.25 9.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.612 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 95.89 8.5 58.03 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.832 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.2 m -133.75 127.33 32.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.805 0.336 . . . . 0.0 111.212 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -87.8 121.0 29.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.453 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.412 ' CG1' HD13 ' A' ' 88' ' ' LEU . 14.9 t -77.1 119.08 24.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.117 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.7 p -108.52 -167.06 1.18 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.906 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -67.58 -16.74 64.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.171 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -166.93 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.599 0.238 . . . . 0.0 110.441 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 21.4 t -68.7 133.53 48.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.942 0.401 . . . . 0.0 110.621 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.461 ' CG2' ' CZ ' ' B' ' 126' ' ' TYR . 0.6 OUTLIER -89.6 -26.2 5.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.095 179.746 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -45.49 -27.76 0.79 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.309 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -51.49 68.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.593 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.0 mp -80.78 -29.68 36.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.752 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -63.32 -43.06 98.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.728 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.93 -41.41 51.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.823 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.6 -45.42 87.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.142 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 70.1 mmm -70.43 -30.32 67.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.999 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -76.5 -28.52 56.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.027 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.12 -0.27 26.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.424 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 12.3 t -60.97 153.69 24.45 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.818 0.342 . . . . 0.0 110.886 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.02 118.18 6.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.849 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 129.98 -153.12 19.91 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.585 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 18.3 mmm -85.34 113.52 21.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.77 0.319 . . . . 0.0 110.975 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.435 HG21 HD12 ' A' ' 144' ' ' ILE . 49.6 mt -85.26 148.19 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.11 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.404 ' N ' HG23 ' A' ' 144' ' ' ILE . 48.8 p -128.3 115.24 17.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.399 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.466 ' CD2' ' CZ ' ' A' ' 74' ' ' PHE . 2.3 mm? -117.71 131.86 56.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.25 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.95 105.42 17.44 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 117' ' ' ILE . 5.3 p -139.05 157.86 28.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.101 0.477 . . . . 0.0 112.045 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.9 mp -137.68 127.32 15.22 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.679 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -60.95 120.15 7.7 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.378 2.052 . . . . 0.0 112.241 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 55.85 -164.5 0.13 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.956 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -111.12 -144.93 0.39 Allowed 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.247 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.171 -0.918 . . . . 0.0 110.869 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.869 0.366 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 4.2 mmtp -103.85 167.59 9.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.953 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . 0.502 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 13.5 mt-10 -168.01 135.73 2.25 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.196 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 126' ' ' TYR . . . . . 0.461 ' CZ ' ' CG2' ' A' ' 130' ' ' VAL . 37.9 m-85 -129.12 132.64 47.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.175 -179.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 1.8 m -105.81 115.95 31.1 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . 0.478 HG22 HD11 ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.289 -0.862 . . . . 0.0 111.24 -177.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.3 p . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.789 0.328 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -96.68 132.88 41.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.962 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.0 tp -110.25 102.84 11.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.921 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 23.9 mm -89.26 120.5 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.774 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -119.37 123.23 43.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.426 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.443 ' CE2' HD22 ' A' ' 146' ' ' LEU . 18.4 p90 -152.18 135.56 15.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.556 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -80.33 139.9 36.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.253 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -129.21 111.21 12.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.25 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.42 12.95 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.47 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.67 163.11 16.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.012 0.434 . . . . 0.0 111.327 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.95 79.52 6.58 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.285 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.36 126.89 0.95 Allowed Pre-proline 0 N--CA 1.445 -0.684 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.275 -178.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.44 166.76 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.574 2.182 . . . . 0.0 112.411 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 21.9 ttm -58.83 -51.27 70.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 121.79 21.55 2.91 Favored Glycine 0 CA--C 1.517 0.163 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.808 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.7 pt -137.48 166.4 24.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.657 0.265 . . . . 0.0 110.639 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.485 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -130.67 124.94 32.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.582 179.798 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' A' ' 95' ' ' THR . 0.4 OUTLIER -129.22 155.99 44.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.025 -179.564 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.407 ' O ' ' O ' ' A' ' 93' ' ' SER . 0.1 OUTLIER -134.63 166.83 22.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.119 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.512 ' HA ' ' O ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -102.12 106.36 17.21 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.224 179.598 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.411 ' HB2' ' HD2' ' A' ' 91' ' ' LYS . 1.4 m120 -64.22 176.36 1.05 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.809 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -51.19 -23.19 3.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.322 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.411 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -97.1 15.69 21.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.367 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.438 ' HB3' ' HA ' ' A' ' 126' ' ' THR . 1.0 OUTLIER 54.37 75.56 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.723 0.296 . . . . 0.0 110.68 179.925 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 78.8 p -143.93 133.05 22.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.712 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 10.9 p -87.63 112.18 22.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.058 0.456 . . . . 0.0 111.459 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 23.9 m -133.57 134.61 43.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.419 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.462 HG13 ' HA ' ' A' ' 113' ' ' VAL . 2.1 p -58.93 106.21 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.71 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -71.47 -25.33 62.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.862 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.403 ' HA ' ' CG2' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -173.52 131.03 0.45 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.563 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.421 HG22 HD12 ' A' ' 99' ' ' ILE . 39.3 mt -85.92 138.26 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.453 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.404 ' CD2' ' N ' ' A' ' 100' ' ' LEU . 0.9 OUTLIER -97.8 142.24 29.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.85 0.357 . . . . 0.0 111.069 -179.715 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.437 ' HA ' ' CD2' ' A' ' 106' ' ' HIS . 0.5 OUTLIER -75.05 143.54 43.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.87 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.54 -29.01 11.0 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.359 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.5 160.76 27.9 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.424 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 2.3 ppp? -65.47 -31.3 72.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.773 0.321 . . . . 0.0 110.826 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.2 mm -71.9 -36.07 56.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.948 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.437 ' CD2' ' HA ' ' A' ' 101' ' ' HIS . 86.2 t60 -80.48 -47.16 14.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.622 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -64.35 -46.72 82.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.664 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -79.76 -41.79 25.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.682 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 85.17 70.67 1.33 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.418 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.3 m -109.12 -26.79 9.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.774 0.321 . . . . 0.0 111.027 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.2 mt -134.39 168.2 19.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.066 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -133.07 136.73 46.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.65 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.462 ' HA ' HG13 ' A' ' 96' ' ' VAL . 7.5 p -46.02 115.75 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.292 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 112.22 -18.83 23.13 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.725 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.424 ' HB3' ' CG1' ' A' ' 148' ' ' VAL . 0.2 OUTLIER -55.51 132.38 48.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.694 0.247 . . . . 0.0 110.539 179.79 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -89.78 113.13 24.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.86 0.362 . . . . 0.0 111.483 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 148' ' ' VAL . 3.4 mp -87.21 99.79 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.734 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -57.21 -29.44 63.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.125 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -160.55 143.16 13.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.18 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.492 HD12 HG22 ' A' ' 120' ' ' ILE . 17.6 mt -112.56 104.62 17.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.888 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 58.99 30.56 20.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.893 0.378 . . . . 0.0 110.556 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 87.65 13.14 65.6 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.581 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.6 m -133.62 117.14 16.69 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.764 0.316 . . . . 0.0 111.137 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -94.98 84.44 4.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.539 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.2 p -47.11 142.87 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.254 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.438 ' HA ' ' HB3' ' A' ' 92' ' ' GLN . 10.1 p -119.0 -173.42 2.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.868 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 27.9 p30 -51.75 -25.77 8.18 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.202 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.09 -171.61 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.765 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 10.0 m -65.4 134.44 53.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.91 0.386 . . . . 0.0 111.127 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.466 HG22 ' CE1' ' B' ' 126' ' ' TYR . 0.8 OUTLIER -88.82 -16.36 8.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.15 179.612 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -45.18 -25.92 0.42 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.348 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.23 -52.34 62.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.508 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.2 mp -76.87 -33.35 57.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.624 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 11.1 tp60 -64.0 -51.07 65.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.566 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.85 -40.64 97.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.749 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.77 -40.71 79.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.058 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 12.4 mmt -65.8 -33.28 75.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.832 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.15 -37.01 58.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -99.65 10.13 41.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.276 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.9 t -61.32 156.93 17.66 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.778 0.323 . . . . 0.0 110.996 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -154.1 110.29 3.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.016 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 129.21 -158.78 22.17 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.67 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 17.4 mtp -85.24 116.18 23.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.916 0.389 . . . . 0.0 110.937 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.413 HG23 HD12 ' A' ' 144' ' ' ILE . 32.1 mt -87.1 130.13 37.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.257 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.1 m -112.44 113.66 25.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.254 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.443 HD22 ' CE2' ' A' ' 74' ' ' PHE . 0.5 OUTLIER -116.53 129.85 56.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.405 -179.412 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -95.82 107.41 19.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.014 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 117' ' ' ILE . 2.3 t -124.92 157.88 33.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.013 0.435 . . . . 0.0 111.805 -178.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 31.1 mt -137.21 118.82 11.04 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.745 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -57.21 135.59 71.28 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.489 2.126 . . . . 0.0 112.523 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -154.96 110.73 3.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.93 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -146.46 96.6 2.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.856 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.975 179.924 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 16.7 mtp180 . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.805 0.336 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.29 160.77 24.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.962 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -158.69 136.55 10.43 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.009 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 126' ' ' TYR . . . . . 0.466 ' CE1' HG22 ' A' ' 130' ' ' VAL . 34.4 m-85 -117.35 132.52 56.58 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.165 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 2.0 m -105.74 116.12 31.4 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . 0.472 ' N ' ' CD1' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.43 -177.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.3 p . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.843 0.354 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -123.95 119.82 30.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.821 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.7 tp -87.44 99.3 11.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.026 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 37.1 mt -109.11 133.51 54.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.342 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.428 ' HA ' ' O ' ' A' ' 144' ' ' ILE . 0.0 OUTLIER -132.36 126.51 33.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.946 0.403 . . . . 0.0 111.689 -179.436 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.43 ' CE2' HD23 ' A' ' 146' ' ' LEU . 4.5 p90 -117.74 144.06 45.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.324 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -80.27 137.32 36.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.884 0.373 . . . . 0.0 111.333 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -129.2 111.24 12.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.368 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.71 10.85 4.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.562 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.6 152.7 38.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.879 0.371 . . . . 0.0 111.291 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -93.59 87.47 5.52 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.435 0.636 . . . . 0.0 110.374 179.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.41 ' HG2' ' HD2' ' A' ' 81' ' ' PRO . 0.3 OUTLIER -171.22 164.07 4.99 Favored Pre-proline 0 N--CA 1.448 -0.573 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.666 -178.829 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.41 ' HD2' ' HG2' ' A' ' 80' ' ' GLU . 25.0 Cg_endo -61.85 141.82 91.25 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.411 2.074 . . . . 0.0 112.071 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -54.11 -40.67 67.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.96 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.432 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 117.22 15.05 6.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.89 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.9 pt -128.74 163.98 32.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.789 0.328 . . . . 0.0 110.743 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.491 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -129.98 124.96 34.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.062 179.634 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.416 ' HA ' ' O ' ' A' ' 95' ' ' THR . 0.2 OUTLIER -135.9 159.35 41.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.137 -179.293 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.492 ' HB3' ' HA ' ' B' ' 125' ' ' GLU . 0.0 OUTLIER -140.51 166.95 23.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.281 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.518 ' HA ' ' O ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -100.34 102.96 14.33 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.064 179.635 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -64.16 176.39 1.03 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.877 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -51.73 -26.26 9.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.883 0.373 . . . . 0.0 110.766 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.99 4.33 38.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.454 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 59.48 77.04 0.33 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.803 0.335 . . . . 0.0 110.363 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 67.1 m -155.91 138.71 15.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.664 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 8.8 p -87.91 114.98 25.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.149 0.5 . . . . 0.0 111.676 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 28.1 m -130.51 135.16 47.66 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.253 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.498 HG13 ' HA ' ' A' ' 113' ' ' VAL . 4.0 p -60.69 106.13 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.244 0.545 . . . . 0.0 110.955 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -74.29 -24.39 59.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.22 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.7 132.61 1.19 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.997 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 24.3 mm -86.24 110.26 19.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.9 mp -70.21 133.23 46.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.918 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 51.7 m80 -69.77 142.17 53.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.842 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.75 -24.28 28.85 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.591 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.432 ' HA3' ' HA3' ' A' ' 83' ' ' GLY . . . -63.39 162.02 33.66 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.641 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.1 ptm -64.97 -37.27 87.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.784 0.326 . . . . 0.0 110.64 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 35.9 mm -67.56 -29.85 46.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.825 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -85.83 -43.06 13.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.627 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.28 -46.94 68.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.607 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -80.98 -45.34 16.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.725 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.38 73.58 1.26 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.643 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.9 t -111.34 -29.42 7.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.811 0.339 . . . . 0.0 110.967 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.1 tp -136.37 169.01 18.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.865 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.4 ' O ' HG13 ' A' ' 96' ' ' VAL . 0.5 OUTLIER -137.56 139.88 40.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.498 ' HA ' HG13 ' A' ' 96' ' ' VAL . 7.6 p -44.08 111.38 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.638 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 119.06 -24.96 8.06 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.607 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.443 ' HB3' ' CG1' ' A' ' 148' ' ' VAL . 1.0 OUTLIER -54.71 131.55 43.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.719 0.295 . . . . 0.0 110.68 179.835 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -90.16 121.47 32.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.668 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 148' ' ' VAL . 4.4 mp -98.18 95.39 4.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.465 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 8.9 mp -56.94 -27.76 61.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.493 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -156.53 153.44 28.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.051 0.453 . . . . 0.0 111.453 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.402 HD11 HG22 ' A' ' 120' ' ' ILE . 36.2 mt -124.96 101.28 8.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.651 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 65.25 16.47 10.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.969 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.54 10.81 26.45 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.063 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.9 t -129.64 124.3 33.35 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.952 0.406 . . . . 0.0 111.371 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -96.76 75.76 2.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.242 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.406 ' HB ' ' CD1' ' A' ' 133' ' ' LEU . 10.7 p -44.71 143.49 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.723 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 39.3 p -120.04 -171.1 2.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.824 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -48.68 -26.31 2.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.422 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -52.24 -179.02 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.926 0.393 . . . . 0.0 111.07 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.85 134.77 57.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.216 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.446 HG21 ' CZ ' ' B' ' 126' ' ' TYR . 0.4 OUTLIER -88.74 -16.42 8.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.071 179.584 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -48.05 -25.18 1.31 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.031 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -58.73 -45.72 88.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.615 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.406 ' CD1' ' HB ' ' A' ' 125' ' ' VAL . 8.4 mt -73.0 -35.26 66.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.285 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.7 -45.91 87.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.752 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.416 ' HG3' ' N ' ' A' ' 136' ' ' ALA . 0.0 OUTLIER -70.36 -30.18 67.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.992 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.416 ' N ' ' HG3' ' A' ' 135' ' ' LYS . . . -79.59 -35.56 39.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.22 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.65 -30.51 67.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.951 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -85.08 -30.04 24.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.09 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -86.81 -34.69 19.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.105 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 9.1 t -59.65 146.57 40.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.966 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.03 106.91 4.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.73 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 150.23 -146.77 16.23 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.55 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 4.0 mtp -94.27 118.31 31.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.851 0.358 . . . . 0.0 111.021 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.428 ' O ' ' HA ' ' A' ' 73' ' ' GLN . 29.1 mt -89.9 139.03 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.056 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 84.4 p -116.5 113.61 23.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.289 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.43 HD23 ' CE2' ' A' ' 74' ' ' PHE . 6.9 mp -112.19 134.05 53.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.947 0.403 . . . . 0.0 111.417 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -95.85 105.4 17.41 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.54 179.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 117' ' ' ILE . 2.6 t -124.72 158.32 32.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.199 0.523 . . . . 0.0 112.094 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 24.1 mt -133.33 135.62 25.73 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.701 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.63 126.27 13.2 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.403 2.068 . . . . 0.0 112.352 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -61.37 99.82 0.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.838 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -106.79 -146.42 0.39 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.275 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.238 -0.886 . . . . 0.0 110.859 179.925 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 9.2 ttp180 . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.778 0.323 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . 0.416 ' HD3' ' CE1' ' B' ' 126' ' ' TYR . 0.5 OUTLIER -98.57 167.96 10.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.926 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . 0.492 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 3.6 pt-20 -156.01 135.75 12.59 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.171 0.51 . . . . 0.0 110.345 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 126' ' ' TYR . . . . . 0.446 ' CZ ' HG21 ' A' ' 130' ' ' VAL . 32.1 m-85 -115.31 133.14 56.31 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.037 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 1.4 m -105.83 116.08 31.33 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . 0.441 HG21 HD12 ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.409 -177.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.9 0.381 . . . . 0.0 111.264 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.2 ptp85 -120.21 144.85 47.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.783 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.7 tp -92.9 99.08 11.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.959 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 37.2 mt -91.63 145.94 6.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.223 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -143.56 126.36 16.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.014 0.435 . . . . 0.0 111.618 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.433 ' CE2' HD23 ' A' ' 146' ' ' LEU . 3.9 p90 -117.72 133.33 56.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.96 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 10.8 pm0 -80.14 134.14 36.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.941 0.4 . . . . 0.0 111.392 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.09 111.31 12.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.586 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -96.99 -34.11 4.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.065 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.52 155.51 18.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.177 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.15 93.14 7.16 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.266 0.555 . . . . 0.0 110.59 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -167.36 164.75 9.28 Favored Pre-proline 0 N--CA 1.449 -0.52 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.028 -179.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -52.01 141.16 47.89 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.584 2.19 . . . . 0.0 112.288 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.96 -56.14 24.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.866 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 147.64 -17.29 1.44 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.982 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.0 pt -115.98 170.59 5.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.77 0.319 . . . . 0.0 111.188 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.481 ' O ' ' N ' ' A' ' 97' ' ' ALA . 5.0 m -131.79 133.61 44.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.362 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.453 ' HA ' ' O ' ' A' ' 95' ' ' THR . 0.5 OUTLIER -127.96 159.48 34.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.327 -179.228 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.436 ' HB3' ' HA ' ' B' ' 125' ' ' GLU . 7.5 pttm -133.02 160.85 35.95 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.954 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.501 ' HA ' ' O ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -99.66 104.71 16.49 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.389 179.559 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -64.3 176.19 1.12 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.942 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -53.68 -22.75 9.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.227 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.407 ' CD ' ' N ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -95.61 16.3 17.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.945 179.818 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 51.9 85.98 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.737 0.303 . . . . 0.0 110.7 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.501 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 1.1 m -159.3 134.13 8.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.437 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 28.0 p -87.72 115.51 25.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.136 0.493 . . . . 0.0 111.438 -179.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 5.8 m -130.04 130.91 45.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.487 -0.779 . . . . 0.0 108.922 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.508 HG13 ' HA ' ' A' ' 113' ' ' VAL . 2.0 p -58.51 105.92 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.629 -178.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -70.57 -25.37 63.05 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.799 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.44 131.29 0.46 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.974 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.3 mt -85.97 128.44 39.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.167 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.9 mt -89.55 146.34 24.65 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.905 0.383 . . . . 0.0 111.228 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.429 ' HA ' ' CD2' ' A' ' 106' ' ' HIS . 8.4 m-70 -79.72 146.67 32.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.809 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.97 -33.64 5.44 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.387 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.61 171.87 4.15 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.549 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 1.8 tmm? -73.53 -28.55 61.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.758 0.313 . . . . 0.0 111.034 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.6 mm -74.59 -37.15 43.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.124 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.429 ' CD2' ' HA ' ' A' ' 101' ' ' HIS . 78.8 t60 -78.45 -49.69 13.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.621 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.91 -44.19 97.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.592 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -82.26 -47.08 12.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.557 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.83 69.92 1.35 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.476 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.3 p -108.77 -29.22 8.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.833 0.349 . . . . 0.0 110.918 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -123.94 172.56 8.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.948 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -135.09 137.89 43.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.79 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.508 ' HA ' HG13 ' A' ' 96' ' ' VAL . 7.5 p -49.75 118.99 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.117 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.77 -20.13 32.15 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.826 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.419 ' HB3' ' CG1' ' A' ' 148' ' ' VAL . 26.9 m-20 -50.32 138.14 17.27 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.675 0.274 . . . . 0.0 110.684 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -90.01 110.48 21.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.717 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.495 ' HA ' ' HA ' ' A' ' 148' ' ' VAL . 5.3 mp -94.72 94.39 4.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.314 179.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.402 ' CD2' ' CD1' ' A' ' 149' ' ' ILE . 3.4 mm? -54.36 -40.32 68.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.887 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -142.12 164.17 30.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.095 0.474 . . . . 0.0 111.66 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.1 mp -131.48 99.12 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.352 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 69.14 17.61 8.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.917 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.58 -0.32 34.55 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.747 -0.739 . . . . 0.0 113.107 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.5 t -132.58 134.56 45.09 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 117.0 0.4 . . . . 0.0 111.449 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -96.05 122.69 39.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.514 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.7 t -58.48 155.03 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.375 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 74.1 p -119.11 171.04 8.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.696 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.35 -21.12 62.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.196 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -59.4 -107.22 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.762 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.3 t -109.07 134.32 51.84 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.884 0.374 . . . . 0.0 111.242 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.458 ' CG2' ' CZ ' ' B' ' 126' ' ' TYR . 0.5 OUTLIER -89.16 -19.26 7.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.059 179.533 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -46.1 -25.29 0.56 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.444 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -54.24 -55.92 23.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.987 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -70.7 -41.88 71.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.796 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -50.3 -53.29 29.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.18 -32.6 73.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.709 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.19 -27.79 61.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.21 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -78.22 -32.25 49.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.912 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -87.57 -29.29 21.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.976 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -81.73 -30.58 32.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.958 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 12.5 t -71.56 149.06 46.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.992 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 11.6 mttp -140.48 125.35 18.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.711 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 127.95 -136.7 9.33 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.336 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.409 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -100.04 137.06 39.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.86 0.362 . . . . 0.0 111.058 -179.867 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 35.7 mt -109.18 142.96 20.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.177 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 28.0 p -121.08 113.7 20.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.456 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.433 HD23 ' CE2' ' A' ' 74' ' ' PHE . 5.8 mp -112.74 142.68 45.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.339 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.71 108.52 20.83 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.471 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.495 ' HA ' ' HA ' ' A' ' 117' ' ' ILE . 2.7 t -125.05 158.33 33.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.267 0.556 . . . . 0.0 112.274 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.402 ' CD1' ' CD2' ' A' ' 118' ' ' LEU . 12.6 mt -132.32 115.98 15.17 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.426 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.7 120.32 7.9 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.428 2.085 . . . . 0.0 112.391 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -79.77 179.33 7.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.843 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -150.61 102.67 3.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.029 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.873 179.956 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 1.8 mmt85 . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.858 0.361 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.33 160.47 15.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.933 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . 0.436 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 8.6 pt-20 -158.07 135.96 10.63 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.202 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 126' ' ' TYR . . . . . 0.458 ' CZ ' ' CG2' ' A' ' 130' ' ' VAL . 16.8 m-85 -115.7 138.19 51.34 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.352 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 98.9 m -106.4 116.11 31.36 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . 0.431 ' N ' ' CD1' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.45 -177.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.916 0.389 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -95.52 152.61 18.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.864 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.43 99.77 4.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.999 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.0 mp -89.32 159.18 2.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.648 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -146.21 124.69 12.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.011 0.434 . . . . 0.0 111.634 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.464 ' CZ ' ' CD2' ' A' ' 146' ' ' LEU . 0.9 OUTLIER -142.47 130.49 21.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.331 179.078 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 10.5 tt0 -80.21 140.85 36.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.646 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 15.8 tttm -129.2 115.86 18.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.305 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -105.73 -26.54 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.329 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.53 149.09 22.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.282 -179.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -87.62 90.43 8.37 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.434 0.635 . . . . 0.0 110.56 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -161.97 157.14 19.98 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.836 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.07 142.61 99.54 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.441 2.094 . . . . 0.0 112.155 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -53.08 -42.42 65.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.045 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 127.58 -8.29 6.95 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.78 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.2 pt -113.5 168.84 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.854 0.359 . . . . 0.0 111.052 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.47 ' O ' ' N ' ' A' ' 97' ' ' ALA . 17.2 m -135.88 132.54 36.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.225 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.8 159.65 39.96 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.272 -179.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.99 162.4 32.99 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.982 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.512 ' HA ' ' O ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -105.89 103.26 12.71 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.511 179.694 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.2 m-20 -64.13 176.42 1.01 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.709 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -51.42 -24.34 4.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.108 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.11 9.32 25.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.516 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 54.36 79.55 0.14 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.768 0.318 . . . . 0.0 110.649 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 11.2 m -152.44 131.89 12.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.561 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 18.3 p -87.68 111.49 21.35 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.08 0.467 . . . . 0.0 111.255 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.6 m -127.58 132.31 49.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.454 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.544 HG12 ' HA ' ' A' ' 113' ' ' VAL . 3.9 p -58.72 106.22 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.195 0.521 . . . . 0.0 110.561 -179.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -73.77 -27.11 60.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.354 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.9 ttp85 -165.77 129.34 2.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.852 0.358 . . . . 0.0 111.47 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.404 ' CD1' ' CG2' ' A' ' 96' ' ' VAL . 32.6 mm -87.65 103.76 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.439 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.5 mt -65.66 135.4 54.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.93 0.395 . . . . 0.0 111.05 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 22.7 m170 -73.07 140.25 47.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.808 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 103.97 -36.52 4.31 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.44 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -55.59 174.59 1.0 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.51 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.53 -29.42 52.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.793 0.33 . . . . 0.0 111.002 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 28.6 mm -69.03 -35.24 67.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.065 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -80.62 -50.63 9.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.707 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -60.22 -41.72 93.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.628 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.74 -43.82 12.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.672 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.73 51.43 2.67 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.517 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 m -87.64 -22.95 24.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.618 0.247 . . . . 0.0 111.051 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.403 HD22 HG11 ' A' ' 96' ' ' VAL . 0.0 OUTLIER -145.84 165.2 29.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.805 0.336 . . . . 0.0 110.901 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.411 ' O ' HG12 ' A' ' 96' ' ' VAL . 12.1 m-70 -133.5 137.93 45.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.894 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.544 ' HA ' HG12 ' A' ' 96' ' ' VAL . 7.5 p -46.74 111.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.714 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 117.41 -26.0 8.37 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.434 -0.888 . . . . 0.0 113.223 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.404 ' HB3' ' CG2' ' A' ' 148' ' ' VAL . 4.6 m-20 -54.13 138.61 37.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.905 0.352 . . . . 0.0 110.67 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.52 118.84 30.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.62 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.493 HG13 ' HB ' ' A' ' 148' ' ' VAL . 4.5 mp -93.43 99.18 9.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.629 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -56.96 -31.58 65.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.241 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -161.23 141.7 11.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.878 0.371 . . . . 0.0 111.349 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 28.2 mt -107.72 103.28 15.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.675 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 65.19 27.28 12.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.696 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 92.51 5.94 64.64 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.875 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.2 m -133.71 127.0 31.93 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.867 0.365 . . . . 0.0 111.221 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -94.89 120.82 35.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.598 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 17.9 t -54.53 149.48 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.357 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 58.6 p -119.16 161.5 20.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.771 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -61.59 -18.85 61.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.165 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -60.22 -111.98 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.723 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.09 134.29 51.88 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.921 0.391 . . . . 0.0 110.973 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.454 ' CG2' ' CZ ' ' B' ' 126' ' ' TYR . 0.6 OUTLIER -89.06 -26.11 5.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.042 179.652 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -46.05 -27.44 0.94 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.452 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -62.24 -48.71 78.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.673 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.8 mp -81.53 -35.89 29.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.801 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -63.87 -46.09 86.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.529 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -68.05 -45.7 73.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.602 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -65.59 -38.16 88.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.911 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 2.0 mmt -65.55 -32.05 73.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -85.29 -28.17 25.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.958 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -91.45 -15.39 28.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.335 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 9.8 t -60.78 156.93 15.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.931 0.396 . . . . 0.0 111.056 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -146.26 117.25 7.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.639 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 134.81 -152.58 20.77 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.625 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.489 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 9.9 ptm -90.47 115.31 27.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.851 0.358 . . . . 0.0 111.29 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 47.0 mt -87.83 130.14 38.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.063 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 14.6 m -111.9 113.68 26.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.255 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.464 ' CD2' ' CZ ' ' A' ' 74' ' ' PHE . 0.9 OUTLIER -112.53 133.93 54.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.063 0.459 . . . . 0.0 111.197 -179.489 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.37 105.3 17.43 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.493 ' HB ' HG13 ' A' ' 117' ' ' ILE . 2.8 p -133.35 156.45 41.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.149 0.5 . . . . 0.0 112.045 -178.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 26.0 mt -122.71 119.05 28.24 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.62 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -57.18 147.5 75.67 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.543 2.162 . . . . 0.0 112.534 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 56.48 177.23 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.074 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -159.77 108.42 1.77 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.825 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.876 -179.952 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 23.2 mtm105 . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.73 0.3 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.1 167.92 9.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.956 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -164.73 139.98 5.54 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.481 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 126' ' ' TYR . . . . . 0.454 ' CZ ' ' CG2' ' A' ' 130' ' ' VAL . 31.6 m-85 -117.81 132.33 56.46 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.324 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 91.4 m -106.01 116.01 31.2 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . 0.463 HD13 HG23 ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.28 -0.867 . . . . 0.0 111.476 -177.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.9 p . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.85 0.357 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -95.42 114.6 26.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.636 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.7 tp -92.17 102.5 15.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.118 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mt -89.22 152.13 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.638 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -140.8 123.2 15.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.005 0.431 . . . . 0.0 111.52 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.452 ' CE2' HD23 ' A' ' 146' ' ' LEU . 25.9 p90 -146.97 134.55 20.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.133 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.27 143.47 33.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.071 0.462 . . . . 0.0 111.571 -179.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.11 111.23 12.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.159 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -109.72 -25.84 3.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.465 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.57 146.23 24.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.313 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.96 90.54 8.38 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.385 0.612 . . . . 0.0 110.421 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -168.43 174.47 2.18 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.673 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -74.93 142.75 28.46 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.347 2.031 . . . . 0.0 112.415 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -52.55 -58.06 7.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.033 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 143.26 39.0 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.657 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.0 pt -157.88 170.08 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.719 0.295 . . . . 0.0 110.879 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.475 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -135.48 113.56 11.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.48 179.704 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.431 ' N ' ' CD2' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -122.12 159.1 27.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.079 -179.159 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.447 ' HB3' ' HA ' ' B' ' 125' ' ' GLU . 0.0 OUTLIER -136.09 166.79 22.56 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.325 -179.69 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.569 ' HA ' ' O ' ' A' ' 93' ' ' SER . 0.1 OUTLIER -89.65 103.11 15.78 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.201 179.339 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.408 ' O ' ' N ' ' A' ' 92' ' ' GLN . 4.9 t30 -64.07 176.38 1.01 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.71 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.86 -27.41 3.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.946 0.403 . . . . 0.0 110.803 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.401 ' HD2' ' HB2' ' A' ' 93' ' ' SER . 0.1 OUTLIER -93.56 21.11 6.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.418 179.887 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 89' ' ' ASN . 45.5 mm-40 45.57 74.11 0.15 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.889 0.376 . . . . 0.0 110.666 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.569 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 5.5 m -148.28 147.8 29.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.654 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 1.4 m -87.8 114.18 24.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.119 0.485 . . . . 0.0 111.548 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 2.7 m -130.1 126.63 38.03 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.319 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' A' ' 113' ' ' VAL . 3.6 p -58.78 105.83 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.408 0.623 . . . . 0.0 110.597 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -74.4 -22.69 59.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.149 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 24.2 ttt180 -171.59 139.04 1.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.679 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 31.8 mm -86.11 121.0 36.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.9 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.428 ' CD2' ' HB2' ' A' ' 85' ' ' CYS . 4.6 mm? -74.23 143.33 45.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.038 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 16.0 p-80 -85.54 131.33 34.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.945 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.57 -27.9 16.25 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.48 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.28 176.05 8.23 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.516 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -80.48 -30.03 37.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.757 0.313 . . . . 0.0 110.941 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 42.9 mm -65.18 -36.73 78.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.989 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -81.46 -46.02 15.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.757 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -45.66 85.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.715 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -81.97 -43.84 17.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.755 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.39 63.13 1.31 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.503 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -101.1 -27.34 13.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.878 0.371 . . . . 0.0 111.106 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.3 mt -142.3 157.79 44.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.043 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 50.4 m170 -129.52 142.56 50.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.773 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.484 ' HA ' HG12 ' A' ' 96' ' ' VAL . 8.2 p -43.83 113.75 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.654 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 119.07 -28.78 6.47 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.564 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -47.06 126.12 8.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.667 0.27 . . . . 0.0 110.754 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -89.0 111.36 22.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.868 0.366 . . . . 0.0 111.675 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.513 ' HA ' ' HA ' ' A' ' 148' ' ' VAL . 4.4 mp -91.2 98.1 8.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.663 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -60.97 -32.81 72.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.551 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -141.07 146.8 37.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.934 0.397 . . . . 0.0 111.687 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.428 ' CD1' ' CG2' ' A' ' 117' ' ' ILE . 14.9 mm -118.0 99.75 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.772 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 62.19 27.87 16.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.743 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 94.98 2.58 62.46 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.866 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 21.9 m -133.55 131.52 39.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.813 0.339 . . . . 0.0 111.052 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -93.34 116.24 28.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.727 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 25.5 t -56.16 158.76 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.319 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 10.9 p -137.5 -178.94 5.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.908 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -59.64 -25.41 64.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.954 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -54.96 -175.03 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.76 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.7 m -64.32 134.23 54.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.907 0.384 . . . . 0.0 110.885 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.48 ' CG2' ' CZ ' ' B' ' 126' ' ' TYR . 0.3 OUTLIER -88.95 -17.18 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.198 179.663 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.23 -25.94 0.7 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.285 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -65.21 -52.82 52.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.489 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.23 -29.87 60.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.338 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -67.65 -45.58 74.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.507 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.1 pttp -68.98 -38.03 79.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.63 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.04 -38.46 66.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.016 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 5.9 mmt -67.47 -28.87 68.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.992 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -86.85 -34.88 19.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.07 10.05 42.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.324 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.37 129.96 41.56 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.813 0.34 . . . . 0.0 110.901 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.17 93.34 3.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.814 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 151.25 -157.15 27.05 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.594 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 11.5 mmm -90.15 123.13 33.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.848 0.356 . . . . 0.0 110.985 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 29.3 mt -92.79 131.48 39.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.215 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 59.5 m -112.79 113.53 25.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.056 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.452 HD23 ' CE2' ' A' ' 74' ' ' PHE . 1.1 mm? -117.02 136.06 53.23 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.949 0.404 . . . . 0.0 111.456 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 7.3 mttm -100.32 105.96 17.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.649 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 117' ' ' ILE . 4.8 t -123.94 153.58 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.168 0.509 . . . . 0.0 112.16 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.435 HD13 HG21 ' A' ' 149' ' ' ILE . 17.7 mm -117.28 122.43 31.1 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.442 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.56 126.0 13.53 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.526 2.151 . . . . 0.0 112.507 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -104.17 113.16 26.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.846 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 62.25 107.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.837 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.253 -0.879 . . . . 0.0 110.902 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.888 0.375 . . . . 0.0 111.162 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.88 167.66 21.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.025 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . 0.447 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 2.8 pt-20 -152.53 134.3 14.69 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.303 0.573 . . . . 0.0 110.25 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 126' ' ' TYR . . . . . 0.48 ' CZ ' ' CG2' ' A' ' 130' ' ' VAL . 22.0 m-85 -113.02 136.94 52.14 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.174 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 1.7 m -105.86 116.16 31.47 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . 0.401 HD13 ' N ' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.399 -177.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.8 p . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.805 0.335 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.38 122.19 45.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.912 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 tt -90.96 99.31 12.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.977 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.2 mt -96.08 154.9 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.724 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -145.9 128.08 15.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.938 0.399 . . . . 0.0 111.458 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.425 ' CE2' HD21 ' A' ' 146' ' ' LEU . 8.1 p90 -141.05 135.71 31.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.459 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -80.35 138.1 36.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.909 0.385 . . . . 0.0 111.034 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.8 tttm -129.18 111.28 12.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.405 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -130.53 14.25 2.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.67 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.42 154.94 20.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.904 0.383 . . . . 0.0 111.33 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.79 79.08 6.77 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.338 0.589 . . . . 0.0 110.48 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.65 153.24 2.71 Favored Pre-proline 0 N--CA 1.446 -0.655 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.014 -178.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.52 158.49 31.75 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.504 2.136 . . . . 0.0 112.285 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 23.7 ttm -56.07 -54.21 47.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.956 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 132.24 -9.09 5.37 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.939 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.8 pt -114.92 168.07 6.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.802 0.334 . . . . 0.0 111.139 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.471 ' O ' ' N ' ' A' ' 97' ' ' ALA . 19.3 m -135.02 127.68 30.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.275 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.441 ' HA ' ' O ' ' A' ' 95' ' ' THR . 0.1 OUTLIER -125.9 159.56 32.25 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.238 -179.177 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.425 ' HB3' ' HA ' ' B' ' 125' ' ' GLU . 22.4 pttp -137.06 162.3 33.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.178 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.584 ' HA ' ' O ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -103.26 102.96 12.95 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.597 179.504 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -64.37 176.67 1.01 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.638 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -50.29 -27.57 6.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.937 0.399 . . . . 0.0 110.838 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.04 -16.9 57.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.347 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 74.78 78.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.821 0.343 . . . . 0.0 110.248 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.584 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 49.1 p -154.94 150.62 27.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.667 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -87.85 113.58 23.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.062 0.458 . . . . 0.0 111.219 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 2.9 m -131.96 126.76 34.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.322 179.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.558 HG11 ' HA ' ' A' ' 113' ' ' VAL . 2.6 p -58.72 105.91 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.279 0.561 . . . . 0.0 110.02 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -72.04 -25.03 61.64 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.266 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.21 123.03 0.39 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.854 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.0 mt -85.97 120.75 36.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.361 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.421 ' N ' ' CD1' ' A' ' 100' ' ' LEU . 5.9 mp -83.96 135.8 34.32 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.148 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.433 ' HA ' ' CG ' ' A' ' 106' ' ' HIS . 11.7 p80 -73.6 138.63 45.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.826 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.69 -36.53 4.3 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.382 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.16 -171.02 0.12 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.51 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.4 ttp -84.42 -40.6 17.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.865 0.364 . . . . 0.0 110.906 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.6 mm -65.54 -36.88 78.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.105 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.433 ' CG ' ' HA ' ' A' ' 101' ' ' HIS . 63.7 t-80 -75.11 -54.98 6.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.748 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.6 ttt-85 -60.05 -47.17 86.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.693 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -75.99 -47.06 26.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.638 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.72 73.39 1.28 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.565 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.6 m -111.91 -29.26 7.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.776 0.322 . . . . 0.0 110.986 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -134.26 172.53 12.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.09 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -134.46 137.42 43.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.711 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.558 ' HA ' HG11 ' A' ' 96' ' ' VAL . 7.5 p -47.02 115.99 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.901 0.381 . . . . 0.0 111.359 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 112.23 -24.95 13.23 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.853 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -50.29 143.35 8.76 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.74 0.27 . . . . 0.0 110.7 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.401 ' O ' HG21 ' A' ' 148' ' ' VAL . 1.6 mt-10 -95.32 107.71 19.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.819 0.342 . . . . 0.0 111.725 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.471 HG13 ' HB ' ' A' ' 148' ' ' VAL . 3.9 mp -86.67 99.83 8.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.66 179.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.411 ' N ' ' O ' ' A' ' 147' ' ' LYS . 4.3 mm? -51.46 -35.12 38.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.311 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -169.72 145.64 3.1 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.959 0.409 . . . . 0.0 111.271 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 45.1 mt -104.56 125.29 59.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.828 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 60.87 27.74 17.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.777 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 83.32 18.13 65.17 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.743 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 27.4 m -133.58 128.11 34.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.828 0.347 . . . . 0.0 111.023 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -92.56 114.96 27.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.792 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.7 p -82.07 127.04 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.246 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.8 p -98.0 -167.09 1.46 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.714 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -67.05 -15.51 63.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.294 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.9 -166.91 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.678 0.275 . . . . 0.0 110.572 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 28.6 t -67.67 134.03 50.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.941 0.401 . . . . 0.0 110.682 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.448 HG23 ' CZ ' ' B' ' 126' ' ' TYR . 0.6 OUTLIER -89.42 -16.32 8.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.335 179.755 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -45.02 -26.01 0.39 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.328 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 51.1 mm-40 -63.78 -54.07 40.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.884 0.373 . . . . 0.0 110.633 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.8 mp -77.18 -37.64 53.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.789 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -60.29 -49.57 77.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.712 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.29 -44.06 92.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.73 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.17 -35.52 80.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.979 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -68.54 -28.36 66.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.894 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.7 mttp -84.94 -29.38 25.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.898 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.77 10.05 32.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.442 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.55 147.9 52.65 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.771 0.32 . . . . 0.0 110.789 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -150.91 94.97 2.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.783 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 149.2 -154.72 25.95 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.453 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 8.1 mmm -88.03 121.06 29.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.87 0.367 . . . . 0.0 110.833 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.453 HG22 HD22 ' A' ' 146' ' ' LEU . 49.8 mt -95.8 144.02 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.215 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.9 p -116.24 113.57 23.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.178 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.453 HD22 HG22 ' A' ' 144' ' ' ILE . 3.2 mm? -109.49 125.16 52.18 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.987 0.422 . . . . 0.0 111.46 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 118' ' ' LEU . 10.0 ttpt -105.53 112.02 24.95 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.471 ' HB ' HG13 ' A' ' 117' ' ' ILE . 3.4 p -147.03 144.03 20.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.157 0.503 . . . . 0.0 112.131 -178.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.416 ' N ' HG21 ' A' ' 148' ' ' VAL . 14.6 mt -105.4 136.12 19.26 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.381 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -70.06 133.47 25.09 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.456 2.104 . . . . 0.0 112.47 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -135.87 120.07 17.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.733 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 61.51 38.76 15.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.981 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.974 0.416 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -119.17 167.8 11.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.813 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . 0.425 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 1.4 pt-20 -161.45 136.76 7.6 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.348 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 126' ' ' TYR . . . . . 0.448 ' CZ ' HG23 ' A' ' 130' ' ' VAL . 32.1 m-85 -122.41 133.28 54.63 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.327 -179.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 89.0 m -106.01 115.98 31.16 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . 0.458 ' N ' ' CD1' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.512 -177.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.819 0.342 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.3 ttt-85 -95.47 119.95 34.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.762 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.91 99.36 10.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.047 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mp -98.48 148.24 6.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.447 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -135.03 123.14 22.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.959 0.409 . . . . 0.0 111.533 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.441 ' CZ ' HG23 ' A' ' 144' ' ' ILE . 8.1 p90 -126.64 133.23 51.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.285 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -80.43 135.36 36.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.98 0.419 . . . . 0.0 111.324 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.09 113.59 15.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.47 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -110.66 -27.84 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.257 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.55 157.18 17.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.37 -179.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -92.52 89.91 6.94 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.52 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -160.04 152.74 17.75 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.966 -178.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.13 147.56 92.83 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.509 2.139 . . . . 0.0 112.207 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 13.6 ttm -55.39 -41.86 73.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.045 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.422 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 117.14 1.79 18.63 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.581 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.403 ' CG2' HD11 ' A' ' 99' ' ' ILE . 2.0 pp -122.17 165.14 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.67 0.271 . . . . 0.0 110.856 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.472 ' O ' ' N ' ' A' ' 97' ' ' ALA . 6.8 m -135.03 130.13 35.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.368 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.45 ' N ' ' CD1' ' A' ' 86' ' ' LEU . 4.4 mp -121.7 159.5 26.45 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.209 -178.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.425 ' HB3' ' HA ' ' B' ' 125' ' ' GLU . 0.0 OUTLIER -137.39 152.82 50.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.249 179.835 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.537 ' HA ' ' O ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -102.21 103.38 13.89 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.819 179.803 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -64.3 176.45 1.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.759 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -52.45 -29.17 23.27 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.969 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -81.05 -2.36 47.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.234 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 63.99 86.97 0.12 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.826 0.346 . . . . 0.0 110.53 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.537 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 3.3 m -160.66 137.94 9.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.289 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.404 ' O ' ' HB ' ' A' ' 117' ' ' ILE . 12.9 p -87.61 115.22 24.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.234 0.54 . . . . 0.0 111.489 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 9.1 m -132.1 131.53 42.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.53 -0.759 . . . . 0.0 108.97 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.534 HG12 ' HA ' ' A' ' 113' ' ' VAL . 4.4 p -58.8 106.15 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.209 0.528 . . . . 0.0 110.667 -179.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -72.59 -23.34 60.94 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.333 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -172.71 131.53 0.55 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.818 0.342 . . . . 0.0 111.515 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.418 ' CD1' ' CG2' ' A' ' 96' ' ' VAL . 25.1 mm -90.09 103.63 14.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.497 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.6 mp -65.92 147.77 52.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.946 0.403 . . . . 0.0 111.303 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.425 ' HA ' ' CD2' ' A' ' 106' ' ' HIS . 56.3 t-80 -85.57 142.44 29.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.735 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.3 -39.4 2.86 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.457 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.422 ' HA3' ' HA3' ' A' ' 83' ' ' GLY . . . -54.0 -178.85 0.13 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.646 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 18.6 ptm -84.44 -29.46 26.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.759 0.314 . . . . 0.0 111.166 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 32.5 mm -70.02 -37.91 73.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.975 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.425 ' CD2' ' HA ' ' A' ' 101' ' ' HIS . 46.9 t60 -77.87 -44.06 28.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.514 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.9 mtt85 -64.3 -49.98 69.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.512 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -79.07 -44.3 22.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.681 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.13 77.53 1.35 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.625 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.2 m -115.2 -28.19 7.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.666 0.27 . . . . 0.0 111.156 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.44 172.22 12.75 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.846 0.355 . . . . 0.0 111.111 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -142.4 132.3 24.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.771 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.534 ' HA ' HG12 ' A' ' 96' ' ' VAL . 7.4 p -44.07 111.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.732 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 117.35 -28.99 6.92 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.9 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -48.99 137.6 12.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.63 0.252 . . . . 0.0 110.77 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -89.52 111.32 22.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.827 0.346 . . . . 0.0 111.601 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.48 ' HA ' ' HA ' ' A' ' 148' ' ' VAL . 4.6 mp -89.25 110.43 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.687 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.84 -30.11 69.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.095 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -162.48 148.14 12.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.893 0.378 . . . . 0.0 111.582 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 49.6 mt -119.47 106.63 19.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.726 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 66.99 29.2 8.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.827 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 87.35 8.96 73.64 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.891 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.6 124.37 26.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.839 0.352 . . . . 0.0 111.06 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 -88.13 107.75 18.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.732 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.8 t -59.34 126.45 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.114 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 14.2 p -113.38 -171.77 1.94 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.834 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -60.32 -23.69 64.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.041 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -55.29 -176.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.738 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 m -64.28 134.08 54.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.926 0.393 . . . . 0.0 110.878 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.473 ' CG2' ' CZ ' ' B' ' 126' ' ' TYR . 0.4 OUTLIER -89.24 -21.94 6.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.127 179.702 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.402 ' HA ' ' HG2' ' A' ' 134' ' ' GLN . 4.7 t0 -46.87 -25.61 0.8 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.489 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.12 -41.99 48.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.188 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -73.61 -44.7 56.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.318 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.402 ' HG2' ' HA ' ' A' ' 131' ' ' ASP . 17.0 pt20 -68.34 -47.47 67.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.463 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.14 -35.59 80.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.443 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -82.74 -44.97 14.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.773 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.77 -25.24 65.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.509 -179.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -85.18 -47.63 9.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.809 0.338 . . . . 0.0 111.191 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -71.5 -13.62 61.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.492 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 14.0 t -59.48 150.83 25.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.901 0.381 . . . . 0.0 110.964 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.07 113.64 14.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.702 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 145.75 -131.99 4.38 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.473 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 29.1 mtp -109.17 119.68 40.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.769 0.319 . . . . 0.0 111.126 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.441 HG23 ' CZ ' ' A' ' 74' ' ' PHE . 33.6 mt -88.09 130.76 37.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.969 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.5 m -108.78 123.35 48.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.603 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.409 ' CD1' HG23 ' A' ' 144' ' ' ILE . 3.2 mp -122.43 130.25 52.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.287 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -103.26 108.17 19.28 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 117' ' ' ILE . 6.1 t -133.0 158.36 43.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.168 0.509 . . . . 0.0 112.271 -178.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 53.1 mt -125.39 124.25 25.13 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.457 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.52 132.79 24.47 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.502 2.135 . . . . 0.0 112.515 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -103.93 128.05 51.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.694 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 64.21 129.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.86 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.904 -179.965 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 36.7 ttt-85 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.817 0.341 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.3 167.75 10.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.822 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . 0.425 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 6.7 pt-20 -164.72 137.56 4.74 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.35 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 126' ' ' TYR . . . . . 0.473 ' CZ ' ' CG2' ' A' ' 130' ' ' VAL . 26.0 m-85 -121.27 134.73 55.18 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.146 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 96.0 m -106.16 115.9 31.02 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . 0.439 HD11 HG21 ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.234 -0.888 . . . . 0.0 111.523 -177.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.854 0.359 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.5 mtt85 -118.6 125.4 49.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.89 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.99 99.45 10.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.849 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 32.6 mt -93.95 143.26 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.831 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -132.25 123.19 26.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.909 0.385 . . . . 0.0 111.194 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.418 ' CZ ' HD21 ' A' ' 146' ' ' LEU . 42.0 p90 -143.53 130.55 20.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.52 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -80.32 141.09 35.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.369 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -129.08 111.12 12.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.442 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -112.01 -25.29 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.419 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.45 154.22 19.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.282 -179.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -90.89 88.93 7.24 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.251 0.548 . . . . 0.0 110.607 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -166.2 146.15 5.23 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.978 -179.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -51.55 151.43 14.16 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.497 2.131 . . . . 0.0 112.275 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -56.89 -41.5 78.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 120.11 28.22 1.88 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.619 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.2 pt -147.8 168.36 4.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.876 0.369 . . . . 0.0 111.004 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.492 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -131.49 126.77 35.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.746 179.519 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.47 ' HA ' ' O ' ' A' ' 95' ' ' THR . 0.6 OUTLIER -127.9 159.5 34.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.809 -179.337 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' B' ' 124' ' ' LYS . 1.8 pttp -136.22 152.37 50.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.527 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.555 ' HA ' ' O ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -95.46 102.95 14.79 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.304 179.148 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -65.8 176.52 1.56 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.639 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -52.1 -24.6 7.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.873 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.45 2.04 46.2 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.574 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 59.98 80.59 0.2 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.744 0.307 . . . . 0.0 110.529 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.555 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 2.7 m -158.06 139.06 13.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.659 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -87.55 111.42 21.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.062 0.458 . . . . 0.0 111.394 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 6.3 m -126.18 129.41 48.96 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.363 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.498 HG12 ' HA ' ' A' ' 113' ' ' VAL . 4.0 p -58.84 106.08 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.233 0.539 . . . . 0.0 110.801 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -75.71 -21.82 57.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.311 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.8 mtp85 -171.67 133.83 0.79 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.765 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 26.9 mm -86.13 103.88 13.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.86 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.0 mp -58.76 138.65 57.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.011 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -79.76 137.25 36.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.935 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.88 -23.85 32.45 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.638 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.13 176.27 1.98 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.625 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 31.3 ttp -78.33 -33.56 49.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.822 0.344 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 40.1 mm -72.36 -35.86 53.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -77.45 -41.86 38.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.657 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.7 ttt85 -72.15 -41.59 66.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.705 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.49 -44.77 14.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.755 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.52 79.87 1.4 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.559 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.6 t -117.6 -32.41 4.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.713 0.292 . . . . 0.0 111.192 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.68 172.59 12.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.84 0.352 . . . . 0.0 111.029 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.406 ' O ' HG12 ' A' ' 96' ' ' VAL . 10.9 m-70 -137.75 140.58 40.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.849 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.498 ' HA ' HG12 ' A' ' 96' ' ' VAL . 9.2 p -43.59 113.56 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.702 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 96' ' ' VAL . . . 119.0 -28.36 6.67 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.504 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.401 ' HB3' HG11 ' A' ' 148' ' ' VAL . 0.7 OUTLIER -50.02 131.91 23.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.735 0.302 . . . . 0.0 110.785 179.851 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -95.11 109.6 21.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.648 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.6 mp -89.27 94.31 4.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.438 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.69 -26.86 67.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.465 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -135.49 130.07 34.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.867 0.365 . . . . 0.0 111.31 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.1 mt -112.48 98.8 7.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.719 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.9 t30 61.76 27.69 16.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.664 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 96.13 -2.18 63.41 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.814 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 27.9 m -133.63 127.54 33.2 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.854 0.359 . . . . 0.0 111.275 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -85.04 121.39 27.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.59 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.0 p -50.6 141.59 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.259 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 40.8 p -108.99 151.79 25.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.913 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -59.69 -25.36 64.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.006 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -59.26 -105.7 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.398 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 28.8 t -109.15 133.7 52.68 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.963 0.411 . . . . 0.0 110.848 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.481 ' CG2' ' CZ ' ' B' ' 126' ' ' TYR . 0.9 OUTLIER -89.62 -20.47 7.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.185 179.508 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -43.68 -27.68 0.34 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.248 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -62.83 -43.85 97.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.432 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.401 ' N ' ' CD2' ' A' ' 133' ' ' LEU . 3.2 mm? -83.85 -43.14 15.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.62 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -59.35 -49.21 78.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.448 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -68.71 -46.45 68.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.796 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.36 -28.9 69.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.275 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 8.7 mmt -72.3 -36.92 69.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.168 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.3 pttt -90.61 -21.56 21.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.428 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -90.97 -16.99 27.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.554 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 9.7 t -76.5 156.94 32.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.963 0.411 . . . . 0.0 111.082 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -143.81 120.88 11.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.716 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 134.71 -160.28 24.2 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.603 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 60.1 mmm -77.28 111.55 13.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.786 0.327 . . . . 0.0 111.129 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.425 HG22 HD23 ' A' ' 146' ' ' LEU . 22.9 mt -85.93 140.28 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.998 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.4 m -108.47 117.33 33.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.486 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.425 HD23 HG22 ' A' ' 144' ' ' ILE . 3.3 mm? -120.18 119.08 32.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.208 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -95.64 105.29 17.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.774 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.401 HG11 ' HB3' ' A' ' 115' ' ' ASP . 2.7 t -118.62 154.46 20.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.808 -178.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 8.3 mt -130.76 134.19 25.71 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.596 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.55 122.64 11.64 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.453 2.102 . . . . 0.0 112.332 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 39.9 p30 -58.15 146.95 31.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.95 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 62.05 97.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.872 179.951 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.842 0.353 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 0.1 OUTLIER -126.64 164.83 20.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.734 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.67 130.95 25.02 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 121.243 0.544 . . . . 0.0 110.058 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 126' ' ' TYR . . . . . 0.481 ' CZ ' ' CG2' ' A' ' 130' ' ' VAL . 5.2 m-85 -115.69 151.0 35.89 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.3 -0.863 . . . . 0.0 112.098 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 1.2 m -110.31 116.12 30.9 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 176.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.236 -0.888 . . . . 0.0 111.512 -177.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.85 0.357 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.74 129.64 49.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.76 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.52 99.42 9.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.003 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.557 HD13 HD12 ' A' ' 111' ' ' LEU . 18.0 mt -89.34 146.45 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.465 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -138.59 123.16 18.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.957 0.408 . . . . 0.0 111.681 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.763 ' HE1' HD12 ' A' ' 144' ' ' ILE . 20.8 p90 -138.57 131.86 30.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.096 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 2.4 tt0 -80.33 138.11 36.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.047 0.451 . . . . 0.0 111.612 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.13 111.27 12.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.19 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.86 -28.28 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.3 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.46 148.52 22.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.256 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -87.5 90.28 8.31 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.298 0.571 . . . . 0.0 110.463 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.65 153.9 11.61 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.964 -178.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -49.88 140.42 30.93 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.463 2.109 . . . . 0.0 112.247 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.45 ' HG2' ' CZ ' ' A' ' 74' ' ' PHE . 0.3 OUTLIER -55.14 -56.56 18.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.561 ' O ' HG23 ' A' ' 84' ' ' ILE . . . 138.42 39.12 0.11 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.53 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.743 HG22 HD13 ' A' ' 99' ' ' ILE . 15.3 pt -160.02 158.46 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.771 0.32 . . . . 0.0 110.889 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.496 ' HB2' HD21 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -124.61 124.12 41.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.935 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.67 ' CD1' HD11 ' B' ' 128' ' ' ILE . 0.4 OUTLIER -128.21 158.52 37.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.15 -179.26 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.554 ' C ' HD13 ' A' ' 88' ' ' LEU . 2.9 pttt -138.45 166.75 23.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.025 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.683 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -107.29 103.37 12.71 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.802 179.797 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -64.9 176.43 1.21 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.797 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -50.82 -30.1 13.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.984 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -75.95 -18.09 59.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.091 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 76.27 87.71 0.08 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.634 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 3.6 m -165.06 143.71 6.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.355 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -87.93 111.42 21.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.035 0.445 . . . . 0.0 111.463 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 115' ' ' ASP . 7.4 m -130.43 131.03 45.02 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.395 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.887 HG13 ' H ' ' A' ' 114' ' ' GLY . 2.4 p -59.01 106.15 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.295 0.569 . . . . 0.0 110.724 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.534 ' HB2' ' HD3' ' A' ' 87' ' ' LYS . . . -73.16 -22.55 60.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.994 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.478 ' HA ' HG23 ' A' ' 113' ' ' VAL . 1.5 tmm_? -173.57 136.15 0.57 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.854 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.743 HD13 HG22 ' A' ' 84' ' ' ILE . 12.3 mm -86.02 131.8 33.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.462 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.612 HD22 ' N ' ' A' ' 100' ' ' LEU . 2.0 mm? -89.46 147.64 23.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.831 0.348 . . . . 0.0 111.01 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 17.0 m170 -83.16 136.54 34.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.78 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.37 -28.46 15.28 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.346 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.63 166.23 7.44 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.467 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.407 ' SD ' HD13 ' A' ' 105' ' ' ILE . 0.5 OUTLIER -72.34 -25.89 61.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.666 0.269 . . . . 0.0 111.069 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.44 ' HB ' HG23 ' A' ' 84' ' ' ILE . 29.6 mm -76.71 -36.53 27.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.105 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -80.02 -31.19 39.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.783 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -83.46 -51.23 7.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.826 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -73.76 -43.01 60.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.836 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.99 69.54 1.22 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.471 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.59 -27.96 9.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.745 0.307 . . . . 0.0 111.045 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 1.095 HD11 HG21 ' A' ' 148' ' ' VAL . 0.1 OUTLIER -141.82 172.61 12.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.968 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -139.88 141.84 36.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.84 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.478 HG23 ' HA ' ' A' ' 98' ' ' ARG . 7.6 p -44.97 120.57 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.499 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.887 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 110.26 -27.95 10.96 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.711 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.618 ' O ' HG23 ' A' ' 95' ' ' THR . 0.1 OUTLIER -48.11 135.82 12.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.779 0.323 . . . . 0.0 110.92 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.429 ' HA ' HG23 ' A' ' 95' ' ' THR . 7.6 tt0 -94.72 120.41 34.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.336 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.708 HG13 HG22 ' A' ' 148' ' ' VAL . 4.2 mp -99.19 99.03 7.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.633 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -63.92 -28.33 69.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.448 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -147.08 139.05 24.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.868 0.366 . . . . 0.0 111.198 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.944 HD13 HG23 ' A' ' 125' ' ' VAL . 2.7 mp -118.51 98.74 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.953 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 9.3 t30 64.64 28.26 13.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.651 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 92.05 7.51 64.08 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.786 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.58 128.18 34.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.717 0.294 . . . . 0.0 110.948 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -91.78 110.88 22.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.678 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.944 HG23 HD13 ' A' ' 120' ' ' ILE . 6.0 t -63.38 133.63 28.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.237 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 24.5 p -117.07 -177.42 3.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.837 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -59.68 -20.58 57.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.038 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -58.18 -165.2 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.588 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.09 134.08 46.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.917 0.389 . . . . 0.0 110.954 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.628 HG21 ' CE1' ' B' ' 126' ' ' TYR . 0.6 OUTLIER -89.34 -18.75 7.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.16 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 135' ' ' LYS . 3.3 p30 -44.81 -26.53 0.41 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.474 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.49 -42.14 87.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.877 0.37 . . . . 0.0 110.634 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.871 ' HG ' HG22 ' A' ' 125' ' ' VAL . 2.1 mm? -81.61 -39.74 24.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.229 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.415 ' HG3' ' CG2' ' B' ' 128' ' ' ILE . 3.9 tt0 -56.89 -44.7 82.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.644 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -70.6 -48.89 52.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.78 179.808 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.7 -40.35 79.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.072 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.838 ' O ' HG22 ' A' ' 140' ' ' THR . 24.5 mmt -69.07 -33.15 73.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.018 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.71 -26.5 37.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.887 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.02 -14.07 23.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.447 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.838 HG22 ' O ' ' A' ' 137' ' ' MET . 12.6 t -59.31 156.76 12.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.838 0.351 . . . . 0.0 110.981 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -152.08 104.43 2.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.872 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 141.48 -149.3 20.98 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.646 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.407 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 7.8 mtp -87.82 114.37 24.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.869 0.366 . . . . 0.0 110.975 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.763 HD12 ' HE1' ' A' ' 74' ' ' PHE . 32.8 mt -85.33 130.53 36.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.97 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.457 ' O ' HD13 ' A' ' 146' ' ' LEU . 5.4 m -113.57 114.98 27.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.448 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.69 HD22 ' N ' ' A' ' 146' ' ' LEU . 0.4 OUTLIER -120.55 138.66 53.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.074 -179.52 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 7.1 mmtt -95.94 105.42 17.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.872 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 1.095 HG21 HD11 ' A' ' 111' ' ' LEU . 4.2 t -122.79 158.28 27.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.057 0.456 . . . . 0.0 111.926 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.421 ' N ' HG12 ' A' ' 148' ' ' VAL . 26.2 mt -134.07 133.81 22.36 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.619 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo . . . . . 0 C--N 1.346 0.398 0 C-N-CA 122.407 2.071 . . . . 0.0 112.44 -179.844 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.896 0.379 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -152.3 135.15 15.53 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 121.195 0.522 . . . . 0.0 110.017 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 126' ' ' TYR . . . . . 0.628 ' CE1' HG21 ' A' ' 130' ' ' VAL . 39.3 m-85 -117.49 134.26 55.05 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.565 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 1.7 m -106.05 115.98 31.15 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 128' ' ' ILE . . . . . 0.696 HD13 ' N ' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.488 -177.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.608 ' O ' HG13 ' A' ' 69' ' ' VAL . 8.8 p . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.951 0.405 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.08 148.25 37.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.756 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.433 HD23 ' O ' ' A' ' 71' ' ' LEU . 9.2 tt -115.08 99.35 7.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.071 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.9 mm -89.61 110.36 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.41 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -113.05 126.66 55.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.014 0.435 . . . . 0.0 111.772 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.666 ' HE1' HD12 ' A' ' 144' ' ' ILE . 4.5 p90 -143.17 145.42 32.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.234 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 0.0 OUTLIER -80.27 139.68 36.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.014 0.435 . . . . 0.0 111.4 -179.364 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -129.35 111.28 12.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.364 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.62 HG13 ' O ' ' A' ' 77' ' ' VAL . 0.3 OUTLIER -124.69 12.95 4.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.636 -179.642 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.68 147.78 46.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.859 0.361 . . . . 0.0 111.228 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -87.76 84.57 7.03 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.249 0.547 . . . . 0.0 110.462 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -174.08 156.92 2.56 Favored Pre-proline 0 N--CA 1.447 -0.587 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.045 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -51.56 132.15 39.66 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.594 2.196 . . . . 0.0 112.4 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.465 ' HG2' ' CE1' ' A' ' 74' ' ' PHE . 0.7 OUTLIER -46.82 -34.98 5.79 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.144 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.42 ' O ' HG23 ' A' ' 84' ' ' ILE . . . 123.56 36.41 0.64 Allowed Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.533 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.512 HD12 HD11 ' A' ' 86' ' ' LEU . 23.9 pt -157.02 165.39 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.787 0.327 . . . . 0.0 110.897 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.72 ' C ' HD12 ' A' ' 86' ' ' LEU . 0.1 OUTLIER -130.04 123.14 29.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.062 179.716 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.728 HD23 HD13 ' A' ' 117' ' ' ILE . 4.5 mp -121.3 156.11 33.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.812 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.635 ' C ' HD13 ' A' ' 88' ' ' LEU . 36.8 pttt -140.05 159.7 41.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.257 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.673 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -105.95 103.09 12.5 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.621 179.586 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -65.52 176.34 1.49 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.764 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -51.87 -26.96 11.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.876 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.0 -13.24 59.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.252 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.4 ' HG2' ' HB2' ' A' ' 127' ' ' ASN . 4.1 mt-30 71.93 88.81 0.1 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.812 0.339 . . . . 0.0 110.601 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.53 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 2.6 m -166.29 141.67 4.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.483 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.574 ' SG ' HD11 ' A' ' 120' ' ' ILE . 11.5 p -87.79 111.44 21.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.099 0.476 . . . . 0.0 111.359 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.7 HG23 ' O ' ' A' ' 115' ' ' ASP . 15.6 m -132.63 133.95 44.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.323 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.917 HG13 ' H ' ' A' ' 114' ' ' GLY . 2.5 p -58.84 106.01 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.196 0.522 . . . . 0.0 110.729 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -71.32 -23.98 62.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.866 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.407 ' HA ' ' CG2' ' A' ' 113' ' ' VAL . 16.4 ttm180 -173.55 141.25 0.86 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.784 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.546 HD13 HG21 ' A' ' 96' ' ' VAL . 17.2 mm -86.06 138.84 18.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.485 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.657 HD11 ' SG ' ' B' ' 127' ' ' CYS . 1.2 mt -96.37 126.54 41.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.821 0.343 . . . . 0.0 111.005 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.5 132.48 47.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.902 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 101.84 -27.9 18.36 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.545 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.8 166.26 17.85 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.537 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 8.8 ttp -67.88 -25.67 65.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.81 0.338 . . . . 0.0 111.068 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.61 HG23 ' OG ' ' A' ' 110' ' ' SER . 19.9 mm -79.46 -32.31 14.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.969 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -81.67 -47.75 12.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.548 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.22 -42.17 98.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.558 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -87.4 -43.93 11.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.643 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.37 42.35 5.23 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.597 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.61 ' OG ' HG23 ' A' ' 105' ' ' ILE . 11.2 p -74.46 -26.14 59.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.812 0.339 . . . . 0.0 111.019 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.929 HD21 HG21 ' A' ' 148' ' ' VAL . 5.1 mt -140.54 172.7 12.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.033 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -140.87 140.91 34.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.82 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.44 ' O ' HG13 ' A' ' 113' ' ' VAL . 6.0 p -44.96 120.3 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.595 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.917 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 111.23 -27.15 11.07 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.748 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.7 ' O ' HG23 ' A' ' 95' ' ' THR . 0.2 OUTLIER -46.99 133.38 11.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.762 0.315 . . . . 0.0 110.991 179.871 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.53 114.64 26.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.174 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.728 HD13 HD23 ' A' ' 86' ' ' LEU . 4.9 mp -94.02 101.58 12.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.84 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.463 HD21 HD12 ' A' ' 149' ' ' ILE . 4.4 mm? -60.34 -42.43 95.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.96 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -142.72 153.02 42.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.969 0.414 . . . . 0.0 111.218 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.671 HG23 HD12 ' A' ' 146' ' ' LEU . 39.4 mt -124.01 98.77 5.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.723 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 59.05 27.72 16.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.703 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 93.87 13.46 54.82 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.617 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 74.4 m -133.64 127.97 34.08 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.894 0.378 . . . . 0.0 111.098 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -110.72 87.57 2.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.674 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.566 HG21 HG13 ' A' ' 130' ' ' VAL . 9.2 p -51.11 158.32 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.328 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.482 ' N ' HG22 ' A' ' 125' ' ' VAL . 37.9 p -131.9 -176.44 4.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.965 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.4 ' HB2' ' HG2' ' A' ' 92' ' ' GLN . 23.5 t-20 -62.13 -18.55 61.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.277 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -59.47 -109.11 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.684 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.19 133.97 52.34 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.89 0.376 . . . . 0.0 111.071 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.87 HG21 ' CE1' ' B' ' 126' ' ' TYR . 0.8 OUTLIER -89.27 -23.95 6.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.18 179.551 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.3 -26.44 0.51 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.54 -179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -56.77 -57.5 12.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.826 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.52 ' C ' HD12 ' A' ' 133' ' ' LEU . 0.3 OUTLIER -75.49 -38.68 59.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.867 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -58.97 -57.7 11.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.906 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.07 -44.91 87.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.896 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.25 -34.09 75.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.083 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.429 ' O ' HG22 ' A' ' 140' ' ' THR . 0.4 OUTLIER -68.01 -31.37 71.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.984 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -87.92 -24.96 23.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.129 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -90.36 -28.67 18.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.119 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 137' ' ' MET . 12.2 t -59.5 156.79 12.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.949 0.404 . . . . 0.0 111.033 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.4 100.12 1.95 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.797 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 149.6 -152.14 24.14 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.511 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.4 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 22.9 mtp -80.82 118.82 22.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.827 0.346 . . . . 0.0 111.052 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.666 HD12 ' HE1' ' A' ' 74' ' ' PHE . 46.1 mt -93.23 145.58 7.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.191 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.9 m -125.39 113.6 17.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.268 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.671 HD12 HG23 ' A' ' 120' ' ' ILE . 1.9 mm? -115.6 134.36 55.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.13 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 7.5 mmtm -98.72 107.19 19.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.878 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.929 HG21 HD21 ' A' ' 111' ' ' LEU . 10.1 t -125.49 158.29 34.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.056 0.455 . . . . 0.0 111.939 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.463 HD12 HD21 ' A' ' 118' ' ' LEU . 23.8 mt -138.21 126.57 14.17 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.768 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo . . . . . 0 C--N 1.346 0.416 0 C-N-CA 122.513 2.142 . . . . 0.0 112.299 -179.828 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.837 0.351 . . . . 0.0 110.918 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 125' ' ' GLU . . . . . 0.41 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 42.3 mt-10 -159.87 133.25 6.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.794 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 126' ' ' TYR . . . . . 0.87 ' CE1' HG21 ' A' ' 130' ' ' VAL . 33.4 m-85 -124.47 134.91 52.91 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.426 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 127' ' ' CYS . . . . . 0.657 ' SG ' HD11 ' A' ' 100' ' ' LEU . 1.8 m -106.01 116.1 31.36 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 128' ' ' ILE . . . . . 0.488 HG13 HD11 ' A' ' 133' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.372 -177.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.551 ' O ' HG13 ' A' ' 69' ' ' VAL . 14.9 p . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 120.932 0.396 . . . . 0.0 111.258 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.54 146.07 24.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.747 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.82 99.26 6.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.066 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.663 HG21 ' HB3' ' A' ' 110' ' ' SER . 4.0 mp -91.43 140.96 15.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.224 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 144' ' ' ILE . 32.4 mt-30 -135.41 132.33 37.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.113 0.482 . . . . 0.0 111.911 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.623 ' CZ ' HD23 ' A' ' 146' ' ' LEU . 0.8 OUTLIER -144.98 125.97 14.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.298 179.054 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 0.0 OUTLIER -80.26 137.86 36.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.538 -179.216 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -129.07 123.9 33.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.49 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -104.03 -37.31 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.02 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.56 156.53 18.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.258 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -88.63 90.88 8.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.544 0.688 . . . . 0.0 110.565 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -147.18 141.36 15.79 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.947 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.74 144.87 41.54 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.43 2.087 . . . . 0.0 112.082 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.55 -47.01 83.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.97 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 120.74 28.75 1.67 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.755 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.544 HG22 HG23 ' A' ' 99' ' ' ILE . 15.8 pt -146.96 166.3 6.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.844 0.354 . . . . 0.0 110.983 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.481 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -131.18 126.47 35.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.124 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.597 HD12 HD11 ' B' ' 128' ' ' ILE . 0.4 OUTLIER -131.72 156.99 44.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.036 -179.467 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.69 ' C ' HD13 ' A' ' 88' ' ' LEU . 34.3 pttt -136.16 166.78 22.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.327 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.693 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -111.11 103.23 11.66 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.419 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.404 ' OD1' ' HB3' ' A' ' 91' ' ' LYS . 4.9 p30 -66.94 176.67 1.98 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.819 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -47.73 -37.49 13.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.349 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.404 ' HB3' ' OD1' ' A' ' 89' ' ' ASN . 79.0 tttt -70.2 -18.17 63.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.183 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' ' HB ' ' A' ' 126' ' ' THR . 0.0 OUTLIER 76.56 88.51 0.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.546 -179.588 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 1.7 t -162.69 139.55 7.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.46 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.65 111.47 21.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.986 0.422 . . . . 0.0 111.405 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.679 HG23 ' O ' ' A' ' 115' ' ' ASP . 19.0 m -130.0 133.5 46.81 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.424 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.912 HG13 ' H ' ' A' ' 114' ' ' GLY . 3.2 p -61.03 105.91 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.214 0.53 . . . . 0.0 110.458 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -72.98 -25.25 60.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.858 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.573 ' HA ' HG23 ' A' ' 113' ' ' VAL . 47.5 ttt180 -173.61 128.84 0.42 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.387 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.615 HG12 HG21 ' A' ' 96' ' ' VAL . 21.1 mt -85.84 125.51 40.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.897 0.379 . . . . 0.0 110.693 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.459 ' N ' HD12 ' A' ' 100' ' ' LEU . 8.0 mp -83.13 135.73 34.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.146 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.427 ' HA ' ' CG ' ' A' ' 106' ' ' HIS . 32.8 t-80 -79.26 136.98 37.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.869 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 114.57 -41.44 2.18 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.388 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.3 -173.06 0.24 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.702 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 64.7 ttp -84.61 -29.69 25.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.716 0.293 . . . . 0.0 111.157 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 33.4 mm -71.56 -42.15 72.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.257 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.427 ' CG ' ' HA ' ' A' ' 101' ' ' HIS . 5.5 t60 -71.49 -35.97 70.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.843 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.62 -51.0 10.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.746 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -73.15 -46.32 51.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.804 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.42 77.48 1.35 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.471 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.663 ' HB3' HG21 ' A' ' 72' ' ' ILE . 2.0 m -112.4 -30.86 7.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.804 0.335 . . . . 0.0 111.038 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 110' ' ' SER . 5.5 mp -135.53 158.29 44.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.954 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.539 ' CA ' HD11 ' A' ' 99' ' ' ILE . 85.0 m-70 -121.19 135.31 55.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.714 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.573 HG23 ' HA ' ' A' ' 98' ' ' ARG . 7.6 p -45.28 115.01 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.473 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.912 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 112.39 -25.62 12.11 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.707 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.679 ' O ' HG23 ' A' ' 95' ' ' THR . 6.9 m-20 -55.06 137.78 45.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.696 0.284 . . . . 0.0 110.808 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.413 ' HA ' HG23 ' A' ' 95' ' ' THR . 38.8 tt0 -91.62 123.2 34.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.908 0.385 . . . . 0.0 111.492 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.666 HG13 HG22 ' A' ' 148' ' ' VAL . 3.3 mp -97.78 94.25 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.354 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.446 HD13 ' HA ' ' A' ' 118' ' ' LEU . 4.2 mm? -59.05 -26.14 64.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.512 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.16 138.97 25.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.901 0.381 . . . . 0.0 111.481 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.553 ' N ' HD12 ' A' ' 120' ' ' ILE . 2.5 mp -119.88 98.67 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.56 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.407 ' H ' HD13 ' A' ' 146' ' ' LEU . 0.1 OUTLIER 61.99 26.91 16.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.619 -179.526 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 92.03 13.37 57.77 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.796 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.483 ' HB ' HD21 ' A' ' 133' ' ' LEU . 1.3 m -133.58 133.69 42.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.839 0.352 . . . . 0.0 111.161 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.29 84.35 2.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.579 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.885 HG21 HG13 ' A' ' 130' ' ' VAL . 11.2 p -55.79 125.69 11.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.217 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' A' ' 92' ' ' GLN . 26.3 p -103.6 -168.55 1.52 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.696 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.01 -22.27 60.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.937 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -54.57 -176.1 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.685 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.6 p -59.2 134.07 56.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.926 0.393 . . . . 0.0 110.914 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.885 HG13 HG21 ' A' ' 125' ' ' VAL . 0.7 OUTLIER -89.25 -20.0 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.208 179.777 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -45.6 -25.6 0.48 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.417 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.906 ' HG3' HD12 ' A' ' 133' ' ' LEU . 5.9 pt20 -68.9 -47.77 65.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.738 0.304 . . . . 0.0 110.815 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.906 HD12 ' HG3' ' A' ' 132' ' ' GLN . 2.2 mp -81.43 -46.53 14.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.722 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -54.54 -39.55 67.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.955 0.407 . . . . 0.0 110.756 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.36 -50.08 29.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.964 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -58.25 -43.51 87.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.306 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.851 ' HE1' HD13 ' A' ' 144' ' ' ILE . 77.2 mmm -65.06 -37.6 88.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.964 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -74.53 -27.64 60.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.864 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -106.92 10.1 30.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.462 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.817 HG22 ' O ' ' A' ' 137' ' ' MET . 12.8 t -69.3 156.9 38.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.857 0.361 . . . . 0.0 110.846 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -144.55 113.81 6.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.815 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 130.2 -145.39 16.6 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.636 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.466 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 2.4 mtp -97.41 119.97 36.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.858 0.361 . . . . 0.0 111.188 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.851 HD13 ' HE1' ' A' ' 137' ' ' MET . 41.0 mt -90.23 131.75 36.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.122 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.1 m -112.87 114.26 26.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.107 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.647 HD22 ' N ' ' A' ' 146' ' ' LEU . 1.0 OUTLIER -116.96 131.2 57.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.384 -179.251 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.29 110.3 22.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.314 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.666 HG22 HG13 ' A' ' 117' ' ' ILE . 2.8 t -121.79 158.25 25.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.575 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.43 HD12 ' CD2' ' A' ' 118' ' ' LEU . 29.2 mt -140.89 130.5 13.04 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.897 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 C--N 1.347 0.467 0 C-N-CA 122.428 2.085 . . . . 0.0 112.304 -179.924 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 124' ' ' LYS . . . . . 0.435 ' CD ' ' CE1' ' B' ' 126' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.848 0.356 . . . . 0.0 110.988 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 125' ' ' GLU . . . . . 0.422 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 2.0 pt-20 -155.33 135.84 13.34 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.124 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 126' ' ' TYR . . . . . 0.661 ' CE1' HG21 ' A' ' 130' ' ' VAL . 33.1 m-85 -115.53 133.21 56.25 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.42 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 127' ' ' CYS . . . . . 0.449 ' SG ' HD21 ' A' ' 100' ' ' LEU . 1.8 m -105.94 116.05 31.28 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 128' ' ' ILE . . . . . 0.707 HD13 ' N ' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.47 -177.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.441 ' O ' HG13 ' A' ' 69' ' ' VAL . 10.9 p . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.777 0.322 . . . . 0.0 111.077 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 -116.06 137.83 51.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.858 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.412 HD12 ' HG2' ' A' ' 147' ' ' LYS . 1.8 tp -108.93 99.38 8.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.921 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.613 HG21 ' HB3' ' A' ' 110' ' ' SER . 13.1 mm -90.41 118.9 36.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.601 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -113.3 127.32 56.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.0 0.428 . . . . 0.0 111.566 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.683 ' CZ ' HD23 ' A' ' 146' ' ' LEU . 9.9 p90 -145.54 131.52 19.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.378 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.33 141.7 35.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.006 0.432 . . . . 0.0 111.299 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.8 ttpt -129.12 111.21 12.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.358 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -105.69 -22.53 4.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.277 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.54 146.09 24.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.185 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -88.36 89.82 8.14 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.259 0.552 . . . . 0.0 110.54 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -167.86 158.72 9.44 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.899 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -50.88 145.18 24.96 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.559 2.172 . . . . 0.0 112.486 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 19.2 ttm -54.27 -65.68 0.53 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.083 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.655 ' O ' HG23 ' A' ' 84' ' ' ILE . . . 144.62 38.41 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.704 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.856 HD13 HD11 ' A' ' 86' ' ' LEU . 1.9 pp -163.5 164.83 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.777 0.322 . . . . 0.0 110.907 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -129.29 128.07 42.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.27 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.856 HD11 HD13 ' A' ' 84' ' ' ILE . 0.4 OUTLIER -128.78 157.43 41.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.824 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.47 ' C ' HD13 ' A' ' 88' ' ' LEU . 55.4 pttt -138.86 166.21 25.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.399 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.675 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -106.54 102.98 12.33 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.485 179.38 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -67.86 176.73 2.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.613 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -49.46 -25.5 2.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.904 0.383 . . . . 0.0 111.021 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.419 ' O ' ' CG ' ' A' ' 91' ' ' LYS . 12.8 tptt -88.05 12.31 13.8 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.261 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 44.02 87.15 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.849 0.357 . . . . 0.0 111.258 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 1.6 m -160.33 145.05 14.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.428 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.43 ' CB ' HD11 ' A' ' 120' ' ' ILE . 0.8 OUTLIER -87.83 111.63 21.6 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.932 0.396 . . . . 0.0 111.468 -179.328 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.614 HG23 ' O ' ' A' ' 115' ' ' ASP . 3.6 m -132.17 129.3 39.61 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.616 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.932 HG21 HD13 ' A' ' 99' ' ' ILE . 4.1 p -58.79 106.36 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.261 0.553 . . . . 0.0 110.601 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -74.44 -21.5 59.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.384 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.436 ' HA ' HG23 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -173.53 134.43 0.5 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.06 179.779 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.932 HD13 HG21 ' A' ' 96' ' ' VAL . 22.6 mm -86.13 103.71 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.639 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.431 HD21 ' SG ' ' B' ' 127' ' ' CYS . 9.8 mp -57.12 141.87 44.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.216 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.431 ' HA ' ' CD2' ' A' ' 106' ' ' HIS . 78.5 m-70 -78.08 136.36 37.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.819 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.23 -25.03 26.21 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.525 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.51 155.75 18.03 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.459 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 2.9 tmm? -61.26 -37.39 82.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.776 0.322 . . . . 0.0 110.983 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.433 HG23 ' CB ' ' A' ' 110' ' ' SER . 35.3 mm -68.51 -32.02 53.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.185 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.431 ' CD2' ' HA ' ' A' ' 101' ' ' HIS . 17.4 t60 -74.44 -54.3 7.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.774 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -42.84 94.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.743 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -77.23 -49.57 14.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.755 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.41 76.37 1.33 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.521 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.613 ' HB3' HG21 ' A' ' 72' ' ' ILE . 0.9 OUTLIER -113.71 -28.77 7.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.734 0.302 . . . . 0.0 111.149 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.485 HD11 HG21 ' A' ' 148' ' ' VAL . 0.1 OUTLIER -137.83 172.59 12.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.059 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -139.59 132.92 30.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.789 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.595 ' O ' HG13 ' A' ' 113' ' ' VAL . 7.1 p -42.38 108.32 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.768 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.889 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 119.03 -27.45 7.06 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.946 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.614 ' O ' HG23 ' A' ' 95' ' ' THR . 6.4 m-20 -50.49 139.9 14.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.765 0.317 . . . . 0.0 110.835 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -90.77 116.78 28.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.46 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.805 HD13 HD23 ' A' ' 86' ' ' LEU . 4.6 mp -96.7 101.95 12.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.503 179.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.539 HD13 ' CD1' ' A' ' 149' ' ' ILE . 6.0 mp -68.56 -27.31 65.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.481 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -148.45 141.12 24.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.93 0.395 . . . . 0.0 111.286 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.578 HG23 HD11 ' A' ' 146' ' ' LEU . 3.5 mp -119.65 99.14 7.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.818 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 12.6 t30 62.46 25.39 15.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.716 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 99.94 1.44 56.12 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.984 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.8 m -133.62 130.59 38.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.844 0.354 . . . . 0.0 111.142 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.402 ' HA ' HD12 ' A' ' 120' ' ' ILE . 5.1 p-10 -101.42 98.04 8.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.643 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.994 HG21 HG13 ' A' ' 130' ' ' VAL . 9.6 p -58.85 138.33 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.012 0.434 . . . . 0.0 111.189 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.2 p -123.14 -171.19 2.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.515 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 44.4 p-10 -50.21 -24.88 3.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.244 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.26 -166.04 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.652 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.81 133.88 45.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.883 0.373 . . . . 0.0 110.934 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.994 HG13 HG21 ' A' ' 125' ' ' VAL . 0.7 OUTLIER -89.26 -20.48 7.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.282 179.738 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.0 -26.35 0.42 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.429 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.67 -50.65 73.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.766 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.5 mp -72.16 -41.73 66.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.718 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -55.38 -52.41 63.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.559 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -62.5 -34.9 77.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.529 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.78 -30.34 62.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.986 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 3.8 mmt -69.84 -32.73 71.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.823 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -85.39 -25.96 26.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.023 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -88.92 -32.64 17.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.159 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 11.9 t -59.38 150.63 25.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.012 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.94 124.33 8.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.734 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 124.08 -146.61 16.35 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.547 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 1.6 ttm -78.07 121.1 23.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.894 0.378 . . . . 0.0 111.095 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.686 HG22 ' CD2' ' A' ' 146' ' ' LEU . 42.8 mt -96.73 136.35 27.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.035 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.514 ' C ' HD22 ' A' ' 146' ' ' LEU . 87.2 p -107.82 127.67 53.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.632 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.686 ' CD2' HG22 ' A' ' 144' ' ' ILE . 3.3 mm? -130.17 121.16 25.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.186 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.412 ' HG2' HD12 ' A' ' 71' ' ' LEU . 11.8 mmtt -95.87 105.35 17.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.837 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.618 HG22 HG13 ' A' ' 117' ' ' ILE . 2.7 t -127.64 157.93 39.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.002 0.429 . . . . 0.0 111.773 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.539 ' CD1' HD13 ' A' ' 118' ' ' LEU . 46.1 mt -134.36 135.97 24.94 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.845 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.401 ' HD2' HG23 ' A' ' 149' ' ' ILE . 37.5 Cg_endo . . . . . 0 C--N 1.346 0.437 0 C-N-CA 122.436 2.091 . . . . 0.0 112.281 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 124' ' ' LYS . . . . . 0.411 ' HD2' ' CE1' ' B' ' 126' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.048 0 CA-C-O 120.772 0.32 . . . . 0.0 110.875 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 125' ' ' GLU . . . . . 0.401 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 1.6 pt-20 -141.21 133.07 27.47 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.231 0.538 . . . . 0.0 109.814 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 126' ' ' TYR . . . . . 0.738 ' CE1' HG21 ' A' ' 130' ' ' VAL . 42.2 m-85 -109.9 132.34 54.24 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.575 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 127' ' ' CYS . . . . . 0.431 ' SG ' HD21 ' A' ' 100' ' ' LEU . 1.8 m -105.98 115.95 31.1 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 128' ' ' ILE . . . . . 0.708 HD13 ' N ' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.583 -177.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.568 ' O ' HG13 ' A' ' 69' ' ' VAL . 10.2 p . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.887 0.375 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.1 mtt85 -101.92 126.04 48.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.922 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.6 99.47 10.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.507 ' CD1' HG12 ' A' ' 148' ' ' VAL . 3.5 mp -89.37 145.27 7.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.957 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -136.7 123.11 20.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.172 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.509 ' CZ ' HD23 ' A' ' 146' ' ' LEU . 10.8 p90 -148.33 129.36 14.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.779 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 1.3 pt-20 -80.33 129.72 34.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.219 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.36 111.57 12.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.225 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.615 HG13 ' O ' ' A' ' 77' ' ' VAL . 0.3 OUTLIER -125.65 15.52 4.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.568 -179.605 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.15 154.94 21.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.54 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -80.9 79.54 7.55 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.267 0.556 . . . . 0.0 110.001 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.14 137.87 1.66 Allowed Pre-proline 0 N--CA 1.447 -0.601 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.132 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.32 156.4 10.74 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.336 2.024 . . . . 0.0 112.258 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.445 ' HG2' ' CE1' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -59.13 -39.89 83.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.857 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 119.86 35.01 0.93 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.488 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.549 ' CA ' HD23 ' A' ' 100' ' ' LEU . 13.6 pt -152.45 154.31 8.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.77 0.319 . . . . 0.0 110.977 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.618 ' HB2' HD21 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -125.61 122.81 37.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.095 179.618 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.875 HD23 HD13 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -125.17 159.23 32.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.87 -179.663 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.565 ' C ' HD13 ' A' ' 88' ' ' LEU . 7.0 pttt -142.79 161.44 38.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.2 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.632 ' N ' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -101.65 102.9 13.66 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.557 179.389 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -65.25 176.76 1.24 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.448 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -49.67 -27.64 4.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.815 0.34 . . . . 0.0 110.879 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.66 -9.18 59.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.713 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 67.79 76.43 0.27 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.902 0.382 . . . . 0.0 110.946 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.575 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 1.3 p -153.87 145.02 22.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.522 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -87.74 112.63 22.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.105 0.479 . . . . 0.0 111.292 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.644 HG23 ' O ' ' A' ' 115' ' ' ASP . 3.5 m -132.85 130.82 40.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.378 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.923 HG13 ' H ' ' A' ' 114' ' ' GLY . 2.6 p -58.59 106.08 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.312 0.577 . . . . 0.0 110.615 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -71.77 -23.22 61.55 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.038 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.452 ' HA ' HG23 ' A' ' 113' ' ' VAL . 6.1 mtt180 -173.45 145.92 1.3 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.591 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.551 HD11 ' HA ' ' A' ' 112' ' ' HIS . 54.0 mt -86.01 135.67 24.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.634 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.618 HD21 ' HB2' ' A' ' 85' ' ' CYS . 4.1 mm? -85.6 123.35 30.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.028 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -70.14 131.99 45.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.911 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.15 -24.52 28.45 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.543 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.61 -178.05 0.62 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.633 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 29.1 ttp -84.42 -27.18 27.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.707 0.289 . . . . 0.0 111.069 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.431 HG23 ' HB2' ' A' ' 110' ' ' SER . 25.5 mm -78.45 -34.64 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.116 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -72.67 -45.7 57.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.914 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 29.7 ttp180 -71.96 -46.55 57.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.906 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.61 -46.89 29.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.837 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.23 75.55 1.3 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.446 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.431 ' HB2' HG23 ' A' ' 105' ' ' ILE . 0.8 OUTLIER -111.28 -29.82 7.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.785 0.326 . . . . 0.0 111.104 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.529 HD23 HG21 ' A' ' 148' ' ' VAL . 2.6 mp -136.95 172.61 12.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.934 0.397 . . . . 0.0 111.034 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.551 ' HA ' HD11 ' A' ' 99' ' ' ILE . 3.1 m-70 -139.48 134.9 32.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.741 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.564 ' O ' HG13 ' A' ' 113' ' ' VAL . 7.1 p -42.21 113.03 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.705 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.923 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 111.75 -24.17 15.67 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.979 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.644 ' O ' HG23 ' A' ' 95' ' ' THR . 11.4 m-20 -48.95 142.79 6.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.725 0.298 . . . . 0.0 110.848 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.3 mp0 -91.69 114.77 27.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.691 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.875 HD13 HD23 ' A' ' 86' ' ' LEU . 4.6 mp -92.79 107.81 19.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.538 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.508 ' CD2' HD12 ' A' ' 149' ' ' ILE . 4.3 mm? -70.11 -27.97 65.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.584 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -155.05 161.0 41.44 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.046 0.45 . . . . 0.0 111.355 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.561 HG12 HG21 ' A' ' 117' ' ' ILE . 30.2 mt -142.02 98.81 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.861 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.406 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 0.2 OUTLIER 62.83 28.33 16.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.041 -179.802 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.63 -25.09 22.28 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.64 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.532 ' HB ' HD11 ' A' ' 133' ' ' LEU . 2.8 m -120.27 137.13 54.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.805 0.336 . . . . 0.0 110.979 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -93.92 21.39 6.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.205 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 126' ' ' THR . 44.1 t 58.65 156.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.266 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.479 ' N ' HG12 ' A' ' 125' ' ' VAL . 5.5 p -137.8 172.9 12.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.777 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -59.7 -25.65 64.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.811 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -59.23 -163.06 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.48 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.3 m -67.41 134.15 50.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.936 0.398 . . . . 0.0 110.722 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.603 HG21 ' CE1' ' B' ' 126' ' ' TYR . 0.4 OUTLIER -89.13 -16.34 8.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.231 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -44.24 -25.95 0.28 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.432 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -62.03 -58.93 5.99 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.516 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.532 HD11 ' HB ' ' A' ' 123' ' ' THR . 2.7 mm? -74.68 -39.08 62.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.336 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.426 ' HA ' HG21 ' B' ' 128' ' ' ILE . 7.5 tm0? -57.76 -51.28 70.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.791 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -64.29 -37.31 87.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.844 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.45 ' O ' HG23 ' A' ' 140' ' ' THR . . . -67.64 -40.35 84.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.089 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -67.08 -29.03 68.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.913 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -84.32 -30.65 25.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.996 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -104.98 10.08 34.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.378 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 136' ' ' ALA . 0.0 OUTLIER -68.36 138.76 55.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.881 0.372 . . . . 0.0 110.916 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.5 76.5 1.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.762 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 167.21 -161.37 35.2 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.383 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.536 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 4.3 ptm -85.01 120.64 26.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.923 0.392 . . . . 0.0 111.002 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.619 HG22 ' CD2' ' A' ' 146' ' ' LEU . 48.8 mt -95.71 134.36 33.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.354 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.1 m -111.06 113.64 26.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.032 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.619 ' CD2' HG22 ' A' ' 144' ' ' ILE . 2.5 mm? -113.65 142.01 46.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.108 0.48 . . . . 0.0 111.381 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.436 ' O ' ' N ' ' A' ' 118' ' ' LEU . 10.9 mttt -110.61 105.53 14.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.63 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.529 HG21 HD23 ' A' ' 111' ' ' LEU . 5.2 p -141.62 149.66 19.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.007 0.432 . . . . 0.0 111.676 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.508 HD12 ' CD2' ' A' ' 118' ' ' LEU . 3.1 mt -125.15 121.45 25.25 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.947 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo . . . . . 0 C--N 1.346 0.433 0 C-N-CA 122.439 2.093 . . . . 0.0 112.241 -179.931 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.526 0.048 0 CA-C-O 120.935 0.398 . . . . 0.0 110.918 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 125' ' ' GLU . . . . . 0.462 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 3.9 mp0 -163.62 135.53 4.96 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.866 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 126' ' ' TYR . . . . . 0.603 ' CE1' HG21 ' A' ' 130' ' ' VAL . 36.4 m-85 -128.54 131.66 48.25 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.572 -179.021 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 127' ' ' CYS . . . . . 0.518 ' SG ' HD21 ' A' ' 100' ' ' LEU . 1.7 m -106.01 115.92 31.05 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 128' ' ' ILE . . . . . 0.704 HD13 ' N ' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.508 -177.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.788 0.327 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -107.37 161.26 14.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.904 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.4 tp -118.89 101.95 8.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.943 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.497 HG21 ' HB3' ' A' ' 110' ' ' SER . 27.6 mm -89.28 126.79 42.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.915 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -122.57 123.65 41.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.276 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.806 ' CZ ' HD12 ' A' ' 144' ' ' ILE . 10.4 p90 -149.15 130.96 15.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.539 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -82.41 137.58 34.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.079 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -129.2 111.21 12.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.366 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.599 HG13 ' O ' ' A' ' 77' ' ' VAL . 0.3 OUTLIER -125.47 11.9 4.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.706 -179.453 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.7 158.59 18.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.836 0.351 . . . . 0.0 111.404 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.08 78.93 8.82 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.375 0.607 . . . . 0.0 110.297 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -167.53 149.68 5.41 Favored Pre-proline 0 N--CA 1.445 -0.702 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.152 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -64.77 160.68 39.47 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.507 2.138 . . . . 0.0 112.26 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.471 ' HG3' ' CZ ' ' A' ' 74' ' ' PHE . 15.0 ttm -51.52 -47.45 63.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.037 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.426 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 122.71 -6.51 9.68 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.603 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 32.6 pt -113.34 167.84 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.768 0.318 . . . . 0.0 110.779 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.539 ' SG ' HD13 ' A' ' 100' ' ' LEU . 18.7 m -134.27 126.26 29.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.513 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.776 HD23 HD13 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -124.15 159.32 30.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.964 -179.463 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.531 ' C ' HD13 ' A' ' 88' ' ' LEU . 16.4 pttp -136.42 164.83 27.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.102 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.681 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -106.51 103.21 12.61 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.951 179.71 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -64.85 176.5 1.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.665 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -52.24 -26.26 11.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.013 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.0 tptp -81.58 -8.41 59.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.325 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 67.67 89.2 0.1 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.849 0.357 . . . . 0.0 110.704 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.55 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 0.3 OUTLIER -166.31 146.28 6.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.416 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.444 ' SG ' HD11 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -87.88 114.98 25.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.964 0.411 . . . . 0.0 111.348 -179.369 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.592 HG23 ' O ' ' A' ' 115' ' ' ASP . 3.1 m -133.66 128.02 34.17 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.924 HG21 ' CD1' ' A' ' 99' ' ' ILE . 2.8 p -58.54 106.2 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.405 0.621 . . . . 0.0 110.404 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -72.67 -24.09 60.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.311 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.47 ' HA ' HG23 ' A' ' 113' ' ' VAL . 6.6 ttt85 -172.38 126.92 0.53 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.859 0.361 . . . . 0.0 111.175 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.924 ' CD1' HG21 ' A' ' 96' ' ' VAL . 17.7 mm -86.17 103.69 13.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.511 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.539 HD13 ' SG ' ' A' ' 85' ' ' CYS . 8.4 mp -63.87 144.32 57.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.091 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -82.96 128.03 34.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.808 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.36 -35.08 3.88 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.484 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.426 ' HA3' ' HA3' ' A' ' 83' ' ' GLY . . . -56.41 179.33 0.55 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.611 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 12.4 ptm -84.47 -30.31 25.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.772 0.32 . . . . 0.0 110.967 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.429 HD11 ' HG2' ' A' ' 82' ' ' MET . 39.5 mm -68.4 -36.54 75.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.865 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -74.43 -45.24 47.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.631 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.09 -49.8 53.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.604 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -73.79 -48.04 34.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.698 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.34 74.55 1.23 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.598 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.497 ' HB3' HG21 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -109.63 -30.28 7.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.824 0.345 . . . . 0.0 110.814 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.622 HD21 HG11 ' A' ' 148' ' ' VAL . 0.5 OUTLIER -147.81 164.5 33.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.92 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -130.29 143.58 50.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.792 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.559 ' O ' HG13 ' A' ' 113' ' ' VAL . 8.6 p -43.36 113.07 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.637 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.89 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 116.15 -24.18 10.15 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.708 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.708 ' HB3' HG21 ' A' ' 148' ' ' VAL . 0.4 OUTLIER -48.23 134.59 14.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.717 0.294 . . . . 0.0 110.844 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.63 ' C ' HG23 ' A' ' 148' ' ' VAL . 10.7 mt-10 -93.6 107.84 19.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.485 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.776 HD13 HD23 ' A' ' 86' ' ' LEU . 2.6 mp -87.14 98.41 7.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.626 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.606 ' CD2' HD12 ' A' ' 149' ' ' ILE . 3.7 mm? -63.03 -29.49 70.86 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.018 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -156.61 147.64 22.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.821 0.343 . . . . 0.0 111.162 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.706 HD12 HG23 ' A' ' 125' ' ' VAL . 18.6 mt -122.04 107.92 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.826 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 63.05 24.43 14.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.731 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.9 0.43 58.85 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.943 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.2 m -133.6 127.47 33.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.881 0.372 . . . . 0.0 111.181 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -93.02 142.03 27.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.72 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.967 HG11 HG13 ' A' ' 130' ' ' VAL . 13.0 t -91.69 137.32 22.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.178 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 62.7 p -116.07 -177.0 3.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.779 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -56.88 -22.27 35.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.169 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.36 -167.34 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.713 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 42.4 m -68.25 134.07 49.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.964 0.411 . . . . 0.0 110.775 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.967 HG13 HG11 ' A' ' 125' ' ' VAL . 0.6 OUTLIER -89.27 -20.14 7.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.219 179.714 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -44.76 -26.43 0.39 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.426 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.06 -57.6 10.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.831 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.826 HD13 HG22 ' A' ' 125' ' ' VAL . 3.7 mp -77.62 -34.68 53.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.035 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -59.76 -50.54 73.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.645 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -65.79 -44.97 84.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.69 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -65.67 -32.68 74.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.036 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 4.1 mmt -73.55 -26.37 60.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.049 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.35 -19.62 27.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.291 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.59 -23.52 13.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.432 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.4 t -59.32 147.19 36.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.821 0.343 . . . . 0.0 110.99 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -140.68 124.08 16.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.805 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 134.33 -160.02 24.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.493 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 27.8 mtp -77.31 110.17 11.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.774 0.321 . . . . 0.0 110.974 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.806 HD12 ' CZ ' ' A' ' 74' ' ' PHE . 53.8 mt -85.39 128.86 38.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.234 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.571 ' O ' HD13 ' A' ' 146' ' ' LEU . 71.6 m -109.28 120.95 44.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.335 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.721 HD22 ' N ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -123.98 132.28 53.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.993 0.425 . . . . 0.0 111.379 -179.396 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.2 105.22 17.33 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.708 HG21 ' HB3' ' A' ' 115' ' ' ASP . 6.1 p -136.04 141.9 40.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.037 0.446 . . . . 0.0 112.052 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.606 HD12 ' CD2' ' A' ' 118' ' ' LEU . 4.3 mt -105.45 131.58 21.63 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.643 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo . . . . . 0 C--N 1.346 0.446 0 C-N-CA 122.524 2.149 . . . . 0.0 112.322 -179.822 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 124' ' ' LYS . . . . . 0.422 ' HE2' ' CE1' ' B' ' 126' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.038 0 CA-C-O 121.02 0.438 . . . . 0.0 110.94 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -156.48 135.75 12.13 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.848 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 126' ' ' TYR . . . . . 0.623 ' CE1' HG21 ' A' ' 130' ' ' VAL . 38.2 m-85 -121.54 132.04 54.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.433 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 72.3 m -105.91 116.1 31.35 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 128' ' ' ILE . . . . . 0.463 HD13 ' N ' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.576 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.5 p . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.857 0.361 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.79 ' HD3' HD11 ' A' ' 72' ' ' ILE . 9.8 ttt-85 -109.53 129.9 55.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.831 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.59 99.34 10.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.966 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.79 HD11 ' HD3' ' A' ' 70' ' ' ARG . 24.5 mm -98.47 110.4 25.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.428 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -122.27 144.22 49.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.054 0.454 . . . . 0.0 111.737 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.456 ' CZ ' ' CD2' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -153.29 145.04 23.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.271 179.132 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.22 139.07 36.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.016 0.436 . . . . 0.0 111.415 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -129.22 111.24 12.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.369 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -111.63 -28.63 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.263 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.48 150.45 21.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.306 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -89.34 91.32 8.7 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.323 0.582 . . . . 0.0 110.485 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -159.53 159.58 28.11 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.917 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.83 145.18 61.74 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.461 2.107 . . . . 0.0 112.159 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.3 mtm -54.95 -39.58 69.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.874 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 108.2 18.76 9.49 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.682 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.499 HG21 HG21 ' A' ' 105' ' ' ILE . 22.5 pt -127.75 165.85 25.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.731 0.3 . . . . 0.0 110.697 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -133.67 125.18 28.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.247 179.752 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.59 ' CD2' HD13 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -134.1 155.8 49.41 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.364 -179.118 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.443 ' HB3' ' HA ' ' B' ' 125' ' ' GLU . 0.6 OUTLIER -131.61 166.69 20.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.054 179.766 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.668 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.1 OUTLIER -98.59 103.19 15.11 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.643 179.594 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -64.29 176.45 1.05 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.594 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.71 -30.91 24.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.07 0.462 . . . . 0.0 110.833 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.98 -1.26 43.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.211 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 62.34 86.84 0.11 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.923 0.392 . . . . 0.0 110.462 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.559 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 0.3 OUTLIER -165.57 150.11 8.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.284 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.812 ' CB ' HD11 ' A' ' 120' ' ' ILE . 0.0 OUTLIER -87.86 114.95 24.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.036 0.446 . . . . 0.0 111.508 -179.213 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.515 HG23 ' HA ' ' A' ' 116' ' ' GLU . 2.2 m -126.9 124.77 40.32 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.882 HG13 ' H ' ' A' ' 114' ' ' GLY . 2.2 p -58.46 105.86 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.433 0.635 . . . . 0.0 110.504 -178.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -71.78 -24.34 61.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.761 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.525 ' HA ' HG23 ' A' ' 113' ' ' VAL . 11.3 tpp180 -173.52 130.0 0.44 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.736 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.699 HG22 ' CD2' ' A' ' 106' ' ' HIS . 44.4 mt -86.04 130.34 36.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.564 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.756 HD11 ' SG ' ' B' ' 127' ' ' CYS . 0.4 OUTLIER -93.28 122.03 35.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.833 -179.839 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -56.37 141.74 40.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.06 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.0 -36.9 4.05 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.429 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' A' ' 83' ' ' GLY . . . -59.25 160.09 17.81 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.634 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.5 ttp -66.28 -22.06 66.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.775 0.322 . . . . 0.0 111.044 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.65 ' N ' HD12 ' A' ' 105' ' ' ILE . 2.4 mp -83.11 -31.28 8.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.536 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.699 ' CD2' HG22 ' A' ' 99' ' ' ILE . 1.9 t-80 -88.02 -39.6 14.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.551 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.84 -47.5 68.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.6 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -83.26 -37.4 23.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.653 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.15 46.93 4.58 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.489 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.479 ' O ' HD12 ' A' ' 111' ' ' LEU . 1.0 OUTLIER -78.24 -29.13 48.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.731 0.3 . . . . 0.0 111.044 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.761 HD11 HG21 ' A' ' 148' ' ' VAL . 1.4 mp -136.28 166.79 22.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.984 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.523 ' HA ' HD11 ' A' ' 99' ' ' ILE . 27.9 m-70 -126.67 139.39 53.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.722 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.525 HG23 ' HA ' ' A' ' 98' ' ' ARG . 7.2 p -49.68 114.95 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.357 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.882 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 113.41 -21.49 17.02 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.837 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.48 ' O ' HG23 ' A' ' 95' ' ' THR . 6.0 m-20 -54.7 138.67 41.27 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.714 0.292 . . . . 0.0 110.821 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.515 ' HA ' HG23 ' A' ' 95' ' ' THR . 0.1 OUTLIER -93.6 120.01 33.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.911 0.386 . . . . 0.0 111.585 -179.286 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.669 HG13 HG22 ' A' ' 148' ' ' VAL . 4.4 mp -101.95 94.29 3.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.52 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.409 HD22 HD11 ' A' ' 149' ' ' ILE . 10.3 mp -61.73 -31.12 71.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.578 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -137.55 141.51 41.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.921 0.391 . . . . 0.0 111.353 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.889 HD12 HG23 ' A' ' 125' ' ' VAL . 19.8 mt -122.01 98.79 6.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.839 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 63.76 30.04 14.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.617 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 90.78 1.35 73.78 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.817 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 38.9 m -133.64 121.68 22.36 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.874 0.369 . . . . 0.0 111.136 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -88.63 120.59 30.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.647 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.994 HG11 HG13 ' A' ' 130' ' ' VAL . 34.7 t -63.3 136.22 26.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.21 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 73.7 p -103.96 -176.51 3.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.789 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -77.51 -16.56 58.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.23 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -61.25 -112.59 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.488 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 66.0 m -109.15 133.97 52.32 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.912 0.386 . . . . 0.0 110.944 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.994 HG13 HG11 ' A' ' 125' ' ' VAL . 0.7 OUTLIER -89.37 -23.75 6.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.08 179.478 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -45.58 -26.66 0.63 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.404 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -57.97 -56.92 15.83 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.728 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.929 HD13 HG22 ' A' ' 125' ' ' VAL . 4.9 mp -73.73 -33.46 64.36 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.757 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -59.78 -56.48 21.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.586 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.7 tptp -60.51 -38.55 84.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.564 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.4 -32.62 73.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.863 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 3.4 mmt -70.38 -30.27 67.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.805 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -83.84 -28.73 27.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.901 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -98.0 -5.02 34.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.577 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.44 154.07 17.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.799 0.333 . . . . 0.0 110.856 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.05 99.14 2.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 145.92 -149.73 21.89 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.611 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 2.8 mmm -93.42 122.45 35.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.879 0.371 . . . . 0.0 111.001 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 57.2 mt -87.78 152.85 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.09 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.507 ' C ' HD13 ' A' ' 146' ' ' LEU . 67.5 p -139.26 113.7 9.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.236 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.507 HD13 ' C ' ' A' ' 145' ' ' SER . 0.5 OUTLIER -116.4 133.12 56.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.116 -179.418 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.68 105.54 17.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.947 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.761 HG21 HD11 ' A' ' 111' ' ' LEU . 2.7 t -117.92 158.2 18.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.809 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.409 HD11 HD22 ' A' ' 118' ' ' LEU . 31.4 mt -136.63 133.08 18.87 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.8 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo . . . . . 0 C--N 1.346 0.415 0 C-N-CA 122.447 2.098 . . . . 0.0 112.325 -179.901 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.041 0 CA-C-O 120.99 0.424 . . . . 0.0 110.961 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 125' ' ' GLU . . . . . 0.443 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 0.6 OUTLIER -174.99 139.13 0.48 Allowed 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.788 179.634 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 126' ' ' TYR . . . . . 0.591 ' CE1' HG21 ' A' ' 130' ' ' VAL . 29.9 m-85 -129.41 133.22 47.24 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.131 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 127' ' ' CYS . . . . . 0.756 ' SG ' HD11 ' A' ' 100' ' ' LEU . 1.3 m -105.72 116.14 31.44 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 128' ' ' ILE . . . . . 0.692 HD13 ' N ' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.283 -0.865 . . . . 0.0 111.356 -177.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.659 HG23 HG13 ' A' ' 149' ' ' ILE . 13.6 p . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 120.834 0.35 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -101.87 145.15 29.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.821 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.547 HD11 ' HB2' ' A' ' 145' ' ' SER . 10.7 tp -106.94 113.81 27.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.042 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.1 mm -89.31 130.11 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.861 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -119.12 123.43 44.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.962 0.411 . . . . 0.0 111.252 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.581 ' HE1' HD12 ' A' ' 144' ' ' ILE . 19.7 p90 -150.22 132.91 15.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.624 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 22.7 tt0 -83.38 138.04 33.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.349 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.471 ' HZ2' HD11 ' A' ' 144' ' ' ILE . 1.1 ttpm? -129.38 113.59 15.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.31 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.605 HG13 ' O ' ' A' ' 77' ' ' VAL . 0.3 OUTLIER -120.97 13.9 6.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.613 -179.562 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.07 148.57 31.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.756 0.312 . . . . 0.0 110.615 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -83.61 80.29 9.17 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.202 0.525 . . . . 0.0 110.011 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.81 163.25 5.57 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.175 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.5 148.66 92.97 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.507 2.138 . . . . 0.0 112.243 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.466 ' HG2' ' CE1' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -50.38 -41.58 52.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.224 -179.88 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 127.55 6.05 5.26 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.094 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.713 ' H ' HD13 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -127.12 165.1 26.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.814 0.34 . . . . 0.0 110.914 179.728 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.497 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -127.09 127.85 45.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.106 179.855 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.707 HD23 HD13 ' A' ' 117' ' ' ILE . 1.1 mp -130.63 158.43 40.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.816 0.341 . . . . 0.0 110.917 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.62 ' C ' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -138.69 162.89 33.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.179 -179.768 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.67 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -104.66 103.14 12.74 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.474 179.425 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -64.39 176.34 1.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.781 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -52.88 -26.43 14.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.861 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 43.8 tptt -82.54 -8.17 59.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.188 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 68.56 89.84 0.1 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.8 0.333 . . . . 0.0 110.634 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.531 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 0.2 OUTLIER -166.64 146.19 5.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.52 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.663 ' HB2' HD11 ' A' ' 120' ' ' ILE . 0.5 OUTLIER -87.8 111.95 21.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.931 0.396 . . . . 0.0 111.428 -179.474 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 115' ' ' ASP . 1.6 m -129.12 126.13 38.64 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.9 HG13 ' H ' ' A' ' 114' ' ' GLY . 3.4 p -58.8 105.99 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 121.312 0.577 . . . . 0.0 110.549 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -74.9 -22.02 58.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.443 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.407 ' HA ' HG23 ' A' ' 113' ' ' VAL . 3.3 ptt180 -171.22 131.63 0.78 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.075 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.835 ' CD1' HG21 ' A' ' 96' ' ' VAL . 27.3 mm -86.22 103.72 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.73 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.802 HD11 ' SG ' ' B' ' 127' ' ' CYS . 8.6 mt -60.49 131.38 50.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.042 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.433 ' HA ' ' CG ' ' A' ' 106' ' ' HIS . 2.9 p80 -75.52 146.23 40.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.909 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.21 -33.51 5.57 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.525 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.67 -179.93 1.88 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.49 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 48.9 ttp -79.72 -33.21 41.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.772 0.32 . . . . 0.0 110.87 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.693 HG13 HD12 ' A' ' 84' ' ' ILE . 23.1 mm -70.7 -33.93 54.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.997 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.433 ' CG ' ' HA ' ' A' ' 101' ' ' HIS . 46.1 t-80 -78.58 -51.9 9.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.787 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.4 tpm_? -61.09 -43.35 99.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.717 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -83.05 -46.68 12.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.769 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.02 51.35 2.1 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.553 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.64 -29.36 30.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.752 0.31 . . . . 0.0 110.865 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.715 HD21 HG21 ' A' ' 148' ' ' VAL . 46.5 mt -134.41 172.21 13.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.953 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -138.04 131.72 31.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.727 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.562 ' O ' HG13 ' A' ' 113' ' ' VAL . 8.3 p -43.72 112.78 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.595 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.9 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 116.14 -25.49 9.32 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.603 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.509 ' O ' HG23 ' A' ' 95' ' ' THR . 0.2 OUTLIER -47.16 142.35 3.83 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.714 0.292 . . . . 0.0 110.902 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.408 ' HA ' HG23 ' A' ' 95' ' ' THR . 0.2 OUTLIER -96.27 111.18 23.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.428 -179.542 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.707 HD13 HD23 ' A' ' 86' ' ' LEU . 4.4 mp -95.69 95.82 5.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.67 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.862 HD23 ' CD1' ' A' ' 149' ' ' ILE . 3.2 mm? -65.49 -26.04 67.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.572 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.36 145.54 30.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.926 0.393 . . . . 0.0 111.375 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.663 HD11 ' HB2' ' A' ' 94' ' ' CYS . 2.8 mp -126.14 98.79 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.639 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 60.63 28.37 18.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.524 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.51 16.48 52.5 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.578 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 58.9 m -133.65 128.61 35.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.894 0.378 . . . . 0.0 111.228 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -104.56 87.88 2.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.48 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.824 HG11 ' CD2' ' A' ' 133' ' ' LEU . 10.8 m -53.36 156.53 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.709 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 55.9 p -138.08 -172.08 3.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.743 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -55.02 -23.32 19.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.151 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -56.76 -167.69 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.806 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 m -67.55 134.03 50.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.068 0.461 . . . . 0.0 111.001 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.649 HG21 ' CE1' ' B' ' 126' ' ' TYR . 0.4 OUTLIER -89.47 -16.23 8.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.344 179.746 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -43.6 -26.71 0.24 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.467 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.67 -43.37 69.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.979 0.419 . . . . 0.0 110.426 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.824 ' CD2' HG11 ' A' ' 125' ' ' VAL . 0.2 OUTLIER -78.58 -30.5 46.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.546 179.678 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.417 ' HG3' ' CG2' ' B' ' 128' ' ' ILE . 7.4 tt0 -75.09 -54.14 7.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.999 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.6 tptt -60.7 -47.79 84.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.002 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.467 ' O ' HG22 ' A' ' 140' ' ' THR . . . -61.06 -42.47 98.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.223 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.46 ' HG3' HD12 ' A' ' 133' ' ' LEU . 27.4 mmt -69.3 -27.58 65.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.195 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -90.56 -25.94 19.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.271 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -93.46 -26.58 17.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.26 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 136' ' ' ALA . 6.4 t -59.41 153.34 19.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.89 0.376 . . . . 0.0 111.006 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 24.1 mttp -143.82 114.26 7.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.764 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 142.66 -155.41 25.78 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.429 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.503 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 8.6 ptm -86.85 114.29 23.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.932 0.396 . . . . 0.0 110.995 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.581 HD12 ' HE1' ' A' ' 74' ' ' PHE . 45.1 mt -87.38 141.22 14.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.327 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.547 ' HB2' HD11 ' A' ' 71' ' ' LEU . 54.0 p -124.64 113.59 18.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.31 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.701 HD22 ' N ' ' A' ' 146' ' ' LEU . 0.3 OUTLIER -115.63 143.43 45.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.994 -179.566 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.476 ' HD2' HD13 ' A' ' 71' ' ' LEU . 1.3 mptt -97.39 105.23 17.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.837 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.715 HG21 HD21 ' A' ' 111' ' ' LEU . 3.4 t -122.59 158.34 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.081 0.467 . . . . 0.0 111.891 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.862 ' CD1' HD23 ' A' ' 118' ' ' LEU . 2.3 mp -133.04 134.89 24.92 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.62 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo . . . . . 0 C--N 1.346 0.397 0 C-N-CA 122.383 2.056 . . . . 0.0 112.443 -179.842 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.854 0.359 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 125' ' ' GLU . . . . . 0.441 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 13.2 pt-20 -153.08 134.75 14.5 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.148 0.499 . . . . 0.0 110.225 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 126' ' ' TYR . . . . . 0.649 ' CE1' HG21 ' A' ' 130' ' ' VAL . 31.3 m-85 -116.55 134.89 54.31 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.306 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 127' ' ' CYS . . . . . 0.802 ' SG ' HD11 ' A' ' 100' ' ' LEU . 2.0 m -106.02 115.87 30.97 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 128' ' ' ILE . . . . . 0.648 HD13 ' N ' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.337 -177.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.596 ' O ' HG13 ' A' ' 69' ' ' VAL . 10.1 p . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 120.951 0.405 . . . . 0.0 111.055 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -109.39 144.61 37.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.835 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.63 HD12 ' HG2' ' A' ' 147' ' ' LYS . 2.3 tp -117.86 99.51 6.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.99 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.406 HG21 ' HB3' ' A' ' 110' ' ' SER . 26.2 mm -89.33 120.51 38.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.356 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 144' ' ' ILE . 1.4 mt-30 -120.72 125.44 47.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.075 0.464 . . . . 0.0 111.889 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.642 ' HE1' HD12 ' A' ' 144' ' ' ILE . 10.8 p90 -141.58 132.63 26.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.065 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 1.5 pt-20 -80.24 134.26 36.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.089 0.471 . . . . 0.0 111.519 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.18 123.79 32.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.271 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.605 HG13 ' O ' ' A' ' 77' ' ' VAL . 0.3 OUTLIER -140.14 15.67 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.581 -179.608 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -117.75 173.02 6.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.863 0.363 . . . . 0.0 110.831 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -97.9 81.01 2.81 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.317 0.58 . . . . 0.0 110.021 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -162.04 147.77 10.47 Favored Pre-proline 0 N--CA 1.446 -0.627 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.366 -178.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.87 160.83 48.12 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.562 2.174 . . . . 0.0 112.342 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.7 -49.0 78.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.969 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 115.86 16.48 6.83 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.748 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.612 ' O ' HD12 ' A' ' 84' ' ' ILE . 2.6 pp -128.82 162.02 36.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.73 0.3 . . . . 0.0 110.851 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.504 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -125.31 127.39 46.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.251 179.783 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.879 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -126.46 157.87 37.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.803 -179.642 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.591 ' C ' HD13 ' A' ' 88' ' ' LEU . 16.0 pttt -138.96 158.15 44.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.754 0.311 . . . . 0.0 111.407 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.635 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -106.35 106.1 16.46 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.592 179.586 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -64.22 176.21 1.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.905 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -53.09 -29.69 31.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.914 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.2 tptm -82.52 -4.8 58.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.174 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.408 ' HB3' ' HA ' ' A' ' 126' ' ' THR . 1.4 mt-30 69.11 87.09 0.12 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.818 0.342 . . . . 0.0 110.526 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 1.4 t -157.47 136.74 11.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.353 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.79 115.21 25.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.067 0.46 . . . . 0.0 111.598 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.63 HG23 ' O ' ' A' ' 115' ' ' ASP . 9.3 m -133.55 130.49 38.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.159 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.888 HG13 ' H ' ' A' ' 114' ' ' GLY . 3.7 p -59.9 105.97 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.271 0.558 . . . . 0.0 110.638 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -72.62 -24.32 61.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.192 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.418 ' HA ' HG23 ' A' ' 113' ' ' VAL . 11.2 ptt85 -172.2 131.82 0.63 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.09 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.877 ' CD1' HG21 ' A' ' 96' ' ' VAL . 29.3 mm -86.15 107.2 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.675 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.756 HD11 ' SG ' ' B' ' 127' ' ' CYS . 7.2 mt -61.29 135.79 57.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.958 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -81.28 130.31 34.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.989 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.3 -27.3 9.58 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.634 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.97 179.81 10.39 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.643 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 6.3 ptm -80.95 -30.36 35.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.868 0.366 . . . . 0.0 110.965 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.464 HG23 ' HB2' ' A' ' 110' ' ' SER . 37.6 mm -69.47 -34.99 64.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.959 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.419 ' ND1' HG22 ' A' ' 99' ' ' ILE . 2.7 t-160 -80.42 -41.11 25.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.74 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -73.17 -50.48 22.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.714 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -73.37 -44.33 58.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.86 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.24 75.87 1.31 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.502 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.464 ' HB2' HG23 ' A' ' 105' ' ' ILE . 1.1 m -111.76 -30.63 7.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.84 0.352 . . . . 0.0 111.082 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.789 HD21 HG11 ' A' ' 148' ' ' VAL . 1.1 mt -143.36 170.14 16.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.988 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -137.19 138.83 40.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.792 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.526 ' O ' HG13 ' A' ' 113' ' ' VAL . 7.6 p -44.99 114.23 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.633 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.888 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 119.19 -29.22 6.27 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.022 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.63 ' O ' HG23 ' A' ' 95' ' ' THR . 4.8 m-20 -50.65 134.93 24.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.713 0.292 . . . . 0.0 110.68 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.459 ' C ' HG23 ' A' ' 148' ' ' VAL . 7.4 pt-20 -92.25 108.8 20.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.942 0.401 . . . . 0.0 111.568 -179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.803 ' CD1' HD22 ' A' ' 86' ' ' LEU . 2.7 mp -86.9 99.31 8.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.718 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.422 ' N ' ' O ' ' A' ' 147' ' ' LYS . 4.0 mm? -52.06 -38.32 56.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.098 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -164.26 152.55 12.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.808 0.337 . . . . 0.0 111.374 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.862 HG23 HD12 ' A' ' 146' ' ' LEU . 26.8 mt -111.94 114.25 46.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.903 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 62.9 31.06 16.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.92 0.39 . . . . 0.0 110.659 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 83.38 19.57 62.05 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.596 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 19.3 m -133.63 111.61 10.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.832 0.348 . . . . 0.0 111.06 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -73.98 104.84 4.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.772 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.442 HG22 ' CD1' ' A' ' 133' ' ' LEU . 20.1 t -63.25 128.24 24.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.991 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.408 ' HA ' ' HB3' ' A' ' 92' ' ' GLN . 24.6 p -119.51 -170.48 1.95 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.863 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.01 -21.56 45.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.264 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 43.5 m80 -52.37 179.14 0.01 OUTLIER 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.802 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 45.6 m -63.97 133.89 54.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.009 0.433 . . . . 0.0 110.925 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.576 HG21 ' CE1' ' B' ' 126' ' ' TYR . 0.3 OUTLIER -89.56 -24.91 5.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.165 179.765 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.484 ' HA ' ' HG2' ' A' ' 134' ' ' GLN . 7.3 t70 -46.31 -26.01 0.74 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.599 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -70.24 -41.73 73.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.252 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.442 ' CD1' HG22 ' A' ' 125' ' ' VAL . 1.1 mt -74.02 -54.03 8.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.25 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.487 ' HB3' HG21 ' B' ' 128' ' ' ILE . 3.8 pt20 -55.85 -43.03 76.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.817 0.341 . . . . 0.0 111.061 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm -63.91 -40.76 97.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.645 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.547 ' O ' HG23 ' A' ' 140' ' ' THR . . . -76.13 -27.17 56.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.089 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.423 ' HE1' HG23 ' A' ' 144' ' ' ILE . 4.6 mmt -76.34 -27.94 56.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.6 mttm -82.06 -39.15 23.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.01 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -82.58 -16.11 49.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.403 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 136' ' ' ALA . 0.1 OUTLIER -59.29 131.39 50.84 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.879 0.371 . . . . 0.0 111.045 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -119.09 87.49 2.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.689 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 167.17 -150.32 16.9 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.541 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.482 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 1.0 OUTLIER -96.61 126.22 41.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.918 0.389 . . . . 0.0 111.183 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.707 ' CG2' HD11 ' A' ' 146' ' ' LEU . 59.2 mt -92.64 130.63 41.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.095 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.509 ' C ' HD13 ' A' ' 146' ' ' LEU . 5.4 m -116.93 116.79 28.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.409 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.862 HD12 HG23 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -117.76 142.98 46.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.261 -179.457 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.63 ' HG2' HD12 ' A' ' 71' ' ' LEU . 7.5 mttp -104.78 108.64 20.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.505 179.109 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.789 HG11 HD21 ' A' ' 111' ' ' LEU . 2.5 p -138.19 149.7 24.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.176 0.513 . . . . 0.0 111.863 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.415 ' CD1' ' HA ' ' A' ' 69' ' ' VAL . 6.3 mm -107.63 120.0 48.72 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.528 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo . . . . . 0 C--N 1.346 0.425 0 C-N-CA 122.398 2.065 . . . . 0.0 112.359 -179.866 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 2.0 tptt . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.819 0.343 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 125' ' ' GLU . . . . . 0.446 ' OE2' ' HB1' ' A' ' 97' ' ' ALA . 46.8 mt-10 -161.43 133.62 5.84 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.005 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 126' ' ' TYR . . . . . 0.576 ' CE1' HG21 ' A' ' 130' ' ' VAL . 38.0 m-85 -129.02 135.87 49.54 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.555 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 127' ' ' CYS . . . . . 0.756 ' SG ' HD11 ' A' ' 100' ' ' LEU . 1.7 m -106.05 116.04 31.25 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 128' ' ' ILE . . . . . 0.632 HD13 ' N ' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.276 -0.868 . . . . 0.0 111.485 -177.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.553 ' O ' HG13 ' A' ' 69' ' ' VAL . 10.9 p . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.798 0.332 . . . . 0.0 111.066 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.56 138.07 39.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.766 HD12 ' HG2' ' A' ' 147' ' ' LYS . 2.8 tp -112.1 99.33 7.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.982 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.743 HD13 ' O ' ' A' ' 110' ' ' SER . 23.0 mt -94.44 149.27 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.424 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' A' ' 144' ' ' ILE . 10.4 mt-30 -145.92 135.39 23.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.036 0.446 . . . . 0.0 111.846 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.438 ' CZ ' HD23 ' A' ' 146' ' ' LEU . 2.4 p90 -145.52 130.89 18.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.204 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 3.7 tt0 -80.32 136.8 36.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.059 0.457 . . . . 0.0 111.617 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.13 116.41 19.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.29 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -96.28 -30.52 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.035 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.44 150.25 21.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.252 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -91.79 92.5 8.42 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.231 0.539 . . . . 0.0 110.61 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -163.54 159.77 17.72 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.027 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.52 136.47 40.83 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.573 2.182 . . . . 0.0 112.292 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.0 mpp? -58.34 -35.33 71.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.963 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 117.18 32.78 1.45 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.508 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.616 HD12 HD11 ' A' ' 86' ' ' LEU . 14.2 pt -151.27 158.71 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.778 0.323 . . . . 0.0 110.875 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.836 ' SG ' HD21 ' A' ' 100' ' ' LEU . 25.9 m -129.39 122.36 29.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.204 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.701 HD23 HD13 ' A' ' 117' ' ' ILE . 4.2 mp -116.38 159.62 21.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.955 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.508 ' HG2' ' HB2' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -135.62 148.25 48.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.335 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.796 HD23 ' NZ ' ' B' ' 124' ' ' LYS . 0.3 OUTLIER -81.73 107.23 14.3 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.407 179.285 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -64.2 176.11 1.11 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.898 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.31 -23.27 14.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.08 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.404 ' HD2' ' N ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -100.84 17.97 20.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.958 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 56.57 82.18 0.12 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.782 0.325 . . . . 0.0 110.471 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.548 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 1.2 m -151.04 142.42 23.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.484 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -87.67 111.2 21.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.01 0.433 . . . . 0.0 111.495 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.528 HG23 ' HA ' ' A' ' 116' ' ' GLU . 7.0 m -128.82 130.03 46.4 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.912 HG13 ' H ' ' A' ' 114' ' ' GLY . 3.7 p -58.7 105.7 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-O 121.355 0.598 . . . . 0.0 110.657 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.508 ' HB2' ' HG2' ' A' ' 87' ' ' LYS . . . -70.41 -26.65 63.78 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.955 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.507 ' HA ' HG23 ' A' ' 113' ' ' VAL . 33.2 ttt-85 -173.4 133.94 0.51 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.045 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.87 ' CD1' HG21 ' A' ' 96' ' ' VAL . 25.0 mm -86.07 143.04 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.577 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.836 HD21 ' SG ' ' A' ' 85' ' ' CYS . 0.5 OUTLIER -101.54 142.11 33.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.877 0.37 . . . . 0.0 110.956 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.434 ' HA ' ' CD2' ' A' ' 106' ' ' HIS . 43.7 m-70 -77.25 137.25 38.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.95 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.19 -24.95 26.53 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.539 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.16 161.31 11.23 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.49 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 11.8 tmm? -67.47 -22.71 65.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.705 0.288 . . . . 0.0 111.158 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.606 HG21 ' HB2' ' A' ' 111' ' ' LEU . 28.2 mm -84.93 -38.36 13.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.017 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.434 ' CD2' ' HA ' ' A' ' 101' ' ' HIS . 75.1 t60 -76.13 -39.88 54.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.538 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 7.8 tpp85 -71.28 -45.92 62.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.563 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -79.21 -42.74 25.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.663 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.82 72.0 1.21 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.531 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.755 ' O ' HD22 ' A' ' 111' ' ' LEU . 1.3 m -113.48 -29.4 7.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.758 0.313 . . . . 0.0 111.155 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.772 HD11 HG21 ' A' ' 148' ' ' VAL . 3.7 mm? -132.78 169.22 17.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.981 0.42 . . . . 0.0 111.113 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -143.02 132.28 23.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.572 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.584 ' O ' HG13 ' A' ' 113' ' ' VAL . 8.3 p -41.67 110.94 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.773 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.912 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 119.09 -31.45 5.47 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.915 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.488 ' O ' HG23 ' A' ' 95' ' ' THR . 7.7 m-20 -52.0 133.62 32.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.668 0.271 . . . . 0.0 110.548 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.528 ' HA ' HG23 ' A' ' 95' ' ' THR . 57.4 mt-10 -92.75 114.47 27.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.931 0.396 . . . . 0.0 111.735 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.701 HD13 HD23 ' A' ' 86' ' ' LEU . 3.2 mp -89.39 98.58 8.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.552 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.742 HD23 HG12 ' A' ' 149' ' ' ILE . 4.5 mm? -69.91 -24.38 63.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.579 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -142.79 139.04 30.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.99 0.424 . . . . 0.0 111.346 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.456 HD12 ' HA ' ' A' ' 124' ' ' ASN . 4.1 mp -124.28 98.66 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.727 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 62.79 28.68 16.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.714 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 96.78 -1.9 61.78 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.985 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 25.8 m -133.53 134.89 43.98 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.848 0.356 . . . . 0.0 111.158 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.456 ' HA ' HD12 ' A' ' 120' ' ' ILE . 11.6 t-20 -103.72 105.63 15.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.679 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 1.009 HG21 HG13 ' A' ' 130' ' ' VAL . 12.7 p -56.4 137.38 18.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.213 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.1 p -117.62 -173.3 2.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.691 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -52.35 -24.31 7.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.29 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 13.8 m170 -57.31 -166.82 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.813 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.9 m -69.45 134.29 48.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.903 0.382 . . . . 0.0 110.939 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 1.009 HG13 HG21 ' A' ' 125' ' ' VAL . 0.5 OUTLIER -89.11 -21.03 6.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.263 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -46.09 -26.43 0.75 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.278 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.47 -48.94 79.71 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.622 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.536 HD22 ' HB ' ' A' ' 125' ' ' VAL . 5.6 mp -79.47 -35.38 40.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.818 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -58.42 -49.4 77.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.71 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.9 tptm -68.96 -44.91 72.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.723 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.19 -30.96 71.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.01 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.401 ' HA ' ' HE2' ' A' ' 137' ' ' MET . 21.7 mmt -74.35 -31.85 62.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.896 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.6 mttp -83.8 -30.49 26.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.749 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -86.64 -17.03 34.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.229 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.28 145.03 44.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.844 0.354 . . . . 0.0 111.021 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -141.92 93.59 2.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.669 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 151.53 -149.41 21.17 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.626 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.448 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 72.9 mtp -87.83 119.85 28.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.85 0.357 . . . . 0.0 111.333 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.446 HG22 ' CD2' ' A' ' 146' ' ' LEU . 46.2 mt -97.43 130.99 45.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.995 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.6 m -108.99 114.32 27.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.506 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.661 HD22 ' N ' ' A' ' 146' ' ' LEU . 0.7 OUTLIER -116.57 130.58 56.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.929 -179.577 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.766 ' HG2' HD12 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -96.47 119.09 34.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.241 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.772 HG21 HD11 ' A' ' 111' ' ' LEU . 1.8 t -132.01 154.99 41.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.07 0.462 . . . . 0.0 111.843 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.742 HG12 HD23 ' A' ' 118' ' ' LEU . 18.2 mm -119.92 122.4 29.06 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.655 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo . . . . . 0 C--N 1.346 0.44 0 C-N-CA 122.403 2.068 . . . . 0.0 112.439 -179.881 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 124' ' ' LYS . . . . . 0.796 ' NZ ' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.88 0.372 . . . . 0.0 111.005 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -144.32 131.64 20.81 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.298 0.57 . . . . 0.0 109.925 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 126' ' ' TYR . . . . . 0.596 ' CE1' HG21 ' A' ' 130' ' ' VAL . 18.6 m-85 -100.92 140.95 34.49 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.666 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 95.6 m -106.39 116.02 31.21 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 128' ' ' ILE . . . . . 0.623 HD13 ' N ' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.453 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.485 ' O ' HG13 ' A' ' 69' ' ' VAL . 14.2 p . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.867 0.365 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.4 ttt-85 -112.5 156.18 23.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.836 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.9 tp -121.26 100.4 7.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.004 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.402 HG21 ' HB3' ' A' ' 110' ' ' SER . 3.3 mp -89.17 143.22 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.511 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -133.0 131.77 41.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.072 0.463 . . . . 0.0 111.838 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.476 ' CE2' HD23 ' A' ' 146' ' ' LEU . 6.9 p90 -146.69 137.42 23.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.096 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -80.35 139.72 36.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.964 0.411 . . . . 0.0 111.396 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.13 111.14 12.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.292 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -116.12 -22.9 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.573 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.48 151.47 21.36 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.954 0.407 . . . . 0.0 111.501 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -87.22 88.25 7.64 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.37 0.605 . . . . 0.0 110.462 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -167.38 152.95 7.2 Favored Pre-proline 0 N--CA 1.446 -0.641 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.985 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -56.47 142.51 89.33 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.522 2.148 . . . . 0.0 112.119 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -55.01 -37.06 66.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.987 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.404 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 117.57 29.47 2.07 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.527 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.949 HD13 HD21 ' A' ' 86' ' ' LEU . 2.8 pp -145.4 164.59 11.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.684 0.278 . . . . 0.0 110.909 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.498 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -131.98 123.6 27.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.35 -0.386 . . . . 0.0 109.989 179.617 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.949 HD21 HD13 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -126.58 158.01 37.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.944 -179.373 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.602 ' C ' HD13 ' A' ' 88' ' ' LEU . 6.9 pttp -141.54 163.41 33.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.006 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.656 ' N ' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -103.75 103.09 12.94 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.68 179.706 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -68.07 176.75 2.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.626 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.57 -27.3 6.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.941 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -77.04 -15.18 59.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.255 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 71.11 88.57 0.1 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.896 0.379 . . . . 0.0 110.637 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.534 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 10.1 t -171.04 148.67 2.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.386 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.577 ' SG ' HD11 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -87.78 111.43 21.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.962 0.411 . . . . 0.0 111.39 -179.437 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.549 HG23 ' HA ' ' A' ' 116' ' ' GLU . 9.4 m -129.93 132.22 46.27 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.331 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.895 HG13 ' H ' ' A' ' 114' ' ' GLY . 2.2 p -58.67 106.09 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.326 0.584 . . . . 0.0 110.86 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -71.26 -24.56 62.19 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.981 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.448 ' HA ' HG23 ' A' ' 113' ' ' VAL . 7.6 ttt180 -171.44 138.72 1.2 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.031 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.483 HD13 HG21 ' A' ' 96' ' ' VAL . 19.8 mm -86.11 109.13 18.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.657 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.767 HD11 ' SG ' ' B' ' 127' ' ' CYS . 21.4 mt -62.78 146.57 52.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.105 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -80.93 129.59 34.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.17 4.35 81.44 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.806 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.404 ' HA3' ' HA3' ' A' ' 83' ' ' GLY . . . -76.17 160.3 51.1 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.494 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 40.5 ttp -59.72 -31.86 70.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.867 0.365 . . . . 0.0 110.819 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 29.5 mm -80.77 -31.85 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.828 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -77.93 -53.85 6.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.622 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -60.63 -46.13 91.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.605 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -77.88 -42.68 32.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.685 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.32 67.69 1.43 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.523 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.402 ' HB3' HG21 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -112.06 -20.47 11.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.631 0.253 . . . . 0.0 111.226 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 1.09 HD11 HG11 ' A' ' 148' ' ' VAL . 0.4 OUTLIER -141.4 171.06 14.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.876 0.37 . . . . 0.0 111.026 -179.825 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -139.46 142.0 37.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.795 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.468 ' O ' HG13 ' A' ' 113' ' ' VAL . 7.1 p -45.86 121.67 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.509 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.895 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 110.35 -21.75 23.66 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.583 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.844 ' HB3' HG21 ' A' ' 148' ' ' VAL . 0.4 OUTLIER -52.63 121.41 7.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.656 0.265 . . . . 0.0 110.544 179.762 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.803 ' C ' HG23 ' A' ' 148' ' ' VAL . 62.3 mt-10 -85.25 107.58 17.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.809 0.338 . . . . 0.0 111.447 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.494 HD13 HD13 ' A' ' 86' ' ' LEU . 2.8 mp -84.86 96.88 4.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.767 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.662 HD23 HD12 ' A' ' 149' ' ' ILE . 3.9 mm? -57.85 -29.84 65.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.171 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -154.28 145.32 22.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.902 0.382 . . . . 0.0 111.241 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.605 HG23 ' CD1' ' A' ' 146' ' ' LEU . 17.0 mt -116.77 102.6 13.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.664 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.87 25.43 10.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.737 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 95.73 24.78 14.68 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.541 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.4 m -133.57 123.05 24.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.849 0.357 . . . . 0.0 111.225 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.81 82.69 1.91 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.609 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.769 ' CB ' HD11 ' A' ' 133' ' ' LEU . 11.6 p -56.5 158.33 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.347 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.475 ' N ' HG22 ' A' ' 125' ' ' VAL . 1.4 p -136.88 -173.5 3.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.75 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -61.02 -15.37 31.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.493 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -58.87 -116.9 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.833 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 m -109.01 134.15 52.04 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.88 0.372 . . . . 0.0 111.143 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.836 HG21 ' CE1' ' B' ' 126' ' ' TYR . 0.6 OUTLIER -89.26 -20.68 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.984 179.53 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -45.55 -26.4 0.58 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.345 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -59.42 -40.31 86.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.55 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.769 HD11 ' CB ' ' A' ' 125' ' ' VAL . 0.6 OUTLIER -79.41 -51.54 9.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.546 179.598 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -49.74 -46.78 50.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.909 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -53.36 42.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.912 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.76 -64.26 1.01 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.537 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.451 ' HE2' HG21 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -46.0 -35.83 5.11 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.502 -179.784 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -80.52 -26.14 38.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.253 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -99.28 3.22 46.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.597 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.93 149.29 41.51 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.893 0.377 . . . . 0.0 110.83 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.91 89.45 1.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.821 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 161.35 -130.75 2.41 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.43 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 38.6 mmm -109.26 122.6 47.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.814 0.34 . . . . 0.0 110.901 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.534 HG22 ' CD2' ' A' ' 146' ' ' LEU . 46.9 mt -96.69 143.72 11.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.298 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 28.4 p -125.61 113.68 17.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.918 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.605 ' CD1' HG23 ' A' ' 120' ' ' ILE . 2.7 mm? -110.36 123.17 49.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.975 0.417 . . . . 0.0 111.587 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -98.06 105.25 17.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.484 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 1.09 HG11 HD11 ' A' ' 111' ' ' LEU . 2.9 p -135.16 143.22 37.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.033 0.444 . . . . 0.0 111.99 -178.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.662 HD12 HD23 ' A' ' 118' ' ' LEU . 4.6 mt -112.86 130.71 23.24 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.666 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 149' ' ' ILE . 31.2 Cg_exo . . . . . 0 C--N 1.346 0.396 0 C-N-CA 122.435 2.09 . . . . 0.0 112.075 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.906 0.384 . . . . 0.0 110.935 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 125' ' ' GLU . . . . . 0.43 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 1.8 mp0 -164.09 136.18 4.83 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.712 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 126' ' ' TYR . . . . . 0.836 ' CE1' HG21 ' A' ' 130' ' ' VAL . 34.4 m-85 -113.91 131.19 56.38 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.267 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 127' ' ' CYS . . . . . 0.767 ' SG ' HD11 ' A' ' 100' ' ' LEU . 1.8 m -105.83 116.07 31.31 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 128' ' ' ILE . . . . . 0.659 HD13 ' N ' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.458 -177.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.57 ' O ' HG13 ' A' ' 69' ' ' VAL . 14.9 p . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.89 0.376 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -108.97 147.83 31.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.716 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.44 99.24 7.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.002 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.5 mm -91.16 110.37 22.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.307 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.421 ' HA ' ' O ' ' A' ' 144' ' ' ILE . 26.0 mt-30 -113.84 130.71 56.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.98 0.419 . . . . 0.0 111.889 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.552 ' HE1' HD12 ' A' ' 144' ' ' ILE . 4.5 p90 -142.4 146.33 34.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.067 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -80.25 143.49 33.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.992 0.425 . . . . 0.0 111.245 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.482 ' HD3' HD11 ' A' ' 144' ' ' ILE . 1.3 tttt -128.93 111.28 12.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.593 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -105.9 -30.14 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.162 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.59 146.66 23.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.151 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -99.29 96.3 7.64 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.637 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.401 ' CB ' ' CD ' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -174.65 178.09 0.57 Allowed Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.921 -179.135 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.401 ' CD ' ' CB ' ' A' ' 80' ' ' GLU . 51.9 Cg_exo -54.53 125.32 18.58 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.444 2.096 . . . . 0.0 112.327 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.417 ' HB3' ' OXT' ' B' ' 128' ' ' ILE . 26.4 ttm -47.13 -48.15 23.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.06 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.4 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 135.65 -7.88 4.25 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.495 -0.86 . . . . 0.0 113.031 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.51 HG23 ' HB ' ' A' ' 105' ' ' ILE . 17.8 pt -117.81 166.93 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.888 0.375 . . . . 0.0 111.254 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.495 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -129.31 124.28 33.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.711 179.594 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.957 HD12 HD11 ' B' ' 128' ' ' ILE . 0.3 OUTLIER -121.43 157.39 30.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.711 0.291 . . . . 0.0 111.158 -179.294 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.801 ' HG2' ' HB2' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -140.37 160.54 39.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.328 179.923 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.609 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.4 OUTLIER -90.43 103.12 15.84 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.47 179.454 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -64.3 176.51 1.04 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.784 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -51.31 -23.77 3.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.046 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.28 15.48 20.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.273 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.0 mp0 50.17 81.59 0.06 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.776 0.322 . . . . 0.0 110.798 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.565 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 0.3 OUTLIER -153.6 155.37 35.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.774 -179.737 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.448 ' CB ' HD11 ' A' ' 120' ' ' ILE . 0.5 OUTLIER -87.85 111.49 21.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.946 0.403 . . . . 0.0 111.088 -179.624 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 115' ' ' ASP . 1.9 m -133.22 127.87 34.67 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.875 HG13 ' H ' ' A' ' 114' ' ' GLY . 3.9 p -58.68 106.02 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.411 0.624 . . . . 0.0 110.56 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.801 ' HB2' ' HG2' ' A' ' 87' ' ' LYS . . . -73.24 -23.54 60.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.493 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.403 ' HA ' HG23 ' A' ' 113' ' ' VAL . 0.2 OUTLIER -172.16 134.02 0.71 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.124 179.891 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.873 HD13 HG21 ' A' ' 96' ' ' VAL . 29.1 mm -86.21 109.13 18.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.769 HD11 ' SG ' ' B' ' 127' ' ' CYS . 6.5 mt -65.74 143.57 57.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.035 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -78.39 133.24 37.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.933 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.43 45.7 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.676 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.4 ' HA3' ' HA3' ' A' ' 83' ' ' GLY . . . -56.95 164.1 6.18 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.679 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 6.6 tmm? -60.44 -43.36 96.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.82 0.343 . . . . 0.0 110.981 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.51 ' HB ' HG23 ' A' ' 84' ' ' ILE . 32.2 mm -67.94 -38.39 79.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.05 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -71.53 -44.7 64.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.661 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -69.56 -52.02 30.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.712 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -71.54 -52.16 19.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.624 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.98 105.82 1.86 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.579 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.06 -45.58 0.13 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.874 0.368 . . . . 0.0 110.958 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.654 HD11 HG11 ' A' ' 148' ' ' VAL . 1.5 mp -117.41 172.6 7.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.974 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -141.73 143.45 33.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.561 ' O ' HG13 ' A' ' 113' ' ' VAL . 7.1 p -44.31 112.01 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.631 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.875 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 115.84 -23.18 11.05 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.847 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.59 ' O ' HG23 ' A' ' 95' ' ' THR . 1.0 OUTLIER -47.87 140.73 6.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.633 0.254 . . . . 0.0 110.825 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -93.18 111.62 23.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.759 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.889 HD13 HD22 ' A' ' 86' ' ' LEU . 3.7 mp -99.25 109.03 23.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.513 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -71.22 -26.96 63.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.698 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.608 ' C ' HD12 ' A' ' 120' ' ' ILE . 3.4 mt-10 -154.05 156.85 38.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.059 0.456 . . . . 0.0 111.625 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.94 HD13 HG23 ' A' ' 125' ' ' VAL . 3.2 mp -129.54 100.84 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.387 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.424 ' OD1' HG23 ' A' ' 144' ' ' ILE . 1.8 m-20 67.02 24.25 9.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.612 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 95.89 8.5 58.03 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.832 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.2 m -133.75 127.33 32.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.805 0.336 . . . . 0.0 111.212 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -87.8 121.0 29.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.453 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.94 HG23 HD13 ' A' ' 120' ' ' ILE . 14.9 t -77.1 119.08 24.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.117 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.7 p -108.52 -167.06 1.18 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.906 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -67.58 -16.74 64.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.171 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -166.93 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.599 0.238 . . . . 0.0 110.441 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 21.4 t -68.7 133.53 48.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.942 0.401 . . . . 0.0 110.621 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.707 HG21 ' CE1' ' B' ' 126' ' ' TYR . 0.6 OUTLIER -89.6 -26.2 5.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.095 179.746 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -45.49 -27.76 0.79 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.309 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -51.49 68.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.593 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.617 HD22 HG22 ' A' ' 125' ' ' VAL . 2.0 mp -80.78 -29.68 36.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.752 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -63.32 -43.06 98.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.728 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.93 -41.41 51.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.823 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.6 -45.42 87.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.142 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.817 ' O ' HG22 ' A' ' 140' ' ' THR . 70.1 mmm -70.43 -30.32 67.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.999 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -76.5 -28.52 56.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.027 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.12 -0.27 26.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.424 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.817 HG22 ' O ' ' A' ' 137' ' ' MET . 12.3 t -60.97 153.69 24.45 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.818 0.342 . . . . 0.0 110.886 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.02 118.18 6.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.849 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 129.98 -153.12 19.91 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.585 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 18.3 mmm -85.34 113.52 21.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.77 0.319 . . . . 0.0 110.975 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.552 HD12 ' HE1' ' A' ' 74' ' ' PHE . 49.6 mt -85.26 148.19 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.11 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 48.8 p -128.3 115.24 17.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.399 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.534 ' CD2' HG22 ' A' ' 144' ' ' ILE . 2.3 mm? -117.71 131.86 56.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.25 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.95 105.42 17.44 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.654 HG11 HD11 ' A' ' 111' ' ' LEU . 5.3 p -139.05 157.86 28.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.101 0.477 . . . . 0.0 112.045 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.479 ' N ' HG22 ' A' ' 148' ' ' VAL . 2.9 mp -137.68 127.32 15.22 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.679 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 149' ' ' ILE . 34.7 Cg_exo . . . . . 0 C--N 1.348 0.503 0 C-N-CA 122.378 2.052 . . . . 0.0 112.241 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 4.2 mmtp . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.867 0.365 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 125' ' ' GLU . . . . . 0.526 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 13.5 mt-10 -168.01 135.73 2.25 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.196 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 126' ' ' TYR . . . . . 0.707 ' CE1' HG21 ' A' ' 130' ' ' VAL . 37.9 m-85 -129.12 132.64 47.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.175 -179.404 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 127' ' ' CYS . . . . . 0.769 ' SG ' HD11 ' A' ' 100' ' ' LEU . 1.8 m -105.81 115.95 31.1 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.203 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 128' ' ' ILE . . . . . 0.957 HD11 HD12 ' A' ' 86' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.289 -0.862 . . . . 0.0 111.24 -177.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.541 HG21 ' HD2' ' A' ' 147' ' ' LYS . 11.3 p . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.789 0.328 . . . . 0.0 111.013 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -96.68 132.88 41.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.962 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.446 HD23 ' OE1' ' A' ' 73' ' ' GLN . 5.0 tp -110.25 102.84 11.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.921 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 23.9 mm -89.26 120.5 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.774 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.446 ' OE1' HD23 ' A' ' 71' ' ' LEU . 25.7 mt-30 -119.37 123.23 43.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.426 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.745 ' HE1' HD12 ' A' ' 144' ' ' ILE . 18.4 p90 -152.18 135.56 15.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.556 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -80.33 139.9 36.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.253 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -129.21 111.21 12.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.25 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.591 HG13 ' O ' ' A' ' 77' ' ' VAL . 0.3 OUTLIER -131.42 12.95 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.47 -179.589 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.67 163.11 16.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.012 0.434 . . . . 0.0 111.327 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.95 79.52 6.58 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.285 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.36 126.89 0.95 Allowed Pre-proline 0 N--CA 1.445 -0.684 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.275 -178.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.44 166.76 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.574 2.182 . . . . 0.0 112.411 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 21.9 ttm -58.83 -51.27 70.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.415 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 121.79 21.55 2.91 Favored Glycine 0 CA--C 1.517 0.163 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.808 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.428 HG21 HG21 ' A' ' 105' ' ' ILE . 15.7 pt -137.48 166.4 24.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.657 0.265 . . . . 0.0 110.639 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.485 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -130.67 124.94 32.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.582 179.798 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.581 ' CD2' HD13 ' A' ' 117' ' ' ILE . 0.4 OUTLIER -129.22 155.99 44.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.025 -179.564 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.407 ' O ' ' O ' ' A' ' 93' ' ' SER . 0.1 OUTLIER -134.63 166.83 22.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.119 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.706 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -102.12 106.36 17.21 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.224 179.598 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.408 ' HB2' ' HD2' ' A' ' 91' ' ' LYS . 1.4 m120 -64.22 176.36 1.05 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.809 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -51.19 -23.19 3.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.322 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.408 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -97.1 15.69 21.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.367 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.473 ' HB3' ' HA ' ' A' ' 126' ' ' THR . 1.0 OUTLIER 54.37 75.56 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.723 0.296 . . . . 0.0 110.68 179.925 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 78.8 p -143.93 133.05 22.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.712 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.556 ' SG ' HD11 ' A' ' 120' ' ' ILE . 10.9 p -87.63 112.18 22.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.058 0.456 . . . . 0.0 111.459 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.798 HG23 ' O ' ' A' ' 115' ' ' ASP . 23.9 m -133.57 134.61 43.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.419 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.893 HG13 ' H ' ' A' ' 114' ' ' GLY . 2.1 p -58.93 106.21 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.71 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -71.47 -25.33 62.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.862 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.533 ' HA ' HG23 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -173.52 131.03 0.45 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.563 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.552 HD11 ' HA ' ' A' ' 112' ' ' HIS . 39.3 mt -85.92 138.26 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.453 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.658 HD22 ' N ' ' A' ' 100' ' ' LEU . 0.9 OUTLIER -97.8 142.24 29.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.85 0.357 . . . . 0.0 111.069 -179.715 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.05 143.54 43.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.87 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.54 -29.01 11.0 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.359 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.415 ' HA3' ' HA3' ' A' ' 83' ' ' GLY . . . -61.5 160.76 27.9 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.424 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.43 ' SD ' HD13 ' A' ' 105' ' ' ILE . 2.3 ppp? -65.47 -31.3 72.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.773 0.321 . . . . 0.0 110.826 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.43 HD13 ' SD ' ' A' ' 104' ' ' MET . 44.2 mm -71.9 -36.07 56.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.948 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -80.48 -47.16 14.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.622 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -64.35 -46.72 82.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.664 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -79.76 -41.79 25.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.682 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 85.17 70.67 1.33 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.418 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.3 m -109.12 -26.79 9.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.774 0.321 . . . . 0.0 111.027 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.84 ' CD2' HG11 ' A' ' 148' ' ' VAL . 6.2 mt -134.39 168.2 19.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.066 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.552 ' HA ' HD11 ' A' ' 99' ' ' ILE . 76.9 m80 -133.07 136.73 46.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.65 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.533 HG23 ' HA ' ' A' ' 98' ' ' ARG . 7.5 p -46.02 115.75 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.292 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.893 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 112.22 -18.83 23.13 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.725 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.798 ' O ' HG23 ' A' ' 95' ' ' THR . 0.2 OUTLIER -55.51 132.38 48.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.694 0.247 . . . . 0.0 110.539 179.79 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -89.78 113.13 24.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.86 0.362 . . . . 0.0 111.483 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.641 HG21 HG12 ' A' ' 120' ' ' ILE . 3.4 mp -87.21 99.79 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.734 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -57.21 -29.44 63.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.125 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -160.55 143.16 13.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.18 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.641 HG12 HG21 ' A' ' 117' ' ' ILE . 17.6 mt -112.56 104.62 17.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.888 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 58.99 30.56 20.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.893 0.378 . . . . 0.0 110.556 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 87.65 13.14 65.6 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.581 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.6 m -133.62 117.14 16.69 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.764 0.316 . . . . 0.0 111.137 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -94.98 84.44 4.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.539 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.992 HG21 HG13 ' A' ' 130' ' ' VAL . 9.2 p -47.11 142.87 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.254 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.473 ' HA ' ' HB3' ' A' ' 92' ' ' GLN . 10.1 p -119.0 -173.42 2.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.868 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 27.9 p30 -51.75 -25.77 8.18 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.202 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.09 -171.61 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.765 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 10.0 m -65.4 134.44 53.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.91 0.386 . . . . 0.0 111.127 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.992 HG13 HG21 ' A' ' 125' ' ' VAL . 0.8 OUTLIER -88.82 -16.36 8.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.15 179.612 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -45.18 -25.92 0.42 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.348 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.23 -52.34 62.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.508 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.489 HD13 ' HB ' ' A' ' 125' ' ' VAL . 6.2 mp -76.87 -33.35 57.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.624 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 11.1 tp60 -64.0 -51.07 65.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.566 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.85 -40.64 97.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.749 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.77 -40.71 79.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.058 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.701 ' O ' HG22 ' A' ' 140' ' ' THR . 12.4 mmt -65.8 -33.28 75.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.832 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.15 -37.01 58.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -99.65 10.13 41.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.276 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.701 HG22 ' O ' ' A' ' 137' ' ' MET . 10.9 t -61.32 156.93 17.66 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.778 0.323 . . . . 0.0 110.996 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -154.1 110.29 3.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.016 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 129.21 -158.78 22.17 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.67 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 17.4 mtp -85.24 116.18 23.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.916 0.389 . . . . 0.0 110.937 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.745 HD12 ' HE1' ' A' ' 74' ' ' PHE . 32.1 mt -87.1 130.13 37.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.257 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.1 m -112.44 113.66 25.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.254 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.646 HD22 ' N ' ' A' ' 146' ' ' LEU . 0.5 OUTLIER -116.53 129.85 56.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.405 -179.412 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.541 ' HD2' HG21 ' A' ' 69' ' ' VAL . 0.6 OUTLIER -95.82 107.41 19.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.014 179.307 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.84 HG11 ' CD2' ' A' ' 111' ' ' LEU . 2.3 t -124.92 157.88 33.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.013 0.435 . . . . 0.0 111.805 -178.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 31.1 mt -137.21 118.82 11.04 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.745 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo . . . . . 0 C--N 1.349 0.564 0 C-N-CA 122.489 2.126 . . . . 0.0 112.523 -179.818 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.916 0.389 . . . . 0.0 110.962 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 125' ' ' GLU . . . . . 0.405 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 4.7 pm0 -158.69 136.55 10.43 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.009 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 126' ' ' TYR . . . . . 0.63 ' CE1' HG21 ' A' ' 130' ' ' VAL . 34.4 m-85 -117.35 132.52 56.58 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.165 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 2.0 m -105.74 116.12 31.4 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 128' ' ' ILE . . . . . 0.705 HD13 ' N ' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.43 -177.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.58 ' O ' HG13 ' A' ' 69' ' ' VAL . 10.3 p . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.843 0.354 . . . . 0.0 111.074 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -123.95 119.82 30.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.821 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.7 tp -87.44 99.3 11.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.026 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 37.1 mt -109.11 133.51 54.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.342 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 144' ' ' ILE . 0.0 OUTLIER -132.36 126.51 33.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.946 0.403 . . . . 0.0 111.689 -179.436 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.648 ' HE1' HD12 ' A' ' 144' ' ' ILE . 4.5 p90 -117.74 144.06 45.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.324 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -80.27 137.32 36.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.884 0.373 . . . . 0.0 111.333 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -129.2 111.24 12.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.368 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.586 HG13 ' O ' ' A' ' 77' ' ' VAL . 0.3 OUTLIER -124.71 10.85 4.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.562 -179.545 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.6 152.7 38.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.879 0.371 . . . . 0.0 111.291 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -93.59 87.47 5.52 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.435 0.636 . . . . 0.0 110.374 179.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.438 ' HG2' ' HD2' ' A' ' 81' ' ' PRO . 0.3 OUTLIER -171.22 164.07 4.99 Favored Pre-proline 0 N--CA 1.448 -0.573 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.666 -178.829 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.438 ' HD2' ' HG2' ' A' ' 80' ' ' GLU . 25.0 Cg_endo -61.85 141.82 91.25 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.411 2.074 . . . . 0.0 112.071 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -54.11 -40.67 67.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.96 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.467 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 117.22 15.05 6.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.89 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.9 pt -128.74 163.98 32.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.789 0.328 . . . . 0.0 110.743 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.491 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -129.98 124.96 34.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.062 179.634 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.634 ' CD2' HD13 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -135.9 159.35 41.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.137 -179.293 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.555 ' C ' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -140.51 166.95 23.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.281 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.692 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -100.34 102.96 14.33 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.064 179.635 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -64.16 176.39 1.03 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.877 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -51.73 -26.26 9.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.883 0.373 . . . . 0.0 110.766 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.99 4.33 38.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.454 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.414 ' HB3' ' HA ' ' A' ' 126' ' ' THR . 10.4 mt-30 59.48 77.04 0.33 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.803 0.335 . . . . 0.0 110.363 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.528 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 67.1 m -155.91 138.71 15.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.664 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.599 ' SG ' HD11 ' A' ' 120' ' ' ILE . 8.8 p -87.91 114.98 25.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.149 0.5 . . . . 0.0 111.676 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.736 HG23 ' O ' ' A' ' 115' ' ' ASP . 28.1 m -130.51 135.16 47.66 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.253 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.902 HG13 ' H ' ' A' ' 114' ' ' GLY . 4.0 p -60.69 106.13 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.244 0.545 . . . . 0.0 110.955 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -74.29 -24.39 59.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.22 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.44 ' HA ' HG23 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -169.7 132.61 1.19 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.997 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.836 ' CD1' HG21 ' A' ' 96' ' ' VAL . 24.3 mm -86.24 110.26 19.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.468 HD11 ' SG ' ' B' ' 127' ' ' CYS . 10.9 mp -70.21 133.23 46.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.918 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 51.7 m80 -69.77 142.17 53.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.842 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.75 -24.28 28.85 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.591 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.467 ' HA3' ' HA3' ' A' ' 83' ' ' GLY . . . -63.39 162.02 33.66 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.641 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.1 ptm -64.97 -37.27 87.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.784 0.326 . . . . 0.0 110.64 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 35.9 mm -67.56 -29.85 46.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.825 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.495 ' CD2' HG22 ' A' ' 99' ' ' ILE . 3.9 t-80 -85.83 -43.06 13.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.627 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.28 -46.94 68.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.607 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -80.98 -45.34 16.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.725 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.38 73.58 1.26 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.643 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.9 t -111.34 -29.42 7.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.811 0.339 . . . . 0.0 110.967 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.798 HD11 HG21 ' A' ' 148' ' ' VAL . 1.1 tp -136.37 169.01 18.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.865 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -137.56 139.88 40.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.571 ' O ' HG13 ' A' ' 113' ' ' VAL . 7.6 p -44.08 111.38 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.638 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.902 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 119.06 -24.96 8.06 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.607 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.736 ' O ' HG23 ' A' ' 95' ' ' THR . 1.0 OUTLIER -54.71 131.55 43.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.719 0.295 . . . . 0.0 110.68 179.835 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -90.16 121.47 32.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.668 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.634 HD13 ' CD2' ' A' ' 86' ' ' LEU . 4.4 mp -98.18 95.39 4.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.465 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 8.9 mp -56.94 -27.76 61.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.493 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -156.53 153.44 28.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.051 0.453 . . . . 0.0 111.453 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.802 HD12 HD13 ' A' ' 133' ' ' LEU . 36.2 mt -124.96 101.28 8.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.651 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.479 ' ND2' HG23 ' A' ' 144' ' ' ILE . 5.7 t-20 65.25 16.47 10.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.969 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.54 10.81 26.45 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.063 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.68 HG22 ' O ' ' A' ' 120' ' ' ILE . 5.9 t -129.64 124.3 33.35 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.952 0.406 . . . . 0.0 111.371 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -96.76 75.76 2.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.242 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.889 ' HB ' HD11 ' A' ' 133' ' ' LEU . 10.7 p -44.71 143.49 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.723 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.414 ' HA ' ' HB3' ' A' ' 92' ' ' GLN . 39.3 p -120.04 -171.1 2.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.824 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -48.68 -26.31 2.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.422 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -52.24 -179.02 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.926 0.393 . . . . 0.0 111.07 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.85 134.77 57.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.216 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.617 HG22 HD21 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -88.74 -16.42 8.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.071 179.584 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -48.05 -25.18 1.31 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.031 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -58.73 -45.72 88.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.615 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.889 HD11 ' HB ' ' A' ' 125' ' ' VAL . 8.4 mt -73.0 -35.26 66.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.285 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.7 -45.91 87.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.752 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.423 ' HG3' ' N ' ' A' ' 136' ' ' ALA . 0.0 OUTLIER -70.36 -30.18 67.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.992 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.481 ' O ' HG22 ' A' ' 140' ' ' THR . . . -79.59 -35.56 39.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.22 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.65 -30.51 67.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.951 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -85.08 -30.04 24.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.09 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -86.81 -34.69 19.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.105 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.481 HG22 ' O ' ' A' ' 136' ' ' ALA . 9.1 t -59.65 146.57 40.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.966 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.03 106.91 4.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.73 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 150.23 -146.77 16.23 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.55 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 4.0 mtp -94.27 118.31 31.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.851 0.358 . . . . 0.0 111.021 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.648 HD12 ' HE1' ' A' ' 74' ' ' PHE . 29.1 mt -89.9 139.03 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.056 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 84.4 p -116.5 113.61 23.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.289 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.576 ' CD1' HG22 ' A' ' 144' ' ' ILE . 6.9 mp -112.19 134.05 53.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.947 0.403 . . . . 0.0 111.417 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -95.85 105.4 17.41 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.54 179.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.798 HG21 HD11 ' A' ' 111' ' ' LEU . 2.6 t -124.72 158.32 32.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.199 0.523 . . . . 0.0 112.094 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 24.1 mt -133.33 135.62 25.73 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.701 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo . . . . . 0 C--N 1.346 0.397 0 C-N-CA 122.403 2.068 . . . . 0.0 112.352 -179.926 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 124' ' ' LYS . . . . . 0.439 ' HD3' ' CE1' ' B' ' 126' ' ' TYR . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.741 0.305 . . . . 0.0 110.926 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 125' ' ' GLU . . . . . 0.489 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 3.6 pt-20 -156.01 135.75 12.59 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.171 0.51 . . . . 0.0 110.345 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 126' ' ' TYR . . . . . 0.462 ' CD1' HG21 ' A' ' 130' ' ' VAL . 32.1 m-85 -115.31 133.14 56.31 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.037 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 127' ' ' CYS . . . . . 0.468 ' SG ' HD11 ' A' ' 100' ' ' LEU . 1.4 m -105.83 116.08 31.33 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 128' ' ' ILE . . . . . 0.651 HD13 ' N ' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.409 -177.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.56 ' O ' HG13 ' A' ' 69' ' ' VAL . 14.9 p . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.9 0.381 . . . . 0.0 111.264 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.2 ptp85 -120.21 144.85 47.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.783 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.7 tp -92.9 99.08 11.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.959 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 37.2 mt -91.63 145.94 6.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.223 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -143.56 126.36 16.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.014 0.435 . . . . 0.0 111.618 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.536 ' CZ ' HD22 ' A' ' 146' ' ' LEU . 3.9 p90 -117.72 133.33 56.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.96 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 10.8 pm0 -80.14 134.14 36.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.941 0.4 . . . . 0.0 111.392 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.09 111.31 12.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.586 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -96.99 -34.11 4.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.065 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.52 155.51 18.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.177 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.15 93.14 7.16 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.266 0.555 . . . . 0.0 110.59 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -167.36 164.75 9.28 Favored Pre-proline 0 N--CA 1.449 -0.52 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.028 -179.034 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -52.01 141.16 47.89 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.584 2.19 . . . . 0.0 112.288 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.96 -56.14 24.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.866 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 147.64 -17.29 1.44 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.982 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.795 HG22 HG23 ' A' ' 99' ' ' ILE . 6.0 pt -115.98 170.59 5.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.77 0.319 . . . . 0.0 111.188 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.73 ' SG ' HD21 ' A' ' 100' ' ' LEU . 5.0 m -131.79 133.61 44.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.362 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.842 ' CD2' HD13 ' A' ' 117' ' ' ILE . 0.5 OUTLIER -127.96 159.48 34.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.327 -179.228 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.531 ' C ' HD13 ' A' ' 88' ' ' LEU . 7.5 pttm -133.02 160.85 35.95 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.954 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.668 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -99.66 104.71 16.49 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.389 179.559 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -64.3 176.19 1.12 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.942 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -53.68 -22.75 9.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.227 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.407 ' CD ' ' N ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -95.61 16.3 17.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.945 179.818 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 51.9 85.98 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.737 0.303 . . . . 0.0 110.7 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 1.1 m -159.3 134.13 8.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.437 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.544 ' SG ' HD11 ' A' ' 120' ' ' ILE . 28.0 p -87.72 115.51 25.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.136 0.493 . . . . 0.0 111.438 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.698 HG23 ' O ' ' A' ' 115' ' ' ASP . 5.8 m -130.04 130.91 45.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.487 -0.779 . . . . 0.0 108.922 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.882 HG13 ' H ' ' A' ' 114' ' ' GLY . 2.0 p -58.51 105.92 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.629 -178.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -70.57 -25.37 63.05 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.799 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.505 ' HA ' HG23 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -173.44 131.29 0.46 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.974 179.835 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.795 HG23 HG22 ' A' ' 84' ' ' ILE . 37.3 mt -85.97 128.44 39.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.167 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.73 HD21 ' SG ' ' A' ' 85' ' ' CYS . 3.9 mt -89.55 146.34 24.65 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.905 0.383 . . . . 0.0 111.228 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -79.72 146.67 32.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.809 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.97 -33.64 5.44 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.387 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.61 171.87 4.15 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.549 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 1.8 tmm? -73.53 -28.55 61.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.758 0.313 . . . . 0.0 111.034 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.6 mm -74.59 -37.15 43.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.124 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -78.45 -49.69 13.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.621 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.91 -44.19 97.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.592 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -82.26 -47.08 12.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.557 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.83 69.92 1.35 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.476 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.483 ' C ' HD22 ' A' ' 111' ' ' LEU . 1.3 p -108.77 -29.22 8.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.833 0.349 . . . . 0.0 110.918 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.635 HD11 HG21 ' A' ' 148' ' ' VAL . 3.8 mm? -123.94 172.56 8.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.948 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.519 ' CA ' HD11 ' A' ' 99' ' ' ILE . 10.3 m80 -135.09 137.89 43.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.79 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.505 HG23 ' HA ' ' A' ' 98' ' ' ARG . 7.5 p -49.75 118.99 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.117 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.882 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 107.77 -20.13 32.15 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.826 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.698 ' O ' HG23 ' A' ' 95' ' ' THR . 26.9 m-20 -50.32 138.14 17.27 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.675 0.274 . . . . 0.0 110.684 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -90.01 110.48 21.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.717 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.842 HD13 ' CD2' ' A' ' 86' ' ' LEU . 5.3 mp -94.72 94.39 4.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.314 179.218 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.407 HD23 ' CD1' ' A' ' 149' ' ' ILE . 3.4 mm? -54.36 -40.32 68.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.887 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -142.12 164.17 30.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.095 0.474 . . . . 0.0 111.66 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.712 ' CD1' HG23 ' A' ' 125' ' ' VAL . 1.1 mp -131.48 99.12 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.352 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 69.14 17.61 8.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.917 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.58 -0.32 34.55 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.747 -0.739 . . . . 0.0 113.107 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.648 ' O ' HD12 ' A' ' 120' ' ' ILE . 5.5 t -132.58 134.56 45.09 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 117.0 0.4 . . . . 0.0 111.449 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -96.05 122.69 39.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.514 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.801 HG11 HG13 ' A' ' 130' ' ' VAL . 20.7 t -58.48 155.03 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.375 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.421 ' N ' HG12 ' A' ' 125' ' ' VAL . 74.1 p -119.11 171.04 8.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.696 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.35 -21.12 62.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.196 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -59.4 -107.22 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.762 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.3 t -109.07 134.32 51.84 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.884 0.374 . . . . 0.0 111.242 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.801 HG13 HG11 ' A' ' 125' ' ' VAL . 0.5 OUTLIER -89.16 -19.26 7.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.059 179.533 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.418 ' HA ' ' HB2' ' A' ' 134' ' ' GLN . 0.8 OUTLIER -46.1 -25.29 0.56 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.444 -179.584 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -54.24 -55.92 23.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.987 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.692 ' CD2' HG22 ' A' ' 125' ' ' VAL . 3.4 mm? -70.7 -41.88 71.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.796 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.461 ' HG2' HG21 ' B' ' 128' ' ' ILE . 3.9 mm-40 -50.3 -53.29 29.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.18 -32.6 73.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.709 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.427 ' O ' HG22 ' A' ' 140' ' ' THR . . . -73.19 -27.79 61.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.21 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -78.22 -32.25 49.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.912 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -87.57 -29.29 21.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.976 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -81.73 -30.58 32.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.958 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 136' ' ' ALA . 12.5 t -71.56 149.06 46.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.992 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 11.6 mttp -140.48 125.35 18.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.711 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 127.95 -136.7 9.33 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.336 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.429 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -100.04 137.06 39.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.86 0.362 . . . . 0.0 111.058 -179.867 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.564 HG22 HD13 ' A' ' 146' ' ' LEU . 35.7 mt -109.18 142.96 20.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.177 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 28.0 p -121.08 113.7 20.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.456 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.564 HD13 HG22 ' A' ' 144' ' ' ILE . 5.8 mp -112.74 142.68 45.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.339 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.71 108.52 20.83 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.471 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.635 HG21 HD11 ' A' ' 111' ' ' LEU . 2.7 t -125.05 158.33 33.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.267 0.556 . . . . 0.0 112.274 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.407 ' CD1' HD23 ' A' ' 118' ' ' LEU . 12.6 mt -132.32 115.98 15.17 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.426 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 C--N 1.347 0.46 0 C-N-CA 122.428 2.085 . . . . 0.0 112.391 -179.646 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 124' ' ' LYS . . . . . 0.539 ' HD2' HD22 ' A' ' 88' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.074 0 CA-C-O 120.851 0.358 . . . . 0.0 110.933 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 125' ' ' GLU . . . . . 0.463 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 8.6 pt-20 -158.07 135.96 10.63 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.202 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 126' ' ' TYR . . . . . 0.602 ' CE1' HG21 ' A' ' 130' ' ' VAL . 16.8 m-85 -115.7 138.19 51.34 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.352 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 98.9 m -106.4 116.11 31.36 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 128' ' ' ILE . . . . . 0.84 HD11 HD12 ' A' ' 86' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.45 -177.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.643 ' O ' HG13 ' A' ' 69' ' ' VAL . 7.2 p . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.916 0.389 . . . . 0.0 110.988 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -95.52 152.61 18.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.864 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.43 99.77 4.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.999 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.479 HG22 ' N ' ' A' ' 73' ' ' GLN . 4.0 mp -89.32 159.18 2.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.648 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.479 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -146.21 124.69 12.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.011 0.434 . . . . 0.0 111.634 -179.656 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.601 ' CZ ' HD23 ' A' ' 146' ' ' LEU . 0.9 OUTLIER -142.47 130.49 21.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.331 179.078 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 10.5 tt0 -80.21 140.85 36.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.646 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 15.8 tttm -129.2 115.86 18.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.305 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -105.73 -26.54 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.329 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.53 149.09 22.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.282 -179.238 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -87.62 90.43 8.37 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.434 0.635 . . . . 0.0 110.56 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -161.97 157.14 19.98 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.836 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.07 142.61 99.54 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.441 2.094 . . . . 0.0 112.155 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -53.08 -42.42 65.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.045 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 127.58 -8.29 6.95 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.78 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.598 HG21 HG21 ' A' ' 105' ' ' ILE . 43.2 pt -113.5 168.84 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.854 0.359 . . . . 0.0 111.052 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.71 ' SG ' HD21 ' A' ' 100' ' ' LEU . 17.2 m -135.88 132.54 36.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.225 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.686 HD12 HD11 ' B' ' 128' ' ' ILE . 0.2 OUTLIER -133.8 159.65 39.96 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.272 -179.071 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.654 ' C ' HD13 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -135.99 162.4 32.99 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.982 179.831 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.677 ' N ' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -105.89 103.26 12.71 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.511 179.694 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.2 m-20 -64.13 176.42 1.01 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.709 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -51.42 -24.34 4.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.108 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.11 9.32 25.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.516 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 54.36 79.55 0.14 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.768 0.318 . . . . 0.0 110.649 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 11.2 m -152.44 131.89 12.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.561 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.475 ' SG ' HD11 ' A' ' 120' ' ' ILE . 18.3 p -87.68 111.49 21.35 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.08 0.467 . . . . 0.0 111.255 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.703 HG23 ' O ' ' A' ' 115' ' ' ASP . 8.6 m -127.58 132.31 49.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.454 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.916 HG13 ' H ' ' A' ' 114' ' ' GLY . 3.9 p -58.72 106.22 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.195 0.521 . . . . 0.0 110.561 -179.244 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -73.77 -27.11 60.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.354 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.429 ' HA ' HG23 ' A' ' 113' ' ' VAL . 6.9 ttp85 -165.77 129.34 2.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.852 0.358 . . . . 0.0 111.47 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.911 ' CD1' HG21 ' A' ' 96' ' ' VAL . 32.6 mm -87.65 103.76 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.439 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.71 HD21 ' SG ' ' A' ' 85' ' ' CYS . 5.5 mt -65.66 135.4 54.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.93 0.395 . . . . 0.0 111.05 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 22.7 m170 -73.07 140.25 47.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.808 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 103.97 -36.52 4.31 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.44 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -55.59 174.59 1.0 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.51 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.53 -29.42 52.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.793 0.33 . . . . 0.0 111.002 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.598 HG21 HG21 ' A' ' 84' ' ' ILE . 28.6 mm -69.03 -35.24 67.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.065 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -80.62 -50.63 9.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.707 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -60.22 -41.72 93.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.628 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.74 -43.82 12.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.672 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.73 51.43 2.67 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.517 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 m -87.64 -22.95 24.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.618 0.247 . . . . 0.0 111.051 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.423 HD23 ' HB2' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -145.84 165.2 29.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.805 0.336 . . . . 0.0 110.901 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -133.5 137.93 45.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.894 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.583 ' O ' HG13 ' A' ' 113' ' ' VAL . 7.5 p -46.74 111.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.714 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.916 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 117.41 -26.0 8.37 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.434 -0.888 . . . . 0.0 113.223 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.703 ' O ' HG23 ' A' ' 95' ' ' THR . 4.6 m-20 -54.13 138.61 37.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.905 0.352 . . . . 0.0 110.67 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.52 118.84 30.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.62 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.605 HD13 ' CD2' ' A' ' 86' ' ' LEU . 4.5 mp -93.43 99.18 9.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.629 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -56.96 -31.58 65.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.241 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -161.23 141.7 11.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.878 0.371 . . . . 0.0 111.349 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.587 HG23 HD12 ' A' ' 146' ' ' LEU . 28.2 mt -107.72 103.28 15.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.675 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 65.19 27.28 12.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.696 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 92.51 5.94 64.64 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.875 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.2 m -133.71 127.0 31.93 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.867 0.365 . . . . 0.0 111.221 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -94.89 120.82 35.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.598 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.635 HG11 HG13 ' A' ' 130' ' ' VAL . 17.9 t -54.53 149.48 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.357 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 58.6 p -119.16 161.5 20.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.771 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -61.59 -18.85 61.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.165 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -60.22 -111.98 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.723 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.09 134.29 51.88 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.921 0.391 . . . . 0.0 110.973 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.676 HG21 ' CE1' ' B' ' 126' ' ' TYR . 0.6 OUTLIER -89.06 -26.11 5.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.042 179.652 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -46.05 -27.44 0.94 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.452 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.55 ' HG3' HD12 ' A' ' 133' ' ' LEU . 9.7 pt20 -62.24 -48.71 78.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.673 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.635 HD13 HG22 ' A' ' 125' ' ' VAL . 1.8 mp -81.53 -35.89 29.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.801 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.403 ' HG3' ' CG2' ' B' ' 128' ' ' ILE . 2.6 tt0 -63.87 -46.09 86.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.529 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -68.05 -45.7 73.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.602 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -65.59 -38.16 88.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.911 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.772 ' O ' HG22 ' A' ' 140' ' ' THR . 2.0 mmt -65.55 -32.05 73.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -85.29 -28.17 25.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.958 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -91.45 -15.39 28.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.335 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.772 HG22 ' O ' ' A' ' 137' ' ' MET . 9.8 t -60.78 156.93 15.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.931 0.396 . . . . 0.0 111.056 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -146.26 117.25 7.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.639 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 134.81 -152.58 20.77 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.625 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.503 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 9.9 ptm -90.47 115.31 27.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.851 0.358 . . . . 0.0 111.29 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.557 HD13 ' HE2' ' A' ' 137' ' ' MET . 47.0 mt -87.83 130.14 38.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.063 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 14.6 m -111.9 113.68 26.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.255 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.642 HD22 ' N ' ' A' ' 146' ' ' LEU . 0.9 OUTLIER -112.53 133.93 54.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.063 0.459 . . . . 0.0 111.197 -179.489 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.37 105.3 17.43 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.051 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.528 ' HB ' HG13 ' A' ' 117' ' ' ILE . 2.8 p -133.35 156.45 41.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.149 0.5 . . . . 0.0 112.045 -178.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.437 ' N ' HG22 ' A' ' 148' ' ' VAL . 26.0 mt -122.71 119.05 28.24 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.62 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo . . . . . 0 C--N 1.347 0.496 0 C-N-CA 122.543 2.162 . . . . 0.0 112.534 -179.634 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 124' ' ' LYS . . . . . 0.564 ' NZ ' HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 120.92 0.391 . . . . 0.0 110.956 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 125' ' ' GLU . . . . . 0.46 ' HG2' ' HB3' ' A' ' 97' ' ' ALA . 4.4 mt-10 -164.73 139.98 5.54 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.481 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 126' ' ' TYR . . . . . 0.676 ' CE1' HG21 ' A' ' 130' ' ' VAL . 31.6 m-85 -117.81 132.33 56.46 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.324 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 91.4 m -106.01 116.01 31.2 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 128' ' ' ILE . . . . . 0.686 HD11 HD12 ' A' ' 86' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.28 -0.867 . . . . 0.0 111.476 -177.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.629 HG21 ' HD3' ' A' ' 147' ' ' LYS . 10.9 p . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.85 0.357 . . . . 0.0 111.0 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -95.42 114.6 26.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.636 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.479 HD12 ' HG2' ' A' ' 147' ' ' LYS . 4.7 tp -92.17 102.5 15.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.118 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mt -89.22 152.13 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.638 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.436 ' NE2' HD23 ' A' ' 71' ' ' LEU . 9.6 mt-30 -140.8 123.2 15.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.005 0.431 . . . . 0.0 111.52 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.769 ' HE1' HD12 ' A' ' 144' ' ' ILE . 25.9 p90 -146.97 134.55 20.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.133 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 0.4 OUTLIER -80.27 143.47 33.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.071 0.462 . . . . 0.0 111.571 -179.094 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.11 111.23 12.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.159 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -109.72 -25.84 3.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.465 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.57 146.23 24.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.313 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.96 90.54 8.38 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.385 0.612 . . . . 0.0 110.421 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.409 ' CB ' ' HD2' ' A' ' 81' ' ' PRO . 2.3 mt-10 -168.43 174.47 2.18 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.673 -178.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.409 ' HD2' ' CB ' ' A' ' 80' ' ' GLU . 65.8 Cg_endo -74.93 142.75 28.46 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.347 2.031 . . . . 0.0 112.415 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -52.55 -58.06 7.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.033 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.492 ' O ' HG23 ' A' ' 84' ' ' ILE . . . 143.26 39.0 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.657 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.509 HG21 HG21 ' A' ' 105' ' ' ILE . 13.0 pt -157.88 170.08 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.719 0.295 . . . . 0.0 110.879 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' B' ' 126' ' ' TYR . 0.1 OUTLIER -135.48 113.56 11.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.48 179.704 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.754 ' HG ' HD11 ' B' ' 128' ' ' ILE . 0.1 OUTLIER -122.12 159.1 27.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.079 -179.159 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.479 ' HB3' ' HA ' ' B' ' 125' ' ' GLU . 0.0 OUTLIER -136.09 166.79 22.56 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.325 -179.69 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.691 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.1 OUTLIER -89.65 103.11 15.78 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.201 179.339 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.408 ' O ' ' N ' ' A' ' 92' ' ' GLN . 4.9 t30 -64.07 176.38 1.01 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.71 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.86 -27.41 3.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.946 0.403 . . . . 0.0 110.803 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.427 ' HD2' ' HB2' ' A' ' 93' ' ' SER . 0.1 OUTLIER -93.56 21.11 6.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.418 179.887 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 89' ' ' ASN . 45.5 mm-40 45.57 74.11 0.15 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.889 0.376 . . . . 0.0 110.666 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.579 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 5.5 m -148.28 147.8 29.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.654 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.63 ' HB3' HD12 ' A' ' 86' ' ' LEU . 1.4 m -87.8 114.18 24.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.119 0.485 . . . . 0.0 111.548 -179.296 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.613 HG23 ' HA ' ' A' ' 116' ' ' GLU . 2.7 m -130.1 126.63 38.03 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.319 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.898 HG13 ' H ' ' A' ' 114' ' ' GLY . 3.6 p -58.78 105.83 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.408 0.623 . . . . 0.0 110.597 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -74.4 -22.69 59.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.149 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 24.2 ttt180 -171.59 139.04 1.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.679 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.821 HD13 HG21 ' A' ' 96' ' ' VAL . 31.8 mm -86.11 121.0 36.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.9 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.484 HD21 ' SG ' ' B' ' 127' ' ' CYS . 4.6 mm? -74.23 143.33 45.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.038 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 16.0 p-80 -85.54 131.33 34.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.945 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.57 -27.9 16.25 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.48 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.28 176.05 8.23 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.516 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -80.48 -30.03 37.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.757 0.313 . . . . 0.0 110.941 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.509 HG21 HG21 ' A' ' 84' ' ' ILE . 42.9 mm -65.18 -36.73 78.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.989 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -81.46 -46.02 15.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.757 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -45.66 85.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.715 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -81.97 -43.84 17.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.755 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.39 63.13 1.31 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.503 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -101.1 -27.34 13.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.878 0.371 . . . . 0.0 111.106 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.723 ' CD2' HG11 ' A' ' 148' ' ' VAL . 10.3 mt -142.3 157.79 44.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.043 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 50.4 m170 -129.52 142.56 50.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.773 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.567 ' O ' HG13 ' A' ' 113' ' ' VAL . 8.2 p -43.83 113.75 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.654 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.898 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 119.07 -28.78 6.47 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.564 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.554 ' HB3' HG11 ' A' ' 148' ' ' VAL . 0.3 OUTLIER -47.06 126.12 8.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.667 0.27 . . . . 0.0 110.754 179.849 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.613 ' HA ' HG23 ' A' ' 95' ' ' THR . 3.0 mt-10 -89.0 111.36 22.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.868 0.366 . . . . 0.0 111.675 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.741 HG21 HD13 ' A' ' 120' ' ' ILE . 4.4 mp -91.2 98.1 8.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.663 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.608 HD23 HG12 ' A' ' 149' ' ' ILE . 4.3 mm? -60.97 -32.81 72.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.551 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -141.07 146.8 37.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.934 0.397 . . . . 0.0 111.687 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.741 HD13 HG21 ' A' ' 117' ' ' ILE . 14.9 mm -118.0 99.75 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.772 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.413 ' H ' HD13 ' A' ' 146' ' ' LEU . 6.5 t-20 62.19 27.87 16.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.743 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 94.98 2.58 62.46 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.866 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 21.9 m -133.55 131.52 39.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.813 0.339 . . . . 0.0 111.052 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -93.34 116.24 28.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.727 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.795 HG22 HD13 ' A' ' 133' ' ' LEU . 25.5 t -56.16 158.76 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.319 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.485 ' N ' HG12 ' A' ' 125' ' ' VAL . 10.9 p -137.5 -178.94 5.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.908 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -59.64 -25.41 64.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.954 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -54.96 -175.03 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.76 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.7 m -64.32 134.23 54.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.907 0.384 . . . . 0.0 110.885 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.48 ' CG2' ' CZ ' ' B' ' 126' ' ' TYR . 0.3 OUTLIER -88.95 -17.18 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.198 179.663 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.23 -25.94 0.7 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.285 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -65.21 -52.82 52.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.489 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.795 HD13 HG22 ' A' ' 125' ' ' VAL . 0.5 OUTLIER -75.23 -29.87 60.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.338 179.563 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -67.65 -45.58 74.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.507 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.1 pttp -68.98 -38.03 79.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.63 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.622 ' O ' HG23 ' A' ' 140' ' ' THR . . . -73.04 -38.46 66.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.016 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.478 ' HE2' HD13 ' A' ' 144' ' ' ILE . 5.9 mmt -67.47 -28.87 68.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.992 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -86.85 -34.88 19.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.07 10.05 42.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.324 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.622 HG23 ' O ' ' A' ' 136' ' ' ALA . 0.0 OUTLIER -67.37 129.96 41.56 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.813 0.34 . . . . 0.0 110.901 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.17 93.34 3.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.814 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 151.25 -157.15 27.05 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.594 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.409 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 11.5 mmm -90.15 123.13 33.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.848 0.356 . . . . 0.0 110.985 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.769 HD12 ' HE1' ' A' ' 74' ' ' PHE . 29.3 mt -92.79 131.48 39.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.215 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 59.5 m -112.79 113.53 25.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.056 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.654 HD22 ' N ' ' A' ' 146' ' ' LEU . 1.1 mm? -117.02 136.06 53.23 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.949 0.404 . . . . 0.0 111.456 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.629 ' HD3' HG21 ' A' ' 69' ' ' VAL . 7.3 mttm -100.32 105.96 17.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.649 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.723 HG11 ' CD2' ' A' ' 111' ' ' LEU . 4.8 t -123.94 153.58 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.168 0.509 . . . . 0.0 112.16 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.608 HG12 HD23 ' A' ' 118' ' ' LEU . 17.7 mm -117.28 122.43 31.1 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.442 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo . . . . . 0 C--N 1.347 0.45 0 C-N-CA 122.526 2.151 . . . . 0.0 112.507 -179.87 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.845 0.355 . . . . 0.0 111.025 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 125' ' ' GLU . . . . . 0.479 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 2.8 pt-20 -152.53 134.3 14.69 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.303 0.573 . . . . 0.0 110.25 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 126' ' ' TYR . . . . . 0.484 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 22.0 m-85 -113.02 136.94 52.14 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.174 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 127' ' ' CYS . . . . . 0.484 ' SG ' HD21 ' A' ' 100' ' ' LEU . 1.7 m -105.86 116.16 31.47 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 128' ' ' ILE . . . . . 0.754 HD11 ' HG ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.399 -177.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.508 ' O ' HG13 ' A' ' 69' ' ' VAL . 11.8 p . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.805 0.335 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.38 122.19 45.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.912 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 tt -90.96 99.31 12.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.977 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.411 HG22 ' N ' ' A' ' 73' ' ' GLN . 34.2 mt -96.08 154.9 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.724 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.411 ' N ' HG22 ' A' ' 72' ' ' ILE . 1.3 mt-30 -145.9 128.08 15.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.938 0.399 . . . . 0.0 111.458 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.647 ' CE1' HD12 ' A' ' 144' ' ' ILE . 8.1 p90 -141.05 135.71 31.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.459 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -80.35 138.1 36.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.909 0.385 . . . . 0.0 111.034 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.8 tttm -129.18 111.28 12.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.405 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.598 HG13 ' O ' ' A' ' 77' ' ' VAL . 0.3 OUTLIER -130.53 14.25 2.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.67 -179.436 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.42 154.94 20.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.904 0.383 . . . . 0.0 111.33 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.79 79.08 6.77 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.338 0.589 . . . . 0.0 110.48 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.65 153.24 2.71 Favored Pre-proline 0 N--CA 1.446 -0.655 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.014 -178.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.52 158.49 31.75 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.504 2.136 . . . . 0.0 112.285 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 23.7 ttm -56.07 -54.21 47.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.956 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 132.24 -9.09 5.37 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.939 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.505 HG23 ' HB ' ' A' ' 105' ' ' ILE . 15.8 pt -114.92 168.07 6.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.802 0.334 . . . . 0.0 111.139 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.471 ' O ' ' N ' ' A' ' 97' ' ' ALA . 19.3 m -135.02 127.68 30.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.275 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 1.051 HD23 HD13 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -125.9 159.56 32.25 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.238 -179.177 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.585 ' C ' HD13 ' A' ' 88' ' ' LEU . 22.4 pttp -137.06 162.3 33.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.178 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.646 ' N ' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -103.26 102.96 12.95 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.597 179.504 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -64.37 176.67 1.01 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.638 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -50.29 -27.57 6.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.937 0.399 . . . . 0.0 110.838 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.04 -16.9 57.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.347 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 74.78 78.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.821 0.343 . . . . 0.0 110.248 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.599 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 49.1 p -154.94 150.62 27.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.667 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.659 ' SG ' HD11 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -87.85 113.58 23.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.062 0.458 . . . . 0.0 111.219 -179.576 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.599 HG23 ' O ' ' A' ' 115' ' ' ASP . 2.9 m -131.96 126.76 34.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.322 179.446 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.927 HG13 ' H ' ' A' ' 114' ' ' GLY . 2.6 p -58.72 105.91 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.279 0.561 . . . . 0.0 110.02 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -72.04 -25.03 61.64 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.266 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.531 ' HA ' HG23 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -173.21 123.03 0.39 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.854 179.811 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.749 HG12 HG21 ' A' ' 96' ' ' VAL . 11.0 mt -85.97 120.75 36.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.361 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.456 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.9 mp -83.96 135.8 34.32 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.148 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.443 ' HA ' ' CG ' ' A' ' 106' ' ' HIS . 52.0 p-80 -73.6 138.63 45.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.826 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.69 -36.53 4.3 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.382 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.16 -171.02 0.12 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.51 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.4 ttp -84.42 -40.6 17.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.865 0.364 . . . . 0.0 110.906 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.505 ' HB ' HG23 ' A' ' 84' ' ' ILE . 37.6 mm -65.54 -36.88 78.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.105 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.443 ' CG ' ' HA ' ' A' ' 101' ' ' HIS . 63.7 t-80 -75.11 -54.98 6.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.748 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.6 ttt-85 -60.05 -47.17 86.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.693 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -75.99 -47.06 26.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.638 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.72 73.39 1.28 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.565 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.669 ' O ' HD22 ' A' ' 111' ' ' LEU . 4.6 m -111.91 -29.26 7.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.776 0.322 . . . . 0.0 110.986 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.995 HD11 HG11 ' A' ' 148' ' ' VAL . 3.2 mm? -134.26 172.53 12.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.09 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.44 ' CA ' HD11 ' A' ' 99' ' ' ILE . 74.5 m80 -134.46 137.42 43.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.711 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.531 HG23 ' HA ' ' A' ' 98' ' ' ARG . 7.5 p -47.02 115.99 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.901 0.381 . . . . 0.0 111.359 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.927 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 112.23 -24.95 13.23 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.853 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.599 ' O ' HG23 ' A' ' 95' ' ' THR . 24.9 m-20 -50.29 143.35 8.76 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.74 0.27 . . . . 0.0 110.7 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.657 ' C ' HG23 ' A' ' 148' ' ' VAL . 1.6 mt-10 -95.32 107.71 19.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.819 0.342 . . . . 0.0 111.725 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 1.051 HD13 HD23 ' A' ' 86' ' ' LEU . 3.9 mp -86.67 99.83 8.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.66 179.291 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.606 HD21 HD12 ' A' ' 149' ' ' ILE . 4.3 mm? -51.46 -35.12 38.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.311 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -169.72 145.64 3.1 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.959 0.409 . . . . 0.0 111.271 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 1.057 HG23 HD11 ' A' ' 146' ' ' LEU . 45.1 mt -104.56 125.29 59.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.828 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.87 27.74 17.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.777 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 83.32 18.13 65.17 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.743 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 27.4 m -133.58 128.11 34.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.828 0.347 . . . . 0.0 111.023 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -92.56 114.96 27.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.792 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.818 HG21 HG13 ' A' ' 130' ' ' VAL . 13.7 p -82.07 127.04 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.246 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.8 p -98.0 -167.09 1.46 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.714 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -67.05 -15.51 63.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.294 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.438 ' C ' ' CD2' ' A' ' 128' ' ' HIS . 0.6 OUTLIER -57.9 -166.91 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.678 0.275 . . . . 0.0 110.572 179.838 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 28.6 t -67.67 134.03 50.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.941 0.401 . . . . 0.0 110.682 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.818 HG13 HG21 ' A' ' 125' ' ' VAL . 0.6 OUTLIER -89.42 -16.32 8.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.335 179.755 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -45.02 -26.01 0.39 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.328 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 51.1 mm-40 -63.78 -54.07 40.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.884 0.373 . . . . 0.0 110.633 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.592 HD22 ' HB ' ' A' ' 125' ' ' VAL . 6.8 mp -77.18 -37.64 53.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.789 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -60.29 -49.57 77.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.712 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.29 -44.06 92.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.73 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.596 ' O ' HG23 ' A' ' 140' ' ' THR . . . -66.17 -35.52 80.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.979 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.504 ' CE ' HD13 ' A' ' 144' ' ' ILE . 1.0 OUTLIER -68.54 -28.36 66.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.894 179.883 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.7 mttp -84.94 -29.38 25.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.898 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.77 10.05 32.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.442 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.596 HG23 ' O ' ' A' ' 136' ' ' ALA . 0.0 OUTLIER -66.55 147.9 52.65 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.771 0.32 . . . . 0.0 110.789 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -150.91 94.97 2.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.783 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 149.2 -154.72 25.95 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.453 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 8.1 mmm -88.03 121.06 29.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.87 0.367 . . . . 0.0 110.833 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.647 HD12 ' CE1' ' A' ' 74' ' ' PHE . 49.8 mt -95.8 144.02 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.215 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.9 p -116.24 113.57 23.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.178 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 1.057 HD11 HG23 ' A' ' 120' ' ' ILE . 3.2 mm? -109.49 125.16 52.18 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.987 0.422 . . . . 0.0 111.46 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 118' ' ' LEU . 10.0 ttpt -105.53 112.02 24.95 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.995 HG11 HD11 ' A' ' 111' ' ' LEU . 3.4 p -147.03 144.03 20.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.157 0.503 . . . . 0.0 112.131 -178.177 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.606 HD12 HD21 ' A' ' 118' ' ' LEU . 14.6 mt -105.4 136.12 19.26 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.381 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.41 ' HD2' HG23 ' A' ' 149' ' ' ILE . 54.1 Cg_endo . . . . . 0 C--N 1.347 0.472 0 C-N-CA 122.456 2.104 . . . . 0.0 112.47 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 2.6 mttp . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.863 0.363 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 125' ' ' GLU . . . . . 0.455 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 1.4 pt-20 -161.45 136.76 7.6 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.348 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 126' ' ' TYR . . . . . 0.639 ' CE1' HG21 ' A' ' 130' ' ' VAL . 32.1 m-85 -122.41 133.28 54.63 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.327 -179.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 89.0 m -106.01 115.98 31.16 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 128' ' ' ILE . . . . . 0.684 HD13 ' N ' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.512 -177.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.541 ' O ' HG13 ' A' ' 69' ' ' VAL . 10.8 p . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.819 0.342 . . . . 0.0 111.034 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.3 ttt-85 -95.47 119.95 34.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.762 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.425 HD21 ' HB3' ' A' ' 145' ' ' SER . 0.9 OUTLIER -98.91 99.36 10.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.047 -179.784 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mp -98.48 148.24 6.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.447 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.479 ' HB3' ' HE3' ' A' ' 143' ' ' MET . 15.9 mt-30 -135.03 123.14 22.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.959 0.409 . . . . 0.0 111.533 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.63 ' CE1' HD22 ' A' ' 146' ' ' LEU . 8.1 p90 -126.64 133.23 51.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.285 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -80.43 135.36 36.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.98 0.419 . . . . 0.0 111.324 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.465 ' HD2' HD11 ' A' ' 144' ' ' ILE . 0.5 OUTLIER -129.09 113.59 15.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.47 179.67 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -110.66 -27.84 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.257 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.55 157.18 17.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.37 -179.321 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -92.52 89.91 6.94 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.52 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -160.04 152.74 17.75 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.966 -178.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.13 147.56 92.83 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.509 2.139 . . . . 0.0 112.207 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.501 ' HB2' ' HE2' ' A' ' 82' ' ' MET . 13.6 ttm -55.39 -41.86 73.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.045 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.46 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 117.14 1.79 18.63 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.581 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.609 ' O ' HD12 ' A' ' 84' ' ' ILE . 2.0 pp -122.17 165.14 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.67 0.271 . . . . 0.0 110.856 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.719 ' C ' HD12 ' A' ' 86' ' ' LEU . 6.8 m -135.03 130.13 35.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.368 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.844 ' CD2' HD13 ' A' ' 117' ' ' ILE . 4.4 mp -121.7 159.5 26.45 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.209 -178.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.709 ' CG ' ' HB2' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -137.39 152.82 50.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.249 179.835 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.673 ' N ' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -102.21 103.38 13.89 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.819 179.803 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -64.3 176.45 1.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.759 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -52.45 -29.17 23.27 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.969 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -81.05 -2.36 47.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.234 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 63.99 86.97 0.12 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.826 0.346 . . . . 0.0 110.53 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.552 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 3.3 m -160.66 137.94 9.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.289 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.414 ' O ' ' HB ' ' A' ' 117' ' ' ILE . 12.9 p -87.61 115.22 24.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.234 0.54 . . . . 0.0 111.489 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.682 HG23 ' O ' ' A' ' 115' ' ' ASP . 9.1 m -132.1 131.53 42.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.53 -0.759 . . . . 0.0 108.97 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.936 HG21 ' CD1' ' A' ' 99' ' ' ILE . 4.4 p -58.8 106.15 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.209 0.528 . . . . 0.0 110.667 -179.026 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.709 ' HB2' ' CG ' ' A' ' 87' ' ' LYS . . . -72.59 -23.34 60.94 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.333 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.454 ' HA ' HG23 ' A' ' 113' ' ' VAL . 1.0 OUTLIER -172.71 131.53 0.55 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.818 0.342 . . . . 0.0 111.515 179.853 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.936 ' CD1' HG21 ' A' ' 96' ' ' VAL . 25.1 mm -90.09 103.63 14.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.497 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.534 HD13 ' SG ' ' A' ' 85' ' ' CYS . 7.6 mp -65.92 147.77 52.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.946 0.403 . . . . 0.0 111.303 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -85.57 142.44 29.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.735 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.3 -39.4 2.86 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.457 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.46 ' HA3' ' HA3' ' A' ' 83' ' ' GLY . . . -54.0 -178.85 0.13 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.646 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 18.6 ptm -84.44 -29.46 26.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.759 0.314 . . . . 0.0 111.166 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.41 HG21 ' HB2' ' A' ' 111' ' ' LEU . 32.5 mm -70.02 -37.91 73.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.975 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -77.87 -44.06 28.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.514 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.9 mtt85 -64.3 -49.98 69.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.512 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -79.07 -44.3 22.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.681 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.13 77.53 1.35 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.625 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.402 ' HB2' HG23 ' A' ' 105' ' ' ILE . 21.2 m -115.2 -28.19 7.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.666 0.27 . . . . 0.0 111.156 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.463 HD21 HG11 ' A' ' 148' ' ' VAL . 0.2 OUTLIER -132.44 172.22 12.75 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.846 0.355 . . . . 0.0 111.111 -179.833 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -142.4 132.3 24.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.771 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.557 ' O ' HG13 ' A' ' 113' ' ' VAL . 7.4 p -44.07 111.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.732 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.899 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 117.35 -28.99 6.92 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.9 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.682 ' O ' HG23 ' A' ' 95' ' ' THR . 22.1 m-20 -48.99 137.6 12.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.63 0.252 . . . . 0.0 110.77 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -89.52 111.32 22.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.827 0.346 . . . . 0.0 111.601 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.844 HD13 ' CD2' ' A' ' 86' ' ' LEU . 4.6 mp -89.25 110.43 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.687 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.439 HD21 HD12 ' A' ' 149' ' ' ILE . 4.4 mm? -67.84 -30.11 69.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.095 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -162.48 148.14 12.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.893 0.378 . . . . 0.0 111.582 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.454 HG12 HG21 ' A' ' 117' ' ' ILE . 49.6 mt -119.47 106.63 19.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.726 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 66.99 29.2 8.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.827 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 87.35 8.96 73.64 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.891 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.6 124.37 26.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.839 0.352 . . . . 0.0 111.06 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 -88.13 107.75 18.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.732 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.707 HG22 ' HG ' ' A' ' 133' ' ' LEU . 11.8 t -59.34 126.45 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.114 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 14.2 p -113.38 -171.77 1.94 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.834 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -60.32 -23.69 64.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.041 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -55.29 -176.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.738 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 m -64.28 134.08 54.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.926 0.393 . . . . 0.0 110.878 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.58 HG13 ' CG1' ' A' ' 125' ' ' VAL . 0.4 OUTLIER -89.24 -21.94 6.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.127 179.702 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.432 ' HA ' ' HG2' ' A' ' 134' ' ' GLN . 4.7 t0 -46.87 -25.61 0.8 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.489 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.12 -41.99 48.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.188 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.707 ' HG ' HG22 ' A' ' 125' ' ' VAL . 3.3 mm? -73.61 -44.7 56.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.318 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.432 ' HG2' ' HA ' ' A' ' 131' ' ' ASP . 17.0 pt20 -68.34 -47.47 67.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.463 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.14 -35.59 80.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.443 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -82.74 -44.97 14.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.773 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.764 ' O ' HG22 ' A' ' 140' ' ' THR . 0.0 OUTLIER -67.77 -25.24 65.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.509 -179.387 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -85.18 -47.63 9.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.809 0.338 . . . . 0.0 111.191 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -71.5 -13.62 61.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.492 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.764 HG22 ' O ' ' A' ' 137' ' ' MET . 14.0 t -59.48 150.83 25.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.901 0.381 . . . . 0.0 110.964 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.07 113.64 14.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.702 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 145.75 -131.99 4.38 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.473 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.479 ' HE3' ' HB3' ' A' ' 73' ' ' GLN . 29.1 mtp -109.17 119.68 40.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.769 0.319 . . . . 0.0 111.126 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.667 HG22 HD13 ' A' ' 146' ' ' LEU . 33.6 mt -88.09 130.76 37.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.969 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.552 ' O ' HD12 ' A' ' 146' ' ' LEU . 8.5 m -108.78 123.35 48.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.603 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.667 HD13 HG22 ' A' ' 144' ' ' ILE . 3.2 mp -122.43 130.25 52.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.287 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -103.26 108.17 19.28 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.523 HG22 ' CG1' ' A' ' 117' ' ' ILE . 6.1 t -133.0 158.36 43.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.168 0.509 . . . . 0.0 112.271 -178.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.452 ' N ' HG12 ' A' ' 148' ' ' VAL . 53.1 mt -125.39 124.25 25.13 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.457 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo . . . . . 0 C--N 1.346 0.439 0 C-N-CA 122.502 2.135 . . . . 0.0 112.515 -179.709 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.84 0.353 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 125' ' ' GLU . . . . . 0.429 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 6.7 pt-20 -164.72 137.56 4.74 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.35 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 126' ' ' TYR . . . . . 0.511 ' CE1' HG21 ' A' ' 130' ' ' VAL . 26.0 m-85 -121.27 134.73 55.18 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.146 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 96.0 m -106.16 115.9 31.02 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 128' ' ' ILE . . . . . 0.609 HD13 ' N ' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.234 -0.888 . . . . 0.0 111.523 -177.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 69' ' ' VAL . 11.1 p . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.854 0.359 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.5 mtt85 -118.6 125.4 49.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.89 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.437 HD11 ' HE3' ' A' ' 147' ' ' LYS . 0.2 OUTLIER -98.99 99.45 10.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.849 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.523 HG21 ' OG ' ' A' ' 110' ' ' SER . 32.6 mt -93.95 143.26 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.831 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -132.25 123.19 26.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.909 0.385 . . . . 0.0 111.194 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.807 ' CE1' HD12 ' A' ' 144' ' ' ILE . 42.0 p90 -143.53 130.55 20.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.52 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 1.9 pt-20 -80.32 141.09 35.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.369 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -129.08 111.12 12.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.442 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -112.01 -25.29 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.419 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.45 154.22 19.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.282 -179.38 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -90.89 88.93 7.24 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.251 0.548 . . . . 0.0 110.607 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -166.2 146.15 5.23 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.978 -179.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -51.55 151.43 14.16 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.497 2.131 . . . . 0.0 112.275 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -56.89 -41.5 78.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.401 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 120.11 28.22 1.88 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.619 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.559 HG23 ' HB ' ' A' ' 105' ' ' ILE . 16.2 pt -147.8 168.36 4.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.876 0.369 . . . . 0.0 111.004 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.492 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -131.49 126.77 35.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.746 179.519 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.75 ' CD2' HD13 ' A' ' 117' ' ' ILE . 0.6 OUTLIER -127.9 159.5 34.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.809 -179.337 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.476 ' C ' HD13 ' A' ' 88' ' ' LEU . 1.8 pttp -136.22 152.37 50.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.527 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.882 HD12 HG11 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -95.46 102.95 14.79 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.304 179.148 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -65.8 176.52 1.56 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.639 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -52.1 -24.6 7.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.873 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.45 2.04 46.2 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.574 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 59.98 80.59 0.2 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.744 0.307 . . . . 0.0 110.529 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.565 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 2.7 m -158.06 139.06 13.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.659 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.877 ' HB2' HD11 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -87.55 111.42 21.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.062 0.458 . . . . 0.0 111.394 -179.372 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 115' ' ' ASP . 6.3 m -126.18 129.41 48.96 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.363 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.893 HG13 ' H ' ' A' ' 114' ' ' GLY . 4.0 p -58.84 106.08 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.233 0.539 . . . . 0.0 110.801 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -75.71 -21.82 57.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.311 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.8 mtp85 -171.67 133.83 0.79 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.765 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.844 HD13 HG21 ' A' ' 96' ' ' VAL . 26.9 mm -86.13 103.88 13.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.86 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.0 mp -58.76 138.65 57.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.011 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -79.76 137.25 36.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.935 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.88 -23.85 32.45 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.638 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.401 ' HA3' ' HA3' ' A' ' 83' ' ' GLY . . . -58.13 176.27 1.98 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.625 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 31.3 ttp -78.33 -33.56 49.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.822 0.344 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.566 HG23 ' HB3' ' A' ' 110' ' ' SER . 40.1 mm -72.36 -35.86 53.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -77.45 -41.86 38.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.657 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.7 ttt85 -72.15 -41.59 66.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.705 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.49 -44.77 14.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.755 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.52 79.87 1.4 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.559 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.566 ' HB3' HG23 ' A' ' 105' ' ' ILE . 9.6 t -117.6 -32.41 4.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.713 0.292 . . . . 0.0 111.192 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 1.031 HD11 HG21 ' A' ' 148' ' ' VAL . 0.3 OUTLIER -138.68 172.59 12.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.84 0.352 . . . . 0.0 111.029 -179.906 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -137.75 140.58 40.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.849 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.561 ' O ' HG13 ' A' ' 113' ' ' VAL . 9.2 p -43.59 113.56 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.702 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.893 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 119.0 -28.36 6.67 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.504 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.565 ' HB3' HG11 ' A' ' 148' ' ' VAL . 0.7 OUTLIER -50.02 131.91 23.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.735 0.302 . . . . 0.0 110.785 179.851 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.491 ' HA ' HG23 ' A' ' 95' ' ' THR . 1.4 tp10 -95.11 109.6 21.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.648 -179.349 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.75 HD13 ' CD2' ' A' ' 86' ' ' LEU . 3.6 mp -89.27 94.31 4.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.438 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.952 HD23 HD12 ' A' ' 149' ' ' ILE . 4.0 mm? -65.69 -26.86 67.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.465 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -135.49 130.07 34.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.867 0.365 . . . . 0.0 111.31 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.877 HD11 ' HB2' ' A' ' 94' ' ' CYS . 7.1 mt -112.48 98.8 7.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.719 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.9 t30 61.76 27.69 16.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.664 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 96.13 -2.18 63.41 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.814 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 27.9 m -133.63 127.54 33.2 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.854 0.359 . . . . 0.0 111.275 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -85.04 121.39 27.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.59 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.882 HG11 HD12 ' A' ' 88' ' ' LEU . 14.0 p -50.6 141.59 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.259 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 40.8 p -108.99 151.79 25.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.913 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -59.69 -25.36 64.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.006 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -59.26 -105.7 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.398 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 28.8 t -109.15 133.7 52.68 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.963 0.411 . . . . 0.0 110.848 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.717 HG13 ' CG2' ' A' ' 125' ' ' VAL . 0.9 OUTLIER -89.62 -20.47 7.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.185 179.508 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -43.68 -27.68 0.34 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.248 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -62.83 -43.85 97.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.432 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.513 ' N ' HD22 ' A' ' 133' ' ' LEU . 3.2 mm? -83.85 -43.14 15.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.62 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -59.35 -49.21 78.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.448 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -68.71 -46.45 68.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.796 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.4 ' O ' ' HB ' ' A' ' 140' ' ' THR . . . -66.36 -28.9 69.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.275 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 8.7 mmt -72.3 -36.92 69.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.168 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.3 pttt -90.61 -21.56 21.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.428 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -90.97 -16.99 27.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.554 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.4 ' HB ' ' O ' ' A' ' 136' ' ' ALA . 9.7 t -76.5 156.94 32.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.963 0.411 . . . . 0.0 111.082 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -143.81 120.88 11.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.716 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 134.71 -160.28 24.2 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.603 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.405 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 60.1 mmm -77.28 111.55 13.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.786 0.327 . . . . 0.0 111.129 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.807 HD12 ' CE1' ' A' ' 74' ' ' PHE . 22.9 mt -85.93 140.28 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.998 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.4 m -108.47 117.33 33.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.486 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.744 HD23 ' CE2' ' A' ' 74' ' ' PHE . 3.3 mm? -120.18 119.08 32.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.208 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.437 ' HE3' HD11 ' A' ' 71' ' ' LEU . 1.8 mptt -95.64 105.29 17.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.774 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 1.031 HG21 HD11 ' A' ' 111' ' ' LEU . 2.7 t -118.62 154.46 20.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.808 -178.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.952 HD12 HD23 ' A' ' 118' ' ' LEU . 8.3 mt -130.76 134.19 25.71 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.596 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo . . . . . 0 C--N 1.345 0.382 0 C-N-CA 122.453 2.102 . . . . 0.0 112.332 -179.886 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 124' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 0.1 OUTLIER . . . . . 0 CA--C 1.527 0.063 0 CA-C-O 120.617 0.246 . . . . 0.0 110.734 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.67 130.95 25.02 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 121.243 0.544 . . . . 0.0 110.058 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 126' ' ' TYR . . . . . 0.64 ' CE1' HG21 ' A' ' 130' ' ' VAL . 5.2 m-85 -115.69 151.0 35.89 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.3 -0.863 . . . . 0.0 112.098 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 1.2 m -110.31 116.12 30.9 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 176.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 128' ' ' ILE . . . . . 0.518 HD11 HD13 ' A' ' 86' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.236 -0.888 . . . . 0.0 111.512 -177.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.85 0.357 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.74 129.64 49.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.76 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.52 99.42 9.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.003 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.557 HD13 HD12 ' A' ' 111' ' ' LEU . 18.0 mt -89.34 146.45 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.465 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -138.59 123.16 18.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.957 0.408 . . . . 0.0 111.681 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.763 ' HE1' HD12 ' A' ' 144' ' ' ILE . 20.8 p90 -138.57 131.86 30.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.096 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 2.4 tt0 -80.33 138.11 36.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.047 0.451 . . . . 0.0 111.612 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.13 111.27 12.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.19 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.86 -28.28 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.3 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.46 148.52 22.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.256 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -87.5 90.28 8.31 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.298 0.571 . . . . 0.0 110.463 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.65 153.9 11.61 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.964 -178.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -49.88 140.42 30.93 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.463 2.109 . . . . 0.0 112.247 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.45 ' HG2' ' CZ ' ' A' ' 74' ' ' PHE . 0.3 OUTLIER -55.14 -56.56 18.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.561 ' O ' HG23 ' A' ' 84' ' ' ILE . . . 138.42 39.12 0.11 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.53 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.743 HG22 HD13 ' A' ' 99' ' ' ILE . 15.3 pt -160.02 158.46 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.771 0.32 . . . . 0.0 110.889 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.496 ' HB2' HD21 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -124.61 124.12 41.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.935 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.67 ' CD1' HD11 ' B' ' 128' ' ' ILE . 0.4 OUTLIER -128.21 158.52 37.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.15 -179.26 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.554 ' C ' HD13 ' A' ' 88' ' ' LEU . 2.9 pttt -138.45 166.75 23.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.025 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.683 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -107.29 103.37 12.71 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.802 179.797 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -64.9 176.43 1.21 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.797 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -50.82 -30.1 13.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.984 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -75.95 -18.09 59.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.091 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 76.27 87.71 0.08 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.634 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 3.6 m -165.06 143.71 6.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.355 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -87.93 111.42 21.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.035 0.445 . . . . 0.0 111.463 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 115' ' ' ASP . 7.4 m -130.43 131.03 45.02 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.395 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.887 HG13 ' H ' ' A' ' 114' ' ' GLY . 2.4 p -59.01 106.15 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.295 0.569 . . . . 0.0 110.724 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.534 ' HB2' ' HD3' ' A' ' 87' ' ' LYS . . . -73.16 -22.55 60.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.994 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.478 ' HA ' HG23 ' A' ' 113' ' ' VAL . 1.5 tmm_? -173.57 136.15 0.57 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.854 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.743 HD13 HG22 ' A' ' 84' ' ' ILE . 12.3 mm -86.02 131.8 33.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.462 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.612 HD22 ' N ' ' A' ' 100' ' ' LEU . 2.0 mm? -89.46 147.64 23.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.831 0.348 . . . . 0.0 111.01 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 17.0 m170 -83.16 136.54 34.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.78 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.37 -28.46 15.28 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.346 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.63 166.23 7.44 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.467 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.407 ' SD ' HD13 ' A' ' 105' ' ' ILE . 0.5 OUTLIER -72.34 -25.89 61.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.666 0.269 . . . . 0.0 111.069 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.44 ' HB ' HG23 ' A' ' 84' ' ' ILE . 29.6 mm -76.71 -36.53 27.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.105 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -80.02 -31.19 39.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.783 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -83.46 -51.23 7.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.826 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -73.76 -43.01 60.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.836 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.99 69.54 1.22 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.471 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.59 -27.96 9.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.745 0.307 . . . . 0.0 111.045 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 1.095 HD11 HG21 ' A' ' 148' ' ' VAL . 0.1 OUTLIER -141.82 172.61 12.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.968 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -139.88 141.84 36.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.84 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.478 HG23 ' HA ' ' A' ' 98' ' ' ARG . 7.6 p -44.97 120.57 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.499 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.887 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 110.26 -27.95 10.96 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.711 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.618 ' O ' HG23 ' A' ' 95' ' ' THR . 0.1 OUTLIER -48.11 135.82 12.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.779 0.323 . . . . 0.0 110.92 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.429 ' HA ' HG23 ' A' ' 95' ' ' THR . 7.6 tt0 -94.72 120.41 34.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.336 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.708 HG13 HG22 ' A' ' 148' ' ' VAL . 4.2 mp -99.19 99.03 7.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.633 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -63.92 -28.33 69.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.448 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -147.08 139.05 24.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.868 0.366 . . . . 0.0 111.198 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.944 HD13 HG23 ' A' ' 125' ' ' VAL . 2.7 mp -118.51 98.74 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.953 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 9.3 t30 64.64 28.26 13.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.651 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 92.05 7.51 64.08 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.786 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.58 128.18 34.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.717 0.294 . . . . 0.0 110.948 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -91.78 110.88 22.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.678 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.944 HG23 HD13 ' A' ' 120' ' ' ILE . 6.0 t -63.38 133.63 28.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.237 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 24.5 p -117.07 -177.42 3.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.837 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -59.68 -20.58 57.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.038 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -58.18 -165.2 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.588 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.09 134.08 46.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.917 0.389 . . . . 0.0 110.954 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.628 HG21 ' CE1' ' B' ' 126' ' ' TYR . 0.6 OUTLIER -89.34 -18.75 7.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.16 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 135' ' ' LYS . 3.3 p30 -44.81 -26.53 0.41 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.474 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.49 -42.14 87.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.877 0.37 . . . . 0.0 110.634 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.871 ' HG ' HG22 ' A' ' 125' ' ' VAL . 2.1 mm? -81.61 -39.74 24.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.229 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.415 ' HG3' ' CG2' ' B' ' 128' ' ' ILE . 3.9 tt0 -56.89 -44.7 82.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.644 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -70.6 -48.89 52.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.78 179.808 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.7 -40.35 79.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.072 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.838 ' O ' HG22 ' A' ' 140' ' ' THR . 24.5 mmt -69.07 -33.15 73.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.018 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.71 -26.5 37.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.887 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.02 -14.07 23.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.447 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.838 HG22 ' O ' ' A' ' 137' ' ' MET . 12.6 t -59.31 156.76 12.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.838 0.351 . . . . 0.0 110.981 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -152.08 104.43 2.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.872 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 141.48 -149.3 20.98 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.646 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.407 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 7.8 mtp -87.82 114.37 24.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.869 0.366 . . . . 0.0 110.975 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.763 HD12 ' HE1' ' A' ' 74' ' ' PHE . 32.8 mt -85.33 130.53 36.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.97 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.457 ' O ' HD13 ' A' ' 146' ' ' LEU . 5.4 m -113.57 114.98 27.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.448 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.69 HD22 ' N ' ' A' ' 146' ' ' LEU . 0.4 OUTLIER -120.55 138.66 53.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.074 -179.52 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 7.1 mmtt -95.94 105.42 17.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.872 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 1.095 HG21 HD11 ' A' ' 111' ' ' LEU . 4.2 t -122.79 158.28 27.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.057 0.456 . . . . 0.0 111.926 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.421 ' N ' HG12 ' A' ' 148' ' ' VAL . 26.2 mt -134.07 133.81 22.36 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.619 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.88 122.17 8.82 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.407 2.071 . . . . 0.0 112.44 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -96.54 41.09 1.11 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.907 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.1 109.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.914 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.884 -179.989 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.808 0.337 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.87 167.86 15.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.973 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -152.3 135.15 15.53 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 121.195 0.522 . . . . 0.0 110.017 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 126' ' ' TYR . . . . . 0.628 ' CE1' HG21 ' A' ' 130' ' ' VAL . 39.3 m-85 -117.49 134.26 55.05 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.565 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 1.7 m -106.05 115.98 31.15 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.696 HD13 ' N ' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.488 -177.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.608 ' O ' HG13 ' A' ' 69' ' ' VAL . 8.8 p . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.951 0.405 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.08 148.25 37.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.756 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.433 HD23 ' O ' ' A' ' 71' ' ' LEU . 9.2 tt -115.08 99.35 7.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.071 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.9 mm -89.61 110.36 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.41 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -113.05 126.66 55.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.014 0.435 . . . . 0.0 111.772 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.666 ' HE1' HD12 ' A' ' 144' ' ' ILE . 4.5 p90 -143.17 145.42 32.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.234 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 0.0 OUTLIER -80.27 139.68 36.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.014 0.435 . . . . 0.0 111.4 -179.364 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -129.35 111.28 12.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.364 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.62 HG13 ' O ' ' A' ' 77' ' ' VAL . 0.3 OUTLIER -124.69 12.95 4.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.636 -179.642 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.68 147.78 46.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.859 0.361 . . . . 0.0 111.228 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -87.76 84.57 7.03 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.249 0.547 . . . . 0.0 110.462 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -174.08 156.92 2.56 Favored Pre-proline 0 N--CA 1.447 -0.587 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.045 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -51.56 132.15 39.66 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.594 2.196 . . . . 0.0 112.4 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.465 ' HG2' ' CE1' ' A' ' 74' ' ' PHE . 0.7 OUTLIER -46.82 -34.98 5.79 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.144 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.42 ' O ' HG23 ' A' ' 84' ' ' ILE . . . 123.56 36.41 0.64 Allowed Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.533 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.512 HD12 HD11 ' A' ' 86' ' ' LEU . 23.9 pt -157.02 165.39 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.787 0.327 . . . . 0.0 110.897 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.72 ' C ' HD12 ' A' ' 86' ' ' LEU . 0.1 OUTLIER -130.04 123.14 29.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.062 179.716 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.728 HD23 HD13 ' A' ' 117' ' ' ILE . 4.5 mp -121.3 156.11 33.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.812 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.635 ' C ' HD13 ' A' ' 88' ' ' LEU . 36.8 pttt -140.05 159.7 41.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.257 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.673 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -105.95 103.09 12.5 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.621 179.586 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -65.52 176.34 1.49 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.764 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -51.87 -26.96 11.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.876 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.0 -13.24 59.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.252 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.4 ' HG2' ' HB2' ' A' ' 127' ' ' ASN . 4.1 mt-30 71.93 88.81 0.1 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.812 0.339 . . . . 0.0 110.601 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.53 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 2.6 m -166.29 141.67 4.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.483 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.574 ' SG ' HD11 ' A' ' 120' ' ' ILE . 11.5 p -87.79 111.44 21.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.099 0.476 . . . . 0.0 111.359 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.7 HG23 ' O ' ' A' ' 115' ' ' ASP . 15.6 m -132.63 133.95 44.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.323 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.917 HG13 ' H ' ' A' ' 114' ' ' GLY . 2.5 p -58.84 106.01 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.196 0.522 . . . . 0.0 110.729 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -71.32 -23.98 62.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.866 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.407 ' HA ' ' CG2' ' A' ' 113' ' ' VAL . 16.4 ttm180 -173.55 141.25 0.86 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.784 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.546 HD13 HG21 ' A' ' 96' ' ' VAL . 17.2 mm -86.06 138.84 18.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.485 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.657 HD11 ' SG ' ' B' ' 127' ' ' CYS . 1.2 mt -96.37 126.54 41.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.821 0.343 . . . . 0.0 111.005 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.5 132.48 47.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.902 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 101.84 -27.9 18.36 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.545 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.8 166.26 17.85 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.537 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 8.8 ttp -67.88 -25.67 65.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.81 0.338 . . . . 0.0 111.068 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.61 HG23 ' OG ' ' A' ' 110' ' ' SER . 19.9 mm -79.46 -32.31 14.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.969 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -81.67 -47.75 12.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.548 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.22 -42.17 98.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.558 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -87.4 -43.93 11.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.643 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.37 42.35 5.23 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.597 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.61 ' OG ' HG23 ' A' ' 105' ' ' ILE . 11.2 p -74.46 -26.14 59.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.812 0.339 . . . . 0.0 111.019 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.929 HD21 HG21 ' A' ' 148' ' ' VAL . 5.1 mt -140.54 172.7 12.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.033 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -140.87 140.91 34.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.82 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.44 ' O ' HG13 ' A' ' 113' ' ' VAL . 6.0 p -44.96 120.3 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.595 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.917 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 111.23 -27.15 11.07 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.748 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.7 ' O ' HG23 ' A' ' 95' ' ' THR . 0.2 OUTLIER -46.99 133.38 11.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.762 0.315 . . . . 0.0 110.991 179.871 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.53 114.64 26.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.174 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.728 HD13 HD23 ' A' ' 86' ' ' LEU . 4.9 mp -94.02 101.58 12.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.84 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.463 HD21 HD12 ' A' ' 149' ' ' ILE . 4.4 mm? -60.34 -42.43 95.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.96 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -142.72 153.02 42.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.969 0.414 . . . . 0.0 111.218 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.671 HG23 HD12 ' A' ' 146' ' ' LEU . 39.4 mt -124.01 98.77 5.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.723 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 59.05 27.72 16.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.703 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 93.87 13.46 54.82 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.617 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 74.4 m -133.64 127.97 34.08 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.894 0.378 . . . . 0.0 111.098 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -110.72 87.57 2.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.674 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.566 HG21 HG13 ' A' ' 130' ' ' VAL . 9.2 p -51.11 158.32 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.328 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.482 ' N ' HG22 ' A' ' 125' ' ' VAL . 37.9 p -131.9 -176.44 4.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.965 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.4 ' HB2' ' HG2' ' A' ' 92' ' ' GLN . 23.5 t-20 -62.13 -18.55 61.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.277 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -59.47 -109.11 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.684 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.19 133.97 52.34 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.89 0.376 . . . . 0.0 111.071 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.87 HG21 ' CE1' ' B' ' 126' ' ' TYR . 0.8 OUTLIER -89.27 -23.95 6.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.18 179.551 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.3 -26.44 0.51 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.54 -179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -56.77 -57.5 12.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.826 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.52 ' C ' HD12 ' A' ' 133' ' ' LEU . 0.3 OUTLIER -75.49 -38.68 59.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.867 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -58.97 -57.7 11.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.906 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.07 -44.91 87.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.896 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.25 -34.09 75.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.083 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.429 ' O ' HG22 ' A' ' 140' ' ' THR . 0.4 OUTLIER -68.01 -31.37 71.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.984 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -87.92 -24.96 23.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.129 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -90.36 -28.67 18.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.119 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 137' ' ' MET . 12.2 t -59.5 156.79 12.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.949 0.404 . . . . 0.0 111.033 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.4 100.12 1.95 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.797 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 149.6 -152.14 24.14 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.511 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.4 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 22.9 mtp -80.82 118.82 22.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.827 0.346 . . . . 0.0 111.052 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.666 HD12 ' HE1' ' A' ' 74' ' ' PHE . 46.1 mt -93.23 145.58 7.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.191 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.9 m -125.39 113.6 17.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.268 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.671 HD12 HG23 ' A' ' 120' ' ' ILE . 1.9 mm? -115.6 134.36 55.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.13 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 7.5 mmtm -98.72 107.19 19.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.878 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.929 HG21 HD21 ' A' ' 111' ' ' LEU . 10.1 t -125.49 158.29 34.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.056 0.455 . . . . 0.0 111.939 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.463 HD12 HD21 ' A' ' 118' ' ' LEU . 23.8 mt -138.21 126.57 14.17 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.768 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.12 124.62 16.75 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.513 2.142 . . . . 0.0 112.299 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -124.85 -171.76 2.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.912 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 63.11 77.69 0.32 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.951 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.98 179.927 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.809 0.337 . . . . 0.0 111.177 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.87 167.76 16.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.918 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 125' ' ' GLU . . . . . 0.41 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 42.3 mt-10 -159.87 133.25 6.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.794 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 126' ' ' TYR . . . . . 0.87 ' CE1' HG21 ' A' ' 130' ' ' VAL . 33.4 m-85 -124.47 134.91 52.91 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.426 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 127' ' ' CYS . . . . . 0.657 ' SG ' HD11 ' A' ' 100' ' ' LEU . 1.8 m -106.01 116.1 31.36 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.488 HG13 HD11 ' A' ' 133' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.372 -177.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.551 ' O ' HG13 ' A' ' 69' ' ' VAL . 14.9 p . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 120.932 0.396 . . . . 0.0 111.258 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.54 146.07 24.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.747 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.82 99.26 6.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.066 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.663 HG21 ' HB3' ' A' ' 110' ' ' SER . 4.0 mp -91.43 140.96 15.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.224 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 144' ' ' ILE . 32.4 mt-30 -135.41 132.33 37.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.113 0.482 . . . . 0.0 111.911 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.623 ' CZ ' HD23 ' A' ' 146' ' ' LEU . 0.8 OUTLIER -144.98 125.97 14.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.298 179.054 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 0.0 OUTLIER -80.26 137.86 36.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.538 -179.216 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -129.07 123.9 33.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.49 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -104.03 -37.31 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.02 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.56 156.53 18.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.258 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -88.63 90.88 8.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.544 0.688 . . . . 0.0 110.565 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -147.18 141.36 15.79 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.947 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.74 144.87 41.54 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.43 2.087 . . . . 0.0 112.082 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.55 -47.01 83.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.97 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 120.74 28.75 1.67 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.755 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.544 HG22 HG23 ' A' ' 99' ' ' ILE . 15.8 pt -146.96 166.3 6.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.844 0.354 . . . . 0.0 110.983 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.481 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -131.18 126.47 35.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.124 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.597 HD12 HD11 ' B' ' 128' ' ' ILE . 0.4 OUTLIER -131.72 156.99 44.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.036 -179.467 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.69 ' C ' HD13 ' A' ' 88' ' ' LEU . 34.3 pttt -136.16 166.78 22.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.327 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.693 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -111.11 103.23 11.66 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.419 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.404 ' OD1' ' HB3' ' A' ' 91' ' ' LYS . 4.9 p30 -66.94 176.67 1.98 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.819 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -47.73 -37.49 13.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.349 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.404 ' HB3' ' OD1' ' A' ' 89' ' ' ASN . 79.0 tttt -70.2 -18.17 63.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.183 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' ' HB ' ' A' ' 126' ' ' THR . 0.0 OUTLIER 76.56 88.51 0.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.546 -179.588 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 1.7 t -162.69 139.55 7.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.46 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.65 111.47 21.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.986 0.422 . . . . 0.0 111.405 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.679 HG23 ' O ' ' A' ' 115' ' ' ASP . 19.0 m -130.0 133.5 46.81 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.424 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.912 HG13 ' H ' ' A' ' 114' ' ' GLY . 3.2 p -61.03 105.91 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.214 0.53 . . . . 0.0 110.458 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -72.98 -25.25 60.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.858 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.573 ' HA ' HG23 ' A' ' 113' ' ' VAL . 47.5 ttt180 -173.61 128.84 0.42 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.387 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.615 HG12 HG21 ' A' ' 96' ' ' VAL . 21.1 mt -85.84 125.51 40.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.897 0.379 . . . . 0.0 110.693 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.459 ' N ' HD12 ' A' ' 100' ' ' LEU . 8.0 mp -83.13 135.73 34.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.146 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.427 ' HA ' ' CG ' ' A' ' 106' ' ' HIS . 32.8 t-80 -79.26 136.98 37.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.869 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 114.57 -41.44 2.18 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.388 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.3 -173.06 0.24 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.702 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 64.7 ttp -84.61 -29.69 25.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.716 0.293 . . . . 0.0 111.157 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 33.4 mm -71.56 -42.15 72.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.257 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.427 ' CG ' ' HA ' ' A' ' 101' ' ' HIS . 5.5 t60 -71.49 -35.97 70.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.843 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.62 -51.0 10.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.746 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -73.15 -46.32 51.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.804 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.42 77.48 1.35 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.471 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.663 ' HB3' HG21 ' A' ' 72' ' ' ILE . 2.0 m -112.4 -30.86 7.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.804 0.335 . . . . 0.0 111.038 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 110' ' ' SER . 5.5 mp -135.53 158.29 44.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.954 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.539 ' CA ' HD11 ' A' ' 99' ' ' ILE . 85.0 m-70 -121.19 135.31 55.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.714 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.573 HG23 ' HA ' ' A' ' 98' ' ' ARG . 7.6 p -45.28 115.01 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.473 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.912 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 112.39 -25.62 12.11 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.707 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.679 ' O ' HG23 ' A' ' 95' ' ' THR . 6.9 m-20 -55.06 137.78 45.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.696 0.284 . . . . 0.0 110.808 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.413 ' HA ' HG23 ' A' ' 95' ' ' THR . 38.8 tt0 -91.62 123.2 34.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.908 0.385 . . . . 0.0 111.492 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.666 HG13 HG22 ' A' ' 148' ' ' VAL . 3.3 mp -97.78 94.25 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.354 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.446 HD13 ' HA ' ' A' ' 118' ' ' LEU . 4.2 mm? -59.05 -26.14 64.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.512 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.16 138.97 25.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.901 0.381 . . . . 0.0 111.481 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.553 ' N ' HD12 ' A' ' 120' ' ' ILE . 2.5 mp -119.88 98.67 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.56 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.407 ' H ' HD13 ' A' ' 146' ' ' LEU . 0.1 OUTLIER 61.99 26.91 16.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.619 -179.526 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 92.03 13.37 57.77 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.796 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.483 ' HB ' HD21 ' A' ' 133' ' ' LEU . 1.3 m -133.58 133.69 42.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.839 0.352 . . . . 0.0 111.161 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.29 84.35 2.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.579 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.885 HG21 HG13 ' A' ' 130' ' ' VAL . 11.2 p -55.79 125.69 11.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.217 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' A' ' 92' ' ' GLN . 26.3 p -103.6 -168.55 1.52 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.696 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.01 -22.27 60.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.937 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -54.57 -176.1 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.685 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.6 p -59.2 134.07 56.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.926 0.393 . . . . 0.0 110.914 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.885 HG13 HG21 ' A' ' 125' ' ' VAL . 0.7 OUTLIER -89.25 -20.0 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.208 179.777 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -45.6 -25.6 0.48 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.417 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.906 ' HG3' HD12 ' A' ' 133' ' ' LEU . 5.9 pt20 -68.9 -47.77 65.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.738 0.304 . . . . 0.0 110.815 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.906 HD12 ' HG3' ' A' ' 132' ' ' GLN . 2.2 mp -81.43 -46.53 14.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.722 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -54.54 -39.55 67.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.955 0.407 . . . . 0.0 110.756 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.36 -50.08 29.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.964 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -58.25 -43.51 87.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.306 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.851 ' HE1' HD13 ' A' ' 144' ' ' ILE . 77.2 mmm -65.06 -37.6 88.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.964 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -74.53 -27.64 60.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.864 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -106.92 10.1 30.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.462 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.817 HG22 ' O ' ' A' ' 137' ' ' MET . 12.8 t -69.3 156.9 38.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.857 0.361 . . . . 0.0 110.846 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -144.55 113.81 6.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.815 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 130.2 -145.39 16.6 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.636 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.466 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 2.4 mtp -97.41 119.97 36.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.858 0.361 . . . . 0.0 111.188 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.851 HD13 ' HE1' ' A' ' 137' ' ' MET . 41.0 mt -90.23 131.75 36.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.122 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.1 m -112.87 114.26 26.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.107 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.647 HD22 ' N ' ' A' ' 146' ' ' LEU . 1.0 OUTLIER -116.96 131.2 57.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.384 -179.251 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.29 110.3 22.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.314 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.666 HG22 HG13 ' A' ' 117' ' ' ILE . 2.8 t -121.79 158.25 25.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.575 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.43 HD12 ' CD2' ' A' ' 118' ' ' LEU . 29.2 mt -140.89 130.5 13.04 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.897 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.08 126.06 20.83 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.428 2.085 . . . . 0.0 112.304 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -59.93 120.22 9.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.857 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 61.5 105.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.856 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.167 -0.921 . . . . 0.0 110.958 179.977 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.844 0.354 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 124' ' ' LYS . . . . . 0.435 ' CD ' ' CE1' ' B' ' 126' ' ' TYR . 0.0 OUTLIER -127.79 167.81 16.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.988 -179.908 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 125' ' ' GLU . . . . . 0.422 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 2.0 pt-20 -155.33 135.84 13.34 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.124 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 126' ' ' TYR . . . . . 0.661 ' CE1' HG21 ' A' ' 130' ' ' VAL . 33.1 m-85 -115.53 133.21 56.25 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.42 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 127' ' ' CYS . . . . . 0.449 ' SG ' HD21 ' A' ' 100' ' ' LEU . 1.8 m -105.94 116.05 31.28 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.707 HD13 ' N ' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.47 -177.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.441 ' O ' HG13 ' A' ' 69' ' ' VAL . 10.9 p . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.777 0.322 . . . . 0.0 111.077 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 -116.06 137.83 51.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.858 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.412 HD12 ' HG2' ' A' ' 147' ' ' LYS . 1.8 tp -108.93 99.38 8.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.921 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.613 HG21 ' HB3' ' A' ' 110' ' ' SER . 13.1 mm -90.41 118.9 36.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.601 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -113.3 127.32 56.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.0 0.428 . . . . 0.0 111.566 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.683 ' CZ ' HD23 ' A' ' 146' ' ' LEU . 9.9 p90 -145.54 131.52 19.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.378 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.33 141.7 35.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.006 0.432 . . . . 0.0 111.299 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.8 ttpt -129.12 111.21 12.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.358 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -105.69 -22.53 4.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.277 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.54 146.09 24.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.185 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -88.36 89.82 8.14 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.259 0.552 . . . . 0.0 110.54 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -167.86 158.72 9.44 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.899 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -50.88 145.18 24.96 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.559 2.172 . . . . 0.0 112.486 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 19.2 ttm -54.27 -65.68 0.53 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.083 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.655 ' O ' HG23 ' A' ' 84' ' ' ILE . . . 144.62 38.41 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.704 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.856 HD13 HD11 ' A' ' 86' ' ' LEU . 1.9 pp -163.5 164.83 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.777 0.322 . . . . 0.0 110.907 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -129.29 128.07 42.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.27 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.856 HD11 HD13 ' A' ' 84' ' ' ILE . 0.4 OUTLIER -128.78 157.43 41.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.824 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.47 ' C ' HD13 ' A' ' 88' ' ' LEU . 55.4 pttt -138.86 166.21 25.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.399 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.675 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -106.54 102.98 12.33 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.485 179.38 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -67.86 176.73 2.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.613 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -49.46 -25.5 2.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.904 0.383 . . . . 0.0 111.021 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.419 ' O ' ' CG ' ' A' ' 91' ' ' LYS . 12.8 tptt -88.05 12.31 13.8 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.261 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 44.02 87.15 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.849 0.357 . . . . 0.0 111.258 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 1.6 m -160.33 145.05 14.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.428 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.43 ' CB ' HD11 ' A' ' 120' ' ' ILE . 0.8 OUTLIER -87.83 111.63 21.6 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.932 0.396 . . . . 0.0 111.468 -179.328 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.614 HG23 ' O ' ' A' ' 115' ' ' ASP . 3.6 m -132.17 129.3 39.61 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.616 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.932 HG21 HD13 ' A' ' 99' ' ' ILE . 4.1 p -58.79 106.36 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.261 0.553 . . . . 0.0 110.601 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -74.44 -21.5 59.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.384 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.436 ' HA ' HG23 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -173.53 134.43 0.5 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.06 179.779 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.932 HD13 HG21 ' A' ' 96' ' ' VAL . 22.6 mm -86.13 103.71 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.639 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.431 HD21 ' SG ' ' B' ' 127' ' ' CYS . 9.8 mp -57.12 141.87 44.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.216 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.431 ' HA ' ' CD2' ' A' ' 106' ' ' HIS . 78.5 m-70 -78.08 136.36 37.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.819 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.23 -25.03 26.21 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.525 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.51 155.75 18.03 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.459 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 2.9 tmm? -61.26 -37.39 82.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.776 0.322 . . . . 0.0 110.983 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.433 HG23 ' CB ' ' A' ' 110' ' ' SER . 35.3 mm -68.51 -32.02 53.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.185 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.431 ' CD2' ' HA ' ' A' ' 101' ' ' HIS . 17.4 t60 -74.44 -54.3 7.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.774 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -42.84 94.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.743 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -77.23 -49.57 14.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.755 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.41 76.37 1.33 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.521 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.613 ' HB3' HG21 ' A' ' 72' ' ' ILE . 0.9 OUTLIER -113.71 -28.77 7.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.734 0.302 . . . . 0.0 111.149 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.485 HD11 HG21 ' A' ' 148' ' ' VAL . 0.1 OUTLIER -137.83 172.59 12.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.059 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -139.59 132.92 30.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.789 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.595 ' O ' HG13 ' A' ' 113' ' ' VAL . 7.1 p -42.38 108.32 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.768 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.889 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 119.03 -27.45 7.06 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.946 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.614 ' O ' HG23 ' A' ' 95' ' ' THR . 6.4 m-20 -50.49 139.9 14.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.765 0.317 . . . . 0.0 110.835 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -90.77 116.78 28.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.46 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.805 HD13 HD23 ' A' ' 86' ' ' LEU . 4.6 mp -96.7 101.95 12.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.503 179.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.539 HD13 ' CD1' ' A' ' 149' ' ' ILE . 6.0 mp -68.56 -27.31 65.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.481 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -148.45 141.12 24.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.93 0.395 . . . . 0.0 111.286 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.578 HG23 HD11 ' A' ' 146' ' ' LEU . 3.5 mp -119.65 99.14 7.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.818 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 12.6 t30 62.46 25.39 15.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.716 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 99.94 1.44 56.12 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.984 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.8 m -133.62 130.59 38.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.844 0.354 . . . . 0.0 111.142 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.402 ' HA ' HD12 ' A' ' 120' ' ' ILE . 5.1 p-10 -101.42 98.04 8.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.643 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.994 HG21 HG13 ' A' ' 130' ' ' VAL . 9.6 p -58.85 138.33 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.012 0.434 . . . . 0.0 111.189 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.2 p -123.14 -171.19 2.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.515 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 44.4 p-10 -50.21 -24.88 3.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.244 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.26 -166.04 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.652 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.81 133.88 45.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.883 0.373 . . . . 0.0 110.934 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.994 HG13 HG21 ' A' ' 125' ' ' VAL . 0.7 OUTLIER -89.26 -20.48 7.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.282 179.738 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.0 -26.35 0.42 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.429 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.67 -50.65 73.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.766 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.5 mp -72.16 -41.73 66.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.718 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -55.38 -52.41 63.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.559 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -62.5 -34.9 77.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.529 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.78 -30.34 62.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.986 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 3.8 mmt -69.84 -32.73 71.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.823 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -85.39 -25.96 26.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.023 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -88.92 -32.64 17.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.159 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 11.9 t -59.38 150.63 25.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.012 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.94 124.33 8.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.734 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 124.08 -146.61 16.35 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.547 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 1.6 ttm -78.07 121.1 23.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.894 0.378 . . . . 0.0 111.095 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.686 HG22 ' CD2' ' A' ' 146' ' ' LEU . 42.8 mt -96.73 136.35 27.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.035 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.514 ' C ' HD22 ' A' ' 146' ' ' LEU . 87.2 p -107.82 127.67 53.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.632 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.686 ' CD2' HG22 ' A' ' 144' ' ' ILE . 3.3 mm? -130.17 121.16 25.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.186 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.412 ' HG2' HD12 ' A' ' 71' ' ' LEU . 11.8 mmtt -95.87 105.35 17.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.837 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.618 HG22 HG13 ' A' ' 117' ' ' ILE . 2.7 t -127.64 157.93 39.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.002 0.429 . . . . 0.0 111.773 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.539 ' CD1' HD13 ' A' ' 118' ' ' LEU . 46.1 mt -134.36 135.97 24.94 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.845 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.401 ' HD2' HG23 ' A' ' 149' ' ' ILE . 37.5 Cg_endo -65.92 117.7 4.88 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.436 2.091 . . . . 0.0 112.281 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -70.68 65.27 0.31 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.005 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 52.79 29.9 8.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.052 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.154 -0.927 . . . . 0.0 111.001 179.98 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.786 0.327 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 124' ' ' LYS . . . . . 0.411 ' HD2' ' CE1' ' B' ' 126' ' ' TYR . 0.0 OUTLIER -77.8 167.94 20.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.875 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 125' ' ' GLU . . . . . 0.401 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 1.6 pt-20 -141.21 133.07 27.47 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.231 0.538 . . . . 0.0 109.814 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 126' ' ' TYR . . . . . 0.738 ' CE1' HG21 ' A' ' 130' ' ' VAL . 42.2 m-85 -109.9 132.34 54.24 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.575 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 127' ' ' CYS . . . . . 0.431 ' SG ' HD21 ' A' ' 100' ' ' LEU . 1.8 m -105.98 115.95 31.1 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.708 HD13 ' N ' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.583 -177.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.568 ' O ' HG13 ' A' ' 69' ' ' VAL . 10.2 p . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.887 0.375 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.1 mtt85 -101.92 126.04 48.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.922 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.6 99.47 10.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.507 ' CD1' HG12 ' A' ' 148' ' ' VAL . 3.5 mp -89.37 145.27 7.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.957 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -136.7 123.11 20.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.172 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.509 ' CZ ' HD23 ' A' ' 146' ' ' LEU . 10.8 p90 -148.33 129.36 14.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.779 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 1.3 pt-20 -80.33 129.72 34.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.219 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.36 111.57 12.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.225 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.615 HG13 ' O ' ' A' ' 77' ' ' VAL . 0.3 OUTLIER -125.65 15.52 4.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.568 -179.605 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.15 154.94 21.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.54 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -80.9 79.54 7.55 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.267 0.556 . . . . 0.0 110.001 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.14 137.87 1.66 Allowed Pre-proline 0 N--CA 1.447 -0.601 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.132 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.32 156.4 10.74 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.336 2.024 . . . . 0.0 112.258 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.445 ' HG2' ' CE1' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -59.13 -39.89 83.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.857 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 119.86 35.01 0.93 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.488 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.549 ' CA ' HD23 ' A' ' 100' ' ' LEU . 13.6 pt -152.45 154.31 8.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.77 0.319 . . . . 0.0 110.977 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.618 ' HB2' HD21 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -125.61 122.81 37.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.095 179.618 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.875 HD23 HD13 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -125.17 159.23 32.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.87 -179.663 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.565 ' C ' HD13 ' A' ' 88' ' ' LEU . 7.0 pttt -142.79 161.44 38.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.2 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.632 ' N ' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -101.65 102.9 13.66 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.557 179.389 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -65.25 176.76 1.24 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.448 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -49.67 -27.64 4.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.815 0.34 . . . . 0.0 110.879 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.66 -9.18 59.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.713 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 67.79 76.43 0.27 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.902 0.382 . . . . 0.0 110.946 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.575 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 1.3 p -153.87 145.02 22.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.522 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -87.74 112.63 22.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.105 0.479 . . . . 0.0 111.292 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.644 HG23 ' O ' ' A' ' 115' ' ' ASP . 3.5 m -132.85 130.82 40.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.378 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.923 HG13 ' H ' ' A' ' 114' ' ' GLY . 2.6 p -58.59 106.08 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.312 0.577 . . . . 0.0 110.615 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -71.77 -23.22 61.55 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.038 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.452 ' HA ' HG23 ' A' ' 113' ' ' VAL . 6.1 mtt180 -173.45 145.92 1.3 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.591 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.551 HD11 ' HA ' ' A' ' 112' ' ' HIS . 54.0 mt -86.01 135.67 24.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.634 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.618 HD21 ' HB2' ' A' ' 85' ' ' CYS . 4.1 mm? -85.6 123.35 30.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.028 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -70.14 131.99 45.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.911 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.15 -24.52 28.45 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.543 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.61 -178.05 0.62 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.633 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 29.1 ttp -84.42 -27.18 27.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.707 0.289 . . . . 0.0 111.069 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.431 HG23 ' HB2' ' A' ' 110' ' ' SER . 25.5 mm -78.45 -34.64 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.116 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -72.67 -45.7 57.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.914 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 29.7 ttp180 -71.96 -46.55 57.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.906 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.61 -46.89 29.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.837 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.23 75.55 1.3 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.446 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.431 ' HB2' HG23 ' A' ' 105' ' ' ILE . 0.8 OUTLIER -111.28 -29.82 7.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.785 0.326 . . . . 0.0 111.104 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.529 HD23 HG21 ' A' ' 148' ' ' VAL . 2.6 mp -136.95 172.61 12.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.934 0.397 . . . . 0.0 111.034 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.551 ' HA ' HD11 ' A' ' 99' ' ' ILE . 3.1 m-70 -139.48 134.9 32.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.741 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.564 ' O ' HG13 ' A' ' 113' ' ' VAL . 7.1 p -42.21 113.03 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.705 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.923 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 111.75 -24.17 15.67 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.979 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.644 ' O ' HG23 ' A' ' 95' ' ' THR . 11.4 m-20 -48.95 142.79 6.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.725 0.298 . . . . 0.0 110.848 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.3 mp0 -91.69 114.77 27.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.691 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.875 HD13 HD23 ' A' ' 86' ' ' LEU . 4.6 mp -92.79 107.81 19.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.538 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.508 ' CD2' HD12 ' A' ' 149' ' ' ILE . 4.3 mm? -70.11 -27.97 65.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.584 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -155.05 161.0 41.44 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.046 0.45 . . . . 0.0 111.355 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.561 HG12 HG21 ' A' ' 117' ' ' ILE . 30.2 mt -142.02 98.81 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.861 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.406 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 0.2 OUTLIER 62.83 28.33 16.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.041 -179.802 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.63 -25.09 22.28 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.64 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.532 ' HB ' HD11 ' A' ' 133' ' ' LEU . 2.8 m -120.27 137.13 54.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.805 0.336 . . . . 0.0 110.979 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -93.92 21.39 6.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.205 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 126' ' ' THR . 44.1 t 58.65 156.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.266 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.479 ' N ' HG12 ' A' ' 125' ' ' VAL . 5.5 p -137.8 172.9 12.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.777 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -59.7 -25.65 64.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.811 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -59.23 -163.06 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.48 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.3 m -67.41 134.15 50.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.936 0.398 . . . . 0.0 110.722 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.603 HG21 ' CE1' ' B' ' 126' ' ' TYR . 0.4 OUTLIER -89.13 -16.34 8.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.231 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -44.24 -25.95 0.28 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.432 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -62.03 -58.93 5.99 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.516 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.532 HD11 ' HB ' ' A' ' 123' ' ' THR . 2.7 mm? -74.68 -39.08 62.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.336 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.426 ' HA ' HG21 ' B' ' 128' ' ' ILE . 7.5 tm0? -57.76 -51.28 70.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.791 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -64.29 -37.31 87.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.844 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.45 ' O ' HG23 ' A' ' 140' ' ' THR . . . -67.64 -40.35 84.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.089 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -67.08 -29.03 68.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.913 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -84.32 -30.65 25.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.996 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -104.98 10.08 34.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.378 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 136' ' ' ALA . 0.0 OUTLIER -68.36 138.76 55.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.881 0.372 . . . . 0.0 110.916 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.5 76.5 1.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.762 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 167.21 -161.37 35.2 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.383 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.536 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 4.3 ptm -85.01 120.64 26.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.923 0.392 . . . . 0.0 111.002 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.619 HG22 ' CD2' ' A' ' 146' ' ' LEU . 48.8 mt -95.71 134.36 33.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.354 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.1 m -111.06 113.64 26.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.032 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.619 ' CD2' HG22 ' A' ' 144' ' ' ILE . 2.5 mm? -113.65 142.01 46.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.108 0.48 . . . . 0.0 111.381 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.436 ' O ' ' N ' ' A' ' 118' ' ' LEU . 10.9 mttt -110.61 105.53 14.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.63 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.529 HG21 HD23 ' A' ' 111' ' ' LEU . 5.2 p -141.62 149.66 19.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.007 0.432 . . . . 0.0 111.676 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.586 HG22 ' N ' ' A' ' 153' ' ' GLN . 3.1 mt -125.15 121.45 25.25 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.947 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -59.25 117.45 4.19 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.439 2.093 . . . . 0.0 112.241 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 43.67 38.36 1.93 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.473 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 61.41 40.3 14.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.91 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.586 ' N ' HG22 ' A' ' 149' ' ' ILE . 9.1 tt0 . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.866 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.834 0.349 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.63 167.8 13.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.918 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 125' ' ' GLU . . . . . 0.462 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 3.9 mp0 -163.62 135.53 4.96 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.866 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 126' ' ' TYR . . . . . 0.603 ' CE1' HG21 ' A' ' 130' ' ' VAL . 36.4 m-85 -128.54 131.66 48.25 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.572 -179.021 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 127' ' ' CYS . . . . . 0.518 ' SG ' HD21 ' A' ' 100' ' ' LEU . 1.7 m -106.01 115.92 31.05 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.704 HD13 ' N ' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.508 -177.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.788 0.327 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -107.37 161.26 14.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.904 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.4 tp -118.89 101.95 8.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.943 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.497 HG21 ' HB3' ' A' ' 110' ' ' SER . 27.6 mm -89.28 126.79 42.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.915 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -122.57 123.65 41.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.276 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.806 ' CZ ' HD12 ' A' ' 144' ' ' ILE . 10.4 p90 -149.15 130.96 15.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.539 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -82.41 137.58 34.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.079 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -129.2 111.21 12.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.366 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.599 HG13 ' O ' ' A' ' 77' ' ' VAL . 0.3 OUTLIER -125.47 11.9 4.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.706 -179.453 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.7 158.59 18.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.836 0.351 . . . . 0.0 111.404 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.08 78.93 8.82 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.375 0.607 . . . . 0.0 110.297 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -167.53 149.68 5.41 Favored Pre-proline 0 N--CA 1.445 -0.702 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.152 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -64.77 160.68 39.47 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.507 2.138 . . . . 0.0 112.26 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.471 ' HG3' ' CZ ' ' A' ' 74' ' ' PHE . 15.0 ttm -51.52 -47.45 63.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.037 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.426 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 122.71 -6.51 9.68 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.603 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 32.6 pt -113.34 167.84 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.768 0.318 . . . . 0.0 110.779 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.539 ' SG ' HD13 ' A' ' 100' ' ' LEU . 18.7 m -134.27 126.26 29.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.513 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.776 HD23 HD13 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -124.15 159.32 30.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.964 -179.463 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.531 ' C ' HD13 ' A' ' 88' ' ' LEU . 16.4 pttp -136.42 164.83 27.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.102 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.681 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -106.51 103.21 12.61 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.951 179.71 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -64.85 176.5 1.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.665 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -52.24 -26.26 11.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.013 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.0 tptp -81.58 -8.41 59.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.325 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 67.67 89.2 0.1 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.849 0.357 . . . . 0.0 110.704 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.55 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 0.3 OUTLIER -166.31 146.28 6.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.416 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.444 ' SG ' HD11 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -87.88 114.98 25.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.964 0.411 . . . . 0.0 111.348 -179.369 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.592 HG23 ' O ' ' A' ' 115' ' ' ASP . 3.1 m -133.66 128.02 34.17 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.924 HG21 ' CD1' ' A' ' 99' ' ' ILE . 2.8 p -58.54 106.2 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.405 0.621 . . . . 0.0 110.404 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -72.67 -24.09 60.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.311 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.47 ' HA ' HG23 ' A' ' 113' ' ' VAL . 6.6 ttt85 -172.38 126.92 0.53 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.859 0.361 . . . . 0.0 111.175 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.924 ' CD1' HG21 ' A' ' 96' ' ' VAL . 17.7 mm -86.17 103.69 13.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.511 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.539 HD13 ' SG ' ' A' ' 85' ' ' CYS . 8.4 mp -63.87 144.32 57.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.091 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -82.96 128.03 34.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.808 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.36 -35.08 3.88 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.484 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.426 ' HA3' ' HA3' ' A' ' 83' ' ' GLY . . . -56.41 179.33 0.55 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.611 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 12.4 ptm -84.47 -30.31 25.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.772 0.32 . . . . 0.0 110.967 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.429 HD11 ' HG2' ' A' ' 82' ' ' MET . 39.5 mm -68.4 -36.54 75.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.865 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -74.43 -45.24 47.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.631 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.09 -49.8 53.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.604 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -73.79 -48.04 34.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.698 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.34 74.55 1.23 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.598 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.497 ' HB3' HG21 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -109.63 -30.28 7.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.824 0.345 . . . . 0.0 110.814 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.622 HD21 HG11 ' A' ' 148' ' ' VAL . 0.5 OUTLIER -147.81 164.5 33.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.92 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -130.29 143.58 50.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.792 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.559 ' O ' HG13 ' A' ' 113' ' ' VAL . 8.6 p -43.36 113.07 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.637 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.89 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 116.15 -24.18 10.15 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.708 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.708 ' HB3' HG21 ' A' ' 148' ' ' VAL . 0.4 OUTLIER -48.23 134.59 14.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.717 0.294 . . . . 0.0 110.844 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.63 ' C ' HG23 ' A' ' 148' ' ' VAL . 10.7 mt-10 -93.6 107.84 19.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.485 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.776 HD13 HD23 ' A' ' 86' ' ' LEU . 2.6 mp -87.14 98.41 7.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.626 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.606 ' CD2' HD12 ' A' ' 149' ' ' ILE . 3.7 mm? -63.03 -29.49 70.86 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.018 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -156.61 147.64 22.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.821 0.343 . . . . 0.0 111.162 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.706 HD12 HG23 ' A' ' 125' ' ' VAL . 18.6 mt -122.04 107.92 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.826 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 63.05 24.43 14.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.731 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.9 0.43 58.85 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.943 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.2 m -133.6 127.47 33.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.881 0.372 . . . . 0.0 111.181 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -93.02 142.03 27.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.72 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.967 HG11 HG13 ' A' ' 130' ' ' VAL . 13.0 t -91.69 137.32 22.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.178 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 62.7 p -116.07 -177.0 3.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.779 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -56.88 -22.27 35.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.169 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.36 -167.34 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.713 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 42.4 m -68.25 134.07 49.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.964 0.411 . . . . 0.0 110.775 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.967 HG13 HG11 ' A' ' 125' ' ' VAL . 0.6 OUTLIER -89.27 -20.14 7.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.219 179.714 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -44.76 -26.43 0.39 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.426 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.06 -57.6 10.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.831 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.826 HD13 HG22 ' A' ' 125' ' ' VAL . 3.7 mp -77.62 -34.68 53.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.035 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -59.76 -50.54 73.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.645 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -65.79 -44.97 84.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.69 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -65.67 -32.68 74.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.036 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 4.1 mmt -73.55 -26.37 60.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.049 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.35 -19.62 27.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.291 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.59 -23.52 13.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.432 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.4 t -59.32 147.19 36.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.821 0.343 . . . . 0.0 110.99 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -140.68 124.08 16.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.805 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 134.33 -160.02 24.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.493 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 27.8 mtp -77.31 110.17 11.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.774 0.321 . . . . 0.0 110.974 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.806 HD12 ' CZ ' ' A' ' 74' ' ' PHE . 53.8 mt -85.39 128.86 38.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.234 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.571 ' O ' HD13 ' A' ' 146' ' ' LEU . 71.6 m -109.28 120.95 44.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.335 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.721 HD22 ' N ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -123.98 132.28 53.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.993 0.425 . . . . 0.0 111.379 -179.396 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.2 105.22 17.33 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.708 HG21 ' HB3' ' A' ' 115' ' ' ASP . 6.1 p -136.04 141.9 40.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.037 0.446 . . . . 0.0 112.052 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.606 HD12 ' CD2' ' A' ' 118' ' ' LEU . 4.3 mt -105.45 131.58 21.63 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.643 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -56.86 140.82 92.6 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.524 2.149 . . . . 0.0 112.322 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.92 98.12 4.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.802 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -144.87 37.94 1.19 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.904 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.003 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.771 0.32 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 124' ' ' LYS . . . . . 0.422 ' HE2' ' CE1' ' B' ' 126' ' ' TYR . 0.1 OUTLIER -127.79 167.69 16.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.94 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -156.48 135.75 12.13 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.848 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 126' ' ' TYR . . . . . 0.623 ' CE1' HG21 ' A' ' 130' ' ' VAL . 38.2 m-85 -121.54 132.04 54.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.433 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 72.3 m -105.91 116.1 31.35 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.463 HD13 ' N ' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.576 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.5 p . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.857 0.361 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.79 ' HD3' HD11 ' A' ' 72' ' ' ILE . 9.8 ttt-85 -109.53 129.9 55.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.831 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.59 99.34 10.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.966 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.79 HD11 ' HD3' ' A' ' 70' ' ' ARG . 24.5 mm -98.47 110.4 25.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.428 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -122.27 144.22 49.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.054 0.454 . . . . 0.0 111.737 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.456 ' CZ ' ' CD2' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -153.29 145.04 23.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.271 179.132 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.22 139.07 36.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.016 0.436 . . . . 0.0 111.415 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -129.22 111.24 12.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.369 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -111.63 -28.63 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.263 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.48 150.45 21.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.306 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -89.34 91.32 8.7 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.323 0.582 . . . . 0.0 110.485 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -159.53 159.58 28.11 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.917 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.83 145.18 61.74 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.461 2.107 . . . . 0.0 112.159 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.3 mtm -54.95 -39.58 69.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.874 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 108.2 18.76 9.49 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.682 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.499 HG21 HG21 ' A' ' 105' ' ' ILE . 22.5 pt -127.75 165.85 25.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.731 0.3 . . . . 0.0 110.697 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -133.67 125.18 28.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.247 179.752 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.59 ' CD2' HD13 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -134.1 155.8 49.41 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.364 -179.118 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.443 ' HB3' ' HA ' ' B' ' 125' ' ' GLU . 0.6 OUTLIER -131.61 166.69 20.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.054 179.766 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.668 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.1 OUTLIER -98.59 103.19 15.11 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.643 179.594 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -64.29 176.45 1.05 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.594 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.71 -30.91 24.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.07 0.462 . . . . 0.0 110.833 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.98 -1.26 43.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.211 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 62.34 86.84 0.11 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.923 0.392 . . . . 0.0 110.462 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.559 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 0.3 OUTLIER -165.57 150.11 8.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.284 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.812 ' CB ' HD11 ' A' ' 120' ' ' ILE . 0.0 OUTLIER -87.86 114.95 24.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.036 0.446 . . . . 0.0 111.508 -179.213 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.515 HG23 ' HA ' ' A' ' 116' ' ' GLU . 2.2 m -126.9 124.77 40.32 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.882 HG13 ' H ' ' A' ' 114' ' ' GLY . 2.2 p -58.46 105.86 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.433 0.635 . . . . 0.0 110.504 -178.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -71.78 -24.34 61.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.761 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.525 ' HA ' HG23 ' A' ' 113' ' ' VAL . 11.3 tpp180 -173.52 130.0 0.44 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.736 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.699 HG22 ' CD2' ' A' ' 106' ' ' HIS . 44.4 mt -86.04 130.34 36.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.564 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.756 HD11 ' SG ' ' B' ' 127' ' ' CYS . 0.4 OUTLIER -93.28 122.03 35.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.833 -179.839 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -56.37 141.74 40.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.06 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.0 -36.9 4.05 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.429 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' A' ' 83' ' ' GLY . . . -59.25 160.09 17.81 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.634 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.5 ttp -66.28 -22.06 66.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.775 0.322 . . . . 0.0 111.044 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.65 ' N ' HD12 ' A' ' 105' ' ' ILE . 2.4 mp -83.11 -31.28 8.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.536 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.699 ' CD2' HG22 ' A' ' 99' ' ' ILE . 1.9 t-80 -88.02 -39.6 14.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.551 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.84 -47.5 68.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.6 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -83.26 -37.4 23.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.653 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.15 46.93 4.58 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.489 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.479 ' O ' HD12 ' A' ' 111' ' ' LEU . 1.0 OUTLIER -78.24 -29.13 48.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.731 0.3 . . . . 0.0 111.044 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.761 HD11 HG21 ' A' ' 148' ' ' VAL . 1.4 mp -136.28 166.79 22.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.984 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.523 ' HA ' HD11 ' A' ' 99' ' ' ILE . 27.9 m-70 -126.67 139.39 53.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.722 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.525 HG23 ' HA ' ' A' ' 98' ' ' ARG . 7.2 p -49.68 114.95 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.357 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.882 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 113.41 -21.49 17.02 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.837 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.48 ' O ' HG23 ' A' ' 95' ' ' THR . 6.0 m-20 -54.7 138.67 41.27 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.714 0.292 . . . . 0.0 110.821 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.515 ' HA ' HG23 ' A' ' 95' ' ' THR . 0.1 OUTLIER -93.6 120.01 33.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.911 0.386 . . . . 0.0 111.585 -179.286 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.669 HG13 HG22 ' A' ' 148' ' ' VAL . 4.4 mp -101.95 94.29 3.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.52 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.409 HD22 HD11 ' A' ' 149' ' ' ILE . 10.3 mp -61.73 -31.12 71.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.578 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -137.55 141.51 41.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.921 0.391 . . . . 0.0 111.353 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.889 HD12 HG23 ' A' ' 125' ' ' VAL . 19.8 mt -122.01 98.79 6.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.839 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 63.76 30.04 14.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.617 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 90.78 1.35 73.78 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.817 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 38.9 m -133.64 121.68 22.36 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.874 0.369 . . . . 0.0 111.136 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -88.63 120.59 30.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.647 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.994 HG11 HG13 ' A' ' 130' ' ' VAL . 34.7 t -63.3 136.22 26.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.21 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 73.7 p -103.96 -176.51 3.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.789 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -77.51 -16.56 58.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.23 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -61.25 -112.59 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.488 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 66.0 m -109.15 133.97 52.32 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.912 0.386 . . . . 0.0 110.944 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.994 HG13 HG11 ' A' ' 125' ' ' VAL . 0.7 OUTLIER -89.37 -23.75 6.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.08 179.478 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -45.58 -26.66 0.63 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.404 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -57.97 -56.92 15.83 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.728 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.929 HD13 HG22 ' A' ' 125' ' ' VAL . 4.9 mp -73.73 -33.46 64.36 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.757 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -59.78 -56.48 21.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.586 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.7 tptp -60.51 -38.55 84.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.564 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.4 -32.62 73.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.863 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 3.4 mmt -70.38 -30.27 67.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.805 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -83.84 -28.73 27.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.901 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -98.0 -5.02 34.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.577 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.44 154.07 17.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.799 0.333 . . . . 0.0 110.856 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.05 99.14 2.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 145.92 -149.73 21.89 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.611 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 2.8 mmm -93.42 122.45 35.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.879 0.371 . . . . 0.0 111.001 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 57.2 mt -87.78 152.85 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.09 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.507 ' C ' HD13 ' A' ' 146' ' ' LEU . 67.5 p -139.26 113.7 9.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.236 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.507 HD13 ' C ' ' A' ' 145' ' ' SER . 0.5 OUTLIER -116.4 133.12 56.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.116 -179.418 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.68 105.54 17.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.947 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.761 HG21 HD11 ' A' ' 111' ' ' LEU . 2.7 t -117.92 158.2 18.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.809 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.409 HD11 HD22 ' A' ' 118' ' ' LEU . 31.4 mt -136.63 133.08 18.87 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.8 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.03 117.06 3.36 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.447 2.098 . . . . 0.0 112.325 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -65.72 143.5 57.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.956 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -144.83 77.58 1.54 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.902 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.879 -179.992 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.877 0.37 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.88 167.74 13.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.961 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 125' ' ' GLU . . . . . 0.443 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 0.6 OUTLIER -174.99 139.13 0.48 Allowed 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.788 179.634 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 126' ' ' TYR . . . . . 0.591 ' CE1' HG21 ' A' ' 130' ' ' VAL . 29.9 m-85 -129.41 133.22 47.24 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.131 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 127' ' ' CYS . . . . . 0.756 ' SG ' HD11 ' A' ' 100' ' ' LEU . 1.3 m -105.72 116.14 31.44 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.692 HD13 ' N ' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.283 -0.865 . . . . 0.0 111.356 -177.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.659 HG23 HG13 ' A' ' 149' ' ' ILE . 13.6 p . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 120.834 0.35 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -101.87 145.15 29.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.821 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.547 HD11 ' HB2' ' A' ' 145' ' ' SER . 10.7 tp -106.94 113.81 27.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.042 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.1 mm -89.31 130.11 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.861 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -119.12 123.43 44.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.962 0.411 . . . . 0.0 111.252 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.581 ' HE1' HD12 ' A' ' 144' ' ' ILE . 19.7 p90 -150.22 132.91 15.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.624 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 22.7 tt0 -83.38 138.04 33.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.349 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.471 ' HZ2' HD11 ' A' ' 144' ' ' ILE . 1.1 ttpm? -129.38 113.59 15.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.31 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.605 HG13 ' O ' ' A' ' 77' ' ' VAL . 0.3 OUTLIER -120.97 13.9 6.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.613 -179.562 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.07 148.57 31.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.756 0.312 . . . . 0.0 110.615 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -83.61 80.29 9.17 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.202 0.525 . . . . 0.0 110.011 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.81 163.25 5.57 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.175 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.5 148.66 92.97 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.507 2.138 . . . . 0.0 112.243 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.466 ' HG2' ' CE1' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -50.38 -41.58 52.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.224 -179.88 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 127.55 6.05 5.26 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.094 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.713 ' H ' HD13 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -127.12 165.1 26.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.814 0.34 . . . . 0.0 110.914 179.728 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.497 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -127.09 127.85 45.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.106 179.855 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.707 HD23 HD13 ' A' ' 117' ' ' ILE . 1.1 mp -130.63 158.43 40.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.816 0.341 . . . . 0.0 110.917 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.62 ' C ' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -138.69 162.89 33.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.179 -179.768 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.67 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -104.66 103.14 12.74 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.474 179.425 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -64.39 176.34 1.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.781 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -52.88 -26.43 14.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.861 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 43.8 tptt -82.54 -8.17 59.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.188 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 68.56 89.84 0.1 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.8 0.333 . . . . 0.0 110.634 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.531 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 0.2 OUTLIER -166.64 146.19 5.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.52 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.663 ' HB2' HD11 ' A' ' 120' ' ' ILE . 0.5 OUTLIER -87.8 111.95 21.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.931 0.396 . . . . 0.0 111.428 -179.474 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 115' ' ' ASP . 1.6 m -129.12 126.13 38.64 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.9 HG13 ' H ' ' A' ' 114' ' ' GLY . 3.4 p -58.8 105.99 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 121.312 0.577 . . . . 0.0 110.549 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -74.9 -22.02 58.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.443 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.407 ' HA ' HG23 ' A' ' 113' ' ' VAL . 3.3 ptt180 -171.22 131.63 0.78 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.075 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.835 ' CD1' HG21 ' A' ' 96' ' ' VAL . 27.3 mm -86.22 103.72 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.73 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.802 HD11 ' SG ' ' B' ' 127' ' ' CYS . 8.6 mt -60.49 131.38 50.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.042 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.433 ' HA ' ' CG ' ' A' ' 106' ' ' HIS . 2.9 p80 -75.52 146.23 40.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.909 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.21 -33.51 5.57 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.525 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.67 -179.93 1.88 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.49 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 48.9 ttp -79.72 -33.21 41.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.772 0.32 . . . . 0.0 110.87 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.693 HG13 HD12 ' A' ' 84' ' ' ILE . 23.1 mm -70.7 -33.93 54.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.997 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.433 ' CG ' ' HA ' ' A' ' 101' ' ' HIS . 46.1 t-80 -78.58 -51.9 9.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.787 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.4 tpm_? -61.09 -43.35 99.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.717 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -83.05 -46.68 12.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.769 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.02 51.35 2.1 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.553 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.64 -29.36 30.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.752 0.31 . . . . 0.0 110.865 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.715 HD21 HG21 ' A' ' 148' ' ' VAL . 46.5 mt -134.41 172.21 13.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.953 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -138.04 131.72 31.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.727 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.562 ' O ' HG13 ' A' ' 113' ' ' VAL . 8.3 p -43.72 112.78 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.595 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.9 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 116.14 -25.49 9.32 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.603 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.509 ' O ' HG23 ' A' ' 95' ' ' THR . 0.2 OUTLIER -47.16 142.35 3.83 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.714 0.292 . . . . 0.0 110.902 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.408 ' HA ' HG23 ' A' ' 95' ' ' THR . 0.2 OUTLIER -96.27 111.18 23.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.428 -179.542 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.707 HD13 HD23 ' A' ' 86' ' ' LEU . 4.4 mp -95.69 95.82 5.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.67 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.862 HD23 ' CD1' ' A' ' 149' ' ' ILE . 3.2 mm? -65.49 -26.04 67.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.572 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.36 145.54 30.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.926 0.393 . . . . 0.0 111.375 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.663 HD11 ' HB2' ' A' ' 94' ' ' CYS . 2.8 mp -126.14 98.79 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.639 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 60.63 28.37 18.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.524 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.51 16.48 52.5 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.578 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 58.9 m -133.65 128.61 35.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.894 0.378 . . . . 0.0 111.228 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -104.56 87.88 2.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.48 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.824 HG11 ' CD2' ' A' ' 133' ' ' LEU . 10.8 m -53.36 156.53 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.709 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 55.9 p -138.08 -172.08 3.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.743 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -55.02 -23.32 19.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.151 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -56.76 -167.69 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.806 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 m -67.55 134.03 50.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.068 0.461 . . . . 0.0 111.001 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.649 HG21 ' CE1' ' B' ' 126' ' ' TYR . 0.4 OUTLIER -89.47 -16.23 8.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.344 179.746 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -43.6 -26.71 0.24 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.467 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.67 -43.37 69.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.979 0.419 . . . . 0.0 110.426 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.824 ' CD2' HG11 ' A' ' 125' ' ' VAL . 0.2 OUTLIER -78.58 -30.5 46.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.546 179.678 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.417 ' HG3' ' CG2' ' B' ' 128' ' ' ILE . 7.4 tt0 -75.09 -54.14 7.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.999 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.6 tptt -60.7 -47.79 84.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.002 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.467 ' O ' HG22 ' A' ' 140' ' ' THR . . . -61.06 -42.47 98.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.223 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.46 ' HG3' HD12 ' A' ' 133' ' ' LEU . 27.4 mmt -69.3 -27.58 65.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.195 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -90.56 -25.94 19.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.271 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -93.46 -26.58 17.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.26 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 136' ' ' ALA . 6.4 t -59.41 153.34 19.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.89 0.376 . . . . 0.0 111.006 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 24.1 mttp -143.82 114.26 7.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.764 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 142.66 -155.41 25.78 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.429 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.503 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 8.6 ptm -86.85 114.29 23.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.932 0.396 . . . . 0.0 110.995 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.581 HD12 ' HE1' ' A' ' 74' ' ' PHE . 45.1 mt -87.38 141.22 14.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.327 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.547 ' HB2' HD11 ' A' ' 71' ' ' LEU . 54.0 p -124.64 113.59 18.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.31 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.701 HD22 ' N ' ' A' ' 146' ' ' LEU . 0.3 OUTLIER -115.63 143.43 45.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.994 -179.566 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.476 ' HD2' HD13 ' A' ' 71' ' ' LEU . 1.3 mptt -97.39 105.23 17.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.837 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.715 HG21 HD21 ' A' ' 111' ' ' LEU . 3.4 t -122.59 158.34 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.081 0.467 . . . . 0.0 111.891 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.862 ' CD1' HD23 ' A' ' 118' ' ' LEU . 2.3 mp -133.04 134.89 24.92 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.62 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -51.9 128.75 27.8 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.383 2.056 . . . . 0.0 112.443 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -129.09 117.49 20.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.927 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 -72.98 65.91 0.77 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.854 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.24 -0.885 . . . . 0.0 110.91 179.979 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 120.832 0.349 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.57 167.71 9.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.934 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 125' ' ' GLU . . . . . 0.441 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 13.2 pt-20 -153.08 134.75 14.5 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.148 0.499 . . . . 0.0 110.225 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 126' ' ' TYR . . . . . 0.649 ' CE1' HG21 ' A' ' 130' ' ' VAL . 31.3 m-85 -116.55 134.89 54.31 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.306 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 127' ' ' CYS . . . . . 0.802 ' SG ' HD11 ' A' ' 100' ' ' LEU . 2.0 m -106.02 115.87 30.97 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.648 HD13 ' N ' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.337 -177.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.596 ' O ' HG13 ' A' ' 69' ' ' VAL . 10.1 p . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 120.951 0.405 . . . . 0.0 111.055 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -109.39 144.61 37.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.835 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.63 HD12 ' HG2' ' A' ' 147' ' ' LYS . 2.3 tp -117.86 99.51 6.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.99 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.406 HG21 ' HB3' ' A' ' 110' ' ' SER . 26.2 mm -89.33 120.51 38.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.356 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 144' ' ' ILE . 1.4 mt-30 -120.72 125.44 47.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.075 0.464 . . . . 0.0 111.889 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.642 ' HE1' HD12 ' A' ' 144' ' ' ILE . 10.8 p90 -141.58 132.63 26.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.065 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 1.5 pt-20 -80.24 134.26 36.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.089 0.471 . . . . 0.0 111.519 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.18 123.79 32.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.271 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.605 HG13 ' O ' ' A' ' 77' ' ' VAL . 0.3 OUTLIER -140.14 15.67 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.581 -179.608 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -117.75 173.02 6.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.863 0.363 . . . . 0.0 110.831 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -97.9 81.01 2.81 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.317 0.58 . . . . 0.0 110.021 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -162.04 147.77 10.47 Favored Pre-proline 0 N--CA 1.446 -0.627 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.366 -178.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.87 160.83 48.12 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.562 2.174 . . . . 0.0 112.342 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.7 -49.0 78.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.969 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 115.86 16.48 6.83 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.748 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.612 ' O ' HD12 ' A' ' 84' ' ' ILE . 2.6 pp -128.82 162.02 36.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.73 0.3 . . . . 0.0 110.851 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.504 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -125.31 127.39 46.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.251 179.783 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.879 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -126.46 157.87 37.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.803 -179.642 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.591 ' C ' HD13 ' A' ' 88' ' ' LEU . 16.0 pttt -138.96 158.15 44.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.754 0.311 . . . . 0.0 111.407 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.635 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -106.35 106.1 16.46 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.592 179.586 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -64.22 176.21 1.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.905 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -53.09 -29.69 31.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.914 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.2 tptm -82.52 -4.8 58.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.174 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.408 ' HB3' ' HA ' ' A' ' 126' ' ' THR . 1.4 mt-30 69.11 87.09 0.12 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.818 0.342 . . . . 0.0 110.526 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 1.4 t -157.47 136.74 11.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.353 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.79 115.21 25.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.067 0.46 . . . . 0.0 111.598 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.63 HG23 ' O ' ' A' ' 115' ' ' ASP . 9.3 m -133.55 130.49 38.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.159 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.888 HG13 ' H ' ' A' ' 114' ' ' GLY . 3.7 p -59.9 105.97 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.271 0.558 . . . . 0.0 110.638 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -72.62 -24.32 61.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.192 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.418 ' HA ' HG23 ' A' ' 113' ' ' VAL . 11.2 ptt85 -172.2 131.82 0.63 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.09 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.877 ' CD1' HG21 ' A' ' 96' ' ' VAL . 29.3 mm -86.15 107.2 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.675 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.756 HD11 ' SG ' ' B' ' 127' ' ' CYS . 7.2 mt -61.29 135.79 57.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.958 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -81.28 130.31 34.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.989 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.3 -27.3 9.58 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.634 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.97 179.81 10.39 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.643 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 6.3 ptm -80.95 -30.36 35.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.868 0.366 . . . . 0.0 110.965 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.464 HG23 ' HB2' ' A' ' 110' ' ' SER . 37.6 mm -69.47 -34.99 64.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.959 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.419 ' ND1' HG22 ' A' ' 99' ' ' ILE . 2.7 t-160 -80.42 -41.11 25.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.74 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -73.17 -50.48 22.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.714 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -73.37 -44.33 58.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.86 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.24 75.87 1.31 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.502 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.464 ' HB2' HG23 ' A' ' 105' ' ' ILE . 1.1 m -111.76 -30.63 7.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.84 0.352 . . . . 0.0 111.082 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.789 HD21 HG11 ' A' ' 148' ' ' VAL . 1.1 mt -143.36 170.14 16.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.988 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -137.19 138.83 40.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.792 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.526 ' O ' HG13 ' A' ' 113' ' ' VAL . 7.6 p -44.99 114.23 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.633 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.888 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 119.19 -29.22 6.27 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.022 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.63 ' O ' HG23 ' A' ' 95' ' ' THR . 4.8 m-20 -50.65 134.93 24.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.713 0.292 . . . . 0.0 110.68 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.459 ' C ' HG23 ' A' ' 148' ' ' VAL . 7.4 pt-20 -92.25 108.8 20.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.942 0.401 . . . . 0.0 111.568 -179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.803 ' CD1' HD22 ' A' ' 86' ' ' LEU . 2.7 mp -86.9 99.31 8.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.718 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.422 ' N ' ' O ' ' A' ' 147' ' ' LYS . 4.0 mm? -52.06 -38.32 56.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.098 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -164.26 152.55 12.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.808 0.337 . . . . 0.0 111.374 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.862 HG23 HD12 ' A' ' 146' ' ' LEU . 26.8 mt -111.94 114.25 46.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.903 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 62.9 31.06 16.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.92 0.39 . . . . 0.0 110.659 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 83.38 19.57 62.05 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.596 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 19.3 m -133.63 111.61 10.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.832 0.348 . . . . 0.0 111.06 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -73.98 104.84 4.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.772 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.442 HG22 ' CD1' ' A' ' 133' ' ' LEU . 20.1 t -63.25 128.24 24.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.991 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.408 ' HA ' ' HB3' ' A' ' 92' ' ' GLN . 24.6 p -119.51 -170.48 1.95 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.863 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.01 -21.56 45.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.264 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 43.5 m80 -52.37 179.14 0.01 OUTLIER 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.802 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 45.6 m -63.97 133.89 54.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.009 0.433 . . . . 0.0 110.925 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.576 HG21 ' CE1' ' B' ' 126' ' ' TYR . 0.3 OUTLIER -89.56 -24.91 5.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.165 179.765 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.484 ' HA ' ' HG2' ' A' ' 134' ' ' GLN . 7.3 t70 -46.31 -26.01 0.74 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.599 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -70.24 -41.73 73.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.252 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.442 ' CD1' HG22 ' A' ' 125' ' ' VAL . 1.1 mt -74.02 -54.03 8.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.25 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.487 ' HB3' HG21 ' B' ' 128' ' ' ILE . 3.8 pt20 -55.85 -43.03 76.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.817 0.341 . . . . 0.0 111.061 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm -63.91 -40.76 97.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.645 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.547 ' O ' HG23 ' A' ' 140' ' ' THR . . . -76.13 -27.17 56.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.089 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.423 ' HE1' HG23 ' A' ' 144' ' ' ILE . 4.6 mmt -76.34 -27.94 56.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.6 mttm -82.06 -39.15 23.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.01 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -82.58 -16.11 49.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.403 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 136' ' ' ALA . 0.1 OUTLIER -59.29 131.39 50.84 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.879 0.371 . . . . 0.0 111.045 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -119.09 87.49 2.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.689 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 167.17 -150.32 16.9 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.541 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.482 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 1.0 OUTLIER -96.61 126.22 41.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.918 0.389 . . . . 0.0 111.183 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.707 ' CG2' HD11 ' A' ' 146' ' ' LEU . 59.2 mt -92.64 130.63 41.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.095 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.509 ' C ' HD13 ' A' ' 146' ' ' LEU . 5.4 m -116.93 116.79 28.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.409 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.862 HD12 HG23 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -117.76 142.98 46.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.261 -179.457 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.63 ' HG2' HD12 ' A' ' 71' ' ' LEU . 7.5 mttp -104.78 108.64 20.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.505 179.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.789 HG11 HD21 ' A' ' 111' ' ' LEU . 2.5 p -138.19 149.7 24.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.176 0.513 . . . . 0.0 111.863 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.415 ' CD1' ' HA ' ' A' ' 69' ' ' VAL . 6.3 mm -107.63 120.0 48.72 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.528 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.51 145.13 59.53 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.398 2.065 . . . . 0.0 112.359 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.52 122.36 21.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.835 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -130.19 104.85 7.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.002 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.902 179.947 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.752 0.31 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 2.0 tptt -121.67 167.8 12.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.915 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 125' ' ' GLU . . . . . 0.446 ' OE2' ' HB1' ' A' ' 97' ' ' ALA . 46.8 mt-10 -161.43 133.62 5.84 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.005 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 126' ' ' TYR . . . . . 0.576 ' CE1' HG21 ' A' ' 130' ' ' VAL . 38.0 m-85 -129.02 135.87 49.54 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.555 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 127' ' ' CYS . . . . . 0.756 ' SG ' HD11 ' A' ' 100' ' ' LEU . 1.7 m -106.05 116.04 31.25 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.632 HD13 ' N ' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.276 -0.868 . . . . 0.0 111.485 -177.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.553 ' O ' HG13 ' A' ' 69' ' ' VAL . 10.9 p . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.798 0.332 . . . . 0.0 111.066 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.56 138.07 39.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.766 HD12 ' HG2' ' A' ' 147' ' ' LYS . 2.8 tp -112.1 99.33 7.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.982 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.743 HD13 ' O ' ' A' ' 110' ' ' SER . 23.0 mt -94.44 149.27 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.424 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' A' ' 144' ' ' ILE . 10.4 mt-30 -145.92 135.39 23.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.036 0.446 . . . . 0.0 111.846 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.438 ' CZ ' HD23 ' A' ' 146' ' ' LEU . 2.4 p90 -145.52 130.89 18.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.204 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 3.7 tt0 -80.32 136.8 36.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.059 0.457 . . . . 0.0 111.617 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.13 116.41 19.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.29 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -96.28 -30.52 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.035 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.44 150.25 21.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.252 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -91.79 92.5 8.42 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.231 0.539 . . . . 0.0 110.61 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -163.54 159.77 17.72 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.027 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.52 136.47 40.83 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.573 2.182 . . . . 0.0 112.292 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.0 mpp? -58.34 -35.33 71.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.963 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 117.18 32.78 1.45 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.508 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.616 HD12 HD11 ' A' ' 86' ' ' LEU . 14.2 pt -151.27 158.71 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.778 0.323 . . . . 0.0 110.875 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.836 ' SG ' HD21 ' A' ' 100' ' ' LEU . 25.9 m -129.39 122.36 29.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.204 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.701 HD23 HD13 ' A' ' 117' ' ' ILE . 4.2 mp -116.38 159.62 21.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.955 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.508 ' HG2' ' HB2' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -135.62 148.25 48.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.335 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.796 HD23 ' NZ ' ' B' ' 124' ' ' LYS . 0.3 OUTLIER -81.73 107.23 14.3 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.407 179.285 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -64.2 176.11 1.11 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.898 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.31 -23.27 14.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.08 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.404 ' HD2' ' N ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -100.84 17.97 20.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.958 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 56.57 82.18 0.12 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.782 0.325 . . . . 0.0 110.471 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.548 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 1.2 m -151.04 142.42 23.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.484 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -87.67 111.2 21.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.01 0.433 . . . . 0.0 111.495 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.528 HG23 ' HA ' ' A' ' 116' ' ' GLU . 7.0 m -128.82 130.03 46.4 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.912 HG13 ' H ' ' A' ' 114' ' ' GLY . 3.7 p -58.7 105.7 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-O 121.355 0.598 . . . . 0.0 110.657 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.508 ' HB2' ' HG2' ' A' ' 87' ' ' LYS . . . -70.41 -26.65 63.78 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.955 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.507 ' HA ' HG23 ' A' ' 113' ' ' VAL . 33.2 ttt-85 -173.4 133.94 0.51 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.045 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.87 ' CD1' HG21 ' A' ' 96' ' ' VAL . 25.0 mm -86.07 143.04 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.577 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.836 HD21 ' SG ' ' A' ' 85' ' ' CYS . 0.5 OUTLIER -101.54 142.11 33.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.877 0.37 . . . . 0.0 110.956 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.434 ' HA ' ' CD2' ' A' ' 106' ' ' HIS . 43.7 m-70 -77.25 137.25 38.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.95 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.19 -24.95 26.53 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.539 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.16 161.31 11.23 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.49 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 11.8 tmm? -67.47 -22.71 65.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.705 0.288 . . . . 0.0 111.158 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.606 HG21 ' HB2' ' A' ' 111' ' ' LEU . 28.2 mm -84.93 -38.36 13.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.017 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.434 ' CD2' ' HA ' ' A' ' 101' ' ' HIS . 75.1 t60 -76.13 -39.88 54.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.538 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 7.8 tpp85 -71.28 -45.92 62.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.563 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -79.21 -42.74 25.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.663 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.82 72.0 1.21 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.531 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.755 ' O ' HD22 ' A' ' 111' ' ' LEU . 1.3 m -113.48 -29.4 7.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.758 0.313 . . . . 0.0 111.155 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.772 HD11 HG21 ' A' ' 148' ' ' VAL . 3.7 mm? -132.78 169.22 17.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.981 0.42 . . . . 0.0 111.113 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -143.02 132.28 23.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.572 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.584 ' O ' HG13 ' A' ' 113' ' ' VAL . 8.3 p -41.67 110.94 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.773 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.912 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 119.09 -31.45 5.47 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.915 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.488 ' O ' HG23 ' A' ' 95' ' ' THR . 7.7 m-20 -52.0 133.62 32.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.668 0.271 . . . . 0.0 110.548 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.528 ' HA ' HG23 ' A' ' 95' ' ' THR . 57.4 mt-10 -92.75 114.47 27.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.931 0.396 . . . . 0.0 111.735 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.701 HD13 HD23 ' A' ' 86' ' ' LEU . 3.2 mp -89.39 98.58 8.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.552 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.742 HD23 HG12 ' A' ' 149' ' ' ILE . 4.5 mm? -69.91 -24.38 63.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.579 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -142.79 139.04 30.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.99 0.424 . . . . 0.0 111.346 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.456 HD12 ' HA ' ' A' ' 124' ' ' ASN . 4.1 mp -124.28 98.66 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.727 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 62.79 28.68 16.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.714 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 96.78 -1.9 61.78 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.985 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 25.8 m -133.53 134.89 43.98 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.848 0.356 . . . . 0.0 111.158 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.456 ' HA ' HD12 ' A' ' 120' ' ' ILE . 11.6 t-20 -103.72 105.63 15.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.679 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 1.009 HG21 HG13 ' A' ' 130' ' ' VAL . 12.7 p -56.4 137.38 18.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.213 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.1 p -117.62 -173.3 2.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.691 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -52.35 -24.31 7.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.29 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 13.8 m170 -57.31 -166.82 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.813 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.9 m -69.45 134.29 48.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.903 0.382 . . . . 0.0 110.939 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 1.009 HG13 HG21 ' A' ' 125' ' ' VAL . 0.5 OUTLIER -89.11 -21.03 6.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.263 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -46.09 -26.43 0.75 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.278 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.47 -48.94 79.71 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.622 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.536 HD22 ' HB ' ' A' ' 125' ' ' VAL . 5.6 mp -79.47 -35.38 40.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.818 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -58.42 -49.4 77.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.71 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.9 tptm -68.96 -44.91 72.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.723 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.19 -30.96 71.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.01 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.401 ' HA ' ' HE2' ' A' ' 137' ' ' MET . 21.7 mmt -74.35 -31.85 62.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.896 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.6 mttp -83.8 -30.49 26.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.749 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -86.64 -17.03 34.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.229 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.28 145.03 44.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.844 0.354 . . . . 0.0 111.021 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -141.92 93.59 2.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.669 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 151.53 -149.41 21.17 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.626 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.448 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 72.9 mtp -87.83 119.85 28.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.85 0.357 . . . . 0.0 111.333 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.446 HG22 ' CD2' ' A' ' 146' ' ' LEU . 46.2 mt -97.43 130.99 45.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.995 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.6 m -108.99 114.32 27.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.506 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.661 HD22 ' N ' ' A' ' 146' ' ' LEU . 0.7 OUTLIER -116.57 130.58 56.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.929 -179.577 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.766 ' HG2' HD12 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -96.47 119.09 34.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.241 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.772 HG21 HD11 ' A' ' 111' ' ' LEU . 1.8 t -132.01 154.99 41.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.07 0.462 . . . . 0.0 111.843 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.742 HG12 HD23 ' A' ' 118' ' ' LEU . 18.2 mm -119.92 122.4 29.06 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.655 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.44 118.5 5.69 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.403 2.068 . . . . 0.0 112.439 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -107.95 138.2 44.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.855 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 11.6 mp0 -128.48 100.36 5.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.954 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.917 179.967 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.957 0.408 . . . . 0.0 111.067 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 124' ' ' LYS . . . . . 0.796 ' NZ ' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -108.55 162.06 14.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.005 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -144.32 131.64 20.81 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.298 0.57 . . . . 0.0 109.925 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 126' ' ' TYR . . . . . 0.596 ' CE1' HG21 ' A' ' 130' ' ' VAL . 18.6 m-85 -100.92 140.95 34.49 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.666 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 95.6 m -106.39 116.02 31.21 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.623 HD13 ' N ' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.453 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.485 ' O ' HG13 ' A' ' 69' ' ' VAL . 14.2 p . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.867 0.365 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.4 ttt-85 -112.5 156.18 23.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.836 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.9 tp -121.26 100.4 7.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.004 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.402 HG21 ' HB3' ' A' ' 110' ' ' SER . 3.3 mp -89.17 143.22 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.511 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -133.0 131.77 41.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.072 0.463 . . . . 0.0 111.838 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.476 ' CE2' HD23 ' A' ' 146' ' ' LEU . 6.9 p90 -146.69 137.42 23.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.096 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -80.35 139.72 36.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.964 0.411 . . . . 0.0 111.396 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.13 111.14 12.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.292 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -116.12 -22.9 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.573 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.48 151.47 21.36 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.954 0.407 . . . . 0.0 111.501 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -87.22 88.25 7.64 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.37 0.605 . . . . 0.0 110.462 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -167.38 152.95 7.2 Favored Pre-proline 0 N--CA 1.446 -0.641 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.985 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -56.47 142.51 89.33 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.522 2.148 . . . . 0.0 112.119 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -55.01 -37.06 66.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.987 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.404 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 117.57 29.47 2.07 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.527 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.949 HD13 HD21 ' A' ' 86' ' ' LEU . 2.8 pp -145.4 164.59 11.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.684 0.278 . . . . 0.0 110.909 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.498 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -131.98 123.6 27.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.35 -0.386 . . . . 0.0 109.989 179.617 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.949 HD21 HD13 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -126.58 158.01 37.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.944 -179.373 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.602 ' C ' HD13 ' A' ' 88' ' ' LEU . 6.9 pttp -141.54 163.41 33.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.006 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.656 ' N ' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -103.75 103.09 12.94 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.68 179.706 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -68.07 176.75 2.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.626 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.57 -27.3 6.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.941 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -77.04 -15.18 59.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.255 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 71.11 88.57 0.1 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.896 0.379 . . . . 0.0 110.637 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.534 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 10.1 t -171.04 148.67 2.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.386 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.577 ' SG ' HD11 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -87.78 111.43 21.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.962 0.411 . . . . 0.0 111.39 -179.437 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.549 HG23 ' HA ' ' A' ' 116' ' ' GLU . 9.4 m -129.93 132.22 46.27 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.331 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.895 HG13 ' H ' ' A' ' 114' ' ' GLY . 2.2 p -58.67 106.09 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.326 0.584 . . . . 0.0 110.86 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -71.26 -24.56 62.19 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.981 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.448 ' HA ' HG23 ' A' ' 113' ' ' VAL . 7.6 ttt180 -171.44 138.72 1.2 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.031 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.483 HD13 HG21 ' A' ' 96' ' ' VAL . 19.8 mm -86.11 109.13 18.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.657 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.767 HD11 ' SG ' ' B' ' 127' ' ' CYS . 21.4 mt -62.78 146.57 52.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.105 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -80.93 129.59 34.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.17 4.35 81.44 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.806 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.404 ' HA3' ' HA3' ' A' ' 83' ' ' GLY . . . -76.17 160.3 51.1 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.494 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 40.5 ttp -59.72 -31.86 70.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.867 0.365 . . . . 0.0 110.819 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 29.5 mm -80.77 -31.85 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.828 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -77.93 -53.85 6.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.622 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -60.63 -46.13 91.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.605 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -77.88 -42.68 32.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.685 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.32 67.69 1.43 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.523 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.402 ' HB3' HG21 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -112.06 -20.47 11.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.631 0.253 . . . . 0.0 111.226 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 1.09 HD11 HG11 ' A' ' 148' ' ' VAL . 0.4 OUTLIER -141.4 171.06 14.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.876 0.37 . . . . 0.0 111.026 -179.825 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -139.46 142.0 37.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.795 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.468 ' O ' HG13 ' A' ' 113' ' ' VAL . 7.1 p -45.86 121.67 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.509 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.895 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 110.35 -21.75 23.66 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.583 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.844 ' HB3' HG21 ' A' ' 148' ' ' VAL . 0.4 OUTLIER -52.63 121.41 7.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.656 0.265 . . . . 0.0 110.544 179.762 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.803 ' C ' HG23 ' A' ' 148' ' ' VAL . 62.3 mt-10 -85.25 107.58 17.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.809 0.338 . . . . 0.0 111.447 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.494 HD13 HD13 ' A' ' 86' ' ' LEU . 2.8 mp -84.86 96.88 4.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.767 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.662 HD23 HD12 ' A' ' 149' ' ' ILE . 3.9 mm? -57.85 -29.84 65.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.171 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -154.28 145.32 22.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.902 0.382 . . . . 0.0 111.241 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.605 HG23 ' CD1' ' A' ' 146' ' ' LEU . 17.0 mt -116.77 102.6 13.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.664 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.87 25.43 10.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.737 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 95.73 24.78 14.68 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.541 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.4 m -133.57 123.05 24.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.849 0.357 . . . . 0.0 111.225 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.81 82.69 1.91 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.609 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.769 ' CB ' HD11 ' A' ' 133' ' ' LEU . 11.6 p -56.5 158.33 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.347 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.475 ' N ' HG22 ' A' ' 125' ' ' VAL . 1.4 p -136.88 -173.5 3.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.75 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -61.02 -15.37 31.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.493 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -58.87 -116.9 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.833 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 m -109.01 134.15 52.04 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.88 0.372 . . . . 0.0 111.143 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.836 HG21 ' CE1' ' B' ' 126' ' ' TYR . 0.6 OUTLIER -89.26 -20.68 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.984 179.53 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -45.55 -26.4 0.58 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.345 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -59.42 -40.31 86.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.55 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.769 HD11 ' CB ' ' A' ' 125' ' ' VAL . 0.6 OUTLIER -79.41 -51.54 9.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.546 179.598 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -49.74 -46.78 50.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.909 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -53.36 42.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.912 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.76 -64.26 1.01 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.537 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.451 ' HE2' HG21 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -46.0 -35.83 5.11 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.502 -179.784 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -80.52 -26.14 38.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.253 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -99.28 3.22 46.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.597 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.93 149.29 41.51 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.893 0.377 . . . . 0.0 110.83 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.91 89.45 1.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.821 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 161.35 -130.75 2.41 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.43 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 38.6 mmm -109.26 122.6 47.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.814 0.34 . . . . 0.0 110.901 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.534 HG22 ' CD2' ' A' ' 146' ' ' LEU . 46.9 mt -96.69 143.72 11.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.298 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 28.4 p -125.61 113.68 17.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.918 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.605 ' CD1' HG23 ' A' ' 120' ' ' ILE . 2.7 mm? -110.36 123.17 49.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.975 0.417 . . . . 0.0 111.587 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -98.06 105.25 17.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.484 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 1.09 HG11 HD11 ' A' ' 111' ' ' LEU . 2.9 p -135.16 143.22 37.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.033 0.444 . . . . 0.0 111.99 -178.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.662 HD12 HD23 ' A' ' 118' ' ' LEU . 4.6 mt -112.86 130.71 23.24 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.666 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 149' ' ' ILE . 31.2 Cg_exo -59.21 137.54 79.59 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.435 2.09 . . . . 0.0 112.075 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -134.83 23.86 3.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.159 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 173.35 132.96 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.84 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.854 179.891 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.965 0.412 . . . . 0.0 111.061 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.78 167.84 9.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.935 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 125' ' ' GLU . . . . . 0.43 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 1.8 mp0 -164.09 136.18 4.83 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.712 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 126' ' ' TYR . . . . . 0.836 ' CE1' HG21 ' A' ' 130' ' ' VAL . 34.4 m-85 -113.91 131.19 56.38 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.267 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 127' ' ' CYS . . . . . 0.767 ' SG ' HD11 ' A' ' 100' ' ' LEU . 1.8 m -105.83 116.07 31.31 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.659 HD13 ' N ' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.458 -177.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.57 ' O ' HG13 ' A' ' 69' ' ' VAL . 14.9 p . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.89 0.376 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -108.97 147.83 31.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.716 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.44 99.24 7.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.002 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.5 mm -91.16 110.37 22.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.307 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.421 ' HA ' ' O ' ' A' ' 144' ' ' ILE . 26.0 mt-30 -113.84 130.71 56.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.98 0.419 . . . . 0.0 111.889 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.552 ' HE1' HD12 ' A' ' 144' ' ' ILE . 4.5 p90 -142.4 146.33 34.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.067 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -80.25 143.49 33.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.992 0.425 . . . . 0.0 111.245 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.482 ' HD3' HD11 ' A' ' 144' ' ' ILE . 1.3 tttt -128.93 111.28 12.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.593 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -105.9 -30.14 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.162 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.59 146.66 23.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.151 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -99.29 96.3 7.64 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.637 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.401 ' CB ' ' CD ' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -174.65 178.09 0.57 Allowed Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.921 -179.135 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.401 ' CD ' ' CB ' ' A' ' 80' ' ' GLU . 51.9 Cg_exo -54.53 125.32 18.58 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.444 2.096 . . . . 0.0 112.327 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.417 ' HB3' ' OXT' ' B' ' 128' ' ' ILE . 26.4 ttm -47.13 -48.15 23.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.06 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.4 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 135.65 -7.88 4.25 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.495 -0.86 . . . . 0.0 113.031 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.51 HG23 ' HB ' ' A' ' 105' ' ' ILE . 17.8 pt -117.81 166.93 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.888 0.375 . . . . 0.0 111.254 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.495 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -129.31 124.28 33.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.711 179.594 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.957 HD12 HD11 ' B' ' 128' ' ' ILE . 0.3 OUTLIER -121.43 157.39 30.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.711 0.291 . . . . 0.0 111.158 -179.294 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.801 ' HG2' ' HB2' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -140.37 160.54 39.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.328 179.923 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.609 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.4 OUTLIER -90.43 103.12 15.84 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.47 179.454 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -64.3 176.51 1.04 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.784 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -51.31 -23.77 3.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.046 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.28 15.48 20.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.273 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.0 mp0 50.17 81.59 0.06 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.776 0.322 . . . . 0.0 110.798 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.565 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 0.3 OUTLIER -153.6 155.37 35.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.774 -179.737 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.448 ' CB ' HD11 ' A' ' 120' ' ' ILE . 0.5 OUTLIER -87.85 111.49 21.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.946 0.403 . . . . 0.0 111.088 -179.624 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 115' ' ' ASP . 1.9 m -133.22 127.87 34.67 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.875 HG13 ' H ' ' A' ' 114' ' ' GLY . 3.9 p -58.68 106.02 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.411 0.624 . . . . 0.0 110.56 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.801 ' HB2' ' HG2' ' A' ' 87' ' ' LYS . . . -73.24 -23.54 60.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.493 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.403 ' HA ' HG23 ' A' ' 113' ' ' VAL . 0.2 OUTLIER -172.16 134.02 0.71 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.124 179.891 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.873 HD13 HG21 ' A' ' 96' ' ' VAL . 29.1 mm -86.21 109.13 18.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.769 HD11 ' SG ' ' B' ' 127' ' ' CYS . 6.5 mt -65.74 143.57 57.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.035 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -78.39 133.24 37.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.933 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.43 45.7 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.676 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.4 ' HA3' ' HA3' ' A' ' 83' ' ' GLY . . . -56.95 164.1 6.18 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.679 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 6.6 tmm? -60.44 -43.36 96.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.82 0.343 . . . . 0.0 110.981 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.51 ' HB ' HG23 ' A' ' 84' ' ' ILE . 32.2 mm -67.94 -38.39 79.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.05 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -71.53 -44.7 64.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.661 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -69.56 -52.02 30.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.712 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -71.54 -52.16 19.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.624 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.98 105.82 1.86 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.579 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.06 -45.58 0.13 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.874 0.368 . . . . 0.0 110.958 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.654 HD11 HG11 ' A' ' 148' ' ' VAL . 1.5 mp -117.41 172.6 7.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.974 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -141.73 143.45 33.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.561 ' O ' HG13 ' A' ' 113' ' ' VAL . 7.1 p -44.31 112.01 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.631 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.875 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 115.84 -23.18 11.05 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.847 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.59 ' O ' HG23 ' A' ' 95' ' ' THR . 1.0 OUTLIER -47.87 140.73 6.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.633 0.254 . . . . 0.0 110.825 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -93.18 111.62 23.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.759 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.889 HD13 HD22 ' A' ' 86' ' ' LEU . 3.7 mp -99.25 109.03 23.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.513 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -71.22 -26.96 63.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.698 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.608 ' C ' HD12 ' A' ' 120' ' ' ILE . 3.4 mt-10 -154.05 156.85 38.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.059 0.456 . . . . 0.0 111.625 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.94 HD13 HG23 ' A' ' 125' ' ' VAL . 3.2 mp -129.54 100.84 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.387 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.424 ' OD1' HG23 ' A' ' 144' ' ' ILE . 1.8 m-20 67.02 24.25 9.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.612 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 95.89 8.5 58.03 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.832 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.2 m -133.75 127.33 32.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.805 0.336 . . . . 0.0 111.212 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -87.8 121.0 29.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.453 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.94 HG23 HD13 ' A' ' 120' ' ' ILE . 14.9 t -77.1 119.08 24.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.117 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.7 p -108.52 -167.06 1.18 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.906 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -67.58 -16.74 64.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.171 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -166.93 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.599 0.238 . . . . 0.0 110.441 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 21.4 t -68.7 133.53 48.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.942 0.401 . . . . 0.0 110.621 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.707 HG21 ' CE1' ' B' ' 126' ' ' TYR . 0.6 OUTLIER -89.6 -26.2 5.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.095 179.746 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -45.49 -27.76 0.79 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.309 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -51.49 68.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.593 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.617 HD22 HG22 ' A' ' 125' ' ' VAL . 2.0 mp -80.78 -29.68 36.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.752 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -63.32 -43.06 98.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.728 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.93 -41.41 51.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.823 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.6 -45.42 87.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.142 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.817 ' O ' HG22 ' A' ' 140' ' ' THR . 70.1 mmm -70.43 -30.32 67.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.999 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -76.5 -28.52 56.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.027 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.12 -0.27 26.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.424 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.817 HG22 ' O ' ' A' ' 137' ' ' MET . 12.3 t -60.97 153.69 24.45 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.818 0.342 . . . . 0.0 110.886 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.02 118.18 6.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.849 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 129.98 -153.12 19.91 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.585 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 18.3 mmm -85.34 113.52 21.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.77 0.319 . . . . 0.0 110.975 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.552 HD12 ' HE1' ' A' ' 74' ' ' PHE . 49.6 mt -85.26 148.19 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.11 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 48.8 p -128.3 115.24 17.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.399 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.534 ' CD2' HG22 ' A' ' 144' ' ' ILE . 2.3 mm? -117.71 131.86 56.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.25 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.95 105.42 17.44 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.654 HG11 HD11 ' A' ' 111' ' ' LEU . 5.3 p -139.05 157.86 28.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.101 0.477 . . . . 0.0 112.045 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.479 ' N ' HG22 ' A' ' 148' ' ' VAL . 2.9 mp -137.68 127.32 15.22 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.679 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 149' ' ' ILE . 34.7 Cg_exo -60.95 120.15 7.7 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.378 2.052 . . . . 0.0 112.241 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 55.85 -164.5 0.13 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.956 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -111.12 -144.93 0.39 Allowed 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.247 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.171 -0.918 . . . . 0.0 110.869 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.869 0.366 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 4.2 mmtp -103.85 167.59 9.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.953 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 125' ' ' GLU . . . . . 0.526 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 13.5 mt-10 -168.01 135.73 2.25 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.196 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 126' ' ' TYR . . . . . 0.707 ' CE1' HG21 ' A' ' 130' ' ' VAL . 37.9 m-85 -129.12 132.64 47.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.175 -179.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 127' ' ' CYS . . . . . 0.769 ' SG ' HD11 ' A' ' 100' ' ' LEU . 1.8 m -105.81 115.95 31.1 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.203 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.957 HD11 HD12 ' A' ' 86' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.289 -0.862 . . . . 0.0 111.24 -177.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.541 HG21 ' HD2' ' A' ' 147' ' ' LYS . 11.3 p . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.789 0.328 . . . . 0.0 111.013 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -96.68 132.88 41.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.962 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.446 HD23 ' OE1' ' A' ' 73' ' ' GLN . 5.0 tp -110.25 102.84 11.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.921 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 23.9 mm -89.26 120.5 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.774 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.446 ' OE1' HD23 ' A' ' 71' ' ' LEU . 25.7 mt-30 -119.37 123.23 43.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.426 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.745 ' HE1' HD12 ' A' ' 144' ' ' ILE . 18.4 p90 -152.18 135.56 15.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.556 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -80.33 139.9 36.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.253 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -129.21 111.21 12.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.25 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.591 HG13 ' O ' ' A' ' 77' ' ' VAL . 0.3 OUTLIER -131.42 12.95 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.47 -179.589 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.67 163.11 16.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.012 0.434 . . . . 0.0 111.327 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.95 79.52 6.58 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.285 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.36 126.89 0.95 Allowed Pre-proline 0 N--CA 1.445 -0.684 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.275 -178.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.44 166.76 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.574 2.182 . . . . 0.0 112.411 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 21.9 ttm -58.83 -51.27 70.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.415 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 121.79 21.55 2.91 Favored Glycine 0 CA--C 1.517 0.163 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.808 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.428 HG21 HG21 ' A' ' 105' ' ' ILE . 15.7 pt -137.48 166.4 24.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.657 0.265 . . . . 0.0 110.639 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.485 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -130.67 124.94 32.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.582 179.798 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.581 ' CD2' HD13 ' A' ' 117' ' ' ILE . 0.4 OUTLIER -129.22 155.99 44.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.025 -179.564 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.407 ' O ' ' O ' ' A' ' 93' ' ' SER . 0.1 OUTLIER -134.63 166.83 22.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.119 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.706 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -102.12 106.36 17.21 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.224 179.598 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.408 ' HB2' ' HD2' ' A' ' 91' ' ' LYS . 1.4 m120 -64.22 176.36 1.05 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.809 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -51.19 -23.19 3.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.322 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.408 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -97.1 15.69 21.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.367 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.473 ' HB3' ' HA ' ' A' ' 126' ' ' THR . 1.0 OUTLIER 54.37 75.56 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.723 0.296 . . . . 0.0 110.68 179.925 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 78.8 p -143.93 133.05 22.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.712 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.556 ' SG ' HD11 ' A' ' 120' ' ' ILE . 10.9 p -87.63 112.18 22.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.058 0.456 . . . . 0.0 111.459 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.798 HG23 ' O ' ' A' ' 115' ' ' ASP . 23.9 m -133.57 134.61 43.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.419 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.893 HG13 ' H ' ' A' ' 114' ' ' GLY . 2.1 p -58.93 106.21 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.71 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -71.47 -25.33 62.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.862 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.533 ' HA ' HG23 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -173.52 131.03 0.45 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.563 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.552 HD11 ' HA ' ' A' ' 112' ' ' HIS . 39.3 mt -85.92 138.26 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.453 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.658 HD22 ' N ' ' A' ' 100' ' ' LEU . 0.9 OUTLIER -97.8 142.24 29.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.85 0.357 . . . . 0.0 111.069 -179.715 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.05 143.54 43.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.87 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.54 -29.01 11.0 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.359 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.415 ' HA3' ' HA3' ' A' ' 83' ' ' GLY . . . -61.5 160.76 27.9 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.424 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.43 ' SD ' HD13 ' A' ' 105' ' ' ILE . 2.3 ppp? -65.47 -31.3 72.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.773 0.321 . . . . 0.0 110.826 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.43 HD13 ' SD ' ' A' ' 104' ' ' MET . 44.2 mm -71.9 -36.07 56.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.948 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -80.48 -47.16 14.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.622 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -64.35 -46.72 82.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.664 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -79.76 -41.79 25.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.682 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 85.17 70.67 1.33 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.418 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.3 m -109.12 -26.79 9.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.774 0.321 . . . . 0.0 111.027 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.84 ' CD2' HG11 ' A' ' 148' ' ' VAL . 6.2 mt -134.39 168.2 19.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.066 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.552 ' HA ' HD11 ' A' ' 99' ' ' ILE . 76.9 m80 -133.07 136.73 46.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.65 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.533 HG23 ' HA ' ' A' ' 98' ' ' ARG . 7.5 p -46.02 115.75 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.292 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.893 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 112.22 -18.83 23.13 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.725 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.798 ' O ' HG23 ' A' ' 95' ' ' THR . 0.2 OUTLIER -55.51 132.38 48.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.694 0.247 . . . . 0.0 110.539 179.79 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -89.78 113.13 24.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.86 0.362 . . . . 0.0 111.483 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.641 HG21 HG12 ' A' ' 120' ' ' ILE . 3.4 mp -87.21 99.79 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.734 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -57.21 -29.44 63.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.125 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -160.55 143.16 13.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.18 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.641 HG12 HG21 ' A' ' 117' ' ' ILE . 17.6 mt -112.56 104.62 17.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.888 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 58.99 30.56 20.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.893 0.378 . . . . 0.0 110.556 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 87.65 13.14 65.6 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.581 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.6 m -133.62 117.14 16.69 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.764 0.316 . . . . 0.0 111.137 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -94.98 84.44 4.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.539 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.992 HG21 HG13 ' A' ' 130' ' ' VAL . 9.2 p -47.11 142.87 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.254 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.473 ' HA ' ' HB3' ' A' ' 92' ' ' GLN . 10.1 p -119.0 -173.42 2.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.868 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 27.9 p30 -51.75 -25.77 8.18 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.202 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.09 -171.61 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.765 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 10.0 m -65.4 134.44 53.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.91 0.386 . . . . 0.0 111.127 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.992 HG13 HG21 ' A' ' 125' ' ' VAL . 0.8 OUTLIER -88.82 -16.36 8.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.15 179.612 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -45.18 -25.92 0.42 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.348 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.23 -52.34 62.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.508 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.489 HD13 ' HB ' ' A' ' 125' ' ' VAL . 6.2 mp -76.87 -33.35 57.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.624 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 11.1 tp60 -64.0 -51.07 65.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.566 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.85 -40.64 97.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.749 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.77 -40.71 79.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.058 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.701 ' O ' HG22 ' A' ' 140' ' ' THR . 12.4 mmt -65.8 -33.28 75.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.832 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.15 -37.01 58.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -99.65 10.13 41.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.276 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.701 HG22 ' O ' ' A' ' 137' ' ' MET . 10.9 t -61.32 156.93 17.66 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.778 0.323 . . . . 0.0 110.996 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -154.1 110.29 3.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.016 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 129.21 -158.78 22.17 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.67 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 17.4 mtp -85.24 116.18 23.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.916 0.389 . . . . 0.0 110.937 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.745 HD12 ' HE1' ' A' ' 74' ' ' PHE . 32.1 mt -87.1 130.13 37.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.257 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.1 m -112.44 113.66 25.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.254 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.646 HD22 ' N ' ' A' ' 146' ' ' LEU . 0.5 OUTLIER -116.53 129.85 56.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.405 -179.412 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.541 ' HD2' HG21 ' A' ' 69' ' ' VAL . 0.6 OUTLIER -95.82 107.41 19.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.014 179.307 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.84 HG11 ' CD2' ' A' ' 111' ' ' LEU . 2.3 t -124.92 157.88 33.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.013 0.435 . . . . 0.0 111.805 -178.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 31.1 mt -137.21 118.82 11.04 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.745 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -57.21 135.59 71.28 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.489 2.126 . . . . 0.0 112.523 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -154.96 110.73 3.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.93 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -146.46 96.6 2.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.856 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.975 179.924 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 16.7 mtp180 . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.805 0.336 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.29 160.77 24.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.962 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 125' ' ' GLU . . . . . 0.405 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 4.7 pm0 -158.69 136.55 10.43 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.009 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 126' ' ' TYR . . . . . 0.63 ' CE1' HG21 ' A' ' 130' ' ' VAL . 34.4 m-85 -117.35 132.52 56.58 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.165 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 2.0 m -105.74 116.12 31.4 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.705 HD13 ' N ' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.43 -177.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.58 ' O ' HG13 ' A' ' 69' ' ' VAL . 10.3 p . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.843 0.354 . . . . 0.0 111.074 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -123.95 119.82 30.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.821 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.7 tp -87.44 99.3 11.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.026 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 37.1 mt -109.11 133.51 54.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.342 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 144' ' ' ILE . 0.0 OUTLIER -132.36 126.51 33.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.946 0.403 . . . . 0.0 111.689 -179.436 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.648 ' HE1' HD12 ' A' ' 144' ' ' ILE . 4.5 p90 -117.74 144.06 45.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.324 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -80.27 137.32 36.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.884 0.373 . . . . 0.0 111.333 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -129.2 111.24 12.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.368 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.586 HG13 ' O ' ' A' ' 77' ' ' VAL . 0.3 OUTLIER -124.71 10.85 4.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.562 -179.545 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.6 152.7 38.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.879 0.371 . . . . 0.0 111.291 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -93.59 87.47 5.52 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.435 0.636 . . . . 0.0 110.374 179.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.438 ' HG2' ' HD2' ' A' ' 81' ' ' PRO . 0.3 OUTLIER -171.22 164.07 4.99 Favored Pre-proline 0 N--CA 1.448 -0.573 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.666 -178.829 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.438 ' HD2' ' HG2' ' A' ' 80' ' ' GLU . 25.0 Cg_endo -61.85 141.82 91.25 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.411 2.074 . . . . 0.0 112.071 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -54.11 -40.67 67.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.96 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.467 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 117.22 15.05 6.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.89 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.9 pt -128.74 163.98 32.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.789 0.328 . . . . 0.0 110.743 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.491 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -129.98 124.96 34.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.062 179.634 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.634 ' CD2' HD13 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -135.9 159.35 41.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.137 -179.293 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.555 ' C ' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -140.51 166.95 23.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.281 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.692 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -100.34 102.96 14.33 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.064 179.635 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -64.16 176.39 1.03 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.877 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -51.73 -26.26 9.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.883 0.373 . . . . 0.0 110.766 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.99 4.33 38.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.454 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.414 ' HB3' ' HA ' ' A' ' 126' ' ' THR . 10.4 mt-30 59.48 77.04 0.33 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.803 0.335 . . . . 0.0 110.363 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.528 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 67.1 m -155.91 138.71 15.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.664 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.599 ' SG ' HD11 ' A' ' 120' ' ' ILE . 8.8 p -87.91 114.98 25.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.149 0.5 . . . . 0.0 111.676 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.736 HG23 ' O ' ' A' ' 115' ' ' ASP . 28.1 m -130.51 135.16 47.66 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.253 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.902 HG13 ' H ' ' A' ' 114' ' ' GLY . 4.0 p -60.69 106.13 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.244 0.545 . . . . 0.0 110.955 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -74.29 -24.39 59.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.22 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.44 ' HA ' HG23 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -169.7 132.61 1.19 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.997 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.836 ' CD1' HG21 ' A' ' 96' ' ' VAL . 24.3 mm -86.24 110.26 19.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.468 HD11 ' SG ' ' B' ' 127' ' ' CYS . 10.9 mp -70.21 133.23 46.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.918 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 51.7 m80 -69.77 142.17 53.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.842 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.75 -24.28 28.85 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.591 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.467 ' HA3' ' HA3' ' A' ' 83' ' ' GLY . . . -63.39 162.02 33.66 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.641 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.1 ptm -64.97 -37.27 87.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.784 0.326 . . . . 0.0 110.64 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 35.9 mm -67.56 -29.85 46.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.825 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.495 ' CD2' HG22 ' A' ' 99' ' ' ILE . 3.9 t-80 -85.83 -43.06 13.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.627 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.28 -46.94 68.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.607 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -80.98 -45.34 16.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.725 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.38 73.58 1.26 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.643 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.9 t -111.34 -29.42 7.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.811 0.339 . . . . 0.0 110.967 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.798 HD11 HG21 ' A' ' 148' ' ' VAL . 1.1 tp -136.37 169.01 18.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.865 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -137.56 139.88 40.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.571 ' O ' HG13 ' A' ' 113' ' ' VAL . 7.6 p -44.08 111.38 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.638 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.902 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 119.06 -24.96 8.06 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.607 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.736 ' O ' HG23 ' A' ' 95' ' ' THR . 1.0 OUTLIER -54.71 131.55 43.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.719 0.295 . . . . 0.0 110.68 179.835 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -90.16 121.47 32.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.668 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.634 HD13 ' CD2' ' A' ' 86' ' ' LEU . 4.4 mp -98.18 95.39 4.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.465 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 8.9 mp -56.94 -27.76 61.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.493 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -156.53 153.44 28.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.051 0.453 . . . . 0.0 111.453 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.802 HD12 HD13 ' A' ' 133' ' ' LEU . 36.2 mt -124.96 101.28 8.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.651 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.479 ' ND2' HG23 ' A' ' 144' ' ' ILE . 5.7 t-20 65.25 16.47 10.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.969 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.54 10.81 26.45 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.063 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.68 HG22 ' O ' ' A' ' 120' ' ' ILE . 5.9 t -129.64 124.3 33.35 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.952 0.406 . . . . 0.0 111.371 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -96.76 75.76 2.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.242 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.889 ' HB ' HD11 ' A' ' 133' ' ' LEU . 10.7 p -44.71 143.49 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.723 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.414 ' HA ' ' HB3' ' A' ' 92' ' ' GLN . 39.3 p -120.04 -171.1 2.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.824 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -48.68 -26.31 2.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.422 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -52.24 -179.02 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.926 0.393 . . . . 0.0 111.07 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.85 134.77 57.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.216 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.617 HG22 HD21 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -88.74 -16.42 8.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.071 179.584 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -48.05 -25.18 1.31 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.031 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -58.73 -45.72 88.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.615 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.889 HD11 ' HB ' ' A' ' 125' ' ' VAL . 8.4 mt -73.0 -35.26 66.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.285 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.7 -45.91 87.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.752 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.423 ' HG3' ' N ' ' A' ' 136' ' ' ALA . 0.0 OUTLIER -70.36 -30.18 67.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.992 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.481 ' O ' HG22 ' A' ' 140' ' ' THR . . . -79.59 -35.56 39.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.22 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.65 -30.51 67.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.951 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -85.08 -30.04 24.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.09 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -86.81 -34.69 19.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.105 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.481 HG22 ' O ' ' A' ' 136' ' ' ALA . 9.1 t -59.65 146.57 40.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.966 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.03 106.91 4.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.73 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 150.23 -146.77 16.23 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.55 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 4.0 mtp -94.27 118.31 31.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.851 0.358 . . . . 0.0 111.021 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.648 HD12 ' HE1' ' A' ' 74' ' ' PHE . 29.1 mt -89.9 139.03 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.056 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 84.4 p -116.5 113.61 23.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.289 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.576 ' CD1' HG22 ' A' ' 144' ' ' ILE . 6.9 mp -112.19 134.05 53.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.947 0.403 . . . . 0.0 111.417 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -95.85 105.4 17.41 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.54 179.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.798 HG21 HD11 ' A' ' 111' ' ' LEU . 2.6 t -124.72 158.32 32.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.199 0.523 . . . . 0.0 112.094 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 24.1 mt -133.33 135.62 25.73 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.701 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.63 126.27 13.2 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.403 2.068 . . . . 0.0 112.352 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -61.37 99.82 0.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.838 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -106.79 -146.42 0.39 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.275 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.238 -0.886 . . . . 0.0 110.859 179.925 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 9.2 ttp180 . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.778 0.323 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 124' ' ' LYS . . . . . 0.439 ' HD3' ' CE1' ' B' ' 126' ' ' TYR . 0.5 OUTLIER -98.57 167.96 10.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.926 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 125' ' ' GLU . . . . . 0.489 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 3.6 pt-20 -156.01 135.75 12.59 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.171 0.51 . . . . 0.0 110.345 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 126' ' ' TYR . . . . . 0.462 ' CD1' HG21 ' A' ' 130' ' ' VAL . 32.1 m-85 -115.31 133.14 56.31 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.037 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 127' ' ' CYS . . . . . 0.468 ' SG ' HD11 ' A' ' 100' ' ' LEU . 1.4 m -105.83 116.08 31.33 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.651 HD13 ' N ' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.409 -177.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.56 ' O ' HG13 ' A' ' 69' ' ' VAL . 14.9 p . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.9 0.381 . . . . 0.0 111.264 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.2 ptp85 -120.21 144.85 47.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.783 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.7 tp -92.9 99.08 11.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.959 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 37.2 mt -91.63 145.94 6.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.223 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -143.56 126.36 16.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.014 0.435 . . . . 0.0 111.618 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.536 ' CZ ' HD22 ' A' ' 146' ' ' LEU . 3.9 p90 -117.72 133.33 56.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.96 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 10.8 pm0 -80.14 134.14 36.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.941 0.4 . . . . 0.0 111.392 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.09 111.31 12.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.586 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -96.99 -34.11 4.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.065 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.52 155.51 18.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.177 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.15 93.14 7.16 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.266 0.555 . . . . 0.0 110.59 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -167.36 164.75 9.28 Favored Pre-proline 0 N--CA 1.449 -0.52 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.028 -179.034 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -52.01 141.16 47.89 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.584 2.19 . . . . 0.0 112.288 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.96 -56.14 24.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.866 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 147.64 -17.29 1.44 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.982 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.795 HG22 HG23 ' A' ' 99' ' ' ILE . 6.0 pt -115.98 170.59 5.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.77 0.319 . . . . 0.0 111.188 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.73 ' SG ' HD21 ' A' ' 100' ' ' LEU . 5.0 m -131.79 133.61 44.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.362 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.842 ' CD2' HD13 ' A' ' 117' ' ' ILE . 0.5 OUTLIER -127.96 159.48 34.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.327 -179.228 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.531 ' C ' HD13 ' A' ' 88' ' ' LEU . 7.5 pttm -133.02 160.85 35.95 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.954 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.668 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -99.66 104.71 16.49 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.389 179.559 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -64.3 176.19 1.12 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.942 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -53.68 -22.75 9.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.227 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.407 ' CD ' ' N ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -95.61 16.3 17.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.945 179.818 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 51.9 85.98 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.737 0.303 . . . . 0.0 110.7 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 1.1 m -159.3 134.13 8.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.437 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.544 ' SG ' HD11 ' A' ' 120' ' ' ILE . 28.0 p -87.72 115.51 25.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.136 0.493 . . . . 0.0 111.438 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.698 HG23 ' O ' ' A' ' 115' ' ' ASP . 5.8 m -130.04 130.91 45.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.487 -0.779 . . . . 0.0 108.922 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.882 HG13 ' H ' ' A' ' 114' ' ' GLY . 2.0 p -58.51 105.92 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.629 -178.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -70.57 -25.37 63.05 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.799 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.505 ' HA ' HG23 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -173.44 131.29 0.46 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.974 179.835 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.795 HG23 HG22 ' A' ' 84' ' ' ILE . 37.3 mt -85.97 128.44 39.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.167 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.73 HD21 ' SG ' ' A' ' 85' ' ' CYS . 3.9 mt -89.55 146.34 24.65 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.905 0.383 . . . . 0.0 111.228 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -79.72 146.67 32.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.809 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.97 -33.64 5.44 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.387 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.61 171.87 4.15 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.549 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 1.8 tmm? -73.53 -28.55 61.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.758 0.313 . . . . 0.0 111.034 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.6 mm -74.59 -37.15 43.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.124 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -78.45 -49.69 13.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.621 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.91 -44.19 97.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.592 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -82.26 -47.08 12.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.557 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.83 69.92 1.35 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.476 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.483 ' C ' HD22 ' A' ' 111' ' ' LEU . 1.3 p -108.77 -29.22 8.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.833 0.349 . . . . 0.0 110.918 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.635 HD11 HG21 ' A' ' 148' ' ' VAL . 3.8 mm? -123.94 172.56 8.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.948 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.519 ' CA ' HD11 ' A' ' 99' ' ' ILE . 10.3 m80 -135.09 137.89 43.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.79 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.505 HG23 ' HA ' ' A' ' 98' ' ' ARG . 7.5 p -49.75 118.99 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.117 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.882 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 107.77 -20.13 32.15 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.826 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.698 ' O ' HG23 ' A' ' 95' ' ' THR . 26.9 m-20 -50.32 138.14 17.27 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.675 0.274 . . . . 0.0 110.684 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -90.01 110.48 21.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.717 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.842 HD13 ' CD2' ' A' ' 86' ' ' LEU . 5.3 mp -94.72 94.39 4.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.314 179.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.407 HD23 ' CD1' ' A' ' 149' ' ' ILE . 3.4 mm? -54.36 -40.32 68.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.887 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -142.12 164.17 30.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.095 0.474 . . . . 0.0 111.66 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.712 ' CD1' HG23 ' A' ' 125' ' ' VAL . 1.1 mp -131.48 99.12 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.352 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 69.14 17.61 8.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.917 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.58 -0.32 34.55 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.747 -0.739 . . . . 0.0 113.107 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.648 ' O ' HD12 ' A' ' 120' ' ' ILE . 5.5 t -132.58 134.56 45.09 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 117.0 0.4 . . . . 0.0 111.449 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -96.05 122.69 39.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.514 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.801 HG11 HG13 ' A' ' 130' ' ' VAL . 20.7 t -58.48 155.03 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.375 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.421 ' N ' HG12 ' A' ' 125' ' ' VAL . 74.1 p -119.11 171.04 8.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.696 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.35 -21.12 62.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.196 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -59.4 -107.22 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.762 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.3 t -109.07 134.32 51.84 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.884 0.374 . . . . 0.0 111.242 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.801 HG13 HG11 ' A' ' 125' ' ' VAL . 0.5 OUTLIER -89.16 -19.26 7.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.059 179.533 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.418 ' HA ' ' HB2' ' A' ' 134' ' ' GLN . 0.8 OUTLIER -46.1 -25.29 0.56 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.444 -179.584 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -54.24 -55.92 23.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.987 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.692 ' CD2' HG22 ' A' ' 125' ' ' VAL . 3.4 mm? -70.7 -41.88 71.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.796 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.461 ' HG2' HG21 ' B' ' 128' ' ' ILE . 3.9 mm-40 -50.3 -53.29 29.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.18 -32.6 73.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.709 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.427 ' O ' HG22 ' A' ' 140' ' ' THR . . . -73.19 -27.79 61.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.21 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -78.22 -32.25 49.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.912 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -87.57 -29.29 21.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.976 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -81.73 -30.58 32.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.958 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 136' ' ' ALA . 12.5 t -71.56 149.06 46.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.992 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 11.6 mttp -140.48 125.35 18.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.711 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 127.95 -136.7 9.33 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.336 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.429 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -100.04 137.06 39.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.86 0.362 . . . . 0.0 111.058 -179.867 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.564 HG22 HD13 ' A' ' 146' ' ' LEU . 35.7 mt -109.18 142.96 20.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.177 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 28.0 p -121.08 113.7 20.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.456 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.564 HD13 HG22 ' A' ' 144' ' ' ILE . 5.8 mp -112.74 142.68 45.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.339 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.71 108.52 20.83 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.471 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.635 HG21 HD11 ' A' ' 111' ' ' LEU . 2.7 t -125.05 158.33 33.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.267 0.556 . . . . 0.0 112.274 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.407 ' CD1' HD23 ' A' ' 118' ' ' LEU . 12.6 mt -132.32 115.98 15.17 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.426 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.7 120.32 7.9 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.428 2.085 . . . . 0.0 112.391 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -79.77 179.33 7.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.843 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -150.61 102.67 3.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.029 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.873 179.956 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 1.8 mmt85 . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.858 0.361 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 124' ' ' LYS . . . . . 0.539 ' HD2' HD22 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -106.33 160.47 15.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.933 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 125' ' ' GLU . . . . . 0.463 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 8.6 pt-20 -158.07 135.96 10.63 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.202 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 126' ' ' TYR . . . . . 0.602 ' CE1' HG21 ' A' ' 130' ' ' VAL . 16.8 m-85 -115.7 138.19 51.34 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.352 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 98.9 m -106.4 116.11 31.36 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.84 HD11 HD12 ' A' ' 86' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.45 -177.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.643 ' O ' HG13 ' A' ' 69' ' ' VAL . 7.2 p . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.916 0.389 . . . . 0.0 110.988 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -95.52 152.61 18.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.864 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.43 99.77 4.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.999 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.479 HG22 ' N ' ' A' ' 73' ' ' GLN . 4.0 mp -89.32 159.18 2.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.648 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.479 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -146.21 124.69 12.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.011 0.434 . . . . 0.0 111.634 -179.656 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.601 ' CZ ' HD23 ' A' ' 146' ' ' LEU . 0.9 OUTLIER -142.47 130.49 21.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.331 179.078 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 10.5 tt0 -80.21 140.85 36.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.646 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 15.8 tttm -129.2 115.86 18.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.305 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -105.73 -26.54 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.329 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.53 149.09 22.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.282 -179.238 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -87.62 90.43 8.37 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.434 0.635 . . . . 0.0 110.56 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -161.97 157.14 19.98 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.836 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.07 142.61 99.54 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.441 2.094 . . . . 0.0 112.155 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -53.08 -42.42 65.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.045 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 127.58 -8.29 6.95 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.78 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.598 HG21 HG21 ' A' ' 105' ' ' ILE . 43.2 pt -113.5 168.84 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.854 0.359 . . . . 0.0 111.052 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.71 ' SG ' HD21 ' A' ' 100' ' ' LEU . 17.2 m -135.88 132.54 36.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.225 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.686 HD12 HD11 ' B' ' 128' ' ' ILE . 0.2 OUTLIER -133.8 159.65 39.96 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.272 -179.071 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.654 ' C ' HD13 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -135.99 162.4 32.99 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.982 179.831 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.677 ' N ' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -105.89 103.26 12.71 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.511 179.694 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.2 m-20 -64.13 176.42 1.01 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.709 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -51.42 -24.34 4.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.108 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.11 9.32 25.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.516 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 54.36 79.55 0.14 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.768 0.318 . . . . 0.0 110.649 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 11.2 m -152.44 131.89 12.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.561 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.475 ' SG ' HD11 ' A' ' 120' ' ' ILE . 18.3 p -87.68 111.49 21.35 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.08 0.467 . . . . 0.0 111.255 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.703 HG23 ' O ' ' A' ' 115' ' ' ASP . 8.6 m -127.58 132.31 49.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.454 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.916 HG13 ' H ' ' A' ' 114' ' ' GLY . 3.9 p -58.72 106.22 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.195 0.521 . . . . 0.0 110.561 -179.244 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -73.77 -27.11 60.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.354 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.429 ' HA ' HG23 ' A' ' 113' ' ' VAL . 6.9 ttp85 -165.77 129.34 2.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.852 0.358 . . . . 0.0 111.47 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.911 ' CD1' HG21 ' A' ' 96' ' ' VAL . 32.6 mm -87.65 103.76 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.439 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.71 HD21 ' SG ' ' A' ' 85' ' ' CYS . 5.5 mt -65.66 135.4 54.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.93 0.395 . . . . 0.0 111.05 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 22.7 m170 -73.07 140.25 47.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.808 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 103.97 -36.52 4.31 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.44 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -55.59 174.59 1.0 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.51 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.53 -29.42 52.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.793 0.33 . . . . 0.0 111.002 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.598 HG21 HG21 ' A' ' 84' ' ' ILE . 28.6 mm -69.03 -35.24 67.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.065 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -80.62 -50.63 9.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.707 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -60.22 -41.72 93.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.628 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.74 -43.82 12.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.672 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.73 51.43 2.67 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.517 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 m -87.64 -22.95 24.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.618 0.247 . . . . 0.0 111.051 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.423 HD23 ' HB2' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -145.84 165.2 29.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.805 0.336 . . . . 0.0 110.901 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -133.5 137.93 45.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.894 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.583 ' O ' HG13 ' A' ' 113' ' ' VAL . 7.5 p -46.74 111.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.714 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.916 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 117.41 -26.0 8.37 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.434 -0.888 . . . . 0.0 113.223 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.703 ' O ' HG23 ' A' ' 95' ' ' THR . 4.6 m-20 -54.13 138.61 37.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.905 0.352 . . . . 0.0 110.67 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.52 118.84 30.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.62 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.605 HD13 ' CD2' ' A' ' 86' ' ' LEU . 4.5 mp -93.43 99.18 9.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.629 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -56.96 -31.58 65.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.241 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -161.23 141.7 11.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.878 0.371 . . . . 0.0 111.349 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.587 HG23 HD12 ' A' ' 146' ' ' LEU . 28.2 mt -107.72 103.28 15.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.675 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 65.19 27.28 12.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.696 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 92.51 5.94 64.64 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.875 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.2 m -133.71 127.0 31.93 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.867 0.365 . . . . 0.0 111.221 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -94.89 120.82 35.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.598 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.635 HG11 HG13 ' A' ' 130' ' ' VAL . 17.9 t -54.53 149.48 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.357 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 58.6 p -119.16 161.5 20.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.771 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -61.59 -18.85 61.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.165 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -60.22 -111.98 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.723 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.09 134.29 51.88 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.921 0.391 . . . . 0.0 110.973 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.676 HG21 ' CE1' ' B' ' 126' ' ' TYR . 0.6 OUTLIER -89.06 -26.11 5.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.042 179.652 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -46.05 -27.44 0.94 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.452 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.55 ' HG3' HD12 ' A' ' 133' ' ' LEU . 9.7 pt20 -62.24 -48.71 78.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.673 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.635 HD13 HG22 ' A' ' 125' ' ' VAL . 1.8 mp -81.53 -35.89 29.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.801 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.403 ' HG3' ' CG2' ' B' ' 128' ' ' ILE . 2.6 tt0 -63.87 -46.09 86.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.529 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -68.05 -45.7 73.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.602 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -65.59 -38.16 88.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.911 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.772 ' O ' HG22 ' A' ' 140' ' ' THR . 2.0 mmt -65.55 -32.05 73.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -85.29 -28.17 25.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.958 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -91.45 -15.39 28.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.335 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.772 HG22 ' O ' ' A' ' 137' ' ' MET . 9.8 t -60.78 156.93 15.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.931 0.396 . . . . 0.0 111.056 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -146.26 117.25 7.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.639 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 134.81 -152.58 20.77 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.625 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.503 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 9.9 ptm -90.47 115.31 27.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.851 0.358 . . . . 0.0 111.29 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.557 HD13 ' HE2' ' A' ' 137' ' ' MET . 47.0 mt -87.83 130.14 38.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.063 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 14.6 m -111.9 113.68 26.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.255 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.642 HD22 ' N ' ' A' ' 146' ' ' LEU . 0.9 OUTLIER -112.53 133.93 54.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.063 0.459 . . . . 0.0 111.197 -179.489 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.37 105.3 17.43 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.528 ' HB ' HG13 ' A' ' 117' ' ' ILE . 2.8 p -133.35 156.45 41.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.149 0.5 . . . . 0.0 112.045 -178.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.437 ' N ' HG22 ' A' ' 148' ' ' VAL . 26.0 mt -122.71 119.05 28.24 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.62 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -57.18 147.5 75.67 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.543 2.162 . . . . 0.0 112.534 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 56.48 177.23 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.074 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -159.77 108.42 1.77 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.825 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.876 -179.952 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 23.2 mtm105 . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.73 0.3 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 124' ' ' LYS . . . . . 0.564 ' NZ ' HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -107.1 167.92 9.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.956 179.914 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 125' ' ' GLU . . . . . 0.46 ' HG2' ' HB3' ' A' ' 97' ' ' ALA . 4.4 mt-10 -164.73 139.98 5.54 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.481 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 126' ' ' TYR . . . . . 0.676 ' CE1' HG21 ' A' ' 130' ' ' VAL . 31.6 m-85 -117.81 132.33 56.46 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.324 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 91.4 m -106.01 116.01 31.2 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.686 HD11 HD12 ' A' ' 86' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.28 -0.867 . . . . 0.0 111.476 -177.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.629 HG21 ' HD3' ' A' ' 147' ' ' LYS . 10.9 p . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.85 0.357 . . . . 0.0 111.0 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -95.42 114.6 26.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.636 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.479 HD12 ' HG2' ' A' ' 147' ' ' LYS . 4.7 tp -92.17 102.5 15.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.118 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mt -89.22 152.13 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.638 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.436 ' NE2' HD23 ' A' ' 71' ' ' LEU . 9.6 mt-30 -140.8 123.2 15.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.005 0.431 . . . . 0.0 111.52 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.769 ' HE1' HD12 ' A' ' 144' ' ' ILE . 25.9 p90 -146.97 134.55 20.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.133 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 0.4 OUTLIER -80.27 143.47 33.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.071 0.462 . . . . 0.0 111.571 -179.094 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.11 111.23 12.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.159 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -109.72 -25.84 3.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.465 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.57 146.23 24.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.313 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.96 90.54 8.38 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.385 0.612 . . . . 0.0 110.421 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.409 ' CB ' ' HD2' ' A' ' 81' ' ' PRO . 2.3 mt-10 -168.43 174.47 2.18 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.673 -178.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.409 ' HD2' ' CB ' ' A' ' 80' ' ' GLU . 65.8 Cg_endo -74.93 142.75 28.46 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.347 2.031 . . . . 0.0 112.415 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -52.55 -58.06 7.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.033 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.492 ' O ' HG23 ' A' ' 84' ' ' ILE . . . 143.26 39.0 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.657 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.509 HG21 HG21 ' A' ' 105' ' ' ILE . 13.0 pt -157.88 170.08 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.719 0.295 . . . . 0.0 110.879 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' B' ' 126' ' ' TYR . 0.1 OUTLIER -135.48 113.56 11.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.48 179.704 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.754 ' HG ' HD11 ' B' ' 128' ' ' ILE . 0.1 OUTLIER -122.12 159.1 27.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.079 -179.159 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.479 ' HB3' ' HA ' ' B' ' 125' ' ' GLU . 0.0 OUTLIER -136.09 166.79 22.56 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.325 -179.69 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.691 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.1 OUTLIER -89.65 103.11 15.78 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.201 179.339 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.408 ' O ' ' N ' ' A' ' 92' ' ' GLN . 4.9 t30 -64.07 176.38 1.01 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.71 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.86 -27.41 3.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.946 0.403 . . . . 0.0 110.803 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.427 ' HD2' ' HB2' ' A' ' 93' ' ' SER . 0.1 OUTLIER -93.56 21.11 6.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.418 179.887 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 89' ' ' ASN . 45.5 mm-40 45.57 74.11 0.15 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.889 0.376 . . . . 0.0 110.666 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.579 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 5.5 m -148.28 147.8 29.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.654 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.63 ' HB3' HD12 ' A' ' 86' ' ' LEU . 1.4 m -87.8 114.18 24.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.119 0.485 . . . . 0.0 111.548 -179.296 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.613 HG23 ' HA ' ' A' ' 116' ' ' GLU . 2.7 m -130.1 126.63 38.03 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.319 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.898 HG13 ' H ' ' A' ' 114' ' ' GLY . 3.6 p -58.78 105.83 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.408 0.623 . . . . 0.0 110.597 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -74.4 -22.69 59.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.149 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 24.2 ttt180 -171.59 139.04 1.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.679 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.821 HD13 HG21 ' A' ' 96' ' ' VAL . 31.8 mm -86.11 121.0 36.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.9 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.484 HD21 ' SG ' ' B' ' 127' ' ' CYS . 4.6 mm? -74.23 143.33 45.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.038 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 16.0 p-80 -85.54 131.33 34.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.945 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.57 -27.9 16.25 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.48 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.28 176.05 8.23 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.516 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -80.48 -30.03 37.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.757 0.313 . . . . 0.0 110.941 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.509 HG21 HG21 ' A' ' 84' ' ' ILE . 42.9 mm -65.18 -36.73 78.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.989 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -81.46 -46.02 15.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.757 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -45.66 85.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.715 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -81.97 -43.84 17.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.755 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.39 63.13 1.31 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.503 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -101.1 -27.34 13.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.878 0.371 . . . . 0.0 111.106 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.723 ' CD2' HG11 ' A' ' 148' ' ' VAL . 10.3 mt -142.3 157.79 44.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.043 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 50.4 m170 -129.52 142.56 50.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.773 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.567 ' O ' HG13 ' A' ' 113' ' ' VAL . 8.2 p -43.83 113.75 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.654 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.898 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 119.07 -28.78 6.47 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.564 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.554 ' HB3' HG11 ' A' ' 148' ' ' VAL . 0.3 OUTLIER -47.06 126.12 8.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.667 0.27 . . . . 0.0 110.754 179.849 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.613 ' HA ' HG23 ' A' ' 95' ' ' THR . 3.0 mt-10 -89.0 111.36 22.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.868 0.366 . . . . 0.0 111.675 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.741 HG21 HD13 ' A' ' 120' ' ' ILE . 4.4 mp -91.2 98.1 8.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.663 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.608 HD23 HG12 ' A' ' 149' ' ' ILE . 4.3 mm? -60.97 -32.81 72.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.551 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -141.07 146.8 37.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.934 0.397 . . . . 0.0 111.687 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.741 HD13 HG21 ' A' ' 117' ' ' ILE . 14.9 mm -118.0 99.75 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.772 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.413 ' H ' HD13 ' A' ' 146' ' ' LEU . 6.5 t-20 62.19 27.87 16.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.743 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 94.98 2.58 62.46 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.866 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 21.9 m -133.55 131.52 39.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.813 0.339 . . . . 0.0 111.052 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -93.34 116.24 28.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.727 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.795 HG22 HD13 ' A' ' 133' ' ' LEU . 25.5 t -56.16 158.76 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.319 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.485 ' N ' HG12 ' A' ' 125' ' ' VAL . 10.9 p -137.5 -178.94 5.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.908 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -59.64 -25.41 64.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.954 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -54.96 -175.03 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.76 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.7 m -64.32 134.23 54.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.907 0.384 . . . . 0.0 110.885 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.48 ' CG2' ' CZ ' ' B' ' 126' ' ' TYR . 0.3 OUTLIER -88.95 -17.18 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.198 179.663 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.23 -25.94 0.7 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.285 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -65.21 -52.82 52.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.489 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.795 HD13 HG22 ' A' ' 125' ' ' VAL . 0.5 OUTLIER -75.23 -29.87 60.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.338 179.563 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -67.65 -45.58 74.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.507 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.1 pttp -68.98 -38.03 79.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.63 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.622 ' O ' HG23 ' A' ' 140' ' ' THR . . . -73.04 -38.46 66.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.016 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.478 ' HE2' HD13 ' A' ' 144' ' ' ILE . 5.9 mmt -67.47 -28.87 68.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.992 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -86.85 -34.88 19.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.07 10.05 42.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.324 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.622 HG23 ' O ' ' A' ' 136' ' ' ALA . 0.0 OUTLIER -67.37 129.96 41.56 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.813 0.34 . . . . 0.0 110.901 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.17 93.34 3.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.814 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 151.25 -157.15 27.05 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.594 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.409 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 11.5 mmm -90.15 123.13 33.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.848 0.356 . . . . 0.0 110.985 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.769 HD12 ' HE1' ' A' ' 74' ' ' PHE . 29.3 mt -92.79 131.48 39.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.215 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 59.5 m -112.79 113.53 25.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.056 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.654 HD22 ' N ' ' A' ' 146' ' ' LEU . 1.1 mm? -117.02 136.06 53.23 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.949 0.404 . . . . 0.0 111.456 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.629 ' HD3' HG21 ' A' ' 69' ' ' VAL . 7.3 mttm -100.32 105.96 17.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.649 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.723 HG11 ' CD2' ' A' ' 111' ' ' LEU . 4.8 t -123.94 153.58 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.168 0.509 . . . . 0.0 112.16 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.608 HG12 HD23 ' A' ' 118' ' ' LEU . 17.7 mm -117.28 122.43 31.1 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.442 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.56 126.0 13.53 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.526 2.151 . . . . 0.0 112.507 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -104.17 113.16 26.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.846 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 62.25 107.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.837 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.253 -0.879 . . . . 0.0 110.902 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.888 0.375 . . . . 0.0 111.162 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.88 167.66 21.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.025 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 125' ' ' GLU . . . . . 0.479 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 2.8 pt-20 -152.53 134.3 14.69 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.303 0.573 . . . . 0.0 110.25 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 126' ' ' TYR . . . . . 0.484 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 22.0 m-85 -113.02 136.94 52.14 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.174 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 127' ' ' CYS . . . . . 0.484 ' SG ' HD21 ' A' ' 100' ' ' LEU . 1.7 m -105.86 116.16 31.47 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.754 HD11 ' HG ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.399 -177.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.508 ' O ' HG13 ' A' ' 69' ' ' VAL . 11.8 p . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.805 0.335 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.38 122.19 45.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.912 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 tt -90.96 99.31 12.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.977 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.411 HG22 ' N ' ' A' ' 73' ' ' GLN . 34.2 mt -96.08 154.9 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.724 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.411 ' N ' HG22 ' A' ' 72' ' ' ILE . 1.3 mt-30 -145.9 128.08 15.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.938 0.399 . . . . 0.0 111.458 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.647 ' CE1' HD12 ' A' ' 144' ' ' ILE . 8.1 p90 -141.05 135.71 31.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.459 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -80.35 138.1 36.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.909 0.385 . . . . 0.0 111.034 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.8 tttm -129.18 111.28 12.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.405 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.598 HG13 ' O ' ' A' ' 77' ' ' VAL . 0.3 OUTLIER -130.53 14.25 2.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.67 -179.436 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.42 154.94 20.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.904 0.383 . . . . 0.0 111.33 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.79 79.08 6.77 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.338 0.589 . . . . 0.0 110.48 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.65 153.24 2.71 Favored Pre-proline 0 N--CA 1.446 -0.655 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.014 -178.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.52 158.49 31.75 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.504 2.136 . . . . 0.0 112.285 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 23.7 ttm -56.07 -54.21 47.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.956 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 132.24 -9.09 5.37 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.939 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.505 HG23 ' HB ' ' A' ' 105' ' ' ILE . 15.8 pt -114.92 168.07 6.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.802 0.334 . . . . 0.0 111.139 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.471 ' O ' ' N ' ' A' ' 97' ' ' ALA . 19.3 m -135.02 127.68 30.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.275 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 1.051 HD23 HD13 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -125.9 159.56 32.25 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.238 -179.177 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.585 ' C ' HD13 ' A' ' 88' ' ' LEU . 22.4 pttp -137.06 162.3 33.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.178 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.646 ' N ' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -103.26 102.96 12.95 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.597 179.504 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -64.37 176.67 1.01 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.638 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -50.29 -27.57 6.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.937 0.399 . . . . 0.0 110.838 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.04 -16.9 57.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.347 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 74.78 78.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.821 0.343 . . . . 0.0 110.248 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.599 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 49.1 p -154.94 150.62 27.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.667 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.659 ' SG ' HD11 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -87.85 113.58 23.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.062 0.458 . . . . 0.0 111.219 -179.576 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.599 HG23 ' O ' ' A' ' 115' ' ' ASP . 2.9 m -131.96 126.76 34.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.322 179.446 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.927 HG13 ' H ' ' A' ' 114' ' ' GLY . 2.6 p -58.72 105.91 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.279 0.561 . . . . 0.0 110.02 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -72.04 -25.03 61.64 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.266 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.531 ' HA ' HG23 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -173.21 123.03 0.39 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.854 179.811 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.749 HG12 HG21 ' A' ' 96' ' ' VAL . 11.0 mt -85.97 120.75 36.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.361 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.456 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.9 mp -83.96 135.8 34.32 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.148 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.443 ' HA ' ' CG ' ' A' ' 106' ' ' HIS . 52.0 p-80 -73.6 138.63 45.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.826 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.69 -36.53 4.3 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.382 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.16 -171.02 0.12 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.51 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.4 ttp -84.42 -40.6 17.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.865 0.364 . . . . 0.0 110.906 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.505 ' HB ' HG23 ' A' ' 84' ' ' ILE . 37.6 mm -65.54 -36.88 78.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.105 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.443 ' CG ' ' HA ' ' A' ' 101' ' ' HIS . 63.7 t-80 -75.11 -54.98 6.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.748 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.6 ttt-85 -60.05 -47.17 86.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.693 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -75.99 -47.06 26.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.638 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.72 73.39 1.28 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.565 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.669 ' O ' HD22 ' A' ' 111' ' ' LEU . 4.6 m -111.91 -29.26 7.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.776 0.322 . . . . 0.0 110.986 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.995 HD11 HG11 ' A' ' 148' ' ' VAL . 3.2 mm? -134.26 172.53 12.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.09 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.44 ' CA ' HD11 ' A' ' 99' ' ' ILE . 74.5 m80 -134.46 137.42 43.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.711 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.531 HG23 ' HA ' ' A' ' 98' ' ' ARG . 7.5 p -47.02 115.99 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.901 0.381 . . . . 0.0 111.359 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.927 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 112.23 -24.95 13.23 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.853 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.599 ' O ' HG23 ' A' ' 95' ' ' THR . 24.9 m-20 -50.29 143.35 8.76 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.74 0.27 . . . . 0.0 110.7 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.657 ' C ' HG23 ' A' ' 148' ' ' VAL . 1.6 mt-10 -95.32 107.71 19.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.819 0.342 . . . . 0.0 111.725 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 1.051 HD13 HD23 ' A' ' 86' ' ' LEU . 3.9 mp -86.67 99.83 8.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.66 179.291 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.606 HD21 HD12 ' A' ' 149' ' ' ILE . 4.3 mm? -51.46 -35.12 38.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.311 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -169.72 145.64 3.1 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.959 0.409 . . . . 0.0 111.271 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 1.057 HG23 HD11 ' A' ' 146' ' ' LEU . 45.1 mt -104.56 125.29 59.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.828 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.87 27.74 17.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.777 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 83.32 18.13 65.17 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.743 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 27.4 m -133.58 128.11 34.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.828 0.347 . . . . 0.0 111.023 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -92.56 114.96 27.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.792 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.818 HG21 HG13 ' A' ' 130' ' ' VAL . 13.7 p -82.07 127.04 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.246 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.8 p -98.0 -167.09 1.46 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.714 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -67.05 -15.51 63.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.294 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.438 ' C ' ' CD2' ' A' ' 128' ' ' HIS . 0.6 OUTLIER -57.9 -166.91 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.678 0.275 . . . . 0.0 110.572 179.838 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 28.6 t -67.67 134.03 50.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.941 0.401 . . . . 0.0 110.682 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.818 HG13 HG21 ' A' ' 125' ' ' VAL . 0.6 OUTLIER -89.42 -16.32 8.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.335 179.755 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -45.02 -26.01 0.39 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.328 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 51.1 mm-40 -63.78 -54.07 40.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.884 0.373 . . . . 0.0 110.633 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.592 HD22 ' HB ' ' A' ' 125' ' ' VAL . 6.8 mp -77.18 -37.64 53.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.789 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -60.29 -49.57 77.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.712 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.29 -44.06 92.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.73 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.596 ' O ' HG23 ' A' ' 140' ' ' THR . . . -66.17 -35.52 80.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.979 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.504 ' CE ' HD13 ' A' ' 144' ' ' ILE . 1.0 OUTLIER -68.54 -28.36 66.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.894 179.883 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.7 mttp -84.94 -29.38 25.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.898 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.77 10.05 32.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.442 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.596 HG23 ' O ' ' A' ' 136' ' ' ALA . 0.0 OUTLIER -66.55 147.9 52.65 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.771 0.32 . . . . 0.0 110.789 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -150.91 94.97 2.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.783 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 149.2 -154.72 25.95 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.453 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 8.1 mmm -88.03 121.06 29.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.87 0.367 . . . . 0.0 110.833 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.647 HD12 ' CE1' ' A' ' 74' ' ' PHE . 49.8 mt -95.8 144.02 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.215 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.9 p -116.24 113.57 23.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.178 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 1.057 HD11 HG23 ' A' ' 120' ' ' ILE . 3.2 mm? -109.49 125.16 52.18 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.987 0.422 . . . . 0.0 111.46 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 118' ' ' LEU . 10.0 ttpt -105.53 112.02 24.95 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.995 HG11 HD11 ' A' ' 111' ' ' LEU . 3.4 p -147.03 144.03 20.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.157 0.503 . . . . 0.0 112.131 -178.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.606 HD12 HD21 ' A' ' 118' ' ' LEU . 14.6 mt -105.4 136.12 19.26 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.381 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.41 ' HD2' HG23 ' A' ' 149' ' ' ILE . 54.1 Cg_endo -70.06 133.47 25.09 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.456 2.104 . . . . 0.0 112.47 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -135.87 120.07 17.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.733 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 61.51 38.76 15.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.981 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.974 0.416 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -119.17 167.8 11.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.813 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 125' ' ' GLU . . . . . 0.455 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 1.4 pt-20 -161.45 136.76 7.6 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.348 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 126' ' ' TYR . . . . . 0.639 ' CE1' HG21 ' A' ' 130' ' ' VAL . 32.1 m-85 -122.41 133.28 54.63 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.327 -179.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 89.0 m -106.01 115.98 31.16 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.684 HD13 ' N ' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.512 -177.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.541 ' O ' HG13 ' A' ' 69' ' ' VAL . 10.8 p . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.819 0.342 . . . . 0.0 111.034 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.3 ttt-85 -95.47 119.95 34.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.762 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.425 HD21 ' HB3' ' A' ' 145' ' ' SER . 0.9 OUTLIER -98.91 99.36 10.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.047 -179.784 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mp -98.48 148.24 6.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.447 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.479 ' HB3' ' HE3' ' A' ' 143' ' ' MET . 15.9 mt-30 -135.03 123.14 22.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.959 0.409 . . . . 0.0 111.533 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.63 ' CE1' HD22 ' A' ' 146' ' ' LEU . 8.1 p90 -126.64 133.23 51.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.285 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -80.43 135.36 36.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.98 0.419 . . . . 0.0 111.324 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.465 ' HD2' HD11 ' A' ' 144' ' ' ILE . 0.5 OUTLIER -129.09 113.59 15.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.47 179.67 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -110.66 -27.84 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.257 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.55 157.18 17.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.37 -179.321 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -92.52 89.91 6.94 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.52 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -160.04 152.74 17.75 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.966 -178.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.13 147.56 92.83 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.509 2.139 . . . . 0.0 112.207 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.501 ' HB2' ' HE2' ' A' ' 82' ' ' MET . 13.6 ttm -55.39 -41.86 73.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.045 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.46 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 117.14 1.79 18.63 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.581 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.609 ' O ' HD12 ' A' ' 84' ' ' ILE . 2.0 pp -122.17 165.14 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.67 0.271 . . . . 0.0 110.856 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.719 ' C ' HD12 ' A' ' 86' ' ' LEU . 6.8 m -135.03 130.13 35.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.368 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.844 ' CD2' HD13 ' A' ' 117' ' ' ILE . 4.4 mp -121.7 159.5 26.45 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.209 -178.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.709 ' CG ' ' HB2' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -137.39 152.82 50.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.249 179.835 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.673 ' N ' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -102.21 103.38 13.89 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.819 179.803 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -64.3 176.45 1.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.759 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -52.45 -29.17 23.27 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.969 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -81.05 -2.36 47.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.234 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 63.99 86.97 0.12 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.826 0.346 . . . . 0.0 110.53 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.552 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 3.3 m -160.66 137.94 9.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.289 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.414 ' O ' ' HB ' ' A' ' 117' ' ' ILE . 12.9 p -87.61 115.22 24.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.234 0.54 . . . . 0.0 111.489 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.682 HG23 ' O ' ' A' ' 115' ' ' ASP . 9.1 m -132.1 131.53 42.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.53 -0.759 . . . . 0.0 108.97 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.936 HG21 ' CD1' ' A' ' 99' ' ' ILE . 4.4 p -58.8 106.15 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.209 0.528 . . . . 0.0 110.667 -179.026 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.709 ' HB2' ' CG ' ' A' ' 87' ' ' LYS . . . -72.59 -23.34 60.94 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.333 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.454 ' HA ' HG23 ' A' ' 113' ' ' VAL . 1.0 OUTLIER -172.71 131.53 0.55 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.818 0.342 . . . . 0.0 111.515 179.853 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.936 ' CD1' HG21 ' A' ' 96' ' ' VAL . 25.1 mm -90.09 103.63 14.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.497 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.534 HD13 ' SG ' ' A' ' 85' ' ' CYS . 7.6 mp -65.92 147.77 52.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.946 0.403 . . . . 0.0 111.303 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -85.57 142.44 29.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.735 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.3 -39.4 2.86 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.457 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.46 ' HA3' ' HA3' ' A' ' 83' ' ' GLY . . . -54.0 -178.85 0.13 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.646 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 18.6 ptm -84.44 -29.46 26.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.759 0.314 . . . . 0.0 111.166 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.41 HG21 ' HB2' ' A' ' 111' ' ' LEU . 32.5 mm -70.02 -37.91 73.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.975 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -77.87 -44.06 28.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.514 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.9 mtt85 -64.3 -49.98 69.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.512 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -79.07 -44.3 22.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.681 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.13 77.53 1.35 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.625 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.402 ' HB2' HG23 ' A' ' 105' ' ' ILE . 21.2 m -115.2 -28.19 7.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.666 0.27 . . . . 0.0 111.156 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.463 HD21 HG11 ' A' ' 148' ' ' VAL . 0.2 OUTLIER -132.44 172.22 12.75 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.846 0.355 . . . . 0.0 111.111 -179.833 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -142.4 132.3 24.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.771 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.557 ' O ' HG13 ' A' ' 113' ' ' VAL . 7.4 p -44.07 111.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.732 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.899 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 117.35 -28.99 6.92 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.9 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.682 ' O ' HG23 ' A' ' 95' ' ' THR . 22.1 m-20 -48.99 137.6 12.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.63 0.252 . . . . 0.0 110.77 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -89.52 111.32 22.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.827 0.346 . . . . 0.0 111.601 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.844 HD13 ' CD2' ' A' ' 86' ' ' LEU . 4.6 mp -89.25 110.43 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.687 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.439 HD21 HD12 ' A' ' 149' ' ' ILE . 4.4 mm? -67.84 -30.11 69.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.095 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -162.48 148.14 12.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.893 0.378 . . . . 0.0 111.582 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.454 HG12 HG21 ' A' ' 117' ' ' ILE . 49.6 mt -119.47 106.63 19.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.726 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 66.99 29.2 8.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.827 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 87.35 8.96 73.64 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.891 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.6 124.37 26.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.839 0.352 . . . . 0.0 111.06 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 -88.13 107.75 18.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.732 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.707 HG22 ' HG ' ' A' ' 133' ' ' LEU . 11.8 t -59.34 126.45 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.114 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 14.2 p -113.38 -171.77 1.94 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.834 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -60.32 -23.69 64.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.041 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -55.29 -176.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.738 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 m -64.28 134.08 54.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.926 0.393 . . . . 0.0 110.878 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.58 HG13 ' CG1' ' A' ' 125' ' ' VAL . 0.4 OUTLIER -89.24 -21.94 6.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.127 179.702 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.432 ' HA ' ' HG2' ' A' ' 134' ' ' GLN . 4.7 t0 -46.87 -25.61 0.8 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.489 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.12 -41.99 48.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.188 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.707 ' HG ' HG22 ' A' ' 125' ' ' VAL . 3.3 mm? -73.61 -44.7 56.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.318 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.432 ' HG2' ' HA ' ' A' ' 131' ' ' ASP . 17.0 pt20 -68.34 -47.47 67.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.463 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.14 -35.59 80.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.443 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -82.74 -44.97 14.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.773 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.764 ' O ' HG22 ' A' ' 140' ' ' THR . 0.0 OUTLIER -67.77 -25.24 65.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.509 -179.387 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -85.18 -47.63 9.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.809 0.338 . . . . 0.0 111.191 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -71.5 -13.62 61.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.492 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.764 HG22 ' O ' ' A' ' 137' ' ' MET . 14.0 t -59.48 150.83 25.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.901 0.381 . . . . 0.0 110.964 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.07 113.64 14.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.702 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 145.75 -131.99 4.38 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.473 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.479 ' HE3' ' HB3' ' A' ' 73' ' ' GLN . 29.1 mtp -109.17 119.68 40.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.769 0.319 . . . . 0.0 111.126 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.667 HG22 HD13 ' A' ' 146' ' ' LEU . 33.6 mt -88.09 130.76 37.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.969 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.552 ' O ' HD12 ' A' ' 146' ' ' LEU . 8.5 m -108.78 123.35 48.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.603 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.667 HD13 HG22 ' A' ' 144' ' ' ILE . 3.2 mp -122.43 130.25 52.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.287 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -103.26 108.17 19.28 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.523 HG22 ' CG1' ' A' ' 117' ' ' ILE . 6.1 t -133.0 158.36 43.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.168 0.509 . . . . 0.0 112.271 -178.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.452 ' N ' HG12 ' A' ' 148' ' ' VAL . 53.1 mt -125.39 124.25 25.13 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.457 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.52 132.79 24.47 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.502 2.135 . . . . 0.0 112.515 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -103.93 128.05 51.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.694 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 64.21 129.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.86 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.904 -179.965 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 36.7 ttt-85 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.817 0.341 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.3 167.75 10.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.822 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 125' ' ' GLU . . . . . 0.429 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 6.7 pt-20 -164.72 137.56 4.74 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.35 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 126' ' ' TYR . . . . . 0.511 ' CE1' HG21 ' A' ' 130' ' ' VAL . 26.0 m-85 -121.27 134.73 55.18 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.146 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 96.0 m -106.16 115.9 31.02 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.609 HD13 ' N ' ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.234 -0.888 . . . . 0.0 111.523 -177.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 69' ' ' VAL . 11.1 p . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.854 0.359 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.5 mtt85 -118.6 125.4 49.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.89 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.437 HD11 ' HE3' ' A' ' 147' ' ' LYS . 0.2 OUTLIER -98.99 99.45 10.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.849 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.523 HG21 ' OG ' ' A' ' 110' ' ' SER . 32.6 mt -93.95 143.26 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.831 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -132.25 123.19 26.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.909 0.385 . . . . 0.0 111.194 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.807 ' CE1' HD12 ' A' ' 144' ' ' ILE . 42.0 p90 -143.53 130.55 20.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.52 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 1.9 pt-20 -80.32 141.09 35.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.369 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -129.08 111.12 12.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.442 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -112.01 -25.29 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.419 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.45 154.22 19.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.282 -179.38 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -90.89 88.93 7.24 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.251 0.548 . . . . 0.0 110.607 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -166.2 146.15 5.23 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.978 -179.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -51.55 151.43 14.16 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.497 2.131 . . . . 0.0 112.275 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -56.89 -41.5 78.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.401 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 120.11 28.22 1.88 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.619 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.559 HG23 ' HB ' ' A' ' 105' ' ' ILE . 16.2 pt -147.8 168.36 4.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.876 0.369 . . . . 0.0 111.004 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.492 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -131.49 126.77 35.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.746 179.519 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.75 ' CD2' HD13 ' A' ' 117' ' ' ILE . 0.6 OUTLIER -127.9 159.5 34.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.809 -179.337 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.476 ' C ' HD13 ' A' ' 88' ' ' LEU . 1.8 pttp -136.22 152.37 50.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.527 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.882 HD12 HG11 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -95.46 102.95 14.79 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.304 179.148 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -65.8 176.52 1.56 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.639 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -52.1 -24.6 7.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.873 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.45 2.04 46.2 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.574 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 59.98 80.59 0.2 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.744 0.307 . . . . 0.0 110.529 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.565 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 2.7 m -158.06 139.06 13.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.659 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.877 ' HB2' HD11 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -87.55 111.42 21.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.062 0.458 . . . . 0.0 111.394 -179.372 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 115' ' ' ASP . 6.3 m -126.18 129.41 48.96 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.363 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.893 HG13 ' H ' ' A' ' 114' ' ' GLY . 4.0 p -58.84 106.08 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.233 0.539 . . . . 0.0 110.801 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -75.71 -21.82 57.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.311 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.8 mtp85 -171.67 133.83 0.79 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.765 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.844 HD13 HG21 ' A' ' 96' ' ' VAL . 26.9 mm -86.13 103.88 13.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.86 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.0 mp -58.76 138.65 57.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.011 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -79.76 137.25 36.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.935 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.88 -23.85 32.45 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.638 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.401 ' HA3' ' HA3' ' A' ' 83' ' ' GLY . . . -58.13 176.27 1.98 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.625 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 31.3 ttp -78.33 -33.56 49.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.822 0.344 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.566 HG23 ' HB3' ' A' ' 110' ' ' SER . 40.1 mm -72.36 -35.86 53.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -77.45 -41.86 38.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.657 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.7 ttt85 -72.15 -41.59 66.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.705 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.49 -44.77 14.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.755 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.52 79.87 1.4 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.559 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.566 ' HB3' HG23 ' A' ' 105' ' ' ILE . 9.6 t -117.6 -32.41 4.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.713 0.292 . . . . 0.0 111.192 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 1.031 HD11 HG21 ' A' ' 148' ' ' VAL . 0.3 OUTLIER -138.68 172.59 12.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.84 0.352 . . . . 0.0 111.029 -179.906 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -137.75 140.58 40.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.849 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.561 ' O ' HG13 ' A' ' 113' ' ' VAL . 9.2 p -43.59 113.56 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.702 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.893 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 119.0 -28.36 6.67 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.504 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.565 ' HB3' HG11 ' A' ' 148' ' ' VAL . 0.7 OUTLIER -50.02 131.91 23.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.735 0.302 . . . . 0.0 110.785 179.851 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.491 ' HA ' HG23 ' A' ' 95' ' ' THR . 1.4 tp10 -95.11 109.6 21.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.648 -179.349 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.75 HD13 ' CD2' ' A' ' 86' ' ' LEU . 3.6 mp -89.27 94.31 4.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.438 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.952 HD23 HD12 ' A' ' 149' ' ' ILE . 4.0 mm? -65.69 -26.86 67.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.465 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -135.49 130.07 34.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.867 0.365 . . . . 0.0 111.31 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.877 HD11 ' HB2' ' A' ' 94' ' ' CYS . 7.1 mt -112.48 98.8 7.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.719 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.9 t30 61.76 27.69 16.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.664 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 96.13 -2.18 63.41 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.814 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 27.9 m -133.63 127.54 33.2 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.854 0.359 . . . . 0.0 111.275 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -85.04 121.39 27.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.59 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.882 HG11 HD12 ' A' ' 88' ' ' LEU . 14.0 p -50.6 141.59 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.259 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 40.8 p -108.99 151.79 25.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.913 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -59.69 -25.36 64.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.006 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -59.26 -105.7 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.398 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 28.8 t -109.15 133.7 52.68 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.963 0.411 . . . . 0.0 110.848 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.717 HG13 ' CG2' ' A' ' 125' ' ' VAL . 0.9 OUTLIER -89.62 -20.47 7.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.185 179.508 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -43.68 -27.68 0.34 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.248 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -62.83 -43.85 97.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.432 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.513 ' N ' HD22 ' A' ' 133' ' ' LEU . 3.2 mm? -83.85 -43.14 15.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.62 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -59.35 -49.21 78.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.448 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -68.71 -46.45 68.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.796 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.4 ' O ' ' HB ' ' A' ' 140' ' ' THR . . . -66.36 -28.9 69.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.275 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 8.7 mmt -72.3 -36.92 69.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.168 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.3 pttt -90.61 -21.56 21.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.428 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -90.97 -16.99 27.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.554 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.4 ' HB ' ' O ' ' A' ' 136' ' ' ALA . 9.7 t -76.5 156.94 32.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.963 0.411 . . . . 0.0 111.082 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -143.81 120.88 11.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.716 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 134.71 -160.28 24.2 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.603 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.405 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 60.1 mmm -77.28 111.55 13.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.786 0.327 . . . . 0.0 111.129 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.807 HD12 ' CE1' ' A' ' 74' ' ' PHE . 22.9 mt -85.93 140.28 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.998 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.4 m -108.47 117.33 33.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.486 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.744 HD23 ' CE2' ' A' ' 74' ' ' PHE . 3.3 mm? -120.18 119.08 32.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.208 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.437 ' HE3' HD11 ' A' ' 71' ' ' LEU . 1.8 mptt -95.64 105.29 17.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.774 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 1.031 HG21 HD11 ' A' ' 111' ' ' LEU . 2.7 t -118.62 154.46 20.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.808 -178.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.952 HD12 HD23 ' A' ' 118' ' ' LEU . 8.3 mt -130.76 134.19 25.71 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.596 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.55 122.64 11.64 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.453 2.102 . . . . 0.0 112.332 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 39.9 p30 -58.15 146.95 31.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.95 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 62.05 97.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.872 179.951 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.842 0.353 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 124' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 0.1 OUTLIER -126.64 164.83 20.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.734 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.67 130.95 25.02 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 121.243 0.544 . . . . 0.0 110.058 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 126' ' ' TYR . . . . . 0.64 ' CE1' HG21 ' A' ' 130' ' ' VAL . 5.2 m-85 -115.69 151.0 35.89 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.3 -0.863 . . . . 0.0 112.098 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 1.2 m -110.31 116.12 30.9 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 176.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.518 HD11 HD13 ' A' ' 86' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.236 -0.888 . . . . 0.0 111.512 -177.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.85 0.357 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.74 129.64 49.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.76 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.52 99.42 9.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.003 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.557 HD13 HD12 ' A' ' 111' ' ' LEU . 18.0 mt -89.34 146.45 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.465 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -138.59 123.16 18.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.957 0.408 . . . . 0.0 111.681 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.763 ' HE1' HD12 ' A' ' 144' ' ' ILE . 20.8 p90 -138.57 131.86 30.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.096 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 2.4 tt0 -80.33 138.11 36.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.047 0.451 . . . . 0.0 111.612 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.13 111.27 12.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.19 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.86 -28.28 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.3 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.46 148.52 22.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.256 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -87.5 90.28 8.31 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.298 0.571 . . . . 0.0 110.463 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.65 153.9 11.61 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.964 -178.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -49.88 140.42 30.93 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.463 2.109 . . . . 0.0 112.247 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.45 ' HG2' ' CZ ' ' A' ' 74' ' ' PHE . 0.3 OUTLIER -55.14 -56.56 18.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.561 ' O ' HG23 ' A' ' 84' ' ' ILE . . . 138.42 39.12 0.11 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.53 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.743 HG22 HD13 ' A' ' 99' ' ' ILE . 15.3 pt -160.02 158.46 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.771 0.32 . . . . 0.0 110.889 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.496 ' HB2' HD21 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -124.61 124.12 41.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.935 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.67 ' CD1' HD11 ' B' ' 128' ' ' ILE . 0.4 OUTLIER -128.21 158.52 37.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.15 -179.26 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.554 ' C ' HD13 ' A' ' 88' ' ' LEU . 2.9 pttt -138.45 166.75 23.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.025 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.683 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -107.29 103.37 12.71 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.802 179.797 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -64.9 176.43 1.21 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.797 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -50.82 -30.1 13.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.984 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -75.95 -18.09 59.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.091 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 76.27 87.71 0.08 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.634 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 3.6 m -165.06 143.71 6.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.355 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -87.93 111.42 21.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.035 0.445 . . . . 0.0 111.463 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 115' ' ' ASP . 7.4 m -130.43 131.03 45.02 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.395 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.887 HG13 ' H ' ' A' ' 114' ' ' GLY . 2.4 p -59.01 106.15 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.295 0.569 . . . . 0.0 110.724 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.534 ' HB2' ' HD3' ' A' ' 87' ' ' LYS . . . -73.16 -22.55 60.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.994 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.478 ' HA ' HG23 ' A' ' 113' ' ' VAL . 1.5 tmm_? -173.57 136.15 0.57 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.854 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.743 HD13 HG22 ' A' ' 84' ' ' ILE . 12.3 mm -86.02 131.8 33.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.462 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.612 HD22 ' N ' ' A' ' 100' ' ' LEU . 2.0 mm? -89.46 147.64 23.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.831 0.348 . . . . 0.0 111.01 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 17.0 m170 -83.16 136.54 34.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.78 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.37 -28.46 15.28 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.346 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.63 166.23 7.44 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.467 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.407 ' SD ' HD13 ' A' ' 105' ' ' ILE . 0.5 OUTLIER -72.34 -25.89 61.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.666 0.269 . . . . 0.0 111.069 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.44 ' HB ' HG23 ' A' ' 84' ' ' ILE . 29.6 mm -76.71 -36.53 27.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.105 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -80.02 -31.19 39.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.783 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -83.46 -51.23 7.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.826 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -73.76 -43.01 60.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.836 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.99 69.54 1.22 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.471 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.59 -27.96 9.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.745 0.307 . . . . 0.0 111.045 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 1.095 HD11 HG21 ' A' ' 148' ' ' VAL . 0.1 OUTLIER -141.82 172.61 12.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.968 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -139.88 141.84 36.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.84 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.478 HG23 ' HA ' ' A' ' 98' ' ' ARG . 7.6 p -44.97 120.57 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.499 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.887 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 110.26 -27.95 10.96 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.711 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.618 ' O ' HG23 ' A' ' 95' ' ' THR . 0.1 OUTLIER -48.11 135.82 12.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.779 0.323 . . . . 0.0 110.92 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.429 ' HA ' HG23 ' A' ' 95' ' ' THR . 7.6 tt0 -94.72 120.41 34.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.336 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.708 HG13 HG22 ' A' ' 148' ' ' VAL . 4.2 mp -99.19 99.03 7.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.633 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -63.92 -28.33 69.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.448 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -147.08 139.05 24.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.868 0.366 . . . . 0.0 111.198 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.944 HD13 HG23 ' A' ' 125' ' ' VAL . 2.7 mp -118.51 98.74 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.953 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 64.64 28.26 13.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.651 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 92.05 7.51 64.08 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.786 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.58 128.18 34.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.717 0.294 . . . . 0.0 110.948 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -91.78 110.88 22.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.678 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.944 HG23 HD13 ' A' ' 120' ' ' ILE . 6.0 t -63.38 133.63 28.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.237 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 24.5 p -117.07 -177.42 3.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.837 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -59.68 -20.58 57.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.038 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -58.18 -165.2 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.588 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.09 134.08 46.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.917 0.389 . . . . 0.0 110.954 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.628 HG21 ' CE1' ' B' ' 126' ' ' TYR . 0.6 OUTLIER -89.34 -18.75 7.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.16 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 135' ' ' LYS . 3.3 p30 -44.81 -26.53 0.41 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.474 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.49 -42.14 87.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.877 0.37 . . . . 0.0 110.634 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.871 ' HG ' HG22 ' A' ' 125' ' ' VAL . 2.1 mm? -81.61 -39.74 24.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.229 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.415 ' HG3' ' CG2' ' B' ' 128' ' ' ILE . 3.9 tt0 -56.89 -44.7 82.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.644 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -70.6 -48.89 52.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.78 179.808 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.7 -40.35 79.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.072 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.838 ' O ' HG22 ' A' ' 140' ' ' THR . 24.5 mmt -69.07 -33.15 73.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.018 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.71 -26.5 37.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.887 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.02 -14.07 23.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.447 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.838 HG22 ' O ' ' A' ' 137' ' ' MET . 12.6 t -59.31 156.76 12.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.838 0.351 . . . . 0.0 110.981 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -152.08 104.43 2.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.872 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 141.48 -149.3 20.98 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.646 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.407 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 7.8 mtp -87.82 114.37 24.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.869 0.366 . . . . 0.0 110.975 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.763 HD12 ' HE1' ' A' ' 74' ' ' PHE . 32.8 mt -85.33 130.53 36.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.97 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.457 ' O ' HD13 ' A' ' 146' ' ' LEU . 5.4 m -113.57 114.98 27.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.448 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.69 HD22 ' N ' ' A' ' 146' ' ' LEU . 0.4 OUTLIER -120.55 138.66 53.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.074 -179.52 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 7.1 mmtt -95.94 105.42 17.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.872 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 1.095 HG21 HD11 ' A' ' 111' ' ' LEU . 4.2 t -122.79 158.28 27.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.057 0.456 . . . . 0.0 111.926 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.421 ' N ' HG12 ' A' ' 148' ' ' VAL . 26.2 mt -134.07 133.81 22.36 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.619 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo . . . . . 0 C--N 1.346 0.398 0 C-N-CA 122.407 2.071 . . . . 0.0 112.44 -179.844 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.896 0.379 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -152.3 135.15 15.53 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 121.195 0.522 . . . . 0.0 110.017 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 126' ' ' TYR . . . . . 0.628 ' CE1' HG21 ' A' ' 130' ' ' VAL . 39.3 m-85 -117.49 134.26 55.05 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.565 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 1.7 m -106.05 115.98 31.15 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . 0.696 ' N ' HD13 ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.488 -177.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.608 ' O ' HG13 ' A' ' 69' ' ' VAL . 8.8 p . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.951 0.405 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.08 148.25 37.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.756 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.433 ' O ' HD23 ' A' ' 71' ' ' LEU . 9.2 tt -115.08 99.35 7.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.071 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.9 mm -89.61 110.36 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.41 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -113.05 126.66 55.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.014 0.435 . . . . 0.0 111.772 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.666 ' HE1' HD12 ' A' ' 144' ' ' ILE . 4.5 p90 -143.17 145.42 32.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.234 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 0.0 OUTLIER -80.27 139.68 36.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.014 0.435 . . . . 0.0 111.4 -179.364 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -129.35 111.28 12.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.364 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.62 ' O ' HG13 ' A' ' 77' ' ' VAL . 0.3 OUTLIER -124.69 12.95 4.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.636 -179.642 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.68 147.78 46.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.859 0.361 . . . . 0.0 111.228 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -87.76 84.57 7.03 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.249 0.547 . . . . 0.0 110.462 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -174.08 156.92 2.56 Favored Pre-proline 0 N--CA 1.447 -0.587 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.045 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -51.56 132.15 39.66 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.594 2.196 . . . . 0.0 112.4 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.465 ' HG2' ' CE1' ' A' ' 74' ' ' PHE . 0.7 OUTLIER -46.82 -34.98 5.79 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.144 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.42 ' O ' HG23 ' A' ' 84' ' ' ILE . . . 123.56 36.41 0.64 Allowed Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.533 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.512 HD12 HD11 ' A' ' 86' ' ' LEU . 23.9 pt -157.02 165.39 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.787 0.327 . . . . 0.0 110.897 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.72 ' C ' HD12 ' A' ' 86' ' ' LEU . 0.1 OUTLIER -130.04 123.14 29.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.062 179.716 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.728 HD23 HD13 ' A' ' 117' ' ' ILE . 4.5 mp -121.3 156.11 33.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.812 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.635 ' C ' HD13 ' A' ' 88' ' ' LEU . 36.8 pttt -140.05 159.7 41.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.257 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.673 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -105.95 103.09 12.5 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.621 179.586 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -65.52 176.34 1.49 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.764 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -51.87 -26.96 11.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.876 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.0 -13.24 59.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.252 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.4 ' HG2' ' HB2' ' A' ' 127' ' ' ASN . 4.1 mt-30 71.93 88.81 0.1 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.812 0.339 . . . . 0.0 110.601 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.53 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 2.6 m -166.29 141.67 4.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.483 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.574 ' SG ' HD11 ' A' ' 120' ' ' ILE . 11.5 p -87.79 111.44 21.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.099 0.476 . . . . 0.0 111.359 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.7 HG23 ' O ' ' A' ' 115' ' ' ASP . 15.6 m -132.63 133.95 44.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.323 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.917 HG13 ' H ' ' A' ' 114' ' ' GLY . 2.5 p -58.84 106.01 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.196 0.522 . . . . 0.0 110.729 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -71.32 -23.98 62.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.866 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.407 ' HA ' ' CG2' ' A' ' 113' ' ' VAL . 16.4 ttm180 -173.55 141.25 0.86 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.784 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.546 HD13 HG21 ' A' ' 96' ' ' VAL . 17.2 mm -86.06 138.84 18.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.485 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.657 HD11 ' SG ' ' B' ' 127' ' ' CYS . 1.2 mt -96.37 126.54 41.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.821 0.343 . . . . 0.0 111.005 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.428 ' HA ' ' CD2' ' A' ' 106' ' ' HIS . 0.3 OUTLIER -68.5 132.48 47.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.902 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 101.84 -27.9 18.36 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.545 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.8 166.26 17.85 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.537 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 8.8 ttp -67.88 -25.67 65.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.81 0.338 . . . . 0.0 111.068 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.61 HG23 ' OG ' ' A' ' 110' ' ' SER . 19.9 mm -79.46 -32.31 14.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.969 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.428 ' CD2' HG22 ' A' ' 99' ' ' ILE . 6.0 t-80 -81.67 -47.75 12.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.548 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.22 -42.17 98.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.558 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -87.4 -43.93 11.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.643 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.37 42.35 5.23 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.597 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.61 ' OG ' HG23 ' A' ' 105' ' ' ILE . 11.2 p -74.46 -26.14 59.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.812 0.339 . . . . 0.0 111.019 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.929 HD21 HG21 ' A' ' 148' ' ' VAL . 5.1 mt -140.54 172.7 12.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.033 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -140.87 140.91 34.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.82 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.44 ' O ' HG13 ' A' ' 113' ' ' VAL . 6.0 p -44.96 120.3 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.595 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.917 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 111.23 -27.15 11.07 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.748 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.7 ' O ' HG23 ' A' ' 95' ' ' THR . 0.2 OUTLIER -46.99 133.38 11.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.762 0.315 . . . . 0.0 110.991 179.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.53 114.64 26.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.174 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.728 HD13 HD23 ' A' ' 86' ' ' LEU . 4.9 mp -94.02 101.58 12.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.84 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.463 HD21 HD12 ' A' ' 149' ' ' ILE . 4.4 mm? -60.34 -42.43 95.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.96 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -142.72 153.02 42.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.969 0.414 . . . . 0.0 111.218 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.671 HG23 HD12 ' A' ' 146' ' ' LEU . 39.4 mt -124.01 98.77 5.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.723 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 59.05 27.72 16.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.703 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 93.87 13.46 54.82 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.617 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 74.4 m -133.64 127.97 34.08 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.894 0.378 . . . . 0.0 111.098 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -110.72 87.57 2.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.674 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.566 HG21 HG13 ' A' ' 130' ' ' VAL . 9.2 p -51.11 158.32 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.328 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.482 ' N ' HG22 ' A' ' 125' ' ' VAL . 37.9 p -131.9 -176.44 4.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.965 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.4 ' HB2' ' HG2' ' A' ' 92' ' ' GLN . 23.5 t-20 -62.13 -18.55 61.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.277 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -59.47 -109.11 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.684 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.19 133.97 52.34 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.89 0.376 . . . . 0.0 111.071 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.87 HG21 ' CE1' ' B' ' 126' ' ' TYR . 0.8 OUTLIER -89.27 -23.95 6.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.18 179.551 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.3 -26.44 0.51 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.54 -179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -56.77 -57.5 12.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.826 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.52 HD12 ' C ' ' A' ' 133' ' ' LEU . 0.3 OUTLIER -75.49 -38.68 59.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.867 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -58.97 -57.7 11.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.906 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.07 -44.91 87.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.896 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.25 -34.09 75.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.083 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.429 ' O ' HG22 ' A' ' 140' ' ' THR . 0.4 OUTLIER -68.01 -31.37 71.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.984 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -87.92 -24.96 23.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.129 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -90.36 -28.67 18.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.119 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 137' ' ' MET . 12.2 t -59.5 156.79 12.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.949 0.404 . . . . 0.0 111.033 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.4 100.12 1.95 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.797 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 149.6 -152.14 24.14 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.511 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.4 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 22.9 mtp -80.82 118.82 22.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.827 0.346 . . . . 0.0 111.052 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.666 HD12 ' HE1' ' A' ' 74' ' ' PHE . 46.1 mt -93.23 145.58 7.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.191 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.9 m -125.39 113.6 17.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.268 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.671 HD12 HG23 ' A' ' 120' ' ' ILE . 1.9 mm? -115.6 134.36 55.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.13 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 7.5 mmtm -98.72 107.19 19.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.878 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.929 HG21 HD21 ' A' ' 111' ' ' LEU . 10.1 t -125.49 158.29 34.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.056 0.455 . . . . 0.0 111.939 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.463 HD12 HD21 ' A' ' 118' ' ' LEU . 23.8 mt -138.21 126.57 14.17 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.768 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo . . . . . 0 C--N 1.346 0.416 0 C-N-CA 122.513 2.142 . . . . 0.0 112.299 -179.828 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.837 0.351 . . . . 0.0 110.918 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . 0.41 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 42.3 mt-10 -159.87 133.25 6.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.794 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 126' ' ' TYR . . . . . 0.87 ' CE1' HG21 ' A' ' 130' ' ' VAL . 33.4 m-85 -124.47 134.91 52.91 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.426 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 127' ' ' CYS . . . . . 0.657 ' SG ' HD11 ' A' ' 100' ' ' LEU . 1.8 m -106.01 116.1 31.36 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . 0.488 HG13 HD11 ' A' ' 133' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.372 -177.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.551 ' O ' HG13 ' A' ' 69' ' ' VAL . 14.9 p . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 120.932 0.396 . . . . 0.0 111.258 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.54 146.07 24.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.747 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.82 99.26 6.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.066 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.663 HG21 ' HB3' ' A' ' 110' ' ' SER . 4.0 mp -91.43 140.96 15.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.224 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 144' ' ' ILE . 32.4 mt-30 -135.41 132.33 37.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.113 0.482 . . . . 0.0 111.911 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.623 ' CZ ' HD23 ' A' ' 146' ' ' LEU . 0.8 OUTLIER -144.98 125.97 14.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.298 179.054 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 0.0 OUTLIER -80.26 137.86 36.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.538 -179.216 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -129.07 123.9 33.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.49 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -104.03 -37.31 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.02 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.56 156.53 18.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.258 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -88.63 90.88 8.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.544 0.688 . . . . 0.0 110.565 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -147.18 141.36 15.79 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.947 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.74 144.87 41.54 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.43 2.087 . . . . 0.0 112.082 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.55 -47.01 83.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.97 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 120.74 28.75 1.67 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.755 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.544 HG22 HG23 ' A' ' 99' ' ' ILE . 15.8 pt -146.96 166.3 6.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.844 0.354 . . . . 0.0 110.983 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.481 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -131.18 126.47 35.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.124 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.597 HD12 HD11 ' B' ' 128' ' ' ILE . 0.4 OUTLIER -131.72 156.99 44.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.036 -179.467 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.69 ' C ' HD13 ' A' ' 88' ' ' LEU . 34.3 pttt -136.16 166.78 22.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.327 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.693 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -111.11 103.23 11.66 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.419 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.404 ' OD1' ' HB3' ' A' ' 91' ' ' LYS . 4.9 p30 -66.94 176.67 1.98 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.819 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -47.73 -37.49 13.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.349 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.404 ' HB3' ' OD1' ' A' ' 89' ' ' ASN . 79.0 tttt -70.2 -18.17 63.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.183 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' ' HB ' ' A' ' 126' ' ' THR . 0.0 OUTLIER 76.56 88.51 0.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.546 -179.588 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 1.7 t -162.69 139.55 7.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.46 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.65 111.47 21.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.986 0.422 . . . . 0.0 111.405 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.679 HG23 ' O ' ' A' ' 115' ' ' ASP . 19.0 m -130.0 133.5 46.81 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.424 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.912 HG13 ' H ' ' A' ' 114' ' ' GLY . 3.2 p -61.03 105.91 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.214 0.53 . . . . 0.0 110.458 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -72.98 -25.25 60.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.858 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.573 ' HA ' HG23 ' A' ' 113' ' ' VAL . 47.5 ttt180 -173.61 128.84 0.42 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.387 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.615 HG12 HG21 ' A' ' 96' ' ' VAL . 21.1 mt -85.84 125.51 40.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.897 0.379 . . . . 0.0 110.693 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.459 ' N ' HD12 ' A' ' 100' ' ' LEU . 8.0 mp -83.13 135.73 34.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.146 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.427 ' HA ' ' CG ' ' A' ' 106' ' ' HIS . 32.8 t-80 -79.26 136.98 37.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.869 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 114.57 -41.44 2.18 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.388 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.3 -173.06 0.24 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.702 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 64.7 ttp -84.61 -29.69 25.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.716 0.293 . . . . 0.0 111.157 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 33.4 mm -71.56 -42.15 72.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.257 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.427 ' CG ' ' HA ' ' A' ' 101' ' ' HIS . 5.5 t60 -71.49 -35.97 70.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.843 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.62 -51.0 10.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.746 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -73.15 -46.32 51.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.804 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.42 77.48 1.35 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.471 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.663 ' HB3' HG21 ' A' ' 72' ' ' ILE . 2.0 m -112.4 -30.86 7.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.804 0.335 . . . . 0.0 111.038 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 110' ' ' SER . 5.5 mp -135.53 158.29 44.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.954 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.539 ' CA ' HD11 ' A' ' 99' ' ' ILE . 85.0 m-70 -121.19 135.31 55.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.714 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.573 HG23 ' HA ' ' A' ' 98' ' ' ARG . 7.6 p -45.28 115.01 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.473 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.912 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 112.39 -25.62 12.11 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.707 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.679 ' O ' HG23 ' A' ' 95' ' ' THR . 6.9 m-20 -55.06 137.78 45.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.696 0.284 . . . . 0.0 110.808 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.413 ' HA ' HG23 ' A' ' 95' ' ' THR . 38.8 tt0 -91.62 123.2 34.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.908 0.385 . . . . 0.0 111.492 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.666 HG13 HG22 ' A' ' 148' ' ' VAL . 3.3 mp -97.78 94.25 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.354 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.446 HD13 ' HA ' ' A' ' 118' ' ' LEU . 4.2 mm? -59.05 -26.14 64.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.512 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.16 138.97 25.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.901 0.381 . . . . 0.0 111.481 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.553 HD12 ' N ' ' A' ' 120' ' ' ILE . 2.5 mp -119.88 98.67 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.56 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.407 ' H ' HD13 ' A' ' 146' ' ' LEU . 12.5 t-20 61.99 26.91 16.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.619 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 92.03 13.37 57.77 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.796 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.483 ' HB ' HD21 ' A' ' 133' ' ' LEU . 1.3 m -133.58 133.69 42.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.839 0.352 . . . . 0.0 111.161 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.29 84.35 2.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.579 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.885 HG21 HG13 ' A' ' 130' ' ' VAL . 11.2 p -55.79 125.69 11.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.217 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' A' ' 92' ' ' GLN . 26.3 p -103.6 -168.55 1.52 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.696 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.01 -22.27 60.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.937 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -54.57 -176.1 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.685 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.6 p -59.2 134.07 56.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.926 0.393 . . . . 0.0 110.914 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.885 HG13 HG21 ' A' ' 125' ' ' VAL . 0.7 OUTLIER -89.25 -20.0 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.208 179.777 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -45.6 -25.6 0.48 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.417 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.906 ' HG3' HD12 ' A' ' 133' ' ' LEU . 5.9 pt20 -68.9 -47.77 65.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.738 0.304 . . . . 0.0 110.815 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.906 HD12 ' HG3' ' A' ' 132' ' ' GLN . 2.2 mp -81.43 -46.53 14.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.722 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -54.54 -39.55 67.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.955 0.407 . . . . 0.0 110.756 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.36 -50.08 29.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.964 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -58.25 -43.51 87.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.306 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.875 ' HE1' HD13 ' A' ' 144' ' ' ILE . 77.2 mmm -65.06 -37.6 88.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.964 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -74.53 -27.64 60.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.864 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -106.92 10.1 30.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.462 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.817 HG22 ' O ' ' A' ' 137' ' ' MET . 12.8 t -69.3 156.9 38.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.857 0.361 . . . . 0.0 110.846 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -144.55 113.81 6.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.815 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 130.2 -145.39 16.6 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.636 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.466 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 2.4 mtp -97.41 119.97 36.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.858 0.361 . . . . 0.0 111.188 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.875 HD13 ' HE1' ' A' ' 137' ' ' MET . 41.0 mt -90.23 131.75 36.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.122 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.1 m -112.87 114.26 26.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.107 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.647 HD22 ' N ' ' A' ' 146' ' ' LEU . 1.0 OUTLIER -116.96 131.2 57.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.384 -179.251 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.29 110.3 22.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.314 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.666 HG22 HG13 ' A' ' 117' ' ' ILE . 2.8 t -121.79 158.25 25.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.575 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.43 HD12 ' CD2' ' A' ' 118' ' ' LEU . 29.2 mt -140.89 130.5 13.04 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.897 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 C--N 1.347 0.467 0 C-N-CA 122.428 2.085 . . . . 0.0 112.304 -179.924 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . 0.435 ' CD ' ' CE1' ' B' ' 126' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.848 0.356 . . . . 0.0 110.988 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . 0.422 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 2.0 pt-20 -155.33 135.84 13.34 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.124 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 126' ' ' TYR . . . . . 0.661 ' CE1' HG21 ' A' ' 130' ' ' VAL . 33.1 m-85 -115.53 133.21 56.25 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.42 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 127' ' ' CYS . . . . . 0.449 ' SG ' HD21 ' A' ' 100' ' ' LEU . 1.8 m -105.94 116.05 31.28 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . 0.707 ' N ' HD13 ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.47 -177.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.441 ' O ' HG13 ' A' ' 69' ' ' VAL . 10.9 p . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.777 0.322 . . . . 0.0 111.077 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 -116.06 137.83 51.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.858 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.412 HD12 ' HG2' ' A' ' 147' ' ' LYS . 1.8 tp -108.93 99.38 8.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.921 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.613 HG21 ' HB3' ' A' ' 110' ' ' SER . 13.1 mm -90.41 118.9 36.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.601 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -113.3 127.32 56.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.0 0.428 . . . . 0.0 111.566 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.683 ' CZ ' HD23 ' A' ' 146' ' ' LEU . 9.9 p90 -145.54 131.52 19.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.378 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.33 141.7 35.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.006 0.432 . . . . 0.0 111.299 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.8 ttpt -129.12 111.21 12.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.358 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -105.69 -22.53 4.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.277 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.54 146.09 24.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.185 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -88.36 89.82 8.14 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.259 0.552 . . . . 0.0 110.54 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -167.86 158.72 9.44 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.899 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -50.88 145.18 24.96 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.559 2.172 . . . . 0.0 112.486 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 19.2 ttm -54.27 -65.68 0.53 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.083 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.655 ' O ' HG23 ' A' ' 84' ' ' ILE . . . 144.62 38.41 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.704 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.856 HD13 HD11 ' A' ' 86' ' ' LEU . 1.9 pp -163.5 164.83 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.777 0.322 . . . . 0.0 110.907 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -129.29 128.07 42.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.27 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.856 HD11 HD13 ' A' ' 84' ' ' ILE . 0.4 OUTLIER -128.78 157.43 41.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.824 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.47 ' C ' HD13 ' A' ' 88' ' ' LEU . 55.4 pttt -138.86 166.21 25.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.399 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.675 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -106.54 102.98 12.33 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.485 179.38 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -67.86 176.73 2.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.613 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -49.46 -25.5 2.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.904 0.383 . . . . 0.0 111.021 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.419 ' O ' ' CG ' ' A' ' 91' ' ' LYS . 12.8 tptt -88.05 12.31 13.8 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.261 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 44.02 87.15 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.849 0.357 . . . . 0.0 111.258 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 1.6 m -160.33 145.05 14.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.428 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.43 ' CB ' HD11 ' A' ' 120' ' ' ILE . 0.8 OUTLIER -87.83 111.63 21.6 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.932 0.396 . . . . 0.0 111.468 -179.328 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.614 HG23 ' O ' ' A' ' 115' ' ' ASP . 3.6 m -132.17 129.3 39.61 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.616 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.932 HG21 HD13 ' A' ' 99' ' ' ILE . 4.1 p -58.79 106.36 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.261 0.553 . . . . 0.0 110.601 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -74.44 -21.5 59.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.384 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.436 ' HA ' HG23 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -173.53 134.43 0.5 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.06 179.779 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.932 HD13 HG21 ' A' ' 96' ' ' VAL . 22.6 mm -86.13 103.71 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.639 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.431 HD21 ' SG ' ' B' ' 127' ' ' CYS . 9.8 mp -57.12 141.87 44.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.216 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.431 ' HA ' ' CD2' ' A' ' 106' ' ' HIS . 78.5 m-70 -78.08 136.36 37.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.819 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.23 -25.03 26.21 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.525 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.51 155.75 18.03 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.459 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 2.9 tmm? -61.26 -37.39 82.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.776 0.322 . . . . 0.0 110.983 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.433 HG23 ' CB ' ' A' ' 110' ' ' SER . 35.3 mm -68.51 -32.02 53.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.185 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.431 ' CD2' ' HA ' ' A' ' 101' ' ' HIS . 17.4 t60 -74.44 -54.3 7.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.774 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -42.84 94.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.743 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -77.23 -49.57 14.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.755 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.41 76.37 1.33 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.521 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.613 ' HB3' HG21 ' A' ' 72' ' ' ILE . 0.9 OUTLIER -113.71 -28.77 7.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.734 0.302 . . . . 0.0 111.149 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.485 HD11 HG21 ' A' ' 148' ' ' VAL . 0.1 OUTLIER -137.83 172.59 12.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.059 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -139.59 132.92 30.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.789 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.595 ' O ' HG13 ' A' ' 113' ' ' VAL . 7.1 p -42.38 108.32 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.768 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.889 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 119.03 -27.45 7.06 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.946 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.614 ' O ' HG23 ' A' ' 95' ' ' THR . 6.4 m-20 -50.49 139.9 14.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.765 0.317 . . . . 0.0 110.835 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -90.77 116.78 28.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.46 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.805 HD13 HD23 ' A' ' 86' ' ' LEU . 4.6 mp -96.7 101.95 12.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.503 179.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.539 HD13 ' CD1' ' A' ' 149' ' ' ILE . 6.0 mp -68.56 -27.31 65.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.481 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -148.45 141.12 24.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.93 0.395 . . . . 0.0 111.286 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.578 HG23 HD11 ' A' ' 146' ' ' LEU . 3.5 mp -119.65 99.14 7.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.818 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.46 HD22 HG23 ' A' ' 144' ' ' ILE . 20.2 t-20 62.46 25.39 15.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.716 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 99.94 1.44 56.12 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.984 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.8 m -133.62 130.59 38.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.844 0.354 . . . . 0.0 111.142 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.402 ' HA ' HD12 ' A' ' 120' ' ' ILE . 5.1 p-10 -101.42 98.04 8.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.643 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.994 HG21 HG13 ' A' ' 130' ' ' VAL . 9.6 p -58.85 138.33 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.012 0.434 . . . . 0.0 111.189 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.2 p -123.14 -171.19 2.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.515 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 44.4 p-10 -50.21 -24.88 3.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.244 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.26 -166.04 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.652 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.81 133.88 45.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.883 0.373 . . . . 0.0 110.934 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.994 HG13 HG21 ' A' ' 125' ' ' VAL . 0.7 OUTLIER -89.26 -20.48 7.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.282 179.738 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.0 -26.35 0.42 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.429 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.67 -50.65 73.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.766 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.5 mp -72.16 -41.73 66.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.718 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -55.38 -52.41 63.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.559 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -62.5 -34.9 77.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.529 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.78 -30.34 62.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.986 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 3.8 mmt -69.84 -32.73 71.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.823 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -85.39 -25.96 26.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.023 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -88.92 -32.64 17.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.159 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 11.9 t -59.38 150.63 25.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.012 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.94 124.33 8.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.734 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 124.08 -146.61 16.35 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.547 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 1.6 ttm -78.07 121.1 23.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.894 0.378 . . . . 0.0 111.095 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.686 HG22 ' CD2' ' A' ' 146' ' ' LEU . 42.8 mt -96.73 136.35 27.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.035 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.514 ' C ' HD22 ' A' ' 146' ' ' LEU . 87.2 p -107.82 127.67 53.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.632 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.686 ' CD2' HG22 ' A' ' 144' ' ' ILE . 3.3 mm? -130.17 121.16 25.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.186 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.412 ' HG2' HD12 ' A' ' 71' ' ' LEU . 11.8 mmtt -95.87 105.35 17.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.837 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.618 HG22 HG13 ' A' ' 117' ' ' ILE . 2.7 t -127.64 157.93 39.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.002 0.429 . . . . 0.0 111.773 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.539 ' CD1' HD13 ' A' ' 118' ' ' LEU . 46.1 mt -134.36 135.97 24.94 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.845 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.401 ' HD2' HG23 ' A' ' 149' ' ' ILE . 37.5 Cg_endo . . . . . 0 C--N 1.346 0.437 0 C-N-CA 122.436 2.091 . . . . 0.0 112.281 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . 0.411 ' HD2' ' CE1' ' B' ' 126' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.048 0 CA-C-O 120.772 0.32 . . . . 0.0 110.875 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . 0.401 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 1.6 pt-20 -141.21 133.07 27.47 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.231 0.538 . . . . 0.0 109.814 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 126' ' ' TYR . . . . . 0.738 ' CE1' HG21 ' A' ' 130' ' ' VAL . 42.2 m-85 -109.9 132.34 54.24 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.575 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 127' ' ' CYS . . . . . 0.431 ' SG ' HD21 ' A' ' 100' ' ' LEU . 1.8 m -105.98 115.95 31.1 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . 0.708 ' N ' HD13 ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.583 -177.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.568 ' O ' HG13 ' A' ' 69' ' ' VAL . 10.2 p . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.887 0.375 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.1 mtt85 -101.92 126.04 48.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.922 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.6 99.47 10.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.507 ' CD1' HG12 ' A' ' 148' ' ' VAL . 3.5 mp -89.37 145.27 7.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.957 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -136.7 123.11 20.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.172 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.509 ' CZ ' HD23 ' A' ' 146' ' ' LEU . 10.8 p90 -148.33 129.36 14.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.779 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 1.3 pt-20 -80.33 129.72 34.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.219 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.36 111.57 12.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.225 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.615 ' O ' HG13 ' A' ' 77' ' ' VAL . 0.3 OUTLIER -125.65 15.52 4.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.568 -179.605 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.15 154.94 21.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.54 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -80.9 79.54 7.55 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.267 0.556 . . . . 0.0 110.001 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.14 137.87 1.66 Allowed Pre-proline 0 N--CA 1.447 -0.601 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.132 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.32 156.4 10.74 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.336 2.024 . . . . 0.0 112.258 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.445 ' HG2' ' CE1' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -59.13 -39.89 83.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.857 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 119.86 35.01 0.93 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.488 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.549 ' CA ' HD23 ' A' ' 100' ' ' LEU . 13.6 pt -152.45 154.31 8.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.77 0.319 . . . . 0.0 110.977 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.618 ' HB2' HD21 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -125.61 122.81 37.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.095 179.618 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.875 HD23 HD13 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -125.17 159.23 32.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.87 -179.663 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.565 ' C ' HD13 ' A' ' 88' ' ' LEU . 7.0 pttt -142.79 161.44 38.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.2 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.632 ' N ' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -101.65 102.9 13.66 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.557 179.389 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -65.25 176.76 1.24 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.448 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -49.67 -27.64 4.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.815 0.34 . . . . 0.0 110.879 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.66 -9.18 59.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.713 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 67.79 76.43 0.27 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.902 0.382 . . . . 0.0 110.946 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.575 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 1.3 p -153.87 145.02 22.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.522 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -87.74 112.63 22.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.105 0.479 . . . . 0.0 111.292 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.644 HG23 ' O ' ' A' ' 115' ' ' ASP . 3.5 m -132.85 130.82 40.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.378 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.923 HG13 ' H ' ' A' ' 114' ' ' GLY . 2.6 p -58.59 106.08 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.312 0.577 . . . . 0.0 110.615 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -71.77 -23.22 61.55 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.038 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.452 ' HA ' HG23 ' A' ' 113' ' ' VAL . 6.1 mtt180 -173.45 145.92 1.3 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.591 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.551 HD11 ' HA ' ' A' ' 112' ' ' HIS . 54.0 mt -86.01 135.67 24.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.634 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.618 HD21 ' HB2' ' A' ' 85' ' ' CYS . 4.1 mm? -85.6 123.35 30.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.028 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -70.14 131.99 45.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.911 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.15 -24.52 28.45 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.543 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.61 -178.05 0.62 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.633 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 29.1 ttp -84.42 -27.18 27.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.707 0.289 . . . . 0.0 111.069 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.431 HG23 ' HB2' ' A' ' 110' ' ' SER . 25.5 mm -78.45 -34.64 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.116 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -72.67 -45.7 57.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.914 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 29.7 ttp180 -71.96 -46.55 57.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.906 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.61 -46.89 29.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.837 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.23 75.55 1.3 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.446 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.431 ' HB3' HG21 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -111.28 -29.82 7.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.785 0.326 . . . . 0.0 111.104 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.529 HD23 HG21 ' A' ' 148' ' ' VAL . 2.6 mp -136.95 172.61 12.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.934 0.397 . . . . 0.0 111.034 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.551 ' HA ' HD11 ' A' ' 99' ' ' ILE . 32.1 m170 -139.48 134.9 32.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.741 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.564 ' O ' HG13 ' A' ' 113' ' ' VAL . 7.1 p -42.21 113.03 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.705 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.923 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 111.75 -24.17 15.67 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.979 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.644 ' O ' HG23 ' A' ' 95' ' ' THR . 11.4 m-20 -48.95 142.79 6.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.725 0.298 . . . . 0.0 110.848 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.3 mp0 -91.69 114.77 27.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.691 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.875 HD13 HD23 ' A' ' 86' ' ' LEU . 4.6 mp -92.79 107.81 19.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.538 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.508 ' CD2' HD12 ' A' ' 149' ' ' ILE . 4.3 mm? -70.11 -27.97 65.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.584 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -155.05 161.0 41.44 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.046 0.45 . . . . 0.0 111.355 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.561 HG12 HG21 ' A' ' 117' ' ' ILE . 30.2 mt -142.02 98.81 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.861 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 62.83 28.33 16.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.041 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.63 -25.09 22.28 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.64 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.532 ' HB ' HD11 ' A' ' 133' ' ' LEU . 2.8 m -120.27 137.13 54.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.805 0.336 . . . . 0.0 110.979 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -93.92 21.39 6.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.205 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 126' ' ' THR . 44.1 t 58.65 156.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.266 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.479 ' N ' HG12 ' A' ' 125' ' ' VAL . 5.5 p -137.8 172.9 12.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.777 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -59.7 -25.65 64.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.811 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -59.23 -163.06 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.48 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.3 m -67.41 134.15 50.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.936 0.398 . . . . 0.0 110.722 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.603 HG21 ' CE1' ' B' ' 126' ' ' TYR . 0.4 OUTLIER -89.13 -16.34 8.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.231 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -44.24 -25.95 0.28 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.432 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -62.03 -58.93 5.99 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.516 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.532 HD11 ' HB ' ' A' ' 123' ' ' THR . 2.7 mm? -74.68 -39.08 62.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.336 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.426 ' HA ' HG21 ' B' ' 128' ' ' ILE . 7.5 tm0? -57.76 -51.28 70.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.791 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -64.29 -37.31 87.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.844 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.45 ' O ' HG23 ' A' ' 140' ' ' THR . . . -67.64 -40.35 84.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.089 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -67.08 -29.03 68.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.913 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -84.32 -30.65 25.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.996 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -104.98 10.08 34.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.378 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 136' ' ' ALA . 0.0 OUTLIER -68.36 138.76 55.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.881 0.372 . . . . 0.0 110.916 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.5 76.5 1.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.762 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 167.21 -161.37 35.2 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.383 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.536 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 4.3 ptm -85.01 120.64 26.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.923 0.392 . . . . 0.0 111.002 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.619 HG22 ' CD2' ' A' ' 146' ' ' LEU . 48.8 mt -95.71 134.36 33.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.354 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.1 m -111.06 113.64 26.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.032 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.619 ' CD2' HG22 ' A' ' 144' ' ' ILE . 2.5 mm? -113.65 142.01 46.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.108 0.48 . . . . 0.0 111.381 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.436 ' O ' ' N ' ' A' ' 118' ' ' LEU . 10.9 mttt -110.61 105.53 14.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.63 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.529 HG21 HD23 ' A' ' 111' ' ' LEU . 5.2 p -141.62 149.66 19.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.007 0.432 . . . . 0.0 111.676 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.508 HD12 ' CD2' ' A' ' 118' ' ' LEU . 3.1 mt -125.15 121.45 25.25 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.947 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo . . . . . 0 C--N 1.346 0.433 0 C-N-CA 122.439 2.093 . . . . 0.0 112.241 -179.931 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.526 0.048 0 CA-C-O 120.935 0.398 . . . . 0.0 110.918 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . 0.462 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 3.9 mp0 -163.62 135.53 4.96 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.866 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 126' ' ' TYR . . . . . 0.603 ' CE1' HG21 ' A' ' 130' ' ' VAL . 36.4 m-85 -128.54 131.66 48.25 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.572 -179.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 127' ' ' CYS . . . . . 0.518 ' SG ' HD21 ' A' ' 100' ' ' LEU . 1.7 m -106.01 115.92 31.05 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . 0.704 ' N ' HD13 ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.508 -177.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.788 0.327 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -107.37 161.26 14.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.904 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.4 tp -118.89 101.95 8.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.943 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.497 HG21 ' HB3' ' A' ' 110' ' ' SER . 27.6 mm -89.28 126.79 42.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.915 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -122.57 123.65 41.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.276 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.806 ' CZ ' HD12 ' A' ' 144' ' ' ILE . 10.4 p90 -149.15 130.96 15.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.539 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -82.41 137.58 34.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.079 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -129.2 111.21 12.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.366 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.599 ' O ' HG13 ' A' ' 77' ' ' VAL . 0.3 OUTLIER -125.47 11.9 4.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.706 -179.453 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.7 158.59 18.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.836 0.351 . . . . 0.0 111.404 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.08 78.93 8.82 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.375 0.607 . . . . 0.0 110.297 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -167.53 149.68 5.41 Favored Pre-proline 0 N--CA 1.445 -0.702 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.152 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -64.77 160.68 39.47 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.507 2.138 . . . . 0.0 112.26 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.471 ' HG3' ' CZ ' ' A' ' 74' ' ' PHE . 15.0 ttm -51.52 -47.45 63.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.037 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.426 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 122.71 -6.51 9.68 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.603 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 32.6 pt -113.34 167.84 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.768 0.318 . . . . 0.0 110.779 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.539 ' SG ' HD13 ' A' ' 100' ' ' LEU . 18.7 m -134.27 126.26 29.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.513 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.776 HD23 HD13 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -124.15 159.32 30.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.964 -179.463 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.531 ' C ' HD13 ' A' ' 88' ' ' LEU . 16.4 pttp -136.42 164.83 27.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.102 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.681 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -106.51 103.21 12.61 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.951 179.71 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -64.85 176.5 1.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.665 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -52.24 -26.26 11.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.013 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.0 tptp -81.58 -8.41 59.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.325 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 67.67 89.2 0.1 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.849 0.357 . . . . 0.0 110.704 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.55 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 0.3 OUTLIER -166.31 146.28 6.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.416 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.444 ' SG ' HD11 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -87.88 114.98 25.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.964 0.411 . . . . 0.0 111.348 -179.369 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.592 HG23 ' O ' ' A' ' 115' ' ' ASP . 3.1 m -133.66 128.02 34.17 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.924 HG21 ' CD1' ' A' ' 99' ' ' ILE . 2.8 p -58.54 106.2 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.405 0.621 . . . . 0.0 110.404 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -72.67 -24.09 60.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.311 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.47 ' HA ' HG23 ' A' ' 113' ' ' VAL . 6.6 ttt85 -172.38 126.92 0.53 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.859 0.361 . . . . 0.0 111.175 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.924 ' CD1' HG21 ' A' ' 96' ' ' VAL . 17.7 mm -86.17 103.69 13.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.511 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.539 HD13 ' SG ' ' A' ' 85' ' ' CYS . 8.4 mp -63.87 144.32 57.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.091 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -82.96 128.03 34.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.808 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.36 -35.08 3.88 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.484 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.426 ' HA3' ' HA3' ' A' ' 83' ' ' GLY . . . -56.41 179.33 0.55 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.611 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 12.4 ptm -84.47 -30.31 25.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.772 0.32 . . . . 0.0 110.967 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.429 HD11 ' HG2' ' A' ' 82' ' ' MET . 39.5 mm -68.4 -36.54 75.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.865 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 18.5 t60 -74.43 -45.24 47.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.631 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.09 -49.8 53.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.604 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -73.79 -48.04 34.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.698 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.34 74.55 1.23 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.598 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.497 ' HB3' HG21 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -109.63 -30.28 7.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.824 0.345 . . . . 0.0 110.814 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.622 HD21 HG11 ' A' ' 148' ' ' VAL . 0.5 OUTLIER -147.81 164.5 33.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.92 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -130.29 143.58 50.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.792 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.559 ' O ' HG13 ' A' ' 113' ' ' VAL . 8.6 p -43.36 113.07 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.637 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.89 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 116.15 -24.18 10.15 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.708 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.708 ' HB3' HG21 ' A' ' 148' ' ' VAL . 0.4 OUTLIER -48.23 134.59 14.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.717 0.294 . . . . 0.0 110.844 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.63 ' C ' HG23 ' A' ' 148' ' ' VAL . 10.7 mt-10 -93.6 107.84 19.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.485 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.776 HD13 HD23 ' A' ' 86' ' ' LEU . 2.6 mp -87.14 98.41 7.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.626 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.606 ' CD2' HD12 ' A' ' 149' ' ' ILE . 3.7 mm? -63.03 -29.49 70.86 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.018 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -156.61 147.64 22.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.821 0.343 . . . . 0.0 111.162 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.706 HD12 HG23 ' A' ' 125' ' ' VAL . 18.6 mt -122.04 107.92 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.826 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 63.05 24.43 14.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.731 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.9 0.43 58.85 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.943 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.2 m -133.6 127.47 33.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.881 0.372 . . . . 0.0 111.181 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -93.02 142.03 27.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.72 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.967 HG11 HG13 ' A' ' 130' ' ' VAL . 13.0 t -91.69 137.32 22.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.178 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 62.7 p -116.07 -177.0 3.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.779 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -56.88 -22.27 35.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.169 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.36 -167.34 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.713 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 42.4 m -68.25 134.07 49.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.964 0.411 . . . . 0.0 110.775 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.967 HG13 HG11 ' A' ' 125' ' ' VAL . 0.6 OUTLIER -89.27 -20.14 7.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.219 179.714 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -44.76 -26.43 0.39 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.426 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.06 -57.6 10.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.831 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.826 HD13 HG22 ' A' ' 125' ' ' VAL . 3.7 mp -77.62 -34.68 53.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.035 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -59.76 -50.54 73.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.645 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -65.79 -44.97 84.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.69 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -65.67 -32.68 74.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.036 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 4.1 mmt -73.55 -26.37 60.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.049 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.35 -19.62 27.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.291 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.59 -23.52 13.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.432 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.4 t -59.32 147.19 36.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.821 0.343 . . . . 0.0 110.99 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -140.68 124.08 16.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.805 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 134.33 -160.02 24.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.493 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 27.8 mtp -77.31 110.17 11.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.774 0.321 . . . . 0.0 110.974 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.806 HD12 ' CZ ' ' A' ' 74' ' ' PHE . 53.8 mt -85.39 128.86 38.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.234 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.571 ' O ' HD13 ' A' ' 146' ' ' LEU . 71.6 m -109.28 120.95 44.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.335 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.721 HD22 ' N ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -123.98 132.28 53.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.993 0.425 . . . . 0.0 111.379 -179.396 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.2 105.22 17.33 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.708 HG21 ' HB3' ' A' ' 115' ' ' ASP . 6.1 p -136.04 141.9 40.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.037 0.446 . . . . 0.0 112.052 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.606 HD12 ' CD2' ' A' ' 118' ' ' LEU . 4.3 mt -105.45 131.58 21.63 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.643 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo . . . . . 0 C--N 1.346 0.446 0 C-N-CA 122.524 2.149 . . . . 0.0 112.322 -179.822 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . 0.422 ' HE2' ' CE1' ' B' ' 126' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.038 0 CA-C-O 121.02 0.438 . . . . 0.0 110.94 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -156.48 135.75 12.13 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.848 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 126' ' ' TYR . . . . . 0.623 ' CE1' HG21 ' A' ' 130' ' ' VAL . 38.2 m-85 -121.54 132.04 54.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.433 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 72.3 m -105.91 116.1 31.35 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . 0.463 ' N ' HD13 ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.576 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.5 p . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.857 0.361 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.79 ' HD3' HD11 ' A' ' 72' ' ' ILE . 9.8 ttt-85 -109.53 129.9 55.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.831 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.59 99.34 10.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.966 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.79 HD11 ' HD3' ' A' ' 70' ' ' ARG . 24.5 mm -98.47 110.4 25.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.428 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -122.27 144.22 49.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.054 0.454 . . . . 0.0 111.737 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.456 ' CZ ' ' CD2' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -153.29 145.04 23.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.271 179.132 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.22 139.07 36.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.016 0.436 . . . . 0.0 111.415 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -129.22 111.24 12.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.369 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -111.63 -28.63 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.263 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.48 150.45 21.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.306 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -89.34 91.32 8.7 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.323 0.582 . . . . 0.0 110.485 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -159.53 159.58 28.11 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.917 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.83 145.18 61.74 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.461 2.107 . . . . 0.0 112.159 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.3 mtm -54.95 -39.58 69.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.874 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 108.2 18.76 9.49 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.682 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.499 HG21 HG21 ' A' ' 105' ' ' ILE . 22.5 pt -127.75 165.85 25.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.731 0.3 . . . . 0.0 110.697 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -133.67 125.18 28.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.247 179.752 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.59 ' CD2' HD13 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -134.1 155.8 49.41 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.364 -179.118 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.443 ' HB3' ' HA ' ' B' ' 125' ' ' GLU . 0.6 OUTLIER -131.61 166.69 20.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.054 179.766 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.668 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.1 OUTLIER -98.59 103.19 15.11 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.643 179.594 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -64.29 176.45 1.05 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.594 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.71 -30.91 24.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.07 0.462 . . . . 0.0 110.833 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.98 -1.26 43.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.211 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 62.34 86.84 0.11 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.923 0.392 . . . . 0.0 110.462 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.559 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 0.3 OUTLIER -165.57 150.11 8.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.284 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.812 ' CB ' HD11 ' A' ' 120' ' ' ILE . 0.0 OUTLIER -87.86 114.95 24.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.036 0.446 . . . . 0.0 111.508 -179.213 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.515 HG23 ' HA ' ' A' ' 116' ' ' GLU . 2.2 m -126.9 124.77 40.32 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.882 HG13 ' H ' ' A' ' 114' ' ' GLY . 2.2 p -58.46 105.86 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.433 0.635 . . . . 0.0 110.504 -178.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -71.78 -24.34 61.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.761 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.525 ' HA ' HG23 ' A' ' 113' ' ' VAL . 11.3 tpp180 -173.52 130.0 0.44 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.736 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.699 HG22 ' CD2' ' A' ' 106' ' ' HIS . 44.4 mt -86.04 130.34 36.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.564 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.756 HD11 ' SG ' ' B' ' 127' ' ' CYS . 0.4 OUTLIER -93.28 122.03 35.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.833 -179.839 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -56.37 141.74 40.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.06 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.0 -36.9 4.05 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.429 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' A' ' 83' ' ' GLY . . . -59.25 160.09 17.81 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.634 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.5 ttp -66.28 -22.06 66.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.775 0.322 . . . . 0.0 111.044 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.65 ' N ' HD12 ' A' ' 105' ' ' ILE . 2.4 mp -83.11 -31.28 8.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.536 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.699 ' CD2' HG22 ' A' ' 99' ' ' ILE . 1.9 t-80 -88.02 -39.6 14.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.551 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.84 -47.5 68.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.6 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -83.26 -37.4 23.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.653 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.15 46.93 4.58 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.489 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.479 ' O ' HD12 ' A' ' 111' ' ' LEU . 1.0 OUTLIER -78.24 -29.13 48.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.731 0.3 . . . . 0.0 111.044 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.761 HD11 HG21 ' A' ' 148' ' ' VAL . 1.4 mp -136.28 166.79 22.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.984 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.523 ' HA ' HD11 ' A' ' 99' ' ' ILE . 27.9 m-70 -126.67 139.39 53.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.722 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.525 HG23 ' HA ' ' A' ' 98' ' ' ARG . 7.2 p -49.68 114.95 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.357 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.882 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 113.41 -21.49 17.02 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.837 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.48 ' O ' HG23 ' A' ' 95' ' ' THR . 6.0 m-20 -54.7 138.67 41.27 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.714 0.292 . . . . 0.0 110.821 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.515 ' HA ' HG23 ' A' ' 95' ' ' THR . 0.1 OUTLIER -93.6 120.01 33.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.911 0.386 . . . . 0.0 111.585 -179.286 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.669 HG13 HG22 ' A' ' 148' ' ' VAL . 4.4 mp -101.95 94.29 3.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.52 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.409 HD22 HD11 ' A' ' 149' ' ' ILE . 10.3 mp -61.73 -31.12 71.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.578 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -137.55 141.51 41.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.921 0.391 . . . . 0.0 111.353 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.889 HD12 HG23 ' A' ' 125' ' ' VAL . 19.8 mt -122.01 98.79 6.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.839 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 63.76 30.04 14.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.617 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 90.78 1.35 73.78 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.817 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 38.9 m -133.64 121.68 22.36 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.874 0.369 . . . . 0.0 111.136 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -88.63 120.59 30.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.647 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.994 HG11 HG13 ' A' ' 130' ' ' VAL . 34.7 t -63.3 136.22 26.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.21 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 73.7 p -103.96 -176.51 3.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.789 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -77.51 -16.56 58.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.23 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -61.25 -112.59 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.488 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 66.0 m -109.15 133.97 52.32 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.912 0.386 . . . . 0.0 110.944 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.994 HG13 HG11 ' A' ' 125' ' ' VAL . 0.7 OUTLIER -89.37 -23.75 6.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.08 179.478 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -45.58 -26.66 0.63 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.404 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -57.97 -56.92 15.83 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.728 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.929 HD13 HG22 ' A' ' 125' ' ' VAL . 4.9 mp -73.73 -33.46 64.36 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.757 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -59.78 -56.48 21.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.586 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.7 tptp -60.51 -38.55 84.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.564 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.4 -32.62 73.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.863 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 3.4 mmt -70.38 -30.27 67.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.805 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -83.84 -28.73 27.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.901 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -98.0 -5.02 34.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.577 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.44 154.07 17.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.799 0.333 . . . . 0.0 110.856 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.05 99.14 2.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 145.92 -149.73 21.89 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.611 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 2.8 mmm -93.42 122.45 35.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.879 0.371 . . . . 0.0 111.001 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 57.2 mt -87.78 152.85 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.09 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.507 ' C ' HD13 ' A' ' 146' ' ' LEU . 67.5 p -139.26 113.7 9.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.236 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.507 HD13 ' C ' ' A' ' 145' ' ' SER . 0.5 OUTLIER -116.4 133.12 56.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.116 -179.418 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.68 105.54 17.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.947 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.761 HG21 HD11 ' A' ' 111' ' ' LEU . 2.7 t -117.92 158.2 18.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.809 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.409 HD11 HD22 ' A' ' 118' ' ' LEU . 31.4 mt -136.63 133.08 18.87 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.8 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo . . . . . 0 C--N 1.346 0.415 0 C-N-CA 122.447 2.098 . . . . 0.0 112.325 -179.901 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.041 0 CA-C-O 120.99 0.424 . . . . 0.0 110.961 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . 0.443 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 0.6 OUTLIER -174.99 139.13 0.48 Allowed 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.788 179.634 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 126' ' ' TYR . . . . . 0.591 ' CE1' HG21 ' A' ' 130' ' ' VAL . 29.9 m-85 -129.41 133.22 47.24 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.131 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 127' ' ' CYS . . . . . 0.756 ' SG ' HD11 ' A' ' 100' ' ' LEU . 1.3 m -105.72 116.14 31.44 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . 0.692 ' N ' HD13 ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.283 -0.865 . . . . 0.0 111.356 -177.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.659 HG23 HG13 ' A' ' 149' ' ' ILE . 13.6 p . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 120.834 0.35 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -101.87 145.15 29.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.821 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.547 HD11 ' HB2' ' A' ' 145' ' ' SER . 10.7 tp -106.94 113.81 27.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.042 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.1 mm -89.31 130.11 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.861 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -119.12 123.43 44.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.962 0.411 . . . . 0.0 111.252 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.581 ' HE1' HD12 ' A' ' 144' ' ' ILE . 19.7 p90 -150.22 132.91 15.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.624 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 22.7 tt0 -83.38 138.04 33.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.349 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.471 ' HZ2' HD11 ' A' ' 144' ' ' ILE . 1.1 ttpm? -129.38 113.59 15.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.31 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.605 ' O ' HG13 ' A' ' 77' ' ' VAL . 0.3 OUTLIER -120.97 13.9 6.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.613 -179.562 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.07 148.57 31.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.756 0.312 . . . . 0.0 110.615 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -83.61 80.29 9.17 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.202 0.525 . . . . 0.0 110.011 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.81 163.25 5.57 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.175 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.5 148.66 92.97 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.507 2.138 . . . . 0.0 112.243 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.466 ' HG2' ' CE1' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -50.38 -41.58 52.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.224 -179.88 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 127.55 6.05 5.26 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.094 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.713 HD13 ' H ' ' A' ' 84' ' ' ILE . 0.2 OUTLIER -127.12 165.1 26.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.814 0.34 . . . . 0.0 110.914 179.728 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.497 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -127.09 127.85 45.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.106 179.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.707 HD23 HD13 ' A' ' 117' ' ' ILE . 1.1 mp -130.63 158.43 40.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.816 0.341 . . . . 0.0 110.917 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.62 ' C ' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -138.69 162.89 33.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.179 -179.768 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.67 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -104.66 103.14 12.74 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.474 179.425 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -64.39 176.34 1.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.781 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -52.88 -26.43 14.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.861 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 43.8 tptt -82.54 -8.17 59.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.188 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 68.56 89.84 0.1 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.8 0.333 . . . . 0.0 110.634 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.531 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 0.2 OUTLIER -166.64 146.19 5.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.52 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.663 ' HB2' HD11 ' A' ' 120' ' ' ILE . 0.5 OUTLIER -87.8 111.95 21.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.931 0.396 . . . . 0.0 111.428 -179.474 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 115' ' ' ASP . 1.6 m -129.12 126.13 38.64 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.9 HG13 ' H ' ' A' ' 114' ' ' GLY . 3.4 p -58.8 105.99 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 121.312 0.577 . . . . 0.0 110.549 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -74.9 -22.02 58.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.443 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.407 ' HA ' HG23 ' A' ' 113' ' ' VAL . 3.3 ptt180 -171.22 131.63 0.78 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.075 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.835 ' CD1' HG21 ' A' ' 96' ' ' VAL . 27.3 mm -86.22 103.72 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.73 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.802 HD11 ' SG ' ' B' ' 127' ' ' CYS . 8.6 mt -60.49 131.38 50.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.042 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.433 ' HA ' ' CG ' ' A' ' 106' ' ' HIS . 2.9 p80 -75.52 146.23 40.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.909 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.21 -33.51 5.57 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.525 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.67 -179.93 1.88 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.49 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 48.9 ttp -79.72 -33.21 41.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.772 0.32 . . . . 0.0 110.87 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.693 HG13 HD12 ' A' ' 84' ' ' ILE . 23.1 mm -70.7 -33.93 54.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.997 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.433 ' CG ' ' HA ' ' A' ' 101' ' ' HIS . 46.1 t-80 -78.58 -51.9 9.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.787 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.4 tpm_? -61.09 -43.35 99.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.717 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -83.05 -46.68 12.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.769 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.02 51.35 2.1 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.553 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.64 -29.36 30.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.752 0.31 . . . . 0.0 110.865 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.715 HD21 HG21 ' A' ' 148' ' ' VAL . 46.5 mt -134.41 172.21 13.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.953 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -138.04 131.72 31.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.727 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.562 ' O ' HG13 ' A' ' 113' ' ' VAL . 8.3 p -43.72 112.78 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.595 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.9 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 116.14 -25.49 9.32 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.603 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.509 ' O ' HG23 ' A' ' 95' ' ' THR . 0.2 OUTLIER -47.16 142.35 3.83 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.714 0.292 . . . . 0.0 110.902 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.408 ' HA ' HG23 ' A' ' 95' ' ' THR . 0.2 OUTLIER -96.27 111.18 23.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.428 -179.542 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.707 HD13 HD23 ' A' ' 86' ' ' LEU . 4.4 mp -95.69 95.82 5.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.67 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.862 HD23 ' CD1' ' A' ' 149' ' ' ILE . 3.2 mm? -65.49 -26.04 67.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.572 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.36 145.54 30.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.926 0.393 . . . . 0.0 111.375 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.663 HD11 ' HB2' ' A' ' 94' ' ' CYS . 2.8 mp -126.14 98.79 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.639 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 60.63 28.37 18.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.524 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.51 16.48 52.5 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.578 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 58.9 m -133.65 128.61 35.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.894 0.378 . . . . 0.0 111.228 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -104.56 87.88 2.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.48 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.824 HG11 ' CD2' ' A' ' 133' ' ' LEU . 10.8 m -53.36 156.53 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.709 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 55.9 p -138.08 -172.08 3.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.743 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -55.02 -23.32 19.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.151 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -56.76 -167.69 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.806 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 m -67.55 134.03 50.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.068 0.461 . . . . 0.0 111.001 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.649 HG21 ' CE1' ' B' ' 126' ' ' TYR . 0.4 OUTLIER -89.47 -16.23 8.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.344 179.746 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -43.6 -26.71 0.24 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.467 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.67 -43.37 69.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.979 0.419 . . . . 0.0 110.426 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.824 ' CD2' HG11 ' A' ' 125' ' ' VAL . 0.2 OUTLIER -78.58 -30.5 46.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.546 179.678 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.417 ' HG3' ' CG2' ' B' ' 128' ' ' ILE . 7.4 tt0 -75.09 -54.14 7.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.999 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.6 tptt -60.7 -47.79 84.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.002 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.467 ' O ' HG22 ' A' ' 140' ' ' THR . . . -61.06 -42.47 98.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.223 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.46 ' HG3' HD12 ' A' ' 133' ' ' LEU . 27.4 mmt -69.3 -27.58 65.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.195 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -90.56 -25.94 19.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.271 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -93.46 -26.58 17.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.26 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 136' ' ' ALA . 6.4 t -59.41 153.34 19.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.89 0.376 . . . . 0.0 111.006 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 24.1 mttp -143.82 114.26 7.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.764 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 142.66 -155.41 25.78 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.429 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.503 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 8.6 ptm -86.85 114.29 23.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.932 0.396 . . . . 0.0 110.995 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.581 HD12 ' HE1' ' A' ' 74' ' ' PHE . 45.1 mt -87.38 141.22 14.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.327 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.547 ' HB2' HD11 ' A' ' 71' ' ' LEU . 54.0 p -124.64 113.59 18.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.31 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.701 HD22 ' N ' ' A' ' 146' ' ' LEU . 0.3 OUTLIER -115.63 143.43 45.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.994 -179.566 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.476 ' HD2' HD13 ' A' ' 71' ' ' LEU . 1.3 mptt -97.39 105.23 17.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.837 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.715 HG21 HD21 ' A' ' 111' ' ' LEU . 3.4 t -122.59 158.34 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.081 0.467 . . . . 0.0 111.891 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.862 ' CD1' HD23 ' A' ' 118' ' ' LEU . 2.3 mp -133.04 134.89 24.92 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.62 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo . . . . . 0 C--N 1.346 0.397 0 C-N-CA 122.383 2.056 . . . . 0.0 112.443 -179.842 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.854 0.359 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . 0.441 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 13.2 pt-20 -153.08 134.75 14.5 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.148 0.499 . . . . 0.0 110.225 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 126' ' ' TYR . . . . . 0.649 ' CE1' HG21 ' A' ' 130' ' ' VAL . 31.3 m-85 -116.55 134.89 54.31 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.306 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 127' ' ' CYS . . . . . 0.802 ' SG ' HD11 ' A' ' 100' ' ' LEU . 2.0 m -106.02 115.87 30.97 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . 0.648 ' N ' HD13 ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.337 -177.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.596 ' O ' HG13 ' A' ' 69' ' ' VAL . 10.1 p . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 120.951 0.405 . . . . 0.0 111.055 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -109.39 144.61 37.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.835 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.63 HD12 ' HG2' ' A' ' 147' ' ' LYS . 2.3 tp -117.86 99.51 6.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.99 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.406 HG21 ' HB3' ' A' ' 110' ' ' SER . 26.2 mm -89.33 120.51 38.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.356 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 144' ' ' ILE . 0.6 OUTLIER -120.72 125.44 47.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.075 0.464 . . . . 0.0 111.889 -179.224 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.642 ' HE1' HD12 ' A' ' 144' ' ' ILE . 10.8 p90 -141.58 132.63 26.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.065 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 1.5 pt-20 -80.24 134.26 36.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.089 0.471 . . . . 0.0 111.519 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.18 123.79 32.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.271 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.605 ' O ' HG13 ' A' ' 77' ' ' VAL . 0.3 OUTLIER -140.14 15.67 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.581 -179.608 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -117.75 173.02 6.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.863 0.363 . . . . 0.0 110.831 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -97.9 81.01 2.81 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.317 0.58 . . . . 0.0 110.021 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -162.04 147.77 10.47 Favored Pre-proline 0 N--CA 1.446 -0.627 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.366 -178.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.87 160.83 48.12 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.562 2.174 . . . . 0.0 112.342 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.7 -49.0 78.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.969 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 115.86 16.48 6.83 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.748 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.612 HD12 ' O ' ' A' ' 84' ' ' ILE . 2.6 pp -128.82 162.02 36.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.73 0.3 . . . . 0.0 110.851 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.504 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -125.31 127.39 46.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.251 179.783 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.879 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -126.46 157.87 37.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.803 -179.642 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.591 ' C ' HD13 ' A' ' 88' ' ' LEU . 16.0 pttt -138.96 158.15 44.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.754 0.311 . . . . 0.0 111.407 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.635 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -106.35 106.1 16.46 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.592 179.586 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -64.22 176.21 1.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.905 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -53.09 -29.69 31.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.914 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.2 tptm -82.52 -4.8 58.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.174 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.408 ' HB3' ' HA ' ' A' ' 126' ' ' THR . 1.4 mt-30 69.11 87.09 0.12 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.818 0.342 . . . . 0.0 110.526 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 1.4 t -157.47 136.74 11.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.353 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.79 115.21 25.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.067 0.46 . . . . 0.0 111.598 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.63 HG23 ' O ' ' A' ' 115' ' ' ASP . 9.3 m -133.55 130.49 38.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.159 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.888 HG13 ' H ' ' A' ' 114' ' ' GLY . 3.7 p -59.9 105.97 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.271 0.558 . . . . 0.0 110.638 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -72.62 -24.32 61.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.192 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.418 ' HA ' HG23 ' A' ' 113' ' ' VAL . 11.2 ptt85 -172.2 131.82 0.63 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.09 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.877 ' CD1' HG21 ' A' ' 96' ' ' VAL . 29.3 mm -86.15 107.2 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.675 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.756 HD11 ' SG ' ' B' ' 127' ' ' CYS . 7.2 mt -61.29 135.79 57.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.958 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -81.28 130.31 34.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.989 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.3 -27.3 9.58 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.634 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.97 179.81 10.39 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.643 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 6.3 ptm -80.95 -30.36 35.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.868 0.366 . . . . 0.0 110.965 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.464 HG23 ' HB2' ' A' ' 110' ' ' SER . 37.6 mm -69.47 -34.99 64.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.959 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.419 ' ND1' HG22 ' A' ' 99' ' ' ILE . 2.7 t-160 -80.42 -41.11 25.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.74 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -73.17 -50.48 22.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.714 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -73.37 -44.33 58.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.86 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.24 75.87 1.31 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.502 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.464 ' HB2' HG23 ' A' ' 105' ' ' ILE . 1.1 m -111.76 -30.63 7.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.84 0.352 . . . . 0.0 111.082 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.789 HD21 HG11 ' A' ' 148' ' ' VAL . 1.1 mt -143.36 170.14 16.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.988 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -137.19 138.83 40.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.792 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.526 ' O ' HG13 ' A' ' 113' ' ' VAL . 7.6 p -44.99 114.23 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.633 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.888 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 119.19 -29.22 6.27 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.022 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.63 ' O ' HG23 ' A' ' 95' ' ' THR . 4.8 m-20 -50.65 134.93 24.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.713 0.292 . . . . 0.0 110.68 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.459 ' C ' HG23 ' A' ' 148' ' ' VAL . 7.4 pt-20 -92.25 108.8 20.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.942 0.401 . . . . 0.0 111.568 -179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.803 ' CD1' HD22 ' A' ' 86' ' ' LEU . 2.7 mp -86.9 99.31 8.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.718 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.422 ' N ' ' O ' ' A' ' 147' ' ' LYS . 4.0 mm? -52.06 -38.32 56.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.098 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -164.26 152.55 12.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.808 0.337 . . . . 0.0 111.374 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.862 HG23 HD12 ' A' ' 146' ' ' LEU . 26.8 mt -111.94 114.25 46.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.903 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 62.9 31.06 16.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.92 0.39 . . . . 0.0 110.659 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 83.38 19.57 62.05 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.596 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 19.3 m -133.63 111.61 10.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.832 0.348 . . . . 0.0 111.06 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -73.98 104.84 4.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.772 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.442 HG22 ' CD1' ' A' ' 133' ' ' LEU . 20.1 t -63.25 128.24 24.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.991 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.408 ' HA ' ' HB3' ' A' ' 92' ' ' GLN . 24.6 p -119.51 -170.48 1.95 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.863 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.01 -21.56 45.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.264 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 43.5 m80 -52.37 179.14 0.01 OUTLIER 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.802 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 45.6 m -63.97 133.89 54.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.009 0.433 . . . . 0.0 110.925 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.576 HG21 ' CE1' ' B' ' 126' ' ' TYR . 0.3 OUTLIER -89.56 -24.91 5.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.165 179.765 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.484 ' HA ' ' HG2' ' A' ' 134' ' ' GLN . 7.3 t70 -46.31 -26.01 0.74 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.599 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -70.24 -41.73 73.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.252 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.442 ' CD1' HG22 ' A' ' 125' ' ' VAL . 1.1 mt -74.02 -54.03 8.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.25 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.487 ' HB3' HG21 ' B' ' 128' ' ' ILE . 3.8 pt20 -55.85 -43.03 76.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.817 0.341 . . . . 0.0 111.061 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm -63.91 -40.76 97.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.645 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.547 ' O ' HG23 ' A' ' 140' ' ' THR . . . -76.13 -27.17 56.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.089 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.423 ' HE1' HG23 ' A' ' 144' ' ' ILE . 4.6 mmt -76.34 -27.94 56.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.6 mttm -82.06 -39.15 23.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.01 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -82.58 -16.11 49.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.403 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 136' ' ' ALA . 0.1 OUTLIER -59.29 131.39 50.84 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.879 0.371 . . . . 0.0 111.045 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -119.09 87.49 2.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.689 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 167.17 -150.32 16.9 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.541 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.482 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 1.0 OUTLIER -96.61 126.22 41.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.918 0.389 . . . . 0.0 111.183 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.707 ' CG2' HD11 ' A' ' 146' ' ' LEU . 59.2 mt -92.64 130.63 41.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.095 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.509 ' C ' HD13 ' A' ' 146' ' ' LEU . 5.4 m -116.93 116.79 28.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.409 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.862 HD12 HG23 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -117.76 142.98 46.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.261 -179.457 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.63 ' HG2' HD12 ' A' ' 71' ' ' LEU . 7.5 mttp -104.78 108.64 20.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.505 179.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.789 HG11 HD21 ' A' ' 111' ' ' LEU . 2.5 p -138.19 149.7 24.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.176 0.513 . . . . 0.0 111.863 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.415 ' CD1' ' HA ' ' A' ' 69' ' ' VAL . 6.3 mm -107.63 120.0 48.72 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.528 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo . . . . . 0 C--N 1.346 0.425 0 C-N-CA 122.398 2.065 . . . . 0.0 112.359 -179.866 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 2.0 tptt . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.819 0.343 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . 0.446 ' OE2' ' HB1' ' A' ' 97' ' ' ALA . 46.8 mt-10 -161.43 133.62 5.84 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.005 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 126' ' ' TYR . . . . . 0.576 ' CE1' HG21 ' A' ' 130' ' ' VAL . 38.0 m-85 -129.02 135.87 49.54 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.555 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 127' ' ' CYS . . . . . 0.756 ' SG ' HD11 ' A' ' 100' ' ' LEU . 1.7 m -106.05 116.04 31.25 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . 0.632 ' N ' HD13 ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.276 -0.868 . . . . 0.0 111.485 -177.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.553 ' O ' HG13 ' A' ' 69' ' ' VAL . 10.9 p . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.798 0.332 . . . . 0.0 111.066 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.56 138.07 39.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.766 HD12 ' HG2' ' A' ' 147' ' ' LYS . 2.8 tp -112.1 99.33 7.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.982 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.743 HD13 ' O ' ' A' ' 110' ' ' SER . 23.0 mt -94.44 149.27 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.424 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' A' ' 144' ' ' ILE . 10.4 mt-30 -145.92 135.39 23.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.036 0.446 . . . . 0.0 111.846 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.438 ' CZ ' HD23 ' A' ' 146' ' ' LEU . 2.4 p90 -145.52 130.89 18.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.204 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 3.7 tt0 -80.32 136.8 36.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.059 0.457 . . . . 0.0 111.617 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.13 116.41 19.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.29 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -96.28 -30.52 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.035 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.44 150.25 21.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.252 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -91.79 92.5 8.42 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.231 0.539 . . . . 0.0 110.61 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -163.54 159.77 17.72 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.027 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.52 136.47 40.83 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.573 2.182 . . . . 0.0 112.292 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.0 mpp? -58.34 -35.33 71.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.963 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 117.18 32.78 1.45 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.508 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.616 HD12 HD11 ' A' ' 86' ' ' LEU . 14.2 pt -151.27 158.71 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.778 0.323 . . . . 0.0 110.875 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.836 ' SG ' HD21 ' A' ' 100' ' ' LEU . 25.9 m -129.39 122.36 29.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.204 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.701 HD23 HD13 ' A' ' 117' ' ' ILE . 4.2 mp -116.38 159.62 21.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.955 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.508 ' HG2' ' HB2' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -135.62 148.25 48.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.335 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.796 HD23 ' NZ ' ' B' ' 124' ' ' LYS . 0.3 OUTLIER -81.73 107.23 14.3 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.407 179.285 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -64.2 176.11 1.11 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.898 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.31 -23.27 14.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.08 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.404 ' HD2' ' N ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -100.84 17.97 20.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.958 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 56.57 82.18 0.12 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.782 0.325 . . . . 0.0 110.471 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.548 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 1.2 m -151.04 142.42 23.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.484 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -87.67 111.2 21.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.01 0.433 . . . . 0.0 111.495 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.528 HG23 ' HA ' ' A' ' 116' ' ' GLU . 7.0 m -128.82 130.03 46.4 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.912 HG13 ' H ' ' A' ' 114' ' ' GLY . 3.7 p -58.7 105.7 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-O 121.355 0.598 . . . . 0.0 110.657 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.508 ' HB2' ' HG2' ' A' ' 87' ' ' LYS . . . -70.41 -26.65 63.78 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.955 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.507 ' HA ' HG23 ' A' ' 113' ' ' VAL . 33.2 ttt-85 -173.4 133.94 0.51 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.045 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.87 ' CD1' HG21 ' A' ' 96' ' ' VAL . 25.0 mm -86.07 143.04 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.577 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.836 HD21 ' SG ' ' A' ' 85' ' ' CYS . 0.5 OUTLIER -101.54 142.11 33.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.877 0.37 . . . . 0.0 110.956 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.434 ' HA ' ' CD2' ' A' ' 106' ' ' HIS . 43.7 m-70 -77.25 137.25 38.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.95 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.19 -24.95 26.53 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.539 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.16 161.31 11.23 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.49 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 11.8 tmm? -67.47 -22.71 65.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.705 0.288 . . . . 0.0 111.158 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.606 HG21 ' HB2' ' A' ' 111' ' ' LEU . 28.2 mm -84.93 -38.36 13.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.017 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.434 ' CD2' ' HA ' ' A' ' 101' ' ' HIS . 75.1 t60 -76.13 -39.88 54.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.538 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 7.8 tpp85 -71.28 -45.92 62.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.563 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -79.21 -42.74 25.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.663 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.82 72.0 1.21 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.531 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.755 ' O ' HD22 ' A' ' 111' ' ' LEU . 1.3 m -113.48 -29.4 7.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.758 0.313 . . . . 0.0 111.155 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.772 HD11 HG21 ' A' ' 148' ' ' VAL . 3.7 mm? -132.78 169.22 17.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.981 0.42 . . . . 0.0 111.113 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -143.02 132.28 23.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.572 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.584 ' O ' HG13 ' A' ' 113' ' ' VAL . 8.3 p -41.67 110.94 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.773 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.912 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 119.09 -31.45 5.47 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.915 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.488 ' O ' HG23 ' A' ' 95' ' ' THR . 7.7 m-20 -52.0 133.62 32.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.668 0.271 . . . . 0.0 110.548 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.528 ' HA ' HG23 ' A' ' 95' ' ' THR . 57.4 mt-10 -92.75 114.47 27.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.931 0.396 . . . . 0.0 111.735 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.701 HD13 HD23 ' A' ' 86' ' ' LEU . 3.2 mp -89.39 98.58 8.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.552 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.742 HD23 HG12 ' A' ' 149' ' ' ILE . 4.5 mm? -69.91 -24.38 63.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.579 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -142.79 139.04 30.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.99 0.424 . . . . 0.0 111.346 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.456 HD12 ' HA ' ' A' ' 124' ' ' ASN . 4.1 mp -124.28 98.66 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.727 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 62.79 28.68 16.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.714 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 96.78 -1.9 61.78 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.985 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 25.8 m -133.53 134.89 43.98 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.848 0.356 . . . . 0.0 111.158 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.456 ' HA ' HD12 ' A' ' 120' ' ' ILE . 11.6 t-20 -103.72 105.63 15.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.679 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 1.009 HG21 HG13 ' A' ' 130' ' ' VAL . 12.7 p -56.4 137.38 18.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.213 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.1 p -117.62 -173.3 2.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.691 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -52.35 -24.31 7.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.29 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 13.8 m170 -57.31 -166.82 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.813 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.9 m -69.45 134.29 48.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.903 0.382 . . . . 0.0 110.939 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 1.009 HG13 HG21 ' A' ' 125' ' ' VAL . 0.5 OUTLIER -89.11 -21.03 6.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.263 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -46.09 -26.43 0.75 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.278 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.47 -48.94 79.71 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.622 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.536 HD22 ' HB ' ' A' ' 125' ' ' VAL . 5.6 mp -79.47 -35.38 40.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.818 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -58.42 -49.4 77.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.71 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.9 tptm -68.96 -44.91 72.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.723 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.19 -30.96 71.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.01 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.401 ' HE2' ' HA ' ' A' ' 137' ' ' MET . 21.7 mmt -74.35 -31.85 62.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.896 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.6 mttp -83.8 -30.49 26.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.749 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -86.64 -17.03 34.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.229 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.28 145.03 44.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.844 0.354 . . . . 0.0 111.021 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -141.92 93.59 2.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.669 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 151.53 -149.41 21.17 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.626 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.448 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 72.9 mtp -87.83 119.85 28.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.85 0.357 . . . . 0.0 111.333 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.446 HG22 ' CD2' ' A' ' 146' ' ' LEU . 46.2 mt -97.43 130.99 45.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.995 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.6 m -108.99 114.32 27.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.506 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.661 HD22 ' N ' ' A' ' 146' ' ' LEU . 0.7 OUTLIER -116.57 130.58 56.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.929 -179.577 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.766 ' HG2' HD12 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -96.47 119.09 34.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.241 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.772 HG21 HD11 ' A' ' 111' ' ' LEU . 1.8 t -132.01 154.99 41.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.07 0.462 . . . . 0.0 111.843 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.742 HG12 HD23 ' A' ' 118' ' ' LEU . 18.2 mm -119.92 122.4 29.06 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.655 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo . . . . . 0 C--N 1.346 0.44 0 C-N-CA 122.403 2.068 . . . . 0.0 112.439 -179.881 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . 0.796 ' NZ ' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.88 0.372 . . . . 0.0 111.005 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -144.32 131.64 20.81 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.298 0.57 . . . . 0.0 109.925 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 126' ' ' TYR . . . . . 0.596 ' CE1' HG21 ' A' ' 130' ' ' VAL . 18.6 m-85 -100.92 140.95 34.49 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.666 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 95.6 m -106.39 116.02 31.21 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . 0.623 ' N ' HD13 ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.453 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.485 ' O ' HG13 ' A' ' 69' ' ' VAL . 14.2 p . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.867 0.365 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.4 ttt-85 -112.5 156.18 23.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.836 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.9 tp -121.26 100.4 7.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.004 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.402 HG21 ' HB3' ' A' ' 110' ' ' SER . 3.3 mp -89.17 143.22 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.511 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -133.0 131.77 41.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.072 0.463 . . . . 0.0 111.838 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.476 ' CE2' HD23 ' A' ' 146' ' ' LEU . 6.9 p90 -146.69 137.42 23.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.096 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -80.35 139.72 36.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.964 0.411 . . . . 0.0 111.396 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.13 111.14 12.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.292 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -116.12 -22.9 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.573 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.48 151.47 21.36 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.954 0.407 . . . . 0.0 111.501 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -87.22 88.25 7.64 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.37 0.605 . . . . 0.0 110.462 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -167.38 152.95 7.2 Favored Pre-proline 0 N--CA 1.446 -0.641 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.985 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -56.47 142.51 89.33 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.522 2.148 . . . . 0.0 112.119 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -55.01 -37.06 66.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.987 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.404 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 117.57 29.47 2.07 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.527 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.949 HD13 HD21 ' A' ' 86' ' ' LEU . 2.8 pp -145.4 164.59 11.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.684 0.278 . . . . 0.0 110.909 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.498 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -131.98 123.6 27.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.35 -0.386 . . . . 0.0 109.989 179.617 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.949 HD21 HD13 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -126.58 158.01 37.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.944 -179.373 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.602 ' C ' HD13 ' A' ' 88' ' ' LEU . 6.9 pttp -141.54 163.41 33.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.006 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.656 ' N ' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -103.75 103.09 12.94 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.68 179.706 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -68.07 176.75 2.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.626 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.57 -27.3 6.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.941 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -77.04 -15.18 59.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.255 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 71.11 88.57 0.1 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.896 0.379 . . . . 0.0 110.637 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.534 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 10.1 t -171.04 148.67 2.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.386 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.577 ' SG ' HD11 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -87.78 111.43 21.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.962 0.411 . . . . 0.0 111.39 -179.437 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.549 HG23 ' HA ' ' A' ' 116' ' ' GLU . 9.4 m -129.93 132.22 46.27 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.331 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.895 HG13 ' H ' ' A' ' 114' ' ' GLY . 2.2 p -58.67 106.09 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.326 0.584 . . . . 0.0 110.86 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -71.26 -24.56 62.19 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.981 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.448 ' HA ' HG23 ' A' ' 113' ' ' VAL . 7.6 ttt180 -171.44 138.72 1.2 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.031 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.483 HD13 HG21 ' A' ' 96' ' ' VAL . 19.8 mm -86.11 109.13 18.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.657 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.767 HD11 ' SG ' ' B' ' 127' ' ' CYS . 21.4 mt -62.78 146.57 52.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.105 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -80.93 129.59 34.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.17 4.35 81.44 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.806 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.404 ' HA3' ' HA3' ' A' ' 83' ' ' GLY . . . -76.17 160.3 51.1 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.494 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 40.5 ttp -59.72 -31.86 70.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.867 0.365 . . . . 0.0 110.819 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 29.5 mm -80.77 -31.85 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.828 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -77.93 -53.85 6.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.622 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -60.63 -46.13 91.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.605 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -77.88 -42.68 32.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.685 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.32 67.69 1.43 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.523 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.402 ' HB3' HG21 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -112.06 -20.47 11.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.631 0.253 . . . . 0.0 111.226 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 1.09 HD11 HG11 ' A' ' 148' ' ' VAL . 0.4 OUTLIER -141.4 171.06 14.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.876 0.37 . . . . 0.0 111.026 -179.825 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -139.46 142.0 37.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.795 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.468 ' O ' HG13 ' A' ' 113' ' ' VAL . 7.1 p -45.86 121.67 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.509 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.895 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 110.35 -21.75 23.66 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.583 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.844 ' HB3' HG21 ' A' ' 148' ' ' VAL . 0.4 OUTLIER -52.63 121.41 7.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.656 0.265 . . . . 0.0 110.544 179.762 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.803 ' C ' HG23 ' A' ' 148' ' ' VAL . 62.3 mt-10 -85.25 107.58 17.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.809 0.338 . . . . 0.0 111.447 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.494 HD13 HD13 ' A' ' 86' ' ' LEU . 2.8 mp -84.86 96.88 4.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.767 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.662 HD23 HD12 ' A' ' 149' ' ' ILE . 3.9 mm? -57.85 -29.84 65.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.171 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -154.28 145.32 22.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.902 0.382 . . . . 0.0 111.241 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.605 HG23 ' CD1' ' A' ' 146' ' ' LEU . 17.0 mt -116.77 102.6 13.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.664 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 56.87 25.43 10.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.737 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 95.73 24.78 14.68 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.541 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.4 m -133.57 123.05 24.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.849 0.357 . . . . 0.0 111.225 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.81 82.69 1.91 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.609 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.769 ' CB ' HD11 ' A' ' 133' ' ' LEU . 11.6 p -56.5 158.33 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.347 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.475 ' N ' HG22 ' A' ' 125' ' ' VAL . 1.4 p -136.88 -173.5 3.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.75 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -61.02 -15.37 31.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.493 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -58.87 -116.9 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.833 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 m -109.01 134.15 52.04 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.88 0.372 . . . . 0.0 111.143 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.836 HG21 ' CE1' ' B' ' 126' ' ' TYR . 0.6 OUTLIER -89.26 -20.68 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.984 179.53 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -45.55 -26.4 0.58 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.345 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -59.42 -40.31 86.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.55 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.769 HD11 ' CB ' ' A' ' 125' ' ' VAL . 0.6 OUTLIER -79.41 -51.54 9.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.546 179.598 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -49.74 -46.78 50.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.909 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -53.36 42.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.912 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.76 -64.26 1.01 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.537 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.511 ' HE3' HD13 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -46.0 -35.83 5.11 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.502 -179.784 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -80.52 -26.14 38.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.253 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -99.28 3.22 46.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.597 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.93 149.29 41.51 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.893 0.377 . . . . 0.0 110.83 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.91 89.45 1.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.821 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 161.35 -130.75 2.41 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.43 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 38.6 mmm -109.26 122.6 47.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.814 0.34 . . . . 0.0 110.901 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.534 HG22 ' CD2' ' A' ' 146' ' ' LEU . 46.9 mt -96.69 143.72 11.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.298 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 28.4 p -125.61 113.68 17.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.918 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.605 ' CD1' HG23 ' A' ' 120' ' ' ILE . 2.7 mm? -110.36 123.17 49.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.975 0.417 . . . . 0.0 111.587 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -98.06 105.25 17.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.484 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 1.09 HG11 HD11 ' A' ' 111' ' ' LEU . 2.9 p -135.16 143.22 37.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.033 0.444 . . . . 0.0 111.99 -178.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.662 HD12 HD23 ' A' ' 118' ' ' LEU . 4.6 mt -112.86 130.71 23.24 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.666 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 149' ' ' ILE . 31.2 Cg_exo . . . . . 0 C--N 1.346 0.396 0 C-N-CA 122.435 2.09 . . . . 0.0 112.075 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.906 0.384 . . . . 0.0 110.935 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . 0.43 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 1.8 mp0 -164.09 136.18 4.83 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.712 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 126' ' ' TYR . . . . . 0.836 ' CE1' HG21 ' A' ' 130' ' ' VAL . 34.4 m-85 -113.91 131.19 56.38 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.267 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 127' ' ' CYS . . . . . 0.767 ' SG ' HD11 ' A' ' 100' ' ' LEU . 1.8 m -105.83 116.07 31.31 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . 0.659 ' N ' HD13 ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.458 -177.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.57 ' O ' HG13 ' A' ' 69' ' ' VAL . 14.9 p . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.89 0.376 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -108.97 147.83 31.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.716 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.44 99.24 7.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.002 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.5 mm -91.16 110.37 22.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.307 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.421 ' HA ' ' O ' ' A' ' 144' ' ' ILE . 26.0 mt-30 -113.84 130.71 56.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.98 0.419 . . . . 0.0 111.889 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.552 ' HE1' HD12 ' A' ' 144' ' ' ILE . 4.5 p90 -142.4 146.33 34.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.067 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -80.25 143.49 33.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.992 0.425 . . . . 0.0 111.245 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.482 ' HD3' HD11 ' A' ' 144' ' ' ILE . 1.3 tttt -128.93 111.28 12.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.593 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -105.9 -30.14 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.162 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.59 146.66 23.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.151 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -99.29 96.3 7.64 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.637 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.401 ' CB ' ' CD ' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -174.65 178.09 0.57 Allowed Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.921 -179.135 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.401 ' CD ' ' CB ' ' A' ' 80' ' ' GLU . 51.9 Cg_exo -54.53 125.32 18.58 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.444 2.096 . . . . 0.0 112.327 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.417 ' HB3' ' OXT' ' B' ' 128' ' ' ILE . 26.4 ttm -47.13 -48.15 23.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.06 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.4 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 135.65 -7.88 4.25 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.495 -0.86 . . . . 0.0 113.031 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.51 HG23 ' HB ' ' A' ' 105' ' ' ILE . 17.8 pt -117.81 166.93 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.888 0.375 . . . . 0.0 111.254 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.495 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -129.31 124.28 33.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.711 179.594 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.957 HD12 HD11 ' B' ' 128' ' ' ILE . 0.3 OUTLIER -121.43 157.39 30.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.711 0.291 . . . . 0.0 111.158 -179.294 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.801 ' HG2' ' HB2' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -140.37 160.54 39.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.328 179.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.609 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.4 OUTLIER -90.43 103.12 15.84 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.47 179.454 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -64.3 176.51 1.04 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.784 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -51.31 -23.77 3.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.046 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.28 15.48 20.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.273 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.0 mp0 50.17 81.59 0.06 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.776 0.322 . . . . 0.0 110.798 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.565 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 0.3 OUTLIER -153.6 155.37 35.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.774 -179.737 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.448 ' CB ' HD11 ' A' ' 120' ' ' ILE . 0.5 OUTLIER -87.85 111.49 21.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.946 0.403 . . . . 0.0 111.088 -179.624 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 115' ' ' ASP . 1.9 m -133.22 127.87 34.67 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.875 HG13 ' H ' ' A' ' 114' ' ' GLY . 3.9 p -58.68 106.02 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.411 0.624 . . . . 0.0 110.56 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.801 ' HB2' ' HG2' ' A' ' 87' ' ' LYS . . . -73.24 -23.54 60.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.493 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.403 ' HA ' HG23 ' A' ' 113' ' ' VAL . 0.2 OUTLIER -172.16 134.02 0.71 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.124 179.891 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.873 HD13 HG21 ' A' ' 96' ' ' VAL . 29.1 mm -86.21 109.13 18.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.769 HD11 ' SG ' ' B' ' 127' ' ' CYS . 6.5 mt -65.74 143.57 57.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.035 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -78.39 133.24 37.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.933 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.43 45.7 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.676 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.4 ' HA3' ' HA3' ' A' ' 83' ' ' GLY . . . -56.95 164.1 6.18 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.679 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 6.6 tmm? -60.44 -43.36 96.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.82 0.343 . . . . 0.0 110.981 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.51 ' HB ' HG23 ' A' ' 84' ' ' ILE . 32.2 mm -67.94 -38.39 79.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.05 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -71.53 -44.7 64.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.661 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -69.56 -52.02 30.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.712 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -71.54 -52.16 19.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.624 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.98 105.82 1.86 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.579 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.06 -45.58 0.13 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.874 0.368 . . . . 0.0 110.958 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.654 HD11 HG11 ' A' ' 148' ' ' VAL . 1.5 mp -117.41 172.6 7.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.974 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -141.73 143.45 33.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.561 ' O ' HG13 ' A' ' 113' ' ' VAL . 7.1 p -44.31 112.01 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.631 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.875 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 115.84 -23.18 11.05 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.847 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.59 ' O ' HG23 ' A' ' 95' ' ' THR . 1.0 OUTLIER -47.87 140.73 6.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.633 0.254 . . . . 0.0 110.825 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -93.18 111.62 23.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.759 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.889 HD13 HD22 ' A' ' 86' ' ' LEU . 3.7 mp -99.25 109.03 23.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.513 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -71.22 -26.96 63.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.698 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.608 ' C ' HD12 ' A' ' 120' ' ' ILE . 3.4 mt-10 -154.05 156.85 38.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.059 0.456 . . . . 0.0 111.625 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.94 HD13 HG23 ' A' ' 125' ' ' VAL . 3.2 mp -129.54 100.84 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.387 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.424 ' OD1' HG23 ' A' ' 144' ' ' ILE . 1.8 m-20 67.02 24.25 9.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.612 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 95.89 8.5 58.03 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.832 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.2 m -133.75 127.33 32.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.805 0.336 . . . . 0.0 111.212 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -87.8 121.0 29.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.453 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.94 HG23 HD13 ' A' ' 120' ' ' ILE . 14.9 t -77.1 119.08 24.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.117 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.7 p -108.52 -167.06 1.18 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.906 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -67.58 -16.74 64.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.171 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -166.93 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.599 0.238 . . . . 0.0 110.441 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 21.4 t -68.7 133.53 48.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.942 0.401 . . . . 0.0 110.621 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.707 HG21 ' CE1' ' B' ' 126' ' ' TYR . 0.6 OUTLIER -89.6 -26.2 5.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.095 179.746 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -45.49 -27.76 0.79 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.309 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -51.49 68.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.593 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.617 HD22 HG22 ' A' ' 125' ' ' VAL . 2.0 mp -80.78 -29.68 36.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.752 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -63.32 -43.06 98.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.728 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.93 -41.41 51.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.823 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.6 -45.42 87.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.142 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.817 ' O ' HG22 ' A' ' 140' ' ' THR . 70.1 mmm -70.43 -30.32 67.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.999 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -76.5 -28.52 56.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.027 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.12 -0.27 26.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.424 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.817 HG22 ' O ' ' A' ' 137' ' ' MET . 12.3 t -60.97 153.69 24.45 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.818 0.342 . . . . 0.0 110.886 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.02 118.18 6.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.849 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 129.98 -153.12 19.91 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.585 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 18.3 mmm -85.34 113.52 21.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.77 0.319 . . . . 0.0 110.975 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.552 HD12 ' HE1' ' A' ' 74' ' ' PHE . 49.6 mt -85.26 148.19 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.11 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 48.8 p -128.3 115.24 17.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.399 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.534 ' CD2' HG22 ' A' ' 144' ' ' ILE . 2.3 mm? -117.71 131.86 56.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.25 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.95 105.42 17.44 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.654 HG11 HD11 ' A' ' 111' ' ' LEU . 5.3 p -139.05 157.86 28.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.101 0.477 . . . . 0.0 112.045 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.479 ' N ' HG22 ' A' ' 148' ' ' VAL . 2.9 mp -137.68 127.32 15.22 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.679 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 149' ' ' ILE . 34.7 Cg_exo . . . . . 0 C--N 1.348 0.503 0 C-N-CA 122.378 2.052 . . . . 0.0 112.241 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 4.2 mmtp . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.867 0.365 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . 0.526 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 13.5 mt-10 -168.01 135.73 2.25 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.196 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 126' ' ' TYR . . . . . 0.707 ' CE1' HG21 ' A' ' 130' ' ' VAL . 37.9 m-85 -129.12 132.64 47.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.175 -179.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 127' ' ' CYS . . . . . 0.769 ' SG ' HD11 ' A' ' 100' ' ' LEU . 1.8 m -105.81 115.95 31.1 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . 0.957 HD11 HD12 ' A' ' 86' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.289 -0.862 . . . . 0.0 111.24 -177.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.541 HG21 ' HD2' ' A' ' 147' ' ' LYS . 11.3 p . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.789 0.328 . . . . 0.0 111.013 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -96.68 132.88 41.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.962 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.446 HD23 ' OE1' ' A' ' 73' ' ' GLN . 5.0 tp -110.25 102.84 11.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.921 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 23.9 mm -89.26 120.5 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.774 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.446 ' OE1' HD23 ' A' ' 71' ' ' LEU . 25.7 mt-30 -119.37 123.23 43.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.426 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.745 ' HE1' HD12 ' A' ' 144' ' ' ILE . 18.4 p90 -152.18 135.56 15.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.556 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -80.33 139.9 36.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.253 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -129.21 111.21 12.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.25 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.591 ' O ' HG13 ' A' ' 77' ' ' VAL . 0.3 OUTLIER -131.42 12.95 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.47 -179.589 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.67 163.11 16.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.012 0.434 . . . . 0.0 111.327 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.95 79.52 6.58 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.285 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.36 126.89 0.95 Allowed Pre-proline 0 N--CA 1.445 -0.684 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.275 -178.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.44 166.76 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.574 2.182 . . . . 0.0 112.411 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 21.9 ttm -58.83 -51.27 70.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.415 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 121.79 21.55 2.91 Favored Glycine 0 CA--C 1.517 0.163 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.808 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.428 HG21 HG21 ' A' ' 105' ' ' ILE . 15.7 pt -137.48 166.4 24.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.657 0.265 . . . . 0.0 110.639 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.485 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -130.67 124.94 32.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.582 179.798 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.581 ' CD2' HD13 ' A' ' 117' ' ' ILE . 0.4 OUTLIER -129.22 155.99 44.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.025 -179.564 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.407 ' O ' ' O ' ' A' ' 93' ' ' SER . 0.1 OUTLIER -134.63 166.83 22.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.119 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.706 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -102.12 106.36 17.21 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.224 179.598 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.408 ' HB2' ' HD2' ' A' ' 91' ' ' LYS . 1.4 m120 -64.22 176.36 1.05 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.809 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -51.19 -23.19 3.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.322 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.408 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -97.1 15.69 21.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.367 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.473 ' HB3' ' HA ' ' A' ' 126' ' ' THR . 1.0 OUTLIER 54.37 75.56 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.723 0.296 . . . . 0.0 110.68 179.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 78.8 p -143.93 133.05 22.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.712 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.556 ' SG ' HD11 ' A' ' 120' ' ' ILE . 10.9 p -87.63 112.18 22.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.058 0.456 . . . . 0.0 111.459 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.798 HG23 ' O ' ' A' ' 115' ' ' ASP . 23.9 m -133.57 134.61 43.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.419 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.893 HG13 ' H ' ' A' ' 114' ' ' GLY . 2.1 p -58.93 106.21 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.71 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -71.47 -25.33 62.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.862 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.533 ' HA ' HG23 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -173.52 131.03 0.45 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.563 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.552 HD11 ' HA ' ' A' ' 112' ' ' HIS . 39.3 mt -85.92 138.26 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.453 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.658 HD22 ' N ' ' A' ' 100' ' ' LEU . 0.9 OUTLIER -97.8 142.24 29.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.85 0.357 . . . . 0.0 111.069 -179.715 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.447 ' HA ' ' CD2' ' A' ' 106' ' ' HIS . 0.5 OUTLIER -75.05 143.54 43.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.87 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.54 -29.01 11.0 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.359 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.415 ' HA3' ' HA3' ' A' ' 83' ' ' GLY . . . -61.5 160.76 27.9 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.424 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.43 ' SD ' HD13 ' A' ' 105' ' ' ILE . 2.3 ppp? -65.47 -31.3 72.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.773 0.321 . . . . 0.0 110.826 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.43 HD13 ' SD ' ' A' ' 104' ' ' MET . 44.2 mm -71.9 -36.07 56.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.948 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.447 ' CD2' ' HA ' ' A' ' 101' ' ' HIS . 86.2 t60 -80.48 -47.16 14.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.622 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -64.35 -46.72 82.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.664 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -79.76 -41.79 25.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.682 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 85.17 70.67 1.33 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.418 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.3 m -109.12 -26.79 9.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.774 0.321 . . . . 0.0 111.027 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.84 ' CD2' HG11 ' A' ' 148' ' ' VAL . 6.2 mt -134.39 168.2 19.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.066 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.552 ' HA ' HD11 ' A' ' 99' ' ' ILE . 76.9 m80 -133.07 136.73 46.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.65 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.533 HG23 ' HA ' ' A' ' 98' ' ' ARG . 7.5 p -46.02 115.75 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.292 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.893 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 112.22 -18.83 23.13 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.725 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.798 ' O ' HG23 ' A' ' 95' ' ' THR . 0.2 OUTLIER -55.51 132.38 48.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.694 0.247 . . . . 0.0 110.539 179.79 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -89.78 113.13 24.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.86 0.362 . . . . 0.0 111.483 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.641 HG21 HG12 ' A' ' 120' ' ' ILE . 3.4 mp -87.21 99.79 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.734 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -57.21 -29.44 63.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.125 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -160.55 143.16 13.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.18 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.641 HG12 HG21 ' A' ' 117' ' ' ILE . 17.6 mt -112.56 104.62 17.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.888 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 58.99 30.56 20.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.893 0.378 . . . . 0.0 110.556 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 87.65 13.14 65.6 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.581 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.6 m -133.62 117.14 16.69 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.764 0.316 . . . . 0.0 111.137 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -94.98 84.44 4.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.539 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.992 HG21 HG13 ' A' ' 130' ' ' VAL . 9.2 p -47.11 142.87 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.254 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.473 ' HA ' ' HB3' ' A' ' 92' ' ' GLN . 10.1 p -119.0 -173.42 2.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.868 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 27.9 p30 -51.75 -25.77 8.18 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.202 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.09 -171.61 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.765 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 10.0 m -65.4 134.44 53.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.91 0.386 . . . . 0.0 111.127 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.992 HG13 HG21 ' A' ' 125' ' ' VAL . 0.8 OUTLIER -88.82 -16.36 8.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.15 179.612 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -45.18 -25.92 0.42 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.348 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.23 -52.34 62.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.508 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.489 HD13 ' HB ' ' A' ' 125' ' ' VAL . 6.2 mp -76.87 -33.35 57.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.624 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 11.1 tp60 -64.0 -51.07 65.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.566 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.85 -40.64 97.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.749 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.77 -40.71 79.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.058 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.701 ' O ' HG22 ' A' ' 140' ' ' THR . 12.4 mmt -65.8 -33.28 75.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.832 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.15 -37.01 58.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -99.65 10.13 41.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.276 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.701 HG22 ' O ' ' A' ' 137' ' ' MET . 10.9 t -61.32 156.93 17.66 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.778 0.323 . . . . 0.0 110.996 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -154.1 110.29 3.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.016 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 129.21 -158.78 22.17 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.67 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 17.4 mtp -85.24 116.18 23.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.916 0.389 . . . . 0.0 110.937 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.745 HD12 ' HE1' ' A' ' 74' ' ' PHE . 32.1 mt -87.1 130.13 37.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.257 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.1 m -112.44 113.66 25.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.254 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.646 HD22 ' N ' ' A' ' 146' ' ' LEU . 0.5 OUTLIER -116.53 129.85 56.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.405 -179.412 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.541 ' HD2' HG21 ' A' ' 69' ' ' VAL . 0.6 OUTLIER -95.82 107.41 19.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.014 179.307 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.84 HG11 ' CD2' ' A' ' 111' ' ' LEU . 2.3 t -124.92 157.88 33.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.013 0.435 . . . . 0.0 111.805 -178.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 31.1 mt -137.21 118.82 11.04 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.745 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo . . . . . 0 C--N 1.349 0.564 0 C-N-CA 122.489 2.126 . . . . 0.0 112.523 -179.818 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.916 0.389 . . . . 0.0 110.962 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . 0.405 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 4.7 pm0 -158.69 136.55 10.43 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.009 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 126' ' ' TYR . . . . . 0.63 ' CE1' HG21 ' A' ' 130' ' ' VAL . 34.4 m-85 -117.35 132.52 56.58 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.165 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 2.0 m -105.74 116.12 31.4 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . 0.705 ' N ' HD13 ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.43 -177.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.58 ' O ' HG13 ' A' ' 69' ' ' VAL . 10.3 p . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.843 0.354 . . . . 0.0 111.074 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -123.95 119.82 30.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.821 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.7 tp -87.44 99.3 11.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.026 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 37.1 mt -109.11 133.51 54.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.342 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 144' ' ' ILE . 0.0 OUTLIER -132.36 126.51 33.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.946 0.403 . . . . 0.0 111.689 -179.436 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.648 ' HE1' HD12 ' A' ' 144' ' ' ILE . 4.5 p90 -117.74 144.06 45.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.324 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -80.27 137.32 36.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.884 0.373 . . . . 0.0 111.333 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -129.2 111.24 12.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.368 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.586 ' O ' HG13 ' A' ' 77' ' ' VAL . 0.3 OUTLIER -124.71 10.85 4.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.562 -179.545 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.6 152.7 38.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.879 0.371 . . . . 0.0 111.291 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -93.59 87.47 5.52 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.435 0.636 . . . . 0.0 110.374 179.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.438 ' HG2' ' HD2' ' A' ' 81' ' ' PRO . 0.3 OUTLIER -171.22 164.07 4.99 Favored Pre-proline 0 N--CA 1.448 -0.573 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.666 -178.829 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.438 ' HD2' ' HG2' ' A' ' 80' ' ' GLU . 25.0 Cg_endo -61.85 141.82 91.25 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.411 2.074 . . . . 0.0 112.071 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -54.11 -40.67 67.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.96 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.467 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 117.22 15.05 6.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.89 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.9 pt -128.74 163.98 32.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.789 0.328 . . . . 0.0 110.743 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.491 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -129.98 124.96 34.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.062 179.634 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.634 ' CD2' HD13 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -135.9 159.35 41.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.137 -179.293 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.555 ' C ' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -140.51 166.95 23.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.281 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.692 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -100.34 102.96 14.33 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.064 179.635 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -64.16 176.39 1.03 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.877 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -51.73 -26.26 9.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.883 0.373 . . . . 0.0 110.766 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.99 4.33 38.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.454 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.414 ' HB3' ' HA ' ' A' ' 126' ' ' THR . 10.4 mt-30 59.48 77.04 0.33 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.803 0.335 . . . . 0.0 110.363 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.528 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 67.1 m -155.91 138.71 15.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.664 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.599 ' SG ' HD11 ' A' ' 120' ' ' ILE . 8.8 p -87.91 114.98 25.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.149 0.5 . . . . 0.0 111.676 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.736 HG23 ' O ' ' A' ' 115' ' ' ASP . 28.1 m -130.51 135.16 47.66 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.253 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.902 HG13 ' H ' ' A' ' 114' ' ' GLY . 4.0 p -60.69 106.13 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.244 0.545 . . . . 0.0 110.955 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -74.29 -24.39 59.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.22 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.44 ' HA ' HG23 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -169.7 132.61 1.19 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.997 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.836 ' CD1' HG21 ' A' ' 96' ' ' VAL . 24.3 mm -86.24 110.26 19.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.468 HD11 ' SG ' ' B' ' 127' ' ' CYS . 10.9 mp -70.21 133.23 46.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.918 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 51.7 m80 -69.77 142.17 53.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.842 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.75 -24.28 28.85 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.591 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.467 ' HA3' ' HA3' ' A' ' 83' ' ' GLY . . . -63.39 162.02 33.66 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.641 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.1 ptm -64.97 -37.27 87.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.784 0.326 . . . . 0.0 110.64 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 35.9 mm -67.56 -29.85 46.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.825 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.495 ' CD2' HG22 ' A' ' 99' ' ' ILE . 3.9 t-80 -85.83 -43.06 13.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.627 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.28 -46.94 68.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.607 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -80.98 -45.34 16.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.725 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.38 73.58 1.26 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.643 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.9 t -111.34 -29.42 7.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.811 0.339 . . . . 0.0 110.967 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.798 HD11 HG21 ' A' ' 148' ' ' VAL . 1.1 tp -136.37 169.01 18.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.865 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -137.56 139.88 40.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.571 ' O ' HG13 ' A' ' 113' ' ' VAL . 7.6 p -44.08 111.38 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.638 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.902 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 119.06 -24.96 8.06 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.607 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.736 ' O ' HG23 ' A' ' 95' ' ' THR . 1.0 OUTLIER -54.71 131.55 43.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.719 0.295 . . . . 0.0 110.68 179.835 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -90.16 121.47 32.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.668 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.634 HD13 ' CD2' ' A' ' 86' ' ' LEU . 4.4 mp -98.18 95.39 4.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.465 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 8.9 mp -56.94 -27.76 61.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.493 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -156.53 153.44 28.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.051 0.453 . . . . 0.0 111.453 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.802 HD12 HD13 ' A' ' 133' ' ' LEU . 36.2 mt -124.96 101.28 8.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.651 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.479 ' ND2' HG23 ' A' ' 144' ' ' ILE . 5.7 t-20 65.25 16.47 10.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.969 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.54 10.81 26.45 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.063 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.68 HG22 ' O ' ' A' ' 120' ' ' ILE . 5.9 t -129.64 124.3 33.35 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.952 0.406 . . . . 0.0 111.371 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -96.76 75.76 2.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.242 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.889 ' HB ' HD11 ' A' ' 133' ' ' LEU . 10.7 p -44.71 143.49 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.723 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.414 ' HA ' ' HB3' ' A' ' 92' ' ' GLN . 39.3 p -120.04 -171.1 2.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.824 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -48.68 -26.31 2.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.422 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -52.24 -179.02 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.926 0.393 . . . . 0.0 111.07 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.85 134.77 57.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.216 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.617 HG22 HD21 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -88.74 -16.42 8.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.071 179.584 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -48.05 -25.18 1.31 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.031 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -58.73 -45.72 88.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.615 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.889 HD11 ' HB ' ' A' ' 125' ' ' VAL . 8.4 mt -73.0 -35.26 66.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.285 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.7 -45.91 87.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.752 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.423 ' HG3' ' N ' ' A' ' 136' ' ' ALA . 0.0 OUTLIER -70.36 -30.18 67.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.992 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.481 ' O ' HG22 ' A' ' 140' ' ' THR . . . -79.59 -35.56 39.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.22 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.65 -30.51 67.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.951 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -85.08 -30.04 24.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.09 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -86.81 -34.69 19.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.105 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.481 HG22 ' O ' ' A' ' 136' ' ' ALA . 9.1 t -59.65 146.57 40.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.966 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.03 106.91 4.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.73 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 150.23 -146.77 16.23 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.55 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 4.0 mtp -94.27 118.31 31.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.851 0.358 . . . . 0.0 111.021 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.648 HD12 ' HE1' ' A' ' 74' ' ' PHE . 29.1 mt -89.9 139.03 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.056 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 84.4 p -116.5 113.61 23.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.289 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.576 ' CD1' HG22 ' A' ' 144' ' ' ILE . 6.9 mp -112.19 134.05 53.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.947 0.403 . . . . 0.0 111.417 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -95.85 105.4 17.41 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.54 179.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.798 HG21 HD11 ' A' ' 111' ' ' LEU . 2.6 t -124.72 158.32 32.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.199 0.523 . . . . 0.0 112.094 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 24.1 mt -133.33 135.62 25.73 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.701 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo . . . . . 0 C--N 1.346 0.397 0 C-N-CA 122.403 2.068 . . . . 0.0 112.352 -179.926 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . 0.439 ' HD3' ' CE1' ' B' ' 126' ' ' TYR . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.741 0.305 . . . . 0.0 110.926 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . 0.489 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 3.6 pt-20 -156.01 135.75 12.59 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.171 0.51 . . . . 0.0 110.345 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 126' ' ' TYR . . . . . 0.462 ' CE1' HG21 ' A' ' 130' ' ' VAL . 32.1 m-85 -115.31 133.14 56.31 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.037 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 127' ' ' CYS . . . . . 0.468 ' SG ' HD11 ' A' ' 100' ' ' LEU . 1.4 m -105.83 116.08 31.33 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . 0.651 ' N ' HD13 ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.409 -177.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.56 ' O ' HG13 ' A' ' 69' ' ' VAL . 14.9 p . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.9 0.381 . . . . 0.0 111.264 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.2 ptp85 -120.21 144.85 47.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.783 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.7 tp -92.9 99.08 11.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.959 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 37.2 mt -91.63 145.94 6.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.223 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -143.56 126.36 16.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.014 0.435 . . . . 0.0 111.618 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.536 ' CZ ' HD22 ' A' ' 146' ' ' LEU . 3.9 p90 -117.72 133.33 56.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.96 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 10.8 pm0 -80.14 134.14 36.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.941 0.4 . . . . 0.0 111.392 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.09 111.31 12.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.586 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -96.99 -34.11 4.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.065 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.52 155.51 18.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.177 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.15 93.14 7.16 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.266 0.555 . . . . 0.0 110.59 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -167.36 164.75 9.28 Favored Pre-proline 0 N--CA 1.449 -0.52 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.028 -179.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -52.01 141.16 47.89 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.584 2.19 . . . . 0.0 112.288 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.96 -56.14 24.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.866 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 147.64 -17.29 1.44 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.982 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.795 HG22 HG23 ' A' ' 99' ' ' ILE . 6.0 pt -115.98 170.59 5.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.77 0.319 . . . . 0.0 111.188 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.73 ' SG ' HD21 ' A' ' 100' ' ' LEU . 5.0 m -131.79 133.61 44.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.362 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.842 ' CD2' HD13 ' A' ' 117' ' ' ILE . 0.5 OUTLIER -127.96 159.48 34.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.327 -179.228 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.531 ' C ' HD13 ' A' ' 88' ' ' LEU . 7.5 pttm -133.02 160.85 35.95 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.954 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.668 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -99.66 104.71 16.49 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.389 179.559 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -64.3 176.19 1.12 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.942 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -53.68 -22.75 9.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.227 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.407 ' CD ' ' N ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -95.61 16.3 17.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.945 179.818 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 51.9 85.98 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.737 0.303 . . . . 0.0 110.7 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 1.1 m -159.3 134.13 8.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.437 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.544 ' SG ' HD11 ' A' ' 120' ' ' ILE . 28.0 p -87.72 115.51 25.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.136 0.493 . . . . 0.0 111.438 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.698 HG23 ' O ' ' A' ' 115' ' ' ASP . 5.8 m -130.04 130.91 45.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.487 -0.779 . . . . 0.0 108.922 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.882 HG13 ' H ' ' A' ' 114' ' ' GLY . 2.0 p -58.51 105.92 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.629 -178.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -70.57 -25.37 63.05 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.799 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.505 ' HA ' HG23 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -173.44 131.29 0.46 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.974 179.835 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.795 HG23 HG22 ' A' ' 84' ' ' ILE . 37.3 mt -85.97 128.44 39.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.167 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.73 HD21 ' SG ' ' A' ' 85' ' ' CYS . 3.9 mt -89.55 146.34 24.65 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.905 0.383 . . . . 0.0 111.228 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.441 ' HA ' ' CD2' ' A' ' 106' ' ' HIS . 8.4 m-70 -79.72 146.67 32.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.809 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.97 -33.64 5.44 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.387 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.61 171.87 4.15 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.549 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 1.8 tmm? -73.53 -28.55 61.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.758 0.313 . . . . 0.0 111.034 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.6 mm -74.59 -37.15 43.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.124 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.441 ' CD2' ' HA ' ' A' ' 101' ' ' HIS . 78.8 t60 -78.45 -49.69 13.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.621 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.91 -44.19 97.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.592 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -82.26 -47.08 12.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.557 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.83 69.92 1.35 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.476 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.483 ' C ' HD22 ' A' ' 111' ' ' LEU . 1.3 p -108.77 -29.22 8.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.833 0.349 . . . . 0.0 110.918 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.635 HD11 HG21 ' A' ' 148' ' ' VAL . 3.8 mm? -123.94 172.56 8.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.948 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.519 ' CA ' HD11 ' A' ' 99' ' ' ILE . 10.3 m80 -135.09 137.89 43.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.79 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.505 HG23 ' HA ' ' A' ' 98' ' ' ARG . 7.5 p -49.75 118.99 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.117 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.882 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 107.77 -20.13 32.15 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.826 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.698 ' O ' HG23 ' A' ' 95' ' ' THR . 26.9 m-20 -50.32 138.14 17.27 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.675 0.274 . . . . 0.0 110.684 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -90.01 110.48 21.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.717 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.842 HD13 ' CD2' ' A' ' 86' ' ' LEU . 5.3 mp -94.72 94.39 4.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.314 179.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.407 HD23 ' CD1' ' A' ' 149' ' ' ILE . 3.4 mm? -54.36 -40.32 68.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.887 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -142.12 164.17 30.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.095 0.474 . . . . 0.0 111.66 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.712 ' CD1' HG23 ' A' ' 125' ' ' VAL . 1.1 mp -131.48 99.12 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.352 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 69.14 17.61 8.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.917 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.58 -0.32 34.55 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.747 -0.739 . . . . 0.0 113.107 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.648 ' O ' HD12 ' A' ' 120' ' ' ILE . 5.5 t -132.58 134.56 45.09 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 117.0 0.4 . . . . 0.0 111.449 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -96.05 122.69 39.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.514 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.801 HG11 HG13 ' A' ' 130' ' ' VAL . 20.7 t -58.48 155.03 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.375 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.421 ' N ' HG12 ' A' ' 125' ' ' VAL . 74.1 p -119.11 171.04 8.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.696 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.35 -21.12 62.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.196 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -59.4 -107.22 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.762 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.3 t -109.07 134.32 51.84 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.884 0.374 . . . . 0.0 111.242 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.801 HG13 HG11 ' A' ' 125' ' ' VAL . 0.5 OUTLIER -89.16 -19.26 7.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.059 179.533 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.418 ' HA ' ' HB2' ' A' ' 134' ' ' GLN . 0.8 OUTLIER -46.1 -25.29 0.56 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.444 -179.584 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -54.24 -55.92 23.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.987 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.692 ' CD2' HG22 ' A' ' 125' ' ' VAL . 3.4 mm? -70.7 -41.88 71.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.796 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.461 ' HG2' HG21 ' B' ' 128' ' ' ILE . 3.9 mm-40 -50.3 -53.29 29.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.18 -32.6 73.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.709 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.427 ' O ' HG22 ' A' ' 140' ' ' THR . . . -73.19 -27.79 61.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.21 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -78.22 -32.25 49.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.912 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -87.57 -29.29 21.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.976 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -81.73 -30.58 32.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.958 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 136' ' ' ALA . 12.5 t -71.56 149.06 46.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.992 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 11.6 mttp -140.48 125.35 18.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.711 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 127.95 -136.7 9.33 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.336 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.429 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -100.04 137.06 39.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.86 0.362 . . . . 0.0 111.058 -179.867 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.564 HG22 HD13 ' A' ' 146' ' ' LEU . 35.7 mt -109.18 142.96 20.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.177 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 28.0 p -121.08 113.7 20.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.456 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.564 HD13 HG22 ' A' ' 144' ' ' ILE . 5.8 mp -112.74 142.68 45.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.339 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.71 108.52 20.83 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.471 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.635 HG21 HD11 ' A' ' 111' ' ' LEU . 2.7 t -125.05 158.33 33.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.267 0.556 . . . . 0.0 112.274 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.407 ' CD1' HD23 ' A' ' 118' ' ' LEU . 12.6 mt -132.32 115.98 15.17 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.426 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 C--N 1.347 0.46 0 C-N-CA 122.428 2.085 . . . . 0.0 112.391 -179.646 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . 0.539 ' HD2' HD22 ' A' ' 88' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.074 0 CA-C-O 120.851 0.358 . . . . 0.0 110.933 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . 0.463 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 8.6 pt-20 -158.07 135.96 10.63 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.202 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 126' ' ' TYR . . . . . 0.602 ' CE1' HG21 ' A' ' 130' ' ' VAL . 16.8 m-85 -115.7 138.19 51.34 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.352 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 98.9 m -106.4 116.11 31.36 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . 0.84 HD11 HD12 ' A' ' 86' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.45 -177.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.643 ' O ' HG13 ' A' ' 69' ' ' VAL . 7.2 p . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.916 0.389 . . . . 0.0 110.988 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -95.52 152.61 18.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.864 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.43 99.77 4.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.999 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.479 HG22 ' N ' ' A' ' 73' ' ' GLN . 4.0 mp -89.32 159.18 2.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.648 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.479 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -146.21 124.69 12.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.011 0.434 . . . . 0.0 111.634 -179.656 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.601 ' CZ ' HD23 ' A' ' 146' ' ' LEU . 0.9 OUTLIER -142.47 130.49 21.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.331 179.078 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 10.5 tt0 -80.21 140.85 36.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.646 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 15.8 tttm -129.2 115.86 18.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.305 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -105.73 -26.54 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.329 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.53 149.09 22.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.282 -179.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -87.62 90.43 8.37 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.434 0.635 . . . . 0.0 110.56 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -161.97 157.14 19.98 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.836 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.07 142.61 99.54 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.441 2.094 . . . . 0.0 112.155 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -53.08 -42.42 65.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.045 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 127.58 -8.29 6.95 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.78 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.598 HG21 HG21 ' A' ' 105' ' ' ILE . 43.2 pt -113.5 168.84 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.854 0.359 . . . . 0.0 111.052 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.71 ' SG ' HD21 ' A' ' 100' ' ' LEU . 17.2 m -135.88 132.54 36.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.225 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.686 HD12 HD11 ' B' ' 128' ' ' ILE . 0.2 OUTLIER -133.8 159.65 39.96 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.272 -179.071 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.654 ' C ' HD13 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -135.99 162.4 32.99 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.982 179.831 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.677 ' N ' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -105.89 103.26 12.71 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.511 179.694 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.2 m-20 -64.13 176.42 1.01 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.709 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -51.42 -24.34 4.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.108 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.11 9.32 25.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.516 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 54.36 79.55 0.14 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.768 0.318 . . . . 0.0 110.649 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 11.2 m -152.44 131.89 12.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.561 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.475 ' SG ' HD11 ' A' ' 120' ' ' ILE . 18.3 p -87.68 111.49 21.35 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.08 0.467 . . . . 0.0 111.255 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.703 HG23 ' O ' ' A' ' 115' ' ' ASP . 8.6 m -127.58 132.31 49.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.454 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.916 HG13 ' H ' ' A' ' 114' ' ' GLY . 3.9 p -58.72 106.22 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.195 0.521 . . . . 0.0 110.561 -179.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -73.77 -27.11 60.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.354 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.429 ' HA ' HG23 ' A' ' 113' ' ' VAL . 6.9 ttp85 -165.77 129.34 2.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.852 0.358 . . . . 0.0 111.47 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.911 ' CD1' HG21 ' A' ' 96' ' ' VAL . 32.6 mm -87.65 103.76 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.439 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.71 HD21 ' SG ' ' A' ' 85' ' ' CYS . 5.5 mt -65.66 135.4 54.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.93 0.395 . . . . 0.0 111.05 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 22.7 m170 -73.07 140.25 47.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.808 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 103.97 -36.52 4.31 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.44 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -55.59 174.59 1.0 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.51 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.53 -29.42 52.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.793 0.33 . . . . 0.0 111.002 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.598 HG21 HG21 ' A' ' 84' ' ' ILE . 28.6 mm -69.03 -35.24 67.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.065 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -80.62 -50.63 9.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.707 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -60.22 -41.72 93.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.628 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.74 -43.82 12.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.672 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.73 51.43 2.67 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.517 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 m -87.64 -22.95 24.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.618 0.247 . . . . 0.0 111.051 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.423 HD23 ' HB2' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -145.84 165.2 29.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.805 0.336 . . . . 0.0 110.901 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -133.5 137.93 45.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.894 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.583 ' O ' HG13 ' A' ' 113' ' ' VAL . 7.5 p -46.74 111.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.714 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.916 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 117.41 -26.0 8.37 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.434 -0.888 . . . . 0.0 113.223 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.703 ' O ' HG23 ' A' ' 95' ' ' THR . 4.6 m-20 -54.13 138.61 37.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.905 0.352 . . . . 0.0 110.67 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.52 118.84 30.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.62 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.605 HD13 ' CD2' ' A' ' 86' ' ' LEU . 4.5 mp -93.43 99.18 9.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.629 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -56.96 -31.58 65.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.241 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -161.23 141.7 11.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.878 0.371 . . . . 0.0 111.349 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.587 HG23 HD12 ' A' ' 146' ' ' LEU . 28.2 mt -107.72 103.28 15.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.675 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 65.19 27.28 12.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.696 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 92.51 5.94 64.64 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.875 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.2 m -133.71 127.0 31.93 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.867 0.365 . . . . 0.0 111.221 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -94.89 120.82 35.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.598 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.635 HG11 HG13 ' A' ' 130' ' ' VAL . 17.9 t -54.53 149.48 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.357 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 58.6 p -119.16 161.5 20.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.771 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -61.59 -18.85 61.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.165 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -60.22 -111.98 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.723 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.09 134.29 51.88 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.921 0.391 . . . . 0.0 110.973 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.676 HG21 ' CE1' ' B' ' 126' ' ' TYR . 0.6 OUTLIER -89.06 -26.11 5.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.042 179.652 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -46.05 -27.44 0.94 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.452 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.55 ' HG3' HD12 ' A' ' 133' ' ' LEU . 9.7 pt20 -62.24 -48.71 78.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.673 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.635 HD13 HG22 ' A' ' 125' ' ' VAL . 1.8 mp -81.53 -35.89 29.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.801 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.403 ' HG3' ' CG2' ' B' ' 128' ' ' ILE . 2.6 tt0 -63.87 -46.09 86.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.529 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -68.05 -45.7 73.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.602 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -65.59 -38.16 88.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.911 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.772 ' O ' HG22 ' A' ' 140' ' ' THR . 2.0 mmt -65.55 -32.05 73.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -85.29 -28.17 25.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.958 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -91.45 -15.39 28.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.335 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.772 HG22 ' O ' ' A' ' 137' ' ' MET . 9.8 t -60.78 156.93 15.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.931 0.396 . . . . 0.0 111.056 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -146.26 117.25 7.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.639 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 134.81 -152.58 20.77 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.625 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.503 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 9.9 ptm -90.47 115.31 27.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.851 0.358 . . . . 0.0 111.29 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.557 HD13 ' HE2' ' A' ' 137' ' ' MET . 47.0 mt -87.83 130.14 38.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.063 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 14.6 m -111.9 113.68 26.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.255 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.642 HD22 ' N ' ' A' ' 146' ' ' LEU . 0.9 OUTLIER -112.53 133.93 54.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.063 0.459 . . . . 0.0 111.197 -179.489 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.37 105.3 17.43 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.528 ' HB ' HG13 ' A' ' 117' ' ' ILE . 2.8 p -133.35 156.45 41.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.149 0.5 . . . . 0.0 112.045 -178.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.437 ' N ' HG22 ' A' ' 148' ' ' VAL . 26.0 mt -122.71 119.05 28.24 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.62 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo . . . . . 0 C--N 1.347 0.496 0 C-N-CA 122.543 2.162 . . . . 0.0 112.534 -179.634 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . 0.564 ' NZ ' HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 120.92 0.391 . . . . 0.0 110.956 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . 0.46 ' HG2' ' HB3' ' A' ' 97' ' ' ALA . 4.4 mt-10 -164.73 139.98 5.54 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.481 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 126' ' ' TYR . . . . . 0.676 ' CE1' HG21 ' A' ' 130' ' ' VAL . 31.6 m-85 -117.81 132.33 56.46 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.324 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 91.4 m -106.01 116.01 31.2 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . 0.686 HD11 HD12 ' A' ' 86' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.28 -0.867 . . . . 0.0 111.476 -177.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.629 HG21 ' HD3' ' A' ' 147' ' ' LYS . 10.9 p . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.85 0.357 . . . . 0.0 111.0 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -95.42 114.6 26.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.636 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.479 HD12 ' HG2' ' A' ' 147' ' ' LYS . 4.7 tp -92.17 102.5 15.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.118 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mt -89.22 152.13 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.638 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.436 ' NE2' HD23 ' A' ' 71' ' ' LEU . 9.6 mt-30 -140.8 123.2 15.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.005 0.431 . . . . 0.0 111.52 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.769 ' HE1' HD12 ' A' ' 144' ' ' ILE . 25.9 p90 -146.97 134.55 20.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.133 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 0.4 OUTLIER -80.27 143.47 33.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.071 0.462 . . . . 0.0 111.571 -179.094 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.11 111.23 12.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.159 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -109.72 -25.84 3.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.465 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.57 146.23 24.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.313 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.96 90.54 8.38 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.385 0.612 . . . . 0.0 110.421 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.409 ' CB ' ' HD2' ' A' ' 81' ' ' PRO . 2.3 mt-10 -168.43 174.47 2.18 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.673 -178.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.409 ' HD2' ' CB ' ' A' ' 80' ' ' GLU . 65.8 Cg_endo -74.93 142.75 28.46 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.347 2.031 . . . . 0.0 112.415 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -52.55 -58.06 7.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.033 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.492 ' O ' HG23 ' A' ' 84' ' ' ILE . . . 143.26 39.0 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.657 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.509 HG21 HG21 ' A' ' 105' ' ' ILE . 13.0 pt -157.88 170.08 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.719 0.295 . . . . 0.0 110.879 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' B' ' 126' ' ' TYR . 0.1 OUTLIER -135.48 113.56 11.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.48 179.704 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.754 ' HG ' HD11 ' B' ' 128' ' ' ILE . 0.1 OUTLIER -122.12 159.1 27.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.079 -179.159 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.479 ' HB3' ' HA ' ' B' ' 125' ' ' GLU . 0.0 OUTLIER -136.09 166.79 22.56 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.325 -179.69 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.691 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.1 OUTLIER -89.65 103.11 15.78 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.201 179.339 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.408 ' O ' ' N ' ' A' ' 92' ' ' GLN . 4.9 t30 -64.07 176.38 1.01 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.71 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.86 -27.41 3.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.946 0.403 . . . . 0.0 110.803 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.427 ' HD2' ' HB2' ' A' ' 93' ' ' SER . 0.1 OUTLIER -93.56 21.11 6.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.418 179.887 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 89' ' ' ASN . 45.5 mm-40 45.57 74.11 0.15 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.889 0.376 . . . . 0.0 110.666 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.579 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 5.5 m -148.28 147.8 29.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.654 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.63 ' HB3' HD12 ' A' ' 86' ' ' LEU . 1.4 m -87.8 114.18 24.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.119 0.485 . . . . 0.0 111.548 -179.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.613 HG23 ' HA ' ' A' ' 116' ' ' GLU . 2.7 m -130.1 126.63 38.03 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.319 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.898 HG13 ' H ' ' A' ' 114' ' ' GLY . 3.6 p -58.78 105.83 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.408 0.623 . . . . 0.0 110.597 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -74.4 -22.69 59.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.149 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 24.2 ttt180 -171.59 139.04 1.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.679 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.821 HD13 HG21 ' A' ' 96' ' ' VAL . 31.8 mm -86.11 121.0 36.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.9 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.484 HD21 ' SG ' ' B' ' 127' ' ' CYS . 4.6 mm? -74.23 143.33 45.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.038 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 16.0 p-80 -85.54 131.33 34.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.945 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.57 -27.9 16.25 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.48 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.28 176.05 8.23 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.516 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -80.48 -30.03 37.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.757 0.313 . . . . 0.0 110.941 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.509 HG21 HG21 ' A' ' 84' ' ' ILE . 42.9 mm -65.18 -36.73 78.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.989 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -81.46 -46.02 15.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.757 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -45.66 85.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.715 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -81.97 -43.84 17.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.755 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.39 63.13 1.31 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.503 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -101.1 -27.34 13.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.878 0.371 . . . . 0.0 111.106 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.723 ' CD2' HG11 ' A' ' 148' ' ' VAL . 10.3 mt -142.3 157.79 44.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.043 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 50.4 m170 -129.52 142.56 50.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.773 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.567 ' O ' HG13 ' A' ' 113' ' ' VAL . 8.2 p -43.83 113.75 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.654 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.898 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 119.07 -28.78 6.47 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.564 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.554 ' HB3' HG11 ' A' ' 148' ' ' VAL . 0.3 OUTLIER -47.06 126.12 8.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.667 0.27 . . . . 0.0 110.754 179.849 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.613 ' HA ' HG23 ' A' ' 95' ' ' THR . 3.0 mt-10 -89.0 111.36 22.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.868 0.366 . . . . 0.0 111.675 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.741 HG21 HD13 ' A' ' 120' ' ' ILE . 4.4 mp -91.2 98.1 8.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.663 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.608 HD23 HG12 ' A' ' 149' ' ' ILE . 4.3 mm? -60.97 -32.81 72.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.551 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -141.07 146.8 37.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.934 0.397 . . . . 0.0 111.687 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.741 HD13 HG21 ' A' ' 117' ' ' ILE . 14.9 mm -118.0 99.75 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.772 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.413 ' H ' HD13 ' A' ' 146' ' ' LEU . 6.5 t-20 62.19 27.87 16.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.743 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 94.98 2.58 62.46 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.866 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 21.9 m -133.55 131.52 39.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.813 0.339 . . . . 0.0 111.052 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -93.34 116.24 28.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.727 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.795 HG22 HD13 ' A' ' 133' ' ' LEU . 25.5 t -56.16 158.76 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.319 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.485 ' N ' HG12 ' A' ' 125' ' ' VAL . 10.9 p -137.5 -178.94 5.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.908 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -59.64 -25.41 64.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.954 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -54.96 -175.03 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.76 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.7 m -64.32 134.23 54.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.907 0.384 . . . . 0.0 110.885 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.48 ' CG2' ' CZ ' ' B' ' 126' ' ' TYR . 0.3 OUTLIER -88.95 -17.18 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.198 179.663 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.23 -25.94 0.7 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.285 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -65.21 -52.82 52.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.489 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.795 HD13 HG22 ' A' ' 125' ' ' VAL . 0.5 OUTLIER -75.23 -29.87 60.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.338 179.563 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -67.65 -45.58 74.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.507 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.1 pttp -68.98 -38.03 79.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.63 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.622 ' O ' HG23 ' A' ' 140' ' ' THR . . . -73.04 -38.46 66.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.016 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.478 ' HE2' HD13 ' A' ' 144' ' ' ILE . 5.9 mmt -67.47 -28.87 68.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.992 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -86.85 -34.88 19.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.07 10.05 42.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.324 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.622 HG23 ' O ' ' A' ' 136' ' ' ALA . 0.0 OUTLIER -67.37 129.96 41.56 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.813 0.34 . . . . 0.0 110.901 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.17 93.34 3.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.814 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 151.25 -157.15 27.05 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.594 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.409 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 11.5 mmm -90.15 123.13 33.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.848 0.356 . . . . 0.0 110.985 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.769 HD12 ' HE1' ' A' ' 74' ' ' PHE . 29.3 mt -92.79 131.48 39.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.215 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 59.5 m -112.79 113.53 25.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.056 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.654 HD22 ' N ' ' A' ' 146' ' ' LEU . 1.1 mm? -117.02 136.06 53.23 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.949 0.404 . . . . 0.0 111.456 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.629 ' HD3' HG21 ' A' ' 69' ' ' VAL . 7.3 mttm -100.32 105.96 17.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.649 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.723 HG11 ' CD2' ' A' ' 111' ' ' LEU . 4.8 t -123.94 153.58 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.168 0.509 . . . . 0.0 112.16 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.608 HG12 HD23 ' A' ' 118' ' ' LEU . 17.7 mm -117.28 122.43 31.1 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.442 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo . . . . . 0 C--N 1.347 0.45 0 C-N-CA 122.526 2.151 . . . . 0.0 112.507 -179.87 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.845 0.355 . . . . 0.0 111.025 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . 0.479 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 2.8 pt-20 -152.53 134.3 14.69 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.303 0.573 . . . . 0.0 110.25 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 126' ' ' TYR . . . . . 0.484 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 22.0 m-85 -113.02 136.94 52.14 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.174 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 127' ' ' CYS . . . . . 0.484 ' SG ' HD21 ' A' ' 100' ' ' LEU . 1.7 m -105.86 116.16 31.47 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . 0.754 HD11 ' HG ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.399 -177.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.508 ' O ' HG13 ' A' ' 69' ' ' VAL . 11.8 p . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.805 0.335 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.38 122.19 45.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.912 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 tt -90.96 99.31 12.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.977 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.411 HG22 ' N ' ' A' ' 73' ' ' GLN . 34.2 mt -96.08 154.9 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.724 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.411 ' N ' HG22 ' A' ' 72' ' ' ILE . 1.3 mt-30 -145.9 128.08 15.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.938 0.399 . . . . 0.0 111.458 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.647 ' CE1' HD12 ' A' ' 144' ' ' ILE . 8.1 p90 -141.05 135.71 31.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.459 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -80.35 138.1 36.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.909 0.385 . . . . 0.0 111.034 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.8 tttm -129.18 111.28 12.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.405 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.598 ' O ' HG13 ' A' ' 77' ' ' VAL . 0.3 OUTLIER -130.53 14.25 2.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.67 -179.436 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.42 154.94 20.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.904 0.383 . . . . 0.0 111.33 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.79 79.08 6.77 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.338 0.589 . . . . 0.0 110.48 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.65 153.24 2.71 Favored Pre-proline 0 N--CA 1.446 -0.655 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.014 -178.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.52 158.49 31.75 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.504 2.136 . . . . 0.0 112.285 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 23.7 ttm -56.07 -54.21 47.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.956 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 132.24 -9.09 5.37 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.939 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.505 HG23 ' HB ' ' A' ' 105' ' ' ILE . 15.8 pt -114.92 168.07 6.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.802 0.334 . . . . 0.0 111.139 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.471 ' O ' ' N ' ' A' ' 97' ' ' ALA . 19.3 m -135.02 127.68 30.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.275 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 1.051 HD23 HD13 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -125.9 159.56 32.25 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.238 -179.177 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.585 ' C ' HD13 ' A' ' 88' ' ' LEU . 22.4 pttp -137.06 162.3 33.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.178 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.646 ' N ' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -103.26 102.96 12.95 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.597 179.504 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -64.37 176.67 1.01 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.638 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -50.29 -27.57 6.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.937 0.399 . . . . 0.0 110.838 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.04 -16.9 57.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.347 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 74.78 78.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.821 0.343 . . . . 0.0 110.248 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.599 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 49.1 p -154.94 150.62 27.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.667 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.659 ' SG ' HD11 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -87.85 113.58 23.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.062 0.458 . . . . 0.0 111.219 -179.576 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.599 HG23 ' O ' ' A' ' 115' ' ' ASP . 2.9 m -131.96 126.76 34.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.322 179.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.927 HG13 ' H ' ' A' ' 114' ' ' GLY . 2.6 p -58.72 105.91 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.279 0.561 . . . . 0.0 110.02 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -72.04 -25.03 61.64 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.266 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.531 ' HA ' HG23 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -173.21 123.03 0.39 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.854 179.811 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.749 HG12 HG21 ' A' ' 96' ' ' VAL . 11.0 mt -85.97 120.75 36.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.361 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.456 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.9 mp -83.96 135.8 34.32 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.148 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.443 ' HA ' ' CG ' ' A' ' 106' ' ' HIS . 11.7 p80 -73.6 138.63 45.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.826 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.69 -36.53 4.3 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.382 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.16 -171.02 0.12 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.51 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.4 ttp -84.42 -40.6 17.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.865 0.364 . . . . 0.0 110.906 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.505 ' HB ' HG23 ' A' ' 84' ' ' ILE . 37.6 mm -65.54 -36.88 78.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.105 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.443 ' CG ' ' HA ' ' A' ' 101' ' ' HIS . 63.7 t-80 -75.11 -54.98 6.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.748 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.6 ttt-85 -60.05 -47.17 86.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.693 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -75.99 -47.06 26.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.638 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.72 73.39 1.28 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.565 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.669 ' O ' HD22 ' A' ' 111' ' ' LEU . 4.6 m -111.91 -29.26 7.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.776 0.322 . . . . 0.0 110.986 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.995 HD11 HG11 ' A' ' 148' ' ' VAL . 3.2 mm? -134.26 172.53 12.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.09 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.44 ' CA ' HD11 ' A' ' 99' ' ' ILE . 74.5 m80 -134.46 137.42 43.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.711 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.531 HG23 ' HA ' ' A' ' 98' ' ' ARG . 7.5 p -47.02 115.99 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.901 0.381 . . . . 0.0 111.359 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.927 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 112.23 -24.95 13.23 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.853 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.599 ' O ' HG23 ' A' ' 95' ' ' THR . 24.9 m-20 -50.29 143.35 8.76 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.74 0.27 . . . . 0.0 110.7 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.657 ' C ' HG23 ' A' ' 148' ' ' VAL . 1.6 mt-10 -95.32 107.71 19.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.819 0.342 . . . . 0.0 111.725 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 1.051 HD13 HD23 ' A' ' 86' ' ' LEU . 3.9 mp -86.67 99.83 8.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.66 179.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.606 HD21 HD12 ' A' ' 149' ' ' ILE . 4.3 mm? -51.46 -35.12 38.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.311 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -169.72 145.64 3.1 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.959 0.409 . . . . 0.0 111.271 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 1.057 HG23 HD11 ' A' ' 146' ' ' LEU . 45.1 mt -104.56 125.29 59.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.828 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 60.87 27.74 17.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.777 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 83.32 18.13 65.17 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.743 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 27.4 m -133.58 128.11 34.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.828 0.347 . . . . 0.0 111.023 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -92.56 114.96 27.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.792 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.818 HG21 HG13 ' A' ' 130' ' ' VAL . 13.7 p -82.07 127.04 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.246 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.8 p -98.0 -167.09 1.46 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.714 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -67.05 -15.51 63.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.294 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.545 ' HE1' HG23 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -57.9 -166.91 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.678 0.275 . . . . 0.0 110.572 179.838 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 28.6 t -67.67 134.03 50.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.941 0.401 . . . . 0.0 110.682 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.818 HG13 HG21 ' A' ' 125' ' ' VAL . 0.6 OUTLIER -89.42 -16.32 8.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.335 179.755 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -45.02 -26.01 0.39 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.328 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 51.1 mm-40 -63.78 -54.07 40.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.884 0.373 . . . . 0.0 110.633 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.592 HD22 ' HB ' ' A' ' 125' ' ' VAL . 6.8 mp -77.18 -37.64 53.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.789 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -60.29 -49.57 77.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.712 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.29 -44.06 92.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.73 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.596 ' O ' HG23 ' A' ' 140' ' ' THR . . . -66.17 -35.52 80.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.979 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.504 ' CE ' HD13 ' A' ' 144' ' ' ILE . 1.0 OUTLIER -68.54 -28.36 66.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.894 179.883 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.7 mttp -84.94 -29.38 25.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.898 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.77 10.05 32.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.442 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.596 HG23 ' O ' ' A' ' 136' ' ' ALA . 0.0 OUTLIER -66.55 147.9 52.65 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.771 0.32 . . . . 0.0 110.789 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -150.91 94.97 2.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.783 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 149.2 -154.72 25.95 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.453 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 8.1 mmm -88.03 121.06 29.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.87 0.367 . . . . 0.0 110.833 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.647 HD12 ' CE1' ' A' ' 74' ' ' PHE . 49.8 mt -95.8 144.02 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.215 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.9 p -116.24 113.57 23.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.178 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 1.057 HD11 HG23 ' A' ' 120' ' ' ILE . 3.2 mm? -109.49 125.16 52.18 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.987 0.422 . . . . 0.0 111.46 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 118' ' ' LEU . 10.0 ttpt -105.53 112.02 24.95 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.995 HG11 HD11 ' A' ' 111' ' ' LEU . 3.4 p -147.03 144.03 20.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.157 0.503 . . . . 0.0 112.131 -178.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.606 HD12 HD21 ' A' ' 118' ' ' LEU . 14.6 mt -105.4 136.12 19.26 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.381 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.41 ' HD2' HG23 ' A' ' 149' ' ' ILE . 54.1 Cg_endo . . . . . 0 C--N 1.347 0.472 0 C-N-CA 122.456 2.104 . . . . 0.0 112.47 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 2.6 mttp . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.863 0.363 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . 0.455 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 1.4 pt-20 -161.45 136.76 7.6 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.348 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 126' ' ' TYR . . . . . 0.639 ' CE1' HG21 ' A' ' 130' ' ' VAL . 32.1 m-85 -122.41 133.28 54.63 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.327 -179.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 89.0 m -106.01 115.98 31.16 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . 0.684 ' N ' HD13 ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.512 -177.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.541 ' O ' HG13 ' A' ' 69' ' ' VAL . 10.8 p . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.819 0.342 . . . . 0.0 111.034 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.3 ttt-85 -95.47 119.95 34.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.762 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.425 HD21 ' HB3' ' A' ' 145' ' ' SER . 0.9 OUTLIER -98.91 99.36 10.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.047 -179.784 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mp -98.48 148.24 6.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.447 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.479 ' HB3' ' HE3' ' A' ' 143' ' ' MET . 15.9 mt-30 -135.03 123.14 22.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.959 0.409 . . . . 0.0 111.533 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.63 ' CE1' HD22 ' A' ' 146' ' ' LEU . 8.1 p90 -126.64 133.23 51.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.285 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -80.43 135.36 36.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.98 0.419 . . . . 0.0 111.324 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.465 ' HD2' HD11 ' A' ' 144' ' ' ILE . 0.5 OUTLIER -129.09 113.59 15.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.47 179.67 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -110.66 -27.84 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.257 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.55 157.18 17.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.37 -179.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -92.52 89.91 6.94 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.52 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -160.04 152.74 17.75 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.966 -178.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.13 147.56 92.83 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.509 2.139 . . . . 0.0 112.207 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.501 ' HE2' ' HB2' ' A' ' 82' ' ' MET . 13.6 ttm -55.39 -41.86 73.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.045 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.46 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 117.14 1.79 18.63 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.581 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.609 HD12 ' O ' ' A' ' 84' ' ' ILE . 2.0 pp -122.17 165.14 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.67 0.271 . . . . 0.0 110.856 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.719 ' C ' HD12 ' A' ' 86' ' ' LEU . 6.8 m -135.03 130.13 35.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.368 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.844 ' CD2' HD13 ' A' ' 117' ' ' ILE . 4.4 mp -121.7 159.5 26.45 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.209 -178.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.709 ' CG ' ' HB2' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -137.39 152.82 50.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.249 179.835 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.673 ' N ' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -102.21 103.38 13.89 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.819 179.803 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -64.3 176.45 1.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.759 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -52.45 -29.17 23.27 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.969 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -81.05 -2.36 47.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.234 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 63.99 86.97 0.12 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.826 0.346 . . . . 0.0 110.53 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.552 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 3.3 m -160.66 137.94 9.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.289 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.414 ' O ' ' HB ' ' A' ' 117' ' ' ILE . 12.9 p -87.61 115.22 24.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.234 0.54 . . . . 0.0 111.489 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.682 HG23 ' O ' ' A' ' 115' ' ' ASP . 9.1 m -132.1 131.53 42.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.53 -0.759 . . . . 0.0 108.97 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.936 HG21 ' CD1' ' A' ' 99' ' ' ILE . 4.4 p -58.8 106.15 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.209 0.528 . . . . 0.0 110.667 -179.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.709 ' HB2' ' CG ' ' A' ' 87' ' ' LYS . . . -72.59 -23.34 60.94 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.333 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.454 ' HA ' HG23 ' A' ' 113' ' ' VAL . 1.0 OUTLIER -172.71 131.53 0.55 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.818 0.342 . . . . 0.0 111.515 179.853 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.936 ' CD1' HG21 ' A' ' 96' ' ' VAL . 25.1 mm -90.09 103.63 14.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.497 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.534 HD13 ' SG ' ' A' ' 85' ' ' CYS . 7.6 mp -65.92 147.77 52.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.946 0.403 . . . . 0.0 111.303 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.433 ' HA ' ' CD2' ' A' ' 106' ' ' HIS . 56.3 t-80 -85.57 142.44 29.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.735 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.3 -39.4 2.86 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.457 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.46 ' HA3' ' HA3' ' A' ' 83' ' ' GLY . . . -54.0 -178.85 0.13 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.646 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 18.6 ptm -84.44 -29.46 26.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.759 0.314 . . . . 0.0 111.166 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.41 HG21 ' HB2' ' A' ' 111' ' ' LEU . 32.5 mm -70.02 -37.91 73.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.975 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.433 ' CD2' ' HA ' ' A' ' 101' ' ' HIS . 46.9 t60 -77.87 -44.06 28.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.514 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.9 mtt85 -64.3 -49.98 69.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.512 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -79.07 -44.3 22.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.681 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.13 77.53 1.35 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.625 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.402 ' HB2' HG23 ' A' ' 105' ' ' ILE . 21.2 m -115.2 -28.19 7.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.666 0.27 . . . . 0.0 111.156 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.463 HD21 HG11 ' A' ' 148' ' ' VAL . 0.2 OUTLIER -132.44 172.22 12.75 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.846 0.355 . . . . 0.0 111.111 -179.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -142.4 132.3 24.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.771 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.557 ' O ' HG13 ' A' ' 113' ' ' VAL . 7.4 p -44.07 111.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.732 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.899 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 117.35 -28.99 6.92 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.9 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.682 ' O ' HG23 ' A' ' 95' ' ' THR . 22.1 m-20 -48.99 137.6 12.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.63 0.252 . . . . 0.0 110.77 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -89.52 111.32 22.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.827 0.346 . . . . 0.0 111.601 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.844 HD13 ' CD2' ' A' ' 86' ' ' LEU . 4.6 mp -89.25 110.43 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.687 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.439 HD21 HD12 ' A' ' 149' ' ' ILE . 4.4 mm? -67.84 -30.11 69.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.095 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -162.48 148.14 12.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.893 0.378 . . . . 0.0 111.582 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.454 HG12 HG21 ' A' ' 117' ' ' ILE . 49.6 mt -119.47 106.63 19.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.726 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 66.99 29.2 8.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.827 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 87.35 8.96 73.64 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.891 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.6 124.37 26.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.839 0.352 . . . . 0.0 111.06 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 -88.13 107.75 18.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.732 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.707 HG22 ' HG ' ' A' ' 133' ' ' LEU . 11.8 t -59.34 126.45 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.114 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 14.2 p -113.38 -171.77 1.94 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.834 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -60.32 -23.69 64.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.041 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -55.29 -176.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.738 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 m -64.28 134.08 54.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.926 0.393 . . . . 0.0 110.878 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.58 HG13 ' CG1' ' A' ' 125' ' ' VAL . 0.4 OUTLIER -89.24 -21.94 6.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.127 179.702 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.432 ' HA ' ' HG2' ' A' ' 134' ' ' GLN . 4.7 t0 -46.87 -25.61 0.8 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.489 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.12 -41.99 48.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.188 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.707 ' HG ' HG22 ' A' ' 125' ' ' VAL . 3.3 mm? -73.61 -44.7 56.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.318 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.432 ' HG2' ' HA ' ' A' ' 131' ' ' ASP . 17.0 pt20 -68.34 -47.47 67.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.463 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.14 -35.59 80.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.443 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -82.74 -44.97 14.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.773 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.764 ' O ' HG22 ' A' ' 140' ' ' THR . 0.0 OUTLIER -67.77 -25.24 65.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.509 -179.387 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -85.18 -47.63 9.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.809 0.338 . . . . 0.0 111.191 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -71.5 -13.62 61.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.492 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.764 HG22 ' O ' ' A' ' 137' ' ' MET . 14.0 t -59.48 150.83 25.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.901 0.381 . . . . 0.0 110.964 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.07 113.64 14.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.702 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 145.75 -131.99 4.38 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.473 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.479 ' HE3' ' HB3' ' A' ' 73' ' ' GLN . 29.1 mtp -109.17 119.68 40.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.769 0.319 . . . . 0.0 111.126 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.667 HG22 HD13 ' A' ' 146' ' ' LEU . 33.6 mt -88.09 130.76 37.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.969 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.552 ' O ' HD12 ' A' ' 146' ' ' LEU . 8.5 m -108.78 123.35 48.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.603 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.667 HD13 HG22 ' A' ' 144' ' ' ILE . 3.2 mp -122.43 130.25 52.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.287 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -103.26 108.17 19.28 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.523 HG22 ' CG1' ' A' ' 117' ' ' ILE . 6.1 t -133.0 158.36 43.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.168 0.509 . . . . 0.0 112.271 -178.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.452 ' N ' HG12 ' A' ' 148' ' ' VAL . 53.1 mt -125.39 124.25 25.13 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.457 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo . . . . . 0 C--N 1.346 0.439 0 C-N-CA 122.502 2.135 . . . . 0.0 112.515 -179.709 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.84 0.353 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . 0.429 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 6.7 pt-20 -164.72 137.56 4.74 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.35 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 126' ' ' TYR . . . . . 0.511 ' CE1' HG21 ' A' ' 130' ' ' VAL . 26.0 m-85 -121.27 134.73 55.18 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.146 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 96.0 m -106.16 115.9 31.02 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . 0.609 ' N ' HD13 ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.234 -0.888 . . . . 0.0 111.523 -177.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 69' ' ' VAL . 11.1 p . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.854 0.359 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.5 mtt85 -118.6 125.4 49.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.89 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.437 HD11 ' HE3' ' A' ' 147' ' ' LYS . 0.2 OUTLIER -98.99 99.45 10.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.849 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.523 HG21 ' OG ' ' A' ' 110' ' ' SER . 32.6 mt -93.95 143.26 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.831 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -132.25 123.19 26.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.909 0.385 . . . . 0.0 111.194 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.807 ' CE1' HD12 ' A' ' 144' ' ' ILE . 42.0 p90 -143.53 130.55 20.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.52 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 1.9 pt-20 -80.32 141.09 35.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.369 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -129.08 111.12 12.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.442 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -112.01 -25.29 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.419 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.45 154.22 19.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.282 -179.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -90.89 88.93 7.24 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.251 0.548 . . . . 0.0 110.607 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -166.2 146.15 5.23 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.978 -179.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -51.55 151.43 14.16 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.497 2.131 . . . . 0.0 112.275 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -56.89 -41.5 78.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.401 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 120.11 28.22 1.88 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.619 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.559 HG23 ' HB ' ' A' ' 105' ' ' ILE . 16.2 pt -147.8 168.36 4.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.876 0.369 . . . . 0.0 111.004 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.492 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -131.49 126.77 35.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.746 179.519 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.75 ' CD2' HD13 ' A' ' 117' ' ' ILE . 0.6 OUTLIER -127.9 159.5 34.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.809 -179.337 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.476 ' C ' HD13 ' A' ' 88' ' ' LEU . 1.8 pttp -136.22 152.37 50.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.527 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.882 HD12 HG11 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -95.46 102.95 14.79 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.304 179.148 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -65.8 176.52 1.56 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.639 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -52.1 -24.6 7.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.873 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.45 2.04 46.2 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.574 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 59.98 80.59 0.2 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.744 0.307 . . . . 0.0 110.529 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.565 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 2.7 m -158.06 139.06 13.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.659 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.877 ' HB2' HD11 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -87.55 111.42 21.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.062 0.458 . . . . 0.0 111.394 -179.372 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 115' ' ' ASP . 6.3 m -126.18 129.41 48.96 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.363 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.893 HG13 ' H ' ' A' ' 114' ' ' GLY . 4.0 p -58.84 106.08 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.233 0.539 . . . . 0.0 110.801 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -75.71 -21.82 57.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.311 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.8 mtp85 -171.67 133.83 0.79 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.765 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.844 HD13 HG21 ' A' ' 96' ' ' VAL . 26.9 mm -86.13 103.88 13.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.86 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.0 mp -58.76 138.65 57.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.011 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -79.76 137.25 36.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.935 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.88 -23.85 32.45 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.638 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.401 ' HA3' ' HA3' ' A' ' 83' ' ' GLY . . . -58.13 176.27 1.98 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.625 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 31.3 ttp -78.33 -33.56 49.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.822 0.344 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.566 HG23 ' HB3' ' A' ' 110' ' ' SER . 40.1 mm -72.36 -35.86 53.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -77.45 -41.86 38.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.657 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.7 ttt85 -72.15 -41.59 66.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.705 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.49 -44.77 14.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.755 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.52 79.87 1.4 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.559 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.566 ' HB3' HG23 ' A' ' 105' ' ' ILE . 9.6 t -117.6 -32.41 4.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.713 0.292 . . . . 0.0 111.192 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 1.031 HD11 HG21 ' A' ' 148' ' ' VAL . 0.3 OUTLIER -138.68 172.59 12.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.84 0.352 . . . . 0.0 111.029 -179.906 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -137.75 140.58 40.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.849 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.561 ' O ' HG13 ' A' ' 113' ' ' VAL . 9.2 p -43.59 113.56 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.702 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.893 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 119.0 -28.36 6.67 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.504 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.565 ' HB3' HG11 ' A' ' 148' ' ' VAL . 0.7 OUTLIER -50.02 131.91 23.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.735 0.302 . . . . 0.0 110.785 179.851 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.491 ' HA ' HG23 ' A' ' 95' ' ' THR . 1.4 tp10 -95.11 109.6 21.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.648 -179.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.75 HD13 ' CD2' ' A' ' 86' ' ' LEU . 3.6 mp -89.27 94.31 4.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.438 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.952 HD23 HD12 ' A' ' 149' ' ' ILE . 4.0 mm? -65.69 -26.86 67.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.465 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -135.49 130.07 34.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.867 0.365 . . . . 0.0 111.31 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.877 HD11 ' HB2' ' A' ' 94' ' ' CYS . 7.1 mt -112.48 98.8 7.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.719 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.9 t30 61.76 27.69 16.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.664 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 96.13 -2.18 63.41 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.814 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 27.9 m -133.63 127.54 33.2 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.854 0.359 . . . . 0.0 111.275 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -85.04 121.39 27.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.59 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.882 HG11 HD12 ' A' ' 88' ' ' LEU . 14.0 p -50.6 141.59 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.259 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 40.8 p -108.99 151.79 25.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.913 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -59.69 -25.36 64.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.006 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -59.26 -105.7 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.398 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 28.8 t -109.15 133.7 52.68 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.963 0.411 . . . . 0.0 110.848 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.717 HG13 ' CG2' ' A' ' 125' ' ' VAL . 0.9 OUTLIER -89.62 -20.47 7.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.185 179.508 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -43.68 -27.68 0.34 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.248 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -62.83 -43.85 97.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.432 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.513 HD22 ' N ' ' A' ' 133' ' ' LEU . 3.2 mm? -83.85 -43.14 15.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.62 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -59.35 -49.21 78.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.448 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -68.71 -46.45 68.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.796 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.4 ' O ' ' HB ' ' A' ' 140' ' ' THR . . . -66.36 -28.9 69.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.275 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 8.7 mmt -72.3 -36.92 69.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.168 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.3 pttt -90.61 -21.56 21.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.428 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -90.97 -16.99 27.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.554 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.4 ' HB ' ' O ' ' A' ' 136' ' ' ALA . 9.7 t -76.5 156.94 32.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.963 0.411 . . . . 0.0 111.082 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -143.81 120.88 11.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.716 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 134.71 -160.28 24.2 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.603 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.405 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 60.1 mmm -77.28 111.55 13.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.786 0.327 . . . . 0.0 111.129 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.807 HD12 ' CE1' ' A' ' 74' ' ' PHE . 22.9 mt -85.93 140.28 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.998 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.4 m -108.47 117.33 33.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.486 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.744 HD23 ' CE2' ' A' ' 74' ' ' PHE . 3.3 mm? -120.18 119.08 32.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.208 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.437 ' HE3' HD11 ' A' ' 71' ' ' LEU . 1.8 mptt -95.64 105.29 17.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.774 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 1.031 HG21 HD11 ' A' ' 111' ' ' LEU . 2.7 t -118.62 154.46 20.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.808 -178.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.952 HD12 HD23 ' A' ' 118' ' ' LEU . 8.3 mt -130.76 134.19 25.71 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.596 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo . . . . . 0 C--N 1.345 0.382 0 C-N-CA 122.453 2.102 . . . . 0.0 112.332 -179.886 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 0.1 OUTLIER . . . . . 0 CA--C 1.527 0.063 0 CA-C-O 120.617 0.246 . . . . 0.0 110.734 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.67 130.95 25.02 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 121.243 0.544 . . . . 0.0 110.058 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 126' ' ' TYR . . . . . 0.64 ' CE1' HG21 ' A' ' 130' ' ' VAL . 5.2 m-85 -115.69 151.0 35.89 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.3 -0.863 . . . . 0.0 112.098 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 1.2 m -110.31 116.12 30.9 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 176.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . 0.518 HD11 HD13 ' A' ' 86' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.236 -0.888 . . . . 0.0 111.512 -177.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.85 0.357 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.74 129.64 49.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.76 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.52 99.42 9.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.003 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.557 HD13 HD12 ' A' ' 111' ' ' LEU . 18.0 mt -89.34 146.45 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.465 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -138.59 123.16 18.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.957 0.408 . . . . 0.0 111.681 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.763 ' HE1' HD12 ' A' ' 144' ' ' ILE . 20.8 p90 -138.57 131.86 30.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.096 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 2.4 tt0 -80.33 138.11 36.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.047 0.451 . . . . 0.0 111.612 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.13 111.27 12.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.19 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.86 -28.28 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.3 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.46 148.52 22.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.256 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -87.5 90.28 8.31 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.298 0.571 . . . . 0.0 110.463 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.65 153.9 11.61 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.964 -178.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -49.88 140.42 30.93 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.463 2.109 . . . . 0.0 112.247 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.45 ' HG2' ' CZ ' ' A' ' 74' ' ' PHE . 0.3 OUTLIER -55.14 -56.56 18.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.561 ' O ' HG23 ' A' ' 84' ' ' ILE . . . 138.42 39.12 0.11 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.53 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.743 HG22 HD13 ' A' ' 99' ' ' ILE . 15.3 pt -160.02 158.46 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.771 0.32 . . . . 0.0 110.889 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.496 ' HB2' HD21 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -124.61 124.12 41.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.935 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.67 ' CD1' HD11 ' B' ' 128' ' ' ILE . 0.4 OUTLIER -128.21 158.52 37.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.15 -179.26 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.554 ' C ' HD13 ' A' ' 88' ' ' LEU . 2.9 pttt -138.45 166.75 23.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.025 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.683 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -107.29 103.37 12.71 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.802 179.797 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -64.9 176.43 1.21 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.797 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -50.82 -30.1 13.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.984 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -75.95 -18.09 59.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.091 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 76.27 87.71 0.08 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.634 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 3.6 m -165.06 143.71 6.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.355 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -87.93 111.42 21.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.035 0.445 . . . . 0.0 111.463 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 115' ' ' ASP . 7.4 m -130.43 131.03 45.02 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.395 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.887 HG13 ' H ' ' A' ' 114' ' ' GLY . 2.4 p -59.01 106.15 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.295 0.569 . . . . 0.0 110.724 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.534 ' HB2' ' HD3' ' A' ' 87' ' ' LYS . . . -73.16 -22.55 60.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.994 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.478 ' HA ' HG23 ' A' ' 113' ' ' VAL . 1.5 tmm_? -173.57 136.15 0.57 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.854 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.743 HD13 HG22 ' A' ' 84' ' ' ILE . 12.3 mm -86.02 131.8 33.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.462 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.612 HD22 ' N ' ' A' ' 100' ' ' LEU . 2.0 mm? -89.46 147.64 23.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.831 0.348 . . . . 0.0 111.01 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 17.0 m170 -83.16 136.54 34.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.78 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.37 -28.46 15.28 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.346 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.63 166.23 7.44 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.467 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.407 ' SD ' HD13 ' A' ' 105' ' ' ILE . 0.5 OUTLIER -72.34 -25.89 61.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.666 0.269 . . . . 0.0 111.069 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.44 ' HB ' HG23 ' A' ' 84' ' ' ILE . 29.6 mm -76.71 -36.53 27.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.105 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -80.02 -31.19 39.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.783 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -83.46 -51.23 7.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.826 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -73.76 -43.01 60.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.836 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.99 69.54 1.22 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.471 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.59 -27.96 9.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.745 0.307 . . . . 0.0 111.045 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 1.095 HD11 HG21 ' A' ' 148' ' ' VAL . 0.1 OUTLIER -141.82 172.61 12.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.968 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -139.88 141.84 36.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.84 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.478 HG23 ' HA ' ' A' ' 98' ' ' ARG . 7.6 p -44.97 120.57 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.499 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.887 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 110.26 -27.95 10.96 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.711 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.618 ' O ' HG23 ' A' ' 95' ' ' THR . 0.1 OUTLIER -48.11 135.82 12.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.779 0.323 . . . . 0.0 110.92 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.429 ' HA ' HG23 ' A' ' 95' ' ' THR . 7.6 tt0 -94.72 120.41 34.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.336 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.708 HG13 HG22 ' A' ' 148' ' ' VAL . 4.2 mp -99.19 99.03 7.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.633 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -63.92 -28.33 69.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.448 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -147.08 139.05 24.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.868 0.366 . . . . 0.0 111.198 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.944 HD13 HG23 ' A' ' 125' ' ' VAL . 2.7 mp -118.51 98.74 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.953 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 64.64 28.26 13.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.651 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 92.05 7.51 64.08 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.786 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.58 128.18 34.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.717 0.294 . . . . 0.0 110.948 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -91.78 110.88 22.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.678 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.944 HG23 HD13 ' A' ' 120' ' ' ILE . 6.0 t -63.38 133.63 28.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.237 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 24.5 p -117.07 -177.42 3.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.837 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -59.68 -20.58 57.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.038 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -58.18 -165.2 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.588 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.09 134.08 46.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.917 0.389 . . . . 0.0 110.954 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.628 HG21 ' CE1' ' B' ' 126' ' ' TYR . 0.6 OUTLIER -89.34 -18.75 7.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.16 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 135' ' ' LYS . 3.3 p30 -44.81 -26.53 0.41 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.474 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.49 -42.14 87.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.877 0.37 . . . . 0.0 110.634 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.871 ' HG ' HG22 ' A' ' 125' ' ' VAL . 2.1 mm? -81.61 -39.74 24.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.229 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.415 ' HG3' ' CG2' ' B' ' 128' ' ' ILE . 3.9 tt0 -56.89 -44.7 82.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.644 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -70.6 -48.89 52.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.78 179.808 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.7 -40.35 79.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.072 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.838 ' O ' HG22 ' A' ' 140' ' ' THR . 24.5 mmt -69.07 -33.15 73.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.018 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.71 -26.5 37.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.887 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.02 -14.07 23.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.447 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.838 HG22 ' O ' ' A' ' 137' ' ' MET . 12.6 t -59.31 156.76 12.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.838 0.351 . . . . 0.0 110.981 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -152.08 104.43 2.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.872 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 141.48 -149.3 20.98 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.646 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.407 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 7.8 mtp -87.82 114.37 24.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.869 0.366 . . . . 0.0 110.975 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.763 HD12 ' HE1' ' A' ' 74' ' ' PHE . 32.8 mt -85.33 130.53 36.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.97 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.457 ' O ' HD13 ' A' ' 146' ' ' LEU . 5.4 m -113.57 114.98 27.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.448 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.69 HD22 ' N ' ' A' ' 146' ' ' LEU . 0.4 OUTLIER -120.55 138.66 53.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.074 -179.52 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 7.1 mmtt -95.94 105.42 17.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.872 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 1.095 HG21 HD11 ' A' ' 111' ' ' LEU . 4.2 t -122.79 158.28 27.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.057 0.456 . . . . 0.0 111.926 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.421 ' N ' HG12 ' A' ' 148' ' ' VAL . 26.2 mt -134.07 133.81 22.36 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.619 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.88 122.17 8.82 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.407 2.071 . . . . 0.0 112.44 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -96.54 41.09 1.11 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.907 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.1 109.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.914 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.884 -179.989 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.808 0.337 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.87 167.86 15.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.973 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -152.3 135.15 15.53 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 121.195 0.522 . . . . 0.0 110.017 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' TYR . . . . . 0.628 ' CE1' HG21 ' A' ' 130' ' ' VAL . 39.3 m-85 -117.49 134.26 55.05 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.565 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 1.7 m -106.05 115.98 31.15 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.696 ' N ' HD13 ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.488 -177.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.608 ' O ' HG13 ' A' ' 69' ' ' VAL . 8.8 p . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.951 0.405 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.08 148.25 37.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.756 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.433 ' O ' HD23 ' A' ' 71' ' ' LEU . 9.2 tt -115.08 99.35 7.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.071 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.9 mm -89.61 110.36 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.41 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -113.05 126.66 55.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.014 0.435 . . . . 0.0 111.772 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.666 ' HE1' HD12 ' A' ' 144' ' ' ILE . 4.5 p90 -143.17 145.42 32.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.234 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 0.0 OUTLIER -80.27 139.68 36.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.014 0.435 . . . . 0.0 111.4 -179.364 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -129.35 111.28 12.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.364 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.62 ' O ' HG13 ' A' ' 77' ' ' VAL . 0.3 OUTLIER -124.69 12.95 4.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.636 -179.642 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.68 147.78 46.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.859 0.361 . . . . 0.0 111.228 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -87.76 84.57 7.03 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.249 0.547 . . . . 0.0 110.462 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -174.08 156.92 2.56 Favored Pre-proline 0 N--CA 1.447 -0.587 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.045 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -51.56 132.15 39.66 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.594 2.196 . . . . 0.0 112.4 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.465 ' HG2' ' CE1' ' A' ' 74' ' ' PHE . 0.7 OUTLIER -46.82 -34.98 5.79 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.144 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.42 ' O ' HG23 ' A' ' 84' ' ' ILE . . . 123.56 36.41 0.64 Allowed Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.533 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.512 HD12 HD11 ' A' ' 86' ' ' LEU . 23.9 pt -157.02 165.39 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.787 0.327 . . . . 0.0 110.897 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.72 ' C ' HD12 ' A' ' 86' ' ' LEU . 0.1 OUTLIER -130.04 123.14 29.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.062 179.716 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.728 HD23 HD13 ' A' ' 117' ' ' ILE . 4.5 mp -121.3 156.11 33.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.812 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.635 ' C ' HD13 ' A' ' 88' ' ' LEU . 36.8 pttt -140.05 159.7 41.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.257 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.673 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -105.95 103.09 12.5 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.621 179.586 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -65.52 176.34 1.49 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.764 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -51.87 -26.96 11.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.876 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.0 -13.24 59.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.252 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.4 ' HG2' ' HB2' ' A' ' 127' ' ' ASN . 4.1 mt-30 71.93 88.81 0.1 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.812 0.339 . . . . 0.0 110.601 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.53 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 2.6 m -166.29 141.67 4.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.483 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.574 ' SG ' HD11 ' A' ' 120' ' ' ILE . 11.5 p -87.79 111.44 21.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.099 0.476 . . . . 0.0 111.359 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.7 HG23 ' O ' ' A' ' 115' ' ' ASP . 15.6 m -132.63 133.95 44.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.323 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.917 HG13 ' H ' ' A' ' 114' ' ' GLY . 2.5 p -58.84 106.01 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.196 0.522 . . . . 0.0 110.729 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -71.32 -23.98 62.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.866 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.407 ' HA ' ' CG2' ' A' ' 113' ' ' VAL . 16.4 ttm180 -173.55 141.25 0.86 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.784 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.546 HD13 HG21 ' A' ' 96' ' ' VAL . 17.2 mm -86.06 138.84 18.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.485 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.657 HD11 ' SG ' ' B' ' 127' ' ' CYS . 1.2 mt -96.37 126.54 41.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.821 0.343 . . . . 0.0 111.005 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.428 ' HA ' ' CD2' ' A' ' 106' ' ' HIS . 0.3 OUTLIER -68.5 132.48 47.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.902 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 101.84 -27.9 18.36 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.545 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.8 166.26 17.85 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.537 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 8.8 ttp -67.88 -25.67 65.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.81 0.338 . . . . 0.0 111.068 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.61 HG23 ' OG ' ' A' ' 110' ' ' SER . 19.9 mm -79.46 -32.31 14.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.969 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.428 ' CD2' HG22 ' A' ' 99' ' ' ILE . 6.0 t-80 -81.67 -47.75 12.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.548 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.22 -42.17 98.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.558 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -87.4 -43.93 11.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.643 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.37 42.35 5.23 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.597 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.61 ' OG ' HG23 ' A' ' 105' ' ' ILE . 11.2 p -74.46 -26.14 59.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.812 0.339 . . . . 0.0 111.019 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.929 HD21 HG21 ' A' ' 148' ' ' VAL . 5.1 mt -140.54 172.7 12.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.033 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -140.87 140.91 34.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.82 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.44 ' O ' HG13 ' A' ' 113' ' ' VAL . 6.0 p -44.96 120.3 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.595 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.917 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 111.23 -27.15 11.07 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.748 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.7 ' O ' HG23 ' A' ' 95' ' ' THR . 0.2 OUTLIER -46.99 133.38 11.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.762 0.315 . . . . 0.0 110.991 179.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.53 114.64 26.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.174 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.728 HD13 HD23 ' A' ' 86' ' ' LEU . 4.9 mp -94.02 101.58 12.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.84 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.463 HD21 HD12 ' A' ' 149' ' ' ILE . 4.4 mm? -60.34 -42.43 95.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.96 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -142.72 153.02 42.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.969 0.414 . . . . 0.0 111.218 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.671 HG23 HD12 ' A' ' 146' ' ' LEU . 39.4 mt -124.01 98.77 5.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.723 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 59.05 27.72 16.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.703 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 93.87 13.46 54.82 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.617 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 74.4 m -133.64 127.97 34.08 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.894 0.378 . . . . 0.0 111.098 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -110.72 87.57 2.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.674 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.566 HG21 HG13 ' A' ' 130' ' ' VAL . 9.2 p -51.11 158.32 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.328 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.482 ' N ' HG22 ' A' ' 125' ' ' VAL . 37.9 p -131.9 -176.44 4.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.965 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.4 ' HB2' ' HG2' ' A' ' 92' ' ' GLN . 23.5 t-20 -62.13 -18.55 61.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.277 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -59.47 -109.11 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.684 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.19 133.97 52.34 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.89 0.376 . . . . 0.0 111.071 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.87 HG21 ' CE1' ' B' ' 126' ' ' TYR . 0.8 OUTLIER -89.27 -23.95 6.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.18 179.551 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.3 -26.44 0.51 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.54 -179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -56.77 -57.5 12.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.826 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.52 HD12 ' C ' ' A' ' 133' ' ' LEU . 0.3 OUTLIER -75.49 -38.68 59.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.867 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -58.97 -57.7 11.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.906 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.07 -44.91 87.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.896 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.25 -34.09 75.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.083 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.429 ' O ' HG22 ' A' ' 140' ' ' THR . 0.4 OUTLIER -68.01 -31.37 71.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.984 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -87.92 -24.96 23.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.129 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -90.36 -28.67 18.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.119 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 137' ' ' MET . 12.2 t -59.5 156.79 12.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.949 0.404 . . . . 0.0 111.033 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.4 100.12 1.95 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.797 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 149.6 -152.14 24.14 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.511 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.4 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 22.9 mtp -80.82 118.82 22.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.827 0.346 . . . . 0.0 111.052 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.666 HD12 ' HE1' ' A' ' 74' ' ' PHE . 46.1 mt -93.23 145.58 7.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.191 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.9 m -125.39 113.6 17.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.268 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.671 HD12 HG23 ' A' ' 120' ' ' ILE . 1.9 mm? -115.6 134.36 55.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.13 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 7.5 mmtm -98.72 107.19 19.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.878 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.929 HG21 HD21 ' A' ' 111' ' ' LEU . 10.1 t -125.49 158.29 34.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.056 0.455 . . . . 0.0 111.939 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.463 HD12 HD21 ' A' ' 118' ' ' LEU . 23.8 mt -138.21 126.57 14.17 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.768 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.12 124.62 16.75 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.513 2.142 . . . . 0.0 112.299 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -124.85 -171.76 2.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.912 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 63.11 77.69 0.32 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.951 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.98 179.927 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.809 0.337 . . . . 0.0 111.177 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.87 167.76 16.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.918 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . 0.41 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 42.3 mt-10 -159.87 133.25 6.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.794 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' TYR . . . . . 0.87 ' CE1' HG21 ' A' ' 130' ' ' VAL . 33.4 m-85 -124.47 134.91 52.91 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.426 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' CYS . . . . . 0.657 ' SG ' HD11 ' A' ' 100' ' ' LEU . 1.8 m -106.01 116.1 31.36 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.488 HG13 HD11 ' A' ' 133' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.372 -177.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.551 ' O ' HG13 ' A' ' 69' ' ' VAL . 14.9 p . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 120.932 0.396 . . . . 0.0 111.258 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.54 146.07 24.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.747 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.82 99.26 6.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.066 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.663 HG21 ' HB3' ' A' ' 110' ' ' SER . 4.0 mp -91.43 140.96 15.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.224 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 144' ' ' ILE . 32.4 mt-30 -135.41 132.33 37.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.113 0.482 . . . . 0.0 111.911 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.623 ' CZ ' HD23 ' A' ' 146' ' ' LEU . 0.8 OUTLIER -144.98 125.97 14.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.298 179.054 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 0.0 OUTLIER -80.26 137.86 36.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.538 -179.216 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -129.07 123.9 33.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.49 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -104.03 -37.31 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.02 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.56 156.53 18.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.258 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -88.63 90.88 8.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.544 0.688 . . . . 0.0 110.565 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -147.18 141.36 15.79 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.947 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.74 144.87 41.54 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.43 2.087 . . . . 0.0 112.082 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.55 -47.01 83.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.97 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 120.74 28.75 1.67 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.755 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.544 HG22 HG23 ' A' ' 99' ' ' ILE . 15.8 pt -146.96 166.3 6.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.844 0.354 . . . . 0.0 110.983 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.481 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -131.18 126.47 35.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.124 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.597 HD12 HD11 ' B' ' 128' ' ' ILE . 0.4 OUTLIER -131.72 156.99 44.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.036 -179.467 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.69 ' C ' HD13 ' A' ' 88' ' ' LEU . 34.3 pttt -136.16 166.78 22.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.327 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.693 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -111.11 103.23 11.66 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.419 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.404 ' OD1' ' HB3' ' A' ' 91' ' ' LYS . 4.9 p30 -66.94 176.67 1.98 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.819 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -47.73 -37.49 13.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.349 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.404 ' HB3' ' OD1' ' A' ' 89' ' ' ASN . 79.0 tttt -70.2 -18.17 63.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.183 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' ' HB ' ' A' ' 126' ' ' THR . 0.0 OUTLIER 76.56 88.51 0.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.546 -179.588 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 1.7 t -162.69 139.55 7.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.46 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.65 111.47 21.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.986 0.422 . . . . 0.0 111.405 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.679 HG23 ' O ' ' A' ' 115' ' ' ASP . 19.0 m -130.0 133.5 46.81 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.424 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.912 HG13 ' H ' ' A' ' 114' ' ' GLY . 3.2 p -61.03 105.91 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.214 0.53 . . . . 0.0 110.458 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -72.98 -25.25 60.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.858 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.573 ' HA ' HG23 ' A' ' 113' ' ' VAL . 47.5 ttt180 -173.61 128.84 0.42 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.387 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.615 HG12 HG21 ' A' ' 96' ' ' VAL . 21.1 mt -85.84 125.51 40.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.897 0.379 . . . . 0.0 110.693 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.459 ' N ' HD12 ' A' ' 100' ' ' LEU . 8.0 mp -83.13 135.73 34.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.146 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.427 ' HA ' ' CG ' ' A' ' 106' ' ' HIS . 32.8 t-80 -79.26 136.98 37.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.869 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 114.57 -41.44 2.18 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.388 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.3 -173.06 0.24 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.702 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 64.7 ttp -84.61 -29.69 25.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.716 0.293 . . . . 0.0 111.157 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 33.4 mm -71.56 -42.15 72.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.257 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.427 ' CG ' ' HA ' ' A' ' 101' ' ' HIS . 5.5 t60 -71.49 -35.97 70.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.843 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.62 -51.0 10.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.746 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -73.15 -46.32 51.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.804 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.42 77.48 1.35 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.471 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.663 ' HB3' HG21 ' A' ' 72' ' ' ILE . 2.0 m -112.4 -30.86 7.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.804 0.335 . . . . 0.0 111.038 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 110' ' ' SER . 5.5 mp -135.53 158.29 44.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.954 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.539 ' CA ' HD11 ' A' ' 99' ' ' ILE . 85.0 m-70 -121.19 135.31 55.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.714 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.573 HG23 ' HA ' ' A' ' 98' ' ' ARG . 7.6 p -45.28 115.01 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.473 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.912 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 112.39 -25.62 12.11 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.707 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.679 ' O ' HG23 ' A' ' 95' ' ' THR . 6.9 m-20 -55.06 137.78 45.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.696 0.284 . . . . 0.0 110.808 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.413 ' HA ' HG23 ' A' ' 95' ' ' THR . 38.8 tt0 -91.62 123.2 34.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.908 0.385 . . . . 0.0 111.492 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.666 HG13 HG22 ' A' ' 148' ' ' VAL . 3.3 mp -97.78 94.25 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.354 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.446 HD13 ' HA ' ' A' ' 118' ' ' LEU . 4.2 mm? -59.05 -26.14 64.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.512 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.16 138.97 25.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.901 0.381 . . . . 0.0 111.481 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.553 HD12 ' N ' ' A' ' 120' ' ' ILE . 2.5 mp -119.88 98.67 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.56 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.407 ' H ' HD13 ' A' ' 146' ' ' LEU . 12.5 t-20 61.99 26.91 16.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.619 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 92.03 13.37 57.77 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.796 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.483 ' HB ' HD21 ' A' ' 133' ' ' LEU . 1.3 m -133.58 133.69 42.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.839 0.352 . . . . 0.0 111.161 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.29 84.35 2.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.579 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.885 HG21 HG13 ' A' ' 130' ' ' VAL . 11.2 p -55.79 125.69 11.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.217 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' A' ' 92' ' ' GLN . 26.3 p -103.6 -168.55 1.52 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.696 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.01 -22.27 60.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.937 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -54.57 -176.1 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.685 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.6 p -59.2 134.07 56.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.926 0.393 . . . . 0.0 110.914 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.885 HG13 HG21 ' A' ' 125' ' ' VAL . 0.7 OUTLIER -89.25 -20.0 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.208 179.777 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -45.6 -25.6 0.48 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.417 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.906 ' HG3' HD12 ' A' ' 133' ' ' LEU . 5.9 pt20 -68.9 -47.77 65.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.738 0.304 . . . . 0.0 110.815 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.906 HD12 ' HG3' ' A' ' 132' ' ' GLN . 2.2 mp -81.43 -46.53 14.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.722 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -54.54 -39.55 67.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.955 0.407 . . . . 0.0 110.756 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.36 -50.08 29.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.964 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -58.25 -43.51 87.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.306 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.875 ' HE1' HD13 ' A' ' 144' ' ' ILE . 77.2 mmm -65.06 -37.6 88.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.964 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -74.53 -27.64 60.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.864 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -106.92 10.1 30.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.462 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.817 HG22 ' O ' ' A' ' 137' ' ' MET . 12.8 t -69.3 156.9 38.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.857 0.361 . . . . 0.0 110.846 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -144.55 113.81 6.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.815 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 130.2 -145.39 16.6 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.636 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.466 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 2.4 mtp -97.41 119.97 36.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.858 0.361 . . . . 0.0 111.188 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.875 HD13 ' HE1' ' A' ' 137' ' ' MET . 41.0 mt -90.23 131.75 36.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.122 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.1 m -112.87 114.26 26.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.107 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.647 HD22 ' N ' ' A' ' 146' ' ' LEU . 1.0 OUTLIER -116.96 131.2 57.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.384 -179.251 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.29 110.3 22.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.314 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.666 HG22 HG13 ' A' ' 117' ' ' ILE . 2.8 t -121.79 158.25 25.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.575 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.43 HD12 ' CD2' ' A' ' 118' ' ' LEU . 29.2 mt -140.89 130.5 13.04 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.897 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.08 126.06 20.83 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.428 2.085 . . . . 0.0 112.304 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -59.93 120.22 9.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.857 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 61.5 105.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.856 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.167 -0.921 . . . . 0.0 110.958 179.977 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.844 0.354 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . 0.435 ' CD ' ' CE1' ' B' ' 126' ' ' TYR . 0.0 OUTLIER -127.79 167.81 16.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.988 -179.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . 0.422 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 2.0 pt-20 -155.33 135.84 13.34 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.124 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' TYR . . . . . 0.661 ' CE1' HG21 ' A' ' 130' ' ' VAL . 33.1 m-85 -115.53 133.21 56.25 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.42 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' CYS . . . . . 0.449 ' SG ' HD21 ' A' ' 100' ' ' LEU . 1.8 m -105.94 116.05 31.28 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.707 ' N ' HD13 ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.47 -177.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.441 ' O ' HG13 ' A' ' 69' ' ' VAL . 10.9 p . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.777 0.322 . . . . 0.0 111.077 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 -116.06 137.83 51.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.858 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.412 HD12 ' HG2' ' A' ' 147' ' ' LYS . 1.8 tp -108.93 99.38 8.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.921 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.613 HG21 ' HB3' ' A' ' 110' ' ' SER . 13.1 mm -90.41 118.9 36.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.601 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -113.3 127.32 56.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.0 0.428 . . . . 0.0 111.566 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.683 ' CZ ' HD23 ' A' ' 146' ' ' LEU . 9.9 p90 -145.54 131.52 19.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.378 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.33 141.7 35.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.006 0.432 . . . . 0.0 111.299 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.8 ttpt -129.12 111.21 12.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.358 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -105.69 -22.53 4.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.277 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.54 146.09 24.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.185 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -88.36 89.82 8.14 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.259 0.552 . . . . 0.0 110.54 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -167.86 158.72 9.44 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.899 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -50.88 145.18 24.96 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.559 2.172 . . . . 0.0 112.486 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 19.2 ttm -54.27 -65.68 0.53 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.083 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.655 ' O ' HG23 ' A' ' 84' ' ' ILE . . . 144.62 38.41 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.704 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.856 HD13 HD11 ' A' ' 86' ' ' LEU . 1.9 pp -163.5 164.83 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.777 0.322 . . . . 0.0 110.907 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -129.29 128.07 42.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.27 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.856 HD11 HD13 ' A' ' 84' ' ' ILE . 0.4 OUTLIER -128.78 157.43 41.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.824 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.47 ' C ' HD13 ' A' ' 88' ' ' LEU . 55.4 pttt -138.86 166.21 25.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.399 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.675 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -106.54 102.98 12.33 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.485 179.38 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -67.86 176.73 2.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.613 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -49.46 -25.5 2.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.904 0.383 . . . . 0.0 111.021 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.419 ' O ' ' CG ' ' A' ' 91' ' ' LYS . 12.8 tptt -88.05 12.31 13.8 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.261 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 44.02 87.15 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.849 0.357 . . . . 0.0 111.258 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 1.6 m -160.33 145.05 14.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.428 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.43 ' CB ' HD11 ' A' ' 120' ' ' ILE . 0.8 OUTLIER -87.83 111.63 21.6 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.932 0.396 . . . . 0.0 111.468 -179.328 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.614 HG23 ' O ' ' A' ' 115' ' ' ASP . 3.6 m -132.17 129.3 39.61 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.616 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.932 HG21 HD13 ' A' ' 99' ' ' ILE . 4.1 p -58.79 106.36 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.261 0.553 . . . . 0.0 110.601 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -74.44 -21.5 59.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.384 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.436 ' HA ' HG23 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -173.53 134.43 0.5 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.06 179.779 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.932 HD13 HG21 ' A' ' 96' ' ' VAL . 22.6 mm -86.13 103.71 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.639 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.431 HD21 ' SG ' ' B' ' 127' ' ' CYS . 9.8 mp -57.12 141.87 44.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.216 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.431 ' HA ' ' CD2' ' A' ' 106' ' ' HIS . 78.5 m-70 -78.08 136.36 37.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.819 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.23 -25.03 26.21 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.525 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.51 155.75 18.03 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.459 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 2.9 tmm? -61.26 -37.39 82.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.776 0.322 . . . . 0.0 110.983 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.433 HG23 ' CB ' ' A' ' 110' ' ' SER . 35.3 mm -68.51 -32.02 53.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.185 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.431 ' CD2' ' HA ' ' A' ' 101' ' ' HIS . 17.4 t60 -74.44 -54.3 7.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.774 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -42.84 94.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.743 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -77.23 -49.57 14.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.755 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.41 76.37 1.33 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.521 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.613 ' HB3' HG21 ' A' ' 72' ' ' ILE . 0.9 OUTLIER -113.71 -28.77 7.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.734 0.302 . . . . 0.0 111.149 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.485 HD11 HG21 ' A' ' 148' ' ' VAL . 0.1 OUTLIER -137.83 172.59 12.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.059 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -139.59 132.92 30.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.789 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.595 ' O ' HG13 ' A' ' 113' ' ' VAL . 7.1 p -42.38 108.32 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.768 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.889 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 119.03 -27.45 7.06 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.946 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.614 ' O ' HG23 ' A' ' 95' ' ' THR . 6.4 m-20 -50.49 139.9 14.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.765 0.317 . . . . 0.0 110.835 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -90.77 116.78 28.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.46 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.805 HD13 HD23 ' A' ' 86' ' ' LEU . 4.6 mp -96.7 101.95 12.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.503 179.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.539 HD13 ' CD1' ' A' ' 149' ' ' ILE . 6.0 mp -68.56 -27.31 65.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.481 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -148.45 141.12 24.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.93 0.395 . . . . 0.0 111.286 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.578 HG23 HD11 ' A' ' 146' ' ' LEU . 3.5 mp -119.65 99.14 7.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.818 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.46 HD22 HG23 ' A' ' 144' ' ' ILE . 20.2 t-20 62.46 25.39 15.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.716 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 99.94 1.44 56.12 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.984 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.8 m -133.62 130.59 38.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.844 0.354 . . . . 0.0 111.142 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.402 ' HA ' HD12 ' A' ' 120' ' ' ILE . 5.1 p-10 -101.42 98.04 8.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.643 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.994 HG21 HG13 ' A' ' 130' ' ' VAL . 9.6 p -58.85 138.33 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.012 0.434 . . . . 0.0 111.189 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.2 p -123.14 -171.19 2.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.515 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 44.4 p-10 -50.21 -24.88 3.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.244 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.26 -166.04 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.652 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.81 133.88 45.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.883 0.373 . . . . 0.0 110.934 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.994 HG13 HG21 ' A' ' 125' ' ' VAL . 0.7 OUTLIER -89.26 -20.48 7.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.282 179.738 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.0 -26.35 0.42 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.429 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.67 -50.65 73.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.766 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.5 mp -72.16 -41.73 66.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.718 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -55.38 -52.41 63.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.559 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -62.5 -34.9 77.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.529 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.78 -30.34 62.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.986 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 3.8 mmt -69.84 -32.73 71.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.823 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -85.39 -25.96 26.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.023 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -88.92 -32.64 17.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.159 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 11.9 t -59.38 150.63 25.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.012 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.94 124.33 8.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.734 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 124.08 -146.61 16.35 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.547 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 1.6 ttm -78.07 121.1 23.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.894 0.378 . . . . 0.0 111.095 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.686 HG22 ' CD2' ' A' ' 146' ' ' LEU . 42.8 mt -96.73 136.35 27.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.035 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.514 ' C ' HD22 ' A' ' 146' ' ' LEU . 87.2 p -107.82 127.67 53.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.632 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.686 ' CD2' HG22 ' A' ' 144' ' ' ILE . 3.3 mm? -130.17 121.16 25.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.186 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.412 ' HG2' HD12 ' A' ' 71' ' ' LEU . 11.8 mmtt -95.87 105.35 17.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.837 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.618 HG22 HG13 ' A' ' 117' ' ' ILE . 2.7 t -127.64 157.93 39.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.002 0.429 . . . . 0.0 111.773 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.539 ' CD1' HD13 ' A' ' 118' ' ' LEU . 46.1 mt -134.36 135.97 24.94 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.845 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.401 ' HD2' HG23 ' A' ' 149' ' ' ILE . 37.5 Cg_endo -65.92 117.7 4.88 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.436 2.091 . . . . 0.0 112.281 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -70.68 65.27 0.31 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.005 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 52.79 29.9 8.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.052 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.154 -0.927 . . . . 0.0 111.001 179.98 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.786 0.327 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . 0.411 ' HD2' ' CE1' ' B' ' 126' ' ' TYR . 0.0 OUTLIER -77.8 167.94 20.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.875 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . 0.401 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 1.6 pt-20 -141.21 133.07 27.47 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.231 0.538 . . . . 0.0 109.814 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' TYR . . . . . 0.738 ' CE1' HG21 ' A' ' 130' ' ' VAL . 42.2 m-85 -109.9 132.34 54.24 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.575 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' CYS . . . . . 0.431 ' SG ' HD21 ' A' ' 100' ' ' LEU . 1.8 m -105.98 115.95 31.1 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.708 ' N ' HD13 ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.583 -177.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.568 ' O ' HG13 ' A' ' 69' ' ' VAL . 10.2 p . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.887 0.375 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.1 mtt85 -101.92 126.04 48.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.922 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.6 99.47 10.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.507 ' CD1' HG12 ' A' ' 148' ' ' VAL . 3.5 mp -89.37 145.27 7.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.957 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -136.7 123.11 20.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.172 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.509 ' CZ ' HD23 ' A' ' 146' ' ' LEU . 10.8 p90 -148.33 129.36 14.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.779 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 1.3 pt-20 -80.33 129.72 34.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.219 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.36 111.57 12.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.225 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.615 ' O ' HG13 ' A' ' 77' ' ' VAL . 0.3 OUTLIER -125.65 15.52 4.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.568 -179.605 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.15 154.94 21.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.54 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -80.9 79.54 7.55 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.267 0.556 . . . . 0.0 110.001 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.14 137.87 1.66 Allowed Pre-proline 0 N--CA 1.447 -0.601 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.132 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.32 156.4 10.74 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.336 2.024 . . . . 0.0 112.258 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.445 ' HG2' ' CE1' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -59.13 -39.89 83.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.857 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 119.86 35.01 0.93 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.488 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.549 ' CA ' HD23 ' A' ' 100' ' ' LEU . 13.6 pt -152.45 154.31 8.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.77 0.319 . . . . 0.0 110.977 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.618 ' HB2' HD21 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -125.61 122.81 37.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.095 179.618 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.875 HD23 HD13 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -125.17 159.23 32.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.87 -179.663 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.565 ' C ' HD13 ' A' ' 88' ' ' LEU . 7.0 pttt -142.79 161.44 38.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.2 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.632 ' N ' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -101.65 102.9 13.66 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.557 179.389 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -65.25 176.76 1.24 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.448 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -49.67 -27.64 4.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.815 0.34 . . . . 0.0 110.879 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.66 -9.18 59.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.713 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 67.79 76.43 0.27 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.902 0.382 . . . . 0.0 110.946 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.575 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 1.3 p -153.87 145.02 22.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.522 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -87.74 112.63 22.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.105 0.479 . . . . 0.0 111.292 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.644 HG23 ' O ' ' A' ' 115' ' ' ASP . 3.5 m -132.85 130.82 40.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.378 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.923 HG13 ' H ' ' A' ' 114' ' ' GLY . 2.6 p -58.59 106.08 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.312 0.577 . . . . 0.0 110.615 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -71.77 -23.22 61.55 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.038 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.452 ' HA ' HG23 ' A' ' 113' ' ' VAL . 6.1 mtt180 -173.45 145.92 1.3 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.591 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.551 HD11 ' HA ' ' A' ' 112' ' ' HIS . 54.0 mt -86.01 135.67 24.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.634 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.618 HD21 ' HB2' ' A' ' 85' ' ' CYS . 4.1 mm? -85.6 123.35 30.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.028 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -70.14 131.99 45.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.911 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.15 -24.52 28.45 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.543 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.61 -178.05 0.62 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.633 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 29.1 ttp -84.42 -27.18 27.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.707 0.289 . . . . 0.0 111.069 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.431 HG23 ' HB2' ' A' ' 110' ' ' SER . 25.5 mm -78.45 -34.64 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.116 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -72.67 -45.7 57.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.914 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 29.7 ttp180 -71.96 -46.55 57.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.906 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.61 -46.89 29.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.837 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.23 75.55 1.3 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.446 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.431 ' HB3' HG21 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -111.28 -29.82 7.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.785 0.326 . . . . 0.0 111.104 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.529 HD23 HG21 ' A' ' 148' ' ' VAL . 2.6 mp -136.95 172.61 12.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.934 0.397 . . . . 0.0 111.034 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.551 ' HA ' HD11 ' A' ' 99' ' ' ILE . 32.1 m170 -139.48 134.9 32.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.741 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.564 ' O ' HG13 ' A' ' 113' ' ' VAL . 7.1 p -42.21 113.03 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.705 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.923 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 111.75 -24.17 15.67 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.979 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.644 ' O ' HG23 ' A' ' 95' ' ' THR . 11.4 m-20 -48.95 142.79 6.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.725 0.298 . . . . 0.0 110.848 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.3 mp0 -91.69 114.77 27.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.691 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.875 HD13 HD23 ' A' ' 86' ' ' LEU . 4.6 mp -92.79 107.81 19.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.538 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.508 ' CD2' HD12 ' A' ' 149' ' ' ILE . 4.3 mm? -70.11 -27.97 65.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.584 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -155.05 161.0 41.44 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.046 0.45 . . . . 0.0 111.355 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.561 HG12 HG21 ' A' ' 117' ' ' ILE . 30.2 mt -142.02 98.81 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.861 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 62.83 28.33 16.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.041 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.63 -25.09 22.28 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.64 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.532 ' HB ' HD11 ' A' ' 133' ' ' LEU . 2.8 m -120.27 137.13 54.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.805 0.336 . . . . 0.0 110.979 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -93.92 21.39 6.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.205 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 126' ' ' THR . 44.1 t 58.65 156.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.266 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.479 ' N ' HG12 ' A' ' 125' ' ' VAL . 5.5 p -137.8 172.9 12.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.777 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -59.7 -25.65 64.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.811 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -59.23 -163.06 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.48 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.3 m -67.41 134.15 50.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.936 0.398 . . . . 0.0 110.722 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.603 HG21 ' CE1' ' B' ' 126' ' ' TYR . 0.4 OUTLIER -89.13 -16.34 8.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.231 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -44.24 -25.95 0.28 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.432 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -62.03 -58.93 5.99 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.516 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.532 HD11 ' HB ' ' A' ' 123' ' ' THR . 2.7 mm? -74.68 -39.08 62.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.336 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.426 ' HA ' HG21 ' B' ' 128' ' ' ILE . 7.5 tm0? -57.76 -51.28 70.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.791 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -64.29 -37.31 87.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.844 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.45 ' O ' HG23 ' A' ' 140' ' ' THR . . . -67.64 -40.35 84.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.089 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -67.08 -29.03 68.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.913 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -84.32 -30.65 25.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.996 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -104.98 10.08 34.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.378 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 136' ' ' ALA . 0.0 OUTLIER -68.36 138.76 55.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.881 0.372 . . . . 0.0 110.916 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.5 76.5 1.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.762 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 167.21 -161.37 35.2 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.383 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.536 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 4.3 ptm -85.01 120.64 26.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.923 0.392 . . . . 0.0 111.002 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.619 HG22 ' CD2' ' A' ' 146' ' ' LEU . 48.8 mt -95.71 134.36 33.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.354 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.1 m -111.06 113.64 26.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.032 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.619 ' CD2' HG22 ' A' ' 144' ' ' ILE . 2.5 mm? -113.65 142.01 46.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.108 0.48 . . . . 0.0 111.381 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.436 ' O ' ' N ' ' A' ' 118' ' ' LEU . 10.9 mttt -110.61 105.53 14.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.63 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.529 HG21 HD23 ' A' ' 111' ' ' LEU . 5.2 p -141.62 149.66 19.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.007 0.432 . . . . 0.0 111.676 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.586 HG22 ' N ' ' A' ' 153' ' ' GLN . 3.1 mt -125.15 121.45 25.25 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.947 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -59.25 117.45 4.19 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.439 2.093 . . . . 0.0 112.241 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 13.0 p30 43.67 38.36 1.93 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.473 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 61.41 40.3 14.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.91 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.586 ' N ' HG22 ' A' ' 149' ' ' ILE . 9.1 tt0 . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.866 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.834 0.349 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.63 167.8 13.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.918 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . 0.462 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 3.9 mp0 -163.62 135.53 4.96 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.866 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' TYR . . . . . 0.603 ' CE1' HG21 ' A' ' 130' ' ' VAL . 36.4 m-85 -128.54 131.66 48.25 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.572 -179.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' CYS . . . . . 0.518 ' SG ' HD21 ' A' ' 100' ' ' LEU . 1.7 m -106.01 115.92 31.05 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.704 ' N ' HD13 ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.508 -177.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.788 0.327 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -107.37 161.26 14.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.904 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.4 tp -118.89 101.95 8.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.943 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.497 HG21 ' HB3' ' A' ' 110' ' ' SER . 27.6 mm -89.28 126.79 42.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.915 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -122.57 123.65 41.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.276 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.806 ' CZ ' HD12 ' A' ' 144' ' ' ILE . 10.4 p90 -149.15 130.96 15.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.539 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -82.41 137.58 34.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.079 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -129.2 111.21 12.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.366 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.599 ' O ' HG13 ' A' ' 77' ' ' VAL . 0.3 OUTLIER -125.47 11.9 4.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.706 -179.453 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.7 158.59 18.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.836 0.351 . . . . 0.0 111.404 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.08 78.93 8.82 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.375 0.607 . . . . 0.0 110.297 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -167.53 149.68 5.41 Favored Pre-proline 0 N--CA 1.445 -0.702 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.152 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -64.77 160.68 39.47 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.507 2.138 . . . . 0.0 112.26 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.471 ' HG3' ' CZ ' ' A' ' 74' ' ' PHE . 15.0 ttm -51.52 -47.45 63.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.037 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.426 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 122.71 -6.51 9.68 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.603 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 32.6 pt -113.34 167.84 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.768 0.318 . . . . 0.0 110.779 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.539 ' SG ' HD13 ' A' ' 100' ' ' LEU . 18.7 m -134.27 126.26 29.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.513 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.776 HD23 HD13 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -124.15 159.32 30.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.964 -179.463 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.531 ' C ' HD13 ' A' ' 88' ' ' LEU . 16.4 pttp -136.42 164.83 27.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.102 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.681 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -106.51 103.21 12.61 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.951 179.71 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -64.85 176.5 1.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.665 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -52.24 -26.26 11.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.013 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.0 tptp -81.58 -8.41 59.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.325 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 67.67 89.2 0.1 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.849 0.357 . . . . 0.0 110.704 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.55 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 0.3 OUTLIER -166.31 146.28 6.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.416 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.444 ' SG ' HD11 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -87.88 114.98 25.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.964 0.411 . . . . 0.0 111.348 -179.369 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.592 HG23 ' O ' ' A' ' 115' ' ' ASP . 3.1 m -133.66 128.02 34.17 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.924 HG21 ' CD1' ' A' ' 99' ' ' ILE . 2.8 p -58.54 106.2 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.405 0.621 . . . . 0.0 110.404 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -72.67 -24.09 60.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.311 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.47 ' HA ' HG23 ' A' ' 113' ' ' VAL . 6.6 ttt85 -172.38 126.92 0.53 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.859 0.361 . . . . 0.0 111.175 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.924 ' CD1' HG21 ' A' ' 96' ' ' VAL . 17.7 mm -86.17 103.69 13.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.511 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.539 HD13 ' SG ' ' A' ' 85' ' ' CYS . 8.4 mp -63.87 144.32 57.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.091 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -82.96 128.03 34.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.808 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.36 -35.08 3.88 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.484 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.426 ' HA3' ' HA3' ' A' ' 83' ' ' GLY . . . -56.41 179.33 0.55 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.611 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 12.4 ptm -84.47 -30.31 25.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.772 0.32 . . . . 0.0 110.967 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.429 HD11 ' HG2' ' A' ' 82' ' ' MET . 39.5 mm -68.4 -36.54 75.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.865 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 18.5 t60 -74.43 -45.24 47.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.631 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.09 -49.8 53.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.604 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -73.79 -48.04 34.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.698 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.34 74.55 1.23 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.598 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.497 ' HB3' HG21 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -109.63 -30.28 7.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.824 0.345 . . . . 0.0 110.814 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.622 HD21 HG11 ' A' ' 148' ' ' VAL . 0.5 OUTLIER -147.81 164.5 33.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.92 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -130.29 143.58 50.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.792 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.559 ' O ' HG13 ' A' ' 113' ' ' VAL . 8.6 p -43.36 113.07 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.637 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.89 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 116.15 -24.18 10.15 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.708 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.708 ' HB3' HG21 ' A' ' 148' ' ' VAL . 0.4 OUTLIER -48.23 134.59 14.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.717 0.294 . . . . 0.0 110.844 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.63 ' C ' HG23 ' A' ' 148' ' ' VAL . 10.7 mt-10 -93.6 107.84 19.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.485 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.776 HD13 HD23 ' A' ' 86' ' ' LEU . 2.6 mp -87.14 98.41 7.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.626 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.606 ' CD2' HD12 ' A' ' 149' ' ' ILE . 3.7 mm? -63.03 -29.49 70.86 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.018 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -156.61 147.64 22.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.821 0.343 . . . . 0.0 111.162 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.706 HD12 HG23 ' A' ' 125' ' ' VAL . 18.6 mt -122.04 107.92 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.826 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 63.05 24.43 14.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.731 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.9 0.43 58.85 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.943 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.2 m -133.6 127.47 33.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.881 0.372 . . . . 0.0 111.181 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -93.02 142.03 27.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.72 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.967 HG11 HG13 ' A' ' 130' ' ' VAL . 13.0 t -91.69 137.32 22.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.178 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 62.7 p -116.07 -177.0 3.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.779 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -56.88 -22.27 35.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.169 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.36 -167.34 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.713 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 42.4 m -68.25 134.07 49.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.964 0.411 . . . . 0.0 110.775 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.967 HG13 HG11 ' A' ' 125' ' ' VAL . 0.6 OUTLIER -89.27 -20.14 7.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.219 179.714 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -44.76 -26.43 0.39 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.426 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.06 -57.6 10.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.831 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.826 HD13 HG22 ' A' ' 125' ' ' VAL . 3.7 mp -77.62 -34.68 53.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.035 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -59.76 -50.54 73.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.645 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -65.79 -44.97 84.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.69 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -65.67 -32.68 74.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.036 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 4.1 mmt -73.55 -26.37 60.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.049 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.35 -19.62 27.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.291 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.59 -23.52 13.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.432 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.4 t -59.32 147.19 36.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.821 0.343 . . . . 0.0 110.99 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -140.68 124.08 16.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.805 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 134.33 -160.02 24.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.493 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 27.8 mtp -77.31 110.17 11.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.774 0.321 . . . . 0.0 110.974 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.806 HD12 ' CZ ' ' A' ' 74' ' ' PHE . 53.8 mt -85.39 128.86 38.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.234 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.571 ' O ' HD13 ' A' ' 146' ' ' LEU . 71.6 m -109.28 120.95 44.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.335 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.721 HD22 ' N ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -123.98 132.28 53.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.993 0.425 . . . . 0.0 111.379 -179.396 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.2 105.22 17.33 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.708 HG21 ' HB3' ' A' ' 115' ' ' ASP . 6.1 p -136.04 141.9 40.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.037 0.446 . . . . 0.0 112.052 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.606 HD12 ' CD2' ' A' ' 118' ' ' LEU . 4.3 mt -105.45 131.58 21.63 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.643 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -56.86 140.82 92.6 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.524 2.149 . . . . 0.0 112.322 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.92 98.12 4.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.802 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -144.87 37.94 1.19 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.904 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.003 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.771 0.32 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . 0.422 ' HE2' ' CE1' ' B' ' 126' ' ' TYR . 0.1 OUTLIER -127.79 167.69 16.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.94 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -156.48 135.75 12.13 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.848 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' TYR . . . . . 0.623 ' CE1' HG21 ' A' ' 130' ' ' VAL . 38.2 m-85 -121.54 132.04 54.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.433 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 72.3 m -105.91 116.1 31.35 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.463 ' N ' HD13 ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.576 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.5 p . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.857 0.361 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.79 ' HD3' HD11 ' A' ' 72' ' ' ILE . 9.8 ttt-85 -109.53 129.9 55.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.831 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.59 99.34 10.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.966 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.79 HD11 ' HD3' ' A' ' 70' ' ' ARG . 24.5 mm -98.47 110.4 25.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.428 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -122.27 144.22 49.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.054 0.454 . . . . 0.0 111.737 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.456 ' CZ ' ' CD2' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -153.29 145.04 23.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.271 179.132 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.22 139.07 36.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.016 0.436 . . . . 0.0 111.415 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -129.22 111.24 12.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.369 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -111.63 -28.63 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.263 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.48 150.45 21.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.306 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -89.34 91.32 8.7 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.323 0.582 . . . . 0.0 110.485 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -159.53 159.58 28.11 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.917 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.83 145.18 61.74 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.461 2.107 . . . . 0.0 112.159 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.3 mtm -54.95 -39.58 69.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.874 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 108.2 18.76 9.49 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.682 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.499 HG21 HG21 ' A' ' 105' ' ' ILE . 22.5 pt -127.75 165.85 25.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.731 0.3 . . . . 0.0 110.697 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -133.67 125.18 28.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.247 179.752 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.59 ' CD2' HD13 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -134.1 155.8 49.41 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.364 -179.118 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.443 ' HB3' ' HA ' ' B' ' 125' ' ' GLU . 0.6 OUTLIER -131.61 166.69 20.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.054 179.766 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.668 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.1 OUTLIER -98.59 103.19 15.11 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.643 179.594 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -64.29 176.45 1.05 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.594 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.71 -30.91 24.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.07 0.462 . . . . 0.0 110.833 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.98 -1.26 43.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.211 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 62.34 86.84 0.11 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.923 0.392 . . . . 0.0 110.462 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.559 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 0.3 OUTLIER -165.57 150.11 8.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.284 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.812 ' CB ' HD11 ' A' ' 120' ' ' ILE . 0.0 OUTLIER -87.86 114.95 24.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.036 0.446 . . . . 0.0 111.508 -179.213 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.515 HG23 ' HA ' ' A' ' 116' ' ' GLU . 2.2 m -126.9 124.77 40.32 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.882 HG13 ' H ' ' A' ' 114' ' ' GLY . 2.2 p -58.46 105.86 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.433 0.635 . . . . 0.0 110.504 -178.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -71.78 -24.34 61.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.761 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.525 ' HA ' HG23 ' A' ' 113' ' ' VAL . 11.3 tpp180 -173.52 130.0 0.44 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.736 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.699 HG22 ' CD2' ' A' ' 106' ' ' HIS . 44.4 mt -86.04 130.34 36.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.564 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.756 HD11 ' SG ' ' B' ' 127' ' ' CYS . 0.4 OUTLIER -93.28 122.03 35.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.833 -179.839 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -56.37 141.74 40.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.06 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.0 -36.9 4.05 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.429 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' A' ' 83' ' ' GLY . . . -59.25 160.09 17.81 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.634 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.5 ttp -66.28 -22.06 66.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.775 0.322 . . . . 0.0 111.044 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.65 ' N ' HD12 ' A' ' 105' ' ' ILE . 2.4 mp -83.11 -31.28 8.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.536 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.699 ' CD2' HG22 ' A' ' 99' ' ' ILE . 1.9 t-80 -88.02 -39.6 14.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.551 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.84 -47.5 68.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.6 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -83.26 -37.4 23.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.653 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.15 46.93 4.58 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.489 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.479 ' O ' HD12 ' A' ' 111' ' ' LEU . 1.0 OUTLIER -78.24 -29.13 48.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.731 0.3 . . . . 0.0 111.044 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.761 HD11 HG21 ' A' ' 148' ' ' VAL . 1.4 mp -136.28 166.79 22.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.984 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.523 ' HA ' HD11 ' A' ' 99' ' ' ILE . 27.9 m-70 -126.67 139.39 53.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.722 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.525 HG23 ' HA ' ' A' ' 98' ' ' ARG . 7.2 p -49.68 114.95 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.357 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.882 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 113.41 -21.49 17.02 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.837 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.48 ' O ' HG23 ' A' ' 95' ' ' THR . 6.0 m-20 -54.7 138.67 41.27 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.714 0.292 . . . . 0.0 110.821 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.515 ' HA ' HG23 ' A' ' 95' ' ' THR . 0.1 OUTLIER -93.6 120.01 33.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.911 0.386 . . . . 0.0 111.585 -179.286 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.669 HG13 HG22 ' A' ' 148' ' ' VAL . 4.4 mp -101.95 94.29 3.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.52 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.409 HD22 HD11 ' A' ' 149' ' ' ILE . 10.3 mp -61.73 -31.12 71.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.578 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -137.55 141.51 41.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.921 0.391 . . . . 0.0 111.353 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.889 HD12 HG23 ' A' ' 125' ' ' VAL . 19.8 mt -122.01 98.79 6.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.839 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 63.76 30.04 14.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.617 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 90.78 1.35 73.78 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.817 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 38.9 m -133.64 121.68 22.36 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.874 0.369 . . . . 0.0 111.136 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -88.63 120.59 30.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.647 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.994 HG11 HG13 ' A' ' 130' ' ' VAL . 34.7 t -63.3 136.22 26.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.21 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 73.7 p -103.96 -176.51 3.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.789 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -77.51 -16.56 58.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.23 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -61.25 -112.59 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.488 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 66.0 m -109.15 133.97 52.32 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.912 0.386 . . . . 0.0 110.944 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.994 HG13 HG11 ' A' ' 125' ' ' VAL . 0.7 OUTLIER -89.37 -23.75 6.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.08 179.478 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -45.58 -26.66 0.63 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.404 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -57.97 -56.92 15.83 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.728 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.929 HD13 HG22 ' A' ' 125' ' ' VAL . 4.9 mp -73.73 -33.46 64.36 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.757 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -59.78 -56.48 21.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.586 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.7 tptp -60.51 -38.55 84.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.564 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.4 -32.62 73.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.863 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 3.4 mmt -70.38 -30.27 67.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.805 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -83.84 -28.73 27.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.901 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -98.0 -5.02 34.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.577 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.44 154.07 17.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.799 0.333 . . . . 0.0 110.856 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.05 99.14 2.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 145.92 -149.73 21.89 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.611 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 2.8 mmm -93.42 122.45 35.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.879 0.371 . . . . 0.0 111.001 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 57.2 mt -87.78 152.85 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.09 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.507 ' C ' HD13 ' A' ' 146' ' ' LEU . 67.5 p -139.26 113.7 9.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.236 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.507 HD13 ' C ' ' A' ' 145' ' ' SER . 0.5 OUTLIER -116.4 133.12 56.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.116 -179.418 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.68 105.54 17.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.947 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.761 HG21 HD11 ' A' ' 111' ' ' LEU . 2.7 t -117.92 158.2 18.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.809 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.409 HD11 HD22 ' A' ' 118' ' ' LEU . 31.4 mt -136.63 133.08 18.87 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.8 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.03 117.06 3.36 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.447 2.098 . . . . 0.0 112.325 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -65.72 143.5 57.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.956 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -144.83 77.58 1.54 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.902 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.879 -179.992 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.877 0.37 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.88 167.74 13.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.961 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . 0.443 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 0.6 OUTLIER -174.99 139.13 0.48 Allowed 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.788 179.634 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' TYR . . . . . 0.591 ' CE1' HG21 ' A' ' 130' ' ' VAL . 29.9 m-85 -129.41 133.22 47.24 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.131 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' CYS . . . . . 0.756 ' SG ' HD11 ' A' ' 100' ' ' LEU . 1.3 m -105.72 116.14 31.44 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.692 ' N ' HD13 ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.283 -0.865 . . . . 0.0 111.356 -177.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.659 HG23 HG13 ' A' ' 149' ' ' ILE . 13.6 p . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 120.834 0.35 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -101.87 145.15 29.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.821 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.547 HD11 ' HB2' ' A' ' 145' ' ' SER . 10.7 tp -106.94 113.81 27.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.042 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.1 mm -89.31 130.11 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.861 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -119.12 123.43 44.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.962 0.411 . . . . 0.0 111.252 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.581 ' HE1' HD12 ' A' ' 144' ' ' ILE . 19.7 p90 -150.22 132.91 15.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.624 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 22.7 tt0 -83.38 138.04 33.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.349 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.471 ' HZ2' HD11 ' A' ' 144' ' ' ILE . 1.1 ttpm? -129.38 113.59 15.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.31 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.605 ' O ' HG13 ' A' ' 77' ' ' VAL . 0.3 OUTLIER -120.97 13.9 6.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.613 -179.562 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.07 148.57 31.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.756 0.312 . . . . 0.0 110.615 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -83.61 80.29 9.17 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.202 0.525 . . . . 0.0 110.011 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.81 163.25 5.57 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.175 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.5 148.66 92.97 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.507 2.138 . . . . 0.0 112.243 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.466 ' HG2' ' CE1' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -50.38 -41.58 52.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.224 -179.88 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 127.55 6.05 5.26 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.094 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.713 HD13 ' H ' ' A' ' 84' ' ' ILE . 0.2 OUTLIER -127.12 165.1 26.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.814 0.34 . . . . 0.0 110.914 179.728 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.497 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -127.09 127.85 45.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.106 179.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.707 HD23 HD13 ' A' ' 117' ' ' ILE . 1.1 mp -130.63 158.43 40.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.816 0.341 . . . . 0.0 110.917 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.62 ' C ' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -138.69 162.89 33.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.179 -179.768 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.67 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -104.66 103.14 12.74 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.474 179.425 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -64.39 176.34 1.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.781 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -52.88 -26.43 14.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.861 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 43.8 tptt -82.54 -8.17 59.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.188 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 68.56 89.84 0.1 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.8 0.333 . . . . 0.0 110.634 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.531 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 0.2 OUTLIER -166.64 146.19 5.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.52 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.663 ' HB2' HD11 ' A' ' 120' ' ' ILE . 0.5 OUTLIER -87.8 111.95 21.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.931 0.396 . . . . 0.0 111.428 -179.474 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 115' ' ' ASP . 1.6 m -129.12 126.13 38.64 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.9 HG13 ' H ' ' A' ' 114' ' ' GLY . 3.4 p -58.8 105.99 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 121.312 0.577 . . . . 0.0 110.549 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -74.9 -22.02 58.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.443 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.407 ' HA ' HG23 ' A' ' 113' ' ' VAL . 3.3 ptt180 -171.22 131.63 0.78 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.075 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.835 ' CD1' HG21 ' A' ' 96' ' ' VAL . 27.3 mm -86.22 103.72 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.73 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.802 HD11 ' SG ' ' B' ' 127' ' ' CYS . 8.6 mt -60.49 131.38 50.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.042 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.433 ' HA ' ' CG ' ' A' ' 106' ' ' HIS . 2.9 p80 -75.52 146.23 40.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.909 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.21 -33.51 5.57 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.525 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.67 -179.93 1.88 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.49 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 48.9 ttp -79.72 -33.21 41.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.772 0.32 . . . . 0.0 110.87 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.693 HG13 HD12 ' A' ' 84' ' ' ILE . 23.1 mm -70.7 -33.93 54.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.997 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.433 ' CG ' ' HA ' ' A' ' 101' ' ' HIS . 46.1 t-80 -78.58 -51.9 9.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.787 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.4 tpm_? -61.09 -43.35 99.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.717 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -83.05 -46.68 12.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.769 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.02 51.35 2.1 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.553 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.64 -29.36 30.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.752 0.31 . . . . 0.0 110.865 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.715 HD21 HG21 ' A' ' 148' ' ' VAL . 46.5 mt -134.41 172.21 13.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.953 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -138.04 131.72 31.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.727 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.562 ' O ' HG13 ' A' ' 113' ' ' VAL . 8.3 p -43.72 112.78 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.595 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.9 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 116.14 -25.49 9.32 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.603 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.509 ' O ' HG23 ' A' ' 95' ' ' THR . 0.2 OUTLIER -47.16 142.35 3.83 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.714 0.292 . . . . 0.0 110.902 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.408 ' HA ' HG23 ' A' ' 95' ' ' THR . 0.2 OUTLIER -96.27 111.18 23.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.428 -179.542 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.707 HD13 HD23 ' A' ' 86' ' ' LEU . 4.4 mp -95.69 95.82 5.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.67 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.862 HD23 ' CD1' ' A' ' 149' ' ' ILE . 3.2 mm? -65.49 -26.04 67.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.572 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.36 145.54 30.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.926 0.393 . . . . 0.0 111.375 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.663 HD11 ' HB2' ' A' ' 94' ' ' CYS . 2.8 mp -126.14 98.79 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.639 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 60.63 28.37 18.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.524 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.51 16.48 52.5 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.578 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 58.9 m -133.65 128.61 35.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.894 0.378 . . . . 0.0 111.228 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -104.56 87.88 2.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.48 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.824 HG11 ' CD2' ' A' ' 133' ' ' LEU . 10.8 m -53.36 156.53 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.709 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 55.9 p -138.08 -172.08 3.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.743 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -55.02 -23.32 19.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.151 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -56.76 -167.69 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.806 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 m -67.55 134.03 50.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.068 0.461 . . . . 0.0 111.001 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.649 HG21 ' CE1' ' B' ' 126' ' ' TYR . 0.4 OUTLIER -89.47 -16.23 8.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.344 179.746 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -43.6 -26.71 0.24 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.467 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.67 -43.37 69.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.979 0.419 . . . . 0.0 110.426 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.824 ' CD2' HG11 ' A' ' 125' ' ' VAL . 0.2 OUTLIER -78.58 -30.5 46.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.546 179.678 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.417 ' HG3' ' CG2' ' B' ' 128' ' ' ILE . 7.4 tt0 -75.09 -54.14 7.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.999 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.6 tptt -60.7 -47.79 84.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.002 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.467 ' O ' HG22 ' A' ' 140' ' ' THR . . . -61.06 -42.47 98.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.223 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.46 ' HG3' HD12 ' A' ' 133' ' ' LEU . 27.4 mmt -69.3 -27.58 65.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.195 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -90.56 -25.94 19.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.271 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -93.46 -26.58 17.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.26 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 136' ' ' ALA . 6.4 t -59.41 153.34 19.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.89 0.376 . . . . 0.0 111.006 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 24.1 mttp -143.82 114.26 7.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.764 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 142.66 -155.41 25.78 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.429 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.503 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 8.6 ptm -86.85 114.29 23.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.932 0.396 . . . . 0.0 110.995 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.581 HD12 ' HE1' ' A' ' 74' ' ' PHE . 45.1 mt -87.38 141.22 14.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.327 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.547 ' HB2' HD11 ' A' ' 71' ' ' LEU . 54.0 p -124.64 113.59 18.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.31 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.701 HD22 ' N ' ' A' ' 146' ' ' LEU . 0.3 OUTLIER -115.63 143.43 45.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.994 -179.566 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.476 ' HD2' HD13 ' A' ' 71' ' ' LEU . 1.3 mptt -97.39 105.23 17.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.837 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.715 HG21 HD21 ' A' ' 111' ' ' LEU . 3.4 t -122.59 158.34 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.081 0.467 . . . . 0.0 111.891 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.862 ' CD1' HD23 ' A' ' 118' ' ' LEU . 2.3 mp -133.04 134.89 24.92 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.62 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -51.9 128.75 27.8 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.383 2.056 . . . . 0.0 112.443 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -129.09 117.49 20.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.927 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 -72.98 65.91 0.77 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.854 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.24 -0.885 . . . . 0.0 110.91 179.979 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 120.832 0.349 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.57 167.71 9.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.934 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . 0.441 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 13.2 pt-20 -153.08 134.75 14.5 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.148 0.499 . . . . 0.0 110.225 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' TYR . . . . . 0.649 ' CE1' HG21 ' A' ' 130' ' ' VAL . 31.3 m-85 -116.55 134.89 54.31 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.306 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' CYS . . . . . 0.802 ' SG ' HD11 ' A' ' 100' ' ' LEU . 2.0 m -106.02 115.87 30.97 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.648 ' N ' HD13 ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.337 -177.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.596 ' O ' HG13 ' A' ' 69' ' ' VAL . 10.1 p . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 120.951 0.405 . . . . 0.0 111.055 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -109.39 144.61 37.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.835 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.63 HD12 ' HG2' ' A' ' 147' ' ' LYS . 2.3 tp -117.86 99.51 6.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.99 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.406 HG21 ' HB3' ' A' ' 110' ' ' SER . 26.2 mm -89.33 120.51 38.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.356 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 144' ' ' ILE . 0.6 OUTLIER -120.72 125.44 47.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.075 0.464 . . . . 0.0 111.889 -179.224 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.642 ' HE1' HD12 ' A' ' 144' ' ' ILE . 10.8 p90 -141.58 132.63 26.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.065 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 1.5 pt-20 -80.24 134.26 36.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.089 0.471 . . . . 0.0 111.519 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.18 123.79 32.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.271 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.605 ' O ' HG13 ' A' ' 77' ' ' VAL . 0.3 OUTLIER -140.14 15.67 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.581 -179.608 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -117.75 173.02 6.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.863 0.363 . . . . 0.0 110.831 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -97.9 81.01 2.81 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.317 0.58 . . . . 0.0 110.021 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -162.04 147.77 10.47 Favored Pre-proline 0 N--CA 1.446 -0.627 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.366 -178.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.87 160.83 48.12 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.562 2.174 . . . . 0.0 112.342 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.7 -49.0 78.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.969 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 115.86 16.48 6.83 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.748 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.612 HD12 ' O ' ' A' ' 84' ' ' ILE . 2.6 pp -128.82 162.02 36.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.73 0.3 . . . . 0.0 110.851 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.504 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -125.31 127.39 46.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.251 179.783 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.879 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -126.46 157.87 37.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.803 -179.642 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.591 ' C ' HD13 ' A' ' 88' ' ' LEU . 16.0 pttt -138.96 158.15 44.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.754 0.311 . . . . 0.0 111.407 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.635 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -106.35 106.1 16.46 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.592 179.586 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -64.22 176.21 1.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.905 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -53.09 -29.69 31.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.914 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.2 tptm -82.52 -4.8 58.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.174 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.408 ' HB3' ' HA ' ' A' ' 126' ' ' THR . 1.4 mt-30 69.11 87.09 0.12 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.818 0.342 . . . . 0.0 110.526 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 1.4 t -157.47 136.74 11.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.353 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.79 115.21 25.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.067 0.46 . . . . 0.0 111.598 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.63 HG23 ' O ' ' A' ' 115' ' ' ASP . 9.3 m -133.55 130.49 38.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.159 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.888 HG13 ' H ' ' A' ' 114' ' ' GLY . 3.7 p -59.9 105.97 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.271 0.558 . . . . 0.0 110.638 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -72.62 -24.32 61.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.192 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.418 ' HA ' HG23 ' A' ' 113' ' ' VAL . 11.2 ptt85 -172.2 131.82 0.63 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.09 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.877 ' CD1' HG21 ' A' ' 96' ' ' VAL . 29.3 mm -86.15 107.2 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.675 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.756 HD11 ' SG ' ' B' ' 127' ' ' CYS . 7.2 mt -61.29 135.79 57.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.958 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -81.28 130.31 34.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.989 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.3 -27.3 9.58 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.634 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.97 179.81 10.39 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.643 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 6.3 ptm -80.95 -30.36 35.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.868 0.366 . . . . 0.0 110.965 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.464 HG23 ' HB2' ' A' ' 110' ' ' SER . 37.6 mm -69.47 -34.99 64.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.959 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.419 ' ND1' HG22 ' A' ' 99' ' ' ILE . 2.7 t-160 -80.42 -41.11 25.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.74 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -73.17 -50.48 22.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.714 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -73.37 -44.33 58.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.86 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.24 75.87 1.31 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.502 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.464 ' HB2' HG23 ' A' ' 105' ' ' ILE . 1.1 m -111.76 -30.63 7.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.84 0.352 . . . . 0.0 111.082 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.789 HD21 HG11 ' A' ' 148' ' ' VAL . 1.1 mt -143.36 170.14 16.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.988 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -137.19 138.83 40.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.792 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.526 ' O ' HG13 ' A' ' 113' ' ' VAL . 7.6 p -44.99 114.23 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.633 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.888 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 119.19 -29.22 6.27 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.022 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.63 ' O ' HG23 ' A' ' 95' ' ' THR . 4.8 m-20 -50.65 134.93 24.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.713 0.292 . . . . 0.0 110.68 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.459 ' C ' HG23 ' A' ' 148' ' ' VAL . 7.4 pt-20 -92.25 108.8 20.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.942 0.401 . . . . 0.0 111.568 -179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.803 ' CD1' HD22 ' A' ' 86' ' ' LEU . 2.7 mp -86.9 99.31 8.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.718 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.422 ' N ' ' O ' ' A' ' 147' ' ' LYS . 4.0 mm? -52.06 -38.32 56.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.098 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -164.26 152.55 12.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.808 0.337 . . . . 0.0 111.374 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.862 HG23 HD12 ' A' ' 146' ' ' LEU . 26.8 mt -111.94 114.25 46.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.903 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 62.9 31.06 16.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.92 0.39 . . . . 0.0 110.659 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 83.38 19.57 62.05 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.596 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 19.3 m -133.63 111.61 10.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.832 0.348 . . . . 0.0 111.06 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -73.98 104.84 4.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.772 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.442 HG22 ' CD1' ' A' ' 133' ' ' LEU . 20.1 t -63.25 128.24 24.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.991 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.408 ' HA ' ' HB3' ' A' ' 92' ' ' GLN . 24.6 p -119.51 -170.48 1.95 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.863 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.01 -21.56 45.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.264 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 43.5 m80 -52.37 179.14 0.01 OUTLIER 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.802 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 45.6 m -63.97 133.89 54.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.009 0.433 . . . . 0.0 110.925 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.576 HG21 ' CE1' ' B' ' 126' ' ' TYR . 0.3 OUTLIER -89.56 -24.91 5.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.165 179.765 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.484 ' HA ' ' HG2' ' A' ' 134' ' ' GLN . 7.3 t70 -46.31 -26.01 0.74 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.599 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -70.24 -41.73 73.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.252 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.442 ' CD1' HG22 ' A' ' 125' ' ' VAL . 1.1 mt -74.02 -54.03 8.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.25 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.487 ' HB3' HG21 ' B' ' 128' ' ' ILE . 3.8 pt20 -55.85 -43.03 76.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.817 0.341 . . . . 0.0 111.061 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm -63.91 -40.76 97.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.645 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.547 ' O ' HG23 ' A' ' 140' ' ' THR . . . -76.13 -27.17 56.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.089 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.423 ' HE1' HG23 ' A' ' 144' ' ' ILE . 4.6 mmt -76.34 -27.94 56.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.6 mttm -82.06 -39.15 23.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.01 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -82.58 -16.11 49.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.403 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 136' ' ' ALA . 0.1 OUTLIER -59.29 131.39 50.84 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.879 0.371 . . . . 0.0 111.045 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -119.09 87.49 2.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.689 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 167.17 -150.32 16.9 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.541 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.482 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 1.0 OUTLIER -96.61 126.22 41.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.918 0.389 . . . . 0.0 111.183 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.707 ' CG2' HD11 ' A' ' 146' ' ' LEU . 59.2 mt -92.64 130.63 41.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.095 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.509 ' C ' HD13 ' A' ' 146' ' ' LEU . 5.4 m -116.93 116.79 28.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.409 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.862 HD12 HG23 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -117.76 142.98 46.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.261 -179.457 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.63 ' HG2' HD12 ' A' ' 71' ' ' LEU . 7.5 mttp -104.78 108.64 20.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.505 179.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.789 HG11 HD21 ' A' ' 111' ' ' LEU . 2.5 p -138.19 149.7 24.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.176 0.513 . . . . 0.0 111.863 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.415 ' CD1' ' HA ' ' A' ' 69' ' ' VAL . 6.3 mm -107.63 120.0 48.72 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.528 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.51 145.13 59.53 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.398 2.065 . . . . 0.0 112.359 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.52 122.36 21.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.835 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -130.19 104.85 7.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.002 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.902 179.947 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.752 0.31 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 2.0 tptt -121.67 167.8 12.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.915 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . 0.446 ' OE2' ' HB1' ' A' ' 97' ' ' ALA . 46.8 mt-10 -161.43 133.62 5.84 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.005 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' TYR . . . . . 0.576 ' CE1' HG21 ' A' ' 130' ' ' VAL . 38.0 m-85 -129.02 135.87 49.54 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.555 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' CYS . . . . . 0.756 ' SG ' HD11 ' A' ' 100' ' ' LEU . 1.7 m -106.05 116.04 31.25 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.632 ' N ' HD13 ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.276 -0.868 . . . . 0.0 111.485 -177.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.553 ' O ' HG13 ' A' ' 69' ' ' VAL . 10.9 p . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.798 0.332 . . . . 0.0 111.066 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.56 138.07 39.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.766 HD12 ' HG2' ' A' ' 147' ' ' LYS . 2.8 tp -112.1 99.33 7.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.982 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.743 HD13 ' O ' ' A' ' 110' ' ' SER . 23.0 mt -94.44 149.27 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.424 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' A' ' 144' ' ' ILE . 10.4 mt-30 -145.92 135.39 23.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.036 0.446 . . . . 0.0 111.846 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.438 ' CZ ' HD23 ' A' ' 146' ' ' LEU . 2.4 p90 -145.52 130.89 18.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.204 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 3.7 tt0 -80.32 136.8 36.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.059 0.457 . . . . 0.0 111.617 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.13 116.41 19.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.29 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -96.28 -30.52 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.035 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.44 150.25 21.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.252 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -91.79 92.5 8.42 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.231 0.539 . . . . 0.0 110.61 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -163.54 159.77 17.72 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.027 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.52 136.47 40.83 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.573 2.182 . . . . 0.0 112.292 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.0 mpp? -58.34 -35.33 71.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.963 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 117.18 32.78 1.45 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.508 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.616 HD12 HD11 ' A' ' 86' ' ' LEU . 14.2 pt -151.27 158.71 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.778 0.323 . . . . 0.0 110.875 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.836 ' SG ' HD21 ' A' ' 100' ' ' LEU . 25.9 m -129.39 122.36 29.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.204 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.701 HD23 HD13 ' A' ' 117' ' ' ILE . 4.2 mp -116.38 159.62 21.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.955 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.508 ' HG2' ' HB2' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -135.62 148.25 48.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.335 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.796 HD23 ' NZ ' ' B' ' 124' ' ' LYS . 0.3 OUTLIER -81.73 107.23 14.3 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.407 179.285 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -64.2 176.11 1.11 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.898 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.31 -23.27 14.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.08 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.404 ' HD2' ' N ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -100.84 17.97 20.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.958 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 56.57 82.18 0.12 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.782 0.325 . . . . 0.0 110.471 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.548 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 1.2 m -151.04 142.42 23.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.484 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -87.67 111.2 21.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.01 0.433 . . . . 0.0 111.495 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.528 HG23 ' HA ' ' A' ' 116' ' ' GLU . 7.0 m -128.82 130.03 46.4 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.912 HG13 ' H ' ' A' ' 114' ' ' GLY . 3.7 p -58.7 105.7 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-O 121.355 0.598 . . . . 0.0 110.657 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.508 ' HB2' ' HG2' ' A' ' 87' ' ' LYS . . . -70.41 -26.65 63.78 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.955 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.507 ' HA ' HG23 ' A' ' 113' ' ' VAL . 33.2 ttt-85 -173.4 133.94 0.51 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.045 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.87 ' CD1' HG21 ' A' ' 96' ' ' VAL . 25.0 mm -86.07 143.04 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.577 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.836 HD21 ' SG ' ' A' ' 85' ' ' CYS . 0.5 OUTLIER -101.54 142.11 33.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.877 0.37 . . . . 0.0 110.956 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.434 ' HA ' ' CD2' ' A' ' 106' ' ' HIS . 43.7 m-70 -77.25 137.25 38.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.95 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.19 -24.95 26.53 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.539 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.16 161.31 11.23 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.49 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 11.8 tmm? -67.47 -22.71 65.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.705 0.288 . . . . 0.0 111.158 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.606 HG21 ' HB2' ' A' ' 111' ' ' LEU . 28.2 mm -84.93 -38.36 13.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.017 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.434 ' CD2' ' HA ' ' A' ' 101' ' ' HIS . 75.1 t60 -76.13 -39.88 54.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.538 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 7.8 tpp85 -71.28 -45.92 62.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.563 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -79.21 -42.74 25.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.663 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.82 72.0 1.21 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.531 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.755 ' O ' HD22 ' A' ' 111' ' ' LEU . 1.3 m -113.48 -29.4 7.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.758 0.313 . . . . 0.0 111.155 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.772 HD11 HG21 ' A' ' 148' ' ' VAL . 3.7 mm? -132.78 169.22 17.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.981 0.42 . . . . 0.0 111.113 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -143.02 132.28 23.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.572 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.584 ' O ' HG13 ' A' ' 113' ' ' VAL . 8.3 p -41.67 110.94 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.773 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.912 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 119.09 -31.45 5.47 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.915 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.488 ' O ' HG23 ' A' ' 95' ' ' THR . 7.7 m-20 -52.0 133.62 32.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.668 0.271 . . . . 0.0 110.548 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.528 ' HA ' HG23 ' A' ' 95' ' ' THR . 57.4 mt-10 -92.75 114.47 27.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.931 0.396 . . . . 0.0 111.735 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.701 HD13 HD23 ' A' ' 86' ' ' LEU . 3.2 mp -89.39 98.58 8.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.552 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.742 HD23 HG12 ' A' ' 149' ' ' ILE . 4.5 mm? -69.91 -24.38 63.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.579 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -142.79 139.04 30.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.99 0.424 . . . . 0.0 111.346 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.456 HD12 ' HA ' ' A' ' 124' ' ' ASN . 4.1 mp -124.28 98.66 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.727 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 62.79 28.68 16.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.714 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 96.78 -1.9 61.78 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.985 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 25.8 m -133.53 134.89 43.98 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.848 0.356 . . . . 0.0 111.158 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.456 ' HA ' HD12 ' A' ' 120' ' ' ILE . 11.6 t-20 -103.72 105.63 15.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.679 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 1.009 HG21 HG13 ' A' ' 130' ' ' VAL . 12.7 p -56.4 137.38 18.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.213 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.1 p -117.62 -173.3 2.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.691 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -52.35 -24.31 7.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.29 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 13.8 m170 -57.31 -166.82 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.813 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.9 m -69.45 134.29 48.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.903 0.382 . . . . 0.0 110.939 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 1.009 HG13 HG21 ' A' ' 125' ' ' VAL . 0.5 OUTLIER -89.11 -21.03 6.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.263 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -46.09 -26.43 0.75 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.278 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.47 -48.94 79.71 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.622 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.536 HD22 ' HB ' ' A' ' 125' ' ' VAL . 5.6 mp -79.47 -35.38 40.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.818 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -58.42 -49.4 77.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.71 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.9 tptm -68.96 -44.91 72.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.723 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.19 -30.96 71.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.01 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.401 ' HE2' ' HA ' ' A' ' 137' ' ' MET . 21.7 mmt -74.35 -31.85 62.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.896 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.6 mttp -83.8 -30.49 26.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.749 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -86.64 -17.03 34.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.229 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.28 145.03 44.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.844 0.354 . . . . 0.0 111.021 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -141.92 93.59 2.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.669 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 151.53 -149.41 21.17 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.626 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.448 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 72.9 mtp -87.83 119.85 28.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.85 0.357 . . . . 0.0 111.333 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.446 HG22 ' CD2' ' A' ' 146' ' ' LEU . 46.2 mt -97.43 130.99 45.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.995 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.6 m -108.99 114.32 27.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.506 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.661 HD22 ' N ' ' A' ' 146' ' ' LEU . 0.7 OUTLIER -116.57 130.58 56.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.929 -179.577 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.766 ' HG2' HD12 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -96.47 119.09 34.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.241 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.772 HG21 HD11 ' A' ' 111' ' ' LEU . 1.8 t -132.01 154.99 41.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.07 0.462 . . . . 0.0 111.843 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.742 HG12 HD23 ' A' ' 118' ' ' LEU . 18.2 mm -119.92 122.4 29.06 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.655 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.44 118.5 5.69 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.403 2.068 . . . . 0.0 112.439 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -107.95 138.2 44.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.855 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 11.6 mp0 -128.48 100.36 5.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.954 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.917 179.967 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.957 0.408 . . . . 0.0 111.067 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . 0.796 ' NZ ' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -108.55 162.06 14.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.005 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -144.32 131.64 20.81 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.298 0.57 . . . . 0.0 109.925 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' TYR . . . . . 0.596 ' CE1' HG21 ' A' ' 130' ' ' VAL . 18.6 m-85 -100.92 140.95 34.49 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.666 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 95.6 m -106.39 116.02 31.21 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.623 ' N ' HD13 ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.453 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.485 ' O ' HG13 ' A' ' 69' ' ' VAL . 14.2 p . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.867 0.365 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.4 ttt-85 -112.5 156.18 23.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.836 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.9 tp -121.26 100.4 7.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.004 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.402 HG21 ' HB3' ' A' ' 110' ' ' SER . 3.3 mp -89.17 143.22 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.511 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -133.0 131.77 41.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.072 0.463 . . . . 0.0 111.838 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.476 ' CE2' HD23 ' A' ' 146' ' ' LEU . 6.9 p90 -146.69 137.42 23.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.096 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -80.35 139.72 36.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.964 0.411 . . . . 0.0 111.396 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.13 111.14 12.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.292 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -116.12 -22.9 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.573 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.48 151.47 21.36 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.954 0.407 . . . . 0.0 111.501 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -87.22 88.25 7.64 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.37 0.605 . . . . 0.0 110.462 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -167.38 152.95 7.2 Favored Pre-proline 0 N--CA 1.446 -0.641 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.985 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -56.47 142.51 89.33 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.522 2.148 . . . . 0.0 112.119 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -55.01 -37.06 66.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.987 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.404 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 117.57 29.47 2.07 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.527 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.949 HD13 HD21 ' A' ' 86' ' ' LEU . 2.8 pp -145.4 164.59 11.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.684 0.278 . . . . 0.0 110.909 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.498 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -131.98 123.6 27.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.35 -0.386 . . . . 0.0 109.989 179.617 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.949 HD21 HD13 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -126.58 158.01 37.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.944 -179.373 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.602 ' C ' HD13 ' A' ' 88' ' ' LEU . 6.9 pttp -141.54 163.41 33.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.006 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.656 ' N ' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -103.75 103.09 12.94 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.68 179.706 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -68.07 176.75 2.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.626 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.57 -27.3 6.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.941 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -77.04 -15.18 59.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.255 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 71.11 88.57 0.1 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.896 0.379 . . . . 0.0 110.637 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.534 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 10.1 t -171.04 148.67 2.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.386 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.577 ' SG ' HD11 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -87.78 111.43 21.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.962 0.411 . . . . 0.0 111.39 -179.437 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.549 HG23 ' HA ' ' A' ' 116' ' ' GLU . 9.4 m -129.93 132.22 46.27 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.331 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.895 HG13 ' H ' ' A' ' 114' ' ' GLY . 2.2 p -58.67 106.09 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.326 0.584 . . . . 0.0 110.86 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -71.26 -24.56 62.19 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.981 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.448 ' HA ' HG23 ' A' ' 113' ' ' VAL . 7.6 ttt180 -171.44 138.72 1.2 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.031 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.483 HD13 HG21 ' A' ' 96' ' ' VAL . 19.8 mm -86.11 109.13 18.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.657 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.767 HD11 ' SG ' ' B' ' 127' ' ' CYS . 21.4 mt -62.78 146.57 52.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.105 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -80.93 129.59 34.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.17 4.35 81.44 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.806 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.404 ' HA3' ' HA3' ' A' ' 83' ' ' GLY . . . -76.17 160.3 51.1 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.494 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 40.5 ttp -59.72 -31.86 70.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.867 0.365 . . . . 0.0 110.819 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 29.5 mm -80.77 -31.85 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.828 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -77.93 -53.85 6.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.622 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -60.63 -46.13 91.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.605 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -77.88 -42.68 32.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.685 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.32 67.69 1.43 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.523 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.402 ' HB3' HG21 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -112.06 -20.47 11.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.631 0.253 . . . . 0.0 111.226 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 1.09 HD11 HG11 ' A' ' 148' ' ' VAL . 0.4 OUTLIER -141.4 171.06 14.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.876 0.37 . . . . 0.0 111.026 -179.825 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -139.46 142.0 37.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.795 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.468 ' O ' HG13 ' A' ' 113' ' ' VAL . 7.1 p -45.86 121.67 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.509 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.895 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 110.35 -21.75 23.66 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.583 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.844 ' HB3' HG21 ' A' ' 148' ' ' VAL . 0.4 OUTLIER -52.63 121.41 7.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.656 0.265 . . . . 0.0 110.544 179.762 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.803 ' C ' HG23 ' A' ' 148' ' ' VAL . 62.3 mt-10 -85.25 107.58 17.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.809 0.338 . . . . 0.0 111.447 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.494 HD13 HD13 ' A' ' 86' ' ' LEU . 2.8 mp -84.86 96.88 4.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.767 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.662 HD23 HD12 ' A' ' 149' ' ' ILE . 3.9 mm? -57.85 -29.84 65.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.171 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -154.28 145.32 22.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.902 0.382 . . . . 0.0 111.241 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.605 HG23 ' CD1' ' A' ' 146' ' ' LEU . 17.0 mt -116.77 102.6 13.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.664 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 56.87 25.43 10.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.737 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 95.73 24.78 14.68 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.541 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.4 m -133.57 123.05 24.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.849 0.357 . . . . 0.0 111.225 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.81 82.69 1.91 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.609 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.769 ' CB ' HD11 ' A' ' 133' ' ' LEU . 11.6 p -56.5 158.33 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.347 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.475 ' N ' HG22 ' A' ' 125' ' ' VAL . 1.4 p -136.88 -173.5 3.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.75 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -61.02 -15.37 31.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.493 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -58.87 -116.9 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.833 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 m -109.01 134.15 52.04 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.88 0.372 . . . . 0.0 111.143 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.836 HG21 ' CE1' ' B' ' 126' ' ' TYR . 0.6 OUTLIER -89.26 -20.68 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.984 179.53 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -45.55 -26.4 0.58 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.345 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -59.42 -40.31 86.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.55 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.769 HD11 ' CB ' ' A' ' 125' ' ' VAL . 0.6 OUTLIER -79.41 -51.54 9.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.546 179.598 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -49.74 -46.78 50.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.909 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -53.36 42.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.912 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.76 -64.26 1.01 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.537 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.511 ' HE3' HD13 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -46.0 -35.83 5.11 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.502 -179.784 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -80.52 -26.14 38.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.253 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -99.28 3.22 46.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.597 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.93 149.29 41.51 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.893 0.377 . . . . 0.0 110.83 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.91 89.45 1.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.821 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 161.35 -130.75 2.41 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.43 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 38.6 mmm -109.26 122.6 47.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.814 0.34 . . . . 0.0 110.901 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.534 HG22 ' CD2' ' A' ' 146' ' ' LEU . 46.9 mt -96.69 143.72 11.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.298 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 28.4 p -125.61 113.68 17.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.918 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.605 ' CD1' HG23 ' A' ' 120' ' ' ILE . 2.7 mm? -110.36 123.17 49.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.975 0.417 . . . . 0.0 111.587 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -98.06 105.25 17.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.484 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 1.09 HG11 HD11 ' A' ' 111' ' ' LEU . 2.9 p -135.16 143.22 37.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.033 0.444 . . . . 0.0 111.99 -178.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.662 HD12 HD23 ' A' ' 118' ' ' LEU . 4.6 mt -112.86 130.71 23.24 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.666 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 149' ' ' ILE . 31.2 Cg_exo -59.21 137.54 79.59 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.435 2.09 . . . . 0.0 112.075 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -134.83 23.86 3.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.159 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 173.35 132.96 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.84 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.854 179.891 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.965 0.412 . . . . 0.0 111.061 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.78 167.84 9.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.935 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . 0.43 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 1.8 mp0 -164.09 136.18 4.83 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.712 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 126' ' ' TYR . . . . . 0.836 ' CE1' HG21 ' A' ' 130' ' ' VAL . 34.4 m-85 -113.91 131.19 56.38 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.267 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 127' ' ' CYS . . . . . 0.767 ' SG ' HD11 ' A' ' 100' ' ' LEU . 1.8 m -105.83 116.07 31.31 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.659 ' N ' HD13 ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.458 -177.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.57 ' O ' HG13 ' A' ' 69' ' ' VAL . 14.9 p . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.89 0.376 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -108.97 147.83 31.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.716 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.44 99.24 7.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.002 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.5 mm -91.16 110.37 22.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.307 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.421 ' HA ' ' O ' ' A' ' 144' ' ' ILE . 26.0 mt-30 -113.84 130.71 56.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.98 0.419 . . . . 0.0 111.889 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.552 ' HE1' HD12 ' A' ' 144' ' ' ILE . 4.5 p90 -142.4 146.33 34.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.067 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -80.25 143.49 33.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.992 0.425 . . . . 0.0 111.245 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.482 ' HD3' HD11 ' A' ' 144' ' ' ILE . 1.3 tttt -128.93 111.28 12.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.593 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -105.9 -30.14 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.162 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.59 146.66 23.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.151 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -99.29 96.3 7.64 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.637 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.401 ' CB ' ' CD ' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -174.65 178.09 0.57 Allowed Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.921 -179.135 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.401 ' CD ' ' CB ' ' A' ' 80' ' ' GLU . 51.9 Cg_exo -54.53 125.32 18.58 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.444 2.096 . . . . 0.0 112.327 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.417 ' HB3' ' OXT' ' B' ' 128' ' ' ILE . 26.4 ttm -47.13 -48.15 23.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.06 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.4 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 135.65 -7.88 4.25 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.495 -0.86 . . . . 0.0 113.031 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.51 HG23 ' HB ' ' A' ' 105' ' ' ILE . 17.8 pt -117.81 166.93 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.888 0.375 . . . . 0.0 111.254 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.495 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -129.31 124.28 33.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.711 179.594 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.957 HD12 HD11 ' B' ' 128' ' ' ILE . 0.3 OUTLIER -121.43 157.39 30.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.711 0.291 . . . . 0.0 111.158 -179.294 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.801 ' HG2' ' HB2' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -140.37 160.54 39.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.328 179.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.609 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.4 OUTLIER -90.43 103.12 15.84 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.47 179.454 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -64.3 176.51 1.04 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.784 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -51.31 -23.77 3.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.046 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.28 15.48 20.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.273 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.0 mp0 50.17 81.59 0.06 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.776 0.322 . . . . 0.0 110.798 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.565 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 0.3 OUTLIER -153.6 155.37 35.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.774 -179.737 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.448 ' CB ' HD11 ' A' ' 120' ' ' ILE . 0.5 OUTLIER -87.85 111.49 21.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.946 0.403 . . . . 0.0 111.088 -179.624 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 115' ' ' ASP . 1.9 m -133.22 127.87 34.67 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.875 HG13 ' H ' ' A' ' 114' ' ' GLY . 3.9 p -58.68 106.02 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.411 0.624 . . . . 0.0 110.56 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.801 ' HB2' ' HG2' ' A' ' 87' ' ' LYS . . . -73.24 -23.54 60.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.493 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.403 ' HA ' HG23 ' A' ' 113' ' ' VAL . 0.2 OUTLIER -172.16 134.02 0.71 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.124 179.891 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.873 HD13 HG21 ' A' ' 96' ' ' VAL . 29.1 mm -86.21 109.13 18.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.769 HD11 ' SG ' ' B' ' 127' ' ' CYS . 6.5 mt -65.74 143.57 57.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.035 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -78.39 133.24 37.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.933 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.43 45.7 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.676 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.4 ' HA3' ' HA3' ' A' ' 83' ' ' GLY . . . -56.95 164.1 6.18 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.679 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 6.6 tmm? -60.44 -43.36 96.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.82 0.343 . . . . 0.0 110.981 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.51 ' HB ' HG23 ' A' ' 84' ' ' ILE . 32.2 mm -67.94 -38.39 79.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.05 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -71.53 -44.7 64.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.661 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -69.56 -52.02 30.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.712 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -71.54 -52.16 19.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.624 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.98 105.82 1.86 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.579 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.06 -45.58 0.13 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.874 0.368 . . . . 0.0 110.958 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.654 HD11 HG11 ' A' ' 148' ' ' VAL . 1.5 mp -117.41 172.6 7.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.974 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -141.73 143.45 33.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.561 ' O ' HG13 ' A' ' 113' ' ' VAL . 7.1 p -44.31 112.01 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.631 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.875 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 115.84 -23.18 11.05 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.847 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.59 ' O ' HG23 ' A' ' 95' ' ' THR . 1.0 OUTLIER -47.87 140.73 6.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.633 0.254 . . . . 0.0 110.825 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -93.18 111.62 23.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.759 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.889 HD13 HD22 ' A' ' 86' ' ' LEU . 3.7 mp -99.25 109.03 23.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.513 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -71.22 -26.96 63.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.698 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.608 ' C ' HD12 ' A' ' 120' ' ' ILE . 3.4 mt-10 -154.05 156.85 38.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.059 0.456 . . . . 0.0 111.625 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.94 HD13 HG23 ' A' ' 125' ' ' VAL . 3.2 mp -129.54 100.84 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.387 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.424 ' OD1' HG23 ' A' ' 144' ' ' ILE . 1.8 m-20 67.02 24.25 9.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.612 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 95.89 8.5 58.03 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.832 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.2 m -133.75 127.33 32.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.805 0.336 . . . . 0.0 111.212 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -87.8 121.0 29.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.453 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.94 HG23 HD13 ' A' ' 120' ' ' ILE . 14.9 t -77.1 119.08 24.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.117 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.7 p -108.52 -167.06 1.18 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.906 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -67.58 -16.74 64.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.171 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -166.93 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.599 0.238 . . . . 0.0 110.441 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 21.4 t -68.7 133.53 48.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.942 0.401 . . . . 0.0 110.621 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.707 HG21 ' CE1' ' B' ' 126' ' ' TYR . 0.6 OUTLIER -89.6 -26.2 5.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.095 179.746 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -45.49 -27.76 0.79 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.309 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -51.49 68.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.593 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.617 HD22 HG22 ' A' ' 125' ' ' VAL . 2.0 mp -80.78 -29.68 36.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.752 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -63.32 -43.06 98.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.728 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.93 -41.41 51.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.823 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.6 -45.42 87.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.142 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.817 ' O ' HG22 ' A' ' 140' ' ' THR . 70.1 mmm -70.43 -30.32 67.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.999 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -76.5 -28.52 56.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.027 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.12 -0.27 26.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.424 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.817 HG22 ' O ' ' A' ' 137' ' ' MET . 12.3 t -60.97 153.69 24.45 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.818 0.342 . . . . 0.0 110.886 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.02 118.18 6.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.849 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 129.98 -153.12 19.91 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.585 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 18.3 mmm -85.34 113.52 21.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.77 0.319 . . . . 0.0 110.975 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.552 HD12 ' HE1' ' A' ' 74' ' ' PHE . 49.6 mt -85.26 148.19 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.11 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 48.8 p -128.3 115.24 17.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.399 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.534 ' CD2' HG22 ' A' ' 144' ' ' ILE . 2.3 mm? -117.71 131.86 56.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.25 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.95 105.42 17.44 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.654 HG11 HD11 ' A' ' 111' ' ' LEU . 5.3 p -139.05 157.86 28.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.101 0.477 . . . . 0.0 112.045 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.479 ' N ' HG22 ' A' ' 148' ' ' VAL . 2.9 mp -137.68 127.32 15.22 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.679 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 149' ' ' ILE . 34.7 Cg_exo -60.95 120.15 7.7 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.378 2.052 . . . . 0.0 112.241 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 55.85 -164.5 0.13 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.956 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -111.12 -144.93 0.39 Allowed 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.247 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.171 -0.918 . . . . 0.0 110.869 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.869 0.366 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 4.2 mmtp -103.85 167.59 9.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.953 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . 0.526 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 13.5 mt-10 -168.01 135.73 2.25 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.196 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 126' ' ' TYR . . . . . 0.707 ' CE1' HG21 ' A' ' 130' ' ' VAL . 37.9 m-85 -129.12 132.64 47.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.175 -179.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 127' ' ' CYS . . . . . 0.769 ' SG ' HD11 ' A' ' 100' ' ' LEU . 1.8 m -105.81 115.95 31.1 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.957 HD11 HD12 ' A' ' 86' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.289 -0.862 . . . . 0.0 111.24 -177.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.541 HG21 ' HD2' ' A' ' 147' ' ' LYS . 11.3 p . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.789 0.328 . . . . 0.0 111.013 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -96.68 132.88 41.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.962 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.446 HD23 ' OE1' ' A' ' 73' ' ' GLN . 5.0 tp -110.25 102.84 11.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.921 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 23.9 mm -89.26 120.5 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.774 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.446 ' OE1' HD23 ' A' ' 71' ' ' LEU . 25.7 mt-30 -119.37 123.23 43.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.426 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.745 ' HE1' HD12 ' A' ' 144' ' ' ILE . 18.4 p90 -152.18 135.56 15.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.556 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -80.33 139.9 36.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.253 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -129.21 111.21 12.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.25 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.591 ' O ' HG13 ' A' ' 77' ' ' VAL . 0.3 OUTLIER -131.42 12.95 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.47 -179.589 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.67 163.11 16.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.012 0.434 . . . . 0.0 111.327 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.95 79.52 6.58 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.285 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.36 126.89 0.95 Allowed Pre-proline 0 N--CA 1.445 -0.684 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.275 -178.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.44 166.76 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.574 2.182 . . . . 0.0 112.411 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 21.9 ttm -58.83 -51.27 70.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.415 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 121.79 21.55 2.91 Favored Glycine 0 CA--C 1.517 0.163 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.808 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.428 HG21 HG21 ' A' ' 105' ' ' ILE . 15.7 pt -137.48 166.4 24.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.657 0.265 . . . . 0.0 110.639 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.485 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -130.67 124.94 32.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.582 179.798 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.581 ' CD2' HD13 ' A' ' 117' ' ' ILE . 0.4 OUTLIER -129.22 155.99 44.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.025 -179.564 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.407 ' O ' ' O ' ' A' ' 93' ' ' SER . 0.1 OUTLIER -134.63 166.83 22.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.119 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.706 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -102.12 106.36 17.21 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.224 179.598 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.408 ' HB2' ' HD2' ' A' ' 91' ' ' LYS . 1.4 m120 -64.22 176.36 1.05 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.809 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -51.19 -23.19 3.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.322 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.408 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -97.1 15.69 21.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.367 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.473 ' HB3' ' HA ' ' A' ' 126' ' ' THR . 1.0 OUTLIER 54.37 75.56 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.723 0.296 . . . . 0.0 110.68 179.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 78.8 p -143.93 133.05 22.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.712 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.556 ' SG ' HD11 ' A' ' 120' ' ' ILE . 10.9 p -87.63 112.18 22.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.058 0.456 . . . . 0.0 111.459 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.798 HG23 ' O ' ' A' ' 115' ' ' ASP . 23.9 m -133.57 134.61 43.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.419 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.893 HG13 ' H ' ' A' ' 114' ' ' GLY . 2.1 p -58.93 106.21 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.71 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -71.47 -25.33 62.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.862 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.533 ' HA ' HG23 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -173.52 131.03 0.45 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.563 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.552 HD11 ' HA ' ' A' ' 112' ' ' HIS . 39.3 mt -85.92 138.26 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.453 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.658 HD22 ' N ' ' A' ' 100' ' ' LEU . 0.9 OUTLIER -97.8 142.24 29.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.85 0.357 . . . . 0.0 111.069 -179.715 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.447 ' HA ' ' CD2' ' A' ' 106' ' ' HIS . 0.5 OUTLIER -75.05 143.54 43.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.87 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.54 -29.01 11.0 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.359 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.415 ' HA3' ' HA3' ' A' ' 83' ' ' GLY . . . -61.5 160.76 27.9 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.424 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.43 ' SD ' HD13 ' A' ' 105' ' ' ILE . 2.3 ppp? -65.47 -31.3 72.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.773 0.321 . . . . 0.0 110.826 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.43 HD13 ' SD ' ' A' ' 104' ' ' MET . 44.2 mm -71.9 -36.07 56.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.948 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.447 ' CD2' ' HA ' ' A' ' 101' ' ' HIS . 86.2 t60 -80.48 -47.16 14.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.622 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -64.35 -46.72 82.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.664 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -79.76 -41.79 25.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.682 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 85.17 70.67 1.33 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.418 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.3 m -109.12 -26.79 9.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.774 0.321 . . . . 0.0 111.027 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.84 ' CD2' HG11 ' A' ' 148' ' ' VAL . 6.2 mt -134.39 168.2 19.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.066 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.552 ' HA ' HD11 ' A' ' 99' ' ' ILE . 76.9 m80 -133.07 136.73 46.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.65 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.533 HG23 ' HA ' ' A' ' 98' ' ' ARG . 7.5 p -46.02 115.75 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.292 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.893 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 112.22 -18.83 23.13 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.725 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.798 ' O ' HG23 ' A' ' 95' ' ' THR . 0.2 OUTLIER -55.51 132.38 48.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.694 0.247 . . . . 0.0 110.539 179.79 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -89.78 113.13 24.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.86 0.362 . . . . 0.0 111.483 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.641 HG21 HG12 ' A' ' 120' ' ' ILE . 3.4 mp -87.21 99.79 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.734 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -57.21 -29.44 63.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.125 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -160.55 143.16 13.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.18 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.641 HG12 HG21 ' A' ' 117' ' ' ILE . 17.6 mt -112.56 104.62 17.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.888 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 58.99 30.56 20.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.893 0.378 . . . . 0.0 110.556 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 87.65 13.14 65.6 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.581 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.6 m -133.62 117.14 16.69 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.764 0.316 . . . . 0.0 111.137 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -94.98 84.44 4.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.539 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.992 HG21 HG13 ' A' ' 130' ' ' VAL . 9.2 p -47.11 142.87 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.254 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.473 ' HA ' ' HB3' ' A' ' 92' ' ' GLN . 10.1 p -119.0 -173.42 2.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.868 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 27.9 p30 -51.75 -25.77 8.18 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.202 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.09 -171.61 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.765 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 10.0 m -65.4 134.44 53.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.91 0.386 . . . . 0.0 111.127 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.992 HG13 HG21 ' A' ' 125' ' ' VAL . 0.8 OUTLIER -88.82 -16.36 8.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.15 179.612 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -45.18 -25.92 0.42 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.348 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.23 -52.34 62.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.508 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.489 HD13 ' HB ' ' A' ' 125' ' ' VAL . 6.2 mp -76.87 -33.35 57.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.624 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 11.1 tp60 -64.0 -51.07 65.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.566 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.85 -40.64 97.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.749 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.77 -40.71 79.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.058 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.701 ' O ' HG22 ' A' ' 140' ' ' THR . 12.4 mmt -65.8 -33.28 75.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.832 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.15 -37.01 58.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -99.65 10.13 41.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.276 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.701 HG22 ' O ' ' A' ' 137' ' ' MET . 10.9 t -61.32 156.93 17.66 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.778 0.323 . . . . 0.0 110.996 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -154.1 110.29 3.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.016 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 129.21 -158.78 22.17 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.67 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 17.4 mtp -85.24 116.18 23.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.916 0.389 . . . . 0.0 110.937 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.745 HD12 ' HE1' ' A' ' 74' ' ' PHE . 32.1 mt -87.1 130.13 37.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.257 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.1 m -112.44 113.66 25.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.254 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.646 HD22 ' N ' ' A' ' 146' ' ' LEU . 0.5 OUTLIER -116.53 129.85 56.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.405 -179.412 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.541 ' HD2' HG21 ' A' ' 69' ' ' VAL . 0.6 OUTLIER -95.82 107.41 19.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.014 179.307 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.84 HG11 ' CD2' ' A' ' 111' ' ' LEU . 2.3 t -124.92 157.88 33.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.013 0.435 . . . . 0.0 111.805 -178.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 31.1 mt -137.21 118.82 11.04 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.745 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -57.21 135.59 71.28 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.489 2.126 . . . . 0.0 112.523 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -154.96 110.73 3.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.93 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -146.46 96.6 2.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.856 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.975 179.924 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 16.7 mtp180 . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.805 0.336 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.29 160.77 24.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.962 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . 0.405 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 4.7 pm0 -158.69 136.55 10.43 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.009 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 126' ' ' TYR . . . . . 0.63 ' CE1' HG21 ' A' ' 130' ' ' VAL . 34.4 m-85 -117.35 132.52 56.58 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.165 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 2.0 m -105.74 116.12 31.4 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.705 ' N ' HD13 ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.43 -177.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.58 ' O ' HG13 ' A' ' 69' ' ' VAL . 10.3 p . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.843 0.354 . . . . 0.0 111.074 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -123.95 119.82 30.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.821 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.7 tp -87.44 99.3 11.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.026 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 37.1 mt -109.11 133.51 54.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.342 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 144' ' ' ILE . 0.0 OUTLIER -132.36 126.51 33.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.946 0.403 . . . . 0.0 111.689 -179.436 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.648 ' HE1' HD12 ' A' ' 144' ' ' ILE . 4.5 p90 -117.74 144.06 45.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.324 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -80.27 137.32 36.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.884 0.373 . . . . 0.0 111.333 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -129.2 111.24 12.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.368 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.586 ' O ' HG13 ' A' ' 77' ' ' VAL . 0.3 OUTLIER -124.71 10.85 4.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.562 -179.545 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.6 152.7 38.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.879 0.371 . . . . 0.0 111.291 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -93.59 87.47 5.52 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.435 0.636 . . . . 0.0 110.374 179.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.438 ' HG2' ' HD2' ' A' ' 81' ' ' PRO . 0.3 OUTLIER -171.22 164.07 4.99 Favored Pre-proline 0 N--CA 1.448 -0.573 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.666 -178.829 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.438 ' HD2' ' HG2' ' A' ' 80' ' ' GLU . 25.0 Cg_endo -61.85 141.82 91.25 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.411 2.074 . . . . 0.0 112.071 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -54.11 -40.67 67.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.96 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.467 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 117.22 15.05 6.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.89 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.9 pt -128.74 163.98 32.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.789 0.328 . . . . 0.0 110.743 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.491 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -129.98 124.96 34.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.062 179.634 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.634 ' CD2' HD13 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -135.9 159.35 41.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.137 -179.293 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.555 ' C ' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -140.51 166.95 23.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.281 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.692 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -100.34 102.96 14.33 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.064 179.635 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -64.16 176.39 1.03 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.877 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -51.73 -26.26 9.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.883 0.373 . . . . 0.0 110.766 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.99 4.33 38.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.454 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.414 ' HB3' ' HA ' ' A' ' 126' ' ' THR . 10.4 mt-30 59.48 77.04 0.33 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.803 0.335 . . . . 0.0 110.363 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.528 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 67.1 m -155.91 138.71 15.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.664 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.599 ' SG ' HD11 ' A' ' 120' ' ' ILE . 8.8 p -87.91 114.98 25.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.149 0.5 . . . . 0.0 111.676 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.736 HG23 ' O ' ' A' ' 115' ' ' ASP . 28.1 m -130.51 135.16 47.66 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.253 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.902 HG13 ' H ' ' A' ' 114' ' ' GLY . 4.0 p -60.69 106.13 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.244 0.545 . . . . 0.0 110.955 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -74.29 -24.39 59.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.22 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.44 ' HA ' HG23 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -169.7 132.61 1.19 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.997 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.836 ' CD1' HG21 ' A' ' 96' ' ' VAL . 24.3 mm -86.24 110.26 19.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.468 HD11 ' SG ' ' B' ' 127' ' ' CYS . 10.9 mp -70.21 133.23 46.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.918 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 51.7 m80 -69.77 142.17 53.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.842 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.75 -24.28 28.85 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.591 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.467 ' HA3' ' HA3' ' A' ' 83' ' ' GLY . . . -63.39 162.02 33.66 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.641 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.1 ptm -64.97 -37.27 87.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.784 0.326 . . . . 0.0 110.64 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 35.9 mm -67.56 -29.85 46.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.825 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.495 ' CD2' HG22 ' A' ' 99' ' ' ILE . 3.9 t-80 -85.83 -43.06 13.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.627 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.28 -46.94 68.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.607 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -80.98 -45.34 16.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.725 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.38 73.58 1.26 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.643 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.9 t -111.34 -29.42 7.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.811 0.339 . . . . 0.0 110.967 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.798 HD11 HG21 ' A' ' 148' ' ' VAL . 1.1 tp -136.37 169.01 18.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.865 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -137.56 139.88 40.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.571 ' O ' HG13 ' A' ' 113' ' ' VAL . 7.6 p -44.08 111.38 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.638 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.902 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 119.06 -24.96 8.06 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.607 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.736 ' O ' HG23 ' A' ' 95' ' ' THR . 1.0 OUTLIER -54.71 131.55 43.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.719 0.295 . . . . 0.0 110.68 179.835 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -90.16 121.47 32.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.668 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.634 HD13 ' CD2' ' A' ' 86' ' ' LEU . 4.4 mp -98.18 95.39 4.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.465 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 8.9 mp -56.94 -27.76 61.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.493 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -156.53 153.44 28.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.051 0.453 . . . . 0.0 111.453 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.802 HD12 HD13 ' A' ' 133' ' ' LEU . 36.2 mt -124.96 101.28 8.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.651 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.479 ' ND2' HG23 ' A' ' 144' ' ' ILE . 5.7 t-20 65.25 16.47 10.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.969 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.54 10.81 26.45 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.063 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.68 HG22 ' O ' ' A' ' 120' ' ' ILE . 5.9 t -129.64 124.3 33.35 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.952 0.406 . . . . 0.0 111.371 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -96.76 75.76 2.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.242 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.889 ' HB ' HD11 ' A' ' 133' ' ' LEU . 10.7 p -44.71 143.49 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.723 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.414 ' HA ' ' HB3' ' A' ' 92' ' ' GLN . 39.3 p -120.04 -171.1 2.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.824 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -48.68 -26.31 2.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.422 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -52.24 -179.02 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.926 0.393 . . . . 0.0 111.07 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.85 134.77 57.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.216 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.617 HG22 HD21 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -88.74 -16.42 8.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.071 179.584 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -48.05 -25.18 1.31 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.031 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -58.73 -45.72 88.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.615 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.889 HD11 ' HB ' ' A' ' 125' ' ' VAL . 8.4 mt -73.0 -35.26 66.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.285 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.7 -45.91 87.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.752 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.423 ' HG3' ' N ' ' A' ' 136' ' ' ALA . 0.0 OUTLIER -70.36 -30.18 67.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.992 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.481 ' O ' HG22 ' A' ' 140' ' ' THR . . . -79.59 -35.56 39.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.22 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.65 -30.51 67.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.951 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -85.08 -30.04 24.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.09 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -86.81 -34.69 19.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.105 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.481 HG22 ' O ' ' A' ' 136' ' ' ALA . 9.1 t -59.65 146.57 40.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.966 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.03 106.91 4.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.73 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 150.23 -146.77 16.23 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.55 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 4.0 mtp -94.27 118.31 31.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.851 0.358 . . . . 0.0 111.021 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.648 HD12 ' HE1' ' A' ' 74' ' ' PHE . 29.1 mt -89.9 139.03 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.056 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 84.4 p -116.5 113.61 23.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.289 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.576 ' CD1' HG22 ' A' ' 144' ' ' ILE . 6.9 mp -112.19 134.05 53.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.947 0.403 . . . . 0.0 111.417 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -95.85 105.4 17.41 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.54 179.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.798 HG21 HD11 ' A' ' 111' ' ' LEU . 2.6 t -124.72 158.32 32.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.199 0.523 . . . . 0.0 112.094 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 24.1 mt -133.33 135.62 25.73 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.701 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.63 126.27 13.2 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.403 2.068 . . . . 0.0 112.352 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -61.37 99.82 0.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.838 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -106.79 -146.42 0.39 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.275 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.238 -0.886 . . . . 0.0 110.859 179.925 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 9.2 ttp180 . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.778 0.323 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . 0.439 ' HD3' ' CE1' ' B' ' 126' ' ' TYR . 0.5 OUTLIER -98.57 167.96 10.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.926 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . 0.489 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 3.6 pt-20 -156.01 135.75 12.59 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.171 0.51 . . . . 0.0 110.345 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 126' ' ' TYR . . . . . 0.462 ' CE1' HG21 ' A' ' 130' ' ' VAL . 32.1 m-85 -115.31 133.14 56.31 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.037 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 127' ' ' CYS . . . . . 0.468 ' SG ' HD11 ' A' ' 100' ' ' LEU . 1.4 m -105.83 116.08 31.33 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.651 ' N ' HD13 ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.409 -177.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.56 ' O ' HG13 ' A' ' 69' ' ' VAL . 14.9 p . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.9 0.381 . . . . 0.0 111.264 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.2 ptp85 -120.21 144.85 47.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.783 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.7 tp -92.9 99.08 11.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.959 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 37.2 mt -91.63 145.94 6.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.223 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -143.56 126.36 16.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.014 0.435 . . . . 0.0 111.618 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.536 ' CZ ' HD22 ' A' ' 146' ' ' LEU . 3.9 p90 -117.72 133.33 56.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.96 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 10.8 pm0 -80.14 134.14 36.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.941 0.4 . . . . 0.0 111.392 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.09 111.31 12.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.586 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -96.99 -34.11 4.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.065 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.52 155.51 18.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.177 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.15 93.14 7.16 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.266 0.555 . . . . 0.0 110.59 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -167.36 164.75 9.28 Favored Pre-proline 0 N--CA 1.449 -0.52 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.028 -179.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -52.01 141.16 47.89 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.584 2.19 . . . . 0.0 112.288 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.96 -56.14 24.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.866 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 147.64 -17.29 1.44 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.982 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.795 HG22 HG23 ' A' ' 99' ' ' ILE . 6.0 pt -115.98 170.59 5.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.77 0.319 . . . . 0.0 111.188 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.73 ' SG ' HD21 ' A' ' 100' ' ' LEU . 5.0 m -131.79 133.61 44.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.362 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.842 ' CD2' HD13 ' A' ' 117' ' ' ILE . 0.5 OUTLIER -127.96 159.48 34.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.327 -179.228 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.531 ' C ' HD13 ' A' ' 88' ' ' LEU . 7.5 pttm -133.02 160.85 35.95 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.954 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.668 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -99.66 104.71 16.49 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.389 179.559 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -64.3 176.19 1.12 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.942 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -53.68 -22.75 9.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.227 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.407 ' CD ' ' N ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -95.61 16.3 17.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.945 179.818 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 51.9 85.98 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.737 0.303 . . . . 0.0 110.7 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 1.1 m -159.3 134.13 8.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.437 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.544 ' SG ' HD11 ' A' ' 120' ' ' ILE . 28.0 p -87.72 115.51 25.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.136 0.493 . . . . 0.0 111.438 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.698 HG23 ' O ' ' A' ' 115' ' ' ASP . 5.8 m -130.04 130.91 45.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.487 -0.779 . . . . 0.0 108.922 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.882 HG13 ' H ' ' A' ' 114' ' ' GLY . 2.0 p -58.51 105.92 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.629 -178.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -70.57 -25.37 63.05 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.799 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.505 ' HA ' HG23 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -173.44 131.29 0.46 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.974 179.835 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.795 HG23 HG22 ' A' ' 84' ' ' ILE . 37.3 mt -85.97 128.44 39.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.167 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.73 HD21 ' SG ' ' A' ' 85' ' ' CYS . 3.9 mt -89.55 146.34 24.65 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.905 0.383 . . . . 0.0 111.228 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.441 ' HA ' ' CD2' ' A' ' 106' ' ' HIS . 8.4 m-70 -79.72 146.67 32.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.809 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.97 -33.64 5.44 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.387 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.61 171.87 4.15 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.549 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 1.8 tmm? -73.53 -28.55 61.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.758 0.313 . . . . 0.0 111.034 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.6 mm -74.59 -37.15 43.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.124 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.441 ' CD2' ' HA ' ' A' ' 101' ' ' HIS . 78.8 t60 -78.45 -49.69 13.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.621 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.91 -44.19 97.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.592 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -82.26 -47.08 12.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.557 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.83 69.92 1.35 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.476 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.483 ' C ' HD22 ' A' ' 111' ' ' LEU . 1.3 p -108.77 -29.22 8.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.833 0.349 . . . . 0.0 110.918 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.635 HD11 HG21 ' A' ' 148' ' ' VAL . 3.8 mm? -123.94 172.56 8.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.948 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.519 ' CA ' HD11 ' A' ' 99' ' ' ILE . 10.3 m80 -135.09 137.89 43.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.79 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.505 HG23 ' HA ' ' A' ' 98' ' ' ARG . 7.5 p -49.75 118.99 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.117 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.882 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 107.77 -20.13 32.15 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.826 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.698 ' O ' HG23 ' A' ' 95' ' ' THR . 26.9 m-20 -50.32 138.14 17.27 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.675 0.274 . . . . 0.0 110.684 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -90.01 110.48 21.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.717 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.842 HD13 ' CD2' ' A' ' 86' ' ' LEU . 5.3 mp -94.72 94.39 4.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.314 179.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.407 HD23 ' CD1' ' A' ' 149' ' ' ILE . 3.4 mm? -54.36 -40.32 68.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.887 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -142.12 164.17 30.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.095 0.474 . . . . 0.0 111.66 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.712 ' CD1' HG23 ' A' ' 125' ' ' VAL . 1.1 mp -131.48 99.12 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.352 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 69.14 17.61 8.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.917 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.58 -0.32 34.55 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.747 -0.739 . . . . 0.0 113.107 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.648 ' O ' HD12 ' A' ' 120' ' ' ILE . 5.5 t -132.58 134.56 45.09 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 117.0 0.4 . . . . 0.0 111.449 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -96.05 122.69 39.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.514 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.801 HG11 HG13 ' A' ' 130' ' ' VAL . 20.7 t -58.48 155.03 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.375 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.421 ' N ' HG12 ' A' ' 125' ' ' VAL . 74.1 p -119.11 171.04 8.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.696 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.35 -21.12 62.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.196 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -59.4 -107.22 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.762 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.3 t -109.07 134.32 51.84 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.884 0.374 . . . . 0.0 111.242 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.801 HG13 HG11 ' A' ' 125' ' ' VAL . 0.5 OUTLIER -89.16 -19.26 7.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.059 179.533 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.418 ' HA ' ' HB2' ' A' ' 134' ' ' GLN . 0.8 OUTLIER -46.1 -25.29 0.56 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.444 -179.584 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -54.24 -55.92 23.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.987 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.692 ' CD2' HG22 ' A' ' 125' ' ' VAL . 3.4 mm? -70.7 -41.88 71.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.796 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.461 ' HG2' HG21 ' B' ' 128' ' ' ILE . 3.9 mm-40 -50.3 -53.29 29.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.18 -32.6 73.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.709 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.427 ' O ' HG22 ' A' ' 140' ' ' THR . . . -73.19 -27.79 61.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.21 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -78.22 -32.25 49.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.912 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -87.57 -29.29 21.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.976 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -81.73 -30.58 32.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.958 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 136' ' ' ALA . 12.5 t -71.56 149.06 46.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.992 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 11.6 mttp -140.48 125.35 18.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.711 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 127.95 -136.7 9.33 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.336 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.429 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -100.04 137.06 39.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.86 0.362 . . . . 0.0 111.058 -179.867 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.564 HG22 HD13 ' A' ' 146' ' ' LEU . 35.7 mt -109.18 142.96 20.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.177 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 28.0 p -121.08 113.7 20.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.456 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.564 HD13 HG22 ' A' ' 144' ' ' ILE . 5.8 mp -112.74 142.68 45.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.339 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.71 108.52 20.83 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.471 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.635 HG21 HD11 ' A' ' 111' ' ' LEU . 2.7 t -125.05 158.33 33.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.267 0.556 . . . . 0.0 112.274 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.407 ' CD1' HD23 ' A' ' 118' ' ' LEU . 12.6 mt -132.32 115.98 15.17 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.426 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.7 120.32 7.9 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.428 2.085 . . . . 0.0 112.391 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -79.77 179.33 7.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.843 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -150.61 102.67 3.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.029 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.873 179.956 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 1.8 mmt85 . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.858 0.361 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . 0.539 ' HD2' HD22 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -106.33 160.47 15.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.933 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . 0.463 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 8.6 pt-20 -158.07 135.96 10.63 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.202 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 126' ' ' TYR . . . . . 0.602 ' CE1' HG21 ' A' ' 130' ' ' VAL . 16.8 m-85 -115.7 138.19 51.34 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.352 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 98.9 m -106.4 116.11 31.36 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.84 HD11 HD12 ' A' ' 86' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.45 -177.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.643 ' O ' HG13 ' A' ' 69' ' ' VAL . 7.2 p . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.916 0.389 . . . . 0.0 110.988 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -95.52 152.61 18.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.864 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.43 99.77 4.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.999 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.479 HG22 ' N ' ' A' ' 73' ' ' GLN . 4.0 mp -89.32 159.18 2.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.648 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.479 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -146.21 124.69 12.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.011 0.434 . . . . 0.0 111.634 -179.656 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.601 ' CZ ' HD23 ' A' ' 146' ' ' LEU . 0.9 OUTLIER -142.47 130.49 21.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.331 179.078 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 10.5 tt0 -80.21 140.85 36.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.646 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 15.8 tttm -129.2 115.86 18.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.305 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -105.73 -26.54 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.329 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.53 149.09 22.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.282 -179.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -87.62 90.43 8.37 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.434 0.635 . . . . 0.0 110.56 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -161.97 157.14 19.98 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.836 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.07 142.61 99.54 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.441 2.094 . . . . 0.0 112.155 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -53.08 -42.42 65.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.045 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 127.58 -8.29 6.95 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.78 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.598 HG21 HG21 ' A' ' 105' ' ' ILE . 43.2 pt -113.5 168.84 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.854 0.359 . . . . 0.0 111.052 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.71 ' SG ' HD21 ' A' ' 100' ' ' LEU . 17.2 m -135.88 132.54 36.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.225 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.686 HD12 HD11 ' B' ' 128' ' ' ILE . 0.2 OUTLIER -133.8 159.65 39.96 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.272 -179.071 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.654 ' C ' HD13 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -135.99 162.4 32.99 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.982 179.831 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.677 ' N ' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -105.89 103.26 12.71 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.511 179.694 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.2 m-20 -64.13 176.42 1.01 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.709 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -51.42 -24.34 4.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.108 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.11 9.32 25.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.516 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 54.36 79.55 0.14 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.768 0.318 . . . . 0.0 110.649 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 11.2 m -152.44 131.89 12.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.561 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.475 ' SG ' HD11 ' A' ' 120' ' ' ILE . 18.3 p -87.68 111.49 21.35 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.08 0.467 . . . . 0.0 111.255 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.703 HG23 ' O ' ' A' ' 115' ' ' ASP . 8.6 m -127.58 132.31 49.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.454 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.916 HG13 ' H ' ' A' ' 114' ' ' GLY . 3.9 p -58.72 106.22 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.195 0.521 . . . . 0.0 110.561 -179.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -73.77 -27.11 60.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.354 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.429 ' HA ' HG23 ' A' ' 113' ' ' VAL . 6.9 ttp85 -165.77 129.34 2.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.852 0.358 . . . . 0.0 111.47 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.911 ' CD1' HG21 ' A' ' 96' ' ' VAL . 32.6 mm -87.65 103.76 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.439 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.71 HD21 ' SG ' ' A' ' 85' ' ' CYS . 5.5 mt -65.66 135.4 54.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.93 0.395 . . . . 0.0 111.05 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 22.7 m170 -73.07 140.25 47.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.808 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 103.97 -36.52 4.31 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.44 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -55.59 174.59 1.0 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.51 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.53 -29.42 52.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.793 0.33 . . . . 0.0 111.002 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.598 HG21 HG21 ' A' ' 84' ' ' ILE . 28.6 mm -69.03 -35.24 67.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.065 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -80.62 -50.63 9.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.707 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -60.22 -41.72 93.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.628 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.74 -43.82 12.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.672 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.73 51.43 2.67 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.517 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 m -87.64 -22.95 24.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.618 0.247 . . . . 0.0 111.051 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.423 HD23 ' HB2' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -145.84 165.2 29.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.805 0.336 . . . . 0.0 110.901 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -133.5 137.93 45.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.894 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.583 ' O ' HG13 ' A' ' 113' ' ' VAL . 7.5 p -46.74 111.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.714 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.916 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 117.41 -26.0 8.37 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.434 -0.888 . . . . 0.0 113.223 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.703 ' O ' HG23 ' A' ' 95' ' ' THR . 4.6 m-20 -54.13 138.61 37.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.905 0.352 . . . . 0.0 110.67 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.52 118.84 30.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.62 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.605 HD13 ' CD2' ' A' ' 86' ' ' LEU . 4.5 mp -93.43 99.18 9.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.629 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -56.96 -31.58 65.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.241 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -161.23 141.7 11.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.878 0.371 . . . . 0.0 111.349 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.587 HG23 HD12 ' A' ' 146' ' ' LEU . 28.2 mt -107.72 103.28 15.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.675 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 65.19 27.28 12.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.696 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 92.51 5.94 64.64 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.875 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.2 m -133.71 127.0 31.93 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.867 0.365 . . . . 0.0 111.221 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -94.89 120.82 35.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.598 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.635 HG11 HG13 ' A' ' 130' ' ' VAL . 17.9 t -54.53 149.48 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.357 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 58.6 p -119.16 161.5 20.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.771 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -61.59 -18.85 61.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.165 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -60.22 -111.98 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.723 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.09 134.29 51.88 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.921 0.391 . . . . 0.0 110.973 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.676 HG21 ' CE1' ' B' ' 126' ' ' TYR . 0.6 OUTLIER -89.06 -26.11 5.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.042 179.652 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -46.05 -27.44 0.94 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.452 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.55 ' HG3' HD12 ' A' ' 133' ' ' LEU . 9.7 pt20 -62.24 -48.71 78.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.673 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.635 HD13 HG22 ' A' ' 125' ' ' VAL . 1.8 mp -81.53 -35.89 29.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.801 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.403 ' HG3' ' CG2' ' B' ' 128' ' ' ILE . 2.6 tt0 -63.87 -46.09 86.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.529 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -68.05 -45.7 73.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.602 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -65.59 -38.16 88.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.911 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.772 ' O ' HG22 ' A' ' 140' ' ' THR . 2.0 mmt -65.55 -32.05 73.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -85.29 -28.17 25.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.958 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -91.45 -15.39 28.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.335 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.772 HG22 ' O ' ' A' ' 137' ' ' MET . 9.8 t -60.78 156.93 15.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.931 0.396 . . . . 0.0 111.056 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -146.26 117.25 7.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.639 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 134.81 -152.58 20.77 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.625 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.503 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 9.9 ptm -90.47 115.31 27.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.851 0.358 . . . . 0.0 111.29 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.557 HD13 ' HE2' ' A' ' 137' ' ' MET . 47.0 mt -87.83 130.14 38.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.063 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 14.6 m -111.9 113.68 26.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.255 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.642 HD22 ' N ' ' A' ' 146' ' ' LEU . 0.9 OUTLIER -112.53 133.93 54.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.063 0.459 . . . . 0.0 111.197 -179.489 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.37 105.3 17.43 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.528 ' HB ' HG13 ' A' ' 117' ' ' ILE . 2.8 p -133.35 156.45 41.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.149 0.5 . . . . 0.0 112.045 -178.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.437 ' N ' HG22 ' A' ' 148' ' ' VAL . 26.0 mt -122.71 119.05 28.24 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.62 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -57.18 147.5 75.67 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.543 2.162 . . . . 0.0 112.534 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 56.48 177.23 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.074 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -159.77 108.42 1.77 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.825 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.876 -179.952 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 23.2 mtm105 . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.73 0.3 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . 0.564 ' NZ ' HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -107.1 167.92 9.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.956 179.914 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . 0.46 ' HG2' ' HB3' ' A' ' 97' ' ' ALA . 4.4 mt-10 -164.73 139.98 5.54 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.481 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 126' ' ' TYR . . . . . 0.676 ' CE1' HG21 ' A' ' 130' ' ' VAL . 31.6 m-85 -117.81 132.33 56.46 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.324 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 91.4 m -106.01 116.01 31.2 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.686 HD11 HD12 ' A' ' 86' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.28 -0.867 . . . . 0.0 111.476 -177.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.629 HG21 ' HD3' ' A' ' 147' ' ' LYS . 10.9 p . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.85 0.357 . . . . 0.0 111.0 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -95.42 114.6 26.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.636 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.479 HD12 ' HG2' ' A' ' 147' ' ' LYS . 4.7 tp -92.17 102.5 15.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.118 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mt -89.22 152.13 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.638 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.436 ' NE2' HD23 ' A' ' 71' ' ' LEU . 9.6 mt-30 -140.8 123.2 15.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.005 0.431 . . . . 0.0 111.52 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.769 ' HE1' HD12 ' A' ' 144' ' ' ILE . 25.9 p90 -146.97 134.55 20.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.133 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 0.4 OUTLIER -80.27 143.47 33.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.071 0.462 . . . . 0.0 111.571 -179.094 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.11 111.23 12.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.159 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -109.72 -25.84 3.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.465 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.57 146.23 24.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.313 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.96 90.54 8.38 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.385 0.612 . . . . 0.0 110.421 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.409 ' CB ' ' HD2' ' A' ' 81' ' ' PRO . 2.3 mt-10 -168.43 174.47 2.18 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.673 -178.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.409 ' HD2' ' CB ' ' A' ' 80' ' ' GLU . 65.8 Cg_endo -74.93 142.75 28.46 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.347 2.031 . . . . 0.0 112.415 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -52.55 -58.06 7.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.033 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.492 ' O ' HG23 ' A' ' 84' ' ' ILE . . . 143.26 39.0 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.657 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.509 HG21 HG21 ' A' ' 105' ' ' ILE . 13.0 pt -157.88 170.08 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.719 0.295 . . . . 0.0 110.879 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' B' ' 126' ' ' TYR . 0.1 OUTLIER -135.48 113.56 11.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.48 179.704 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.754 ' HG ' HD11 ' B' ' 128' ' ' ILE . 0.1 OUTLIER -122.12 159.1 27.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.079 -179.159 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.479 ' HB3' ' HA ' ' B' ' 125' ' ' GLU . 0.0 OUTLIER -136.09 166.79 22.56 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.325 -179.69 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.691 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.1 OUTLIER -89.65 103.11 15.78 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.201 179.339 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.408 ' O ' ' N ' ' A' ' 92' ' ' GLN . 4.9 t30 -64.07 176.38 1.01 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.71 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.86 -27.41 3.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.946 0.403 . . . . 0.0 110.803 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.427 ' HD2' ' HB2' ' A' ' 93' ' ' SER . 0.1 OUTLIER -93.56 21.11 6.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.418 179.887 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 89' ' ' ASN . 45.5 mm-40 45.57 74.11 0.15 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.889 0.376 . . . . 0.0 110.666 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.579 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 5.5 m -148.28 147.8 29.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.654 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.63 ' HB3' HD12 ' A' ' 86' ' ' LEU . 1.4 m -87.8 114.18 24.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.119 0.485 . . . . 0.0 111.548 -179.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.613 HG23 ' HA ' ' A' ' 116' ' ' GLU . 2.7 m -130.1 126.63 38.03 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.319 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.898 HG13 ' H ' ' A' ' 114' ' ' GLY . 3.6 p -58.78 105.83 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.408 0.623 . . . . 0.0 110.597 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -74.4 -22.69 59.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.149 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 24.2 ttt180 -171.59 139.04 1.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.679 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.821 HD13 HG21 ' A' ' 96' ' ' VAL . 31.8 mm -86.11 121.0 36.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.9 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.484 HD21 ' SG ' ' B' ' 127' ' ' CYS . 4.6 mm? -74.23 143.33 45.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.038 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 16.0 p-80 -85.54 131.33 34.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.945 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.57 -27.9 16.25 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.48 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.28 176.05 8.23 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.516 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -80.48 -30.03 37.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.757 0.313 . . . . 0.0 110.941 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.509 HG21 HG21 ' A' ' 84' ' ' ILE . 42.9 mm -65.18 -36.73 78.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.989 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -81.46 -46.02 15.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.757 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -45.66 85.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.715 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -81.97 -43.84 17.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.755 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.39 63.13 1.31 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.503 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -101.1 -27.34 13.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.878 0.371 . . . . 0.0 111.106 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.723 ' CD2' HG11 ' A' ' 148' ' ' VAL . 10.3 mt -142.3 157.79 44.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.043 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 50.4 m170 -129.52 142.56 50.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.773 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.567 ' O ' HG13 ' A' ' 113' ' ' VAL . 8.2 p -43.83 113.75 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.654 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.898 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 119.07 -28.78 6.47 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.564 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.554 ' HB3' HG11 ' A' ' 148' ' ' VAL . 0.3 OUTLIER -47.06 126.12 8.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.667 0.27 . . . . 0.0 110.754 179.849 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.613 ' HA ' HG23 ' A' ' 95' ' ' THR . 3.0 mt-10 -89.0 111.36 22.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.868 0.366 . . . . 0.0 111.675 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.741 HG21 HD13 ' A' ' 120' ' ' ILE . 4.4 mp -91.2 98.1 8.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.663 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.608 HD23 HG12 ' A' ' 149' ' ' ILE . 4.3 mm? -60.97 -32.81 72.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.551 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -141.07 146.8 37.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.934 0.397 . . . . 0.0 111.687 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.741 HD13 HG21 ' A' ' 117' ' ' ILE . 14.9 mm -118.0 99.75 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.772 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.413 ' H ' HD13 ' A' ' 146' ' ' LEU . 6.5 t-20 62.19 27.87 16.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.743 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 94.98 2.58 62.46 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.866 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 21.9 m -133.55 131.52 39.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.813 0.339 . . . . 0.0 111.052 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -93.34 116.24 28.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.727 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.795 HG22 HD13 ' A' ' 133' ' ' LEU . 25.5 t -56.16 158.76 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.319 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.485 ' N ' HG12 ' A' ' 125' ' ' VAL . 10.9 p -137.5 -178.94 5.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.908 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -59.64 -25.41 64.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.954 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -54.96 -175.03 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.76 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.7 m -64.32 134.23 54.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.907 0.384 . . . . 0.0 110.885 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.48 ' CG2' ' CZ ' ' B' ' 126' ' ' TYR . 0.3 OUTLIER -88.95 -17.18 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.198 179.663 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.23 -25.94 0.7 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.285 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -65.21 -52.82 52.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.489 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.795 HD13 HG22 ' A' ' 125' ' ' VAL . 0.5 OUTLIER -75.23 -29.87 60.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.338 179.563 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -67.65 -45.58 74.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.507 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.1 pttp -68.98 -38.03 79.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.63 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.622 ' O ' HG23 ' A' ' 140' ' ' THR . . . -73.04 -38.46 66.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.016 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.478 ' HE2' HD13 ' A' ' 144' ' ' ILE . 5.9 mmt -67.47 -28.87 68.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.992 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -86.85 -34.88 19.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.07 10.05 42.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.324 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.622 HG23 ' O ' ' A' ' 136' ' ' ALA . 0.0 OUTLIER -67.37 129.96 41.56 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.813 0.34 . . . . 0.0 110.901 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.17 93.34 3.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.814 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 151.25 -157.15 27.05 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.594 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.409 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 11.5 mmm -90.15 123.13 33.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.848 0.356 . . . . 0.0 110.985 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.769 HD12 ' HE1' ' A' ' 74' ' ' PHE . 29.3 mt -92.79 131.48 39.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.215 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 59.5 m -112.79 113.53 25.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.056 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.654 HD22 ' N ' ' A' ' 146' ' ' LEU . 1.1 mm? -117.02 136.06 53.23 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.949 0.404 . . . . 0.0 111.456 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.629 ' HD3' HG21 ' A' ' 69' ' ' VAL . 7.3 mttm -100.32 105.96 17.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.649 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.723 HG11 ' CD2' ' A' ' 111' ' ' LEU . 4.8 t -123.94 153.58 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.168 0.509 . . . . 0.0 112.16 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.608 HG12 HD23 ' A' ' 118' ' ' LEU . 17.7 mm -117.28 122.43 31.1 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.442 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.56 126.0 13.53 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.526 2.151 . . . . 0.0 112.507 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -104.17 113.16 26.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.846 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 62.25 107.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.837 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.253 -0.879 . . . . 0.0 110.902 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.888 0.375 . . . . 0.0 111.162 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.88 167.66 21.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.025 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . 0.479 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 2.8 pt-20 -152.53 134.3 14.69 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.303 0.573 . . . . 0.0 110.25 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 126' ' ' TYR . . . . . 0.484 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 22.0 m-85 -113.02 136.94 52.14 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.174 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 127' ' ' CYS . . . . . 0.484 ' SG ' HD21 ' A' ' 100' ' ' LEU . 1.7 m -105.86 116.16 31.47 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.754 HD11 ' HG ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.399 -177.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.508 ' O ' HG13 ' A' ' 69' ' ' VAL . 11.8 p . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.805 0.335 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.38 122.19 45.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.912 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 tt -90.96 99.31 12.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.977 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.411 HG22 ' N ' ' A' ' 73' ' ' GLN . 34.2 mt -96.08 154.9 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.724 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.411 ' N ' HG22 ' A' ' 72' ' ' ILE . 1.3 mt-30 -145.9 128.08 15.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.938 0.399 . . . . 0.0 111.458 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.647 ' CE1' HD12 ' A' ' 144' ' ' ILE . 8.1 p90 -141.05 135.71 31.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.459 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -80.35 138.1 36.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.909 0.385 . . . . 0.0 111.034 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.8 tttm -129.18 111.28 12.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.405 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.598 ' O ' HG13 ' A' ' 77' ' ' VAL . 0.3 OUTLIER -130.53 14.25 2.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.67 -179.436 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.42 154.94 20.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.904 0.383 . . . . 0.0 111.33 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.79 79.08 6.77 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.338 0.589 . . . . 0.0 110.48 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.65 153.24 2.71 Favored Pre-proline 0 N--CA 1.446 -0.655 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.014 -178.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.52 158.49 31.75 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.504 2.136 . . . . 0.0 112.285 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 23.7 ttm -56.07 -54.21 47.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.956 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 132.24 -9.09 5.37 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.939 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.505 HG23 ' HB ' ' A' ' 105' ' ' ILE . 15.8 pt -114.92 168.07 6.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.802 0.334 . . . . 0.0 111.139 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.471 ' O ' ' N ' ' A' ' 97' ' ' ALA . 19.3 m -135.02 127.68 30.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.275 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 1.051 HD23 HD13 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -125.9 159.56 32.25 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.238 -179.177 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.585 ' C ' HD13 ' A' ' 88' ' ' LEU . 22.4 pttp -137.06 162.3 33.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.178 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.646 ' N ' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -103.26 102.96 12.95 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.597 179.504 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -64.37 176.67 1.01 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.638 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -50.29 -27.57 6.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.937 0.399 . . . . 0.0 110.838 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.04 -16.9 57.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.347 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 74.78 78.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.821 0.343 . . . . 0.0 110.248 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.599 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 49.1 p -154.94 150.62 27.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.667 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.659 ' SG ' HD11 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -87.85 113.58 23.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.062 0.458 . . . . 0.0 111.219 -179.576 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.599 HG23 ' O ' ' A' ' 115' ' ' ASP . 2.9 m -131.96 126.76 34.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.322 179.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.927 HG13 ' H ' ' A' ' 114' ' ' GLY . 2.6 p -58.72 105.91 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.279 0.561 . . . . 0.0 110.02 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -72.04 -25.03 61.64 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.266 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.531 ' HA ' HG23 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -173.21 123.03 0.39 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.854 179.811 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.749 HG12 HG21 ' A' ' 96' ' ' VAL . 11.0 mt -85.97 120.75 36.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.361 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.456 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.9 mp -83.96 135.8 34.32 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.148 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.443 ' HA ' ' CG ' ' A' ' 106' ' ' HIS . 11.7 p80 -73.6 138.63 45.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.826 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.69 -36.53 4.3 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.382 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.16 -171.02 0.12 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.51 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.4 ttp -84.42 -40.6 17.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.865 0.364 . . . . 0.0 110.906 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.505 ' HB ' HG23 ' A' ' 84' ' ' ILE . 37.6 mm -65.54 -36.88 78.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.105 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.443 ' CG ' ' HA ' ' A' ' 101' ' ' HIS . 63.7 t-80 -75.11 -54.98 6.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.748 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.6 ttt-85 -60.05 -47.17 86.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.693 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -75.99 -47.06 26.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.638 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.72 73.39 1.28 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.565 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.669 ' O ' HD22 ' A' ' 111' ' ' LEU . 4.6 m -111.91 -29.26 7.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.776 0.322 . . . . 0.0 110.986 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.995 HD11 HG11 ' A' ' 148' ' ' VAL . 3.2 mm? -134.26 172.53 12.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.09 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.44 ' CA ' HD11 ' A' ' 99' ' ' ILE . 74.5 m80 -134.46 137.42 43.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.711 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.531 HG23 ' HA ' ' A' ' 98' ' ' ARG . 7.5 p -47.02 115.99 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.901 0.381 . . . . 0.0 111.359 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.927 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 112.23 -24.95 13.23 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.853 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.599 ' O ' HG23 ' A' ' 95' ' ' THR . 24.9 m-20 -50.29 143.35 8.76 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.74 0.27 . . . . 0.0 110.7 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.657 ' C ' HG23 ' A' ' 148' ' ' VAL . 1.6 mt-10 -95.32 107.71 19.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.819 0.342 . . . . 0.0 111.725 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 1.051 HD13 HD23 ' A' ' 86' ' ' LEU . 3.9 mp -86.67 99.83 8.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.66 179.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.606 HD21 HD12 ' A' ' 149' ' ' ILE . 4.3 mm? -51.46 -35.12 38.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.311 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -169.72 145.64 3.1 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.959 0.409 . . . . 0.0 111.271 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 1.057 HG23 HD11 ' A' ' 146' ' ' LEU . 45.1 mt -104.56 125.29 59.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.828 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 60.87 27.74 17.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.777 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 83.32 18.13 65.17 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.743 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 27.4 m -133.58 128.11 34.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.828 0.347 . . . . 0.0 111.023 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -92.56 114.96 27.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.792 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.818 HG21 HG13 ' A' ' 130' ' ' VAL . 13.7 p -82.07 127.04 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.246 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.8 p -98.0 -167.09 1.46 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.714 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -67.05 -15.51 63.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.294 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.545 ' HE1' HG23 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -57.9 -166.91 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.678 0.275 . . . . 0.0 110.572 179.838 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 28.6 t -67.67 134.03 50.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.941 0.401 . . . . 0.0 110.682 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.818 HG13 HG21 ' A' ' 125' ' ' VAL . 0.6 OUTLIER -89.42 -16.32 8.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.335 179.755 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -45.02 -26.01 0.39 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.328 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 51.1 mm-40 -63.78 -54.07 40.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.884 0.373 . . . . 0.0 110.633 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.592 HD22 ' HB ' ' A' ' 125' ' ' VAL . 6.8 mp -77.18 -37.64 53.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.789 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -60.29 -49.57 77.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.712 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.29 -44.06 92.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.73 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.596 ' O ' HG23 ' A' ' 140' ' ' THR . . . -66.17 -35.52 80.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.979 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.504 ' CE ' HD13 ' A' ' 144' ' ' ILE . 1.0 OUTLIER -68.54 -28.36 66.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.894 179.883 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.7 mttp -84.94 -29.38 25.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.898 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.77 10.05 32.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.442 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.596 HG23 ' O ' ' A' ' 136' ' ' ALA . 0.0 OUTLIER -66.55 147.9 52.65 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.771 0.32 . . . . 0.0 110.789 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -150.91 94.97 2.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.783 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 149.2 -154.72 25.95 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.453 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 8.1 mmm -88.03 121.06 29.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.87 0.367 . . . . 0.0 110.833 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.647 HD12 ' CE1' ' A' ' 74' ' ' PHE . 49.8 mt -95.8 144.02 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.215 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.9 p -116.24 113.57 23.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.178 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 1.057 HD11 HG23 ' A' ' 120' ' ' ILE . 3.2 mm? -109.49 125.16 52.18 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.987 0.422 . . . . 0.0 111.46 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 118' ' ' LEU . 10.0 ttpt -105.53 112.02 24.95 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.995 HG11 HD11 ' A' ' 111' ' ' LEU . 3.4 p -147.03 144.03 20.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.157 0.503 . . . . 0.0 112.131 -178.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.606 HD12 HD21 ' A' ' 118' ' ' LEU . 14.6 mt -105.4 136.12 19.26 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.381 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.41 ' HD2' HG23 ' A' ' 149' ' ' ILE . 54.1 Cg_endo -70.06 133.47 25.09 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.456 2.104 . . . . 0.0 112.47 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -135.87 120.07 17.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.733 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 61.51 38.76 15.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.981 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.974 0.416 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -119.17 167.8 11.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.813 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . 0.455 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 1.4 pt-20 -161.45 136.76 7.6 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.348 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 126' ' ' TYR . . . . . 0.639 ' CE1' HG21 ' A' ' 130' ' ' VAL . 32.1 m-85 -122.41 133.28 54.63 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.327 -179.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 89.0 m -106.01 115.98 31.16 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.684 ' N ' HD13 ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.512 -177.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.541 ' O ' HG13 ' A' ' 69' ' ' VAL . 10.8 p . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.819 0.342 . . . . 0.0 111.034 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.3 ttt-85 -95.47 119.95 34.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.762 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.425 HD21 ' HB3' ' A' ' 145' ' ' SER . 0.9 OUTLIER -98.91 99.36 10.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.047 -179.784 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mp -98.48 148.24 6.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.447 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.479 ' HB3' ' HE3' ' A' ' 143' ' ' MET . 15.9 mt-30 -135.03 123.14 22.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.959 0.409 . . . . 0.0 111.533 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.63 ' CE1' HD22 ' A' ' 146' ' ' LEU . 8.1 p90 -126.64 133.23 51.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.285 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -80.43 135.36 36.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.98 0.419 . . . . 0.0 111.324 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.465 ' HD2' HD11 ' A' ' 144' ' ' ILE . 0.5 OUTLIER -129.09 113.59 15.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.47 179.67 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -110.66 -27.84 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.257 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.55 157.18 17.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.37 -179.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -92.52 89.91 6.94 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.52 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -160.04 152.74 17.75 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.966 -178.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.13 147.56 92.83 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.509 2.139 . . . . 0.0 112.207 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.501 ' HE2' ' HB2' ' A' ' 82' ' ' MET . 13.6 ttm -55.39 -41.86 73.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.045 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.46 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 117.14 1.79 18.63 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.581 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.609 HD12 ' O ' ' A' ' 84' ' ' ILE . 2.0 pp -122.17 165.14 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.67 0.271 . . . . 0.0 110.856 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.719 ' C ' HD12 ' A' ' 86' ' ' LEU . 6.8 m -135.03 130.13 35.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.368 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.844 ' CD2' HD13 ' A' ' 117' ' ' ILE . 4.4 mp -121.7 159.5 26.45 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.209 -178.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.709 ' CG ' ' HB2' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -137.39 152.82 50.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.249 179.835 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.673 ' N ' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -102.21 103.38 13.89 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.819 179.803 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -64.3 176.45 1.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.759 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -52.45 -29.17 23.27 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.969 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -81.05 -2.36 47.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.234 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 63.99 86.97 0.12 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.826 0.346 . . . . 0.0 110.53 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.552 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 3.3 m -160.66 137.94 9.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.289 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.414 ' O ' ' HB ' ' A' ' 117' ' ' ILE . 12.9 p -87.61 115.22 24.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.234 0.54 . . . . 0.0 111.489 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.682 HG23 ' O ' ' A' ' 115' ' ' ASP . 9.1 m -132.1 131.53 42.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.53 -0.759 . . . . 0.0 108.97 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.936 HG21 ' CD1' ' A' ' 99' ' ' ILE . 4.4 p -58.8 106.15 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.209 0.528 . . . . 0.0 110.667 -179.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.709 ' HB2' ' CG ' ' A' ' 87' ' ' LYS . . . -72.59 -23.34 60.94 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.333 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.454 ' HA ' HG23 ' A' ' 113' ' ' VAL . 1.0 OUTLIER -172.71 131.53 0.55 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.818 0.342 . . . . 0.0 111.515 179.853 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.936 ' CD1' HG21 ' A' ' 96' ' ' VAL . 25.1 mm -90.09 103.63 14.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.497 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.534 HD13 ' SG ' ' A' ' 85' ' ' CYS . 7.6 mp -65.92 147.77 52.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.946 0.403 . . . . 0.0 111.303 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.433 ' HA ' ' CD2' ' A' ' 106' ' ' HIS . 56.3 t-80 -85.57 142.44 29.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.735 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.3 -39.4 2.86 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.457 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.46 ' HA3' ' HA3' ' A' ' 83' ' ' GLY . . . -54.0 -178.85 0.13 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.646 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 18.6 ptm -84.44 -29.46 26.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.759 0.314 . . . . 0.0 111.166 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.41 HG21 ' HB2' ' A' ' 111' ' ' LEU . 32.5 mm -70.02 -37.91 73.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.975 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.433 ' CD2' ' HA ' ' A' ' 101' ' ' HIS . 46.9 t60 -77.87 -44.06 28.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.514 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.9 mtt85 -64.3 -49.98 69.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.512 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -79.07 -44.3 22.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.681 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.13 77.53 1.35 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.625 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.402 ' HB2' HG23 ' A' ' 105' ' ' ILE . 21.2 m -115.2 -28.19 7.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.666 0.27 . . . . 0.0 111.156 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.463 HD21 HG11 ' A' ' 148' ' ' VAL . 0.2 OUTLIER -132.44 172.22 12.75 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.846 0.355 . . . . 0.0 111.111 -179.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -142.4 132.3 24.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.771 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.557 ' O ' HG13 ' A' ' 113' ' ' VAL . 7.4 p -44.07 111.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.732 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.899 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 117.35 -28.99 6.92 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.9 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.682 ' O ' HG23 ' A' ' 95' ' ' THR . 22.1 m-20 -48.99 137.6 12.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.63 0.252 . . . . 0.0 110.77 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -89.52 111.32 22.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.827 0.346 . . . . 0.0 111.601 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.844 HD13 ' CD2' ' A' ' 86' ' ' LEU . 4.6 mp -89.25 110.43 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.687 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.439 HD21 HD12 ' A' ' 149' ' ' ILE . 4.4 mm? -67.84 -30.11 69.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.095 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -162.48 148.14 12.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.893 0.378 . . . . 0.0 111.582 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.454 HG12 HG21 ' A' ' 117' ' ' ILE . 49.6 mt -119.47 106.63 19.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.726 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 66.99 29.2 8.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.827 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 87.35 8.96 73.64 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.891 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.6 124.37 26.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.839 0.352 . . . . 0.0 111.06 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 -88.13 107.75 18.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.732 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.707 HG22 ' HG ' ' A' ' 133' ' ' LEU . 11.8 t -59.34 126.45 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.114 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 14.2 p -113.38 -171.77 1.94 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.834 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -60.32 -23.69 64.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.041 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -55.29 -176.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.738 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 m -64.28 134.08 54.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.926 0.393 . . . . 0.0 110.878 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.58 HG13 ' CG1' ' A' ' 125' ' ' VAL . 0.4 OUTLIER -89.24 -21.94 6.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.127 179.702 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.432 ' HA ' ' HG2' ' A' ' 134' ' ' GLN . 4.7 t0 -46.87 -25.61 0.8 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.489 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.12 -41.99 48.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.188 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.707 ' HG ' HG22 ' A' ' 125' ' ' VAL . 3.3 mm? -73.61 -44.7 56.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.318 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.432 ' HG2' ' HA ' ' A' ' 131' ' ' ASP . 17.0 pt20 -68.34 -47.47 67.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.463 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.14 -35.59 80.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.443 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -82.74 -44.97 14.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.773 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.764 ' O ' HG22 ' A' ' 140' ' ' THR . 0.0 OUTLIER -67.77 -25.24 65.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.509 -179.387 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -85.18 -47.63 9.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.809 0.338 . . . . 0.0 111.191 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -71.5 -13.62 61.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.492 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.764 HG22 ' O ' ' A' ' 137' ' ' MET . 14.0 t -59.48 150.83 25.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.901 0.381 . . . . 0.0 110.964 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.07 113.64 14.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.702 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 145.75 -131.99 4.38 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.473 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.479 ' HE3' ' HB3' ' A' ' 73' ' ' GLN . 29.1 mtp -109.17 119.68 40.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.769 0.319 . . . . 0.0 111.126 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.667 HG22 HD13 ' A' ' 146' ' ' LEU . 33.6 mt -88.09 130.76 37.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.969 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.552 ' O ' HD12 ' A' ' 146' ' ' LEU . 8.5 m -108.78 123.35 48.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.603 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.667 HD13 HG22 ' A' ' 144' ' ' ILE . 3.2 mp -122.43 130.25 52.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.287 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -103.26 108.17 19.28 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.523 HG22 ' CG1' ' A' ' 117' ' ' ILE . 6.1 t -133.0 158.36 43.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.168 0.509 . . . . 0.0 112.271 -178.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.452 ' N ' HG12 ' A' ' 148' ' ' VAL . 53.1 mt -125.39 124.25 25.13 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.457 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.52 132.79 24.47 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.502 2.135 . . . . 0.0 112.515 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -103.93 128.05 51.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.694 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 64.21 129.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.86 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.904 -179.965 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 36.7 ttt-85 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.817 0.341 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.3 167.75 10.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.822 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . 0.429 ' HA ' ' HB3' ' A' ' 87' ' ' LYS . 6.7 pt-20 -164.72 137.56 4.74 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.35 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 126' ' ' TYR . . . . . 0.511 ' CE1' HG21 ' A' ' 130' ' ' VAL . 26.0 m-85 -121.27 134.73 55.18 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.146 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 96.0 m -106.16 115.9 31.02 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.609 ' N ' HD13 ' B' ' 128' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.234 -0.888 . . . . 0.0 111.523 -177.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 69' ' ' VAL . 11.1 p . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.854 0.359 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.5 mtt85 -118.6 125.4 49.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.89 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.437 HD11 ' HE3' ' A' ' 147' ' ' LYS . 0.2 OUTLIER -98.99 99.45 10.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.849 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.523 HG21 ' OG ' ' A' ' 110' ' ' SER . 32.6 mt -93.95 143.26 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.831 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -132.25 123.19 26.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.909 0.385 . . . . 0.0 111.194 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.807 ' CE1' HD12 ' A' ' 144' ' ' ILE . 42.0 p90 -143.53 130.55 20.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.52 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 143' ' ' MET . 1.9 pt-20 -80.32 141.09 35.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.369 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -129.08 111.12 12.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.442 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -112.01 -25.29 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.419 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.45 154.22 19.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.282 -179.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -90.89 88.93 7.24 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.251 0.548 . . . . 0.0 110.607 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -166.2 146.15 5.23 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.978 -179.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -51.55 151.43 14.16 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.497 2.131 . . . . 0.0 112.275 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -56.89 -41.5 78.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.401 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 120.11 28.22 1.88 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.619 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.559 HG23 ' HB ' ' A' ' 105' ' ' ILE . 16.2 pt -147.8 168.36 4.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.876 0.369 . . . . 0.0 111.004 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.492 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -131.49 126.77 35.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.746 179.519 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.75 ' CD2' HD13 ' A' ' 117' ' ' ILE . 0.6 OUTLIER -127.9 159.5 34.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.809 -179.337 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.476 ' C ' HD13 ' A' ' 88' ' ' LEU . 1.8 pttp -136.22 152.37 50.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.527 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.882 HD12 HG11 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -95.46 102.95 14.79 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.304 179.148 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -65.8 176.52 1.56 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.639 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -52.1 -24.6 7.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.873 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.45 2.04 46.2 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.574 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 59.98 80.59 0.2 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.744 0.307 . . . . 0.0 110.529 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.565 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 2.7 m -158.06 139.06 13.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.659 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.877 ' HB2' HD11 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -87.55 111.42 21.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.062 0.458 . . . . 0.0 111.394 -179.372 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 115' ' ' ASP . 6.3 m -126.18 129.41 48.96 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.363 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.893 HG13 ' H ' ' A' ' 114' ' ' GLY . 4.0 p -58.84 106.08 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.233 0.539 . . . . 0.0 110.801 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -75.71 -21.82 57.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.311 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.8 mtp85 -171.67 133.83 0.79 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.765 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.844 HD13 HG21 ' A' ' 96' ' ' VAL . 26.9 mm -86.13 103.88 13.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.86 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.0 mp -58.76 138.65 57.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.011 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -79.76 137.25 36.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.935 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.88 -23.85 32.45 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.638 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.401 ' HA3' ' HA3' ' A' ' 83' ' ' GLY . . . -58.13 176.27 1.98 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.625 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 31.3 ttp -78.33 -33.56 49.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.822 0.344 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.566 HG23 ' HB3' ' A' ' 110' ' ' SER . 40.1 mm -72.36 -35.86 53.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -77.45 -41.86 38.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.657 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.7 ttt85 -72.15 -41.59 66.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.705 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.49 -44.77 14.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.755 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.52 79.87 1.4 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.559 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.566 ' HB3' HG23 ' A' ' 105' ' ' ILE . 9.6 t -117.6 -32.41 4.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.713 0.292 . . . . 0.0 111.192 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 1.031 HD11 HG21 ' A' ' 148' ' ' VAL . 0.3 OUTLIER -138.68 172.59 12.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.84 0.352 . . . . 0.0 111.029 -179.906 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -137.75 140.58 40.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.849 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.561 ' O ' HG13 ' A' ' 113' ' ' VAL . 9.2 p -43.59 113.56 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.702 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.893 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 119.0 -28.36 6.67 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.504 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.565 ' HB3' HG11 ' A' ' 148' ' ' VAL . 0.7 OUTLIER -50.02 131.91 23.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.735 0.302 . . . . 0.0 110.785 179.851 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.491 ' HA ' HG23 ' A' ' 95' ' ' THR . 1.4 tp10 -95.11 109.6 21.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.648 -179.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.75 HD13 ' CD2' ' A' ' 86' ' ' LEU . 3.6 mp -89.27 94.31 4.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.438 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.952 HD23 HD12 ' A' ' 149' ' ' ILE . 4.0 mm? -65.69 -26.86 67.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.465 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -135.49 130.07 34.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.867 0.365 . . . . 0.0 111.31 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.877 HD11 ' HB2' ' A' ' 94' ' ' CYS . 7.1 mt -112.48 98.8 7.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.719 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.9 t30 61.76 27.69 16.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.664 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 96.13 -2.18 63.41 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.814 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 27.9 m -133.63 127.54 33.2 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.854 0.359 . . . . 0.0 111.275 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -85.04 121.39 27.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.59 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.882 HG11 HD12 ' A' ' 88' ' ' LEU . 14.0 p -50.6 141.59 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.259 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 40.8 p -108.99 151.79 25.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.913 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -59.69 -25.36 64.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.006 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -59.26 -105.7 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.398 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 28.8 t -109.15 133.7 52.68 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.963 0.411 . . . . 0.0 110.848 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.717 HG13 ' CG2' ' A' ' 125' ' ' VAL . 0.9 OUTLIER -89.62 -20.47 7.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.185 179.508 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -43.68 -27.68 0.34 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.248 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -62.83 -43.85 97.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.432 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.513 HD22 ' N ' ' A' ' 133' ' ' LEU . 3.2 mm? -83.85 -43.14 15.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.62 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -59.35 -49.21 78.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.448 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -68.71 -46.45 68.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.796 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.4 ' O ' ' HB ' ' A' ' 140' ' ' THR . . . -66.36 -28.9 69.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.275 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 8.7 mmt -72.3 -36.92 69.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.168 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.3 pttt -90.61 -21.56 21.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.428 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -90.97 -16.99 27.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.554 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.4 ' HB ' ' O ' ' A' ' 136' ' ' ALA . 9.7 t -76.5 156.94 32.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.963 0.411 . . . . 0.0 111.082 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -143.81 120.88 11.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.716 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 134.71 -160.28 24.2 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.603 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.405 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 60.1 mmm -77.28 111.55 13.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.786 0.327 . . . . 0.0 111.129 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.807 HD12 ' CE1' ' A' ' 74' ' ' PHE . 22.9 mt -85.93 140.28 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.998 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.4 m -108.47 117.33 33.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.486 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.744 HD23 ' CE2' ' A' ' 74' ' ' PHE . 3.3 mm? -120.18 119.08 32.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.208 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.437 ' HE3' HD11 ' A' ' 71' ' ' LEU . 1.8 mptt -95.64 105.29 17.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.774 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 1.031 HG21 HD11 ' A' ' 111' ' ' LEU . 2.7 t -118.62 154.46 20.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.808 -178.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.952 HD12 HD23 ' A' ' 118' ' ' LEU . 8.3 mt -130.76 134.19 25.71 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.596 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.55 122.64 11.64 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.453 2.102 . . . . 0.0 112.332 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 39.9 p30 -58.15 146.95 31.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.95 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 62.05 97.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.872 179.951 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.842 0.353 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 0.1 OUTLIER -126.64 164.83 20.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.734 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.67 130.95 25.02 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 121.243 0.544 . . . . 0.0 110.058 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 126' ' ' TYR . . . . . 0.64 ' CE1' HG21 ' A' ' 130' ' ' VAL . 5.2 m-85 -115.69 151.0 35.89 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.3 -0.863 . . . . 0.0 112.098 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 1.2 m -110.31 116.12 30.9 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 176.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.518 HD11 HD13 ' A' ' 86' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.236 -0.888 . . . . 0.0 111.512 -177.62 . . . . . . . . 2 2 . 1 stop_ save_